Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cellular potassium ion homeostasis (GO:0030007),-0.7593177525398522,-1.95021800850418,0.003105590062111801,0.1562967318939688,0.149,9/13,23.21%,ATP1B3;ATP1B1;ATP1A1;ATP1A2;KCNJ2;ATP1A3;KCNMA1;SLC12A2;ATP1B2
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.7929771110194758,-1.9444933303094651,0.0,0.08500348576689531,0.163,11/13,17.67%,CNOT1;CNOT7;PRR5L;PNPT1;MOV10;GTPBP1;NUDT21;CNOT8;ZC3HAV1;UPF1;ZC3H12A
prerank,membrane repolarization (GO:0086009),-0.7432320431632948,-1.9092655744544667,0.0,0.10145577333468153,0.271,6/15,8.31%,ATP1B3;ATP1B1;ATP1A1;ATP1A2;KCNJ2;KCND3
prerank,focal adhesion assembly (GO:0048041),-0.6476216569397886,-1.8776461559543358,0.0,0.12636270868035784,0.404,12/21,16.51%,PIP5K1A;PTPRK;SORBS1;TAOK2;TESK2;ARHGEF7;PEAK1;FERMT2;BCR;RCC2;ACTN1;WHAMM
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.9377256606329115,1.8703721833506717,0.0,0.2655836500106999,0.18,1/14,0.07%,ACE2
prerank,sterol transport (GO:0015918),0.8415126365281954,1.80767689171178,0.0,0.8003261145514745,0.662,4/19,2.58%,LCAT;CD36;LDLRAP1;OSBP
prerank,blood circulation (GO:0008015),0.7617071601186932,1.8012646770424656,0.0011049723756906078,0.624802561243121,0.719,5/49,4.50%,CXCL12;ACE2;ITGB1BP1;SGCG;MYOF
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.8575283609351237,1.7703678154032163,0.004155124653739612,0.9583994600866892,0.906,3/16,2.53%,BMP5;IGFBP3;IGFBP2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.5750270280875056,-1.7659650116745729,0.0,0.44238373237825096,0.881,8/24,10.71%,PLCG2;RYR2;PTPRC;ITPR2;ITPR1;IBTK;ERO1A;FGF2
prerank,neuromuscular junction development (GO:0007528),0.8026813759966246,1.7479932042685413,0.002574002574002574,1.0,0.968,6/24,7.47%,MUSK;LRRK2;DVL1;PPFIBP2;DCTN1;NEDD4
prerank,epidermis development (GO:0008544),0.7286554330226966,1.745606690553334,0.0,1.0,0.972,2/56,2.36%,POU2F3;FLOT2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.7975936287649966,1.7375387448149142,0.005277044854881266,1.0,0.982,1/21,0.03%,EVC
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.6672437529873871,-1.7290817964772944,0.009287925696594427,0.5680609290766178,0.967,4/14,12.91%,CSF1;TYROBP;ATP6AP1;TRAF6
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.8164504176944581,1.7285053271377715,0.0066050198150594455,1.0,0.991,4/20,1.78%,BMP5;WNT4;BRCA1;FBXW7
prerank,positive regulation of calcium ion import (GO:0090280),0.9016583746375505,1.7284912739446257,0.002861230329041488,0.9680183551031024,0.991,2/12,5.17%,CXCL12;PDGFB
prerank,pharyngeal system development (GO:0060037),0.8523949007364671,1.7229925875858405,0.006802721088435374,0.9597784521155909,0.993,4/15,4.03%,ISL1;BMP5;TGFB2;BMPR1A
prerank,positive regulation of positive chemotaxis (GO:0050927),0.8437883047514187,1.7229822725965294,0.008287292817679558,0.8727115883918034,0.993,3/15,3.19%,CXCL12;IL16;VEGFC
prerank,negative regulation of signaling receptor activity (GO:2000272),0.7847172908514869,1.7221740225646163,0.0024390243902439024,0.8115623458980811,0.994,7/25,11.44%,ACE2;TSG101;SOCS4;EPHB2;PPARG;SOCS5;CBL
prerank,development of primary male sexual characteristics (GO:0046546),0.7636635371568522,1.716667825446852,0.004634994206257242,0.8194591378584584,0.998,9/34,11.11%,WNT4;WNT2B;CSDE1;TGFB2;AR;KITLG;MAMLD1;LHFPL2;NR5A1
prerank,regulation of multicellular organism growth (GO:0040014),-0.668368783594677,-1.7129916391633953,0.0035460992907801418,0.5817058818610118,0.981,10/15,28.10%,APP;GHR;IGF1;PTCH1;PPIB;STAT5B;BBS2;STAT5A;SOD1;MBD5
prerank,modulation by host of symbiont process (GO:0051851),0.7530611881454747,1.7058209193485332,0.007352941176470588,0.9073621625090835,0.999,8/31,7.41%,POU2F3;SMARCA4;SP1;TFAP4;TARDBP;JUN;EP300;RRP1B
prerank,neuromuscular process controlling balance (GO:0050885),-0.7113228019011953,-1.703562127568991,0.003215434083601286,0.56634714912164,0.985,7/12,19.48%,PCDH15;NRXN1;CLN3;CDH23;TPP1;MYO7A;TIFAB
prerank,negative regulation by host of viral transcription (GO:0043922),0.872429761269781,1.6969755589046236,0.007530120481927711,0.9678821583595071,1.0,4/12,4.24%,POU2F3;TFAP4;TARDBP;JUN
prerank,chemokine-mediated signaling pathway (GO:0070098),0.7363792779349406,1.6959559643975124,0.0034522439585730723,0.9221370771044589,1.0,4/42,7.28%,CXCL12;CX3CL1;RBM15;CCL25
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.8138753239312604,1.6953536401648832,0.012379642365887207,0.8765462186325996,1.0,2/17,1.05%,CXCL12;PLA2G7
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.4897053300310031,-1.6947631035812092,0.0,0.5517609775048296,0.99,10/41,10.71%,PLCG2;RYR2;CACNA2D1;PTPRC;GRIN2B;ITPR2;ITPR1;IBTK;ERO1A;FGF2
prerank,positive regulation of calcium ion transport (GO:0051928),0.7388728373473785,1.692403247619451,0.00702576112412178,0.8639980921822449,1.0,4/36,5.17%,CXCL12;WFS1;CACNA1D;PDGFB
prerank,motor neuron axon guidance (GO:0008045),-0.6353361717738567,-1.6866023892197743,0.009584664536741214,0.539726433820986,0.991,10/15,28.74%,SLIT2;RAC1;TMEFF1;CHN1;EPHA4;SEMA3A;SLIT1;RHOH;RHOG;RAC2
prerank,receptor clustering (GO:0043113),0.7514712586524814,1.6864852225752613,0.014634146341463415,0.8942749866959478,1.0,6/27,7.48%,MUSK;DVL1;ITGB1BP1;FLNA;ITGA4;DLG1
prerank,neuron fate commitment (GO:0048663),0.8438479727026187,1.6824582522401577,0.009708737864077669,0.8988985077285228,1.0,1/14,0.09%,ISL1
prerank,male gonad development (GO:0008584),0.7501560356794303,1.681243346729437,0.006968641114982578,0.8696162078555482,1.0,7/34,6.87%,WNT4;WNT2B;CSDE1;TGFB2;AR;KITLG;MAMLD1
prerank,mesonephric tubule development (GO:0072164),-0.6537522398733157,-1.6812252931636107,0.0070921985815602835,0.5195765361685205,0.993,5/15,9.43%,SLIT2;SALL1;FGFR2;PKD1;NPNT
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.817291806567792,1.6811803396013039,0.0110803324099723,0.83083108973627,1.0,1/16,0.05%,CXCL12
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.8318893840061309,1.6748203055043198,0.01276595744680851,0.870163955628703,1.0,1/15,0.08%,LCAT
prerank,cholesterol homeostasis (GO:0042632),0.6906270467188238,1.6732940069044062,0.0032119914346895075,0.8515275778468065,1.0,11/64,9.50%,LCAT;RORA;INSIG1;LDLRAP1;EHD1;SOAT1;HDAC9;LRP5;TTC39B;IL18;ABCG1
prerank,postsynaptic membrane organization (GO:0001941),0.8168193676315909,1.6732328914105432,0.009602194787379973,0.8183245142175843,1.0,1/17,0.01%,MUSK
prerank,antibacterial humoral response (GO:0019731),0.8050840825444919,1.6714264754170856,0.00980392156862745,0.8065728305798326,1.0,3/16,4.23%,ANG;RNASE6;PLA2G6
prerank,regulation of blood circulation (GO:1903522),0.7343815606055594,1.6664836488976855,0.007211538461538462,0.8276222119136855,1.0,3/34,8.39%,ACE2;TPM1;CAMK2D
prerank,Golgi inheritance (GO:0048313),-0.6785883361099758,-1.6638649350665322,0.008928571428571428,0.5656997211386484,0.999,8/11,20.37%,STX5;GBF1;VRK1;PDCD10;GOLGA2;STK25;PLK3;YWHAZ
prerank,cholesterol transport (GO:0030301),0.7003974700745763,1.6638030051610404,0.012387387387387387,0.8258630039755802,1.0,14/45,14.68%,LCAT;CD36;LDLRAP1;OSBP;VPS4A;SOAT1;CEL;ABCA7;STARD5;ABCG1;RELCH;ABCA1;LIMA1;ABCA5
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.6931162064743625,1.662589719458613,0.0021008403361344537,0.8081985211532506,1.0,19/72,14.08%,FGF22;FGF18;POLR2D;HNRNPM;FGF1;GRB2;POLR2A;MAPK1;SPRED2;FLRT2;GALNT3;KIF16B;SETX;CBL;GTF2F2;FRS2;SPRED1;HNRNPH1;SHOC2
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.7384026040317848,1.660807800952197,0.011138613861386138,0.8010070982694506,1.0,3/29,3.74%,CXCL12;PLA2G7;GAS6
prerank,negative regulation of interferon-beta production (GO:0032688),-0.7193308897321019,-1.656888378467868,0.00804289544235925,0.5582528345650528,0.999,7/10,14.23%,REL;PTPRS;RELB;NLRC3;PYCARD;SIRPA;LILRB1
prerank,sensory perception of chemical stimulus (GO:0007606),0.8231583003839893,1.6567297417171427,0.007102272727272727,0.8158294777437864,1.0,4/15,3.53%,C5AR1;CD36;ADCY3;BBS4
prerank,vascular process in circulatory system (GO:0003018),0.843582640479054,1.6562551501451026,0.010218978102189781,0.7716474138830698,1.0,2/13,3.16%,ACE2;ITGB1BP1
prerank,regulation of tube diameter (GO:0035296),0.843582640479054,1.6562551501451026,0.010218978102189781,0.7716474138830698,1.0,2/13,3.16%,ACE2;ITGB1BP1
prerank,regulation of transmembrane transport (GO:0034762),0.7396882121515107,1.649567653033821,0.008225616921269096,0.813875687645912,1.0,4/31,7.47%,ACE2;KCNJ6;PRKCB;NEDD4
prerank,sterol homeostasis (GO:0055092),0.6808973111532073,1.6485460193928327,0.004291845493562232,0.801829142900436,1.0,16/65,15.44%,LCAT;RORA;INSIG1;LDLRAP1;EHD1;SOAT1;HDAC9;LRP5;TTC39B;IL18;ABCG1;ABCA1;ABCD1;LIMA1;ABCA5;GRAMD1B
prerank,heart trabecula morphogenesis (GO:0061384),0.788701912821471,1.647510641766141,0.013422818791946308,0.7894020007422737,1.0,4/18,4.03%,BMP5;S1PR1;TGFB2;BMPR1A
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.7688567214228972,1.6467522001947343,0.015544041450777202,0.7750791033316424,1.0,2/22,4.00%,ALDH1A2;VKORC1L1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.7935306039462195,1.6462515021788433,0.02200825309491059,0.759574615217849,1.0,3/16,3.64%,WNT4;RGCC;RUNX1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.856916227365569,1.642379348409347,0.011922503725782414,0.7733355868063042,1.0,3/11,6.15%,CXCL12;GAS6;AXL
prerank,positive regulation of T cell migration (GO:2000406),0.7643606237322231,1.6409952068587583,0.027237354085603113,0.766157756502021,1.0,2/20,2.59%,CXCL12;DOCK8
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.8534392227638116,1.6403497339536337,0.011695906432748537,0.7530018984918756,1.0,3/11,4.03%,ISL1;TGFB2;BMPR1A
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.7510686905631497,1.6398765819641505,0.012738853503184714,0.7388673340041266,1.0,3/24,0.58%,ISL1;BRCA1;RORA
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.6764931873419523,1.6388462093463252,0.0010427528675703858,0.730830142448943,1.0,22/87,14.08%,FGF22;FGF18;POLR2D;HNRNPM;FGF1;GRB2;ITGB1BP1;POLR2A;MAPK1;SPRED2;FLRT2;GALNT3;KIF16B;CD44;SETX;CBL;GTF2F2;FRS2;ZFP36L1;SPRED1;HNRNPH1;SHOC2
prerank,pancreas development (GO:0031016),0.829154316904963,1.6373287571091713,0.025449101796407185,0.7268727344261375,1.0,1/12,0.09%,ISL1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5465248038982952,-1.635091288741258,0.021505376344086023,0.6402681911796794,1.0,16/25,28.95%,CSNK2A1;TAF1;CSNK2A2;RPL5;PML;EPHA4;RPL11;RPL23;PSME3IP1;RPS7;SGTA;PSMF1;GABARAPL2;TRIM39;PRKCG;PDCL3
prerank,reverse cholesterol transport (GO:0043691),0.82589832596674,1.6349226491235689,0.021834061135371178,0.7305366331875517,1.0,1/13,0.08%,LCAT
prerank,regulation of cytoplasmic translation (GO:2000765),-0.656812402944217,-1.6332851398451416,0.010380622837370242,0.6076378208369033,1.0,5/14,6.16%,CPEB3;DHX9;PKM;CPEB4;FMR1
prerank,negative regulation of heart contraction (GO:0045822),-0.7016197194530532,-1.6326509034929018,0.011904761904761904,0.5733165209385493,1.0,7/11,22.22%,PDE4D;PIK3CG;GRK2;ATP1A2;ZC3H12A;SRI;SPTBN4
prerank,blood vessel diameter maintenance (GO:0097746),0.7301453885904103,1.6307397801567214,0.013110846245530394,0.7490524817860309,1.0,2/34,3.16%,ACE2;ITGB1BP1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.7726215655548152,1.630180668811827,0.022636484687083888,0.7370706961098917,1.0,3/19,3.64%,WNT4;RGCC;RUNX1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.6759891028143121,1.6286912817182924,0.007829977628635347,0.7340153250135465,1.0,7/51,5.62%,CXCL12;PLA2G7;VEGFC;GAS6;THBS1;CMKLR1;MAPK1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.7391481319750306,1.6278679363789532,0.020330368487928845,0.7254561240480658,1.0,2/24,1.05%,CXCL12;PLA2G7
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.507664620275756,-1.623980367779896,0.03167420814479638,0.5872821473951915,1.0,9/26,10.71%,PLCG2;RYR2;PTPRC;ITPR2;ITPR1;SLC8B1;IBTK;ERO1A;FGF2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.7314464791692863,1.6236067986396192,0.017369727047146403,0.7440428102607455,1.0,3/26,0.58%,ISL1;BRCA1;RORA
prerank,gonad development (GO:0008406),0.7055629675842083,1.6193146667202336,0.012528473804100227,0.7646445706228122,1.0,7/41,6.87%,WNT4;WNT2B;CSDE1;TGFB2;AR;KITLG;MAMLD1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.7405901495117243,1.6173021224158475,0.02402022756005057,0.7661066827231727,1.0,1/24,0.05%,CXCL12
prerank,T cell activation involved in immune response (GO:0002286),-0.6632394267562814,-1.6138887772025439,0.018292682926829267,0.6135078345493605,1.0,6/12,19.83%,FCER1G;EIF2AK4;SLC11A1;ICAM1;LILRB1;CD74
prerank,positive regulation of collagen metabolic process (GO:0010714),0.765917424405246,1.6114543920720144,0.03485254691689008,0.7991408174197141,1.0,3/17,3.64%,WNT4;RGCC;RUNX1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.6456539627442108,-1.6098218012176635,0.01929260450160772,0.6033948624641584,1.0,6/13,16.17%,GLUD1;GLUL;ASPA;GOT1;MTHFS;GOT2
prerank,retinoic acid metabolic process (GO:0042573),0.8039474797294892,1.6096313437637568,0.015299026425591099,0.7994748849040044,1.0,1/14,0.31%,ALDH1A2
prerank,rRNA transcription (GO:0009303),0.7661688187766138,1.6078964032302534,0.026490066225165563,0.7999453827455151,1.0,4/17,1.87%,ANG;CAVIN1;SIRT7;GTF3A
prerank,glutathione metabolic process (GO:0006749),-0.4789034683601901,-1.6072851274692466,0.0,0.5856100358155897,1.0,17/38,33.06%,GCLC;CNDP2;GSR;CTNS;HAGH;GSTZ1;GCLM;GLRX2;GGT5;SOD1;GSS;ETHE1;GGT7;CHAC2;PARK7;GPX1;OPLAH
prerank,regulation of extracellular matrix organization (GO:1903053),0.7874620668157745,1.6058309643154323,0.02127659574468085,0.8028433222232793,1.0,3/15,3.64%,DDR1;DDR2;RUNX1
prerank,cell chemotaxis (GO:0060326),0.6628970376457359,1.6056476840044263,0.011827956989247311,0.7903353665837981,1.0,7/60,7.28%,CXCL12;CX3CL1;PLEKHG5;NRP1;PDGFB;ARRB2;CCL25
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.7993343694686976,1.6052761645912055,0.014347202295552367,0.7795267584067374,1.0,3/14,1.44%,SMPDL3A;AK4;AK3
prerank,mesenchyme morphogenesis (GO:0072132),0.7822083820324708,1.6036791890027486,0.020491803278688523,0.7787452788449337,1.0,4/17,6.38%,ISL1;TGFB2;BMPR1A;ACVR1
prerank,chordate embryonic development (GO:0043009),0.6674244981264935,1.6032594703346916,0.008879023307436182,0.7690008635245714,1.0,6/55,4.15%,ISL1;BMP5;ALDH1A2;BRCA1;DVL1;MBNL1
prerank,serine family amino acid biosynthetic process (GO:0009070),0.8193087715488596,1.6025787646622565,0.02608695652173913,0.7620375259165776,1.0,6/12,10.40%,CBS;SERINC5;SEPHS1;PSAT1;SERINC3;SRR
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.6190882754776078,-1.5995331288806163,0.024054982817869417,0.5971135797419544,1.0,7/15,15.31%,PRKN;OPA1;BCL2L1;IGF1;GHITM;AKT1;HGF
prerank,establishment of spindle localization (GO:0051293),0.8050038320363659,1.5989714917683189,0.027181688125894134,0.7787927503725673,1.0,4/14,3.39%,LLGL2;CFL1;KPNB1;LLGL1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.8463448718584474,1.5972044441884525,0.02127659574468085,0.7805370519850485,1.0,2/11,0.22%,BMP5;WNT4
prerank,ncRNA transcription (GO:0098781),0.7956120033587767,1.5954864391097436,0.03536067892503536,0.7807903941420334,1.0,4/13,1.87%,ANG;CAVIN1;SIRT7;GTF3A
prerank,regulation of cellular localization (GO:0060341),0.678841521088186,1.592612490905808,0.013259668508287293,0.7909521117567181,1.0,11/46,10.08%,STXBP2;LRRK2;DVL1;UNC13D;ADCY5;LRP5;HSP90AA1;REEP5;CAMK2D;LYN;EPHA5
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.8434425334028633,1.591326795178562,0.016566265060240965,0.7891363139129118,1.0,4/10,9.65%,CXCL12;GAS6;AXL;LYN
prerank,regulation of calcium ion import (GO:0090279),0.7485184312207546,1.5892986447446154,0.013613861386138614,0.7929242280945173,1.0,2/21,5.17%,CXCL12;PDGFB
prerank,positive regulation of vasculature development (GO:1904018),0.6535192508443514,1.5859914954506107,0.001034126163391934,0.8061395123203741,1.0,18/94,10.13%,FGF18;ISL1;BRCA1;VASH2;SP1;FGF1;VEGFC;RUNX1;SASH1;ADAM12;THBS1;PRKCB;PRKCA;IL1A;AGO2;ITGB8;MTDH;F3
prerank,regulation of feeding behavior (GO:0060259),-0.6746830498095024,-1.5835057367873018,0.02608695652173913,0.6570943943740061,1.0,5/11,23.32%,SGIP1;EIF2AK4;CFAP20;AGRP;STAT3
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.8019588758842998,1.5833871296643511,0.01867816091954023,0.8136423070366822,1.0,1/13,0.10%,BMP5
prerank,endocardial cushion morphogenesis (GO:0003203),0.778071831322677,1.5832132167455173,0.018842530282637954,0.8032446161999437,1.0,4/18,6.38%,ISL1;TGFB2;BMPR1A;ACVR1
prerank,positive regulation of transporter activity (GO:0032411),0.7876715750090075,1.5821009923365819,0.03125,0.800146277302009,1.0,1/13,0.11%,SGK2
prerank,regulation of endothelial cell proliferation (GO:0001936),0.6438373423225134,1.5816927997722334,0.005241090146750524,0.792253620061299,1.0,12/88,5.26%,FGF18;ANG;RGCC;VASH2;ATP5F1A;NRAS;VEGFC;NF1;THBS1;NRP1;PDGFB;PRKCA
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.6899721163249213,1.5815023611172607,0.026347305389221556,0.783037990231758,1.0,9/32,10.80%,PLK1;BRCA1;BLM;CDK5RAP3;MRE11;NBN;BABAM2;TAOK1;FOXN3
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.7084883990224242,1.5786872533828518,0.01982651796778191,0.7929963371005555,1.0,3/29,4.91%,ISL1;S1PR1;TPM1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.5844052029667077,-1.5782018967918883,0.023166023166023165,0.6569787876102448,1.0,5/16,14.23%,FCGR2B;VSIR;TYROBP;CD274;LILRB1
prerank,L-serine metabolic process (GO:0006563),0.8301259405774779,1.577490491980545,0.0382262996941896,0.7919840640062666,1.0,5/10,10.40%,CBS;SERINC5;PSAT1;SERINC3;SRR
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.6933378823741696,-1.5774831040420298,0.02881844380403458,0.6331845673657713,1.0,3/10,1.98%,ANO6;RAB31;APPL2
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.6837862249448076,-1.5769938882788923,0.014124293785310734,0.6102701868477493,1.0,6/11,17.06%,RAPGEF6;TJP1;F11R;TJP2;RAP2C;RAP2B
prerank,regulation of T cell migration (GO:2000404),0.7404439223472504,1.5765633883214538,0.04423592493297587,0.7885925858845038,1.0,2/18,2.59%,CXCL12;DOCK8
prerank,metanephric mesenchyme development (GO:0072075),0.836821673046725,1.5754993837543554,0.018867924528301886,0.785846366600092,1.0,1/10,0.22%,WNT4
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.7747096317835223,1.574152772299701,0.02575107296137339,0.786771919395603,1.0,1/15,0.08%,FGF18
prerank,positive regulation of lymphocyte migration (GO:2000403),0.8001208889352207,1.5731019970216726,0.028901734104046242,0.7838725997199937,1.0,2/12,2.59%,CXCL12;DOCK8
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.6668161137941392,1.5715802481553436,0.02,0.7850933600099955,1.0,15/49,12.31%,ISL1;PRKCZ;RIOK3;SMAD6;PMEPA1;IMPACT;EP300;PYDC1;LDLRAD4;CDC42;PPM1A;HMGB1;RAF1;AIDA;SORL1
prerank,cellular response to heat (GO:0034605),0.693495104788928,1.5710477221780965,0.025059665871121718,0.7792723679373785,1.0,11/35,7.60%,POLR2D;HSBP1;FGF1;BAG3;HIKESHI;THBS1;YWHAE;PRKACA;IL1A;HSP90AA1;MAPT
prerank,positive regulation of cellular senescence (GO:2000774),-0.6826955840847927,-1.5688134097143545,0.016304347826086956,0.6282453656493739,1.0,5/10,14.18%,B2M;ABI3;YPEL3;SIRT1;CGAS
prerank,response to chemokine (GO:1990868),0.7974702612828075,1.568184003043292,0.030882352941176472,0.790559811474158,1.0,2/13,2.59%,CXCL12;DOCK8
prerank,regulation of vasoconstriction (GO:0019229),0.7039036087372305,1.5675539627068205,0.02236024844720497,0.7851824314496132,1.0,1/27,0.07%,ACE2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.7444639059531921,1.566521582498462,0.02361111111111111,0.7833744841432824,1.0,4/18,5.09%,RGCC;DDR2;RUNX1;SMAD3
prerank,male meiosis I (GO:0007141),-0.5943816265576047,-1.5656284829755671,0.03180212014134275,0.6201429134861631,1.0,5/16,18.18%,FOXJ3;FOXJ2;BRDT;ZSCAN21;ING2
prerank,endocardial cushion development (GO:0003197),0.749044352629106,1.5650010506238579,0.02457956015523933,0.7843971042306971,1.0,4/21,6.38%,ISL1;TGFB2;BMPR1A;ACVR1
prerank,cellular response to chemokine (GO:1990869),0.6720533293351822,1.5601502067276178,0.022779043280182234,0.8097688248268996,1.0,3/46,2.59%,CXCL12;CX3CL1;DOCK8
prerank,positive regulation of embryonic development (GO:0040019),0.7399347338416234,1.556823691031801,0.03875968992248062,0.8257866868347726,1.0,5/19,11.33%,WNT4;CFL1;TENM4;B4GALT5;NR2C2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.7461685652690473,1.5563968108942499,0.022636484687083888,0.8196412890977073,1.0,4/18,6.35%,ISL1;KLF9;BCL2L11;NR3C1
prerank,regulation of developmental growth (GO:0048638),0.6966395504537,1.5552902730933729,0.024096385542168676,0.8183052324314123,1.0,2/29,3.85%,MUSK;OLFM1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.6445791758254082,1.5549687132878918,0.02097130242825607,0.811585045355347,1.0,13/55,13.46%,ACE2;EIF6;BRCA1;PID1;GRB2;THBS1;PDGFB;ALOX5;TGFBR2;PARL;MAPK14;TP53;COQ7
prerank,potassium ion homeostasis (GO:0055075),-0.5065163579236172,-1.5544019190934197,0.02252252252252252,0.652346259433808,1.0,7/23,8.21%,ATP1B3;ATP1B1;ATP1A1;ATP1A2;KCNJ2;SLC12A9;ATP1A3
prerank,homologous chromosome segregation (GO:0045143),0.7446608581131663,1.5542321655175342,0.034974093264248704,0.8077065562201996,1.0,2/20,1.00%,MAJIN;SIRT7
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.6874301940784584,1.551877857878061,0.029904306220095694,0.8166697237829023,1.0,2/32,0.81%,ANG;RNASE6
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.6601571723343388,-1.5483781779342887,0.03225806451612903,0.6603292659630048,1.0,8/11,31.86%,PRKN;NONO;FBXO7;RACK1;REST;ATF4;PINK1;PARK7
prerank,response to copper ion (GO:0046688),0.7231287987696396,1.547386404720799,0.03851444291609354,0.8414981704681457,1.0,10/20,11.35%,IL1A;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;PRNP
prerank,cranial nerve development (GO:0021545),0.8051948576415202,1.5463250242566091,0.022321428571428572,0.840054994438509,1.0,2/11,1.97%,ISL1;TMEM126A
prerank,detection of calcium ion (GO:0005513),-0.632493687606903,-1.5410162361828728,0.02464788732394366,0.6771944366095994,1.0,4/13,1.83%,RYR2;STIM1;CALM2;SYT1
prerank,DNA double-strand break processing (GO:0000729),0.738398528194286,1.5407330082729036,0.03021978021978022,0.8717595145047573,1.0,8/18,9.23%,BRCA1;BLM;RAD50;UBE2V2;RBBP8;MRE11;NBN;EXD2
prerank,cellular response to glucagon stimulus (GO:0071377),0.7455516750689736,1.539085873117709,0.039030955585464336,0.8751066390817309,1.0,6/17,7.05%,ADCY8;ADCY3;PRKAR2A;ADCY5;PRKACA;ADCY9
prerank,negative regulation of histone modification (GO:0031057),0.7594935274752893,1.5357659494966858,0.03541076487252125,0.8915902185490054,1.0,5/14,10.74%,BRCA1;THAP7;SET;CTBP1;NOC2L
prerank,serine family amino acid catabolic process (GO:0009071),0.801771216646555,1.5342660519504971,0.03129657228017884,0.8934471635779891,1.0,1/10,0.33%,CBS
prerank,secondary alcohol metabolic process (GO:1902652),0.6595664722108829,1.5331749201442961,0.03644646924829157,0.8923466189267825,1.0,11/42,14.68%,LCAT;GBA2;LDLRAP1;SOAT1;ABCG1;IDH2;ABCA1;RXRA;PPARD;OSBPL1A;ABCA5
prerank,sensory perception of smell (GO:0007608),0.7879724776368372,1.5313107401905592,0.03759398496240601,0.8969883483995997,1.0,2/11,3.53%,ADCY3;BBS4
prerank,muscle organ development (GO:0007517),0.6309086487142475,1.530401391305746,0.02224694104560623,0.8956621494648739,1.0,6/54,10.73%,EVC;CHODL;SGCG;MEF2A;TCF12;FKTN
prerank,establishment of spindle orientation (GO:0051294),0.6808032499160188,1.5302472042831994,0.0389768574908648,0.8881730141703983,1.0,6/28,11.05%,PLK1;LLGL2;NDEL1;LLGL1;DCTN1;FBXW11
prerank,regulation of presynapse assembly (GO:1905606),-0.5738269669482087,-1.5299242600134215,0.022813688212927757,0.6961374177119533,1.0,5/18,3.90%,IL1RAPL1;APP;LRFN5;EIF4G1;IL1RAPL2
prerank,regulation of presynapse organization (GO:0099174),-0.5738269669482087,-1.5299242600134215,0.022813688212927757,0.6961374177119533,1.0,5/18,3.90%,IL1RAPL1;APP;LRFN5;EIF4G1;IL1RAPL2
prerank,atrial septum development (GO:0003283),0.7805669918037821,1.529384983762129,0.036211699164345405,0.885758166568546,1.0,3/13,3.69%,ISL1;DAND5;TGFB2
prerank,negative regulation of intracellular protein transport (GO:0090317),0.7159109549652927,1.5278887866873447,0.0438489646772229,0.8876720982624638,1.0,5/22,3.91%,LMAN1;LRRK2;INSIG1;ITGB1BP1;GDI1
prerank,renal water homeostasis (GO:0003091),0.6971675637338776,1.5268810677919586,0.035175879396984924,0.8865435174166697,1.0,7/23,7.05%,WFS1;ADCY8;ADCY3;PRKAR2A;ADCY5;PRKACA;ADCY9
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.796258541499015,1.5268757380657239,0.03857566765578635,0.8781991724519269,1.0,3/12,11.13%,ISL1;IL18;PAEP
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.6977173120590469,1.5262465195522508,0.03878787878787879,0.8751181744367668,1.0,2/29,1.00%,MAJIN;SIRT7
prerank,cell differentiation in spinal cord (GO:0021515),0.8060140613872065,1.5260355559781866,0.03343949044585987,0.868519067421031,1.0,2/10,2.70%,ISL1;SOX13
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.8238307527877304,1.5259976634704406,0.030349013657056147,0.8529599651899585,1.0,1/10,4.37%,CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.8238307527877304,1.5259976634704406,0.030349013657056147,0.8529599651899585,1.0,1/10,4.37%,CEP250
prerank,leukotriene biosynthetic process (GO:0019370),0.7603907270883934,1.5259437493537147,0.04505813953488372,0.8456621454516031,1.0,4/14,8.47%,GGTA1;MGST3;PLA2G4A;ALOX5
prerank,positive regulation of insulin secretion (GO:0032024),0.664971131663796,1.525371022133874,0.040183696900114814,0.8420698084422359,1.0,10/36,12.47%,ISL1;ADCY8;NNAT;PSMD9;PLA2G6;IRS2;TRPM4;TM7SF3;GCK;TCF7L2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.7065352687407066,1.5250619307789604,0.041666666666666664,0.8369229629881089,1.0,3/23,4.91%,ISL1;HOPX;TPM1
prerank,monoacylglycerol metabolic process (GO:0046462),0.7567581404455835,1.5233959807120412,0.047895500725689405,0.8405399951603821,1.0,4/13,10.19%,MOGAT3;ABHD6;PLA2G4A;ABHD16A
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.5263030999562713,-1.5230843247096046,0.049019607843137254,0.7130432510860062,1.0,6/23,9.85%,TGFB1;MAML1;AKAP6;ATP11A;NIBAN2;IGF1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.6591813036128363,1.5230205754122323,0.028768699654775604,0.8354426684082406,1.0,6/38,8.61%,ISL1;CACNA1D;AKAP9;YWHAE;CAMK2D;TRPM4
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.6646434356011318,1.5223426774231719,0.041176470588235294,0.8327227408243314,1.0,9/33,9.43%,RELA;SMARCA4;TGFB2;JUN;SMAD3;PDGFB;TEAD1;NR3C1;PPARG
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.7673697724879075,1.5220973053597484,0.045584045584045586,0.827299181175671,1.0,4/14,14.08%,ISL1;IL18;PAEP;CD84
prerank,cellular response to copper ion (GO:0071280),0.7330451228617424,1.5219257671478315,0.04630969609261939,0.8214308387602779,1.0,9/16,11.35%,MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;PRNP
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.7077230406519276,1.521307211156899,0.045133991537376586,0.8189487302172215,1.0,11/18,17.42%,CTSC;MSN;HSP90AA1;EZR;PTTG1IP;VPS35;FAF1;VPS11;CD81;RDX;VGLL4
prerank,negative regulation of leukocyte migration (GO:0002686),0.8004472881006303,1.5201025990980086,0.05082212257100149,0.820330011267024,1.0,1/10,0.10%,BMP5
prerank,cardiac atrium morphogenesis (GO:0003209),0.7463688405980528,1.5190217556853964,0.033921302578018994,0.8209962215778953,1.0,2/16,3.69%,ISL1;TGFB2
prerank,response to purine-containing compound (GO:0014074),-0.5580755264538907,-1.5186761389386743,0.031578947368421054,0.7170455331626815,1.0,3/17,1.85%,RYR2;P2RX7;NDUFS4
prerank,spliceosomal snRNP assembly (GO:0000387),0.6501879779178962,1.5183423638858653,0.028604118993135013,0.8190224667101723,1.0,9/38,9.48%,SNRPD2;SNRPD1;GEMIN8;SART1;PRPF3;GEMIN2;TGS1;PRPF6;SNRPD3
prerank,modulation by host of viral genome replication (GO:0044827),-0.614478303165355,-1.5159307270038265,0.03353658536585366,0.7123579369429711,1.0,11/13,24.56%,PRKN;EIF2AK4;FMR1;NUCKS1;TBC1D20;ZC3H12A;CCNK;PPIB;VAPA;FBXL2;IFI27
prerank,platelet degranulation (GO:0002576),0.6136416818875521,1.5145391167296829,0.004081632653061225,0.8381913006747949,1.0,27/118,12.08%,STXBP2;HABP4;VCL;FAM3C;CD36;ENDOD1;SELENOP;VEGFC;TGFB2;GAS6;SCG3;THBS1;FLNA;ALDOA;PDGFB;QSOX1;FERMT3;LHFPL2;PHACTR2;F13A1;LYN;CD63;ACTN4;CYRIB;TMSB4X;APOOL;WDR1
prerank,negative regulation by host of viral process (GO:0044793),-0.6688717405879201,-1.5142945368728344,0.034031413612565446,0.7009740855848905,1.0,6/10,25.76%,PRKN;EIF2AK4;ZC3H12A;CCNK;VAPA;PSMC3
prerank,DNA replication initiation (GO:0006270),0.6632614244361952,1.513952619564365,0.04540162980209546,0.8356082104880697,1.0,9/37,9.38%,POLE4;POLE2;ORC4;POLA1;CDK2;NOC3L;POLA2;PRIM2;ORC2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.6295014808957693,1.5119867197311692,0.026373626373626374,0.8422842453508572,1.0,15/54,13.90%,FGF18;RGCC;ATP5F1A;SP1;NF1;THBS1;PDGFB;PRKCA;MECP2;PPARG;TMSB4X;HMGB1;MAPK14;NUS1;PRKD2
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.7392500714789826,1.5112102576847932,0.03523035230352303,0.8406662928925382,1.0,3/15,6.35%,ISL1;BCL2L11;NR3C1
prerank,DNA strand elongation (GO:0022616),0.7111902987788077,1.511109384480725,0.05100671140939597,0.8348431416266084,1.0,5/18,8.15%,RAD50;POLA1;POLD3;MRE11;NBN
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.682620227672358,1.5103931436208116,0.03575685339690107,0.8333564849659663,1.0,3/28,2.93%,CXCL12;GBA2;PLEKHG2
prerank,negative regulation of histone acetylation (GO:0035067),0.7823799682986814,1.509984920714683,0.030911901081916538,0.8295965368014611,1.0,5/11,10.74%,BRCA1;THAP7;SET;CTBP1;NOC2L
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.6692235215235521,1.5072955317588077,0.04808877928483354,0.8412637126744256,1.0,4/30,9.66%,CXCL12;PTTG1IP;THOC5;CD44
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.5447294465257589,-1.505852827929371,0.043668122270742356,0.7271861698692524,1.0,12/20,27.12%,BCL2L1;APPL1;GSK3B;MCL1;DCC;BAX;CASP9;CASP2;GSK3A;CASP3;ITGAV;BCL2L2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.7173915265480421,1.5058129116133552,0.027247956403269755,0.8452203560352268,1.0,9/18,12.69%,CDK5RAP3;MSN;NELL1;HSP90AA1;EZR;PTTG1IP;VPS35;FAF1;VPS11
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.7867349998056924,1.505456616770283,0.049079754601226995,0.8413321682055158,1.0,1/10,0.10%,BMP5
prerank,neurotransmitter uptake (GO:0001504),-0.6406430012919402,-1.5051234175581034,0.03194888178913738,0.7119462861387478,1.0,3/12,6.97%,SNAP25;GLUL;ATP1A2
prerank,regulation of dendritic spine development (GO:0060998),-0.5488048299946843,-1.5035518667391998,0.06374501992031872,0.7017767791022647,1.0,6/19,8.27%,CPEB3;PPFIA2;GRIN3A;FMR1;PTPRS;KIF1A
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.7735494456300952,1.5021954699694424,0.04984894259818731,0.857386661912796,1.0,2/11,9.50%,PLA2G7;ABCG1
prerank,regulation of mast cell degranulation (GO:0043304),0.7655979475649277,1.5020686615002379,0.04160688665710186,0.8518572705237,1.0,2/14,2.71%,STXBP2;UNC13D
prerank,sterol metabolic process (GO:0016125),0.6306372116830822,1.5016642836446676,0.03027027027027027,0.8481349547962781,1.0,13/60,14.68%,LCAT;INSIG1;GBA2;LDLRAP1;INSIG2;SOAT1;LIPA;ABCG1;ABCA1;RXRA;PPARD;OSBPL1A;ABCA5
prerank,sensory perception of taste (GO:0050909),0.8018321695520416,1.5004349594754292,0.0514820592823713,0.850611254167471,1.0,1/10,1.63%,CD36
prerank,negative regulation of DNA binding (GO:0043392),0.6789062213406736,1.4994516819205777,0.047503045066991476,0.8510457321594977,1.0,6/28,7.33%,MDFI;HABP4;TFAP4;JUN;ILRUN;SUMO3
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.7138507669079143,1.49747792307057,0.04909560723514212,0.8583577705181381,1.0,4/20,11.56%,WNT4;EP300;NCOR1;GCK
prerank,regulation of epithelial cell proliferation (GO:0050678),0.6132041745930893,1.4974602522754314,0.01981230448383733,0.852263370955753,1.0,16/85,12.68%,FGF18;BMP5;C5AR1;FGF1;NUPR1;TGFB2;PRKDC;SGPP2;CDK6;DUSP10;LIMS1;DEAF1;LAMC1;ZFP36L1;TCF7L2;TGFA
prerank,outflow tract septum morphogenesis (GO:0003148),0.6999820753222963,1.4958187393942919,0.04466501240694789,0.8571128603765645,1.0,6/24,6.38%,ISL1;SMAD6;TGFB2;BMPR1A;NRP1;ACVR1
prerank,positive regulation of translational initiation (GO:0045948),0.7140985157444076,1.4951823725437379,0.052083333333333336,0.8553372833009631,1.0,3/18,1.67%,POLR2D;HABP4;RPS6KB2
prerank,"base-excision repair, gap-filling (GO:0006287)",0.6586659201537389,1.494819113038377,0.04523809523809524,0.8518315027984034,1.0,6/35,6.74%,POLG;MPG;RFC2;PARG;POLD3;POLB
prerank,negative regulation of centrosome duplication (GO:0010826),0.754007335817821,1.493661717984838,0.05214723926380368,0.8533392683587475,1.0,3/11,3.49%,BRCA1;TMEM67;MDM1
prerank,maturation of 5.8S rRNA (GO:0000460),0.7342083194655341,1.4923550048148337,0.05787348586810229,0.8561951537471015,1.0,4/17,5.51%,EIF6;C1D;MPHOSPH6;PRKDC
prerank,nucleocytoplasmic transport (GO:0006913),0.6348448136414401,1.4919818069204187,0.05005688282138794,0.8527630349454969,1.0,10/40,9.48%,SNRPD2;SNRPD1;GEMIN8;PHAX;ATXN1;NUP205;GEMIN2;RGS14;NUP98;SNRPD3
prerank,peptidyl-proline hydroxylation (GO:0019511),0.764878286829223,1.4904438698152958,0.0689149560117302,0.8571299516019716,1.0,6/11,12.46%,CRTAP;P4HTM;EGLN3;EGLN2;EGLN1;P4HA1
prerank,ovarian follicle development (GO:0001541),0.7437479909879131,1.488462891030011,0.06528189910979229,0.8640919011638029,1.0,1/13,0.24%,ANG
prerank,positive regulation of cell aging (GO:0090343),-0.6312970875181526,-1.486924867912557,0.031791907514450865,0.7725948541033596,1.0,5/11,14.18%,B2M;ABI3;YPEL3;SIRT1;CGAS
prerank,regulation of phospholipase activity (GO:0010517),-0.6606192501149124,-1.4865720927628843,0.05093833780160858,0.755668281416326,1.0,4/10,11.79%,FGFR2;SNCA;RGS2;PDPK1
prerank,positive regulation of angiogenesis (GO:0045766),0.6063237236140879,1.4864813725360184,0.007164790174002047,0.8719053254210424,1.0,18/108,10.13%,FGF18;ISL1;BRCA1;VASH2;SP1;FGF1;VEGFC;RUNX1;SASH1;ADAM12;THBS1;PRKCB;PRKCA;IL1A;AGO2;ITGB8;MTDH;F3
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.7885488939122481,1.4863025768037923,0.04566929133858268,0.8672121982202766,1.0,5/10,8.59%,DNAJB1;BAG3;IMPACT;JUN;NCK1
prerank,response to estrogen (GO:0043627),0.6642439853606741,1.483797320234279,0.037897310513447434,0.878244271562306,1.0,6/31,6.00%,BRCA1;PELP1;AR;WBP2;EP300;ESR1
prerank,sodium ion import across plasma membrane (GO:0098719),0.7232289493748822,1.4828836087661372,0.07267833109017496,0.8788884100022963,1.0,5/17,8.80%,SLC9A9;SLC9A1;TRPM4;SLC9A7;SLC9A6
prerank,DNA replication (GO:0006260),0.5975856156741951,1.4822748003326236,0.010256410256410256,0.8772727945267406,1.0,21/105,9.38%,POLG;BRCA1;PCLAF;BLM;RFC2;POLE2;RNASEH2A;RAD50;ORC4;POLA1;WRN;CDK2;CDK2AP1;POLA2;POLG2;POLB;RBBP8;MRE11;NBN;SET;ORC2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.7831756284925896,1.4809918043193393,0.043010752688172046,0.880284952770508,1.0,5/10,10.74%,BRCA1;THAP7;SET;CTBP1;NOC2L
prerank,cAMP biosynthetic process (GO:0006171),0.788776622391933,1.4797212019381027,0.05555555555555555,0.883112066993621,1.0,4/10,7.05%,ADCY8;ADCY3;ADCY5;ADCY9
prerank,myotube cell development (GO:0014904),0.7908191122801689,1.4790196982996588,0.05426356589147287,0.8817245377054983,1.0,1/10,0.70%,SELENON
prerank,skeletal muscle tissue development (GO:0007519),0.6530288325552499,1.4788680400252505,0.050647820965842166,0.8772052475587632,1.0,6/32,16.32%,SELENON;SVIL;LEMD2;ZBTB18;MEF2C;CFLAR
prerank,response to interleukin-6 (GO:0070741),0.7833933167599072,1.4788292829067493,0.06086956521739131,0.8718521766875016,1.0,3/10,8.51%,RELA;PID1;PTPRT
prerank,lymphocyte migration (GO:0072676),0.6610290197212455,1.4785960385630306,0.053763440860215055,0.8677628977370055,1.0,5/32,8.96%,S1PR1;CX3CL1;MSN;CCL25;MYO1G
prerank,superoxide anion generation (GO:0042554),-0.5983212218301843,-1.478500280093471,0.04451038575667656,0.7814183726144164,1.0,4/13,7.61%,NCF2;NCF1;CYBA;CYBB
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.44308538114125223,-1.4782766225551283,0.028368794326241134,0.7641811244825342,1.0,8/34,4.82%,PDE4D;RYR2;CALM2;ASB3;SMAD7;PIK3CG;ATP1B1;PDE4B
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.7719508782120098,1.477091391408975,0.05547445255474453,0.8720510458660479,1.0,5/12,8.30%,INSIG1;TAPT1;INSIG2;KDELR2;ANKRD13C
prerank,peptidyl-lysine dimethylation (GO:0018027),0.6999846467356989,1.4763535533913175,0.07057256990679095,0.8716187256012219,1.0,7/18,8.35%,EHMT1;SUV39H1;SETD1A;EHMT2;SETD2;SETD3;ASH1L
prerank,nuclear membrane disassembly (GO:0051081),0.7458342070180332,1.4762412588630613,0.061313868613138686,0.8670614614850042,1.0,5/14,7.27%,PLK1;PRKCB;PRKCA;CTDNEP1;DCTN1
prerank,positive regulation of transferase activity (GO:0051347),0.59205451105238,1.4754120622211846,0.006066734074823054,0.8671381837706905,1.0,26/142,11.25%,MUSK;PLK1;ROR2;DDR1;DDR2;SERINC5;RFC2;FBXW7;RAD50;TCP1;EPHB2;MAPK1;AXL;DCUN1D4;POLG2;HSP90AA1;HNRNPA2B1;MRE11;PKIB;NBN;NEK7;HMBOX1;EPHA5;UBE2I;SERINC1;IGF1R
prerank,regulation of smoothened signaling pathway (GO:0008589),0.6190687271065257,1.4732153549887053,0.04035874439461883,0.8764448451993029,1.0,4/50,4.29%,EVC;RORA;GAS1;HERC4
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.6599489082984697,1.4731654900765343,0.05172413793103448,0.8714743798908793,1.0,9/27,12.18%,RNASE6;ZC3H12D;CSTF3;RNASE4;XRN1;POP1;ZC3H12B;CPSF3;ERN1
prerank,atrial septum morphogenesis (GO:0060413),0.7832000664726422,1.4731387738922719,0.041916167664670656,0.8663784398146251,1.0,3/10,6.38%,ISL1;TGFB2;ACVR1
prerank,positive regulation of exosomal secretion (GO:1903543),0.7282988530779789,1.4729087484551093,0.059065934065934064,0.8628576495702126,1.0,8/15,14.59%,TSG101;SMPD3;VPS4A;SDCBP;HGS;VPS4B;PDCD6IP;RAB7A
prerank,cellular response to alcohol (GO:0097306),0.631466450629915,1.4727015439413231,0.041189931350114416,0.8590915433280244,1.0,9/42,7.03%,BRCA1;BLM;ADCY8;ADCY3;KLF9;ADAM15;ADCY5;CTNNA1;GOLPH3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.6048727812688868,1.472246532107002,0.032665964172813484,0.8570848914024335,1.0,21/74,15.19%,BMP5;RGCC;TGFB2;OLFM1;SMAD3;SPRED2;SDCBP;MCRIP1;LDLRAD4;EZH2;DAB2;TGFBR2;USF3;MTOR;TGFBR1;SPRED1;ADIPOR1;PTEN;DAG1;CLASP1;SMAD4
prerank,activation of protein kinase A activity (GO:0034199),0.7232305022330228,1.471385611760616,0.06336088154269973,0.8577191402382429,1.0,6/16,7.05%,ADCY8;ADCY3;PRKAR2A;ADCY5;PRKACA;ADCY9
prerank,positive regulation of lipid transport (GO:0032370),-0.6202619150051661,-1.4699638411882205,0.07471264367816093,0.7949030758445789,1.0,4/12,19.81%,ABCA3;SPP1;ABCB4;DBI
prerank,positive regulation of kinase activity (GO:0033674),0.5965788316507958,1.469638090444632,0.013278855975485188,0.8637597478809532,1.0,13/107,8.15%,MUSK;CAMKK1;ROR2;DDR1;DDR2;RAD50;GAS6;EPHB2;RAP1A;AXL;MRE11;MAPT;NBN
prerank,regulation of histone acetylation (GO:0035065),0.6485026863764165,1.4686183446519891,0.05502392344497608,0.8653152580578042,1.0,10/33,12.73%,BRCA1;THAP7;HDAC5;SET;RPS6KA5;TADA2A;CTBP1;GLYR1;NOC2L;BRD7
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.7288598162009989,1.4683316904788555,0.07323943661971831,0.862279796056654,1.0,5/14,10.27%,ITGB1BP1;FLNA;LIMS1;CD63;LOXL3
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.6515980093869345,1.4675317726686936,0.04988399071925754,0.8624619424947293,1.0,11/37,12.02%,DFFB;RNASE6;RNASEH2A;NUDT5;PPP1R8;EXOSC7;NUDT9;PABPC4;ENTPD1;XRN2;RNASE3
prerank,positive regulation of MAP kinase activity (GO:0043406),0.6082957927145553,1.4674211938257866,0.022727272727272728,0.8581979894808618,1.0,8/66,5.17%,FGF18;TNFRSF11A;LRRK2;TPD52L1;FGF1;SASH1;MAP3K11;PDGFB
prerank,gas transport (GO:0015669),-0.6327878930618699,-1.4674105201874363,0.05263157894736842,0.7914565893411812,1.0,1/10,2.94%,CA2
prerank,response to glucagon (GO:0033762),0.701362404959649,1.4672013107625133,0.060526315789473685,0.8546481857344322,1.0,6/19,7.05%,ADCY8;ADCY3;PRKAR2A;ADCY5;PRKACA;ADCY9
prerank,cellular response to ketone (GO:1901655),0.6369972974377682,1.4670256397955572,0.052132701421800945,0.8508543325801711,1.0,13/35,14.41%,ADCY8;ADCY3;KLF9;ADAM15;MSN;AR;ADCY5;NR3C1;GOLPH3;DCPS;GNG2;ROCK2;GNB1
prerank,natural killer cell mediated immunity (GO:0002228),0.7233787377649075,1.4667580696224394,0.0700280112044818,0.8478824393648855,1.0,2/15,3.27%,TUBB4B;RAET1E
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6733499996063752,1.4665066613295894,0.05025125628140704,0.844553711583291,1.0,7/25,6.24%,ANG;GLMN;ITGA6;AR;THBS1;NRP1;SDCBP
prerank,lipoprotein transport (GO:0042953),0.7774345403673153,1.4655217352213536,0.05819295558958652,0.8457931908613209,1.0,4/10,11.09%,CD36;PRKCB;PPARG;MIA3
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.7577916879772448,1.465004328144658,0.06896551724137931,0.844499258390861,1.0,4/12,6.77%,PLK1;PRKCB;PRKCA;CTDNEP1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.709604758095473,1.4633766559274866,0.0506155950752394,0.8499523327063638,1.0,7/18,9.89%,PLK1;LDLRAP1;VPS4A;AR;STX7;SPTBN1;CDK5
prerank,regulation of actin filament-based movement (GO:1903115),-0.6312890265163427,-1.4608808004248182,0.06424581005586592,0.8114673574647588,1.0,2/10,4.82%,PDE4D;PDE4B
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.6672472587207899,1.4604164894734488,0.046172539489671933,0.8642020131307597,1.0,7/29,14.70%,BMP5;SPRED2;LDLRAD4;USF3;SPRED1;ADIPOR1;PTEN
prerank,cellular response to cAMP (GO:0071320),0.6501168654079099,1.458529694414934,0.04981773997569866,0.8716200861731992,1.0,9/30,15.36%,HCN3;RAPGEF1;AKAP9;RAP1A;EZR;RAP1B;ZFP36L1;PKD2;HCN1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.6188080722850173,1.4576482546142782,0.03090507726269316,0.8724456211837697,1.0,9/56,8.83%,BMP5;SMAD6;PMEPA1;TGFB2;BMPR1A;SDCBP;ACVR1;LDLRAD4;DAB2
prerank,regulation of kinase activity (GO:0043549),0.5968267388483224,1.4567449559228665,0.021761658031088083,0.8735659134198098,1.0,12/89,8.15%,MUSK;ROR2;DDR1;DDR2;RAD50;ANKRD54;EPHB2;AXL;IRS2;MRE11;MAPT;NBN
prerank,cell part morphogenesis (GO:0032990),0.7402474223780742,1.4563008435244924,0.05758426966292135,0.8718733393723884,1.0,5/13,6.28%,NUBPL;PID1;SLIRP;WASF1;PACSIN2
prerank,regulation of cell motility (GO:2000145),0.591547114446652,1.455327654295648,0.013224821973550356,0.8732469071433676,1.0,19/121,12.02%,FGF22;FGF18;SGK3;MGAT3;CAVIN1;PLXNA1;NRG2;MINK1;FGF1;FLNA;CDK6;CAMSAP3;PKN2;TBCCD1;DIAPH1;CYRIB;TMSB4X;ABL1;RAF1
prerank,cholesterol metabolic process (GO:0008203),0.6023780297514265,1.452984121869234,0.03805496828752643,0.8838697766334002,1.0,14/68,14.68%,LCAT;INSIG1;GBA2;LDLRAP1;INSIG2;SOAT1;GGPS1;CEL;ABCG1;ABCA1;RXRA;PPARD;OSBPL1A;ABCA5
prerank,negative regulation of cell division (GO:0051782),0.7505863622121295,1.4521784754032203,0.07692307692307693,0.8842303346286237,1.0,2/11,2.78%,BLM;VPS4A
prerank,acylglycerol biosynthetic process (GO:0046463),0.670514064257466,1.4518035796621285,0.06874189364461739,0.8818022322824898,1.0,5/23,11.55%,ANG;MOGAT3;GPAM;PLA2G4A;GK
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.744116567131979,1.4502854019402158,0.0718562874251497,0.887154212613269,1.0,1/12,0.10%,BMP5
prerank,sulfur amino acid catabolic process (GO:0000098),0.7648371321738126,1.4499634712785119,0.07587253414264036,0.8846563716892871,1.0,1/10,0.33%,CBS
prerank,mitochondrion morphogenesis (GO:0070584),0.7596870462728011,1.4491459549144172,0.07309941520467836,0.8850159665970349,1.0,4/11,3.80%,NUBPL;PID1;SLIRP;WASF1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.6199689041136881,1.44908923940565,0.04692737430167598,0.8808068062725996,1.0,6/45,8.83%,BMP5;TGFB2;BMPR1A;SDCBP;ACVR1;DAB2
prerank,AMP metabolic process (GO:0046033),0.7316359656029205,1.4481517836295605,0.06726457399103139,0.8820729715582196,1.0,3/13,2.57%,AK4;AK3;ADSS1
prerank,positive regulation of ruffle assembly (GO:1900029),0.7210293723777694,1.4480161579108854,0.08708272859216255,0.8783803988177669,1.0,6/13,15.93%,FAM98A;NDEL1;EPS8L1;EPS8;P2RY12;PLEKHM1
prerank,mesenchyme development (GO:0060485),0.7290797883311808,1.4464660189780816,0.06762589928057554,0.8834571155041598,1.0,1/15,0.09%,ISL1
prerank,sulfation (GO:0051923),0.7542594541786634,1.4459301455254832,0.07598784194528875,0.8823691756649198,1.0,1/11,1.12%,UST
prerank,regulation of centriole replication (GO:0046599),0.6873319229477916,1.4448112021564037,0.07468879668049792,0.8851830165644603,1.0,3/17,3.49%,BRCA1;ALMS1;MDM1
prerank,cellular response to zinc ion (GO:0071294),0.6930372929138492,1.4418145585373257,0.07947976878612717,0.9000323456189531,1.0,9/15,10.60%,HVCN1;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E
prerank,heterocycle biosynthetic process (GO:0018130),0.7199593330453271,1.4408073780853763,0.06871345029239766,0.9016580163767395,1.0,4/14,8.47%,PYCR2;LIAS;NFS1;ALOX5
prerank,muscle cell migration (GO:0014812),0.7520116718234806,1.4394251397456752,0.08661417322834646,0.9062612227783244,1.0,2/10,3.16%,DDR1;ITGB1BP1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.7006697656213883,1.4389418031920496,0.08807588075880758,0.9048562766109152,1.0,3/16,3.27%,TUBB4B;VAMP7;RAET1E
prerank,positive regulation of phosphorylation (GO:0042327),0.5749568821130183,1.4386623595114778,0.004012036108324975,0.9021732382546727,1.0,34/240,10.08%,MUSK;FGF22;FGF18;ANG;ROR2;DDR1;LRRK2;DDR2;RAD50;GLMN;FGF1;ITGA6;VEGFC;GAS6;NIBAN1;EPHB2;AR;THBS1;NRP1;AKTIP;CDK2AP1;AXL;SDCBP;HSP90AA1;MRE11;NBN;NPTN;DAB2;KRAS;FNIP1;FXR2;MAVS;LYN;EPHA5
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.5849192355962426,1.4382098652282052,0.026694045174537988,0.9006375076132082,1.0,23/94,10.46%,TUBB4B;PLK1;CETN2;CEP89;NPHP4;ALMS1;TMEM67;MAPRE1;IQCB1;AKAP9;CEP250;YWHAE;PRKACA;PCNT;HSP90AA1;DCTN1;TUBA1A;DCTN2;CCP110;ODF2;AHI1;CEP152;CNTRL
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.6725904293464768,1.4380085026404792,0.08005249343832022,0.8977282735723889,1.0,5/20,9.84%,PLK1;TFAP4;IPO7;APC;IPO5
prerank,negative regulation of nervous system development (GO:0051961),-0.5347291998996976,-1.4379657179428824,0.076,0.92852354871338,1.0,7/17,21.23%,PCM1;B2M;APPL2;NOTCH1;TLR2;REST;SLIT1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.6167709634933773,1.4370363913553186,0.05930232558139535,0.8997176620559434,1.0,9/43,10.80%,PLK1;BRCA1;BLM;CDK5RAP3;MRE11;NBN;BABAM2;TAOK1;FOXN3
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.5887509605012203,1.4365899668599673,0.03691983122362869,0.898117668224978,1.0,19/82,10.46%,TUBB4B;PLK1;CETN2;ALMS1;MAPRE1;AKAP9;CEP250;YWHAE;PRKACA;CDK2;PCNT;HSP90AA1;DCTN1;TUBA1A;DCTN2;CCP110;ODF2;CEP152;CNTRL
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.6176401119635834,1.4361288233438194,0.07399103139013453,0.896430349037772,1.0,3/41,4.56%,ACE2;KCNJ6;FLNA
prerank,regulation of neuroblast proliferation (GO:1902692),0.7053258497633103,1.435790509926021,0.06950354609929078,0.8944380643757789,1.0,3/15,4.01%,LRRK2;CX3CL1;NF1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.5288477417390554,-1.4354101782643145,0.08270676691729323,0.9245652437109848,1.0,7/18,14.16%,PRKN;NONO;PPIA;SOD2;TRAP1;AKT1;SIRT1
prerank,heart morphogenesis (GO:0003007),0.604958011234293,1.4341255502005068,0.059734513274336286,0.9008155898540101,1.0,7/50,8.95%,ISL1;TGFB2;OLFM1;BMPR1A;FLRT2;ACVR1;CHD7
prerank,canonical Wnt signaling pathway (GO:0060070),0.5887216548627217,1.4329144979887425,0.04430379746835443,0.9040829781097186,1.0,13/68,14.70%,WNT4;LRRK2;WNT2B;DVL1;LRP5;DIXDC1;APC;TCF7L2;LRP6;CSNK1A1;FZD9;FZD3;PTEN
prerank,neurotrophin signaling pathway (GO:0038179),0.679182630994294,1.4305575720607415,0.07464607464607464,0.9144460374023163,1.0,4/21,4.54%,RAPGEF1;ZFYVE27;GRB2;RAP1A
prerank,cardiac ventricle morphogenesis (GO:0003208),0.6200121233454245,1.4303285221815911,0.06314580941446613,0.9116049001859002,1.0,5/41,4.91%,ISL1;TGFB2;BMPR1A;CPE;TPM1
prerank,signal release from synapse (GO:0099643),0.6234632630222731,1.4300417373387453,0.06407322654462243,0.9090610019570181,1.0,7/43,9.89%,STXBP2;PDZD11;DVL1;GAD2;SYN3;VAMP2;CDK5
prerank,response to fatty acid (GO:0070542),0.6920564510058196,1.4299711250644578,0.06584362139917696,0.9053016462989375,1.0,3/17,4.54%,CD36;PID1;IRS1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6099668339500329,1.4295601704068233,0.06418918918918919,0.903770522577177,1.0,12/43,14.36%,RELA;SMARCA4;TGFB2;JUN;SMAD3;PDGFB;TEAD1;NR3C1;PPARG;TP53;DDX5;PPARD
prerank,positive regulation of dendrite development (GO:1900006),0.7577075154488533,1.4293069602380426,0.07313195548489666,0.9012038562783687,1.0,1/10,0.10%,BMP5
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5247370983638404,-1.428861365490183,0.05970149253731343,0.9477972603251522,1.0,3/17,1.51%,XIAP;SLIT2;CASK
prerank,regulation of angiogenesis (GO:0045765),0.5754688765944735,1.4271128619514368,0.009009009009009009,0.9111049076596432,1.0,29/192,10.13%,FGF18;ISL1;THBS2;RGCC;BRCA1;VASH2;SP1;FGF1;VEGFC;RUNX1;TGFB2;SASH1;NF1;ADAM12;THBS1;CEMIP2;PRKCB;PRKCA;IL1A;PDE3B;MECP2;AGO2;EGLN1;ALOX5;ITGB8;PPARG;MTDH;HGS;F3
prerank,positive regulation of nuclear division (GO:0051785),0.6595635033273219,1.4263865686284574,0.08261405672009864,0.9116623093697711,1.0,7/25,15.29%,RGCC;PDGFB;LRP5;IL1A;TGFA;INSR;PHIP
prerank,regulation of inclusion body assembly (GO:0090083),0.7363174697909096,1.4263740241771437,0.08920863309352518,0.9076203376549098,1.0,2/11,2.09%,DNAJB1;SACS
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.6449628720437295,1.4263496796534265,0.07411907654921021,0.9036837987197065,1.0,8/29,9.30%,ISL1;BRCA1;UBA5;RUNX1;WBP2;ESR1;GPAM;CNOT9
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.6726607827681047,1.4261080252242577,0.07493540051679587,0.9011384250250947,1.0,4/21,7.05%,ADCY8;ADCY3;ADCY5;ADCY9
prerank,endocrine system development (GO:0035270),0.6705541741057004,1.4257720404735659,0.07898089171974522,0.8991538766227638,1.0,2/21,4.01%,WNT4;NF1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.6190773882774633,1.4249794130786777,0.05698324022346369,0.8998246455849704,1.0,18/43,16.09%,TSG101;DUSP3;GRB2;SOCS4;AREG;PTPRJ;RNF115;PTPN3;HGS;SOCS5;MVP;CDC42;CBL;TGFA;EPS15;RAB7A;SH3KBP1;SH3GL2
prerank,membrane depolarization (GO:0051899),-0.4400502327322161,-1.4248789910527715,0.07228915662650602,0.9527885336895381,1.0,12/32,22.12%,P2RX7;CACNB4;CACNA1E;SCN2A;SCN3A;SCN8A;CACNA1B;ATP5IF1;SCN1B;P2RX4;SCN9A;CACNG2
prerank,cellular response to organic cyclic compound (GO:0071407),0.571778115577695,1.4241268516488408,0.01417004048582996,0.9013663204056133,1.0,40/141,16.27%,HCN3;BRCA1;RORA;URI1;LRRK2;BLM;INSIG1;RIOK3;RAPGEF1;ADCY8;ADCY3;IMPACT;MSN;AR;AKAP9;ADCY5;RAP1A;PDGFB;CTNNA1;ESR1;NR3C1;EZR;GOLPH3;RAP1B;IL18;NCOA3;GABRG2;DIAPH1;ZFP36L1;LCOR;PKD2;GNG2;ROCK2;GNB1;P2RY12;SPIDR;HCN1;ARL6IP5;EPG5;MEF2C
prerank,negative regulation of cellular component organization (GO:0051129),0.5837775380845835,1.4233740589749273,0.047872340425531915,0.9025209211181977,1.0,16/74,12.31%,ISL1;DNAJB1;PRKCZ;RIOK3;SACS;IMPACT;AR;EP300;TERF2;SYT11;ABCA7;CDC42;SCAMP5;RAF1;AIDA;SORL1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.5912070256421884,1.421600822849133,0.04746136865342163,0.9095388783219002,1.0,13/57,10.80%,PLK1;BRCA1;BLM;CDK5RAP3;CDK2;PRKDC;MRE11;NBN;BABAM2;CHEK2;RFWD3;TAOK1;FOXN3
prerank,regulation of mononuclear cell migration (GO:0071675),0.6558014554558074,1.4212179114240175,0.09749670619235837,0.908283593378884,1.0,6/23,9.65%,BMP5;MSN;THBS1;CMKLR1;MAPK1;LYN
prerank,negative regulation of transposition (GO:0010529),0.6893223665435886,1.4211040215928046,0.07862068965517241,0.9049740668123796,1.0,2/16,3.35%,SIRT7;TUT4
prerank,mesenchymal cell differentiation (GO:0048762),0.5918972574602047,1.4209545321893735,0.06263736263736264,0.9019717784038047,1.0,10/51,14.30%,ISL1;WNT4;TGFB2;LIMS1;LOXL3;TGFBR1;LRP6;DDX5;RBPJ;ROCK2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.5853538311875964,1.4204211057896763,0.0425531914893617,0.9015666723821449,1.0,22/75,14.70%,PLK1;CDK5RAP3;TFAP4;PRKAR2A;SMPD1;NF1;LRP5;PTPRJ;IPO7;RGS14;PKIB;PTPN1;APC;LYN;IPO5;PKIA;ABL1;SORL1;SH2B3;LRP6;HEG1;PTEN
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.6115803451448552,1.4204072651444482,0.05961754780652419,0.8977805838138193,1.0,14/46,12.39%,MTAP;CFL1;TCP1;MSN;RPLP0;HNRNPA2B1;HSPA9;RAP1B;PAK2;ANXA2;CDC42;ARF1;TALDO1;PITPNA
prerank,icosanoid biosynthetic process (GO:0046456),0.7394288181874678,1.4202753088080964,0.09953343701399689,0.8947689526182315,1.0,4/10,9.99%,MGST3;PLA2G4A;ALOX5;FADS1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6178245864596249,1.418780648188779,0.07308584686774942,0.9000069173971436,1.0,12/34,13.90%,GAS1;RELA;ITGB1BP1;VEGFC;NRP1;MT1G;SEMA6A;ERN1;MAPK14;MAPKAPK2;NUS1;PRKD2
prerank,negative regulation of cartilage development (GO:0061037),0.7124139973097439,1.4186529518335933,0.10027855153203342,0.8969940617375726,1.0,1/13,0.64%,ADAMTS12
prerank,mitochondrial fission (GO:0000266),-0.5295199126333843,-1.4184812081008122,0.06611570247933884,0.9724771546875972,1.0,9/16,26.55%,PRKN;OPA1;DNM2;SLC25A46;DNM1;MIEF1;GDAP1;FIS1;MTFR1
prerank,lipoprotein catabolic process (GO:0042159),-0.629252117871707,-1.4183986715585346,0.08196721311475409,0.9542502561619065,1.0,9/11,35.28%,CTSD;PPT1;ABHD17B;ABHD17C;LYPLA1;ABHD10;LYPLA2;LYPLAL1;ABHD17A
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.6644186968545176,1.4167284427742763,0.07566204287515763,0.9050747714491545,1.0,9/22,11.58%,TSG101;VPS4A;RNF115;NEDD4;PTPN23;PLAA;VPS37C;VPS37A;VPS4B
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.574182357664693,-1.4152434837093544,0.10377358490566038,0.9541809421782412,1.0,7/12,33.06%,GCLC;CNDP2;HAGH;GCLM;GSS;CHAC2;OPLAH
prerank,B cell mediated immunity (GO:0019724),-0.6372749884349932,-1.4149709064659646,0.06705539358600583,0.938085063355809,1.0,6/10,26.09%,FCER1G;FCGR2B;MSH2;CD74;CARD9;TLR8
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6403124303472288,1.4134019809524305,0.07542579075425791,0.9219417950088629,1.0,10/26,12.69%,ISL1;BRCA1;SMARCA4;CLOCK;ZBTB7A;DAB2;NCOR1;CNOT9;NCOR2;VPS11
prerank,activation of protein kinase B activity (GO:0032148),0.645015640923271,1.4133898765528368,0.08182912154031288,0.9181484073044511,1.0,9/29,13.60%,ANG;FGF1;ITGB1BP1;GAS6;PDGFB;MAPKAP1;IL18;MTOR;INSR
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.6742696234702115,1.4128384262841016,0.08949416342412451,0.9139366626956146,1.0,5/19,13.42%,POLR2D;POLR2A;TERF2;ATRX;TERF1
prerank,regulation of DNA recombination at telomere (GO:0072695),0.6742696234702115,1.4128384262841016,0.08949416342412451,0.9139366626956146,1.0,5/19,13.42%,POLR2D;POLR2A;TERF2;ATRX;TERF1
prerank,positive regulation of cell junction assembly (GO:1901890),0.5918236440928536,1.4121360559109157,0.0605726872246696,0.914689169436883,1.0,10/56,11.90%,ACE2;NPHP4;EPHB2;NRP1;CLSTN3;PTPRJ;IL1RAP;LIMS1;CLSTN1;ABL1
prerank,establishment of mitotic spindle localization (GO:0040001),0.6376921538121396,1.411791177427808,0.08969696969696969,0.9129217279949946,1.0,5/28,11.05%,PLK1;KPNB1;NDEL1;DCTN1;FBXW11
prerank,eye photoreceptor cell differentiation (GO:0001754),0.7194874406801602,1.4117188270247891,0.08726752503576538,0.9096281876619626,1.0,1/12,0.17%,SDK2
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.6115876352517047,1.4112098156729997,0.07630057803468208,0.9090548934651957,1.0,7/39,12.47%,ISL1;NNAT;PSMD9;IRS2;TM7SF3;GCK;TCF7L2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.6811978655107862,1.4108965319168412,0.09289617486338798,0.9071824255173181,1.0,3/17,5.27%,GJC1;GJD3;PRKACA
prerank,megakaryocyte differentiation (GO:0030219),0.7328893755906501,1.410684150550035,0.10391566265060241,0.9049074308594094,1.0,4/11,17.53%,UBA5;TAL1;SH2B3;MED1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.4857607347043121,-1.410125012904549,0.07883817427385892,0.948881530853996,1.0,6/22,14.13%,CACNB4;NOS1AP;PDE4B;FMR1;AHNAK;STAC
prerank,regulation of synapse assembly (GO:0051963),0.5957703941394744,1.4099445580390142,0.06792873051224944,0.9058181809918289,1.0,6/46,10.25%,MUSK;EPHB2;CLSTN3;IL1RAP;VPS35;CLSTN1
prerank,positive regulation by host of viral transcription (GO:0043923),0.6887851238150551,1.4083521671350905,0.09375,0.9120546208824355,1.0,6/15,7.41%,SMARCA4;SP1;TFAP4;JUN;EP300;RRP1B
prerank,water-soluble vitamin metabolic process (GO:0006767),0.5795960143515988,1.4079327825812196,0.05042918454935622,0.9109886926574713,1.0,14/68,12.20%,PDZD11;BTD;PDXK;ALDH1L1;SLC2A3;MMADHC;TPK1;MCCC2;MTHFD2L;MTHFR;LMBRD1;MTR;PCCA;SLC25A32
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5981828171859328,1.4071266005132528,0.08084163898117387,0.9122305953386216,1.0,11/47,13.36%,ACE2;CD36;PID1;GRB2;THBS1;PDGFB;MAPT;TGFBR2;MAPK14;TP53;SYK
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5553867089282541,-1.4069887789845357,0.05517241379310345,0.9510499447294977,1.0,6/13,25.52%,TOX;CLPTM1;CAMK4;ADAM8;ZC3H8;SOD1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.6464571436543803,1.4069502798315128,0.09331651954602774,0.9096280547611589,1.0,4/23,11.05%,PLK1;NDEL1;DCTN1;FBXW11
prerank,calcium ion homeostasis (GO:0055074),0.5676853389072216,1.4068094623374723,0.036885245901639344,0.906912851682175,1.0,4/95,1.09%,CXCL12;WFS1;SELENON;SLC24A5
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.5695106351723421,1.4066926396292558,0.034764826175869123,0.9039938209411752,1.0,24/113,13.90%,BMP5;ANG;VASH2;NRAS;C5AR1;FGF1;VEGFC;AREG;NRP1;PDGFB;PRKCA;F3;NOTCH2;SOX11;LAMC1;TCF7L2;TGFA;TGFBR1;AGGF1;RTN4;PPP1R16B;RREB1;NRP2;PRKD2
prerank,nuclear transport (GO:0051169),0.6866001746001971,1.402588503864895,0.1150070126227209,0.9258614571738021,1.0,5/16,7.61%,BANF1;PSIP1;NUP205;RGS14;NUP98
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6527757913277059,1.4024426425992795,0.08472400513478819,0.9195426483773641,1.0,9/23,15.19%,ZEB2;THBS1;EP300;SDCBP;STK11;GIPC1;DAB2;HIPK2;SMAD4
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6527757913277059,1.4024426425992795,0.08472400513478819,0.9195426483773641,1.0,9/23,15.19%,ZEB2;THBS1;EP300;SDCBP;STK11;GIPC1;DAB2;HIPK2;SMAD4
prerank,positive regulation of protein secretion (GO:0050714),0.5840245553353772,1.4023826145489657,0.05106382978723404,0.9163546543131557,1.0,18/69,12.93%,ISL1;ANG;NNAT;PPID;TGFB2;PSMD9;IL1A;IRS2;EZR;GOLPH3;TM7SF3;ABCG1;PTPN23;WLS;CD2AP;GCK;TCF7L2;FRMD4A
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.6887665930261313,1.402364961111971,0.10664819944598337,0.9128954838777353,1.0,2/16,5.26%,PDE6H;PRKCA
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5768070864663487,1.4022977600994406,0.0627659574468085,0.9097693651187536,1.0,17/74,13.03%,BMP5;BRCA1;EYA2;RELA;ITGA6;AR;THBS1;ACVR1;IL1A;RNF34;BIRC6;TRAF2;ZMYND11;MAP2K5;TCF7L2;TGFBR1;BCL2
prerank,regulation of MAP kinase activity (GO:0043405),0.5731273552439888,1.401270767925212,0.04573804573804574,0.9126042834776751,1.0,15/92,10.01%,FGF18;LRRK2;CDK5RAP3;TSG101;TPD52L1;FGF1;SMPD1;NF1;PDGFB;PTPRJ;RGS14;PTPN1;EZH2;LYN;HGS
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.632458404513737,1.3998568516975223,0.10178117048346055,0.9173396507782968,1.0,2/26,0.41%,EIF6;BRCA1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.7003390380856145,1.3996384681641074,0.09361702127659574,0.9152032775844005,1.0,4/14,6.71%,TYSND1;IRS1;ABCD2;IRS2
prerank,presynapse organization (GO:0099172),0.7453558793982173,1.3988851846803587,0.0967741935483871,0.916522830656826,1.0,2/10,1.89%,C5AR1;DVL1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.6424848253575217,1.397738556327877,0.09192546583850932,0.9201066534811914,1.0,7/23,13.69%,UACA;RELA;IFI35;TMSB4X;PPM1A;CYLD;ADIPOR1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.6549642167680767,1.3977080641365291,0.08796895213454076,0.9099670341296575,1.0,4/20,9.63%,PLK1;ZWINT;BUB3;APC
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.6549642167680767,1.3977080641365291,0.08796895213454076,0.9099670341296575,1.0,4/20,9.63%,PLK1;ZWINT;BUB3;APC
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.6549642167680767,1.3977080641365291,0.08796895213454076,0.9099670341296575,1.0,4/20,9.63%,PLK1;ZWINT;BUB3;APC
prerank,sister chromatid segregation (GO:0000819),0.6236330852114992,1.3968966202897577,0.10179640718562874,0.9114903776661191,1.0,2/31,0.85%,PLK1;ZWINT
prerank,liver development (GO:0001889),0.6092293801252198,1.3968640054381198,0.09166666666666666,0.9082544673649396,1.0,4/32,5.16%,WNT4;CDK5RAP3;NF1;ARID5B
prerank,regulation of telomere capping (GO:1904353),0.6397661535562992,1.3957624797475556,0.08571428571428572,0.9114803729532703,1.0,8/23,9.59%,RAD50;SMG6;TERF2;MAPK1;PKIB;NBN;TNKS2;NEK7
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.6478883762394518,1.3957419232419686,0.10116731517509728,0.9082720483171358,1.0,5/22,9.84%,PLK1;TFAP4;IPO7;APC;IPO5
prerank,striated muscle tissue development (GO:0014706),0.6296712871485795,1.3954602792040771,0.09397590361445783,0.9065764120652648,1.0,4/29,8.91%,BMP5;SVIL;SGCG;NDUFV2
prerank,establishment of epithelial cell polarity (GO:0090162),0.6594757244239333,1.3951646655087642,0.10775295663600526,0.9048409605375773,1.0,8/19,11.78%,SIPA1L3;MSN;CAMSAP3;EZR;GOLPH3;MYO9A;CDC42;CYTH1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.5723235161902932,1.3946691086323384,0.062432723358449946,0.9044924794336432,1.0,18/65,14.87%,RGCC;RORA;AK4;SUV39H1;UBQLN1;EGLN3;EGLN2;HP1BP3;BNIP3L;EGLN1;BNIP3;MTOR;ZFP36L1;HIPK2;TP53;FMN2;NDRG1;TSC1
prerank,cellular response to inorganic substance (GO:0071241),0.6373161480716361,1.3944338585324878,0.11447368421052631,0.9026550211727934,1.0,6/21,14.72%,BLM;CDK2;RTF2;MTR;ATRX;SPIDR
prerank,telomere capping (GO:0016233),0.6876417678595496,1.3941917662349816,0.08599167822468794,0.9009008948703696,1.0,8/16,15.15%,RAD50;DCLRE1A;TERF2;PRKDC;MRE11;NBN;TERF1;CTC1
prerank,mesoderm formation (GO:0001707),-0.5141342231191267,-1.393531493052283,0.0970464135021097,1.0,1.0,2/17,2.27%,BMPR2;SMAD2
prerank,homocysteine metabolic process (GO:0050667),0.7304781235398695,1.393040056209108,0.09370424597364568,0.9041528605165042,1.0,2/11,6.57%,CBS;MTHFR
prerank,hepaticobiliary system development (GO:0061008),0.6507769489261801,1.3927474316598802,0.09247027741083223,0.9024791640520747,1.0,4/20,5.16%,WNT4;CDK5RAP3;NF1;ARID5B
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.593289064815419,1.3921908722108922,0.07897664071190211,0.9027144486338963,1.0,13/48,13.90%,FGF18;ATP5F1A;SP1;THBS1;HDAC9;PDGFB;PRKCA;TMSB4X;HMGB1;MAPK14;PIK3C2A;NUS1;PRKD2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.6472980438764345,1.3915915724978438,0.09137709137709138,0.9028353691158975,1.0,4/21,9.63%,PLK1;ZWINT;BUB3;APC
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5926860827391536,1.3914816387523279,0.08425720620842572,0.9002713419259321,1.0,11/46,14.65%,ANG;IGFBP3;CX3CL1;THBS1;PDGFB;PRKDC;IL18;PPARG;TCF7L2;NDRG4;AIF1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.5611780531206262,1.3913752968832256,0.019114688128772636,0.8977543107041493,1.0,33/150,15.24%,FGF22;FGF18;NRG2;CX3CL1;FGF1;GRB2;ITGB1BP1;GAS6;AREG;IRS1;THBS1;PDGFB;KITLG;PTPRJ;ESR1;AXL;IRS2;HSP90AA1;IL18;MTDH;F3;IGF1R;FRS2;TCF7L2;TGFA;TGFBR1;RTN4;INSR;FYN;P2RY12;PIK3AP1;VAV1;HIP1
prerank,intracellular cholesterol transport (GO:0032367),0.6852584234400279,1.3899532322629122,0.11468531468531469,0.9030203774862728,1.0,7/15,13.13%,LDLRAP1;OSBP;VPS4A;ABCG1;RELCH;ABCA1;LRP6
prerank,positive regulation of cell adhesion (GO:0045785),0.5685742310404992,1.3898769237106805,0.06170212765957447,0.9002353862906549,1.0,9/74,8.94%,CXCL12;RSU1;TGFB2;TPM1;PDGFB;PRKCA;PTPRJ;STX3;LIMS1
prerank,monocyte chemotaxis (GO:0002548),0.6159159815462726,1.3897141877463302,0.09647058823529411,0.8980913277271455,1.0,4/32,7.28%,TNFRSF11A;CX3CL1;PDGFB;CCL25
prerank,substrate-dependent cell migration (GO:0006929),0.7009502434012534,1.3892492080073116,0.11360448807854137,0.8978449998163923,1.0,7/14,14.62%,ITGB1BP1;VEGFC;NRP1;SDCBP;ANKS1A;CD2AP;P2RY12
prerank,microtubule bundle formation (GO:0001578),0.6060993229625314,1.3888859442843227,0.08755760368663594,0.8969087584275612,1.0,5/42,7.32%,PLK1;RSPH4A;NAV1;NCKAP5L;CCDC66
prerank,B cell activation involved in immune response (GO:0002312),-0.5776917511954192,-1.3887692964540725,0.10472972972972973,1.0,1.0,8/13,29.86%,FCGR2B;GPR183;RNF168;MSH2;CD180;RNF8;BATF;MSH6
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.6545121733036467,1.3879560579233856,0.09147869674185463,0.8994216163284906,1.0,6/22,7.60%,RAPGEF1;EHD1;STMN2;WASF1;RAP1A;MAPT
prerank,epithelial cell-cell adhesion (GO:0090136),0.7256223392684541,1.3878273386716709,0.1184407796101949,0.8971373429406533,1.0,3/11,7.03%,VCL;CAMSAP3;ITGB5
prerank,neurotransmitter secretion (GO:0007269),0.5988817548360302,1.3860880203667427,0.08710407239819004,0.9042726627399738,1.0,7/44,9.89%,STXBP2;PDZD11;DVL1;GAD2;SYN3;VAMP2;CDK5
prerank,positive regulation of DNA binding (GO:0043388),-0.4326826867500897,-1.384846217000391,0.043010752688172046,1.0,1.0,9/31,15.49%,PRKN;TGFB1;SIRT2;CEBPG;NIBAN2;IGF1;PINX1;TRAF6;PLAUR
prerank,negative regulation of neuron differentiation (GO:0045665),-0.47322088289724135,-1.3845573653863137,0.08771929824561403,1.0,1.0,4/22,9.40%,B2M;EIF2AK4;GSK3B;CALR
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.5321057617870816,-1.3837174976525193,0.11904761904761904,1.0,1.0,11/15,29.24%,VCP;NPLOC4;FAF2;UFD1;DERL2;OS9;HERPUD1;AUP1;SELENOS;SYVN1;HSP90B1
prerank,cellular response to nitrogen compound (GO:1901699),0.6423655781121619,1.3837030069656353,0.11494252873563218,0.9151021887987224,1.0,7/20,15.96%,BLM;RIOK3;RTF2;ATRX;ROCK2;SPIDR;EPG5
prerank,central nervous system neuron development (GO:0021954),0.69208850918219,1.383537493073394,0.1044776119402985,0.912993476184722,1.0,7/15,14.70%,GBA2;ATP7A;HSP90AA1;MAPT;B4GALT5;ARHGAP35;PTEN
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.6976616088476845,1.3831979674909343,0.1172316384180791,0.9119518537919737,1.0,1/14,0.64%,ADAMTS12
prerank,response to interferon-alpha (GO:0035455),0.6882322449858088,1.3829768575359174,0.07951482479784366,0.9101970663984695,1.0,6/16,10.94%,IFITM3;EIF2AK2;GAS6;AXL;ADAR;IFNAR2
prerank,regulation of phosphate metabolic process (GO:0019220),0.6757296095379403,1.382710499946407,0.1087866108786611,0.9086922499157677,1.0,4/16,7.16%,SMG6;PGAM1;IGBP1;IKBKB
prerank,regulation of mRNA processing (GO:0050684),-0.41033232019705324,-1.3822535977531352,0.06451612903225806,0.99946172754985,1.0,10/32,9.83%,DHX9;TIA1;AHCYL1;SRSF10;SAFB;CDK11B;METTL16;YTHDC1;SRPK1;CWC22
prerank,regulation of B cell apoptotic process (GO:0002902),0.7017922934502014,1.382118306725312,0.1085383502170767,0.9090169627703705,1.0,6/12,10.74%,BCL6;BTK;IRS2;FNIP1;LYN;NOC2L
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.5644136871329111,1.3819399153479817,0.08085106382978724,0.907073740114629,1.0,12/66,8.47%,RGCC;ATP5F1A;FBXW7;NUPR1;KLF9;TGFB2;NF1;THBS1;CDK6;BRCA2;DUSP10;ALOX5
prerank,cellular response to sterol (GO:0036315),0.7170769271999443,1.3814347000698004,0.11323529411764706,0.9071078917132888,1.0,3/13,3.74%,RORA;INSIG1;INSIG2
prerank,collagen fibril organization (GO:0030199),0.5619180604263145,1.3811199660637472,0.046632124352331605,0.905888805593548,1.0,13/88,12.97%,COL14A1;CRTAP;DDR2;ADAMTS2;ITGA6;TGFB2;NF1;ATP7A;COL11A1;LOXL3;PXDN;P4HA1;TGFBR1
prerank,lipoprotein localization (GO:0044872),0.724076617387192,1.3804124799712296,0.09104477611940298,0.9070974611967805,1.0,4/11,11.09%,CD36;PRKCB;PPARG;MIA3
prerank,regulation of programmed necrotic cell death (GO:0062098),0.6589794712852775,1.3799129625999815,0.1046831955922865,0.9068166346347257,1.0,9/20,13.31%,FLOT2;NUPR1;PELI1;SDCBP;BIRC3;HSP90AA1;ASAH1;CYLD;PDCD6IP
prerank,regulation of viral life cycle (GO:1903900),0.6483179665606218,1.3793302075796356,0.09419354838709677,0.9071950469856481,1.0,5/21,10.54%,TSG101;VPS4A;AXL;KPNA6;TRIM5
prerank,synapse organization (GO:0050808),0.5562546912744564,1.3792978620836704,0.030425963488843813,0.9043418973162928,1.0,18/125,11.46%,MUSK;SDK2;PCDHB16;LRRK2;C5AR1;CX3CL1;DVL1;PPFIBP2;FARP1;PPFIA1;DCTN1;NEDD4;MAPT;CDK5;CDC42;C1QB;DBNL;ARHGAP39
prerank,positive regulation of translation (GO:0045727),0.5514783658616416,1.3790106990649575,0.060291060291060294,0.9030446938409218,1.0,18/94,9.11%,POLR2D;EIF6;HABP4;EIF4A3;COA3;RPS6KB2;EIF3C;EIF3E;NIBAN1;THBS1;PYM1;RBM3;PRKDC;METTL3;LARP4B;AGO2;YTHDF1;FXR2
prerank,heart contraction (GO:0060047),-0.39497563947594433,-1.378728915630258,0.05925925925925926,1.0,1.0,7/41,7.09%,SGCZ;RYR2;ATP1B1;GRK2;SGCD;ATP1A2;PIK3CA
prerank,protein O-linked glycosylation via serine (GO:0018242),0.7453609386055535,1.37825392763821,0.11394302848575712,0.9044331695148192,1.0,3/10,7.26%,POGLUT3;GALNT1;GALNT3
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.6165150606118094,1.3779187525406207,0.11960542540073983,0.9034968114658666,1.0,8/27,9.22%,PRKCZ;PID1;PIP4K2A;IRS1;PRKCB;PTPN1;NCK1;PIP4K2B
prerank,metal ion export (GO:0070839),-0.42367728465778015,-1.3774906522995425,0.05357142857142857,0.9960774728323053,1.0,9/31,9.60%,KCNT2;ATP1B3;ATP1B1;SLC11A1;ATP1A1;ATP1A2;ATP1A3;KCND3;SLC40A1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.6010381912585988,1.3768992923814127,0.09015421115065243,0.9064468142647909,1.0,6/35,9.43%,RGCC;ATP5F1A;NF1;THBS1;ALOX5;PPARG
prerank,cellular response to interleukin-12 (GO:0071349),0.5884714606830126,1.3756621927808017,0.08918617614269789,0.9104884539189324,1.0,14/48,12.39%,MTAP;CFL1;TCP1;MSN;RPLP0;HNRNPA2B1;HSPA9;RAP1B;PAK2;ANXA2;CDC42;ARF1;TALDO1;PITPNA
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6901650882076007,1.375527977495437,0.10057471264367816,0.9083125584491253,1.0,5/14,9.28%,DDX60;PUM2;ZDHHC5;TLR3;PUM1
prerank,glutathione biosynthetic process (GO:0006750),-0.574203092091324,-1.3755189321618135,0.12111801242236025,0.9924666702963945,1.0,7/11,33.06%,GCLC;CNDP2;HAGH;GCLM;GSS;CHAC2;OPLAH
prerank,regulation of ossification (GO:0030278),0.6012092878646573,1.3753256078370542,0.11241217798594848,0.9064955270517326,1.0,11/36,14.21%,S1PR1;DDR2;SMAD6;CHSY1;TGFB2;ACVR1;TXLNG;SOX11;BMP2K;LRP6;RBPJ
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.6221853303553713,-1.37518024843975,0.11080332409972299,0.9795066055403616,1.0,8/10,32.15%,CPEB3;NUDT21;HSF1;NCBP1;CDC73;NCBP2;PAF1;LEO1
prerank,maturation of LSU-rRNA (GO:0000470),0.6189110571009914,1.3740654358297375,0.10827250608272507,0.9105963674608727,1.0,3/26,1.18%,EIF6;ZNHIT3;BOP1
prerank,nuclear membrane organization (GO:0071763),0.658293712173431,1.3735852647631148,0.12207792207792208,0.9104154000962761,1.0,4/19,7.27%,PLK1;VPS4A;TARDBP;DCTN1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6961075810301794,1.373199354719759,0.10571428571428572,0.9098452125580917,1.0,3/14,6.60%,RGCC;THBS1;ITGA4
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.6786827422326037,1.3731462003095756,0.11677852348993288,0.9072713646800201,1.0,3/16,4.94%,BLM;SSBP1;WRN
prerank,protein import into mitochondrial matrix (GO:0030150),0.6649714119404196,1.37094313038921,0.1270053475935829,0.9168098880195317,1.0,4/18,6.70%,TIMM17A;TOMM40;DNAJC15;TIMM23
prerank,positive regulation of neuron projection development (GO:0010976),0.5653886066318714,1.3705528125711393,0.06165099268547544,0.9161798122056809,1.0,20/85,11.34%,BMP5;ROR2;CX3CL1;RAPGEF1;ITGA6;CAMK1D;STMN2;RAP1A;EP300;SERPINI1;SNX3;ARSB;TWF2;NPTN;LRP8;LYN;SETX;ARHGAP35;RIT2;DBNL
prerank,negative regulation of protein processing (GO:0010955),0.7029382028702699,1.3695357082029074,0.11477761836441894,0.9192701998955264,1.0,5/12,11.35%,GAS1;LRRK2;THBS1;CTSZ;PRNP
prerank,response to glucocorticoid (GO:0051384),0.6240843674527371,1.3694953126883835,0.08958837772397095,0.9166350382012652,1.0,3/26,6.35%,ISL1;BCL2L11;NR3C1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.6738775100560915,1.3692928650556406,0.1278735632183908,0.9148079898397407,1.0,3/15,6.66%,BRCA1;TGFB2;CAMSAP3
prerank,activation of adenylate cyclase activity (GO:0007190),0.6108619466490289,1.368958293356179,0.08254716981132075,0.9138737851901853,1.0,5/35,7.05%,RXFP1;ADCY8;ADCY3;ADCY5;ADCY9
prerank,negative regulation of blood pressure (GO:0045776),-0.551470780656703,-1.3669862453172517,0.09970674486803519,1.0,1.0,2/13,9.69%,BMPR2;SCPEP1
prerank,defense response to virus (GO:0051607),0.5541572331682447,1.3669588872600011,0.04918032786885246,0.9224432025491083,1.0,28/100,15.14%,RNASE6;SERINC5;IFITM3;RELA;IRF1;EIF2AK2;TTC4;TLR7;FLNA;IRF3;EXOSC5;AKAP1;NT5C3A;SETD2;TLR3;BNIP3L;ZDHHC1;SERINC3;MAVS;TRIM5;BNIP3;IFNAR2;ZMYND11;BCL2;TRIM56;RNF135;G3BP1;ATG7
prerank,positive regulation of lipid localization (GO:1905954),-0.5795668786912668,-1.3669210101465106,0.1021021021021021,0.9965059178210498,1.0,4/11,20.74%,IKBKE;LPL;ZC3H12A;VSTM2A
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5904381982296383,1.3669118431056697,0.10180995475113122,0.9198624755294388,1.0,17/46,15.19%,DUSP3;CNKSR3;ITGB1BP1;EPHB2;SPRED2;EZR;DLG1;RGS14;RANBP9;DUSP10;PTPN1;LYN;SEMA6A;SPRED1;PTEN;TLR4;SMAD4
prerank,negative regulation of cell communication (GO:0010648),0.6387741421536266,1.3652179638133894,0.10478654592496765,0.9268251455703412,1.0,4/21,10.11%,IGFBP3;ACVR1;PTPN1;SOCS5
prerank,positive regulation of interleukin-12 production (GO:0032735),0.612254630371013,1.3641739726234945,0.09112709832134293,0.9300519413250442,1.0,8/31,14.85%,ISL1;IL16;TLR3;HMGB1;MAPK14;SYK;LGALS9;TLR4
prerank,apoptotic nuclear changes (GO:0030262),0.6245414956438057,1.3639365489584885,0.11636828644501279,0.9286184336411168,1.0,5/24,12.01%,DFFB;CDK5RAP3;KPNB1;ACIN1;HMGB1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.680082159732331,1.3633641134036907,0.1350210970464135,0.9289367620040213,1.0,3/13,1.44%,LRRK2;AK4;AK3
prerank,regulation of axon regeneration (GO:0048679),-0.5640142175767375,-1.3623486036358934,0.10030395136778116,1.0,1.0,5/12,17.09%,RTN4RL1;GRN;PTPRS;EPHA4;CERS2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6580377186520134,1.361454570869479,0.12722298221614228,0.936851931071398,1.0,2/15,1.19%,DDR1;DDR2
prerank,RNA methylation (GO:0001510),0.5607418908259718,1.3613894914167457,0.09269356597600872,0.934380036280338,1.0,11/60,6.76%,WDR6;NSUN6;TRMO;TFB2M;METTL8;TARBP1;RBM15;TGS1;METTL3;CBLL1;NSUN3
prerank,intraciliary retrograde transport (GO:0035721),-0.5646189829750494,-1.3612565103134304,0.11436950146627566,1.0,1.0,9/12,35.89%,TTC21B;IFT140;DYNC2I1;IFT43;WDR35;IFT122;DYNLT2B;DYNC2I2;WDR19
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.6862598429346288,1.361221099784858,0.1174785100286533,0.9324121927945582,1.0,3/13,4.54%,PRKCZ;SNX5;IRS1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.5836353283707766,-1.3611052448769465,0.11764705882352941,0.9869441521004135,1.0,2/11,4.37%,NOS1AP;AKAP6
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.5065114533918363,-1.3608519922702336,0.12595419847328243,0.9748107330576651,1.0,9/17,17.36%,VCP;NPLOC4;FAF2;HM13;UFD1;DERL2;OS9;HERPUD1;AUP1
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.5864754078869381,-1.3608494087677547,0.10773480662983426,0.9614571613719436,1.0,3/10,15.07%,PRKN;SNCA;OXA1L
prerank,negative regulation of binding (GO:0051100),0.5555513724170217,1.3606263688070364,0.06295907660020986,0.9332984722494301,1.0,15/81,10.38%,MDFI;HABP4;LRRK2;DVL1;TFAP4;ITGB1BP1;JUN;ILRUN;STYX;PDGFB;USP33;SUMO3;MAPK8;DAB2;CTSZ
prerank,synaptic membrane adhesion (GO:0099560),-0.5331362067619261,-1.3600498590490475,0.1111111111111111,0.9529604675055615,1.0,8/14,26.98%,LRFN5;NTNG1;PTPRS;LRRC4C;LRRC4;SLITRK1;LRRC4B;PTPRF
prerank,potassium ion export across plasma membrane (GO:0097623),-0.5481754566335463,-1.3598996006963247,0.14705882352941177,0.941168343914809,1.0,2/13,8.31%,KCNT2;KCND3
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.657791988461132,1.3597961679917325,0.10975609756097561,0.9354408734743185,1.0,5/17,10.54%,CD36;CX3CL1;SASH1;PRKCA;TRIM5
prerank,negative regulation of inclusion body assembly (GO:0090084),0.7143198404740717,1.359620225467678,0.12443778110944528,0.9335550574839038,1.0,2/10,2.09%,DNAJB1;SACS
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.6850685074769233,1.3596102912214294,0.14325842696629212,0.9308089154232677,1.0,5/13,15.94%,RELA;PDGFB;PPARG;PPARD;NFIB
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.6896229626990682,1.3596039147147438,0.11127167630057803,0.9280639223364715,1.0,1/13,0.29%,GJC1
prerank,regulation of organelle organization (GO:0033043),0.5511365897693118,1.3595185897334063,0.07894736842105263,0.925827765647419,1.0,32/80,16.98%,MIEF2;LMAN1;SIRT7;ZEB2;MSN;AKAP9;EP300;MYO5A;SQSTM1;MAPK1;TMED9;CAMSAP3;EZR;GOLPH3;MAPT;SYT11;PAK2;ARMH3;VPS35;MAVS;TAOK1;CAPN2;DIAPH1;PARL;VPS11;SAR1B;SCARB2;MTM1;DNM1L;RDX;ARL6IP1;MFF
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.572264241005981,1.358699131235687,0.1091314031180401,0.9276240983602438,1.0,9/47,14.30%,WNT4;BRCA1;FBXW7;EP300;ACADL;GCK;SLC27A1;FYN;ROCK2
prerank,chromosome condensation (GO:0030261),0.5944429622861789,1.3586719580950701,0.10672853828306264,0.9250095994000345,1.0,6/36,9.00%,PLK1;DFFB;BANF1;NCAPD3;SET;ACIN1
prerank,mRNA destabilization (GO:0061157),0.5992925430098074,1.357374511654095,0.09714285714285714,0.9296813823428784,1.0,11/38,12.05%,POLR2D;ZC3H12D;TUT4;TARDBP;FTO;RC3H2;METTL3;YTHDF1;PUM1;DCPS;ZFP36L1
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.5209480662644461,-1.3570666789061758,0.12131147540983607,0.9434328585837394,1.0,8/16,25.30%,PHKA2;PHKB;PYGB;PGM2L1;PHKG2;PYGL;GAA;PGM2
prerank,glutamate receptor signaling pathway (GO:0007215),-0.40035518278253024,-1.3566709148137481,0.08163265306122448,0.9333290148573773,1.0,13/37,13.22%,APP;GRIK1;GRIN2B;PTK2B;GRIN3A;GRM1;CLN3;CPEB4;FMR1;DAGLA;GRIK4;GRM3;GRIK2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.7162376538738016,1.3566613728341446,0.10989010989010989,0.9311260621817442,1.0,1/10,0.38%,RGCC
prerank,detection of visible light (GO:0009584),0.6634896847727815,1.3564334716955244,0.13202614379084968,0.9297045336332153,1.0,2/16,9.87%,CEP250;GNAQ
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.5414650126371676,1.3561410484419947,0.05416666666666667,0.9286407702882006,1.0,28/101,12.87%,PLK1;EIF6;EIF4A3;EIF3C;EIF3E;NIBAN1;MSN;THBS1;PYM1;RBM3;PRKDC;METTL3;HSP90AA1;EZR;PTTG1IP;LARP4B;VPS35;YTHDF1;FXR2;FAF1;ASPSCR1;FBXW11;MTOR;CYFIP2;PLD1;TBC1D10A;VPS11;SAMD4A
prerank,protein kinase A signaling (GO:0010737),0.6921211890406771,1.3556285348031247,0.12404287901990811,0.9287535883672003,1.0,4/12,16.82%,PRKACA;EZR;RDX;PRKACB
prerank,GTP metabolic process (GO:0046039),0.6661256551387228,1.3555381057078393,0.12208504801097393,0.9265496140444848,1.0,3/15,1.44%,LRRK2;AK4;AK3
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.6551956750799465,1.3542708967774664,0.12889518413597734,0.9310024488329377,1.0,3/14,5.28%,AK4;AK3;NMNAT3
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.5424117969980574,1.3537872368205335,0.04554655870445344,0.9309864211563383,1.0,27/128,11.05%,TUBB4B;PLK1;CETN2;CCDC57;TPD52L1;ALMS1;MAPRE1;AKAP9;CEP250;PPP2R2A;YWHAE;CDK7;PRKACA;CDK2;PCNT;HSP90AA1;MNAT1;DCTN1;TUBA1A;DCTN2;CCP110;PPP1R12B;CHEK2;ODF2;CEP152;CNTRL;FBXW11
prerank,defense response to symbiont (GO:0140546),0.5513137174071101,1.3536028314675626,0.06191950464396285,0.9293543760837732,1.0,25/92,15.14%,RNASE6;SERINC5;IFITM3;RELA;IRF1;EIF2AK2;TTC4;TLR7;FLNA;IRF3;EXOSC5;NT5C3A;SETD2;TLR3;BNIP3L;SERINC3;MAVS;TRIM5;BNIP3;IFNAR2;ZMYND11;BCL2;TRIM56;G3BP1;ATG7
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.5902829913396834,1.3530008237403734,0.09954233409610984,0.9301327652413859,1.0,17/39,16.49%,TSG101;DUSP3;GRB2;AREG;PTPRJ;RNF115;PTPN3;HGS;MVP;CDC42;CBL;TGFA;EPS15;PTPN18;SH3KBP1;SH3GL2;LGMN
prerank,high-density lipoprotein particle assembly (GO:0034380),0.7152927344462203,1.3520828268514558,0.13271604938271606,0.9327037882842159,1.0,4/10,16.82%,PRKACA;ABCA7;ABCA1;PRKACB
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.6665567143719995,1.350792794631623,0.14469914040114612,0.9373439299438079,1.0,6/14,13.91%,MDFI;G3BP2;KEAP1;FAF1;TMSB4X;PKD2
prerank,N-glycan processing (GO:0006491),0.6338168036823213,1.3506275578912812,0.11662198391420911,0.9356687183124062,1.0,9/18,16.30%,MAN1B1;ST8SIA5;ST8SIA4;GANAB;MAN2A2;PRKCSH;MGAT4B;MAN1A2;MGAT4A
prerank,relaxation of muscle (GO:0090075),-0.5361157393049685,-1.3496529609380756,0.11604095563139932,0.9585332412801586,1.0,7/13,17.48%,ATP1B1;ATP1A1;ATP1A2;KCNJ2;PIK3CA;RGS2;P2RX4
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6489887374962724,1.3490315444035093,0.1447721179624665,0.9421429084328437,1.0,5/17,10.28%,MID1;EIF2AK2;TGFB2;LYN;TAOK1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7047854849968376,1.3488972389722564,0.1259150805270864,0.9402465658566866,1.0,6/12,13.74%,PTPRJ;IFT20;HGS;F3;CBL;NDRG4
prerank,sulfur compound biosynthetic process (GO:0044272),0.5399892663530195,1.3482059072978925,0.05452674897119342,0.941494616392777,1.0,15/104,9.84%,CBS;GGTA1;MGST3;UST;B4GALT3;CHSY1;TPK1;UGDH;DSE;LIAS;GLCE;MAT2B;B4GALT5;B4GALT1;BGN
prerank,response to cAMP (GO:0051591),0.5906059834334622,1.34774459193512,0.10119047619047619,0.9413947691262261,1.0,9/37,15.36%,HCN3;RAPGEF1;AKAP9;RAP1A;EZR;RAP1B;ZFP36L1;PKD2;HCN1
prerank,regulation of striated muscle contraction (GO:0006942),-0.45492338766214646,-1.3467264295668353,0.09782608695652174,0.9614406783371764,1.0,6/27,6.97%,RYR2;CALM2;ASB3;SMAD7;GRK2;ATP1A2
prerank,regulation of mitochondrion organization (GO:0010821),0.5753734962198956,1.3461003582596796,0.09320175438596491,0.9480441079595434,1.0,13/47,12.32%,MIEF2;SIRT7;LRRK2;FBXW7;PID1;INF2;EP300;SQSTM1;GOLPH3;MAPT;VPS35;CYRIB;PARL
prerank,nerve growth factor signaling pathway (GO:0038180),0.7255242330284479,1.3460373761910875,0.12593703148425786,0.9457118464251943,1.0,2/10,4.54%,RAPGEF1;RAP1A
prerank,sympathetic nervous system development (GO:0048485),0.6684166320345465,1.3453890426632913,0.14165497896213183,0.9467166898356276,1.0,6/15,17.61%,NF1;NRP1;SOX11;NRP2;FZD3;CTNNB1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6410529931553335,1.344833421571737,0.1348464619492657,0.9470956520131943,1.0,3/20,6.60%,RGCC;THBS1;ITGA4
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.7046713195582246,1.3447943996421161,0.14349775784753363,0.9446946627624191,1.0,4/10,10.43%,CDK5RAP3;NELL1;ANXA2;FURIN
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.5526394295144548,1.3445350802721854,0.08289611752360965,0.9435010548744707,1.0,11/75,10.93%,WNT4;THBS2;RGCC;TGFB2;THBS1;PDE3B;MECP2;ALOX5;PPARG;HGS;SEMA6A
prerank,DNA alkylation (GO:0006305),0.6374203231030671,1.344341980472064,0.13793103448275862,0.9394395508065494,1.0,6/19,12.96%,EHMT1;DMAP1;EHMT2;KMT2E;DNMT3A;ATRX
prerank,DNA methylation or demethylation (GO:0044728),0.6374203231030671,1.344341980472064,0.13793103448275862,0.9394395508065494,1.0,6/19,12.96%,EHMT1;DMAP1;EHMT2;KMT2E;DNMT3A;ATRX
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6704676113204877,1.3436736657783186,0.12893982808022922,0.9406386938048028,1.0,9/16,17.50%,NRP1;PDGFB;PTPRJ;RGS14;PTPN1;ABL1;PIK3C2A;PDGFC;FER
prerank,glycerophospholipid metabolic process (GO:0006650),0.5550251350575943,1.343103448846475,0.09643605870020965,0.9413639060979891,1.0,13/75,12.07%,LCAT;PLA2G7;SERINC5;PLA2G6;FAR1;PIGP;CRLS1;HDHD5;ABHD6;PLA2G4A;PNPLA6;SERINC1;GPCPD1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.39397423330818276,-1.3418992980166213,0.08823529411764706,0.9738268964168445,1.0,15/37,27.36%,IL1RAPL1;CADM1;ICAM1;ALCAM;FAT4;HMCN1;CADM3;CD164;TENM1;TENM3;ADGRL1;NECTIN3;NECTIN1;PVR;NECTIN4
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.6937057465130589,1.341870240049778,0.13843888070692195,0.945732883840645,1.0,3/12,4.54%,PRKCZ;SNX5;IRS1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.5091370169971963,-1.3418482364724738,0.14444444444444443,0.9621090141320895,1.0,4/17,8.32%,NOS1AP;KCNAB1;AKAP6;SUMO1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.6846381030612858,1.3413598217357086,0.12946428571428573,0.9460144166300227,1.0,5/13,8.59%,WFS1;BFAR;PTPN1;ABCA7;NCK1
prerank,regulation of transposition (GO:0010528),0.6792944463123267,1.341251706056705,0.12184249628528974,0.9440627172741342,1.0,1/13,1.00%,SIRT7
prerank,relaxation of cardiac muscle (GO:0055119),-0.525726830832369,-1.3408149738437174,0.1291390728476821,0.9553919187060231,1.0,7/13,17.48%,ATP1B1;ATP1A1;ATP1A2;KCNJ2;PIK3CA;RGS2;P2RX4
prerank,positive regulation of exocytosis (GO:0045921),0.5820550319160068,1.3406763892948363,0.10556844547563805,0.9446932786491711,1.0,12/35,15.10%,TSG101;SMPD3;UNC13D;VPS4A;CADPS;SDCBP;HGS;STXBP5;VPS4B;PDCD6IP;RAB7A;CLASP1
prerank,response to zinc ion (GO:0010043),0.6039068552041008,1.3404351750627825,0.12810457516339868,0.943534229697057,1.0,10/25,10.60%,D2HGDH;HVCN1;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.5506656638114218,1.340211457048432,0.07740585774058577,0.9422410105117327,1.0,17/75,14.95%,ANG;VASH2;NRAS;SP1;VEGFC;NRP1;PDGFB;PRKCA;ITGA4;F3;HMGB1;TGFBR1;AGGF1;PPP1R16B;NRP2;PRKD2;ARNT
prerank,response to nitric oxide (GO:0071731),0.6653591985262108,1.3398323404658343,0.14285714285714285,0.9418114655693749,1.0,3/13,9.04%,CDK2;EGLN1;MTR
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.664281676822918,1.3388157825638751,0.13585434173669467,0.944911463879067,1.0,2/14,1.18%,ZNHIT3;BOP1
prerank,placenta development (GO:0001890),0.6831355003597619,1.3373808060394063,0.15151515151515152,0.9505977355262658,1.0,2/12,9.43%,ANG;PPARG
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.6868750328517588,1.3370075084402466,0.155096011816839,0.9501847534967428,1.0,3/12,8.61%,ADCY8;PLA2G6;TRPM4
prerank,positive regulation of histone acetylation (GO:0035066),0.6250776661723645,1.336907415906404,0.12564766839378239,0.9482499048857893,1.0,7/23,15.19%,BRCA1;WBP2;RPS6KA5;TADA2A;GLYR1;BRD7;SMAD4
prerank,cell-cell junction maintenance (GO:0045217),-0.5654148486532806,-1.3365259897956037,0.11607142857142858,0.9660267886940482,1.0,3/11,12.05%,TJP1;CSF1R;FERMT2
prerank,female gonad development (GO:0008585),0.6297486345823758,1.336154972103337,0.14323607427055704,0.9498964210166414,1.0,1/19,0.24%,ANG
prerank,regulation of mitochondrial translation (GO:0070129),0.6034381642215684,1.3359711500264162,0.1378413524057217,0.9483454921393468,1.0,4/21,6.76%,COA3;MALSU1;MTG2;NSUN3
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.6121943365030854,1.3354456592689523,0.12484394506866417,0.9488160516888249,1.0,3/23,2.78%,ZWINT;CDK5RAP3;VPS4A
prerank,cell cycle G2/M phase transition (GO:0044839),0.5342460395488595,1.3352215160749648,0.04939516129032258,0.9475771951581154,1.0,27/129,11.05%,TUBB4B;PLK1;CETN2;CCDC57;TPD52L1;ALMS1;MAPRE1;AKAP9;CEP250;PPP2R2A;YWHAE;CDK7;PRKACA;CDK2;PCNT;HSP90AA1;MNAT1;DCTN1;TUBA1A;DCTN2;CCP110;PPP1R12B;CHEK2;ODF2;CEP152;CNTRL;FBXW11
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5980883285960579,1.3348453621319947,0.14355828220858896,0.9471089377153227,1.0,4/31,4.91%,ISL1;TGFB2;BMPR1A;TPM1
prerank,negative regulation of cell cycle process (GO:0010948),0.5462737483937791,1.3342694431863475,0.09148936170212765,0.9478437667880864,1.0,15/61,13.42%,BRCA1;EHMT1;VPS4A;MAX;APAF1;TERF2;EHMT2;RBBP8;EZH2;CCP110;TOM1L2;PHC3;RBBP7;EPC1;TERF1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5724118923037297,1.3333646324528465,0.12270642201834862,0.9504656886178267,1.0,11/40,12.97%,RGCC;TGFB2;OLFM1;SMAD3;SDCBP;EZH2;DAB2;TGFBR2;MTOR;TCF7L2;TGFBR1
prerank,aminoglycan metabolic process (GO:0006022),-0.5887330332022469,-1.3328958397163653,0.13855421686746988,0.9734923012827774,1.0,8/10,36.15%,XYLT1;B3GAT3;CHST9;XYLT2;B4GALT7;B3GAT1;B3GAT2;CLN6
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.6778660963551426,1.3328339155146045,0.14947683109118087,0.9511187865081707,1.0,6/12,9.95%,BRCA1;RLIM;RBM15;METTL3;PCGF5;SMCHD1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5786696824907821,1.3325012095861997,0.12647754137115838,0.9504870041401916,1.0,13/35,13.71%,PMEPA1;AR;WBP2;PADI2;ESR1;NR3C1;EGLN2;KDM3A;NEDD4;UBE3A;UBR5;PPARGC1B;DDX5
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.6927866230108332,1.3319521472382927,0.14984709480122324,0.951141955501652,1.0,3/10,8.07%,ATP5F1A;ATP5MC3;ATP5MC2
prerank,stress granule assembly (GO:0034063),0.6359967954264921,1.3312938507038607,0.1422872340425532,0.9522686270210725,1.0,12/20,16.59%,RPS23;ATXN2L;CSDE1;MAPT;YTHDF1;PRRC2C;ATXN2;LSM14A;EIF2S1;BICD1;G3BP1;YTHDF3
prerank,regulation of insulin secretion (GO:0050796),0.5375363500634089,1.330794382515258,0.07755102040816327,0.9526813029908997,1.0,19/101,12.47%,ISL1;EIPR1;NNAT;CLOCK;CACNA1D;PSMD9;ADCY5;IRS1;RAP1A;PRKCA;LRP5;IRS2;ALOX5;RAPGEF4;TM7SF3;CACNA1A;EPHA5;GCK;TCF7L2
prerank,positive regulation of glycolytic process (GO:0045821),-0.48462227093285065,-1.3305898027797094,0.1016949152542373,0.963096508280135,1.0,7/20,15.19%,APP;P2RX7;PFKFB4;PRKAA1;IGF1;PRKAA2;PRXL2C
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.48462227093285065,-1.3305898027797094,0.1016949152542373,0.963096508280135,1.0,7/20,15.19%,APP;P2RX7;PFKFB4;PRKAA1;IGF1;PRKAA2;PRXL2C
prerank,positive regulation of interleukin-13 production (GO:0032736),0.7239617439053071,1.3304734597168881,0.13862928348909656,0.9519469642987834,1.0,3/10,13.99%,PRKCZ;IL18;LGALS9
prerank,response to organophosphorus (GO:0046683),-0.4993481710067326,-1.3303799058412273,0.13588850174216027,0.9531715799249924,1.0,8/16,38.52%,P2RX7;NDUFS4;P2RX4;DGKQ;TRPC3;TYMS;RFC3;VGF
prerank,glucan catabolic process (GO:0009251),-0.5260797390070021,-1.3300791253361735,0.14743589743589744,0.9437734279336442,1.0,8/15,25.30%,PHKA2;PHKB;PYGB;PGM2L1;PHKG2;PYGL;GAA;PGM2
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.6237999262027428,1.3300348455586786,0.14285714285714285,0.9520676210935839,1.0,5/23,14.29%,FNTB;METAP1;NMT1;NMT2;CALM1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6784677743204347,1.329915696413596,0.14577656675749318,0.9502857829174906,1.0,4/13,11.44%,TSG101;SOCS4;SOCS5;CBL
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.4633803204734009,-1.3286691936505914,0.1276595744680851,0.9398959789037405,1.0,9/19,22.78%,DLG2;SYNJ2BP;PATJ;PRKCI;PARD3B;FSCN1;DLG3;MTCL1;SCRIB
prerank,ribosomal subunit export from nucleus (GO:0000054),0.6678187193583511,1.3285713929666787,0.14977307110438728,0.9553741204314457,1.0,2/13,2.84%,EIF6;NMD3
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.701907467996944,1.3278305436572515,0.15619967793880837,0.9570914255215309,1.0,2/10,6.16%,BRCA1;HDAC5
prerank,cellular macromolecule catabolic process (GO:0044265),0.5648721298579635,1.326255880016225,0.11745334796926454,0.9635470229244111,1.0,13/49,14.35%,DFFB;RNASE6;FBXO17;RNASEH2A;RAB12;PPP1R8;EXOSC7;PABPC4;CHEK2;XRN2;RNASE3;HTRA2;MTREX
prerank,response to alcohol (GO:0097305),-0.42777261914916676,-1.326058832236527,0.11734693877551021,0.9425637416381508,1.0,12/27,25.52%,SLIT2;GRIN2B;TGFB1;SMAD2;GRIN3A;GLRA1;TGFBR3;GOT2;ABCA2;SLIT3;GRIN1;SOD1
prerank,iron-sulfur cluster assembly (GO:0016226),0.6111583660376856,1.3260100290964532,0.1355081555834379,0.9624523907145303,1.0,6/24,7.64%,NUBPL;NFU1;NFS1;ABCB7;HSPA9;GLRX3
prerank,regulation of mitochondrial fission (GO:0090140),0.6091782847084083,1.325615512388206,0.17016029593094945,0.9622635267894479,1.0,11/24,17.12%,MIEF2;LRRK2;INF2;MAPT;VPS35;BNIP3;CYRIB;DNM1L;STAT2;MFF;RALBP1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.6270130914749069,1.3256065700341961,0.14789687924016282,0.9598782839855813,1.0,9/19,18.14%,FLOT2;RTN3;ABCA7;PRNP;SORL1;RTN4;GGA3;BIN1;ROCK1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.5932536796773633,1.325232759617911,0.14657210401891252,0.9595223132648848,1.0,6/30,8.81%,CAVIN1;POLR1C;CDK7;POLR1A;MNAT1;UBTF
prerank,embryonic hemopoiesis (GO:0035162),0.683095992411689,1.3248691880446457,0.15178571428571427,0.9590734035594608,1.0,5/12,12.90%,KITLG;THOC5;TAL1;TGFBR2;SH2B3
prerank,protein trimerization (GO:0070206),-0.5179454580907525,-1.32325743562573,0.1412639405204461,0.9359225545430545,1.0,4/14,9.62%,SLC1A2;CLYBL;DISP1;PNPT1
prerank,protein homotrimerization (GO:0070207),-0.5179454580907525,-1.32325743562573,0.1412639405204461,0.9359225545430545,1.0,4/14,9.62%,SLC1A2;CLYBL;DISP1;PNPT1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5775763840781762,-1.3231876027995952,0.1532258064516129,0.9260947462514485,1.0,5/10,34.06%,WHRN;IFT88;PLS1;SOD1;ADGRV1
prerank,cellular response to cadmium ion (GO:0071276),0.6002839671032236,1.323061899331426,0.15532734274711169,0.9668368483524138,1.0,11/24,10.60%,JUN;MAPK1;MAPK8;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E
prerank,glutamate metabolic process (GO:0006536),-0.4769156128642364,-1.3223094368834862,0.11646586345381527,0.9203168520779123,1.0,7/19,17.17%,GLUD1;GLUL;GCLC;GOT1;MTHFS;GOT2;GCLM
prerank,copper ion transport (GO:0006825),0.704254844080332,1.3207278742098287,0.14666666666666667,0.9775648637579725,1.0,4/11,11.64%,STEAP3;COX17;ATP7A;SLC31A1
prerank,regulation of membrane depolarization (GO:0003254),0.6331182591012476,1.3207219900641405,0.155467720685112,0.9751636021738073,1.0,5/18,12.94%,LRRK2;GPD1L;CAMK2D;PTPN3;ABCD1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.5252716669799968,1.320668270535483,0.045408678102926335,0.9730049132960247,1.0,43/166,14.50%,POLR2D;CAVIN1;RORA;POLR1C;POLR3H;TFB2M;POLR2A;AR;HDAC9;CDK7;TEAD1;ESR1;POLR1A;HDAC5;NR3C1;MAML3;MAML2;MNAT1;CDK9;UBTF;TAF4;CRCP;NCOR1;PPARG;NR6A1;GTF2E1;GTF2E2;GTF2B;NR5A1;NOTCH2;KAT2B;NR2C2;GTF2F2;NCOR2;BRF1;NRBP1;NR1D2;RXRA;MED27;GTF2H1;RBPJ;PPARD;TBL1XR1
prerank,regulation of cell division (GO:0051302),0.5478274300042957,1.3205199484357024,0.09503695881731784,0.9714258020978767,1.0,14/72,9.73%,PLK1;CETN2;BLM;FGF1;BBS4;PIK3R4;KIF13A;AHCTF1;PRPF40A;SETD2;CCP110;BIRC6;NCOA3;TAL1
prerank,positive regulation of vascular permeability (GO:0043117),-0.5654517236627088,-1.3204582240227227,0.13253012048192772,0.9196924962600479,1.0,8/12,33.46%,TJP1;TGFB1;TJP2;PDE3A;ANGPT1;VEGFA;TRPV4;BMP6
prerank,regulation of DNA metabolic process (GO:0051052),0.5619343948900739,1.3201987013697418,0.11797752808988764,0.9708633537470915,1.0,9/44,8.29%,SIRT7;KDM1B;SMG6;PARG;UBE2V2;TERF2;USP1;NBN;CDK9
prerank,protein localization to cilium (GO:0061512),0.5818656467585813,1.3188846021995924,0.13333333333333333,0.9757632869202326,1.0,8/32,10.70%,NPHP4;ARL6;EHD1;BBS4;RABEP1;IFT20;SNX10;TULP3
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.7062671297154542,1.3188772488217344,0.14508580343213728,0.9733984611108477,1.0,4/10,11.89%,KDM1B;MECP2;PCGF5;DNMT3A
prerank,dorsal/ventral pattern formation (GO:0009953),0.6293620966658898,1.3186593719317286,0.15159574468085107,0.9722319418580797,1.0,3/20,6.38%,MDFI;BMPR1A;ACVR1
prerank,endothelial cell differentiation (GO:0045446),0.6737831003303264,1.3186445675990393,0.16666666666666666,0.9699097915422733,1.0,1/12,0.19%,SCUBE1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.6104845156370136,1.3181904206869166,0.15572715572715573,0.9701402007121623,1.0,5/23,9.99%,ACSBG1;HPGD;GPX4;ALOX5;FADS1
prerank,protein localization to Golgi apparatus (GO:0034067),0.5914457682291558,1.3179368560931217,0.15679012345679014,0.969156641755778,1.0,11/27,14.38%,RIPOR1;SYS1;ARL5A;IFT20;VPS13A;GOLPH3;VPS13C;RAB6A;SORL1;VPS13D;OPTN
prerank,regulation of response to external stimulus (GO:0032101),0.5365167256347145,1.317856735917047,0.06592292089249494,0.9672456369279715,1.0,27/121,14.86%,ACE2;ADAMTS12;FNTB;CD36;RELA;CX3CL1;IRF1;METAP1;EPHB2;BCL6;BIRC3;LACC1;ALOX5;AREL1;LRP8;NMT1;TRIM5;CYRIB;TMSB4X;NMT2;ERAP1;CYLD;NR1D2;RNF135;CALM1;P2RY12;PIK3AP1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5876176441083527,1.3176566642670038,0.14583333333333334,0.9659869460460888,1.0,8/28,9.22%,PRKCZ;PID1;PIP4K2A;IRS1;PRKCB;PTPN1;NCK1;PIP4K2B
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.53382950414179,1.3167607051840324,0.11087645195353749,0.9683613142944021,1.0,15/78,14.70%,PLK1;RGCC;BLM;CDK5RAP3;TFAP4;CDK7;PDGFB;IPO7;MNAT1;APC;IPO5;CCNI;GTF2H1;PKD2;PTEN
prerank,metal ion homeostasis (GO:0055065),0.5602631858936404,1.3163941311354779,0.13157894736842105,0.9680068686307508,1.0,5/40,8.66%,WFS1;SELENON;LETM1;LETM2;SLC7A8
prerank,negative regulation of hormone secretion (GO:0046888),-0.5735577710714741,-1.316300886853539,0.14814814814814814,0.9305063475549076,1.0,2/10,5.34%,RAB11FIP5;RAB11FIP3
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5653297943754194,1.3158802030650936,0.14957780458383596,0.9683490250815426,1.0,8/33,12.01%,RGCC;ITGB1BP1;THBS1;HDAC5;MECP2;PPARG;MAP2K5;HMGB1
prerank,regulation of cellular senescence (GO:2000772),-0.42748650631882334,-1.315859686272735,0.13368983957219252,0.9229959473810773,1.0,13/28,19.74%,AKT3;MAP3K3;B2M;ABI3;YBX1;YPEL3;PNPT1;RBL1;SIRT1;CGAS;RSL1D1;ING2;NEK4
prerank,diacylglycerol metabolic process (GO:0046339),0.600846169083661,1.315843272415808,0.13693467336683418,0.966230160447985,1.0,5/23,10.16%,ANG;LIPE;GPAM;DGKI;DGKD
prerank,sphingolipid catabolic process (GO:0030149),0.657173537316393,1.3156639291296346,0.15519765739385066,0.9648912061876592,1.0,6/15,12.29%,SMPDL3A;SMPD1;ACER3;PDXDC1;ASAH1;SGPL1
prerank,positive regulation of protein modification process (GO:0031401),0.5272571427327837,1.3155541253647776,0.04225352112676056,0.9631880839579349,1.0,32/203,14.30%,MUSK;FGF22;FGF18;LRRK2;FGF1;RAB3GAP1;VEGFC;SMPD1;GAS6;NIBAN1;AKTIP;CDK2AP1;SPPL3;HSP90AA1;NPTN;DAB2;KRAS;FNIP1;FXR2;MAVS;LYN;ASPSCR1;TAOK1;RAMP1;ABL1;RB1CC1;ERP29;PPP1R16B;INSR;CAMKK2;CALM1;ROCK2
prerank,mitotic nuclear division (GO:0140014),0.5441046884848951,1.3154136538472772,0.10180275715800637,0.9616487252553182,1.0,12/71,11.55%,TOGARAM2;PLK1;ZWINT;KPNB1;NDEL1;CCDC61;FLNA;KIF11;STAG2;CHEK2;EPS8;LSM14A
prerank,axoneme assembly (GO:0035082),0.5936943003524109,1.3153865916455398,0.1537544696066746,0.9594931183202204,1.0,4/30,10.67%,RSPH4A;SPAG1;DNAI4;CFAP74
prerank,regulation of inflammatory response (GO:0050727),0.5253826764913655,1.3152025892625903,0.03406813627254509,0.9582505957549752,1.0,27/190,11.87%,ACE2;ISL1;RORA;ADAMTS12;PLA2G7;TNFAIP8L2;RELA;CX3CL1;IFI35;IL16;TLR7;FEM1A;VAMP3;BCL6;BIRC3;TLR3;LACC1;ALOX5;VPS35;IL18;AREL1;PPARG;PROC;VAMP2;NFKBIZ;TMSB4X;IL17RA
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5217010277965041,-1.315159605552029,0.15807560137457044,0.9169352310951044,1.0,9/13,31.86%,TPR;NUP153;SUFU;CHP1;RANGAP1;RAB23;UFM1;CABP1;PARK7
prerank,protein localization to phagophore assembly site (GO:0034497),0.6900193672092325,1.313855723343423,0.17298937784522003,0.9632732026001835,1.0,5/11,11.84%,WDR45;WDR45B;STX17;TRAPPC8;PACS2
prerank,response to cadmium ion (GO:0046686),0.5902002751314822,1.3134226837687144,0.15452261306532664,0.9633309707141557,1.0,11/26,10.60%,JUN;MAPK1;MAPK8;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E
prerank,regulation of pH (GO:0006885),0.6725718390115707,1.3132458885573168,0.1884498480243161,0.9621098199030151,1.0,3/11,8.79%,SLC9A1;LACC1;SLC9A7
prerank,ribonucleoprotein complex assembly (GO:0022618),0.522392626427528,1.31299695285104,0.05864509605662285,0.9611653569834689,1.0,28/132,12.74%,POLR2D;EIF6;SNRPD2;SNRPD1;BOP1;DENR;GEMIN8;SART1;EIF4B;GEMIN2;RPLP0;PRKDC;TRAF7;TGS1;RPL38;RBM5;HSP90AA1;LUC7L;SRSF5;PRPF6;SNRPD3;SETX;SCAF11;DDX23;SF1;EIF3A;SRSF9;SRPK2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.5262427790861856,1.3126925926736053,0.01,0.9605410900873383,1.0,43/348,9.66%,MUSK;FGF22;FGF18;BMP5;PLK1;CAMKK1;LRRK2;DDR2;CX3CL1;RAD50;FGF1;VEGFC;BRAF;TGFB2;GAS6;NIBAN1;BMPR1A;AKAP9;RAP1A;NRP1;PDGFB;AKTIP;CDK2AP1;MAPK1;PTPRJ;SDCBP;ACVR1;HSP90AA1;MRE11;PAK2;NBN;RPS6KA5;CDK9;NPTN;DAB2;KRAS;FNIP1;FXR2;LRP8;CNOT9;MAVS;LYN;CD44
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.543343913209295,1.3122120471345087,0.10212765957446808,0.9608767770233454,1.0,9/66,5.09%,PLK1;CDK5RAP3;PARP9;DMAP1;BAG3;NMD3;TCP1;FLNA;SMAD3
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6005201352231402,1.3117895788458576,0.14321608040201006,0.9609180283653233,1.0,7/26,9.85%,CACNA1D;AKAP9;YWHAE;NEDD4;DLG1;NETO1;VAMP2
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5922870839109756,1.3117439925663927,0.14215686274509803,0.9589422674572388,1.0,7/26,9.33%,CTR9;SUV39H1;SETD1A;SETD2;KMT5B;SETD3;KMT5C
prerank,negative regulation of MAP kinase activity (GO:0043407),0.5618579533279141,1.3106668351930222,0.14988814317673377,0.9623911543801973,1.0,11/44,12.90%,CDK5RAP3;SMPD1;NF1;PTPRJ;RGS14;DUSP10;PTPN1;LYN;AIDA;SORL1;SH2B3
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5868796893786097,1.310051773709416,0.1303827751196172,0.9636179707310412,1.0,2/30,0.41%,BMP5;BRCA1
prerank,ureteric bud development (GO:0001657),-0.497800601286006,-1.3095514952550456,0.14285714285714285,0.9338011904986525,1.0,4/17,9.43%,SLIT2;SALL1;FGFR2;NPNT
prerank,regulation of dendrite development (GO:0050773),0.5665182399240939,1.3087403196851004,0.1403301886792453,0.968391873886057,1.0,10/37,12.22%,BMP5;CAMK1D;NEDD4;HECW1;ADGRB3;LRP8;SDC2;BCL11A;LZTS1;CDKL5
prerank,cellular response to estrogen stimulus (GO:0071391),0.6424612060726067,1.3085167506887756,0.18435754189944134,0.9673067741904244,1.0,3/14,4.50%,PELP1;AR;WBP2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.5897000163048957,1.3084156709151997,0.147024504084014,0.9656137781127315,1.0,11/34,16.70%,RGCC;PDGFB;CDC23;LRP5;IL1A;CDC16;TGFA;INSR;PHIP;RB1;NSMCE2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.5582378180764235,1.3083872891740338,0.12097669256381798,0.963537294812108,1.0,14/45,13.71%,HABP4;SIRT7;RELA;NMD3;POLR2A;SLC38A2;LIN28B;SETX;U2AF2;HEATR1;ERN1;TP53;MAP2K2;DDX5
prerank,regulation of steroid metabolic process (GO:0019218),0.6007722928208018,1.3083076426262958,0.1493099121706399,0.9617531490662073,1.0,6/23,11.42%,RORA;TTC39B;ABCG1;ASAH1;NR5A1;ACADL
prerank,central nervous system neuron differentiation (GO:0021953),0.578758065363921,1.307344210841638,0.13636363636363635,0.9646764041857742,1.0,4/33,7.60%,ISL1;GBA2;ATP7A;MAPT
prerank,postreplication repair (GO:0006301),0.5515918343793316,1.3068980646990669,0.14399092970521543,0.9647243484399536,1.0,7/45,6.62%,BRCA1;PCLAF;RFC2;RAD18;UBE2V2;UBE2A;POLD3
prerank,base-excision repair (GO:0006284),0.5524461443451861,1.3068636735682484,0.1329608938547486,0.9627360882179827,1.0,7/48,6.74%,POLG;MPG;RFC2;PARG;WRN;POLD3;POLB
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.4883088586272439,-1.3067667227722028,0.12802768166089964,0.9377164102454938,1.0,9/16,35.82%,BMPR2;KLK3;PLCB3;GSK3A;DDAH1;GPR37L1;SLC2A5;KLK1;PRCP
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.5916130201279554,1.3066878743628108,0.16053921568627452,0.9615420609688802,1.0,6/26,10.08%,ADCY8;PLA2G6;ADCY5;LRP5;TRPM4;EPHA5
prerank,natural killer cell activation (GO:0030101),-0.45270631848166376,-1.3065604084571616,0.1256544502617801,0.9293642046542193,1.0,11/23,24.58%,ELF4;PTPRC;IL21R;PRDX1;TOX;SNX27;PBX1;ULBP1;CASP8;SLAMF7;BAG6
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.698168790839785,1.3064940640518772,0.15968992248062017,0.9604158343873708,1.0,3/10,7.65%,UBAC2;INSIG1;ERLEC1
prerank,neural tube development (GO:0021915),0.6335236376585353,1.3062765025464156,0.15950069348127602,0.9594445702565741,1.0,2/15,1.89%,ALDH1A2;DVL1
prerank,negative regulation of MAPK cascade (GO:0043409),0.5378480262104961,1.3061688784739367,0.10651499482936919,0.9577644887820896,1.0,26/87,15.19%,CDK5RAP3;DUSP3;CNKSR3;ITGB1BP1;SMPD1;IGBP1;NF1;EPHB2;SPRED2;PTPRJ;EZR;DLG1;RGS14;RANBP9;DUSP10;PTPN1;ABCA7;LYN;SEMA6A;SORL1;SH2B3;SPRED1;PTEN;TLR4;DAG1;SMAD4
prerank,myelin maintenance (GO:0043217),0.7040630619777087,1.3058869627566045,0.14683153013910355,0.9571019565588711,1.0,5/10,14.70%,DEGS1;ABCD2;EPB41L3;ABCD1;PTEN
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.6677544722967029,1.3053753776555983,0.18285714285714286,0.957724965563335,1.0,4/12,12.94%,IRS1;ABCD2;IRS2;ABCD1
prerank,negative regulation of defense response (GO:0031348),0.5321809512947442,1.3047645356713837,0.10326659641728135,0.9588045082880694,1.0,10/77,10.06%,ISL1;RORA;TNFAIP8L2;FEM1A;ILRUN;ALOX5;VPS35;PPARG;PROC;MAPKBP1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.6281168440396865,1.304638206133908,0.15704697986577182,0.9573209825244032,1.0,8/18,14.25%,ADCY8;CAMK1D;CRTC1;RPS6KA5;LRP8;EPHA5;PRKD2;RELN
prerank,positive regulation of biosynthetic process (GO:0009891),0.5595990538184628,1.3045762455228072,0.13945578231292516,0.9555050897018501,1.0,4/40,3.64%,WNT4;RGCC;CD36;RUNX1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.5281986149984084,1.3028046581711497,0.09336099585062241,0.9624297487242448,1.0,19/98,14.36%,ACE2;PID1;GRB2;VAMP3;THBS1;PDGFB;IL10RB;ARRB2;AHI1;PPARG;CD63;ANXA2;TGFBR2;TBC1D5;MAPK14;TP53;INSR;ACACA;PPARD
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.6639351181914352,1.3014635506370702,0.1777456647398844,0.9675774521194015,1.0,1/12,0.18%,PLK1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6477326372811367,1.3008541585008238,0.18019257221458046,0.9689034832763568,1.0,3/14,7.10%,BRCA1;CTR9;KMT2E
prerank,UV-damage excision repair (GO:0070914),0.6699734453554071,1.2998672567834915,0.18100890207715134,0.9721380811055609,1.0,3/12,6.62%,ACTR5;POLA1;POLD3
prerank,cAMP metabolic process (GO:0046058),0.6601403967556894,1.2997428671751625,0.1828410689170183,0.9706830413916148,1.0,4/13,7.05%,ADCY8;ADCY3;ADCY5;ADCY9
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.6495056524960909,1.2996018197418076,0.18454935622317598,0.9692972574921367,1.0,1/13,1.34%,PARP9
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5672514802417423,1.2993659649208322,0.13093858632676708,0.9684327695367392,1.0,3/40,7.46%,ANG;RNASE6;GSDMD
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.5274405303723649,1.299262575774021,0.1071049840933192,0.9668501029479747,1.0,21/80,12.87%,EIF6;EIF4A3;RELA;SP1;EIF3C;SMPD3;EIF3E;NIBAN1;PLA2G6;THBS1;PYM1;RBM3;PRKDC;METTL3;LARP4B;YTHDF1;FXR2;ABCG1;MTOR;PLD1;SAMD4A
prerank,positive regulation of type I interferon production (GO:0032481),0.5353659076946592,1.2991831773337286,0.1202928870292887,0.965162832766043,1.0,17/73,10.15%,POLR1C;POLR3G;RIOK3;RELA;IRF1;POLR3H;TLR7;IRF3;EP300;PRKDC;HSP90AA1;MRE11;SETD2;TLR3;CRCP;MAVS;POLR3A
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.6333739859059514,1.299176998304579,0.1825962910128388,0.9630778849922949,1.0,1/13,0.26%,MGAT3
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.5277818888667754,1.2988575709447086,0.08793456032719836,0.9625319949752337,1.0,24/102,12.05%,INSIG1;RELA;ADCY8;ADCY3;RAB8B;PRKAR2A;INSIG2;RAB12;ADCY5;IRS1;HDAC9;PRKACA;MYO5A;PRKDC;HDAC5;PDE3B;IRS2;ADCY9;PPARG;VAMP2;KAT2B;GCK;TBC1D4;ZFP36L1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.582111148954099,1.2987895493969408,0.14472123368920523,0.9607897350946072,1.0,7/33,12.68%,PDE6H;FBXW7;AREG;CNOT9;DGKD;CBL;TGFA
prerank,divalent inorganic cation homeostasis (GO:0072507),0.5905311993474464,1.2985554924350293,0.1794228356336261,0.9599681547227413,1.0,2/25,0.70%,WFS1;SELENON
prerank,protein localization to chromatin (GO:0071168),0.6286292454244715,1.2983829648094154,0.18353576248313092,0.9587640364130247,1.0,4/18,7.70%,PLK1;PPHLN1;ESR1;LEMD2
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.5378183265734191,1.2982825534304105,0.12150537634408602,0.9571996665749531,1.0,3/62,1.07%,CXCL12;URI1;LRRK2
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.5568726948737343,1.2975389906252084,0.14685314685314685,0.9590601241292097,1.0,9/38,9.28%,POLR3G;RIOK3;IFI35;DDX60;SASH1;PRKCA;PUM2;AKIRIN2;PUM1
prerank,cellular response to growth factor stimulus (GO:0071363),0.5169134722005502,1.2972373621867352,0.05220883534136546,0.9585693406815705,1.0,36/151,13.90%,WNT4;ADAMTS12;GAS1;URI1;DUSP3;RELA;RAPGEF1;ITGB1BP1;EHD1;STMN2;BMPR1A;RAP1A;NRP1;SMAD3;PDGFB;NR3C1;ACVR1;MAPT;TWF2;LIMS1;CD44;SETX;MT1G;SEMA6A;TGFBR2;MAP2K5;ZFP36L1;ERN1;MAPK14;SOX6;MAPKAPK2;TGFBR1;ACVR1B;WWOX;HTRA2;PRKD2
prerank,regulation of interleukin-12 production (GO:0032655),0.5566039471540949,1.2959477545445304,0.1343612334801762,0.9635336325664092,1.0,12/47,15.45%,ISL1;IL16;THBS1;CMKLR1;TLR3;MAST2;HMGB1;MAPK14;SYK;LGALS9;TLR4;CD47
prerank,regulation of cytokinesis (GO:0032465),0.5369931920314471,1.2958430747440446,0.1192468619246862,0.9619899030869161,1.0,21/78,15.16%,PLK1;CETN2;SVIL;VPS4A;BBS4;PIK3R4;KIF13A;AHCTF1;PRPF40A;KIF20B;GIPC1;SETD2;PKN2;CCP110;BIRC6;CDC42;UVRAG;SH3GLB1;CALM1;PKP4;BECN1
prerank,negative regulation of telomere maintenance (GO:0032205),0.6403574456302584,1.295836679880982,0.16338028169014085,0.9599735996885034,1.0,6/15,8.76%,RAD50;SMG6;TERF2;ERCC4;NBN;TNKS2
prerank,positive regulation of cell cycle (GO:0045787),0.534128388718123,1.2944591868181963,0.13325991189427314,0.9651922726735014,1.0,15/62,13.91%,RGCC;CCDC57;DUSP3;NUPR1;TGFB2;HCFC1;USP19;PDGFB;PRKCA;RPS15A;PKN2;TAL1;SRPK2;LRP6;PKD2
prerank,regulation of dephosphorylation (GO:0035303),0.6392348915548668,1.2943662551898176,0.1571627260083449,0.9636244920055874,1.0,4/15,4.09%,CDK5RAP3;SMG6;IGBP1;MTMR1
prerank,regulation of hormone secretion (GO:0046883),0.6390344226938167,1.2932931221903539,0.17852161785216178,0.9671750606472612,1.0,3/15,11.42%,VAMP3;VAMP2;SOX11
prerank,regulation of sprouting angiogenesis (GO:1903670),0.5668747751822953,1.292773018122166,0.15782983970406905,0.967931252534524,1.0,6/33,10.93%,FGF18;FGF1;THBS1;CEMIP2;ALOX5;SEMA6A
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.5772236584232986,1.2925556919601122,0.14958775029446408,0.9671003200908941,1.0,8/33,16.27%,ANG;IGFBP3;TPM1;PPARG;NDRG4;AIF1;PTEN;MEF2C
prerank,regulation of protein processing (GO:0070613),0.6049937974060919,1.2924391194769511,0.16623711340206185,0.9655868848174445,1.0,3/21,3.64%,GAS1;LRRK2;RUNX1
prerank,triglyceride catabolic process (GO:0019433),-0.46131678277643573,-1.2924262464964111,0.1865671641791045,0.988266332625745,1.0,3/19,16.93%,LPL;FABP5;LIPH
prerank,cell-cell junction organization (GO:0045216),0.5297283216749824,1.291923651953153,0.12215320910973085,0.9663201877223508,1.0,7/79,5.31%,SDK2;ANG;GJC1;TLN2;TGFB2;SMAD3;CTNNA1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.639398114936338,1.2917860989578565,0.17580872011251758,0.9649732014963033,1.0,3/15,9.14%,PLK1;CDC23;CDC16
prerank,regulated exocytosis (GO:0045055),0.5179015449214578,1.2913976742782018,0.046370967741935484,0.9649354078945241,1.0,32/173,12.08%,STXBP2;HABP4;VCL;FAM3C;CD36;VAMP7;ENDOD1;SELENOP;VEGFC;TGFB2;GAS6;SCG3;THBS1;FLNA;ALDOA;PDGFB;QSOX1;FERMT3;SYT12;SYT11;LHFPL2;PHACTR2;F13A1;LYN;VAMP2;CDK5;CD63;ACTN4;CYRIB;TMSB4X;APOOL;WDR1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.55066686057192,-1.2912403824865846,0.16422287390029325,0.9840491224201436,1.0,3/11,14.23%,PTPRC;SMAD7;LILRB1
prerank,muscle cell differentiation (GO:0042692),0.5869556705169225,1.2906039775732767,0.1652892561983471,0.9668490250236966,1.0,4/32,6.05%,RORA;GLMN;NEBL;MRTFB
prerank,regulation of protein kinase B signaling (GO:0051896),0.5196075573543398,1.2904390804467343,0.03707414829659319,0.9657519561667129,1.0,40/193,15.24%,FGF22;FGF18;NRG2;CX3CL1;FGF1;GRB2;ITGB1BP1;GAS6;AREG;IRS1;THBS1;PDGFB;KITLG;PTPRJ;ESR1;ARRB2;AXL;IRS2;HSP90AA1;IL18;PHLPP1;MTDH;F3;IGF1R;FRS2;TCF7L2;BANK1;TGFA;SH2B3;TGFBR1;RTN4;INSR;FYN;PPP2R5C;P2RY12;PTEN;PIK3AP1;VAV1;DAG1;HIP1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.5188607241101214,1.2897818919336506,0.06822810590631365,0.9672099523942367,1.0,21/125,11.83%,PLK1;NUDC;PMF1;ZWINT;SBDS;KPNB1;NDEL1;MAPRE1;AHCTF1;PCNT;DYNLL2;BUB3;KIF11;SETD2;NUP98;DCTN2;MECP2;CENPP;TAOK1;EML4;EML1
prerank,regulation of fibroblast migration (GO:0010762),-0.44932803914037717,-1.289709797776311,0.1511627906976744,0.9819959142022382,1.0,13/20,10.71%,PRKCE;PTK2;TGFB1;RFFL;APPL2;CORO1C;RAC1;APPL1;CLN3;PRR5L;GNA12;ARHGEF7;FGF2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.6012937951096278,1.2889300167860824,0.18356867779204109,0.9697130438369455,1.0,4/20,6.83%,AK4;AK3;ADSS1;HPRT1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.5428200301193251,1.2889178492638957,0.15958668197474168,0.9677772614886636,1.0,9/43,9.22%,PRKCZ;PID1;SNX5;PIP4K2A;IRS1;PRKCB;PTPN1;NCK1;PIP4K2B
prerank,Wnt signaling pathway (GO:0016055),0.5231071126670936,1.2885121014602066,0.11582213029989659,0.9678903189081937,1.0,21/92,14.70%,WNT4;LRRK2;WNT2B;DVL1;ARL6;CPE;USP34;LRP5;DIXDC1;SNX3;CSNK1G1;VPS35;NXN;APC;WLS;TCF7L2;LRP6;CSNK1A1;FZD9;FZD3;PTEN
prerank,import into nucleus (GO:0051170),0.5265199387067815,1.2876424807566085,0.12630480167014613,0.9704144349272804,1.0,18/73,13.36%,SNRPD2;SNRPD1;GEMIN8;KPNB1;EIF4ENIF1;HIKESHI;HEATR3;GEMIN2;RANBP6;IPO7;IPO9;PTTG1IP;CSE1L;SNRPD3;IPO5;BACH2;IPO11;SYK
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.6400316574363277,1.287187105813671,0.1856946354883081,0.9708200566341586,1.0,3/15,11.69%,ZFYVE27;GRB2;FRS2
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.4330504662453721,-1.2871498211591315,0.13471502590673576,0.9854833203963359,1.0,14/23,46.36%,FGF2;SMO;ITGAX;VEGFA;GJA1;PAX8;PAX2;MDK;SOX8;AGT;WNT5B;SOX9;SIRT6;EGF
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.5466074023822761,1.286949829070988,0.14174107142857142,0.9700682978763118,1.0,10/45,12.45%,RGCC;GAS1;ZWINT;BCL6;SMAD3;PTPN3;TOM1L2;PRCC;ZFP36L1;HECA
prerank,mitotic spindle organization (GO:0007052),0.5136070252483733,1.2868590345272881,0.0655241935483871,0.9685179292240766,1.0,26/153,11.83%,TOGARAM2;PLK1;NUDC;PMF1;ZWINT;SBDS;KPNB1;NDEL1;CCDC61;MAPRE1;FLNA;AHCTF1;PCNT;DYNLL2;BUB3;KIF11;NUP98;DCTN2;MECP2;STAG2;CHEK2;CENPP;TAOK1;LSM14A;EML4;EML1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5415828886481612,-1.2868188824725202,0.16417910447761194,0.9775573319037488,1.0,5/12,23.21%,ATP1B3;ATP1B1;WNK2;WNK3;ATP1B2
prerank,phospholipid metabolic process (GO:0006644),0.5338022232839434,1.286715982857315,0.13602550478214664,0.9672914154286985,1.0,11/71,10.71%,LCAT;SMPD3;SMPD1;PIP4K2A;GPX4;GPAM;PLA2G4A;PIP4K2B;FADS1;PLAA;AGPAT4
prerank,response to interleukin-1 (GO:0070555),0.5295833128932159,1.2866543197966074,0.1307531380753138,0.9656508943611181,1.0,11/73,10.86%,ADAMTS12;TNFRSF11A;RELA;CX3CL1;SMPD1;IGBP1;PRKCA;CCL25;IRAK2;YTHDC2;TANK
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.560262171326941,1.286464668981933,0.15393654524089306,0.9646390947592145,1.0,10/36,13.25%,BRCA1;EHMT1;MAX;APAF1;EHMT2;RBBP8;EZH2;PHC3;RBBP7;EPC1
prerank,regulation of cellular component biogenesis (GO:0044087),0.5582239736881359,1.2864425763262874,0.15207373271889402,0.9627967878753279,1.0,12/39,14.30%,CD36;RAPGEF1;HCFC1;MSN;RAP1A;SPTY2D1;HSP90AA1;EZR;RAP1B;TRAF2;VPS11;ROCK2
prerank,organelle fission (GO:0048285),-0.4371114417356762,-1.2862517942535434,0.13218390804597702,0.9710522813308572,1.0,13/24,32.23%,PRKN;OPA1;DNM2;CORO1C;TMCC1;DNM1;PEX19;MIEF1;GDAP1;FIS1;MTFR1;ACOT8;MTFR1L
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.51959217013958,-1.286242412737278,0.18685121107266436,0.9620949089472747,1.0,5/13,12.31%,FGR;STX4;GAB2;ITGB2;AP1G1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.538083115150021,1.2862087805951352,0.12140575079872204,0.9620373013529265,1.0,19/65,16.09%,PDE6H;TSG101;DUSP3;GRB2;AREG;PTPRJ;RNF115;PTPN3;CNOT9;HGS;DGKD;MVP;CDC42;CBL;TGFA;EPS15;HIP1;SH3KBP1;SH3GL2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5717597253253018,1.2857532231269564,0.16967509025270758,0.9624160922896303,1.0,11/29,11.02%,TUT4;SMAD3;PUM2;METTL3;HNRNPA2B1;AGO2;LIN28B;PUM1;ZC3H7A;ADAR;PRKRA
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.5151666836850847,1.2856853655452016,0.012,0.9608143728017243,1.0,63/348,14.30%,MUSK;FGF22;FGF18;RGCC;BRCA1;WFS1;CD36;SP1;PID1;FGF1;FAM98A;PPHLN1;BRAF;GAS6;HCFC1;OLFM1;MSN;RBMS3;VAMP3;EPHB2;AR;SMAD3;TERF2;PDGFB;MAPK1;SLC38A2;TNRC6B;ARRB2;IL1A;EZR;TLE1;MAPK8;TLR3;AGO2;PTPN1;ITGB8;VPS35;KRAS;LIMS1;AHI1;DTNBP1;CD63;HGS;F3;ANXA2;NR5A1;SOX11;MTOR;MAP2K5;TASOR;TBC1D5;MAPK14;ERP29;UBR5;SRPK2;TP53;TGFBR1;FUBP3;FN1;INSR;LGALS9;RBPJ;ROCK2
prerank,pulmonary valve morphogenesis (GO:0003184),0.642052848723284,1.2851578842722016,0.16734143049932523,0.9616595323413956,1.0,4/17,11.19%,SMAD6;TGFB2;NFATC1;NOTCH2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.6166805016173708,1.285126446139618,0.1906005221932115,0.9599198555757422,1.0,6/19,11.20%,SMAD6;TGFB2;OLFM1;BMPR1A;ACVR1;TGFBR2
prerank,regulation of cell adhesion (GO:0030155),0.5138894668276929,1.2844390551806806,0.06945863125638406,0.9614628612396933,1.0,26/129,14.97%,CXCL12;PLXNA1;MINK1;ITGB1BP1;RSU1;EPHB2;TPM1;PRKCA;PTPRJ;CBLL1;PDE3B;STX3;LPXN;IL18;LYN;MIA3;CYTH1;ABL1;ADAM10;PLXNC1;ADAM22;ATXN3;PRKD2;ROCK2;PKP4;ARHGDIB
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6062030964192149,1.2841781264894092,0.1762402088772846,0.9609608254487664,1.0,6/21,11.10%,CGNL1;TGFB2;EPHB2;MAPKAP1;CD2AP;CYRIB
prerank,regulation of hydrolase activity (GO:0051336),0.5278762690211415,1.284017866449979,0.12913553895410887,0.9598172681875156,1.0,21/71,15.08%,PLXNA1;CDK5RAP3;FGD6;FGD3;FGD1;ITGB1BP1;RAB3GAP1;NF1;TBC1D15;WRN;VAV3;TBC1D10B;EPHA5;FBXW11;OCRL;VAV2;RABGAP1;ARHGAP15;PLXNC1;SCARB2;VAV1
prerank,striated muscle cell development (GO:0055002),0.6438473881800595,1.2839179989121294,0.1934566145092461,0.9584519610769223,1.0,2/14,4.80%,TMOD1;TMOD3
prerank,DNA-dependent DNA replication (GO:0006261),0.5150488506444515,1.2827277410017022,0.08113590263691683,0.9626389906934719,1.0,27/128,12.95%,POLG;SIRT7;BLM;RFC2;POLE4;POLE2;SSBP1;PSMD9;ORC4;PSMB8;POLA1;WRN;CDK2;CDK2AP1;NOC3L;POLA2;POLD3;POLG2;POLB;PSMC5;PRIM2;ORC2;DDX23;REV3L;PSMD12;SRPK2;PSMA2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.5233508397938044,1.2826924948632805,0.07575757575757576,0.9609221798391421,1.0,21/138,13.79%,MUSK;ROR2;DDR1;DDR2;RAPGEF1;EPHB2;LIFR;YES1;ABI1;AXL;PTPRT;AHI1;LYN;EPHA5;IGF1R;FRS2;ACVR1B;SYK;PTPRU;INSR;FYN
prerank,body fluid secretion (GO:0007589),-0.4950154820520549,-1.2824658613193978,0.15492957746478872,0.9697961069264062,1.0,6/15,30.95%,ERBB4;GPAT4;PRLR;SLC22A4;VEGFA;ZBTB7B
prerank,epithelial to mesenchymal transition (GO:0001837),0.5414292068711397,1.2818473509578454,0.14253897550111358,0.9633345653047605,1.0,10/47,14.30%,WNT4;TGFB2;OLFM1;LIMS1;LOXL3;TASOR;TGFBR1;DDX5;RBPJ;ROCK2
prerank,RNA catabolic process (GO:0006401),0.5440418978881782,1.2815897940200534,0.1647982062780269,0.9627114017920229,1.0,11/46,12.18%,RNASE6;CNOT10;ZC3H12D;RNASEH2A;METTL3;PPP1R8;EXOSC7;PABPC4;XRN2;RNASE3;ERN1
prerank,ether lipid metabolic process (GO:0046485),0.6408502811275705,1.2815526194646714,0.1647887323943662,0.960980401835995,1.0,4/14,5.02%,PLA2G7;LIPE;PLA2G6;FAR1
prerank,neurotransmitter transport (GO:0006836),0.5316052866577111,1.2813748645921281,0.1368421052631579,0.9599936268525135,1.0,8/73,7.93%,STXBP2;PDZD11;DVL1;GAD2;SLC38A2;PPFIA1;APBA1;SYN3
prerank,response to tumor necrosis factor (GO:0034612),0.5193767175673949,1.281189407431614,0.11618257261410789,0.9590489416051133,1.0,16/91,12.66%,BRCA1;ADAMTS12;TNFRSF11A;RELA;CX3CL1;PID1;SMPD1;IGBP1;IKBKB;CCL25;ZFAND6;YTHDC2;ASAH1;TANK;ZFP36L1;ADAM10
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.56166665042009,1.2808752057232955,0.1705521472392638,0.9587481464943465,1.0,4/31,8.47%,PYCR2;LIAS;NFS1;ALOX5
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.5388938132637802,1.280665211040424,0.14956331877729256,0.9579898684092594,1.0,13/52,12.87%,POLR2D;CNOT10;LSM7;TUT4;EXOSC5;DCP1B;RC3H2;EXOSC7;CNOT9;DCP1A;CNOT3;DCPS;SAMD4A
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6601073454178155,1.280332333276389,0.18711656441717792,0.9577762800257917,1.0,2/11,2.65%,UQCRH;UQCRC1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.6744301679349038,1.2800695461983018,0.2033132530120482,0.9571365811018876,1.0,3/10,7.97%,EHMT1;SETD2;SETD3
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.5539970084633689,1.279167002896286,0.15092165898617513,0.9599938978415704,1.0,10/36,12.73%,DUSP3;IGBP1;EZR;DLG1;DUSP10;NCOR1;FKTN;ZMYND11;AIDA;CYLD
prerank,phagolysosome assembly (GO:0001845),-0.5206593697121983,-1.2783382326946515,0.16905444126074498,0.9800411663990456,1.0,6/12,16.55%,ARL8B;CLN3;RAB14;CORO1A;RAB39A;RAB20
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5154630483048657,1.2779614103251844,0.10526315789473684,0.9641537062600354,1.0,16/110,14.41%,RXFP1;S1PR1;ADGRE1;ADCY8;ADCY3;ADCY5;GPR65;ADCY9;ADGRB3;ADGRE5;GNAQ;RAMP1;ABCA1;CALCRL;GNG2;GNB1
prerank,activation of protein kinase activity (GO:0032147),0.5232721085019871,1.2778257721635575,0.09867751780264497,0.9629579188143748,1.0,23/106,11.90%,ANG;MINK1;ADCY8;ADCY3;FGF1;ITGB1BP1;PRKAR2A;TGFB2;GAS6;ADCY5;PDGFB;PRKACA;STK11;ADCY9;TLR3;PAK2;MAPKAP1;IL18;TAOK1;TRAF2;TGFBR2;MTOR;ABL1
prerank,regulation of telomere maintenance (GO:0032204),0.5766420467338532,1.2769449375337114,0.17530864197530865,0.9655062378411496,1.0,10/26,16.91%,RAD50;SMG6;TERF2;MRE11;ERCC4;NBN;ATRX;PPP1R10;HNRNPD;YLPM1
prerank,regulation of cellular component organization (GO:0051128),0.5147336235819466,1.2765995088287372,0.07489878542510121,0.9653220810785429,1.0,24/135,11.90%,SGK3;SGK2;URI1;CD36;RAPGEF1;SETD1A;HCFC1;RAP1A;STON2;PACSIN2;EGLN2;CAMSAP3;STK11;HSP90AA1;RAB5B;NRG3;NEDD4;RAP1B;CAMK2D;PTPN1;TRAF2;RIT2;MTOR;ABL1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.60778299666029,1.27619040803963,0.18229854689564068,0.9655448592240056,1.0,4/19,12.94%,IRS1;ABCD2;IRS2;ABCD1
prerank,intestinal lipid absorption (GO:0098856),0.664071213537682,1.2759696756743912,0.21116138763197587,0.9647138127259868,1.0,3/11,13.71%,CD36;CEL;LIMA1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5218904998536743,1.2755817829425022,0.12058212058212059,0.964864221863207,1.0,17/86,15.19%,BMP5;ZEB2;TGFB2;BMPR1A;THBS1;EP300;SDCBP;ACVR1;STK11;GIPC1;DAB2;SOX11;HIPK2;TGFBR1;ACVR1B;RBPJ;SMAD4
prerank,positive regulation of gene expression (GO:0010628),0.5103758220801756,1.2750435023729272,0.006,0.9656081171454286,1.0,78/442,13.49%,MUSK;FGF22;FGF18;EIF6;RGCC;BRCA1;HABP4;ELAVL4;POLR1C;EIF4A3;CD36;SP1;EIF2AK2;EIF3C;PID1;GLMN;FGF1;FAM98A;EIF3E;BRAF;GAS6;HCFC1;OLFM1;NIBAN1;MSN;POLR2A;RBMS3;EPHB2;AR;WBP2;THBS1;PYM1;RBM3;EP300;SMAD3;TERF2;PDGFB;PRKDC;MAPK1;SLC38A2;TNRC6B;POLR1A;METTL3;IL1A;EZR;TLE1;MAPK8;LARP4B;TLR3;AGO2;ITGB8;VPS35;YTHDF1;KRAS;LIMS1;FXR2;DTNBP1;SETX;HGS;F3;U2AF2;NR5A1;KAT2B;SOX11;MTOR;SCAMP5;ERN1;PLD1;MAPK14;ERP29;UBR5;SRPK2;SAMD4A;TP53;TGFBR1;MAP2K2;FUBP3;FN1
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.6536458580210293,1.2748341955106373,0.18114874815905743,0.9648482584849376,1.0,7/13,18.59%,AR;ESR1;NR3C1;NR3C2;MED1;PLPP1;PGR
prerank,regulation of mRNA metabolic process (GO:1903311),-0.5331724454013189,-1.274726375512798,0.19117647058823528,0.9882983013880214,1.0,4/11,8.86%,DHX9;SAFB;CDK11B;SRPK1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.5306147265601978,1.2743796659139148,0.14957264957264957,0.9653217637456862,1.0,18/69,11.97%,POLR2D;SNAPC5;RPRD1B;SP1;PHAX;INTS12;INTS2;POLR2A;CDK7;RPRD2;RPRD1A;CDK9;INTS4;GTF2E1;GTF2E2;GTF2B;GTF2F2;RPAP2
prerank,positive regulation of protein deacetylation (GO:0090312),-0.4935679768523543,-1.2732621718244133,0.17279411764705882,0.9860436992387571,1.0,6/14,18.18%,DYRK1A;AKAP8;NIPBL;FNTA;SAP30BP;ING2
prerank,microtubule nucleation (GO:0007020),0.6042497313564482,1.273248981146632,0.18064516129032257,0.9690040920307452,1.0,6/19,8.66%,CCDC57;NDEL1;AKAP9;TUBGCP6;RANBP9;TUBGCP2
prerank,glycoprotein catabolic process (GO:0006516),0.6082848775057526,1.2726578539975837,0.18331053351573187,0.9702519816980641,1.0,2/17,1.05%,ADAMTS12;FBXO17
prerank,regulation of fatty acid metabolic process (GO:0019217),0.6186434037816015,1.2722513625541723,0.19346049046321526,0.970374610553134,1.0,5/17,14.36%,EIF6;NCOR1;PPARG;ADIPOR1;PPARD
prerank,cilium movement (GO:0003341),0.5354860747869012,1.2719650617928853,0.15916575192096596,0.969965684254886,1.0,3/47,10.04%,RSPH4A;CAMSAP3;DNAI4
prerank,regulation of G0 to G1 transition (GO:0070316),0.5528766506810956,1.271902117551464,0.1548311990686845,0.9684265584113211,1.0,10/38,13.25%,BRCA1;EHMT1;MAX;APAF1;EHMT2;RBBP8;EZH2;PHC3;RBBP7;EPC1
prerank,histone H2A acetylation (GO:0043968),0.6273950191923596,1.2718321781559296,0.19293478260869565,0.9669975231780455,1.0,7/16,15.69%,DMAP1;BRD8;ING3;MORF4L2;EPC1;EP400;TRRAP
prerank,embryonic appendage morphogenesis (GO:0035113),0.6473994161273829,1.2718063794678531,0.19941348973607037,0.9652770744195134,1.0,4/12,15.49%,TGFB2;MBNL1;LRP6;FBXW4
prerank,positive regulation of interferon-beta production (GO:0032728),0.566889714293289,1.2714643367628153,0.16488730723606168,0.9651943887246024,1.0,12/33,14.85%,POLR3G;RIOK3;IRF1;TLR7;IRF3;HSP90AA1;TLR3;MAVS;POLR3A;TRIM56;RNF135;TLR4
prerank,apoptotic DNA fragmentation (GO:0006309),0.6197092869471099,1.2710145761804734,0.2011173184357542,0.9655632295935568,1.0,2/16,2.43%,DFFB;KPNB1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.5167473941002556,1.2707032753902323,0.13451511991657977,0.9653040025536834,1.0,11/80,7.08%,PLK1;BRCA1;WFS1;LRRK2;CDK5RAP3;FBXW7;PEF1;UBQLN1;BIRC3;DCUN1D4;PTTG1IP
prerank,regulation of coagulation (GO:0050818),0.648006406635981,1.2707025849150704,0.2088888888888889,0.9634963171556428,1.0,2/11,9.62%,EPHB2;PROC
prerank,regulation of cytokine production (GO:0001817),0.5108926915262529,1.2706790824250584,0.10202020202020202,0.9617965823676492,1.0,22/126,13.99%,ACE2;RGCC;EIF2AK2;GLMN;IRF3;BCL6;HDAC9;POLA1;IL1A;SYT11;RPS6KA5;ALOX5;NPTN;MAST2;ICOSLG;LYN;PLD4;SCAMP5;MAPK14;MAPKAPK2;TRIM56;LGALS9
prerank,mRNA polyadenylation (GO:0006378),-0.42753185610211236,-1.270652011597285,0.16326530612244897,0.980715089183255,1.0,15/26,22.49%,APP;TENT2;TENT4B;WDR33;AHCYL1;PABPC1;MTPAP;PNPT1;PAPOLG;SYMPK;CPSF2;GRSF1;CDC73;TUT1;PCF11
prerank,RNA polyadenylation (GO:0043631),-0.42753185610211236,-1.270652011597285,0.16326530612244897,0.980715089183255,1.0,15/26,22.49%,APP;TENT2;TENT4B;WDR33;AHCYL1;PABPC1;MTPAP;PNPT1;PAPOLG;SYMPK;CPSF2;GRSF1;CDC73;TUT1;PCF11
prerank,glycoprotein metabolic process (GO:0009100),0.5292766099693911,1.2696215028550317,0.15027027027027026,0.965597432575857,1.0,16/53,17.11%,MAN1B1;FBXO17;ST8SIA5;ST8SIA4;ERP44;GOLPH3;GANAB;B4GALT5;MAN2A2;PRKCSH;MGAT4B;PCSK6;MAN1A2;MGAT4A;LARGE1;ST3GAL2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.5731218317872654,1.269442965741408,0.1837968561064087,0.962976164321396,1.0,7/31,13.65%,POLR2D;POLR2A;CDK7;MNAT1;RNGTT;GTF2F2;GTF2H1
prerank,7-methylguanosine RNA capping (GO:0009452),0.5731218317872654,1.269442965741408,0.1837968561064087,0.962976164321396,1.0,7/31,13.65%,POLR2D;POLR2A;CDK7;MNAT1;RNGTT;GTF2F2;GTF2H1
prerank,regulation of protein localization to nucleus (GO:1900180),0.5427409247502832,1.2691943228375886,0.16647662485746864,0.9623342257020361,1.0,6/43,7.33%,PLK1;CDK5RAP3;PARP9;ILRUN;CTNNA1;SUMO3
prerank,regulation of DNA binding (GO:0051101),0.5482117498993758,1.2690203550311137,0.16059225512528474,0.9614355124959996,1.0,9/44,9.43%,MDFI;HABP4;TFAP4;JUN;ZBTB7A;ILRUN;SUMO3;MAPK8;PPARG
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.4866670780168301,-1.2685487764589867,0.15463917525773196,0.9818677532664748,1.0,9/16,18.62%,SIK3;CLEC16A;GPR137B;PIP4P1;FLCN;KLHL22;RRAGD;SEH1L;RRAGB
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.5628953007016883,1.2684853129543459,0.19103773584905662,0.9622715322483517,1.0,6/32,8.81%,CAVIN1;POLR1C;CDK7;POLR1A;MNAT1;UBTF
prerank,gland development (GO:0048732),0.5290602092946232,1.2680482629980194,0.15236051502145923,0.9626314220942043,1.0,10/59,13.91%,WNT4;CDK5RAP3;NF1;MSN;ARID5B;EZR;ARHGAP35;PRKCSH;TGFBR1;PKD2
prerank,nucleoside phosphate catabolic process (GO:1901292),0.6442592937185582,1.2678649971558797,0.2143884892086331,0.9617070281036273,1.0,2/13,8.09%,SMPDL3A;ENTPD1
prerank,regulation of secretion (GO:0051046),-0.5146434627338397,-1.2677810245673535,0.19727891156462585,0.9770279221948202,1.0,8/13,36.88%,MYO6;SGK1;ACSL3;OAS2;FGF10;GPLD1;ERBB3;POFUT2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5498356614483985,1.2675656771648043,0.14959723820483314,0.9614282102808864,1.0,4/38,6.99%,BMP5;BRCA1;THBS1;RNF34
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.666731848864159,1.2675005001805655,0.19672131147540983,0.9581946037209793,1.0,5/11,15.36%,INPP1;INPP5A;OCRL;PTEN;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.666731848864159,1.2675005001805655,0.19672131147540983,0.9581946037209793,1.0,5/11,15.36%,INPP1;INPP5A;OCRL;PTEN;SYNJ2
prerank,regulation of mitotic spindle assembly (GO:1901673),0.6080006349778474,1.2672808015100943,0.19047619047619047,0.957499833287416,1.0,3/19,2.90%,PLK1;EML3;CHMP5
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.6442768456653313,1.2668205264522343,0.20982142857142858,0.9580210667616458,1.0,6/12,13.60%,SETX;BNIP3;IGF1R;UVRAG;FYCO1;INSR
prerank,ESCRT complex disassembly (GO:1904896),0.6704694145452815,1.2666312645622773,0.19461077844311378,0.9554975408339499,1.0,4/10,14.18%,VPS4A;CHMP5;VPS4B;IST1
prerank,ESCRT III complex disassembly (GO:1904903),0.6704694145452815,1.2666312645622773,0.19461077844311378,0.9554975408339499,1.0,4/10,14.18%,VPS4A;CHMP5;VPS4B;IST1
prerank,response to steroid hormone (GO:0048545),0.5514930990812834,1.266452108509965,0.1718377088305489,0.9547181622156244,1.0,8/31,12.58%,URI1;TGFB2;AR;WBP2;THBS1;NR3C1;UBE3A;PAQR8
prerank,glutathione derivative biosynthetic process (GO:1901687),0.5974226757281328,1.2664001777904694,0.18701298701298702,0.951540519424551,1.0,1/20,0.99%,MGST3
prerank,glutathione derivative metabolic process (GO:1901685),0.5974226757281328,1.2664001777904694,0.18701298701298702,0.951540519424551,1.0,1/20,0.99%,MGST3
prerank,positive regulation of phagocytosis (GO:0050766),-0.35360140272742846,-1.2657949879838692,0.11666666666666667,0.9778096038506774,1.0,14/47,13.61%,ANO6;PTPRC;RAB31;APPL2;FCER1G;SLC11A1;FCGR2B;CD300LF;CYBA;RAB27A;CALR;PYCARD;SIRPA;IL15RA
prerank,amyloid fibril formation (GO:1990000),-0.3488441363510706,-1.2657040818868808,0.06060606060606061,0.969949106179734,1.0,15/51,12.33%,USP9X;APP;PRKN;TSPAN14;CST3;B2M;H3-3A;TSPAN5;SIAH1;RIPK1;SNCA;NCSTN;GGA2;UBC;FKBP1A
prerank,cellular response to hydroxyurea (GO:0072711),0.6668857054799899,1.265648904391594,0.21341463414634146,0.9536912689571257,1.0,4/10,14.72%,BLM;RTF2;ATRX;SPIDR
prerank,gastrulation (GO:0007369),0.6268922805791807,1.2656299075963278,0.20874471086036672,0.9520722931232498,1.0,5/15,13.37%,UGDH;LRP5;LMBRD1;TASOR;GPC3
prerank,cellular response to fatty acid (GO:0071398),0.652375535706258,1.2653083532491196,0.19846153846153847,0.9519840055637411,1.0,2/12,4.54%,PID1;IRS1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.5858906824940414,1.2651364965350909,0.17838541666666666,0.9510854565501944,1.0,4/23,10.87%,TNFRSF11A;SASH1;MAP3K11;TRAF2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.6562161609680051,1.264852345457445,0.19760479041916168,0.9507997184061032,1.0,2/12,8.15%,BLM;NBN
prerank,metallo-sulfur cluster assembly (GO:0031163),0.5913802902200923,1.264507417108084,0.189873417721519,0.9507671736536205,1.0,5/22,7.55%,NUBPL;NFU1;NFS1;ABCB7;HSPA9
prerank,filopodium assembly (GO:0046847),0.6184245301992155,1.2643393417952014,0.2,0.9498263614943109,1.0,4/16,7.01%,FGD6;FGD3;FGD1;EZR
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.6240203576686687,1.2642927545909604,0.19363762102351315,0.9483444805770802,1.0,2/16,2.15%,BRCA1;CTR9
prerank,regulation of cell cycle (GO:0051726),0.5045765496882921,1.2639960278492426,0.034,0.9481056399263034,1.0,61/271,13.91%,PLK1;WDR6;RGCC;BRCA1;PCLAF;BOP1;CDK5RAP3;RPRD1B;IRF1;NUPR1;TFAP4;HPGD;TGFB2;HCFC1;TARDBP;RASSF1;JUN;THBS1;CDK7;EP300;SMAD3;PRKACA;LIN9;MAP3K20;RPS15A;KIF20B;SDCBP;CDK6;METTL3;BIRC3;JUND;STK11;MAP2K6;NBN;CDK9;GRK5;PUM1;NEK7;APC;CTBP1;TXLNG;CDK5;HBP1;LIN52;NOTCH2;KAT2B;PRCC;ABL1;ERN1;TCF7L2;ADAM10;CYLD;SRPK2;HIPK2;TP53;TGFBR1;RNF20;LRP6;TTC28;HTRA2;PKD2
prerank,lysosome localization (GO:0032418),0.5466129932518415,1.263641232047217,0.18596491228070175,0.9480889976799511,1.0,4/37,3.12%,BORCS6;MILR1;FAM98A;NDEL1
prerank,DNA catabolic process (GO:0006308),0.6700688515262425,1.2635168837845683,0.22106824925816024,0.9470129052065932,1.0,2/11,10.81%,DFFB;XRN2
prerank,response to hydroxyurea (GO:0072710),0.6541842446289778,1.263274711031092,0.21907600596125187,0.9465480834921852,1.0,4/11,14.72%,BLM;RTF2;ATRX;SPIDR
prerank,heart development (GO:0007507),0.5111307833744118,1.2630919313772135,0.08577194752774975,0.9457438108226226,1.0,30/150,14.84%,ISL1;BMP5;SCUBE1;DAND5;TGFB2;NF1;SGCG;PDLIM2;HDAC9;PDGFB;FLRT2;ACVR1;MEF2A;NDUFV2;CHD7;MICAL2;CACYBP;AKAP13;TGFBR2;KAT2B;TGFBR1;GPC3;FN1;INSR;NDRG4;HEG1;PKD2;PTEN;CACNA1C;SMG9
prerank,DNA methylation (GO:0006306),0.5858478863477602,1.2628523041389486,0.19869281045751633,0.9452324237143129,1.0,6/23,12.96%,EHMT1;DMAP1;EHMT2;KMT2E;DNMT3A;ATRX
prerank,t-circle formation (GO:0090656),0.6716928879596575,1.2616767241369231,0.21786833855799373,0.9459849477017424,1.0,4/10,13.42%,BLM;WRN;NBN;TERF1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.6716928879596575,1.2616767241369231,0.21786833855799373,0.9459849477017424,1.0,4/10,13.42%,BLM;WRN;NBN;TERF1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.6716928879596575,1.2616767241369231,0.21786833855799373,0.9459849477017424,1.0,4/10,13.42%,BLM;WRN;NBN;TERF1
prerank,T cell migration (GO:0072678),0.6426540232673547,1.2616481671728508,0.1988555078683834,0.9444785011181402,1.0,3/13,8.96%,S1PR1;MSN;MYO1G
prerank,positive regulation of axon extension (GO:0045773),0.5873195972700871,1.2612991219266392,0.18628719275549807,0.9443184549741666,1.0,9/22,16.16%,ZFYVE27;NRP1;MAPT;TWF2;DBNL;CDKL5;RUFY3;MACF1;GOLGA4
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.523704368992403,1.2609024141773866,0.15543478260869564,0.9445475916714948,1.0,14/58,8.48%,BRCA1;RAD50;XRCC4;ZBTB7A;POLA1;UBE2V2;DCLRE1A;PRKDC;POLB;MRE11;ERCC4;SMC5;NBN;BABAM2
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.42592778878802545,-1.2605208605062328,0.16595744680851063,0.9857777513129706,1.0,6/22,4.75%,CDK13;CCNT2;TCERG1;CCNT1;ERCC6;CDK12
prerank,regulation of tau-protein kinase activity (GO:1902947),0.6719346623392916,1.2604140754759732,0.22169811320754718,0.9452759903265451,1.0,4/10,16.57%,C5AR1;HSP90AA1;SORL1;RB1
prerank,cellular response to BMP stimulus (GO:0071773),0.5219049378050914,1.259837762900911,0.16276595744680852,0.9464353163615417,1.0,8/66,7.45%,BMP5;ADAMTS12;SMAD6;TGFB2;BMPR1A;SMAD3;ACVR1;SLC33A1
prerank,positive regulation of hemostasis (GO:1900048),0.6647877667857915,1.2596944241085282,0.2081377151799687,0.9438239595770864,1.0,2/10,4.93%,THBS1;ENPP4
prerank,positive regulation of coagulation (GO:0050820),0.6647877667857915,1.2596944241085282,0.2081377151799687,0.9438239595770864,1.0,2/10,4.93%,THBS1;ENPP4
prerank,regulation of programmed cell death (GO:0043067),0.5050356811463549,1.2592348310298844,0.08678102926337034,0.9443400328331617,1.0,40/161,15.24%,WFS1;GAS1;LRRK2;IGFBP3;STEAP3;DDX42;HS1BP3;TNFRSF25;BCL2L11;TARDBP;ZBTB7A;IRF3;BCL6;WRN;APAF1;ACER3;BIRC3;HSP90AA1;PSMC5;BNIP3L;PHLPP1;DAPK1;TM7SF3;LRP8;FBXO11;CDK5;ACTN4;ASAH1;BNIP3;TRAF2;ABL1;DCPS;RAF1;DNAJA3;TP53;RTN4;NDRG1;ANP32A;ANP32B;HIP1
prerank,histone lysine demethylation (GO:0070076),0.585491206512321,1.2587126254245176,0.18216080402010051,0.9452477415074594,1.0,7/25,11.95%,KDM1B;KDM5A;KDM3A;KDM5B;JMJD1C;KDM4B;KDM4C
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.48626067586540034,-1.2585895325982444,0.17894736842105263,0.9860709020951854,1.0,7/15,17.61%,SMAD7;RPL5;RPL11;RPL23;LIMK1;DTX3L;RPS7
prerank,snRNA transcription (GO:0009301),0.5245732647938962,1.2584402956821137,0.16435432230522945,0.944960011590458,1.0,18/70,11.97%,POLR2D;SNAPC5;RPRD1B;SP1;PHAX;INTS12;INTS2;POLR2A;CDK7;RPRD2;RPRD1A;CDK9;INTS4;GTF2E1;GTF2E2;GTF2B;GTF2F2;RPAP2
prerank,DNA modification (GO:0006304),0.5961985171824041,1.2584346282530554,0.18943298969072164,0.9433599463960759,1.0,4/22,8.24%,MPG;EXOSC5;TERF2;PARP2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5384086422715624,-1.2583090048717394,0.19814241486068113,0.9791906027718037,1.0,7/12,28.35%,RIMS2;SYT1;RIMS1;UNC13B;SYT2;SYT7;UNC13A
prerank,vasodilation (GO:0042311),-0.5164274539201017,-1.2582301202978736,0.18566775244299674,0.9715015873303912,1.0,6/13,37.38%,SOD2;KCNMA1;SOD1;ADRB1;ADRB2;KLF2
prerank,tRNA methylation (GO:0030488),0.546741933669586,1.2575878945926273,0.20095693779904306,0.9458144246491944,1.0,4/34,5.02%,WDR6;NSUN6;TRMO;TARBP1
prerank,regulation of lipid metabolic process (GO:0019216),0.5114521052557867,1.2575410267732037,0.13025641025641024,0.9444303873487107,1.0,22/88,14.57%,RORA;SP1;BBS4;GGPS1;TGS1;IRS2;GPAM;NCOA1;CHD9;ABCA7;NCOR1;PPARG;SIN3B;NCOR2;ZFP69;NR1D2;RXRA;ADIPOR1;ACACA;PPARD;TBL1XR1;NCOA2
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5805325087980393,1.257342901399493,0.19363057324840766,0.9437664726262734,1.0,5/24,15.86%,ADAMTS12;TRPS1;SOX6;TGFBR1;MBOAT2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.5057685378829092,1.25683861850587,0.10510204081632653,0.9446064841015016,1.0,33/122,15.24%,EIF6;RGCC;EIF4A3;EIF3C;NMD3;EIF3E;DYRK2;TGFB2;NIBAN1;HSPH1;AR;IRS1;THBS1;PYM1;RBM3;PDGFB;PRKDC;METTL3;IRS2;LARP4B;YTHDF1;FXR2;FAF1;GCK;MTOR;PLD1;SAMD4A;INSR;PRKD2;LDB1;TLR4;CTC1;NPM1
prerank,icosanoid secretion (GO:0032309),-0.5232426848170518,-1.2568187026683881,0.19559228650137742,0.9701499327573435,1.0,2/12,10.26%,PNPLA8;ABCC4
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6688347810680149,1.256052880310605,0.19753086419753085,0.9466951976950061,1.0,5/10,14.50%,LRRK2;MLLT11;ABCD1;BCL2;FZD9
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.63586238440601,1.2559956137245143,0.22048364153627312,0.9453190911886554,1.0,7/13,16.92%,UBA5;DESI1;DESI2;UBA6;ATG7;UBA2;SAE1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.41765830742156895,-1.2559518387666726,0.14832535885167464,0.9664318437724083,1.0,5/23,5.53%,IL10RA;JAK2;PTK2B;ERBB4;GHR
prerank,response to sterol (GO:0036314),0.645528243236401,1.2558169773205612,0.23343373493975902,0.9445400516631847,1.0,4/11,12.97%,RORA;INSIG1;TGFBR2;TGFBR1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4991170352027872,1.2557255243004941,0.13008130081300814,0.9433491707389985,1.0,35/138,14.50%,POLR2D;RORA;POLR2A;AR;HDAC9;CDK7;TEAD1;ESR1;HDAC5;NR3C1;MAML3;MAML2;MNAT1;CDK9;TAF4;NCOR1;PPARG;NR6A1;GTF2E1;GTF2E2;GTF2B;NR5A1;NOTCH2;KAT2B;NR2C2;GTF2F2;NCOR2;NRBP1;NR1D2;RXRA;MED27;GTF2H1;RBPJ;PPARD;TBL1XR1
prerank,negative regulation of calcium ion transport (GO:0051926),-0.4786721132833367,-1.255345911267399,0.19424460431654678,0.9613620035443065,1.0,5/15,19.89%,CD33;ATP1A2;INPP5K;LILRB1;TRIM27
prerank,peptidyl-amino acid modification (GO:0018193),0.654350615029375,1.2553385950235711,0.23700305810397554,0.9436754956048379,1.0,3/10,11.18%,METAP1;ATP7A;TTLL4
prerank,intracellular sterol transport (GO:0032366),0.6335173605278377,1.2552303246478806,0.21418439716312057,0.9425782552429729,1.0,6/13,16.25%,OSBP;VPS4A;ABCG1;RELCH;ABCA1;OSBPL2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.5840485784915691,1.255150626409348,0.1989795918367347,0.9413846447751278,1.0,7/25,15.24%,PDE6H;CNOT9;DGKD;CBL;RTN4;RBPJ;HIP1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.5980285111648225,1.2550110136851056,0.21709633649932158,0.9388891046010871,1.0,3/17,6.71%,SMARCA4;IRS1;IRS2
prerank,cellular response to interleukin-7 (GO:0098761),0.5980285111648225,1.2550110136851056,0.21709633649932158,0.9388891046010871,1.0,3/17,6.71%,SMARCA4;IRS1;IRS2
prerank,regulation of interleukin-13 production (GO:0032656),0.6452038913418194,1.254870981667141,0.2226950354609929,0.9379652274417968,1.0,3/13,13.99%,PRKCZ;IL18;LGALS9
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.4816444759103363,-1.2547421874881985,0.20136518771331058,0.956220300974621,1.0,8/15,44.13%,KYNU;QDPR;GSTZ1;KYAT1;HAAO;KMO;FAH;IL4I1
prerank,protein-containing complex assembly (GO:0065003),0.49928180569493547,1.2541024443659463,0.032,0.9401105911575193,1.0,61/259,14.30%,CXCL12;RSPH4A;LMAN1;PDZD11;LRRK2;BLM;GOSR2;CX3CL1;SMARCA4;ADCY8;TFAP4;PEF1;CTSC;PPID;ITGB1BP1;LLGL1;SLC9A1;NAPG;WASF1;VAMP3;AREG;TLE2;EP300;FARP2;TEAD1;WIPF1;ST13;TRAPPC3;TLE1;MNAT1;GSDMD;FERMT3;RANBP9;REPS2;IL1RAP;LPXN;TUBGCP2;APC;VAMP2;TRAPPC9;CTSZ;TFG;CD2AP;TRAF2;SEC24B;SEC24D;DBNL;LAMC1;TMED2;TCF7L2;ADAM10;TGFA;TP53;LIN7A;NAPA;FN1;FBXL7;CSNK1A1;SAR1B;TRAPPC6B;MDN1
prerank,fatty acid transmembrane transport (GO:1902001),0.5889651923478313,1.2540302726776407,0.2,0.9389020236237049,1.0,7/19,14.13%,CD36;ABCD2;SLC25A20;ABCD3;SLC27A1;ABCD1;ACACA
prerank,positive regulation of behavior (GO:0048520),-0.5592156572644555,-1.2528306321360376,0.22589531680440772,0.9569099540738636,1.0,3/10,15.27%,SGIP1;CFAP20;AGRP
prerank,lamellipodium organization (GO:0097581),0.5584083989866809,1.252535758454027,0.20195838433292534,0.9442790121653266,1.0,10/29,15.12%,VCL;S1PR1;WASF1;PARVB;ABLIM3;GOLPH3;SNX1;PTPRO;P2RY12;ABLIM1
prerank,homeostasis of number of cells (GO:0048872),-0.5161068951370762,-1.2523896811764352,0.21069182389937108,0.951583460751196,1.0,5/12,26.26%,UBAP2L;LPCAT3;NOTCH1;CARD9;NAPEPLD
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.6276839180464691,1.2523583571177883,0.20408163265306123,0.9435330682484923,1.0,4/13,8.47%,WFS1;NUPR1;USP19;ALOX5
prerank,leukotriene metabolic process (GO:0006691),0.5930309922892186,1.251672878141856,0.1907356948228883,0.9452139128473759,1.0,4/19,12.92%,MGST3;PLA2G4A;ALOX5;MAPKAPK2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5664989351094725,1.250344560258901,0.21071863580998781,0.9498006242917537,1.0,6/28,7.60%,GBA2;MAP1A;STMN2;MAPRE1;CAMSAP3;MAPT
prerank,cardiac muscle tissue development (GO:0048738),0.5313687579717865,1.250020929694929,0.19845644983461963,0.949756792559667,1.0,6/50,11.19%,BMP5;BMPR1A;SGCG;NDUFV2;AKAP13;NOTCH2
prerank,regulation of oxidative phosphorylation (GO:0002082),0.6087563626151838,1.250015746571878,0.21458625525946703,0.9481986797291695,1.0,3/16,5.05%,AK4;NUPR1;ATP7A
prerank,regulation of protein-containing complex assembly (GO:0043254),0.5010290181143541,1.2494694176345629,0.12257405515832483,0.9492011063398209,1.0,26/110,14.02%,ISL1;PRKCZ;CD36;RIOK3;EIF2AK2;IMPACT;BCL2L11;HCFC1;EP300;FARP2;HSP90AA1;SLF1;FNIP1;FAF1;TAL1;CDC42;TRAF2;RAF1;AIDA;SORL1;SH3GLB1;ABCA1;FBLIM1;NAPA;SYK;SAR1B
prerank,muscle contraction (GO:0006936),0.49915362837303506,1.2490857075804989,0.1286727456940223,0.9494455090891099,1.0,8/126,7.03%,GJC1;VCL;TMOD1;MYOF;TMOD3;ALDOA;TPM1;ITGB5
prerank,RNA metabolic process (GO:0016070),0.503275981666186,1.2474603260373256,0.1105476673427992,0.955460610798839,1.0,43/127,16.77%,POLR2D;ELAVL4;RNASE6;RNASEH2A;HNRNPM;SYNCRIP;POLR2A;ATXN1;RBM3;FTO;RBM5;METTL3;PPP1R8;EXOSC7;RNASE4;HNRNPA2B1;HNRNPA3;PABPC4;AGO2;SETX;APOBEC1;RNGTT;ADAR;ATXN2;XRN2;RBM6;GTF2F2;RNASE3;DHX8;WTAP;HNRNPH3;HNRNPH1;BICD1;PCBP3;MTREX;RBMS1;HNRNPC;HNRNPK;ALKBH1;HNRNPL;CELF2;DROSHA;HNRNPD
prerank,actin filament capping (GO:0051693),0.604313394308029,1.2472386503734252,0.2054973821989529,0.9533609646009725,1.0,5/18,10.27%,SVIL;CAPZB;TWF2;ADD1;EPS8
prerank,barbed-end actin filament capping (GO:0051016),0.604313394308029,1.2472386503734252,0.2054973821989529,0.9533609646009725,1.0,5/18,10.27%,SVIL;CAPZB;TWF2;ADD1;EPS8
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.6223291112537206,1.247159274153187,0.22943722943722944,0.952169549312076,1.0,7/13,15.96%,IRAK4;TLR7;PIK3R4;IRAK2;UNC93B1;PIK3AP1;EPG5
prerank,triglyceride biosynthetic process (GO:0019432),0.5992294535631716,1.2471284046225477,0.20136986301369864,0.9507760706372963,1.0,3/18,11.55%,MOGAT3;GPAM;GK
prerank,regulation of protein secretion (GO:0050708),0.5012135314130098,1.2469706087386527,0.13109756097560976,0.9499739583861893,1.0,27/119,15.04%,ANG;LLGL2;EIPR1;PPID;LLGL1;CLOCK;CACNA1D;TGFB2;RAP1A;PRKCA;IL1A;EZR;GOLPH3;ALOX5;RAPGEF4;ABCG1;CACNA1A;STXBP5;CD2AP;GCK;DNAJC1;STXBP5L;ERP29;FRMD4A;RFX3;CACNA1C;ENSA
prerank,response to UV-B (GO:0010224),0.6441930009304765,1.2469680959137588,0.2261904761904762,0.9484384041335479,1.0,2/12,6.79%,RELA;STK11
prerank,response to ethanol (GO:0045471),-0.48895760773226593,-1.2466583442324026,0.2126984126984127,0.9687435682248059,1.0,7/14,25.52%,GRIN2B;GRIN3A;GLRA1;GOT2;GLRA2;GRIN1;SOD1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.49723675663829076,1.2464169002176957,0.03,0.9494740464502868,1.0,82/390,14.30%,MUSK;FGF22;FGF18;POLR2D;ROR2;DDR1;DDR2;RAPGEF1;HNRNPM;ACTR3;FGF1;ZFYVE27;GRB2;VEGFC;ITSN1;POLR2A;EPHB2;IRS1;NRP1;PDGFB;DOCK1;YES1;MAPK1;VAV3;SPRED2;PTPRJ;ABI1;AXL;SDCBP;FLRT2;AP2A1;IRS2;HSP90AA1;GALNT3;RGS14;ATP6V0E1;ARPC1A;ARPC4;PAK2;PTPRT;NCK1;ATP6V1E1;AHI1;KALRN;KIF16B;APC;LYN;SETX;ANKS1A;EPHA5;MVP;CDC42;SDC2;PXN;ARPC2;IGF1R;CBL;GTF2F2;CYFIP2;FRS2;VAV2;ANKS1B;MAPK14;NCF4;MAPKAPK2;ATP6V0D2;PIK3C2A;ATP6V1H;WASF2;SYK;NUS1;SPRED1;HNRNPH1;INSR;FYN;ELMO1;NRP2;PRKD2;SHOC2;ATP6V0A2;ARPC3;ROCK2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.5101487763046355,1.246352066363439,0.18046709129511676,0.948217145316641,1.0,12/64,7.28%,VCL;CD36;DUSP3;CX3CL1;MINK1;ADAM15;SLC9A1;NF1;THBS1;CDK6;CAMSAP3;CCL25
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6347337583681042,1.2459799537276781,0.21777777777777776,0.9484940536279569,1.0,7/11,12.69%,EIPR1;MSN;EZR;DAB2;PTPN23;SORL1;VPS11
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5665387482077355,1.2453103167900859,0.2139240506329114,0.9499523877018583,1.0,11/24,18.36%,DUSP3;NRP1;PTPRJ;LIMS1;ABL1;TSC1;PIK3R1;MAP4K4;IQSEC1;ROCK1;MAPRE2
prerank,peptidyl-serine modification (GO:0018209),0.5005349484609652,1.2447361693643524,0.0914572864321608,0.9512934170636346,1.0,42/166,14.30%,SGK3;SGK2;PLK1;LRRK2;POGLUT3;PRKCZ;RPS6KB2;DYRK2;CAMK1D;GAS6;GALNT1;PRKCB;PDGFB;PRKCA;PRKACA;CDK2;PRKDC;MAPK1;IKBKB;GALNT3;MAPK8;PKN2;PAK2;RPS6KA5;PARP2;CAMK2D;CSNK1G1;MAST2;CDK5;MAST3;TGFBR2;ULK2;MTOR;MAPK14;SRPK2;HIPK2;MAPKAPK2;TGFBR1;MAST4;PRKD2;CSNK1A1;ROCK2
prerank,regulation of establishment of protein localization (GO:0070201),-0.4998965184308156,-1.2444654476689974,0.21341463414634146,0.9710435419976576,1.0,5/13,9.26%,GAPVD1;CTSD;CEP120;DNAJA1;CEP135
prerank,protein homotetramerization (GO:0051289),0.5243314248096752,1.2435871489437074,0.17555555555555555,0.9550383426340083,1.0,12/49,16.25%,ALDH1A2;SSBP1;ALDOA;HPRT1;ACOT13;TRPM4;MCOLN1;PKD2;ACACA;HCN1;GLS;OSBPL2
prerank,response to nutrient levels (GO:0031667),-0.4534463660800495,-1.243198213880215,0.18571428571428572,0.9692895222612357,1.0,7/17,23.13%,EIF4G1;PRKAA1;PRKAA2;CD68;RPTOR;ATF4;ULK1
prerank,negative regulation of signaling (GO:0023057),0.5680645423554184,1.242243588611509,0.19900497512437812,0.9599758163789268,1.0,5/25,14.38%,IGFBP3;ACVR1;PTPN1;SOCS5;OPTN
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5531163591057222,-1.2421647018010264,0.22514619883040934,0.9666549869688922,1.0,2/10,8.32%,KCNAB1;SUMO1
prerank,cellular response to calcium ion (GO:0071277),0.5094252321925008,1.2413386502452355,0.17497348886532343,0.9626863624274326,1.0,17/67,16.49%,CPNE5;SLC25A24;ADCY8;BRAF;SMPD1;MEF2A;SYT12;SYT11;CAMK2D;ADD1;MCOLN1;CARF;PKD2;IQGAP1;CPNE8;MEF2C;LGMN
prerank,calcium ion transport into cytosol (GO:0060402),-0.4464895044723015,-1.2398956340976266,0.17355371900826447,0.9695441646045431,1.0,11/21,32.01%,RYR2;CACNA2D1;GRIN2B;JPH1;ATP2B4;GRIN1;ADRA1A;TRPM2;JPH4;TRPV4;ITPR3
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.4456104264844867,-1.2398022555742876,0.19117647058823528,0.9626566321431315,1.0,5/19,11.60%,PAPSS1;ENPP1;TPST1;BPNT2;SLC35B3
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.6419043696509612,1.23964660969345,0.2527131782945736,0.9691566177428114,1.0,3/10,12.96%,SSBP1;WIZ;ATRX
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5781156184429606,1.2396009425670638,0.21240105540897097,0.967828402249294,1.0,6/20,13.74%,IGFBP3;BMPR1A;NRP1;PDGFB;SORL1;NDRG4
prerank,regulation of exosomal secretion (GO:1903541),0.5884162633095819,1.2395829176035404,0.20077720207253885,0.9663519671768509,1.0,8/19,14.59%,TSG101;SMPD3;VPS4A;SDCBP;HGS;VPS4B;PDCD6IP;RAB7A
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.5048631644582131,-1.2394730025676188,0.2264808362369338,0.9570695137015178,1.0,2/13,3.22%,TPR;DYNC1LI1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.4729225450845337,-1.2392230568228106,0.18450184501845018,0.9511344336012277,1.0,5/15,8.31%,KCNN2;ATP1B1;ATP1A1;KCNJ2;KCND3
prerank,regulation of response to cytokine stimulus (GO:0060759),0.5857200281750852,1.2389091516636581,0.21598877980364656,0.967936506098538,1.0,7/19,12.90%,PARP9;RUNX1;LIFR;IRAK2;MAVS;MAP2K5;SH2B3
prerank,microtubule polymerization (GO:0046785),0.5550333386460621,1.2385039857284872,0.1941747572815534,0.9683735562103988,1.0,7/28,8.66%,CCDC57;NDEL1;AKAP9;TUBGCP6;MAPT;RANBP9;TUBGCP2
prerank,alpha-amino acid catabolic process (GO:1901606),0.5557092429134877,1.2381501188465556,0.2078720787207872,0.9684567519694672,1.0,2/29,3.78%,CBS;ACAT1
prerank,regulation of cell cycle process (GO:0010564),0.5047201088469783,1.2379756799293107,0.1601642710472279,0.9677772412508044,1.0,20/104,12.70%,PLK1;CETN2;RPRD1B;BBS4;USP19;CEP250;PIK3R4;KIF13A;AHCTF1;PRPF40A;KIF20B;KIF11;SETD2;CCP110;BIRC6;APC;TXLNG;CDC42;UVRAG;SH3GLB1
prerank,cellular response to leucine (GO:0071233),-0.5527430286822413,-1.237676674146877,0.2208955223880597,0.9441983731082514,1.0,7/10,18.87%,UBR1;SESN1;SESN3;UBR2;KLHL22;RRAGD;RPTOR
prerank,response to leucine (GO:0043201),-0.5527430286822413,-1.237676674146877,0.2208955223880597,0.9441983731082514,1.0,7/10,18.87%,UBR1;SESN1;SESN3;UBR2;KLHL22;RRAGD;RPTOR
prerank,artery morphogenesis (GO:0048844),0.5633024852004184,1.2369173962457694,0.19588875453446192,0.9713338132523254,1.0,5/30,4.64%,HPGD;TGFB2;NF1;BMPR1A;NRP1
prerank,neuron maturation (GO:0042551),0.6027910707445963,1.2367936722480477,0.22576361221779548,0.9703368394147811,1.0,6/18,9.75%,CX3CL1;MTCH1;FARP2;ADGRB3;ANKS1A;B4GALT5
prerank,extracellular transport (GO:0006858),0.6413697819883055,1.2364214922621395,0.24087591240875914,0.970627171298873,1.0,1/12,1.41%,TSG101
prerank,DNA geometric change (GO:0032392),0.5738801600436796,1.23638200297652,0.22363405336721728,0.9692686239418906,1.0,8/24,14.60%,BLM;RAD50;WRN;HNRNPA2B1;MRE11;NBN;HMGB1;RECQL5
prerank,cell-cell junction assembly (GO:0007043),0.5157986095161275,1.2362958947474656,0.1786096256684492,0.9681147918796195,1.0,12/63,12.29%,GJC1;GJD3;VCL;TLN2;PRKCA;CTNNA1;PKN2;PAK2;CDH11;WDR1;EPB41L3;CDH20
prerank,mammary gland development (GO:0030879),0.5875296959737596,1.235871604932065,0.2129032258064516,0.9686670647112219,1.0,1/21,0.22%,WNT4
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4952090663464445,1.2357913488570347,0.10887096774193548,0.9675113766884577,1.0,41/166,15.24%,EIF6;RGCC;EIF4A3;CD36;SP1;EIF3C;NMD3;EIF3E;DYRK2;ZEB2;NIBAN1;IRS1;THBS1;PYM1;RBM3;ATP7A;SMAD3;PDGFB;PRKDC;METTL3;IRS2;CTDNEP1;HSP90AA1;GIPC1;LARP4B;YTHDF1;FXR2;FAF1;GCK;MTOR;PLD1;SLC27A1;SAMD4A;INSR;PRKD2;PKD2;LDB1;TLR4;ARNT;CTC1;NPM1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.5344894629057758,1.2357534803503223,0.21602787456445993,0.9661695111191797,1.0,7/42,6.11%,SRCAP;ACTR5;DMAP1;SMARCA4;VPS72;ZNHIT1;SPTY2D1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5872777211943856,1.2356356087886418,0.23342541436464087,0.9651932363297061,1.0,5/19,6.01%,CAMK1D;THBS1;CMKLR1;MAPK1;MPP1
prerank,regulation of endocytic recycling (GO:2001135),0.6419688556588379,1.2354712202670253,0.22285714285714286,0.9644541483280121,1.0,5/11,15.88%,EIPR1;EHD1;ARHGAP1;SORL1;INPP5F
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6537929082728808,1.2349441883099055,0.23162939297124602,0.9653584625871202,1.0,3/10,8.02%,PLA2G7;PLA2G6;PLA2G4A
prerank,lipid oxidation (GO:0034440),0.6217867815152651,1.2349052181034406,0.2414307004470939,0.9640267674416317,1.0,3/12,13.69%,PLA2G7;ALOX5;ADIPOR1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.4618005525416289,-1.2346561114482626,0.22134387351778656,0.9507015524632133,1.0,12/17,29.66%,AFG1L;COX10;COX7A2L;COX6B1;COX7B;COX8A;NDUFA4;COX4I1;COX6C;COX6A1;COX5A;COX15
prerank,phospholipid catabolic process (GO:0009395),0.559140968792781,1.2335805588683557,0.22418136020151133,0.9686620975240017,1.0,5/24,12.07%,SMPDL3A;SMPD1;PLA2G4A;PNPLA6;GPCPD1
prerank,DNA dealkylation (GO:0035510),0.6489521159881374,1.2331131332181309,0.23751891074130105,0.9678783397592193,1.0,5/10,16.12%,MPG;FTO;ASCC2;ALKBH5;ALKBH1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.6489521159881374,1.2331131332181309,0.23751891074130105,0.9678783397592193,1.0,5/10,16.12%,MPG;FTO;ASCC2;ALKBH5;ALKBH1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.5265098949179936,1.2325984108367725,0.2097902097902098,0.9687814169519388,1.0,6/43,6.38%,WNT4;DDR2;BMPR1A;NELL1;LRP5;ACVR1
prerank,positive chemotaxis (GO:0050918),0.5939403045483865,1.23256727117055,0.2381615598885794,0.9674135062107384,1.0,3/17,5.98%,CX3CL1;NRP1;PTPRJ
prerank,primary alcohol metabolic process (GO:0034308),-0.4078660814229633,-1.2314150407520765,0.17616580310880828,0.9575753659294985,1.0,10/25,28.70%,GPD2;IGF1;GDPD1;GDE1;GDPD3;PECR;ALDH3A2;RDH10;NAPEPLD;NAAA
prerank,endoderm development (GO:0007492),0.6319354483188296,1.2312378217710207,0.23776223776223776,0.9722404541545545,1.0,2/13,11.50%,KIF16B;LAMC1
prerank,positive regulation of secretion by cell (GO:1903532),0.5072983635402357,1.231209679646124,0.1724867724867725,0.9708793300420919,1.0,14/70,11.42%,ANG;RGCC;UNC13D;PPID;TGFB2;CADPS;IL1A;EZR;GOLPH3;DTNBP1;ABCG1;STXBP5;CD2AP;SOX11
prerank,regulation of erythrocyte differentiation (GO:0045646),0.5401949079847149,1.2310224547455375,0.21236872812135357,0.9702518132940535,1.0,14/35,17.53%,ANKRD54;PRKDC;CDK6;HSPA9;LYN;TAL1;ZFP36L1;MAPK14;ACVR1B;LDB1;ARNT;FOXO3;NCKAP1L;MED1
prerank,negative regulation of dephosphorylation (GO:0035305),0.5848279352808547,1.2309618943065637,0.23097463284379172,0.9690256435192756,1.0,7/18,17.30%,URI1;PPP1R8;PPP1R16B;GPATCH2;ENSA;YWHAB;MFHAS1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.481593952943415,-1.2305482013876579,0.23367697594501718,0.9543493618221508,1.0,5/14,10.79%,ACTR2;MMS19;ERCC6;PARP1;WDR48
prerank,response to insulin (GO:0032868),0.49583970428615715,1.2305127905899818,0.1652806652806653,0.9696116891181205,1.0,20/80,13.60%,EIF6;INSIG1;RAB8B;INSIG2;RAB12;IRS1;HDAC9;MYO5A;PRKDC;HDAC5;PDE3B;IRS2;PPARG;VAMP2;KAT2B;GCK;TBC1D4;ZFP36L1;SLC27A1;INSR
prerank,inositol phosphate catabolic process (GO:0071545),0.6408381356079662,1.2304684230673182,0.2168141592920354,0.9683557039603152,1.0,5/12,15.36%,INPP1;INPP5A;OCRL;PTEN;SYNJ2
prerank,rRNA processing (GO:0006364),0.49071443871250525,1.230231346954199,0.10732196589769308,0.9679618679744223,1.0,35/172,12.70%,EIF6;C1D;MPHOSPH6;RPL18;BOP1;UTP3;PELP1;SBDS;RIOK3;SART1;RPL41;RPL31;UTP18;EMG1;RPS17;DDX49;RPL4;UTP20;EXOSC5;RPLP0;PRKDC;RPL38;EXOSC7;MRPL1;RRP36;RRP1B;FCF1;DDX10;UTP6;XRN2;HEATR1;NOP56;RPL21;RPS6;NOL8
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5961807927953229,1.2287648368732593,0.2524137931034483,0.9731419220180287,1.0,5/16,11.09%,LRRK2;UBAC2;TAPT1;BCAP29;MIA3
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.6392540001210054,1.2286932100682866,0.2326283987915408,0.9719848506181442,1.0,2/11,1.93%,SIRT7;SMARCA4
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.5513654830108474,1.2284919490023578,0.22627737226277372,0.9714326450285516,1.0,1/32,0.08%,LCAT
prerank,RNA 3'-end processing (GO:0031123),0.5030778056026891,1.228165317257201,0.18191603875134554,0.971505927441959,1.0,18/69,12.67%,EIF4A3;RPRD1B;TUT4;CSTF3;DHX38;SARNP;CSTF2;RNPS1;U2AF1;RPRD2;RPRD1A;THOC5;SRSF5;LIN28B;U2AF2;CPSF3;SRSF9;SRSF11
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5309993888006322,1.2280447443578777,0.21052631578947367,0.9705808677674683,1.0,10/38,15.04%,RORA;RIOK3;ESR1;TLE1;MAPKBP1;TANK;ZMYND11;PPM1A;TRIM59;OTUD7A
prerank,regulation of spindle assembly (GO:0090169),0.5587733073641792,1.2277865528307175,0.2263681592039801,0.9702634247121379,1.0,3/25,2.90%,PLK1;EML3;CHMP5
prerank,regulation of cellular pH (GO:0030641),0.5515224564613282,1.2276434761967578,0.20024570024570024,0.9694222371903891,1.0,6/29,8.80%,SLC4A3;SLC9A9;SLC9A1;LACC1;SLC9A7;SLC9A6
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.6550182034540777,1.2269961862120011,0.2492063492063492,0.9708792100700476,1.0,1/10,1.00%,SIRT7
prerank,actin cytoskeleton reorganization (GO:0031532),0.5057646976581954,1.2264089990970841,0.1779475982532751,0.972064017463988,1.0,12/63,9.40%,S1PR1;MINK1;GRB2;FLNA;NRP1;GPR65;FARP2;PARVB;EZR;CDC42BPB;PTPN1;DTNBP1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.6156789493093339,1.2261352281446432,0.23633879781420766,0.9717524329938808,1.0,3/15,7.51%,CD36;EIF2AK2;PYDC1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5852029138843517,1.2261179582385335,0.2253711201079622,0.9703740238556181,1.0,6/20,12.73%,BRCA1;RPS6KA5;TADA2A;GLYR1;DIP2B;BRD7
prerank,cell-substrate junction assembly (GO:0007044),-0.3747900692469831,-1.2260476699625316,0.11258278145695365,0.966790743503098,1.0,13/33,16.84%,PIP5K1A;PTPRK;SORBS1;TAOK2;TESK2;ARHGEF7;PEAK1;FERMT2;BCR;RCC2;ACTN1;WHAMM;PLEC
prerank,peptidyl-serine phosphorylation (GO:0018105),0.4913329164213691,1.2250955819969693,0.10653266331658291,0.9735447998912934,1.0,40/153,14.30%,SGK3;SGK2;PLK1;LRRK2;PRKCZ;RPS6KB2;DYRK2;CAMK1D;GAS6;PRKCB;PDGFB;PRKCA;PRKACA;CDK2;PRKDC;MAPK1;IKBKB;MAPK8;PKN2;PAK2;RPS6KA5;CAMK2D;CSNK1G1;MAST2;CDK5;MAST3;TGFBR2;ULK2;MTOR;ERN1;MAPK14;SRPK2;HIPK2;MAPKAPK2;TGFBR1;MAST4;MAP2K2;PRKD2;CSNK1A1;ROCK2
prerank,regulation of cardiac conduction (GO:1903779),0.5087345489679668,1.2250580828314013,0.21397379912663755,0.9722632219836796,1.0,2/54,5.27%,ACE2;PRKACA
prerank,retinoid metabolic process (GO:0001523),0.499365857462745,1.2247398675619166,0.18577494692144372,0.9723802350229813,1.0,8/71,15.11%,ALDH1A2;AKR1B1;ALDH1A1;LRP8;DHRS3;SDC2;GPC3;GPC6
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5770382013696087,1.224626251981518,0.23921568627450981,0.9714386111641088,1.0,10/20,18.67%,LLGL2;LLGL1;IKBKB;DLG1;ROCK2;FMNL3;NCKAP1L;ROCK1;NCKAP1;PLEK
prerank,regulation of JUN kinase activity (GO:0043506),0.5406757871213345,1.224171658711994,0.1978021978021978,0.9721078307887897,1.0,6/33,12.26%,TNFRSF11A;SASH1;MAP3K11;DUSP10;TRAF2;AIDA
prerank,regulation of cell population proliferation (GO:0042127),0.4880822728069823,1.2238010378394086,0.005,0.9723912288430105,1.0,102/691,13.60%,FGF22;ACE2;FGF18;BMP5;SGK3;SGK2;ALDH1A2;WDR6;RGCC;ROR2;TNFRSF11A;IGFBP3;CGRRF1;RPRD1B;CDCA7;RELA;CX3CL1;IRF1;EIF2AK2;SMAD6;GLMN;FGF1;IFI35;NUPR1;COX17;TFAP4;FAM98A;ITGB1BP1;VEGFC;RUNX1;TGFB2;BMPR1A;RERG;EAPP;JUN;AREG;AR;UTP20;IRS1;GID8;THBS1;BCL6;LIFR;PDGFB;KITLG;CDK2;LRP5;PRKDC;ACER3;RPS15A;PTPRJ;KIF20B;ABI1;UBE2A;RBM5;SDCBP;EGLN3;CDK6;DHPS;IL1A;JUND;IRS2;STK11;HP1BP3;MECP2;STX3;SLURP1;EZH2;TRPM4;BIRC6;KRAS;LIMS1;NACC1;GRK5;APC;CTBP1;LYN;HGS;FKTN;PRKRA;TGFBR2;IGF1R;KAT2B;SOX11;KDM4C;RAF1;ZFP36L1;DNAJA3;RPS6;TCF7L2;ADAM10;TGFA;BRD7;SRPK2;SH2B3;TP53;TGFBR1;BCL2;S100B;FN1;PTPRU;INSR
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.4381119175982857,-1.2226942874352198,0.1968503937007874,0.9742898966424434,1.0,10/18,28.57%,GRIK1;CDH8;GRIK4;NAPB;SLC17A6;GRIK2;UNC13B;GRIK5;UNC13A;GRIK3
prerank,regulation of TORC1 signaling (GO:1903432),-0.36963351233961445,-1.222478609968674,0.15568862275449102,0.9683110638950829,1.0,15/33,22.94%,SIK3;SESN1;CLEC16A;GPR137B;PIP4P1;FLCN;SESN3;CASTOR2;KLHL22;RRAGD;SEH1L;RNF152;RRAGB;SMCR8;SZT2
prerank,histone exchange (GO:0043486),0.5355381412596534,1.2222411510879811,0.2235294117647059,0.9780544671619752,1.0,6/37,9.32%,SRCAP;DMAP1;VPS72;ZNHIT1;SPTY2D1;CENPP
prerank,activation of phospholipase C activity (GO:0007202),0.54808432518334,1.2214775115494954,0.22541966426858512,0.980206439064462,1.0,2/29,1.61%,ANG;C5AR1
prerank,lipoprotein biosynthetic process (GO:0042158),0.6388760890818633,1.2213581046442274,0.2777777777777778,0.9793606412910331,1.0,2/11,5.11%,WDR45;WDR45B
prerank,cellular amide metabolic process (GO:0043603),0.4978536671762584,1.221093258355404,0.1704312114989733,0.9791481827437751,1.0,17/102,12.29%,PDZD11;NLN;BTD;ALDH1L1;SMPD3;CPD;SMPD1;CPE;MCCC2;ACOT9;MTHFD2L;MTHFR;ACOT13;ST6GAL1;PCCA;SLC25A32;SGPL1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5733079455954679,1.2210678036093077,0.2346002621231979,0.977811669983388,1.0,3/21,4.56%,CACNA1D;AKAP9;FLNA
prerank,anterograde axonal transport (GO:0008089),-0.35765147583235546,-1.2209894068572509,0.15483870967741936,0.9676529548824868,1.0,15/37,14.75%,DLG2;AP3B1;AP3D1;AP3S1;MAPK8IP3;KIF3B;RAB21;KIF5C;TRAK2;TRAK1;KIF1A;AP3S2;RAB27B;KIF1C;NEFL
prerank,eosinophil chemotaxis (GO:0048245),0.6043034157417219,1.220708959207056,0.2503597122302158,0.9765472978464659,1.0,1/14,1.82%,CX3CL1
prerank,eosinophil migration (GO:0072677),0.6043034157417219,1.220708959207056,0.2503597122302158,0.9765472978464659,1.0,1/14,1.82%,CX3CL1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.5779515982857989,1.2205600057126302,0.24726775956284153,0.9758144098270927,1.0,8/18,14.30%,LLGL2;LLGL1;KIF20B;ARFGEF1;RAP1B;CYRIB;RUFY3;ROCK2
prerank,protein import into peroxisome membrane (GO:0045046),0.5560363881083141,1.2204562786691564,0.23574144486692014,0.9748709423685565,1.0,6/22,15.21%,PXMP2;RAB8B;ABCD2;ABCD3;ABCD1;PEX14
prerank,organic hydroxy compound transport (GO:0015850),0.5238849938610368,1.2204386184945348,0.23121387283236994,0.9735204624881663,1.0,7/36,14.57%,OSBP;SLCO1B1;NCOA1;STARD5;RXRA;SLCO2B1;NCOA2
prerank,negative regulation of organelle assembly (GO:1902116),0.5340746165630375,1.2202810006127172,0.23391812865497075,0.9728088097848595,1.0,11/35,15.54%,BRCA1;LRRK2;NUPR1;MDM1;CCP110;KAT2B;FEZ1;ODF2L;TMEM39A;SMAD4;MTM1
prerank,heme catabolic process (GO:0042167),0.6073430572836223,1.2200839127584542,0.2369186046511628,0.9708502873928359,1.0,5/14,17.27%,SLCO1B1;HMOX2;SLCO2B1;ABCG2;ABCC1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.6073430572836223,1.2200839127584542,0.2369186046511628,0.9708502873928359,1.0,5/14,17.27%,SLCO1B1;HMOX2;SLCO2B1;ABCG2;ABCC1
prerank,regulation of tissue remodeling (GO:0034103),0.5798677229724373,1.2199446488359198,0.26116373477672533,0.9700438323346486,1.0,3/18,8.68%,DDR2;RUNX1;IL18
prerank,positive regulation of cellular respiration (GO:1901857),0.6249821194564458,1.2197954361459888,0.2618343195266272,0.9693534022456647,1.0,2/11,5.19%,NUPR1;IL10RB
prerank,ribosomal large subunit biogenesis (GO:0042273),0.5054600488324085,1.2196592776507635,0.21639344262295082,0.9684977317993092,1.0,8/54,7.30%,EIF6;BOP1;GTF3A;MALSU1;HEATR3;RPLP0;TRAF7;MRPL1
prerank,microtubule anchoring at centrosome (GO:0034454),0.6532764168413366,1.2194640398900523,0.2588597842835131,0.9680024489140693,1.0,4/10,11.52%,BBS4;NIN;DCTN1;KIF3A
prerank,early endosome to Golgi transport (GO:0034498),0.6356273808016956,1.2192119879889163,0.2304075235109718,0.9677766356638499,1.0,5/11,12.31%,LMAN1;TMED9;RAB6A;SNX1;SNX8
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5243025147773658,1.2191986228298386,0.2121559633027523,0.966434844929206,1.0,4/39,6.60%,RGCC;GAS6;THBS1;ITGA4
prerank,regulation of lymphocyte differentiation (GO:0045619),0.5804751902234397,1.2187210478616506,0.22933333333333333,0.9671577223374334,1.0,5/18,12.05%,PRKDC;METTL3;PRDM1;ABL1;ZFP36L1
prerank,skeletal system development (GO:0001501),0.4908948407697143,1.218217441069368,0.12173038229376258,0.9680341689485126,1.0,19/148,13.43%,EVC;BMP5;TGFB2;TRPS1;ATP7A;PLS3;CMKLR1;ITGB8;CHD7;CD44;CDH11;DEAF1;AKAP13;CREB3L2;ANKRD11;SOX11;SOX6;TGFBR1;WWOX
prerank,regulation of myeloid cell differentiation (GO:0045637),0.5021619312570107,1.218137883647351,0.19176598049837487,0.9670235267151024,1.0,14/62,11.25%,EIF6;CTR9;SETD1A;RUNX1;THBS1;PRKCB;EP300;RBM15;TNRC6B;CDK6;KMT2E;HSPA9;LYN;KAT2B
prerank,regulation of platelet activation (GO:0010543),0.5717298674726599,1.2180684069834702,0.24155844155844156,0.9659448533048074,1.0,6/21,14.85%,PDGFB;PRKCA;PLA2G4A;LYN;SYK;TLR4
prerank,regulation of stress fiber assembly (GO:0051492),0.4985058391716364,1.2179663583770257,0.18181818181818182,0.9650124811629894,1.0,24/74,16.41%,RGCC;CGNL1;ALMS1;ITGB1BP1;SLC9A1;NRP1;GPR65;TPM1;PPFIA1;PAK2;CDC42;PXN;ABL1;TGFBR1;WASF2;ROCK2;TMEFF2;TSC1;CLASP1;EVL;CD47;PIK3R1;PAK1;ACTG1
prerank,positive regulation of cell projection organization (GO:0031346),0.49035494117476963,1.2175812864370712,0.17378048780487804,0.96528705027754,1.0,27/115,14.25%,ROR2;CHODL;PLXNA1;CX3CL1;DVL1;RAPGEF1;ITGA6;SS18L1;CAMK1D;STMN2;RAP1A;EP300;SERPINI1;CUX1;SNX3;ARSB;TWF2;NPTN;LYN;SETX;ARHGAP35;RIT2;CDKL5;PLXNC1;NDRG4;MAP6;RELN
prerank,cellular calcium ion homeostasis (GO:0006874),0.48878901588712786,1.2175358852085938,0.1494949494949495,0.9640860175673827,1.0,9/133,5.27%,CXCL12;WFS1;SLC24A5;TRPC5;ADCY8;MICU1;LETM1;YWHAE;PRKACA
prerank,protein localization to organelle (GO:0033365),0.4886709238950646,1.2172336299701259,0.14213709677419356,0.9640348453111137,1.0,29/133,11.35%,TRAM1L1;RIPOR1;LRRK2;UBAC2;SYS1;DVL1;ARL6;SEC61G;EHD1;BBS4;ZBTB7A;CEP250;SCG3;YWHAE;COG3;PACSIN2;TMEM30A;UBE2J2;IFT20;CTDNEP1;SNX10;RAB6A;ABCA7;LMBRD1;VPS35;VAMP2;TULP3;DCP1A;PRNP
prerank,"DNA-templated transcription, termination (GO:0006353)",0.5062733127096664,1.2164649993523131,0.18743343982960597,0.9661045560336177,1.0,13/68,11.07%,CAVIN1;POLR1C;CSTF3;CSTF2;POLR2A;CDK7;POLR1A;MNAT1;UBTF;SSU72;SNRPD3;SETX;CPSF3
prerank,sulfur amino acid metabolic process (GO:0000096),0.559093860855343,1.2154112003021544,0.2129514321295143,0.9694946340096475,1.0,3/24,9.04%,CBS;MTHFR;MTR
prerank,regulation of cell death (GO:0010941),0.4858705286901926,1.2148057886136396,0.1716961498439126,0.9708305837092145,1.0,18/94,11.58%,SLC25A24;LRRK2;CD36;NOA1;TMEM109;IMPACT;RAD18;ACER3;BNIP3L;NCK1;VPS35;FAF1;ADNP2;APC;CTSZ;BNIP3;SOX11;VPS4B
prerank,mRNA processing (GO:0006397),0.4839942599191961,1.214492928205964,0.061,0.9708665037433073,1.0,73/287,13.71%,POLR2D;SNRPD2;SNRPD1;PLRG1;EIF4A3;ELAVL2;RPRD1B;SART1;HNRNPM;LSM7;DDX42;SYNCRIP;PRPF38A;BCAS2;CSTF3;DHX38;DNAJC8;SARNP;CSTF2;POLR2A;FRG1;RNPS1;CDK7;PRPF3;GEMIN2;CTNNBL1;RBM15;SPEN;PRKACA;PRPF40A;BUD31;U2AF1;RBM5;SNRPN;PRPF40B;METTL3;RPRD2;RPRD1A;MNAT1;HNRNPA2B1;THOC5;HNRNPA3;GPKOW;SRSF5;PRPF6;TRA2A;SNRNP70;PRMT9;SNRPD3;SCAF11;FUS;CDC5L;DDX23;DHX16;RNGTT;U2AF2;RBM17;CPSF3;SF1;RBM6;PSPC1;SF3B2;GTF2F2;PRCC;SRSF9;ERN1;SRSF11;DHX8;HNRNPH3;HNRNPH1;GTF2H1;SRRM2;DDX5
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.609813089673645,1.2143089180700677,0.23055162659123055,0.9702938135550255,1.0,5/14,15.61%,ELAVL4;TARDBP;MAPK14;MAPKAPK2;HNRNPC
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.5349999823104646,-1.2143054456941345,0.22010869565217392,0.9889339841021619,1.0,3/10,5.58%,PRKG1;SERPINE2;CD9
prerank,transcription by RNA polymerase I (GO:0006360),0.5375628708645712,1.2137865918524198,0.22769953051643194,0.9713358435437423,1.0,6/34,8.81%,CAVIN1;POLR1C;CDK7;POLR1A;MNAT1;UBTF
prerank,regulation of organelle assembly (GO:1902115),0.4998660472578025,1.2137353502313215,0.19742489270386265,0.9701718933565313,1.0,29/72,16.52%,TSG101;ATXN2L;ALMS1;MSN;TBC1D15;EVI5;IFT20;TBC1D17;EZR;TBC1D14;TBC1D10B;ATXN2;ATG3;TBC1D12;CDKL5;TBC1D5;TBC1D10A;TBC1D13;VPS11;CYLD;RABGAP1;PDCD6IP;TBC1D24;TBC1D22A;TBC1D8;TBC1D1;NPM1;CEP295;RDX
prerank,regulation of intracellular pH (GO:0051453),0.5308898103244741,1.2129930593413683,0.23193473193473194,0.972024825455235,1.0,6/34,8.80%,SLC4A3;LRRK2;SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,negative regulation of cell cycle (GO:0045786),0.4990076259538823,1.21280585193339,0.1900739176346357,0.9715175860686971,1.0,11/73,9.84%,PLK1;GAS1;NUPR1;TFAP4;HPGD;SMAD3;IPO7;CDK6;PTPN3;APC;IPO5
prerank,intermediate filament organization (GO:0045109),-0.448963422858388,-1.212680028499487,0.22137404580152673,0.9891082953215133,1.0,4/17,16.23%,DNAJB6;VIM;NEFL;GFAP
prerank,epiboly involved in wound healing (GO:0090505),0.5927403796114472,1.2126484636066621,0.25034387895460797,0.9707987971345837,1.0,6/16,16.13%,DDR1;FLNA;CD44;ARHGAP35;TMEFF2;MRTFA
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.5761966919560975,1.2122138546529895,0.2658569500674764,0.9713986772555774,1.0,2/16,1.79%,ST8SIA5;ST8SIA4
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.49759905415509004,1.2115606054440027,0.2035306334371755,0.9728940829395879,1.0,20/76,14.85%,UACA;RELA;EIF2AK2;IFI35;TLR7;SASH1;EP300;EZR;DLG1;TLR3;LIMS1;PTP4A3;ACTN4;TRIM44;TMSB4X;PPM1A;CYLD;ADIPOR1;LGALS9;TLR4
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.4379626669867803,-1.2115268596186226,0.2264957264957265,0.9871619572016577,1.0,9/20,17.48%,APP;ANO6;P2RX7;C3AR1;SUGT1;NLRP3;PYCARD;TXNIP;P2RX4
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.636178343718508,1.2113763202800747,0.28091603053435116,0.9722615184814241,1.0,4/11,9.18%,SOAT1;AGO2;ABCA7;ITM2B
prerank,positive regulation of catabolic process (GO:0009896),-0.3203952793504274,-1.2111293868807487,0.14285714285714285,0.9823831441249514,1.0,20/65,19.03%,SMURF2;PRKN;SMURF1;CSNK2A1;HUWE1;NSF;STX5;VCP;GSK3B;RNF41;IDE;VSIR;DDB1;HECW2;TIPARP;SNF8;CDKN1B;TNFAIP3;SEC22B;OAZ2
prerank,negative regulation of inflammatory response (GO:0050728),0.48341754783778323,1.2111059573486442,0.12550200803212852,0.972120585652434,1.0,28/182,14.41%,ISL1;RXFP1;RORA;TNFAIP8L2;ADCY8;ADCY3;PRKAR2A;FEM1A;ADCY5;PRKACA;YES1;ADCY9;ALOX5;VPS35;PPARG;PROC;LYN;FURIN;RAMP1;MAPK14;SYK;FYN;CYSLTR1;CALCRL;CREB1;GNG2;PPARD;GNB1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5812719108226578,1.2110765540890838,0.24412532637075718,0.9708736910586164,1.0,8/17,19.04%,GMFB;WASF1;ARF1;WASF2;CYFIP1;CTNNA2;NCKAP1;BRK1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.45875333256589457,-1.210969168333867,0.2271062271062271,0.9765590425050689,1.0,8/16,15.56%,ZFPM2;ERBB4;FGFR2;AKAP6;IGF1;FGF2;TGFBR3;NOTCH1
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.5223287558492393,-1.2109525009639075,0.22295081967213115,0.9701522949372201,1.0,9/11,47.42%,GOPC;GPM6B;LEPROTL1;COMMD1;ACTN2;LEPROT;SNX33;TAX1BP3;NEDD4L
prerank,mitotic metaphase plate congression (GO:0007080),0.5155350255165251,1.2108711955081901,0.2087912087912088,0.9704693218180124,1.0,12/51,15.16%,NUDC;EML3;KPNB1;VPS4A;CHMP5;CDC23;DCTN2;VPS4B;EML4;PDCD6IP;RMDN1;BECN1
prerank,superoxide metabolic process (GO:0006801),-0.386342865751394,-1.2104143002843182,0.20652173913043478,0.9658322632584484,1.0,7/29,7.61%,SH3PXD2A;NCF2;NCF1;SH3PXD2B;PRDX1;CYBA;CYBB
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5860900162647464,1.2101937503430304,0.27385892116182575,0.9721119089134085,1.0,1/15,0.26%,MGAT3
prerank,ATP transport (GO:0015867),0.6303020666426464,1.2092549849843501,0.24848484848484848,0.9749031673485877,1.0,1/10,0.90%,SLC25A24
prerank,spliceosomal complex assembly (GO:0000245),0.5171756573520461,1.2091779300949141,0.23333333333333334,0.9738625115903558,1.0,12/46,12.74%,SNRPD2;SNRPD1;RBM5;LUC7L;SRSF5;PRPF6;SETX;SCAF11;DDX23;SF1;SRSF9;SRPK2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5520397786525386,1.2086079262371663,0.2506172839506173,0.9749891520707492,1.0,5/27,6.36%,DDR2;GAS6;S100A6;PDGFB;CDK6
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5554745937399931,1.2083485643222656,0.22037914691943128,0.9747587623786569,1.0,7/26,12.68%,TSG101;FBXW7;SOCS4;AREG;SOCS5;CBL;TGFA
prerank,negative regulation of transmembrane transport (GO:0034763),0.640021407736588,1.2079865807612638,0.2808641975308642,0.9750304928852752,1.0,3/10,6.71%,THBS1;PRKCB;IRS2
prerank,mitotic cell cycle phase transition (GO:0044772),0.48204336352964783,1.2079795513131004,0.12324649298597194,0.9736924290484956,1.0,46/203,15.41%,TUBB4B;PLK1;CETN2;CCDC57;TPD52L1;ALMS1;MAX;MAPRE1;AKAP9;CEP250;PPP2R2A;YWHAE;CDK7;CDC23;PRKACA;CDK2;PCNT;CDK6;ACVR1;USP29;HSP90AA1;MNAT1;DCTN1;TUBA1A;DCTN2;CCP110;PPP1R12B;CHEK2;CDC16;ODF2;CEP152;EPS8;CNTRL;FBXW11;CCNI;CUL4A;CTDP1;ACVR1B;USP37;FBXL7;OPTN;ENSA;CLASP1;PPME1;DYNC1I2;CRLF3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.5195326445542875,1.2079695899023877,0.23298731257208766,0.9723978665244121,1.0,12/38,14.53%,LMAN1;LRRK2;FBXW7;RNF31;UBE2J2;ABLIM3;HPS4;PARL;VPS11;SH3GLB1;HTRA2;UBE2D3
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.4842699670632611,1.2079024668090064,0.1993801652892562,0.9713126138388121,1.0,20/88,14.72%,RGCC;TSG101;CX3CL1;SMPD3;VPS4A;BCL2L11;SMAD3;PRKCA;SDCBP;SLF1;FNIP1;FAF1;TAL1;HGS;VPS4B;SH3GLB1;PDCD6IP;SYK;RAB7A;SPIDR
prerank,mitotic spindle assembly (GO:0090307),0.5186892476313092,1.2077172391000366,0.22675736961451248,0.9707092325129693,1.0,8/42,11.55%,TOGARAM2;KPNB1;CCDC61;FLNA;KIF11;STAG2;CHEK2;LSM14A
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5266026302434925,-1.2077029504116341,0.23170731707317074,0.9704818518380547,1.0,3/11,4.45%,CACNA2D1;NOS1AP;SESTD1
prerank,nucleic acid metabolic process (GO:0090304),0.5023487619027511,1.2076483621488256,0.2051009564293305,0.9696774276237673,1.0,19/69,16.13%,POLR2D;POLG;RAD50;HNRNPM;POLR2A;WRN;METTL3;HNRNPA2B1;HNRNPA3;EXD2;ATXN2;XRN2;GTF2F2;WTAP;HNRNPH1;RECQL5;HNRNPC;HNRNPK;HNRNPL
prerank,regulation of protein phosphorylation (GO:0001932),0.4839339001709639,1.2076060916480074,0.09418837675350701,0.968541101940553,1.0,26/256,9.65%,MUSK;FGF22;FGF18;LRRK2;IGFBP3;CDK5RAP3;PID1;FGF1;VEGFC;IMPACT;GAS6;TARDBP;NIBAN1;ANKRD54;EPHB2;AKTIP;PRKDC;CDK2AP1;HSP90AA1;NPTN;DAB2;KRAS;FNIP1;FXR2;MAVS;LYN
prerank,acylglycerol homeostasis (GO:0055090),0.5745942768723277,1.2075993810019463,0.25718194254445964,0.9672273229113648,1.0,2/20,8.68%,RORA;IL18
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.5356566803931905,1.2074298771556533,0.21071428571428572,0.9666286786744877,1.0,3/33,3.74%,WFS1;NUPR1;GAS6
prerank,RNA processing (GO:0006396),0.4804889817244797,1.207216860466357,0.12751004016064257,0.9661836386397946,1.0,58/176,16.48%,SNRPD2;SNRPD1;ELAVL4;SYNCRIP;TUT4;BCAS2;CSTF3;TARDBP;MBNL1;ATXN1;RNPS1;RBM3;PRPF3;GEMIN2;PRKACA;U2AF1;RBM5;SNRPN;METTL3;HNRNPA2B1;PABPC4;SRSF5;PRPF6;LIN28B;PRMT9;SNRPD3;SETX;SCAF11;FUS;APOBEC1;DDX23;DHX16;RNGTT;U2AF2;ADAR;XRN2;RBM6;SF3B2;SRSF9;SRSF11;SRPK2;DHX8;HNRNPH3;HNRNPH1;BICD1;RBMS1;SF3B4;IVNS1ABP;RP9;ALKBH5;AKAP8L;HNRNPC;HNRNPK;PPP1R9B;DHX15;HNRNPL;CELF2;DROSHA
prerank,cell junction assembly (GO:0034329),0.49305676268356957,1.2071936821996485,0.1721311475409836,0.9649642321148475,1.0,21/100,15.73%,SDK2;GJC1;PCDHB16;TLN2;ITGA6;FLNA;FARP1;LIMS1;MYO9A;CDK5;CDH11;CDC42;DBNL;CDH20;FBLIM1;FN1;CDH18;PTEN;PKP4;GPM6A;CAPZA1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.5761976056954535,1.2066577063072617,0.24822695035460993,0.9660282550206926,1.0,6/16,13.16%,NAA35;EP300;NAA25;NAA16;KAT2B;NAA15
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6458075905800408,1.2066436622702825,0.28091603053435116,0.9647521554187353,1.0,3/10,12.68%,FBXW7;AREG;TGFA
prerank,positive regulation of bone resorption (GO:0045780),0.635157035333732,1.2061215335832034,0.2476489028213166,0.9658065573012922,1.0,4/11,15.93%,TNFRSF11A;PRKCA;SYK;PLEKHM1
prerank,isotype switching (GO:0045190),-0.5270454834348943,-1.206070878894528,0.2371967654986523,0.9708274105475913,1.0,6/10,29.86%,RNF168;HSPD1;MSH2;RNF8;BATF;MSH6
prerank,positive regulation of viral transcription (GO:0050434),0.5530407362216919,1.205412663991975,0.25985221674876846,0.9674799028609816,1.0,6/25,13.02%,POLR2D;POLR2A;CDK9;NELFA;GTF2F2;CTDP1
prerank,regulation of cell migration (GO:0030334),0.4800683435846698,1.2049856979967577,0.051,0.9680588233978181,1.0,59/382,13.60%,CXCL12;FGF22;FGF18;SGK3;MGAT3;ROR2;SYNE2;VCL;PLXNA1;RIPOR1;DUSP3;CX3CL1;MINK1;SCAI;FGF1;ADAM15;ITGA6;ZMYND8;SASH1;MAPRE1;NF1;EPHB2;ELP3;THBS1;FLNA;TPM1;PDGFB;PRKCA;SEMA6D;PTPRJ;SDCBP;ACVR1;CAMSAP3;CBLL1;FERMT3;LDLRAD4;DUSP10;SLURP1;ARSB;PTPRT;DAB2;TBCCD1;APC;F3;ACTN4;SEMA3D;SEMA6A;MIA3;CYRIB;IGF1R;TMSB4X;SORL1;RUFY3;ADAM10;TGFBR1;RNF20;PLXNC1;PTPRU;INSR
prerank,regulation of catabolic process (GO:0009894),0.5795954861120576,1.2048693602859828,0.266016713091922,0.967223099901755,1.0,5/18,10.43%,HPGD;CHEK2;FAF1;HGS;FURIN
prerank,positive regulation of RNA splicing (GO:0033120),0.5404327239172119,1.2048197563938374,0.23579201934703747,0.9660918391761576,1.0,11/29,15.70%,HABP4;POLR2A;RBM3;SLC38A2;NUP98;TRA2A;SETX;U2AF2;ERN1;SF3B4;PIK3R1
prerank,telomere organization (GO:0032200),0.5114417678936288,1.2046085419096173,0.23476297968397292,0.9656752152081884,1.0,9/43,8.15%,BLM;RAD50;WRN;TERF2;PRKDC;POLD3;MRE11;ERCC4;NBN
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5999847087241799,1.204514349216545,0.24355300859598855,0.9647753551961643,1.0,6/15,14.36%,LDLRAP1;IRS1;IRS2;PPARG;PPM1K;PPARD
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5513441305437461,1.204430113603519,0.24907521578298397,0.9638516033036268,1.0,4/28,6.92%,FBXW7;ZBTB7A;METTL3;BEND6
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.6105581493656046,1.204121730986349,0.24082232011747431,0.9638341807546431,1.0,4/12,17.19%,BRCA1;ACADL;ERLIN1;PIBF1
prerank,fatty acid biosynthetic process (GO:0006633),0.4990719716330998,1.203818648310875,0.2267818574514039,0.9638181875976418,1.0,13/63,14.15%,DEGS1;ACSBG1;HACD1;HPGD;LIAS;GPX4;ALOX5;TECR;FADS1;ABCD3;ABCD1;ACACA;HACD4
prerank,Golgi to lysosome transport (GO:0090160),-0.504550810186758,-1.2037876945145642,0.24293785310734464,0.9739695271356782,1.0,5/11,12.31%,LAPTM5;GAK;CLN3;CCDC91;AP1G1
prerank,phagosome maturation (GO:0090382),-0.3525017248775557,-1.203608841689593,0.1592356687898089,0.9684057856361842,1.0,14/35,17.49%,ATP6V0A1;RAB31;ATP6V1A;ATP6V1D;RAB14;CORO1A;ATP6V0C;RAB39A;RAB32;ATP6V0B;ATP6V1C1;ATP6V1G1;RAB20;RAB43
prerank,autonomic nervous system development (GO:0048483),0.5890919283561049,1.203575049951763,0.25405405405405407,0.9635786173363781,1.0,4/17,13.49%,NF1;NRP1;SOX11;FN1
prerank,cellular response to metal ion (GO:0071248),0.4802088605625214,1.2028954309455913,0.16411824668705402,0.9651551907665913,1.0,26/123,11.35%,CPNE5;SLC25A24;LRRK2;ADCY8;BRAF;SMPD1;JUN;HVCN1;MAPK1;MEF2A;MAPK8;SYT12;SYT11;CAMK2D;ADD1;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;BNIP3;MCOLN1;PRNP
prerank,regulation of biomineral tissue development (GO:0070167),0.5516316007821427,1.202107591996718,0.2574626865671642,0.9672423824163788,1.0,6/26,14.30%,S1PR1;DDR2;GAS6;TXLNG;BMP2K;ROCK2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.40676467667231675,-1.2020842249297792,0.21693121693121692,0.96835044161804,1.0,3/25,1.52%,PLCG2;LAPTM5;B2M
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.583452312866608,1.201882570677015,0.26943699731903487,0.9669043097340578,1.0,5/16,9.95%,PARP9;PRKDC;KMT5B;KMT5C;SMCHD1
prerank,platelet aggregation (GO:0070527),0.5355633882656551,1.201231785565513,0.23176470588235293,0.9683890518850652,1.0,5/33,7.73%,VCL;CLIC1;METAP1;FLNA;FERMT3
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.35334574865116386,-1.2008525937266734,0.1643835616438356,0.9671098913527989,1.0,8/35,7.85%,IL10RA;PTPRC;JAK2;NLK;ERBB4;NF2;GHR;DOT1L
prerank,bile acid and bile salt transport (GO:0015721),0.542063148447759,1.2007608788838324,0.25406758448060074,0.9691513474768358,1.0,6/24,14.57%,SLCO1B1;NCOA1;STARD5;RXRA;SLCO2B1;NCOA2
prerank,regulation of defense response (GO:0031347),0.49564861457920395,1.200291262859488,0.20488322717622082,0.9698677827339598,1.0,14/76,13.06%,ACE2;ADAMTS12;RELA;IRF1;BCL6;BIRC3;LACC1;ALOX5;AREL1;LRP8;TMSB4X;ERAP1;CYLD;NR1D2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6198406660437284,1.2002774612869307,0.28550074738415543,0.9686090879668888,1.0,3/12,9.84%,UST;DSE;BGN
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.5052212290901729,-1.1994004707538852,0.234375,0.9666782423782299,1.0,6/11,31.50%,JAK2;CANX;JAK1;STAT3;IL6ST;IL12RB2
prerank,sodium ion export across plasma membrane (GO:0036376),-0.4834619788086141,-1.1993178237828552,0.2616822429906542,0.9610420979527107,1.0,5/13,8.21%,ATP1B3;ATP1B1;ATP1A1;ATP1A2;ATP1A3
prerank,positive regulation of response to external stimulus (GO:0032103),0.4875158282569598,1.1991731819089733,0.1617497456765005,0.9720814972599574,1.0,28/128,15.45%,PLA2G7;POLR3G;RIOK3;CX3CL1;IFI35;IL16;DDX60;TLR7;SASH1;FEM1A;THBS1;PDGFB;PRKCA;PUM2;AKIRIN2;TLR3;STX3;IL18;PUM1;NFKBIZ;IL17RA;SLC15A4;OPTN;P2RY12;LY86;AIF1;TLR4;CD47
prerank,renal system development (GO:0072001),0.5040905387978136,1.1982190417816079,0.2361863488624052,0.9750209406783391,1.0,4/52,8.12%,WNT4;WFS1;TGFB2;C1GALT1
prerank,lipoxygenase pathway (GO:0019372),0.6036402327940524,1.197794819491218,0.2723342939481268,0.9755609307634062,1.0,3/14,8.47%,HPGD;GPX4;ALOX5
prerank,histone methylation (GO:0016571),0.5423570203806323,1.1972201841285783,0.24533001245330013,0.976851647897596,1.0,5/26,8.54%,SIRT7;EHMT1;SUV39H1;EHMT2;EZH2
prerank,regulation of nervous system process (GO:0031644),-0.44219656059077506,-1.196979069881107,0.24696356275303644,0.9641960207816559,1.0,4/18,3.24%,APP;DLGAP2;DLGAP1;TMEM108
prerank,regulation of glucose metabolic process (GO:0010906),0.5241835532182905,1.1959353338969714,0.2473246135552913,0.9812835013700887,1.0,4/34,6.71%,RORA;SIRT7;IRS1;IRS2
prerank,serine family amino acid metabolic process (GO:0009069),0.5825153377694278,1.1959210925611108,0.2564102564102564,0.9800440934693546,1.0,1/16,0.33%,CBS
prerank,negative regulation of viral genome replication (GO:0045071),0.5095957090360531,1.1953267445497424,0.24361948955916474,0.981334567222254,1.0,4/40,2.23%,BANF1;IFITM3;EIF2AK2;ILF3
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.638146963397781,1.1951640741872236,0.26582278481012656,0.9807450839251468,1.0,1/10,0.73%,ZNHIT3
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5781962851467897,1.1950903938277768,0.2699868938401048,0.9798126147741615,1.0,4/18,12.01%,IGFBP2;IL18;ICOSLG;HMGB1
prerank,ubiquinone biosynthetic process (GO:0006744),0.5922318733530055,1.1949257299123952,0.2620689655172414,0.9792213019086717,1.0,4/15,13.46%,COQ6;NDUFA9;PDSS2;COQ7
prerank,exit from mitosis (GO:0010458),0.6083613531707706,1.1948954373533665,0.26627218934911245,0.9780493890121561,1.0,6/12,18.03%,SIRT7;EPS8;CTDP1;CLASP1;PPP2R2D;CLASP2
prerank,defense response to fungus (GO:0050832),-0.4344900995645138,-1.1948462824812571,0.2491349480968858,0.9666565257163265,1.0,6/17,33.54%,PLCG2;RNASE7;CARD9;BCL10;GAPDH;FAM3A
prerank,cAMP-mediated signaling (GO:0019933),-0.4018303959595123,-1.1947863104279741,0.19900497512437812,0.9610289204217685,1.0,6/24,7.19%,PDE4D;RIMS2;CAP1;AKAP6;KSR1;ADCY2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.47387295892615144,1.1945240723375188,0.18061224489795918,0.978401338075802,1.0,25/107,13.03%,WFS1;CDK5RAP3;UBA5;BCL2L11;NIBAN1;USP19;JUN;ERP44;UBQLN1;THBS1;UFC1;PDIA4;TMEM259;ERLEC1;NCK1;TRAF2;CREB3L2;DERL1;SCAMP5;ERN1;AIFM1;ATF6;TP53;EIF2S1;BCL2
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.5159871531696437,-1.1944540968564321,0.2571428571428571,0.9563783871679128,1.0,2/10,1.86%,CST3;TGFB1
prerank,telomere maintenance (GO:0000723),0.5041072916378174,1.1943212725770995,0.23333333333333334,0.9779324924025065,1.0,10/50,8.15%,BLM;RAD50;WRN;TERF2;PRKDC;POLD3;MRE11;ERCC4;SMC5;NBN
prerank,sodium ion homeostasis (GO:0055078),-0.41289857583182643,-1.194046152532746,0.2025862068965517,0.9522107648028981,1.0,5/21,8.21%,ATP1B3;ATP1B1;ATP1A1;ATP1A2;ATP1A3
prerank,regulation of mast cell activation (GO:0033003),0.63524924259586,1.1938807660409723,0.28391167192429023,0.9784527974729591,1.0,3/10,14.08%,MILR1;LYN;CD84
prerank,regulation of signal transduction (GO:0009966),0.4766834397994677,1.1938579070884046,0.13827655310621242,0.9772800017714041,1.0,35/190,11.35%,RORA;GAS1;LRRK2;IGFBP3;LLGL2;CD36;CX3CL1;IGFBP2;ITGB1BP1;LLGL1;RUNX1;MTCH1;ANKRD54;LIFR;ESR1;ACVR1;USP33;RGS14;RGS3;SNX3;RIC8B;PTPN1;NCK1;UBTF;IRAK2;GRK5;USP20;DTNBP1;CD63;SOCS5;DHRS3;TRIM5;TULP3;PXN;PRNP
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.5039419099916914,1.1934986012094349,0.24887892376681614,0.9775266906725113,1.0,14/51,16.23%,RGCC;CX3CL1;ITGB1BP1;NRP1;GPR65;TPM1;CDC42;PXN;ABL1;TGFBR1;ROCK2;EVL;CD47;PAK1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.6303459063919774,1.1934694493797242,0.2854938271604938,0.9763541662686952,1.0,5/10,10.69%,MSN;CAMSAP3;EZR;MYO9A;CDC42
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.500921105535394,1.1933147268862518,0.23307436182019978,0.9758136157806412,1.0,8/49,7.10%,EIF6;SETD1A;RUNX1;THBS1;EP300;RBM15;TNRC6B;KMT2E
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.47613609980094634,1.191914811737283,0.1091091091091091,0.9806192209237211,1.0,59/241,13.71%,POLR2D;SNRPD2;SNRPD1;PLRG1;EIF4A3;ELAVL2;SART1;HNRNPM;LSM7;DDX42;SYNCRIP;PRPF38A;BCAS2;CSTF3;DHX38;DNAJC8;CSTF2;POLR2A;FRG1;RNPS1;PRPF3;CTNNBL1;RBM15;SPEN;PRPF40A;BUD31;U2AF1;RBM5;SNRPN;PRPF40B;METTL3;HNRNPA2B1;HNRNPA3;GPKOW;SRSF5;PRPF6;TRA2A;SNRNP70;SNRPD3;FUS;CDC5L;DDX23;DHX16;U2AF2;RBM17;CPSF3;SF1;RBM6;PSPC1;SF3B2;GTF2F2;PRCC;SRSF9;SRSF11;DHX8;HNRNPH3;HNRNPH1;SRRM2;DDX5
prerank,regulation of cell junction assembly (GO:1901888),0.5361966437807779,1.1919065462265594,0.2737789203084833,0.97937932988175,1.0,11/27,18.14%,RAPGEF1;RUNX1;RAP1A;PRKACA;RAP1B;ROCK2;MEF2C;SETD5;RAPGEF2;PRKCH;ROCK1
prerank,ribosome assembly (GO:0042255),0.5030453012015026,1.1918947837969736,0.2530795072788354,0.9781533080932944,1.0,5/47,5.60%,EIF6;BOP1;SBDS;RPLP0;TRAF7
prerank,protein depolymerization (GO:0051261),0.5446720431778629,1.1916214087067676,0.24146341463414633,0.9780489176174273,1.0,10/27,17.39%,CFL1;STMN2;NCKAP5L;TWF2;MICAL2;VPS4B;WDR1;MICAL3;KIF2A;GSN
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5561214545991952,1.1911491842539146,0.26376440460947503,0.9788972910963812,1.0,4/21,5.17%,LDLRAP1;BMPR1A;JUN;PDGFB
prerank,response to acidic pH (GO:0010447),0.6021544158317877,1.1911108267151271,0.28296296296296297,0.977801202911538,1.0,3/13,4.83%,IMPACT;SLC9A1;GPR65
prerank,SNARE complex assembly (GO:0035493),0.6128852252501067,1.1910896160237954,0.2848575712143928,0.9766206261104903,1.0,4/10,12.03%,VAMP1;VAMP3;VAMP2;UVRAG
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.5758254942881376,1.19086213386636,0.26711409395973157,0.9763971858167779,1.0,3/16,8.07%,ATP5F1A;ATP5MC3;ATP5MC2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.42922044213635696,-1.1907531491458145,0.24899598393574296,0.9592652729198712,1.0,3/17,2.38%,PTPRC;CALM2;CD33
prerank,immunoglobulin mediated immune response (GO:0016064),-0.5206590137484942,-1.1905445369527343,0.27575757575757576,0.9543804539696332,1.0,5/10,26.09%,FCER1G;FCGR2B;CD74;CARD9;TLR8
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.5001517462192303,1.190487567256307,0.22863247863247863,0.9767682040375633,1.0,14/62,13.65%,POLR2D;EAF1;CTR9;POLR2A;MLLT1;CDK7;MNAT1;SETD2;CDK9;NELFA;ELOC;GTF2F2;CTDP1;GTF2H1
prerank,positive regulation of locomotion (GO:0040017),0.5347791916993694,1.1901433484888062,0.26438188494492043,0.9770657729768333,1.0,4/27,8.14%,CAVIN1;THBS1;PDGFB;STX3
prerank,sodium-independent organic anion transport (GO:0043252),0.6365987907101556,1.1900823518724157,0.300314465408805,0.9760712508350716,1.0,2/10,3.36%,SLCO4C1;SLCO1B1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.6262427355265289,1.1897041905840207,0.29984544049459044,0.9763755240127056,1.0,1/10,0.41%,BRCA1
prerank,endothelial cell development (GO:0001885),0.5494204955321952,1.1894444319290003,0.25953259532595324,0.976218169331895,1.0,5/25,7.63%,RAPGEF1;MSN;RAP1A;EZR;RAP1B
prerank,cardiac myofibril assembly (GO:0055003),0.5873459550187394,1.189348565592565,0.27448275862068966,0.9753596917700649,1.0,2/15,7.15%,NEBL;MEF2A
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6133509313903377,1.1888253902530315,0.2702312138728324,0.9763027839490968,1.0,5/13,16.68%,GAS6;AXL;IL18;LAMP1;ZBTB1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.4979176691334805,1.1885319006987818,0.2304394426580922,0.9762612226804231,1.0,14/64,13.65%,POLR2D;EAF1;CTR9;POLR2A;MLLT1;CDK7;MNAT1;SETD2;CDK9;NELFA;ELOC;GTF2F2;CTDP1;GTF2H1
prerank,positive regulation of interferon-gamma production (GO:0032729),0.5063082861602377,1.1883780981510035,0.24478594950603733,0.9756894363967749,1.0,6/48,11.10%,ISL1;TLR7;TLR3;IL18;SLAMF6;CYRIB
prerank,positive regulation of lipid storage (GO:0010884),-0.40856376527136273,-1.1882669638513965,0.21982758620689655,0.9573882102772725,1.0,9/21,20.74%,OSBPL11;PLIN2;IKBKE;MSR1;LPL;SREBF2;SCARB1;ZC3H12A;VSTM2A
prerank,lamellipodium assembly (GO:0030032),0.5431076510009814,1.187776972081004,0.2506297229219144,0.9769624630924596,1.0,5/26,7.03%,VCL;S1PR1;PARVB;ABLIM3;GOLPH3
prerank,DNA metabolic process (GO:0006259),0.4723588771515085,1.187618939814468,0.093,0.9763573655424265,1.0,47/270,12.74%,CBS;POLG;BRCA1;DFFB;MPG;SIRT7;BLM;RFC2;POLE4;POLE2;RNASEH2A;RAD50;PARG;RAD18;ORC4;ASF1A;POLA1;WRN;UBE2V2;TERF2;CDK2;PRKDC;NOC3L;UBE2A;POLA2;POLD3;POLB;MNAT1;PDS5A;RBBP8;MRE11;ERCC4;KMT5B;NBN;PARP2;PRIM2;EXD2;KMT5C;ORC2;PARP4;DDX23;RAD51B;HMGB1;UVRAG;USP3;TCF7L2;SRPK2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.47306811471718746,1.1874447063885087,0.101,0.9758175705380892,1.0,65/264,13.71%,POLR2D;SNRPD2;SNRPD1;PLRG1;EIF4A3;ELAVL2;GEMIN8;SART1;HNRNPM;LSM7;DDX42;SYNCRIP;PRPF38A;BCAS2;CSTF3;DHX38;DNAJC8;CSTF2;POLR2A;FRG1;RNPS1;PRPF3;GEMIN2;CTNNBL1;RBM15;SPEN;PRPF40A;BUD31;U2AF1;TGS1;RBM5;SNRPN;PRPF40B;METTL3;HNRNPA2B1;HNRNPA3;GPKOW;SRSF5;PRPF6;TRA2A;SNRNP70;SNRPD3;SCAF11;FUS;CDC5L;DDX23;DHX16;U2AF2;RBM17;CPSF3;SF1;RBM6;PSPC1;SF3B2;GTF2F2;PRCC;DCPS;SRSF9;SRSF11;SRPK2;DHX8;HNRNPH3;HNRNPH1;SRRM2;DDX5
prerank,prostanoid metabolic process (GO:0006692),0.6041984866292277,1.1871274275151977,0.2959770114942529,0.9759432381416876,1.0,3/13,11.28%,HPGD;PLAA;PTGR2
prerank,positive regulation of viral process (GO:0048524),0.49587113928290905,1.1866616628162416,0.24946236559139784,0.976600740118028,1.0,15/60,14.59%,POLR2D;VPS4A;PPID;POLR2A;AXL;KPNA6;PKN2;CDK9;NELFA;ADAR;GTF2F2;SRPK2;CTDP1;TMEM39A;RAB7A
prerank,positive regulation of cellular component organization (GO:0051130),0.47092554562663835,1.1866118812047806,0.2020618556701031,0.975580471885019,1.0,27/107,14.72%,LMAN1;RUNX1;TGFB2;SMPD1;BCL2L11;AR;TMED9;ABCB7;TMEM30A;CBLL1;DCTN1;SLF1;DAB2;ADD1;FNIP1;FAF1;TAL1;PTPN23;BNIP3;IGF1R;SH3GLB1;TGFBR1;SYK;GPC3;INSR;RELN;SPIDR
prerank,mRNA 3'-end processing (GO:0031124),0.4820510356998246,1.1855077464552857,0.2231578947368421,0.9790590949261073,1.0,18/78,12.67%,POLR2D;EIF4A3;RPRD1B;CSTF3;DHX38;SARNP;CSTF2;RNPS1;U2AF1;RPRD2;RPRD1A;THOC5;SRSF5;SSU72;U2AF2;CPSF3;SRSF9;SRSF11
prerank,positive regulation of telomere maintenance (GO:0032206),0.5232021361162635,1.1853535342745103,0.2628434886499403,0.9785128313999386,1.0,12/31,17.17%,RAD50;MAPK1;HNRNPA2B1;MRE11;PKIB;NBN;TNKS2;NEK7;ATRX;PPP1R10;HNRNPD;ATM
prerank,nucleosome organization (GO:0034728),0.4922915523072782,1.1849695473659652,0.26269315673289184,0.9789532662205159,1.0,10/55,9.29%,SRCAP;DMAP1;SMARCA4;VPS72;ASF1A;ZNHIT1;SPTY2D1;SETD2;SET;BRD2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.5613411095320437,1.184847371173778,0.28843537414965986,0.9782073160349425,1.0,2/18,2.48%,COA3;COX17
prerank,positive regulation of endothelial cell migration (GO:0010595),0.48379717348409934,1.1841215921225348,0.21259029927760578,0.9800265969950566,1.0,10/84,5.26%,FGF18;ATP5F1A;SP1;FGF1;ITGB1BP1;SASH1;THBS1;NRP1;PDGFB;PRKCA
prerank,regulation of protein kinase A signaling (GO:0010738),0.5585696713710508,1.1840408459325655,0.261558784676354,0.979134513753844,1.0,2/20,3.26%,LRRK2;PRKAR2A
prerank,cellular defense response (GO:0006968),0.5067519417181412,1.1838429976043847,0.24330616996507567,0.9787650490977298,1.0,3/40,1.76%,CD5L;C5AR1;RELA
prerank,negative regulation of bone remodeling (GO:0046851),-0.49273353070022574,-1.183333177338594,0.2676056338028169,0.9706254743352678,1.0,3/11,16.38%,P2RX7;GPR137B;TNFAIP3
prerank,lipid droplet organization (GO:0034389),0.5472492268724491,1.1824430607994005,0.2603092783505155,0.9834987575864924,1.0,4/22,11.99%,PPID;RAB3GAP1;CDS1;RAB18
prerank,peptidyl-lysine methylation (GO:0018022),0.5471327600117444,1.1813434501650897,0.2564734895191122,0.986950471453236,1.0,5/26,7.97%,EHMT1;SUV39H1;EHMT2;SETD2;SETD3
prerank,stress fiber assembly (GO:0043149),-0.45954871010642584,-1.1809969021971547,0.26578073089701,0.9682636259314168,1.0,13/15,34.09%,RHOA;SORBS1;PDCD10;CUL3;FAM171A1;KCTD13;SRC;TNFAIP1;ZYX;PHACTR1;ITGB1;PDLIM1;FHDC1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.45954871010642584,-1.1809969021971547,0.26578073089701,0.9682636259314168,1.0,13/15,34.09%,RHOA;SORBS1;PDCD10;CUL3;FAM171A1;KCTD13;SRC;TNFAIP1;ZYX;PHACTR1;ITGB1;PDLIM1;FHDC1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.5293964974703396,1.1809636408025586,0.26707317073170733,0.9872830260721647,1.0,4/29,6.69%,PLK1;FBXW7;FEM1A;DCUN1D4
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.5005307721037949,1.1808551749529828,0.25867861142217247,0.9865280721183052,1.0,7/48,7.05%,ADCY8;ADCY3;ADSS1;ACAT1;ADCY5;PANK1;ADCY9
prerank,RNA biosynthetic process (GO:0032774),0.521732327853174,1.1808171200747941,0.2798110979929162,0.9854519638981156,1.0,8/31,12.06%,POLR2A;POLA1;POLA2;PRIM2;TAF4;SETX;GTF2B;BRF1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.40850434192067997,-1.1805280165592613,0.24568965517241378,0.9645844412643018,1.0,5/21,6.97%,PDE4D;RYR2;CALM2;AKAP6;ATP1A2
prerank,cellular sodium ion homeostasis (GO:0006883),-0.4402702466857237,-1.1801369201410563,0.25245901639344265,0.96065192408088,1.0,5/15,8.21%,ATP1B3;ATP1B1;ATP1A1;ATP1A2;ATP1A3
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.601538093173961,1.180039233429613,0.2820874471086037,0.9876623123909387,1.0,2/13,11.10%,STX7;CYRIB
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6035437816607621,1.1797957394992489,0.2983257229832572,0.9874624781078343,1.0,5/12,14.30%,FLOT2;RANBP9;ABCA7;PRNP;ROCK2
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.4821457829952919,-1.1797904476668744,0.2861635220125786,0.9564704421831564,1.0,10/12,33.78%,GLUD1;ACLY;ACO2;ACO1;IDH1;IREB2;IDH3B;IDH3G;SIRT4;IDH3A
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.5780931738212784,1.1791565879985382,0.264945652173913,0.9890605823786731,1.0,5/16,11.97%,SART1;PSIP1;SFSWAP;DDX23;DCPS
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.6165180462510418,1.1790231958299837,0.3093415007656968,0.9872187121800026,1.0,2/10,8.99%,NUPR1;NCOR1
prerank,negative regulation of glycolytic process (GO:0045820),0.6165180462510418,1.1790231958299837,0.3093415007656968,0.9872187121800026,1.0,2/10,8.99%,NUPR1;NCOR1
prerank,protein localization to synapse (GO:0035418),-0.496771331989532,-1.1789095321254393,0.2865853658536585,0.9544102591783625,1.0,7/12,36.29%,NRXN1;DLG4;NRXN2;SHANK1;BSN;NLGN2;ZDHHC15
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.49867168467457046,1.1788697113346316,0.2530657748049052,0.9866642976242137,1.0,8/48,8.68%,EIF6;NOA1;PGAM1;ZBTB7A;NUP205;EP300;NUP98;NUP54
prerank,cellular response to pH (GO:0071467),0.5751086739641735,1.1788524750933722,0.29680998613037446,0.9855264718076492,1.0,4/17,11.17%,IMPACT;SLC9A1;HVCN1;MCOLN1
prerank,endodermal cell fate commitment (GO:0001711),0.6232604922146222,1.1784449361108993,0.29797191887675506,0.9860753800506756,1.0,1/10,2.15%,CTR9
prerank,ribosome biogenesis (GO:0042254),0.46729163585586597,1.1780939751282702,0.16216216216216217,0.9863754538937376,1.0,43/187,15.27%,EIF6;C1D;MPHOSPH6;RPL18;BOP1;UTP3;PELP1;SBDS;GTF3A;RPL41;RPL31;UTP18;EMG1;RPS17;DDX49;MALSU1;RPL4;UTP20;EXOSC5;HEATR3;RPLP0;RPL38;EXOSC7;RRP36;RRP1B;FCF1;DDX10;UTP6;NOC2L;XRN2;CUL4A;HEATR1;NOP56;RPL21;RPS6;NOL8;NVL;MDN1;MTREX;TSC1;RPL35A;NPM1;RPS16
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.48640910625263384,-1.177554254726875,0.2824207492795389,0.9543573174737793,1.0,2/12,2.26%,RYR2;PTK2B
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5821443522574536,1.1773883557378069,0.2937771345875543,0.9881540347788899,1.0,4/13,13.83%,PLXNA1;NRP1;PLXNC1;NRP2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6160025117960253,1.1772962398144207,0.28703703703703703,0.9873184916723772,1.0,2/10,8.37%,IFI35;WDFY1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.551561966699838,1.1769924375053058,0.2667509481668774,0.9873844585704735,1.0,1/21,0.18%,PLK1
prerank,regulation of autophagosome assembly (GO:2000785),0.5198583223868819,1.176759324077271,0.2685851318944844,0.9871361563073923,1.0,12/33,15.54%,LRRK2;NUPR1;RAB3GAP1;PIP4K2A;IFT20;TBC1D14;PIP4K2B;FEZ1;TBC1D12;SH3GLB1;TMEM39A;MTM1
prerank,cellular response to ATP (GO:0071318),-0.4678988175067889,-1.1760248046085051,0.25874125874125875,0.9548626786438622,1.0,4/14,17.48%,P2RX7;TAF1;SSH1;P2RX4
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.5537823391009681,1.1759023490267166,0.29214929214929214,0.9894785447020266,1.0,8/22,15.19%,SLC9A1;PRKCA;MEF2A;MLIP;GLRX3;CAMK2D;ROCK2;SMAD4
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6220897099543764,1.1758988909837709,0.2917933130699088,0.9882769940407599,1.0,3/10,7.12%,ZEB2;ATP7A;GIPC1
prerank,regulation of protein binding (GO:0043393),0.4726653327232926,1.1756298904259852,0.21457905544147843,0.9882162821059428,1.0,22/114,12.87%,PLK1;LRRK2;DVL1;LDLRAP1;NMD3;ITGB1BP1;STYX;PDGFB;PRKACA;AKTIP;SPPL3;HDAC5;USP33;EPB41;MAPK8;DAB2;ADD1;CTSZ;DERL1;SORL1;TCF7L2;HIPK2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.35173140844157885,-1.1753419099365596,0.24113475177304963,0.9521170913916717,1.0,10/35,8.07%,BCAS3;TJP1;HCK;F11R;ABI3;PTK2B;FES;CSF1R;HCLS1;NTRK3
prerank,angiogenesis involved in wound healing (GO:0060055),-0.5233183682410447,-1.1753358365152367,0.26299694189602446,0.946828638902645,1.0,10/11,46.20%,ADIPOR2;HPSE;CD34;ITGB3;VEGFA;PRCP;MCAM;NDNF;KDR;SRF
prerank,rRNA metabolic process (GO:0016072),0.46749249430326695,1.1753187429406453,0.1676706827309237,0.9883332579995207,1.0,32/160,12.70%,C1D;MPHOSPH6;RPL18;BOP1;UTP3;PELP1;SBDS;RPL41;RPL31;UTP18;EMG1;RPS17;DDX49;RPL4;UTP20;EXOSC5;RPLP0;RPL38;EXOSC7;XRN1;RRP36;RRP1B;MAPT;FCF1;DDX10;UTP6;XRN2;HEATR1;NOP56;RPL21;RPS6;NOL8
prerank,regulation of cell differentiation (GO:0045595),0.46953429106586947,1.1752934042682437,0.19839679358717435,0.9872461551547358,1.0,29/148,15.10%,ISL1;CDK5RAP3;EIF2AK2;HOPX;FLOT2;CASZ1;NREP;RUNX1;NF1;AR;BCL6;TRPS1;PRKCB;PRKACA;CDK6;MCRIP1;CDK9;ALOX5;APC;FADS1;RAF1;ZFP36L1;TGFBR1;NR1D2;DDX5;PLEKHB2;ANP32B;DAG1;CLASP1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4893528868133668,1.1750716290774472,0.2368692070030896,0.9870035824932728,1.0,16/75,14.30%,PDE6H;FNTB;METAP1;USP33;RGS14;RGS3;RIC8B;GRK5;USP20;NMT1;RNF157;TULP3;NMT2;RPGRIP1L;CALM1;ROCK2
prerank,negative regulation of signal transduction (GO:0009968),0.4702215580662043,1.1749582580038485,0.139,0.9862421437705032,1.0,42/249,13.74%,BMP5;MDFI;ADAMTS12;LRRK2;IGFBP3;PRKCZ;FBXW7;CX3CL1;PID1;SMPD1;NFATC1;HERC4;ZBTB7A;PIP4K2A;IRS1;THBS1;PRKCB;PTPRJ;METTL3;ACVR1;BEND6;TLE1;NEDD4;RGS14;PTPN1;PTPRT;EZH2;NCK1;NXN;PIP4K2B;LYN;HGS;SOCS5;RNF157;TULP3;SEMA6A;HMGXB4;BCL2;RPGRIP1L;GPC3;WWOX;NDRG4
prerank,response to iron ion (GO:0010039),-0.4886605320621532,-1.1748189834673644,0.254071661237785,0.9434879133472054,1.0,4/12,12.61%,B2M;SNCA;SLC11A2;ACO1
prerank,dermatan sulfate metabolic process (GO:0030205),0.593550336698046,1.1744773299548001,0.30390738060781475,0.9869581629182882,1.0,3/13,9.84%,UST;DSE;BGN
prerank,regulation of receptor internalization (GO:0002090),0.5127298751099874,1.1744736552529431,0.2567409144196952,0.9857748812822288,1.0,10/35,15.06%,RIN3;ARRB2;SDCBP;AHI1;CD63;ATXN2;ARF1;TBC1D5;INSR;ANKRD13A
prerank,positive regulation of immune system process (GO:0002684),0.5794679655972824,1.1742194766011695,0.2709497206703911,0.9855911275338661,1.0,4/16,17.29%,TGFB2;MIA3;LGALS9;NCKAP1L
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.5085759385010746,1.1738075565905985,0.2569444444444444,0.9860809523604893,1.0,8/41,8.68%,EIF6;PGAM1;ZBTB7A;NUP205;EP300;NUP98;LACC1;NUP54
prerank,regulation of ATP metabolic process (GO:1903578),0.4898436392460459,1.1735154427444632,0.24318429661941113,0.9862080492863528,1.0,9/54,8.68%,EIF6;AK4;PGAM1;ZBTB7A;NUP205;EP300;ATP7A;NUP98;NUP54
prerank,nitric oxide mediated signal transduction (GO:0007263),0.5861589323409037,1.1733500168124724,0.2801664355062413,0.9857041453186283,1.0,1/16,1.63%,CD36
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.4848326434973737,1.1732153872904647,0.23655913978494625,0.9850680629296505,1.0,34/70,17.40%,ACTR3;GRB2;PLA2G6;DOCK1;YES1;MAPK1;WIPF1;VAV3;ABI1;HSP90AA1;ARPC1A;ARPC4;NCK1;MYO1G;LYN;CDC42;ARPC2;CYFIP2;ABL1;VAV2;WASF2;SYK;FYN;ELMO1;WIPF2;ARPC3;WASL;VAV1;PIK3R1;PAK1;ACTG1;CYFIP1;NCKAP1L;FCGR1A
prerank,cilium assembly (GO:0060271),0.46869912364210176,1.173183192771195,0.107,0.9840116031462961,1.0,51/296,12.16%,TUBB4B;PLK1;RSPH4A;CETN2;CLUAP1;BBIP1;CCDC57;CEP89;NPHP4;ACTR3;ALMS1;ARL6;EHD4;TMEM67;RAB8B;EHD1;BBS4;MAPRE1;IQCB1;DZIP1;AKAP9;CEP250;FLNA;YWHAE;TTC39C;PRKACA;FNBP1L;EXOC5;PCNT;DYNLL2;IFT52;IFT20;ABLIM3;HSP90AA1;DCTN1;TUBA1A;CCDC66;SNX10;DCTN2;CCP110;ODF2;AHI1;CEP152;PTPN23;CNTRL;CFAP74;POC1B;EXOC4;KIF3A;OCRL;PTPDC1
prerank,cellular response to mechanical stimulus (GO:0071260),0.5017450534860493,1.1723267447014214,0.25140291806958476,0.986412719282573,1.0,8/46,10.86%,HABP4;IRF1;TLR7;SLC9A1;MAPK8;TLR3;PIEZO2;BNIP3
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.47732024115660576,1.1721218873758688,0.21347150259067357,0.9860328358305039,1.0,11/93,6.24%,MID1;UNC5CL;MINK1;EIF2AK2;TPD52L1;SH3RF3;TGFB2;SASH1;MAP3K11;RELL1;SDCBP
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5769065615310462,1.171867586170428,0.2886740331491713,0.9859537945056114,1.0,3/16,11.42%,BRCA1;NCOR1;ACADL
prerank,response to unfolded protein (GO:0006986),0.49101200272698864,1.17185152189036,0.25742574257425743,0.9848325961107757,1.0,13/48,15.57%,DNAJB1;BAG3;HSPH1;ERP44;HSP90AA1;HSPA9;PTPN1;TM7SF3;DERL1;ERN1;DNAJB4;OPTN;RHBDD1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.5389822726565368,1.1717608311397525,0.25692695214105793,0.984061121587573,1.0,7/24,12.74%,FBXW7;NUPR1;TGFB2;NF1;CDK5;PRNP;SRPK2
prerank,regulation of lipid catabolic process (GO:0050994),0.5670551934388828,1.171602233361212,0.28291316526610644,0.9835572767397274,1.0,3/19,12.94%,TYSND1;PDE3B;ABCD1
prerank,positive regulation of cellular process (GO:0048522),0.4658181592536103,1.170946190034082,0.044,0.9851147163964367,1.0,80/565,13.60%,CXCL12;FGF22;FGF18;ISL1;BMP5;TNFRSF11A;RPRD1B;CD36;RELA;CX3CL1;FGF1;NUPR1;COX17;FAM98A;DDX49;ITGB1BP1;VEGFC;CAMK1D;MAP1A;TGFB2;GAS6;HCFC1;RAD18;EAPP;AREG;AR;IRS1;GID8;THBS1;LIFR;TPM1;PDGFB;KITLG;PRKCA;CDK2;LRP5;ACER3;RPS15A;PTPRJ;KIF20B;UBE2A;SDCBP;DHPS;IRS2;MAPT;MAPK8;MECP2;TENM4;SMC5;STX3;ABCA7;EZH2;TRPM4;KRAS;NACC1;GRK5;FXR2;FAF1;ADNP2;APC;LYN;TAL1;ACTN4;COLEC12;CDC42;TGFBR2;IGF1R;SOX11;KDM4C;ZFP36L1;RPS6;ADAM10;TGFA;SRPK2;TGFBR1;BCL2;LRP6;S100B;FN1;INSR
prerank,transition metal ion transport (GO:0000041),0.520068847753941,1.1705940077129724,0.25598086124401914,0.9853879200675337,1.0,4/35,5.05%,CP;TRPC5;COX17;ATP7A
prerank,fatty acid beta-oxidation (GO:0006635),0.4860707023421918,1.1704339694535963,0.2513721185510428,0.9849245691624636,1.0,14/51,14.48%,ACAT1;ECI2;ACADS;ECHS1;DECR1;ABCD2;CROT;ABCD3;ACADL;ABCD1;HSD17B4;ETFA;PPARD;ACOX3
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.46504896854746003,1.1702085902295138,0.18724696356275303,0.9846975804151077,1.0,33/148,13.19%,BRCA1;BLM;BOP1;EHMT1;CDK5RAP3;RFC2;RAD50;DYRK2;PIP4K2A;WRN;EP300;CDK2;EHMT2;STK11;RNF34;RBBP8;MRE11;MAP2K6;MAPKAP1;NBN;PHF20;TAF4;CHEK2;PIP4K2B;CDK5;NOC2L;MTOR;PRDM1;MAPK14;BRD7;HIPK2;TP53;RBBP7
prerank,regulation of blood coagulation (GO:0030193),0.5267901216394131,1.1693245961052703,0.2976629766297663,0.9870509977763118,1.0,4/27,9.62%,EPHB2;THBS1;ENPP4;PROC
prerank,RNA destabilization (GO:0050779),0.5658510249994912,1.1691953471042478,0.297442799461642,0.986403699446105,1.0,10/18,19.06%,FTO;METTL3;LIN28B;YTHDF1;PUM1;ROCK2;YTHDF3;ROCK1;CELF1;YTHDF2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.576182036950578,1.1691128304170004,0.3066104078762307,0.9855611758521551,1.0,6/14,16.27%,IGFBP3;BMPR1A;TPM1;NDRG4;AIF1;MEF2C
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5153488491965826,1.1690268491700437,0.2705479452054795,0.9847388508102747,1.0,9/36,15.59%,FBXW7;EPHB2;AREG;NRP1;BUD31;NCOA3;TGFA;RELN;HDAC2
prerank,cellular response to organonitrogen compound (GO:0071417),0.4721336887893377,1.1688529868372899,0.23608247422680412,0.9842480631432671,1.0,22/99,15.36%,HCN3;BRCA1;RELA;RAPGEF1;IMPACT;AKAP9;RAP1A;CTNNA1;EZR;GOLPH3;RAP1B;IPO5;CAPN2;GABRG2;DIAPH1;MTOR;ZFP36L1;SLC38A9;PKD2;LARS1;P2RY12;HCN1
prerank,ncRNA processing (GO:0034470),0.46453308972958796,1.1680558237960288,0.16332665330661322,0.9862867115611083,1.0,43/200,12.70%,C1D;MPHOSPH6;RPL18;BOP1;UTP3;PELP1;SBDS;RPL41;RPL31;UTP18;EMG1;RPS17;DDX49;INTS12;TUT4;INTS2;RPL4;UTP20;EXOSC5;SMAD3;RPLP0;RPL38;METTL3;EXOSC7;HNRNPA2B1;RRP36;RRP1B;POP1;AGO2;FCF1;AARS1;LIN28B;INTS4;DDX10;ADAR;UTP6;XRN2;PRKRA;HEATR1;NOP56;RPL21;RPS6;NOL8
prerank,regulation of microtubule-based process (GO:0032886),0.5085002965130874,1.167908894225973,0.2773892773892774,0.9856816221311997,1.0,12/36,15.63%,KLHL42;IGBP1;CAMSAP3;MAPT;APC;TAOK1;DIAPH1;CYLD;BICD1;MAP6;CLASP1;MACF1
prerank,protein homooligomerization (GO:0051260),0.4718517647848961,1.167416419675893,0.20081549439347604,0.9865353166259432,1.0,26/114,16.68%,ALDH1A2;BLM;ADCY8;MICU1;EHD4;EHD1;SSBP1;LETM1;ALDOA;G3BP2;HPRT1;GSDMD;ACOT13;TRPM4;FUS;MCOLN1;GLRA3;PDCD6IP;PKD2;RNF135;ACACA;ATL2;HCN1;GLS;OSBPL2;ZBTB1
prerank,neural crest cell differentiation (GO:0014033),0.5548591583483651,1.1673117924345668,0.3027027027027027,0.9858083512396529,1.0,5/18,16.27%,TAPT1;PEF1;SOX11;LRP6;MEF2C
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.5689232919802752,1.1672598793377007,0.30598052851182195,0.9848662777483144,1.0,6/16,13.71%,AR;PADI2;ESR1;EGLN2;PPARGC1B;DDX5
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.58985323806084,1.166646256252782,0.3031674208144796,0.9862593341635908,1.0,5/12,15.70%,BCL2L11;PTPN1;ERN1;ATF6;PIK3R1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5702841805033774,1.1662972934183058,0.29941860465116277,0.986478621961463,1.0,4/14,11.72%,ITGB1BP1;THBS1;HDAC5;MAP2K5
prerank,cellular response to interleukin-6 (GO:0071354),0.5429267671208466,1.1662192506069238,0.2824242424242424,0.9856579139599853,1.0,5/26,11.44%,RELA;CTR9;PID1;PTPRT;CBL
prerank,regulation of interferon-gamma production (GO:0032649),0.4793347129797369,1.1660668637529044,0.2502606882168926,0.9851292699322495,1.0,14/71,15.45%,ISL1;TLR7;GAS6;AXL;TLR3;IL18;SLAMF6;CYRIB;PRNP;HMGB1;LGALS9;HAVCR2;TLR4;CD47
prerank,replication fork processing (GO:0031297),0.5071607792226586,1.1660255959443802,0.2703016241299304,0.9841384292336703,1.0,9/38,12.96%,BLM;WRN;BRCA2;BOD1L1;MRE11;CDK9;EXD2;RFWD3;ATRX
prerank,cellular response to radiation (GO:0071478),0.4998903910480635,1.165975285034148,0.2759815242494226,0.9831774194714696,1.0,7/40,14.72%,BLM;GRB2;CLOCK;TANK;MAPK14;TP53;SPIDR
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.541224468567864,1.1658372272048214,0.28662420382165604,0.9826499473733725,1.0,2/23,2.43%,DFFB;KPNB1
prerank,mammary gland epithelium development (GO:0061180),0.5817663080612683,1.1657216367137722,0.30434782608695654,0.9819470974234125,1.0,1/14,0.22%,WNT4
prerank,activin receptor signaling pathway (GO:0032924),0.5690204958584345,1.1653476544648445,0.310948905109489,0.9823066966722834,1.0,4/15,13.18%,SMAD3;ACVR1;TGFBR1;ACVR1B
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.4556484298783984,-1.1650278032016819,0.28102189781021897,0.9755580351006481,1.0,4/15,7.56%,OSBPL11;PLIN2;OSBPL8;LPL
prerank,protein autophosphorylation (GO:0046777),0.46654285682373997,1.1647423155297254,0.19374369323915236,0.9835988339792456,1.0,29/157,13.90%,MUSK;DDR1;LRRK2;DDR2;MINK1;EIF2AK1;EIF2AK2;MAP3K11;STK11;PAK2;CAMK2D;MAP3K9;GRK5;DAPK1;CHEK2;LYN;TAOK1;IGF1R;ULK2;MTOR;ABL1;ERN1;CDKL5;MAPKAPK2;MAP2K2;ACVR1B;INSR;CAMKK2;PRKD2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4933987394179773,1.1647259867010855,0.27959413754227735,0.9825096727663678,1.0,12/48,13.81%,BRCA1;TMEM109;DYRK2;BCL2L11;EP300;PRKDC;CHEK2;ABL1;HIPK2;TP53;BCL2;HTRA2
prerank,protein localization to chromosome (GO:0034502),0.5147990738751934,1.164659483956507,0.2775800711743772,0.9816083354051555,1.0,7/34,8.76%,PLK1;XRCC4;TERF2;ESR1;LEMD2;SLF1;TNKS2
prerank,recombinational repair (GO:0000725),0.4754051689242611,1.164612785390766,0.24037460978147762,0.9806545181347469,1.0,18/77,14.72%,BRCA1;BLM;RAD50;WRN;SEM1;BRCA2;RBBP8;MRE11;ERCC4;SMC5;NBN;EXD2;RFWD3;RAD51B;REV3L;RNF138;RECQL5;SPIDR
prerank,monosaccharide transmembrane transport (GO:0015749),-0.4331219973657694,-1.1642295574983517,0.3127413127413127,0.9732612862558793,1.0,6/16,44.83%,SLC2A9;SLC5A3;SLC50A1;SLC2A8;SLC2A6;SLC45A3
prerank,plasma membrane repair (GO:0001778),0.5818546032186127,1.1642114697054116,0.3203463203463203,0.9812623824117,1.0,3/13,7.80%,SMPD1;MYOF;SYT11
prerank,positive regulation of MAPK cascade (GO:0043410),0.4632467321145382,1.1638744031085757,0.138,0.9815658278285642,1.0,31/245,11.25%,FGF18;ROR2;MID1;LRRK2;PRKCZ;C5AR1;CD36;FBXW7;CX3CL1;EIF2AK2;TPD52L1;FGF1;BRAF;TGFB2;GAS6;RAP1A;NRP1;PDGFB;PRKCA;TRAF7;PTPRJ;ARRB2;CCL25;ABCA7;EZH2;CD44;TAOK1;TRIM5;RIT2;NOTCH2;IGF1R
prerank,response to growth factor (GO:0070848),0.5023977587524185,1.1633043439710578,0.2920962199312715,0.9827883717501096,1.0,10/41,13.81%,URI1;BMPR1A;PDGFB;ACVR1;TWF2;TGFBR2;MAP2K5;TGFBR1;ACVR1B;HTRA2
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5726973167338201,1.162780541171412,0.29326287978863935,0.983868743179256,1.0,2/17,5.11%,MPG;TERF2
prerank,regulation of plasminogen activation (GO:0010755),0.589080701072697,1.1624113714202267,0.30261136712749614,0.9842707471159557,1.0,4/12,10.38%,RUNX1;THBS1;ENO1;CTSZ
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5749615542043811,1.1621812661909052,0.3153526970954357,0.9840603521687827,1.0,4/15,8.39%,SLC9A1;PRKCA;MEF2A;CAMK2D
prerank,positive regulation of cell motility (GO:2000147),0.46537573579321595,1.162086277082369,0.16016016016016016,0.9833291128774845,1.0,28/205,12.97%,CXCL12;CAVIN1;ROR2;SYNE2;RIPOR1;FGF1;ITGA6;MAPRE1;EPHB2;ELP3;THBS1;PDGFB;PRKCA;SEMA6D;SDCBP;ACVR1;CBLL1;FERMT3;DAB2;APC;F3;ACTN4;SEMA3D;SEMA6A;IGF1R;RUFY3;ADAM10;TGFBR1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.48377897028551853,1.1619963372645492,0.2813522355507088,0.9825807491550596,1.0,14/60,14.13%,RGCC;RFC2;TCP1;PDGFB;MAPK1;POLG2;HSP90AA1;PKIB;TNKS2;NEK7;HMBOX1;CCT3;PRKD2;NVL
prerank,regulation of bone mineralization (GO:0030500),0.492291755946714,1.1619334056352084,0.26490066225165565,0.9816967349555545,1.0,10/55,11.49%,WNT4;S1PR1;DDR2;BMPR1A;NELL1;ACVR1;ALOX5;TRPM4;TXLNG;BMP2K
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.5237271121619994,1.1618633944146022,0.2946859903381642,0.9808382058765295,1.0,6/28,9.95%,SIRT7;PARP9;PRKDC;KMT5B;KMT5C;SMCHD1
prerank,actin filament-based transport (GO:0099515),0.5438646339758986,1.161689561131094,0.3053435114503817,0.9803764134117191,1.0,9/21,17.05%,SYNE2;MYO5A;FNBP1L;MYO1G;ACTN4;MYO1E;WASL;MYO1B;MYO1D
prerank,cardiocyte differentiation (GO:0035051),0.6283102220692806,1.161596103923568,0.33432835820895523,0.9796418813133688,1.0,2/10,10.68%,TGFB2;AKAP13
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.46540061327219523,1.1614016628398596,0.20466058763931105,0.9793297751554121,1.0,20/152,14.62%,RXFP1;S1PR1;ADGRE1;ADCY8;ADCY3;CACNA1D;ADCY5;GPR65;ADCY9;ADGRB3;GRK5;ADGRE5;GNAQ;MTNR1A;RAMP1;GNAI3;ABCA1;WASF2;CALCRL;P2RY12
prerank,wound healing (GO:0042060),0.4781572191887411,1.161037871076681,0.27689030883919064,0.9796908051627667,1.0,15/62,16.32%,FGF1;TGFB2;SMPD1;NF1;MYOF;TPM1;SMAD3;DCBLD2;SYT11;MIA3;RAF1;TGFBR1;MACF1;PAK1;CFLAR
prerank,visual perception (GO:0007601),0.4740458879594087,1.1607851794711246,0.2533889468196038,0.9795892479686459,1.0,15/84,16.46%,WFS1;CEP250;ATXN7;CRYBG3;COL11A1;MYO9A;DHRS3;PITPNA;EML2;ATF6;RPGR;ABLIM1;SLC4A10;DRAM2;RP2
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5447686637923701,1.1607479817811932,0.3018134715025907,0.9786330043901423,1.0,4/22,8.29%,IRF1;RUNX1;BCL6;DUSP10
prerank,epithelial cell migration (GO:0010631),0.5111949295188309,1.1594346096076407,0.27147766323024053,0.9828712459906234,1.0,9/37,11.90%,PLEKHG5;ZEB2;NRP1;GIPC1;PKN2;LPXN;PTP4A3;PXN;ABL1
prerank,cellular zinc ion homeostasis (GO:0006882),0.5254537348850666,1.1592991782406896,0.27478042659974905,0.9823434170339762,1.0,9/26,12.50%,MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;SLC39A10
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.49913137991839024,1.159019154185663,0.2898052691867125,0.9823530623665003,1.0,7/43,8.68%,CX3CL1;LDLRAP1;BMPR1A;JUN;THBS1;PDGFB;IL18
prerank,BMP signaling pathway (GO:0030509),0.4824269160072491,1.158843984157901,0.26344086021505375,0.981940645950239,1.0,7/62,7.45%,BMP5;SMAD6;TGFB2;BMPR1A;SMAD3;ACVR1;SLC33A1
prerank,cellular response to amino acid stimulus (GO:0071230),-0.3573414676418674,-1.1587029016585946,0.22151898734177214,0.9889353182822301,1.0,17/33,24.04%,CPEB3;UBR1;SESN1;CPEB4;SESN3;GLRA1;LAMTOR1;UBR2;LAMTOR3;CASTOR2;KLHL22;RRAGD;RRAGB;RPTOR;NSMF;GLRA2;XBP1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.5042203407240418,1.1585207665638368,0.2706422018348624,0.9821383440309344,1.0,9/40,11.90%,SIRT7;PARG;UBE2V2;USP1;MAPT;CDK9;FXR2;RFWD3;ABL1
prerank,regulation of vasculature development (GO:1901342),0.5282587461084702,1.158461593046799,0.28236744759556104,0.9812932959156998,1.0,3/26,8.34%,VASH2;NF1;EGLN1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.6003842150242291,1.1583449840551443,0.31563421828908556,0.9806385086774737,1.0,5/12,13.76%,BBS4;NIN;DCTN1;KIF3A;BICD1
prerank,chloride transmembrane transport (GO:1902476),-0.3229153715152104,-1.158122697227901,0.21621621621621623,0.9857960349719715,1.0,22/48,33.84%,GABRB1;ANO6;GABRA2;ANO3;GABRA3;SLC12A9;GLRA1;CLCN3;SLC1A1;SLC12A2;GABRA5;SLC6A1;GLRA2;GABRA4;GABRB3;GABRG1;ANO5;GABRA1;SLC12A7;SLC4A8;SLC12A5;LRRC8A
prerank,positive regulation of developmental process (GO:0051094),0.4640660379287894,1.1580792353225668,0.2176529588766299,0.9805738481270764,1.0,31/164,15.51%,ISL1;BMP5;MIEF2;DVL1;TAPT1;CFL1;BMPR1A;AR;PDGFB;ACVR1;KMT5B;AGO2;TRPM4;VPS35;NCOA3;LRP8;KMT5C;B4GALT5;BNIP3;NR2C2;SORL1;ZDHHC6;SOX6;ACVR1B;RTN4;INSR;RREB1;RELN;DAG1;CLASP1;TMEM119
prerank,cellular response to topologically incorrect protein (GO:0035967),0.511948129364719,1.1579961767468614,0.2891566265060241,0.9797922254008652,1.0,12/31,17.68%,BAG3;DNAJC18;HSPA9;PTPN1;TM7SF3;UBE2W;ERN1;ATXN3;OPTN;RHBDD1;HSPA5;TMBIM6
prerank,establishment of protein localization to extracellular region (GO:0035592),0.502329722029388,1.1579853080138716,0.27366020524515394,0.978730221309486,1.0,10/39,13.05%,STEAP3;RAB8B;TVP23B;RAB12;TANGO6;PDIA4;GOLPH3;MIA3;ABCA1;RAB3C
prerank,mononuclear cell differentiation (GO:1903131),0.5337849496302832,1.1575200018780794,0.29974811083123426,0.9795214584472941,1.0,7/24,10.58%,GAS6;AXL;IKZF1;THOC5;PPARG;LYN;MT1G
prerank,glucose import (GO:0046323),0.5959148858624181,1.1574371739509874,0.30835734870317005,0.9787229748633473,1.0,2/13,12.68%,SLC2A3;SLC27A1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.4921454124301373,1.1573354598034848,0.2687704026115343,0.9780341718090662,1.0,5/51,7.51%,ISL1;CD36;IL16;GSDMD;PYDC1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.4273575258793799,-1.1572332809170685,0.2779783393501805,0.9839999559874285,1.0,10/16,43.14%,DNA2;NAE1;TOPBP1;TIPIN;RAD9B;RAD9A;HUS1;CLSPN;TIMELESS;ORC1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5619646620217141,1.1571719875398632,0.30337078651685395,0.977567030838832,1.0,8/17,18.14%,RTN3;ABCA7;PRNP;SORL1;RTN4;GGA3;BIN1;ROCK1
prerank,response to progesterone (GO:0032570),0.5512710529582158,1.1571685988208673,0.3,0.9764859906501119,1.0,4/18,12.10%,TGFB2;WBP2;THBS1;UBE3A
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.49662792428332153,-1.1570511397122332,0.29512893982808025,0.9794762276877872,1.0,7/11,27.99%,RENBP;NAGK;GFPT1;AMDHD2;GNPDA1;UAP1L1;PGM3
prerank,hemidesmosome assembly (GO:0031581),0.5985454683107014,1.1568660734492116,0.32558139534883723,0.9766484701493915,1.0,2/11,11.50%,ITGA6;LAMC1
prerank,regulation of protein ubiquitination (GO:0031396),0.46540538626298905,1.156716760061264,0.25153374233128833,0.9761707356865922,1.0,22/108,13.37%,BRCA1;WFS1;SIRT7;LRRK2;CDK5RAP3;FBXW7;UBXN1;SASH1;UBQLN1;SQSTM1;ARRB2;BIRC3;HSP90AA1;PTTG1IP;RCHY1;NXN;U2AF2;DERL1;UBE3A;CAMLG;TGFBR1;NDFIP1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.48277172019437103,1.156446798014175,0.28869374313940727,0.9761471702438824,1.0,12/51,12.11%,LRRK2;MINK1;WASF1;NYAP1;ATP7A;KIF20B;SLC9A6;DTNBP1;TAOK1;DBNL;SNX1;EPB41L3
prerank,regulation of p38MAPK cascade (GO:1900744),0.5071509236660287,1.1561993386239755,0.28027681660899656,0.9760381544246252,1.0,9/35,13.99%,MINK1;SASH1;RELL1;EZR;DLG1;DUSP10;PHLPP1;CYLD;LGALS9
prerank,positive regulation of cell population proliferation (GO:0008284),0.4616183229693245,1.1556862167269786,0.105,0.9770123507629278,1.0,72/423,15.59%,FGF22;FGF18;BMP5;TNFRSF11A;DDR2;RPRD1B;C5AR1;RELA;CX3CL1;PID1;FGF1;COX17;FAM98A;ITGB1BP1;VEGFC;TGFB2;GAS6;BMPR1A;EAPP;AREG;AR;IRS1;GID8;THBS1;LIFR;S100A6;PDGFB;KITLG;CDK2;LRP5;ACER3;RPS15A;KIF20B;UBE2A;SDCBP;CDK6;DHPS;IRS2;MECP2;STX3;EZH2;TRPM4;IL18;KRAS;NACC1;GRK5;LYN;TGFBR2;IGF1R;SOX11;LAMC1;KDM4C;RPS6;TCF7L2;ADAM10;TGFA;SRPK2;TGFBR1;BCL2;S100B;FN1;INSR;RBPJ;FZD9;TBC1D8;AIF1;PTEN;NPM1;PHIP;CD47;TMEM119;HDAC2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.566163496502974,1.155564683016511,0.31614654002713705,0.976415764012912,1.0,6/18,15.19%,TGFB2;SMAD3;ITGB8;FN1;LGALS9;SMAD4
prerank,ATP synthesis coupled proton transport (GO:0015986),0.5528448956506545,1.155205587948163,0.30238726790450926,0.9767601711179008,1.0,3/17,8.07%,ATP5F1A;ATP5MC3;ATP5MC2
prerank,double-strand break repair (GO:0006302),0.46285972053025404,1.1546270115940402,0.20484359233097882,0.9780197359744455,1.0,33/158,12.76%,BRCA1;ACTR5;BLM;PARP9;RAD50;UBXN1;TDP2;XRCC4;POLA1;WRN;UBE2V2;DCLRE1A;PRKDC;SEM1;POLB;BRCA2;RBBP8;MRE11;MAPK8;ERCC4;SMC5;NBN;PARP2;BABAM2;CHEK2;EXD2;SETX;RFWD3;KDM4B;RAD51B;HMGB1;REV3L;RNF138
prerank,regulation of viral transcription (GO:0046782),0.4988490547068615,1.1545655866706486,0.2809633027522936,0.9771711995256233,1.0,7/39,13.02%,POLR2D;IFITM3;POLR2A;CDK9;NELFA;GTF2F2;CTDP1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5899506224298114,1.1544779428796006,0.34202453987730064,0.9753474140877659,1.0,3/12,11.35%,HOMER2;DYRK2;PRNP
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5899506224298114,1.1544779428796006,0.34202453987730064,0.9753474140877659,1.0,3/12,11.35%,HOMER2;DYRK2;PRNP
prerank,regulation of calcium-mediated signaling (GO:0050848),0.5254843019028638,1.1542779575618651,0.3155940594059406,0.9750684951656453,1.0,5/25,10.91%,LRRK2;CMKLR1;MAPT;TMBIM4;RIT2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.47497547564213644,1.154253078192727,0.25882352941176473,0.974084753704565,1.0,34/71,17.40%,ACTR3;GRB2;PLA2G6;DOCK1;YES1;MAPK1;WIPF1;VAV3;ABI1;HSP90AA1;ARPC1A;ARPC4;NCK1;MYO1G;LYN;CDC42;ARPC2;CYFIP2;ABL1;VAV2;WASF2;SYK;FYN;ELMO1;WIPF2;ARPC3;WASL;VAV1;PIK3R1;PAK1;ACTG1;CYFIP1;NCKAP1L;FCGR1A
prerank,transcription by RNA polymerase II (GO:0006366),0.4602970800038023,1.1542186820270048,0.14,0.9731494095741445,1.0,71/305,14.50%,POLR2D;EAF1;RORA;PMF1;SNAPC5;RPRD1B;C5AR1;SP1;CTR9;PHAX;INTS12;CSTF3;INTS2;CSTF2;POLR2A;AR;MLLT1;HDAC9;CDK7;TEAD1;ESR1;ARRB2;HDAC5;NR3C1;RPRD2;RPRD1A;MAML3;MAML2;MNAT1;SETD2;TFCP2;CDK9;TAF4;NCOR1;INTS4;SSU72;PPARG;SNRPD3;NR6A1;SETX;GTF2E1;GTF2E2;DEAF1;RNGTT;NELFA;ELOC;GTF2B;CPSF3;NR5A1;NOTCH2;KAT2B;NR2C2;GTF2F2;NCOR2;GMEB2;RPAP2;MAF;NRBP1;CTDP1;NR1D2;KLF13;RXRA;MED27;NFX1;GTF2H1;DDX5;RREB1;RBPJ;TRIP11;PPARD;TBL1XR1
prerank,mitotic sister chromatid segregation (GO:0000070),0.47137604149356005,1.1542150552594284,0.24897119341563786,0.9720967493214557,1.0,12/98,8.22%,PLK1;NUDC;ZWINT;EML3;KPNB1;VPS4A;CHMP5;CDC23;PDS5A;NCAPD3;DCTN2;SET
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.48626594716848887,-1.1540377264207773,0.29245283018867924,0.9855927137013306,1.0,6/11,33.96%,JAK2;TMEM106A;SIRT1;XBP1;TAF7;CIITA
prerank,gliogenesis (GO:0042063),0.5661593125036273,1.1539660129926603,0.306064880112835,0.9720318841413726,1.0,5/15,15.94%,TGFB2;CDK6;METTL3;RELN;NFIB
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.5215664413318507,1.1539243186572263,0.3050847457627119,0.9711434635514383,1.0,10/31,13.31%,PDZD11;MSN;CAMSAP3;EZR;DLG1;MYO9A;CDC42;WDR1;LIN7A;PDCD6IP
prerank,regulation of RNA export from nucleus (GO:0046831),-0.4927404792471571,-1.153755678758931,0.28353658536585363,0.9812496298814183,1.0,5/11,11.74%,DHX9;TPR;NUP153;CPSF6;NSUN2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.5450053717960556,1.1537011100815737,0.2977893368010403,0.9710169284634654,1.0,4/19,6.15%,GAS6;BTK;PRKDC;AXL
prerank,positive regulation of cellular protein localization (GO:1903829),0.4717154614434414,1.1535140108279378,0.2648305084745763,0.9707224808986883,1.0,11/69,9.63%,PLK1;CDK5RAP3;PARP9;MAP1A;CEP250;MAPT;GPD1L;SYT11;STX3;ABCA7;APC
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.47348510844610536,1.1531889741457895,0.26567481402763016,0.9709091757874716,1.0,34/73,17.40%,ACTR3;GRB2;PLA2G6;DOCK1;YES1;MAPK1;WIPF1;VAV3;ABI1;HSP90AA1;ARPC1A;ARPC4;NCK1;MYO1G;LYN;CDC42;ARPC2;CYFIP2;ABL1;VAV2;WASF2;SYK;FYN;ELMO1;WIPF2;ARPC3;WASL;VAV1;PIK3R1;PAK1;ACTG1;CYFIP1;NCKAP1L;FCGR1A
prerank,determination of heart left/right asymmetry (GO:0061371),0.4957436527824849,1.1528480420754659,0.28603859250851305,0.9712218874894195,1.0,8/42,16.27%,DAND5;BBS4;AHI1;MICAL2;TGFBR2;NDRG4;PKD2;MEF2C
prerank,positive regulation of stress fiber assembly (GO:0051496),0.49401916683850805,1.1527609497775175,0.28306264501160094,0.9705113217555622,1.0,13/44,16.23%,RGCC;ITGB1BP1;NRP1;GPR65;TPM1;CDC42;PXN;ABL1;TGFBR1;ROCK2;EVL;CD47;PAK1
prerank,C4-dicarboxylate transport (GO:0015740),-0.4614602863509833,-1.152554169006936,0.2827586206896552,0.9804683226868137,1.0,7/14,33.55%,SLC1A2;SLC25A13;SLC1A1;SLC25A30;SLC25A11;SLC25A14;SLC25A12
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.5504805646503078,1.1522535861394474,0.30213903743315507,0.9714221573262324,1.0,11/18,16.52%,MSN;MAPK1;EZR;SNX3;DAB2;PTPN23;VPS11;MAP2K2;DNAJC13;MAP2K1;RDX
prerank,spinal cord development (GO:0021510),0.5975965621594997,1.15171937196652,0.3161764705882353,0.9724313674938299,1.0,5/12,14.25%,NF1;LOXL3;SOX11;PKD2;RELN
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.5283260987017009,1.151509702207331,0.29913473423980225,0.972243127591179,1.0,3/26,9.14%,PLK1;CDC23;CDC16
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.45966774834303686,-1.1514957732451505,0.2789115646258503,0.9792141787384744,1.0,6/13,27.41%,JAK2;CANX;JAK1;STAT3;OAS2;IL6ST
prerank,regulation of DNA repair (GO:0006282),0.4939624643187485,1.1512909998051493,0.28634850166481685,0.972001887309564,1.0,9/44,9.95%,BRCA1;SIRT7;EYA2;PARG;UBE2V2;USP1;CDK9;BABAM2;SMCHD1
prerank,protein-containing complex subunit organization (GO:0043933),0.46076396485467347,1.1511919086152096,0.23625254582484725,0.9713465796616333,1.0,33/109,17.29%,TFAP4;PPID;LLGL1;NAPG;WASF1;VAMP3;NUP205;TEAD1;WIPF1;ST13;MNAT1;NUP98;RANBP9;REPS2;IL1RAP;LPXN;TUBGCP2;NUP54;APC;VAMP2;CD2AP;TRAF2;LAMC1;TP53;LIN7A;MDN1;WASL;PEX14;CAPZA1;DNM1L;TAPBP;SNX9;NCKAP1L
prerank,protein-containing complex disassembly (GO:0032984),0.479889752660658,1.1511906109041863,0.29334787350054525,0.9702963196597019,1.0,14/54,14.49%,TSG101;VPS16;DVL1;VAMP7;VPS4A;UBQLN1;PYM1;STX17;APC;UVRAG;VIPAS39;LRP6;CSNK1A1;SNX14
prerank,ubiquinone metabolic process (GO:0006743),0.5654610322329676,1.1510779480257036,0.3095890410958904,0.969707505270004,1.0,1/15,0.23%,COQ6
prerank,regulation of cholesterol storage (GO:0010885),0.5531029406121928,1.1509644955363343,0.3319838056680162,0.9691288312635982,1.0,6/15,14.36%,EHD1;TTC39B;PPARG;ABCG1;ABCA1;PPARD
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5907503723278507,1.1504896320725335,0.32599118942731276,0.9699502682835146,1.0,6/13,17.02%,INSIG1;TMEM30A;SORL1;SAR1B;CD81;GCC2
prerank,positive regulation of cellular component movement (GO:0051272),0.529890835278057,1.1500514753288429,0.2600502512562814,0.9706350571492866,1.0,5/24,12.97%,CAVIN1;STK11;LYN;ACTN4;TGFBR1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.5427585145552344,1.1496855981687584,0.3009320905459387,0.9709771373328819,1.0,6/20,13.03%,WFS1;CAMK2D;RAP1GDS1;THADA;PACS2;BCL2
prerank,Ras protein signal transduction (GO:0007265),0.4634893301588815,1.1496199268889604,0.22052845528455284,0.9701778677249565,1.0,37/137,14.97%,RIPOR1;NRAS;ARHGEF3;RAPGEF1;CFL1;KPNB1;GRB2;PLEKHG5;WASF1;GDI1;NF1;RERG;RASSF1;JUN;RAP1A;FARP2;CDK2;G3BP2;RAP1B;EPS8L1;ARHGAP1;KRAS;EPS8;RIT2;DBNL;PLD1;MAPK14;MYO9B;TP53;RREB1;ELMO1;SHOC2;ROCK2;GNB1;AIF1;G3BP1;ARHGDIB
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5465521120413572,1.149491224592745,0.32413793103448274,0.9696084190271147,1.0,3/17,8.99%,PID1;NUPR1;NCOR1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4346772709719361,-1.1491224736480778,0.2653846153846154,0.9830026477674138,1.0,8/16,32.30%,FMR1;SYN1;RIMS1;MCTP2;CPLX1;CAMK2A;FLOT1;SNCAIP
prerank,regulation of protein transport (GO:0051223),0.5182577404719138,1.149105331623322,0.3196125907990315,0.9700847884542024,1.0,9/27,13.37%,LLGL2;NDEL1;LLGL1;SNX3;PTPN1;STXBP5;DNAJC1;STXBP5L;NDFIP1
prerank,protein localization to nucleus (GO:0034504),0.46404443710103027,1.1490906341986624,0.24049331963001028,0.9690900431501219,1.0,18/102,9.84%,PLK1;DVL1;KPNB1;EIF4ENIF1;BBS4;HIKESHI;ZBTB7A;YWHAE;WRN;HEATR3;RANBP6;IPO7;IPO9;CTDNEP1;PTTG1IP;CSE1L;ABCA7;IPO5
prerank,negative regulation of T cell differentiation (GO:0045581),0.6227053660742466,1.1490419727092087,0.3395061728395062,0.9682534043218877,1.0,1/10,1.88%,IRF1
prerank,apical protein localization (GO:0045176),-0.5082721763987248,-1.148921649614695,0.3074792243767313,0.9786683247896566,1.0,6/10,19.16%,GOPC;MAL;JAM3;ATP8B1;INSC;SHROOM2
prerank,myofibril assembly (GO:0030239),0.49562246171278534,1.1487721042358878,0.2945128779395297,0.9682765583817764,1.0,4/42,12.08%,TMOD1;TMOD3;TPM1;WDR1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.4736552345148731,1.1486912085952505,0.27560718057022177,0.9675927402793671,1.0,9/68,9.42%,LRRK2;AK4;AK3;ADSS1;ACAT1;ACOT9;HPRT1;ACOT13;CROT
prerank,positive regulation of signal transduction (GO:0009967),0.45447305227609247,1.1482609657390674,0.16816816816816818,0.9682340364414324,1.0,48/238,15.70%,EVC;PDE6H;LRRK2;PRKCZ;SMARCA4;TPD52L1;FGF1;SNX5;ITGB1BP1;TGFB2;GAS6;SASH1;IRS1;FLNA;NRP1;PRKCB;EP300;PRKCA;TRAF7;AXL;ZDHHC5;MAML3;MAML2;UCHL5;NPTN;VPS35;LIMS1;CD63;F3;LOXL3;WLS;KAT2B;TRIM44;BMP2K;ERN1;SORL1;TGFBR1;ARMC9;PRKD2;PKD2;RBPJ;RELN;LY86;PTEN;ARNT;PHIP;MACF1;PIK3R1
prerank,chemical homeostasis (GO:0048878),0.4761122854918742,1.1482233700869402,0.2800429184549356,0.9673417460128648,1.0,11/61,15.33%,SLC4A3;SLC66A1;FBXW7;ADCK1;TLCD3A;IRS2;PPARG;THADA;NR1D2;ACOX3;SLC4A10
prerank,circulatory system development (GO:0072359),0.4689263452155808,1.1481924455325163,0.24873096446700507,0.9664185896094823,1.0,23/118,14.84%,ISL1;FBXW7;TGFB2;NF1;PDLIM2;HDAC9;PDGFB;ACVR1;STK11;MEF2A;NXN;MICAL2;CACYBP;AKAP13;TGFBR2;KAT2B;TGFBR1;FN1;HEG1;PKD2;PTEN;CACNA1C;SMG9
prerank,positive regulation of cyclase activity (GO:0031281),0.5763931386272749,1.1478368913361683,0.325,0.9668015332352443,1.0,5/14,14.78%,CACNA1D;NF1;MAPK8;MAPK14;CACNA1C
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4672959442022702,1.1478216888003026,0.28375527426160335,0.9658253258939316,1.0,5/70,8.02%,LCAT;PLA2G7;PLA2G6;CHKB;PLA2G4A
prerank,purine ribonucleotide transport (GO:0015868),0.5664215676122418,1.1474022243206365,0.31900138696255204,0.9664378630412324,1.0,2/16,5.87%,SLC25A24;ABCC5
prerank,cGMP-mediated signaling (GO:0019934),0.5749687998427948,1.1473856374197087,0.3090128755364807,0.9654739127447218,1.0,1/13,1.63%,CD36
prerank,negative regulation of histone methylation (GO:0031061),0.6033030405303748,1.1469839305524314,0.33070866141732286,0.9659855462598672,1.0,1/10,0.41%,BRCA1
prerank,regulation of mitotic nuclear division (GO:0007088),0.4840101391402783,1.1468027969020176,0.28322440087145967,0.9656765237413906,1.0,9/55,15.29%,RGCC;PDGFB;LRP5;KIF20B;IL1A;TOM1L2;TGFA;INSR;PHIP
prerank,amino sugar biosynthetic process (GO:0046349),-0.4798544311515138,-1.1463602183820996,0.32448377581120946,0.9832586059618125,1.0,7/12,27.99%,RENBP;NAGK;GFPT1;AMDHD2;GNPDA1;UAP1L1;PGM3
prerank,cellular protein localization (GO:0034613),0.4553191909117048,1.1462936704912297,0.15515515515515516,0.966614097277021,1.0,74/285,15.30%,STXBP2;WDR45;VCL;LRRK2;ARL5A;TMED4;ARL4A;ARL6;ARF3;COPB2;EHD1;BBS4;NAPG;ITSN1;TBC1D15;CEP250;CPE;FLNA;STX7;KIF13A;WDR45B;COG3;SIL1;EVI5;TMED9;TM9SF1;AP2A1;TBC1D17;RAB5B;VPS45;RAB6A;STX3;TBC1D14;VPS35;STX16;ARL4C;STX17;AHI1;TBC1D10B;CD63;HGS;WLS;ARF1;SNX1;TMED2;TBC1D4;TRAPPC8;PACS2;RAB18;TBC1D12;EPB41L3;SNX8;PIGU;TBC1D5;TBC1D10A;VIPAS39;TBC1D13;ERP29;RABGAP1;TMED5;NAPA;RPGR;PTPRU;BICD1;SAR1B;UNC93B1;TBC1D22A;GGA1;TBC1D8;CLTC;TM9SF2;TBC1D1;NPM1;SNX13
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5393222834912377,1.1461722654057247,0.2984084880636605,0.9660461742613284,1.0,2/19,5.66%,RGCC;DENND6A
prerank,type I interferon signaling pathway (GO:0060337),0.49437661040927394,1.1460685085815623,0.3130034522439586,0.9644048176916827,1.0,7/41,10.94%,IFITM3;IRF1;IFI35;IRF3;PSMB8;ADAR;IFNAR2
prerank,cellular response to type I interferon (GO:0071357),0.49437661040927394,1.1460685085815623,0.3130034522439586,0.9644048176916827,1.0,7/41,10.94%,IFITM3;IRF1;IFI35;IRF3;PSMB8;ADAR;IFNAR2
prerank,alpha-amino acid metabolic process (GO:1901605),0.4942656998108643,1.1457649653712805,0.2878103837471783,0.9645040184105447,1.0,5/45,6.57%,CBS;PYCR2;ATP7A;FOLH1;MTHFR
prerank,positive regulation of cell differentiation (GO:0045597),0.45366240889776877,1.145224160573051,0.195,0.9656287997759273,1.0,37/237,12.97%,ISL1;WNT4;RGCC;IGFBP3;DDR2;CD36;IMPACT;TGFB2;OLFM1;BMPR1A;AR;RAP1A;NELL1;SMAD3;KITLG;CTNNA1;LRP5;CMKLR1;SDCBP;ACVR1;BEND6;MEF2A;EZH2;TRPM4;IL18;DAB2;CDS1;PPARG;CDC42;TGFBR2;SOX11;MTOR;ABL1;ZFP36L1;MAPK14;SOX6;TGFBR1
prerank,actin filament depolymerization (GO:0030042),0.6081733616765502,1.1449437079535376,0.31784107946026985,0.9656984849372754,1.0,6/11,17.39%,CFL1;TWF2;MICAL2;WDR1;MICAL3;GSN
prerank,peptide cross-linking (GO:0018149),0.5263869441914647,1.144765141343356,0.31738035264483627,0.965352544236631,1.0,4/25,13.49%,THBS1;F13A1;ABCA7;FN1
prerank,pre-miRNA processing (GO:0031054),0.566956742072589,1.144317621457556,0.3286118980169972,0.9660438607334548,1.0,5/14,11.02%,TUT4;AGO2;LIN28B;ADAR;PRKRA
prerank,quinone biosynthetic process (GO:1901663),0.573688757387137,1.1441426060091888,0.31690140845070425,0.965692913857963,1.0,1/14,0.23%,COQ6
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.4767595031097388,1.1440019571791453,0.2950108459869848,0.9652311144969109,1.0,16/57,15.27%,BOP1;GTF3A;EMG1;RPS17;MALSU1;HEATR3;TGS1;RPL38;RRP36;NOC2L;CUL4A;RPS6;NVL;RPL35A;NPM1;RPS16
prerank,negative regulation of cell death (GO:0060548),0.4629482170863462,1.1438185713990285,0.26424870466321243,0.96491819995049,1.0,21/88,13.81%,WFS1;LRRK2;TMEM109;IMPACT;RAD18;INPP5A;PSMC5;BNIP3L;NCK1;VPS35;TM7SF3;ADNP2;CDK5;BNIP3;TRAF2;SOX11;VPS4B;DCPS;SORL1;FYN;HTRA2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4648913183447028,1.1438097324266008,0.27835051546391754,0.9639442308155248,1.0,21/95,13.57%,DAND5;SMAD6;PMEPA1;NREP;ZEB2;ZBTB7A;THBS1;EP300;SMAD3;SPRED2;SDCBP;STK11;GIPC1;LDLRAD4;DAB2;TGFBR2;SOX11;PPM1A;HIPK2;TGFBR1;SPRED1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5241042946587398,1.1433874941581637,0.3283395755305868,0.9646002446820358,1.0,4/23,11.56%,NUPR1;EP300;NCOR1;GCK
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.3016570702780815,-1.1428760437299885,0.18518518518518517,0.9908639893094736,1.0,21/69,13.71%,PLCL1;RHOA;PIK3R5;NYAP2;PLEKHA1;PIK3CG;SIRT2;PI4KB;PLCL2;EXOC1;CSF1R;PIK3CA;PIK3C3;GAB2;MYO16;PTAFR;PIK3C2B;IGF1;PLCB2;PLCE1;AKT1
prerank,protein prenylation (GO:0018342),0.6133537418190869,1.1428367372266282,0.32978723404255317,0.9657111309791225,1.0,1/10,0.72%,FNTB
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5309775465071781,1.142668612824884,0.3290653008962868,0.9653435193707384,1.0,3/21,6.50%,BRCA1;ABCB7;ABCD2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.5559757170339384,1.1426210172061564,0.31550068587105623,0.9645288466776902,1.0,4/17,9.62%,VCL;IKBKB;ADD1;PROC
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6051576744579383,1.1422091417423108,0.33178294573643413,0.9640909943170868,1.0,2/10,4.23%,SMPD3;PLA2G6
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6051576744579383,1.1422091417423108,0.33178294573643413,0.9640909943170868,1.0,2/10,4.23%,SMPD3;PLA2G6
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.44038631933549277,-1.1419877180725442,0.30313588850174217,0.9839242081107643,1.0,5/15,6.70%,CPEB3;CNOT1;TNRC6C;PABPC1;CNOT7
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.44038631933549277,-1.1419877180725442,0.30313588850174217,0.9839242081107643,1.0,5/15,6.70%,CPEB3;CNOT1;TNRC6C;PABPC1;CNOT7
prerank,positive regulation of transmembrane transport (GO:0034764),-0.45873263667629954,-1.1419332384427703,0.32432432432432434,0.9791662924085544,1.0,5/13,7.88%,ANO6;P2RX7;CA2;AZIN1;ACSL1
prerank,NAD biosynthetic process (GO:0009435),0.5319549613558578,1.1419326684305773,0.31752305665349145,0.9641687775298396,1.0,2/20,5.28%,PARP9;NMNAT3
prerank,actin polymerization or depolymerization (GO:0008154),0.4896583223993513,1.1415715142401885,0.3011111111111111,0.964561761033583,1.0,14/50,15.32%,ANG;SVIL;CFL1;WASF1;ABI1;TWF2;MICAL2;DIAPH1;WDR1;WASHC5;AIF1;WASL;EVL;MICAL3
prerank,cobalamin metabolic process (GO:0009235),0.5424643496999904,1.141497786238917,0.3333333333333333,0.9638507771779804,1.0,3/17,9.04%,MMADHC;LMBRD1;MTR
prerank,regulation of ERAD pathway (GO:1904292),0.5818551509605636,1.141328332287701,0.3272450532724505,0.9635089572154459,1.0,3/11,6.98%,UBXN1;USP19;TMEM259
prerank,negative regulation of protein binding (GO:0032091),0.4752813248594807,1.14128842503826,0.2817204301075269,0.962679866163735,1.0,12/71,10.38%,LRRK2;DVL1;ADAM15;ITGB1BP1;STYX;PDGFB;ARRB2;ITGA4;USP33;MAPK8;DAB2;CTSZ
prerank,regulation of lipid kinase activity (GO:0043550),-0.488153088745961,-1.1411006809213833,0.2955223880597015,0.9773692853540863,1.0,4/11,12.23%,RBL2;WDR81;WDR91;RBL1
prerank,kidney development (GO:0001822),0.47498578268785785,1.1410728553898486,0.29336188436830835,0.9625556813654242,1.0,4/65,4.01%,WNT4;WFS1;TGFB2;NF1
prerank,response to calcium ion (GO:0051592),0.45843536532831525,1.140577932600133,0.25895598771750256,0.9634669613396278,1.0,24/102,16.49%,CPNE5;SLC25A24;D2HGDH;ADCY8;PEF1;BRAF;SMPD1;THBS1;MEF2A;NEDD4;SYT12;SYT11;CAMK2D;ADD1;MCOLN1;CARF;PKD2;CALM1;KCNMB2;KCNMB3;IQGAP1;CPNE8;MEF2C;LGMN
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.5125463636052664,-1.140044255922678,0.31176470588235294,0.9764446450616422,1.0,3/10,4.82%,CACNA2D1;NOS1AP;PDE4B
prerank,negative regulation of response to external stimulus (GO:0032102),0.45805249493956274,1.1398870797617053,0.2579324462640737,0.9651551281070663,1.0,11/105,10.06%,ISL1;RORA;DUSP3;TNFAIP8L2;FEM1A;ILRUN;ALOX5;VPS35;PPARG;PROC;MAPKBP1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.45597493700172254,1.1395296307863376,0.23116089613034624,0.965493655405652,1.0,27/145,12.95%,TUBB4B;PLK1;CETN2;ALMS1;MAPRE1;PSMD9;AKAP9;CEP250;YWHAE;PSMB8;PRKACA;CDK2;PCNT;HSP90AA1;PSMC5;DCTN1;TUBA1A;DCTN2;MECP2;CCP110;ODF2;CEP152;CNTRL;RAD51B;VPS4B;PSMD12;PSMA2
prerank,RNA splicing (GO:0008380),0.46246579970708196,1.139207998985382,0.27582644628099173,0.9657577699774496,1.0,28/95,16.08%,SNRPD2;SNRPD1;SYNCRIP;BCAS2;TARDBP;MBNL1;RNPS1;PRPF3;GEMIN2;U2AF1;SNRPN;PRPF6;SNRPD3;SCAF11;FUS;DDX23;DHX16;SF3B2;SRSF11;SRPK2;DHX8;HNRNPH3;SF3B4;IVNS1ABP;RP9;HNRNPC;PPP1R9B;DHX15
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5105129151359491,1.138774871043487,0.30787589498806683,0.9665357602732346,1.0,6/31,9.43%,SMAD6;CRIM1;LRP5;CDK6;TRPM4;PPARG
prerank,negative regulation of viral entry into host cell (GO:0046597),0.5858510623725148,1.1386570582308024,0.36403508771929827,0.9659669967427791,1.0,5/12,17.39%,IFITM3;SNX3;TRIM5;TRIM26;GSN
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5504380268900778,1.1386523004389442,0.3258426966292135,0.9649847231138242,1.0,4/17,11.35%,DUSP3;PTPRJ;EZR;PRNP
prerank,Golgi to endosome transport (GO:0006895),0.560345077992682,1.1386478087124878,0.3140495867768595,0.9640160026456542,1.0,5/16,9.53%,SYS1;AP2A1;VPS13A;VPS13C;KIF16B
prerank,negative regulation of translation (GO:0017148),0.46266446427082,1.138509184879248,0.29214659685863875,0.9635228148972012,1.0,25/87,16.59%,EIF4A3;CNOT10;EIF2AK2;ILF3;EIF4ENIF1;EIF3E;SYNCRIP;MALSU1;FTO;METTL3;AGO2;YTHDF1;DAPK1;FXR2;PUM1;CNOT9;LSM14A;SAMD4A;ROCK2;UNK;EIF4E2;TSC1;CAPRIN1;CPEB2;YTHDF3
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.546197744283895,1.1383495122354286,0.3254901960784314,0.963164601789474,1.0,4/20,14.21%,TGFB2;OLFM1;TGFBR1;RBPJ
prerank,positive regulation of DNA metabolic process (GO:0051054),0.4701598516243905,1.1381839249958003,0.30579399141630903,0.9627893480895331,1.0,14/61,13.90%,RGCC;BRCA1;EYA2;RAD50;WRN;PDGFB;MRE11;MECP2;NBN;BABAM2;SMCHD1;HMGB1;ATRX;PRKD2
prerank,positive regulation of vacuole organization (GO:0044090),0.5984775535955081,1.138136068444753,0.34169278996865204,0.9619772357399519,1.0,5/10,12.70%,RAB3GAP1;PIP4K2A;PIP4K2B;ANXA2;SH3GLB1
prerank,adenine nucleotide transport (GO:0051503),0.5528826123242842,1.1380543619933294,0.3328840970350404,0.9613086830463118,1.0,2/17,5.87%,SLC25A24;ABCC5
prerank,positive regulation of response to wounding (GO:1903036),-0.39630192792306007,-1.137885880877135,0.2604166666666667,0.9797748553805872,1.0,3/24,2.33%,PRKCE;PTK2;GRN
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4853653513209997,1.1378666179696073,0.28634361233480177,0.9610438310446058,1.0,11/50,11.45%,RELA;EIF2AK2;IFI35;TLR7;SASH1;EP300;TLR3;LIMS1;PTP4A3;ACTN4;TRIM44
prerank,transcription by RNA polymerase III (GO:0006383),0.5142106583784457,1.137781515103551,0.3161764705882353,0.9604140369190353,1.0,8/27,15.12%,SNAPC5;POLR3G;GTF3A;POLR3H;CRCP;BRF1;IVNS1ABP;SNAPC3
prerank,cardiolipin metabolic process (GO:0032048),0.5742713217594344,1.1373442289436828,0.32650073206442165,0.9611294627870381,1.0,5/13,12.68%,PLA2G6;CRLS1;PLA2G4A;LCLAT1;SLC27A1
prerank,pseudouridine synthesis (GO:0001522),-0.45964662419756325,-1.137227957803814,0.28825622775800713,0.9773149928326722,1.0,7/13,35.41%,PUS7;TRUB2;TRUB1;DKC1;PUS1;GAR1;PUS3
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5548066985302668,1.1366016451528864,0.3337950138504155,0.9629760967192881,1.0,6/16,13.42%,SMG6;TERF2;HNRNPA2B1;ERCC4;TNKS2;TERF1
prerank,protein secretion (GO:0009306),0.4786832867789506,1.1365696837054116,0.2918918918918919,0.9621054233079923,1.0,14/56,13.39%,STEAP3;RAB8B;TVP23B;SNX19;RAB12;TANGO6;PDIA4;GOLPH3;WLS;MIA3;ABCA1;CYB5R4;RAB3C;CAMK2G
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.37300188764421993,-1.1363130854322836,0.24651162790697675,0.975788976503913,1.0,16/26,34.27%,GRIN2B;MBP;AIM2;VSIR;NCSTN;USP50;EPHA4;PYCARD;STAT3;GRIN1;PSME1;PSME2;APH1A;TTBK1;PRELID1;PSENEN
prerank,mesenchymal cell development (GO:0014031),0.5407685193939846,1.135731051338876,0.3225371120107962,0.9643289443305341,1.0,3/18,11.42%,TAPT1;PEF1;SOX11
prerank,telomere maintenance via recombination (GO:0000722),0.6017698868731807,1.1356923965246288,0.3415384615384615,0.963499068126858,1.0,3/11,7.92%,RAD50;ERCC4;SMC5
prerank,positive regulation of proteolysis (GO:0045862),0.4771411954955658,1.135351132060116,0.2993421052631579,0.9638113660247238,1.0,11/55,15.59%,PLK1;CTSC;NRDC;FURIN;TANK;FBXW11;CYFIP2;TBC1D10A;IST1;RHBDD1;HDAC2
prerank,regulation of lipid biosynthetic process (GO:0046890),0.5048675026094623,1.1350076888532463,0.31227217496962334,0.9641075235081664,1.0,6/32,14.01%,EIF6;ASAH1;NR5A1;MTOR;ADIPOR1;CREB1
prerank,regulation of cellular metabolic process (GO:0031323),0.4841362044027134,1.1349770996465025,0.28243398392652125,0.9632349436887643,1.0,11/45,14.13%,EIF6;PID1;RNF34;VPS35;ABCG1;KIF16B;ARF1;NCOR2;PARL;COQ7;ACACA
prerank,Golgi localization (GO:0051645),0.5877096874282255,1.1349696589299096,0.3392070484581498,0.9622929329045422,1.0,4/11,12.03%,RIPOR1;TBCCD1;CDC42;UVRAG
prerank,tetrapyrrole metabolic process (GO:0033013),0.5380957036043927,1.1349137339706754,0.3324396782841823,0.9615342356653395,1.0,3/18,9.04%,MMADHC;LMBRD1;MTR
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.48394980163276385,1.1348761284738316,0.3119266055045872,0.9607018989879916,1.0,10/41,14.25%,FBXW7;GAS6;AREG;PDGFB;PTPN1;LRP8;PRNP;TGFA;FYN;RELN
prerank,spindle assembly (GO:0051225),0.4709536016135818,1.1347493673067246,0.2838709677419355,0.9601633827912204,1.0,14/67,11.92%,TOGARAM2;KPNB1;CCDC61;MAPRE1;FLNA;TUBGCP6;KIF11;STAG2;TUBGCP2;NCOR1;CHEK2;NEK7;LSM14A;STARD9
prerank,cytoplasmic sequestering of protein (GO:0051220),0.5741671150636118,1.1343147172442878,0.33783783783783783,0.9608159588987932,1.0,3/13,6.98%,MDFI;FLNA;KEAP1
prerank,regulation of viral genome replication (GO:0045069),0.46936645678207084,1.1341191635308432,0.300768386388584,0.9605751004047609,1.0,10/56,14.04%,BANF1;IFITM3;EIF2AK2;ILF3;PPID;PKN2;MAVS;ADAR;SRPK2;TMEM39A
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.4904621076702384,1.1338690842775712,0.2941834451901566,0.9605767619440134,1.0,4/45,7.51%,ISL1;CD36;GSDMD;PYDC1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.5748944664537514,1.133701883174924,0.3372093023255814,0.9602802763258186,1.0,5/12,15.59%,AR;AP2A1;CLTC;TMEFF2;HDAC2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5205428021805634,1.1335752979632407,0.32756489493201485,0.9597909390915819,1.0,5/26,7.91%,CD36;IRF1;FLOT2;BIRC3;TLR3
prerank,peptidyl-threonine modification (GO:0018210),0.466781066841072,1.132898237516491,0.3086680761099366,0.9613363301827207,1.0,19/66,14.30%,LRRK2;DYRK2;GALNT1;PRKCA;PRKDC;MAPK1;ACVR1;GALNT3;CDC42BPB;MAPK8;CAMK2D;CDK5;GALNTL6;TGFBR2;HIPK2;TGFBR1;ACVR1B;PRKD2;ROCK2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.5869871211099691,1.1328730464135157,0.34190620272314676,0.960460797801003,1.0,2/11,4.60%,RIN3;PADI2
prerank,axon development (GO:0061564),0.4634763952646739,1.1327154317336146,0.2897196261682243,0.9601605105132086,1.0,15/78,13.40%,ISL1;VASH2;NREP;LLGL1;MAP1A;EPHB2;S100A6;MAPT;MTR;CDK5;ARHGAP35;GRM7;GAP43;RTN4;S100B
prerank,keratinocyte differentiation (GO:0030216),-0.35840272405744306,-1.1321621644165256,0.28415300546448086,0.9862187355494298,1.0,6/29,17.01%,PIP5K1A;ADAM9;UGCG;BCR;TXNIP;ST14
prerank,mitochondrion distribution (GO:0048311),0.5814060715556388,1.1318057749866852,0.33478893740902477,0.9625847574731428,1.0,3/12,7.60%,LRRK2;MEF2A;MAPT
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.549291013065306,1.1314672067518583,0.312751677852349,0.9628726167197112,1.0,3/17,6.35%,URI1;AR;NR3C1
prerank,positive regulation of viral life cycle (GO:1903902),0.524301959079415,1.131370707430654,0.3135068153655514,0.9622890030455878,1.0,4/22,7.43%,TSG101;VPS4A;AXL;KPNA6
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.564867761804634,1.1310317942430852,0.33099579242636745,0.9626690755393583,1.0,3/14,8.09%,NUDT5;NUDT9;ENTPD1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.45243676641493324,1.130978661804158,0.2696629213483146,0.9619263939003923,1.0,11/107,10.60%,CXCL12;SLC24A5;NPTN;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E
prerank,Rac protein signal transduction (GO:0016601),0.5338393127376284,1.130576974587291,0.3090185676392573,0.9624866303632366,1.0,10/18,19.04%,WASF1;FARP2;EPS8;DBNL;ELMO1;AIF1;CYFIP1;HACE1;NCKAP1;BRK1
prerank,neuron remodeling (GO:0016322),0.6050173779513319,1.1302557595282914,0.3515151515151515,0.962778225928021,1.0,4/10,9.74%,CX3CL1;FARP2;ADGRB3;ANKS1A
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.4461480769843306,-1.1302444997984311,0.30927835051546393,0.9881095161592764,1.0,4/15,9.22%,RNF213;CSNK1D;DAAM2;TIAM1
prerank,regulation of peptide hormone secretion (GO:0090276),0.465459581294936,1.130101965226345,0.296655879180151,0.9624203179883817,1.0,13/67,15.04%,EIPR1;CLOCK;CACNA1D;RAP1A;PRKCA;ALOX5;RAPGEF4;CHD7;CACNA1A;GCK;RFX3;CACNA1C;ENSA
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.5755979669392561,1.1300047572113832,0.3252496433666191,0.9618325282510505,1.0,4/14,10.96%,PRKCZ;IL18;SOCS5;NFKBIZ
prerank,DNA biosynthetic process (GO:0071897),0.5525758251349544,1.1299360368196039,0.3206751054852321,0.9611428444193817,1.0,3/16,6.62%,POLA1;WRN;POLD3
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.4481873955142148,1.1295764927195913,0.238716148445336,0.9615587669601061,1.0,45/190,15.09%,RORA;CGNL1;URI1;UACA;RIOK3;DUSP3;RELA;IFI35;NF1;THBS1;PTPRJ;ESR1;ARRB2;EPM2A;PDE3B;RNF34;TLE1;GPD1L;ABCA7;PHLPP1;FNIP1;LYN;MAPKBP1;DGKD;CD2AP;RNF157;NOC2L;TANK;CYRIB;ZMYND11;TMSB4X;PPM1A;BANK1;MAPK14;CYLD;SH2B3;BCL2;SPRED1;ADIPOR1;TRIM59;PPP2R5C;PTEN;TSC1;OTUD7A;DAG1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.473425389295289,1.1293423741451782,0.29275970619097585,0.9614898522628995,1.0,3/69,1.82%,ISL1;WFS1;CX3CL1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.48088366875226235,1.1293121186830803,0.30724971231300346,0.9606534557508485,1.0,13/42,18.14%,CD36;CX3CL1;NRP1;PTPRJ;CDK6;CCL25;LIMS1;ABL1;TSC1;MAP4K4;RIN2;UTRN;ROCK1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.45109209084079566,1.1289600040523715,0.234,0.961018312126251,1.0,42/214,15.19%,ROR2;PRKCZ;C5AR1;CD36;DUSP3;FBXW7;CX3CL1;CNKSR3;ITGB1BP1;BRAF;GAS6;EPHB2;RAP1A;NRP1;STYX;PDGFB;PRKCA;TRAF7;SPRED2;ARRB2;EZR;CCL25;DLG1;RGS14;RANBP9;DUSP10;PTPN1;ABCA7;LYN;CD44;SEMA6A;NOTCH2;HMGB1;SYK;FN1;SPRED1;NDRG4;PRKD2;LGALS9;PTEN;TLR4;SMAD4
prerank,excitatory postsynaptic potential (GO:0060079),0.539482157678286,1.1279821470640061,0.350597609561753,0.9637803038740048,1.0,6/19,16.27%,LRRK2;RAB3GAP1;ARRB2;GRIN2A;GRID2;MEF2C
prerank,positive regulation of intracellular transport (GO:0032388),0.4914130656686612,1.1278721410071282,0.31627906976744186,0.963256491081089,1.0,10/38,12.56%,RIPOR1;EIPR1;EHD1;PCNT;KIF20B;STK11;NEDD4;VAMP2;SORL1;RUFY3
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3713644938138579,-1.1277946076292802,0.2849740932642487,0.9922066987730178,1.0,6/25,12.91%,NSD1;TGFB1;NIBAN2;DOT1L;IGF1;TRAF6
prerank,vacuolar acidification (GO:0007035),-0.3933678530984574,-1.1275600815674303,0.28936170212765955,0.9881888161366336,1.0,7/21,7.66%,ATP6V0A1;GRN;PPT1;SLC11A1;CLN3;ATP6AP2;DMXL2
prerank,hematopoietic stem cell proliferation (GO:0071425),0.5863670611569367,1.1274977599209848,0.3511450381679389,0.9637240771290867,1.0,2/11,3.64%,WNT2B;RUNX1
prerank,negative regulation of DNA recombination (GO:0045910),0.4911040050960278,1.1270256192814492,0.31214528944381387,0.9645897123503284,1.0,7/43,13.42%,POLR2D;BLM;POLR2A;TERF2;SMCHD1;ATRX;TERF1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.4927218846467853,1.127023389488537,0.3220747889022919,0.96364904339497,1.0,5/35,8.47%,GGTA1;HPGD;ACAT1;FAR1;ALOX5
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.45537411153419605,1.12672796231366,0.27840327533265097,0.9638027257304596,1.0,19/117,14.41%,RXFP1;ADCY8;ADCY3;PRKAR2A;ADCY5;PRKACA;YES1;ADCY9;LYN;FURIN;RAMP1;MAPK14;SYK;FYN;CYSLTR1;CALCRL;CREB1;GNG2;GNB1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.4578073968100136,1.126670745367819,0.3038906414300736,0.9630775583626003,1.0,28/80,17.02%,LMAN1;GOSR2;SNX5;VAMP3;EVI5;TMED9;TBC1D17;DCTN1;RAB6A;SNX3;TBC1D14;VPS35;STX16;TBC1D10B;HEATR5A;SNX1;SNX8;ANKFY1;TBC1D5;TBC1D10A;GGA1;RAB7A;RAB7B;CLTC;VTI1A;VPS53;TBC1D23;GCC2
prerank,neuron migration (GO:0001764),-0.3193407245968963,-1.1265031853112843,0.23809523809523808,0.9870930987060127,1.0,8/48,2.36%,USP9X;ADGRL3;SDCCAG8;ASTN2;NRCAM;LRP12;RAC1;DISC1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.3645474641514357,-1.126481048324482,0.3073170731707317,0.9824265563447712,1.0,11/27,15.94%,IL1RAPL1;DISC1;NTNG1;FCGR2B;GSK3B;FBXO7;ULK4;CCDC88A;MARK1;AKT1;MBOAT1
prerank,cellular metal ion homeostasis (GO:0006875),0.4537900387059572,1.1264780038104334,0.2805755395683453,0.9628700383144146,1.0,6/102,8.63%,CXCL12;SLC24A5;SLC9A1;LETM1;LETM2;NPTN
prerank,regulation of GTPase activity (GO:0043087),0.4486815206850043,1.1262459363980113,0.2399598393574297,0.9627965932344024,1.0,47/177,17.17%,PLXNA1;LRRK2;FGD6;CX3CL1;RAPGEF1;FGD3;DOCK8;FGD1;ITGA6;NDEL1;ITGB1BP1;RAB3GAP1;RSU1;NF1;TBC1D15;RAP1A;EVI5;VAV3;ARFGEF1;CCL25;RRP1B;EZH2;LIMS1;TBC1D10B;RAP1GDS1;EPHA5;LRCH1;TMED2;OCRL;CDKL5;VAV2;RABGAP1;ARHGAP15;PLXNC1;DOCK9;DOCK11;LARS1;PKP4;VAV1;SNX13;MAP4K4;RDX;CPEB2;DOCK10;SNX9;RALBP1;RAPGEF2
prerank,indolalkylamine catabolic process (GO:0046218),-0.4949155122361595,-1.1258571493299872,0.3285302593659942,0.9800044308287187,1.0,5/10,44.13%,KYNU;KYAT1;HAAO;KMO;IL4I1
prerank,intracellular pH reduction (GO:0051452),-0.3402449341735454,-1.1258462254076382,0.2839506172839506,0.9753638578050388,1.0,14/33,16.55%,ATP6V0A1;ATP6V1A;SLC11A1;ATP6V1D;DMXL2;ATP6V0C;RAB39A;ATP6V0B;CLCN3;ATP6V1C1;GPR89B;GPR89A;ATP6V1G1;RAB20
prerank,synaptic vesicle cycle (GO:0099504),-0.35230291434991295,-1.1256167531424823,0.2727272727272727,0.9716726235729649,1.0,8/30,12.69%,SNAP25;RAB5A;PIP5K1C;SYNDIG1;SNCA;RIMS1;PLD2;SLC17A6
prerank,cognition (GO:0050890),0.4795392094945843,1.1255674207525344,0.32878270762229805,0.9643616386311601,1.0,4/42,4.01%,MGAT3;C5AR1;BBS4;NF1
prerank,phosphatidylserine metabolic process (GO:0006658),0.5020301255509729,1.1255534413835404,0.31780167264038234,0.9634595474355397,1.0,6/32,12.68%,SERINC5;PTDSS2;PLA2G4A;ABHD16A;SERINC1;SLC27A1
prerank,arachidonate transport (GO:1903963),-0.48938668129834684,-1.125154648206108,0.33589743589743587,0.964218196190399,1.0,1/10,2.89%,PNPLA8
prerank,arachidonic acid secretion (GO:0050482),-0.48938668129834684,-1.125154648206108,0.33589743589743587,0.964218196190399,1.0,1/10,2.89%,PNPLA8
prerank,cell-matrix adhesion (GO:0007160),0.4597322463199019,1.124955655594977,0.2706611570247934,0.9647483734037845,1.0,14/95,9.92%,ADAMTS12;DDR1;VCL;ADAM15;ITGB1BP1;ITGBL1;SIGLEC1;PPFIA1;ITGA4;ITGB5;FERMT3;ITGB8;CD44;CD63
prerank,inositol lipid-mediated signaling (GO:0048017),-0.3132002822397858,-1.1247694568815632,0.27472527472527475,0.9610963409568931,1.0,15/50,12.55%,PLCL1;RHOA;PIK3CG;PI4KB;PLCL2;EXOC1;CSF1R;PIK3CA;PIK3C3;GAB2;PTAFR;PIK3C2B;IGF1;PLCB2;PLCE1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.5187230539124724,1.1246724009126907,0.34438775510204084,0.9648005745485604,1.0,6/25,14.85%,CD36;SMAD3;HSP90AA1;INSR;PKD2;TLR4
prerank,mitochondrial genome maintenance (GO:0000002),-0.48160251099706847,-1.1246687012084193,0.3371104815864023,0.9570767565499063,1.0,7/11,21.89%,AKT3;OPA1;PARP1;TOP3A;MPV17;SLC25A4;SLC25A33
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.5812656976040025,1.1246556295299404,0.3549337260677467,0.9639264966694323,1.0,2/12,8.39%,GJD3;CAMK2D
prerank,nucleotide-excision repair (GO:0006289),0.45437822836445313,1.12449544133397,0.2964102564102564,0.9636471668978603,1.0,21/101,14.70%,POLR2D;CETN2;RFC2;POLR2A;CDK7;POLA1;EP300;COPS7B;POLD3;POLB;BRCA2;MNAT1;ERCC4;COPS4;CUL4A;TP53;UVSSA;GTF2H1;ATXN3;USP45;RAD23B
prerank,tRNA transport (GO:0051031),-0.3564110341114849,-1.1241794454506888,0.2706766917293233,0.9544188673711522,1.0,20/35,24.24%,TPR;NUP153;NUP214;SSB;XPOT;YBX1;NUP155;NUP188;NUP88;TOMM20;NUP35;NUP133;SEH1L;RAE1;NUP50;NUP210;NUP107;NUP42;RANBP2;POM121
prerank,regulation of response to oxidative stress (GO:1902882),0.5876250136336187,1.124152669302986,0.35454545454545455,0.9640351617847169,1.0,3/11,12.94%,SELENON;ALOX5;ABCD1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.5128354730218705,1.1241079696304699,0.33375,0.9632633467002572,1.0,3/24,2.33%,WFS1;LRRK2;UBXN1
prerank,peptidyl-methionine modification (GO:0018206),0.5730520928783771,1.123996176717845,0.3703170028818444,0.9627491364605241,1.0,4/12,13.16%,METAP1;NAA25;NAA16;NAA15
prerank,regulation of cellular response to heat (GO:1900034),0.4540605232893932,1.123964097019825,0.29811715481171547,0.9619484455898266,1.0,15/77,8.68%,DNAJB1;HSBP1;BAG3;HIKESHI;HSPH1;YWHAE;NUP205;EP300;MAPK1;CHORDC1;HSP90AA1;MAPT;NUP98;CAMK2D;NUP54
prerank,regulation of protein export from nucleus (GO:0046825),0.5296660832454829,1.1239374973889689,0.3501259445843829,0.9611098246308806,1.0,7/23,14.94%,SIRT7;BAG3;GAS6;YWHAE;TCF7L2;TP53;ANP32B
prerank,positive regulation of ion transport (GO:0043270),0.47215368343521225,1.1238810565892285,0.32849162011173183,0.9603960701671453,1.0,6/48,7.63%,WFS1;VAMP7;CNKSR3;CACNA1D;DLG1;GPD1L
prerank,regulation of osteoblast differentiation (GO:0045667),0.4576719387048392,1.123650614098576,0.3050314465408805,0.9603623775948816,1.0,12/82,9.43%,WNT4;DDR2;SMAD6;BMPR1A;NELL1;PRKACA;CRIM1;LRP5;CDK6;ACVR1;TRPM4;PPARG
prerank,regulation of translational initiation (GO:0006446),0.4615736091374842,1.1235041912117243,0.3155080213903743,0.9599498789417056,1.0,11/63,10.49%,POLR2D;HABP4;RPS6KB2;EIF3E;IMPACT;CSDE1;EIF4B;AGO2;NCK1;YTHDF1;EIF1
prerank,regulation of phagocytosis (GO:0050764),-0.3018644861029958,-1.1234027417950756,0.2413793103448276,0.9526489461805782,1.0,15/53,13.76%,HCK;PTPRC;FCER1G;FGR;SLC11A1;FCGR2B;PIP4P2;CYBA;RAB27A;CALR;PYCARD;SIRPA;RACK1;IL15RA;SCARB1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.4530885432587197,-1.1233690932317515,0.315625,0.9484173571027207,1.0,2/13,1.34%,PDE4D;CALM2
prerank,zinc ion transport (GO:0006829),0.5140812894970014,1.1232984797150176,0.3353960396039604,0.9598164010638784,1.0,2/21,3.50%,SLC30A6;SLC39A11
prerank,cell junction organization (GO:0034330),0.46056275773088895,1.1231658947599663,0.313953488372093,0.9593698618848051,1.0,12/71,10.69%,SDK2;DVL1;RAB8B;TGFB2;FLNA;PPFIBP2;SMAD3;PPFIA1;MAPT;LIMS1;MYO9A;CDC42
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.5595470999124201,1.1231524260236456,0.3309248554913295,0.958501264208793,1.0,4/13,8.50%,MAP1A;GPD1L;STX3;ABCA7
prerank,DNA duplex unwinding (GO:0032508),0.47927693870346416,1.123027988053675,0.31549609810479373,0.9580333169696104,1.0,11/50,14.70%,CETN2;BLM;RAD50;SSBP1;WRN;MRE11;NBN;CUL4A;GTF2H1;RECQL5;RAD23B
prerank,cellular response to UV-A (GO:0071492),0.5931831126001876,1.1228399540185658,0.3561643835616438,0.9577817268938127,1.0,1/11,2.94%,PPID
prerank,regulation of cellular component size (GO:0032535),0.5096425182639489,1.1217124581419788,0.32784958871915393,0.9610470778177862,1.0,12/30,16.52%,RIN3;MSN;VAV3;EZR;HP1BP3;EPS8;MTOR;VAV2;LARS1;PTEN;VAV1;RDX
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.5718992494095497,1.121362406884451,0.3554572271386431,0.9614323628105417,1.0,4/12,11.85%,ESR1;NCOR1;PPARG;NCOR2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.4453421784992704,1.1211648272960915,0.128,0.9612563690736957,1.0,112/572,15.19%,ISL1;GLIS1;PLK1;MDFI;WFS1;DNAJB1;URI1;SIRT7;HSBP1;PARP9;KDM1B;THAP7;DMAP1;RELA;SMARCA4;CTR9;SUV39H1;VPS72;BAG3;ZFP90;SOX13;PPID;ZBTB5;IMPACT;TGIF1;ZEB2;RUNX1;MAX;HCFC1;IGBP1;JUN;AR;ATXN1;ZBTB7A;BCL6;HDAC9;TRPS1;N4BP2L2;EP300;SMAD3;SPEN;ARID5B;PDGFB;DPF2;ESR1;HDAC5;SDCBP;NR3C1;EHMT2;EZR;NCOA5;MEF2A;MLIP;NEDD4;DLG1;MECP2;CUX1;EZH2;DAB2;NCOR1;FNIP1;PHF6;ORC2;PPARG;MTDH;NR6A1;SIN3B;CTBP1;HMBOX1;ENO1;DEAF1;HIVEP1;UBE2I;NOC2L;ZNF568;CHD8;NR2C2;SOX11;BCL11A;MAP2K5;PRDM1;PPM1A;NCOR2;DNMT3A;YEATS2;HMGB1;ZFP69;DNAJA3;TCF7L2;MIER3;TP53;ATRX;NR1D2;MYT1L;LCOR;RXRA;EPC1;NFX1;WWOX;DDX5;KCNIP3;RREB1;RBPJ;PPARD;ZMYM5;TBL1XR1;UBE2D3;LDB2;LDB1;CTCF;SMAD4;ZBTB18
prerank,renal absorption (GO:0070293),-0.48974970076898244,-1.1211183299607888,0.31989247311827956,0.952129190110147,1.0,3/10,19.55%,SGK1;SLC15A2;KLHL3
prerank,positive regulation of peptidase activity (GO:0010952),-0.4054981648817385,-1.120555472631082,0.27692307692307694,0.9498412476287834,1.0,14/20,40.25%,GRN;VCP;VSIR;NCSTN;DDRGK1;PSME1;PINK1;PSME2;APH1A;PRELID1;PSENEN;NDUFA13;APH1B;PSME3
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.4735374483697338,1.120163366174451,0.32840909090909093,0.9639597701936742,1.0,5/42,6.62%,PCLAF;RFC2;POLA1;WRN;POLD3
prerank,ncRNA catabolic process (GO:0034661),0.4966597595687027,1.119585296504838,0.34545454545454546,0.9651267734761998,1.0,8/28,14.35%,TUT4;EXOSC5;EXOSC7;XRN1;POP1;LIN28B;RBM7;MTREX
prerank,folic acid metabolic process (GO:0046655),0.5370775552824181,1.1190142838193164,0.34100135317997293,0.9662925255375736,1.0,4/18,12.20%,ALDH1L1;MTHFD2L;MTHFR;SLC25A32
prerank,Rap protein signal transduction (GO:0032486),0.6016810059648108,1.1189370327510144,0.4016260162601626,0.9656738254454987,1.0,3/10,7.63%,RAPGEF1;RAP1A;RAP1B
prerank,positive regulation of macrophage migration (GO:1905523),0.534434106724181,1.1184099939886307,0.3360323886639676,0.9666521760647078,1.0,4/19,5.62%,CX3CL1;THBS1;CMKLR1;MAPK1
prerank,ganglion development (GO:0061548),0.583907039320131,1.11838489267424,0.3588957055214724,0.9658226357386774,1.0,5/11,19.13%,NRP1;NRP2;FZD3;CTNNB1;UNC5C
prerank,base conversion or substitution editing (GO:0016553),0.578361328401823,1.1180640723907629,0.3697996918335901,0.9661131527924112,1.0,3/11,10.36%,METTL3;APOBEC1;ADAR
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.4497469190093106,1.1173843011604427,0.29042224510813597,0.9677211515829229,1.0,17/110,5.94%,RPL18;EIF4A3;RPS23;RPL41;RPL31;SMG6;RPS17;EIF3E;RPL4;PNRC2;RNPS1;PYM1;PPP2R2A;RPLP0;ETF1;RPS15A;RPL38
prerank,protein acetylation (GO:0006473),0.4924722346052715,1.1171038679295158,0.3353658536585366,0.9678640848579874,1.0,9/30,13.16%,CLOCK;NAA35;EP300;MAPT;NAA16;GTF2B;KAT2B;ESCO1;NAA15
prerank,positive regulation of nervous system process (GO:0031646),-0.41590626861307284,-1.1170927921438942,0.3215686274509804,0.957450346032589,1.0,11/18,32.57%,RIMS2;RNF10;RIMS1;ITGAX;TPPP;UNC13B;ATPSCKMT;MYRF;DICER1;NLGN2;CST7
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.44559016652766814,-1.1170156324977452,0.34317343173431736,0.9533845379809076,1.0,11/14,37.06%,PLCG2;LAPTM5;CAMK4;SIRT1;LILRB1;CD74;BCL10;GPRC5B;KIT;SEMA7A;TICAM1
prerank,regulation of ruffle assembly (GO:1900027),0.5047229723391077,1.1169932813376768,0.3573200992555831,0.9673247964016976,1.0,8/23,16.52%,FAM98A;NDEL1;EPS8L1;EPS8;P2RY12;EVL;PLEKHM1;RDX
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.5053599840784823,1.1168513859483806,0.3316770186335404,0.9669024953116788,1.0,7/29,7.94%,COG1;GOSR2;COPB2;NAPG;COG3;TRAPPC3;RAB6A
prerank,regulation of response to stress (GO:0080134),0.5954104045622659,1.116813923442383,0.3644859813084112,0.9661382478817334,1.0,2/10,5.63%,ADCY8;SLC38A2
prerank,cristae formation (GO:0042407),0.5094098222794466,1.1166965725967757,0.3399258343634116,0.965617549899076,1.0,7/27,13.42%,ATP5F1A;ATP5MC3;LETM1;ATP5MC2;DNAJC11;APOOL;CHCHD6
prerank,regulation of necroptotic process (GO:0060544),0.516895205909084,1.1162390482725713,0.3423076923076923,0.9663602239935773,1.0,9/23,16.32%,FLOT2;PELI1;SDCBP;BIRC3;HSP90AA1;CYLD;PDCD6IP;FZD9;CFLAR
prerank,regulation of activated T cell proliferation (GO:0046006),0.49903169951940113,1.1161050650031707,0.32185273159144895,0.9659346476192101,1.0,8/30,18.02%,IGFBP2;IL18;ICOSLG;PRNP;HMGB1;LGALS9;PRKAR1A;RC3H1
prerank,limb morphogenesis (GO:0035108),0.5374250701206088,1.11605396847134,0.3411458333333333,0.9652165110770224,1.0,6/20,17.12%,TGFB2;MBNL1;IQCE;LRP6;FBXW4;PCSK5
prerank,positive regulation of apoptotic process (GO:0043065),0.44493419219013347,1.1160486340944302,0.2,0.9643315617851786,1.0,56/293,12.97%,IGFBP3;UBE2Z;ARHGEF3;TPD52L1;NUPR1;FGD3;TFAP4;FGD1;PLEKHG2;PPID;ITGA6;PLEKHG5;SAP18;TGFB2;SMPD1;BCL2L11;ITSN1;OLFM1;MTCH1;NF1;JUN;BCL6;RNPS1;TNFAIP8;ARHGEF12;MAP3K11;APAF1;CTNNBL1;SQSTM1;TRAF7;VAV3;MAP3K20;RBM5;ING3;RRP1B;MAPK8;BNIP3L;DAPK1;FAF1;KALRN;APC;CDK5;AKAP13;BNIP3;PRNP;ARHGEF17;ABL1;HMGB1;AIFM1;VAV2;RPS6;ATF6;SRPK2;MLLT11;TP53;TGFBR1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5723175203955182,1.1160156805123844,0.3537803138373752,0.9635423592086793,1.0,2/12,10.93%,ADAMTS12;SEMA6A
prerank,regulation of mitotic spindle organization (GO:0060236),0.4925099118078013,1.1156946424475966,0.3301997649823737,0.9638374987275277,1.0,7/35,14.68%,PLK1;EML3;CHMP5;DCTN1;VPS4B;PDCD6IP;CLTC
prerank,folic acid-containing compound metabolic process (GO:0006760),0.5240399750024558,1.115658171080527,0.34656084656084657,0.9630866531305171,1.0,4/19,12.20%,ALDH1L1;MTHFD2L;MTHFR;SLC25A32
prerank,negative regulation of phosphorylation (GO:0042326),0.4581324573740131,1.1153029216149575,0.30072090628218334,0.9635099493076162,1.0,14/85,9.65%,LRRK2;IGFBP3;CDK5RAP3;PID1;NUPR1;IMPACT;TARDBP;NIBAN1;EPHB2;PRKDC;IRS2;MAPT;NCOR1;LYN
prerank,regulation of protein catabolic process (GO:0042176),-0.26264004531488366,-1.1152457257792996,0.2857142857142857,0.9552327681609314,1.0,31/99,19.21%,SMURF2;PRKN;SMURF1;CSNK2A1;HUWE1;EEF1A1;NSF;STX5;SIRT2;VCP;SNX12;GSK3B;AZIN1;RNF41;IDE;ATP13A2;WDR91;MDM4;DDB1;BANP;HECW2;TIPARP;SNF8;CDKN1B;HMGCR;GFAP;TNFAIP3;IRAK3;SEC22B;OAZ2;ZDHHC2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.45343125032660764,1.1151472698659253,0.3178947368421053,0.963191213495482,1.0,21/84,16.03%,EIF4A3;CNOT10;EIF2AK2;ILF3;EIF4ENIF1;SYNCRIP;MALSU1;RTN3;ABCA7;DAPK1;FXR2;CNOT9;PRNP;LSM14A;SORL1;SAMD4A;RTN4;EIF4E2;TSC1;CAPRIN1;GGA3
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5861872716678602,1.114893365187814,0.363905325443787,0.9632304471290062,1.0,5/11,16.80%,ABCB7;ABCD2;ABCD1;FYN;COA8
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5146581736342501,1.1147157859594317,0.3329129886506936,0.9629841670571291,1.0,5/22,9.65%,RELA;SP1;RANBP9;ABCG1;LYN
prerank,positive regulation of neurogenesis (GO:0050769),0.45761475239975435,1.1142768314456575,0.3236870310825295,0.9637111807748387,1.0,14/68,14.51%,CHODL;PLXNA1;CX3CL1;NUMBL;SS18L1;SPEN;RGS14;CUX1;NPTN;SOX11;CDKL5;PLXNC1;MAP6;FZD3
prerank,V(D)J recombination (GO:0033151),0.5791067137413459,1.1138100764300152,0.36716417910447763,0.9645931086410432,1.0,3/11,12.01%,XRCC4;PRKDC;HMGB1
prerank,regulation of Notch signaling pathway (GO:0008593),0.4552366690373217,1.1136737451713155,0.32558139534883723,0.9642091619294837,1.0,11/76,6.97%,LLGL2;FBXW7;ITGB1BP1;LLGL1;TGFB2;ZBTB7A;EP300;METTL3;MAML3;BEND6;MAML2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.4540273066666172,1.113531229598918,0.3158995815899582,0.9638259302024894,1.0,13/72,11.88%,RNASE6;RFC2;RAD50;PNRC2;DCP1B;POLD3;RNASE4;MRE11;ERCC4;EXD2;XRN2;DCP1A;CUL4A
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.4855164308118752,-1.113272875919754,0.3390804597701149,0.9574521369898786,1.0,3/11,6.43%,PCBP2;RASA1;NOVA1
prerank,regulation of supramolecular fiber organization (GO:1902903),0.5177497097434883,1.1129919470191438,0.3522727272727273,0.964859224124919,1.0,6/22,11.90%,GBA2;MAP1A;CAMSAP3;MAPT;AKAP13;ABL1
prerank,protein phosphorylation (GO:0006468),0.44359141036264466,1.1129394749835975,0.157,0.96413814025653,1.0,95/478,14.30%,MUSK;SGK3;SGK2;PLK1;DDR1;RSKR;LRRK2;IGFBP3;DDR2;PRKCZ;RPS6KB2;MINK1;EIF2AK1;EIF2AK2;ILF3;GMFB;LIPE;DYRK2;NEK3;CAMK1D;TLR7;BRAF;TGFB2;GAS6;BMPR1A;EPHB2;PIK3R4;MAP3K11;CDK7;PRKCB;PDGFB;PRKCA;PRKACA;CDK2;BTK;PRKDC;MAPK1;MAP3K20;ABI1;CDK6;ACVR1;STK11;IKBKB;MAP2K6;CDC42BPB;MAPK8;TLR3;PKN2;PAK2;RPS6KA5;CDK9;CAMK2D;MAP3K9;CSNK1G1;MAST2;PPP4R1;BIRC6;GRK5;DAPK1;CHEK2;BRD2;NEK7;CTBP1;LYN;CDK5;MAST3;TAOK1;TGFBR2;IGF1R;ULK2;BMP2K;MTOR;ABL1;ERN1;CDKL5;MAPK14;ADAM10;SRPK2;HIPK2;MAPKAPK2;TGFBR1;NRBP1;MAST4;ACVR1B;CDK8;SYK;INSR;GTF2H1;CAMKK2;FYN;PRKD2;CSNK1A1;CREB1;RELN;ROCK2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4498308286297369,1.1127856957529179,0.3081695966907963,0.9637797531036101,1.0,13/76,12.10%,BRCA1;WFS1;LRRK2;CDK5RAP3;FBXW7;UBQLN1;BIRC3;DCUN1D4;PTTG1IP;RCHY1;TANK;DERL1;UBE3A
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.57828583453286,1.1127085793695035,0.3474320241691843,0.9631567125302412,1.0,5/12,13.60%,DYRK2;IRS1;IRS2;GCK;INSR
prerank,defense response to protozoan (GO:0042832),-0.45583420743659386,-1.112620131606405,0.3385579937304075,0.9555447996437955,1.0,9/12,45.44%,LYST;SLC11A1;BATF;GBP7;MYD88;CD40;IRF4;PF4;GBP2
prerank,androgen receptor signaling pathway (GO:0030521),0.5791127831531786,1.1125020516999498,0.3653543307086614,0.9630261575042226,1.0,3/11,6.72%,PMEPA1;AR;KDM3A
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.45063549533748287,1.1124753735057424,0.3012295081967213,0.9622470180932545,1.0,19/116,14.41%,RXFP1;ADCY8;ADCY3;PRKAR2A;ADCY5;PRKACA;YES1;ADCY9;LYN;FURIN;RAMP1;MAPK14;SYK;FYN;CYSLTR1;CALCRL;CREB1;GNG2;GNB1
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.4307887461795011,-1.1123860793768867,0.3263157894736842,0.952174120826387,1.0,7/15,20.80%,PLCG2;KLHL18;CUL3;STXBP4;DDRGK1;ATAD5;CDC73
prerank,skeletal muscle organ development (GO:0060538),0.5116548827259464,1.1120171238632484,0.34846625766871164,0.9629849971876263,1.0,5/26,16.67%,SVIL;ZBTB18;MEF2C;CFLAR;LARGE1
prerank,regulation of gene expression (GO:0010468),0.44330579110766694,1.1116912880132765,0.096,0.9632420284527131,1.0,149/903,14.30%,MUSK;FGF22;ACE2;FGF18;WNT4;RGCC;BRCA1;C1D;ACTR5;RORA;ZNHIT3;PARP9;ELAVL2;THAP7;CD36;RELA;FBXW7;DVL1;SP1;CTR9;PID1;GLMN;FGF1;FLOT2;CASZ1;SOX13;FAM98A;RLIM;CLOCK;BRAF;RUNX1;TGFB2;GAS6;HCFC1;OLFM1;TARDBP;MSN;BMPR1A;POLR2A;RBMS3;MBNL1;EPHB2;MYCBP;AR;ATXN1;PRDM10;BCL6;NELL1;EP300;SMAD3;TERF2;PDGFB;CDK2;RBAK;MAPK1;SLC38A2;PUM2;TNRC6B;ESR1;SPTY2D1;HDAC5;NR3C1;CDK6;IL1A;BRCA2;PRDM4;EZR;TLE1;PTBP3;RRP1B;HP1BP3;MAPT;MAPK8;MECP2;TLR3;ZBTB11;AGO2;RPS6KA5;EZH2;ITGB8;VPS35;JMJD1C;KRAS;LIMS1;CHD7;SNRNP70;CHEK2;ICOSLG;PUM1;DTNBP1;ADNP2;PTP4A3;ASCC2;MBNL2;LYN;FUS;FADS1;HGS;F3;ZC3H7A;AFF2;TRIM5;TULP3;FOXN3;NFKBIZ;NR5A1;NOTCH2;ZNF711;PSPC1;NR2C2;SOX11;TRIM44;ZBTB38;MTOR;AFF1;PRDM1;ABL1;ZFP36L1;GPBP1;MAPK14;ERP29;SOX6;ADAM10;UBR5;SRPK2;TP53;ATRX;TGFBR1;RNF20;NR1D2;MAP2K2;ACVR1B;HNRNPH3;FUBP3;PPARGC1B;NFX1;NDFIP1;COQ7;CLK1;FN1;HNRNPH1;INSR;RREB1;PCBP3;LGALS9;NSD2;RFX3;RBPJ;ROCK2
prerank,regulation of transferase activity (GO:0051338),0.540075858822205,1.1112548972757674,0.3770053475935829,0.9639173617433234,1.0,7/17,17.17%,SMG6;FEM1A;HMBOX1;PARP4;LDB2;LDB1;ATM
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5005522378665471,1.1106306797417371,0.3516209476309227,0.9653057280789131,1.0,6/27,10.02%,RGCC;SMG6;TERF2;PDGFB;HMBOX1;PARP4
prerank,peroxisomal membrane transport (GO:0015919),0.49381995137446427,1.110623872095776,0.3501228501228501,0.964449937657431,1.0,8/27,17.44%,PXMP2;RAB8B;ABCD2;ABCD3;ABCD1;PEX14;PEX7;ATAD1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.4618533180834027,-1.1104480637633394,0.3807829181494662,0.9547641772083851,1.0,7/12,42.52%,SMO;VEGFA;PAX8;PAX2;SOX8;AGT;SOX9
prerank,positive regulation of organelle assembly (GO:1902117),0.46867805298367066,1.1104380569172558,0.34650112866817157,0.9642466082673504,1.0,12/44,14.77%,TAPT1;RAB3GAP1;BBS4;PIP4K2A;SDCBP;G3BP2;CCP110;PIP4K2B;ARHGAP35;SH3GLB1;PDCD6IP;G3BP1
prerank,thyroid hormone generation (GO:0006590),-0.48520626551881774,-1.110237930928789,0.3467741935483871,0.9512581181676378,1.0,1/10,1.91%,CPQ
prerank,regulation of focal adhesion assembly (GO:0051893),0.4657188954275264,1.110157604475518,0.34210526315789475,0.9643453030897683,1.0,18/54,16.41%,VCL;DUSP3;ITGB1BP1;SLC9A1;THBS1;NRP1;PTPRJ;CAMSAP3;LIMS1;ABL1;ROCK2;PTEN;LDB1;TSC1;CLASP1;MACF1;MAP4K4;ACTG1
prerank,fat cell differentiation (GO:0045444),0.4595172862040959,1.11015566139967,0.3344262295081967,0.9634664671536708,1.0,11/57,12.65%,SMAD6;PID1;BBS4;ZBTB7A;PSMB8;EP300;PPARG;CTBP1;TMEM120B;TCF7L2;ERAP1
prerank,methylguanosine-cap decapping (GO:0110156),0.5866412025931609,1.1098004944215636,0.3723076923076923,0.9637842497271458,1.0,5/10,16.15%,PNRC2;DCP1B;DCP1A;DCPS;PATL1
prerank,regulation of lamellipodium organization (GO:1902743),0.5553530393085567,1.1095267683461845,0.36694677871148457,0.9638943426972668,1.0,4/14,10.69%,CAPZB;TWF2;CD44;CDC42
prerank,protein transport (GO:0015031),0.4388161227499095,1.109115082132428,0.214,0.9644695623179939,1.0,91/332,16.16%,STXBP2;NEURL1B;STEAP3;SYS1;ARL5A;CD36;TMED4;ARL4A;ARL6;ARF3;COPB2;RAB8B;EHD1;NAPG;TVP23B;HIKESHI;RAB12;TBC1D15;STX7;KIF13A;PRKCB;SIL1;EVI5;TMED9;TANGO6;SCAMP1;AP2A1;TBC1D17;PDIA4;RAB5B;GOLPH3;VPS45;ATP6V0E1;RAB6A;STX3;SPTBN1;TBC1D14;VPS35;STX16;ARL4C;ARHGAP1;STX17;ATP6V1E1;PPARG;ABCG1;TBC1D10B;VAMP2;WLS;ARF1;MIA3;MCOLN1;SNX1;KIF3A;RAMP1;TMED2;TBC1D4;SCAMP5;RAB18;TBC1D12;SNX8;TBC1D5;TBC1D10A;VIPAS39;TBC1D13;ERP29;RABGAP1;ABCA1;ATP6V0D2;RAB3C;TMED5;ATP6V1H;NAPA;RPGR;CALCRL;SAR1B;UNC93B1;ATP6V0A2;TBC1D22A;GGA1;OPTN;TBC1D8;RAB7A;CLTC;TBC1D1;NPM1;SNX13;MACF1;STX8;ARL6IP5;GGA3;GOLGA4
prerank,epithelium development (GO:0060429),0.4488423069084772,1.1089642781873328,0.3261758691206544,0.9641186008170548,1.0,12/107,13.91%,WNT4;ALDH1A2;VCL;DVL1;AHI1;PPARG;LOXL3;SOX11;HNRNPH3;NDRG4;PPP2R3A;PKD2
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.4821291218163648,1.1088714220794846,0.3209302325581395,0.9635748273111482,1.0,7/41,8.68%,EIF6;PGAM1;ZBTB7A;NUP205;EP300;NUP98;NUP54
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.4420161542441887,1.108438591379689,0.2780586450960566,0.9642365300769926,1.0,34/168,12.28%,POLR2D;RPL18;EIF4A3;CNOT10;RPS23;RPL41;RPL31;SMG6;RPS17;EIF3E;TUT4;CSDE1;RPL4;PNRC2;RNPS1;PYM1;PPP2R2A;EXOSC5;RPLP0;DCP1B;ETF1;RPS15A;RPL38;RC3H2;EXOSC7;XRN1;CNOT9;XRN2;DCP1A;CNOT3;DCPS;ZFP36L1;RPL21;RPS6
prerank,ERAD pathway (GO:0036503),0.4554683648876742,1.1083890609442555,0.31145833333333334,0.9635331911085417,1.0,14/83,8.19%,WFS1;MAN1B1;FBXO17;TMEM67;DNAJC18;UGGT2;UBXN4;USP19;UBQLN1;POMT2;UBE2J2;RHBDD2;ERLEC1;ECPAS
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.5313922570424662,1.1079769269093556,0.35664335664335667,0.9641266201418398,1.0,2/17,5.17%,RGCC;PDGFB
prerank,positive regulation of protein import into nucleus (GO:0042307),0.5068499950266574,1.107741050939707,0.3415841584158416,0.9640522612342329,1.0,7/28,12.71%,DMAP1;BAG3;FLNA;SMAD3;MAVS;IPO5;UBR5
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.4409961548895957,1.1076951663068828,0.28241206030150756,0.9633379875004547,1.0,27/184,9.42%,TUBB4B;PLK1;RGCC;CETN2;TFAP4;ALMS1;MAPRE1;PSMD9;AKAP9;CEP250;YWHAE;PSMB8;ANAPC10;CDC23;PRKACA;CDK2;PCNT;HSP90AA1;PSMC5;BUB3;DCTN1;TUBA1A;DCTN2;CCP110;CDC16;ODF2;CEP152
prerank,positive regulation of ossification (GO:0045778),0.4836826796488201,1.1071148808289024,0.34454756380510443,0.9645703715738227,1.0,7/39,11.42%,WNT4;TGFB2;BMPR1A;NELL1;ACVR1;ALOX5;SOX11
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5146758185851313,1.107093191520567,0.3448275862068966,0.9637603496374297,1.0,4/19,11.72%,WFS1;PDGFB;MAPK8;MAP2K5
prerank,negative regulation of interleukin-1 production (GO:0032692),0.5109465025349169,1.1070297609430721,0.3494764397905759,0.9631048813014652,1.0,3/23,7.51%,CX3CL1;GAS6;PYDC1
prerank,protein targeting to membrane (GO:0006612),0.45079015494941954,1.1069947304018561,0.30325288562434416,0.9623606904661417,1.0,18/83,12.94%,PXMP2;ZDHHC24;ARL6;SSR2;RAB8B;SIL1;SDCBP;ABCD2;NACA;ZDHHC1;SEC61A1;VPS37C;ABCD3;VPS37A;ATG3;ZDHHC6;SRPRA;ABCD1
prerank,DNA repair (GO:0006281),0.43967899885396683,1.1069325826899052,0.244,0.9617030491636842,1.0,63/284,15.69%,BRCA1;CETN2;ACTR5;MPG;BLM;PARP9;RFC2;POLE2;RNASEH2A;RAD50;UBXN1;TDP2;XRCC4;RAD18;ASF1A;POLA1;WRN;UBE2V2;DCLRE1A;FTO;PRKDC;UBE2A;POLD3;POLB;BRCA2;MNAT1;PDS5A;RBBP8;MRE11;USP1;SETD2;MAPK8;ERCC4;KMT5B;NBN;PARP2;BABAM2;CHEK2;EXD2;KMT5C;ASCC2;SETX;RFWD3;PARP4;KDM4B;RAD51B;ABL1;UVRAG;USP3;MLH3;TP53;GTF2H1;ATXN3;APEX2;NSD2;USP45;RECQL5;RAD23B;NPM1;ALKBH5;VCPIP1;BAZ1B;TRRAP
prerank,secondary palate development (GO:0062009),0.5552907186247797,1.1065129905501556,0.3845029239766082,0.9622734802322953,1.0,4/14,15.19%,TGFB2;CHD7;TGFBR2;SMAD4
prerank,positive regulation of protein import (GO:1904591),0.49571022675896237,1.1057587466271646,0.3474065138721351,0.964174032539541,1.0,7/30,12.71%,DMAP1;BAG3;FLNA;SMAD3;MAVS;IPO5;UBR5
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.4494590859448346,-1.1057469600162269,0.3495440729483283,0.9622911865976254,1.0,7/13,12.91%,RHOA;FUT9;ZDHHC21;ETS1;ITGB2;IRAK1;TRAF6
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5042692503758472,1.1055146578176407,0.3530150753768844,0.9641371789129914,1.0,9/25,17.53%,ANKRD54;PRKDC;TAL1;MAPK14;ACVR1B;ARNT;FOXO3;NCKAP1L;MED1
prerank,positive regulation of innate immune response (GO:0045089),0.48737391251502377,1.1050068169153786,0.35236938031591736,0.9650369751670849,1.0,5/30,9.31%,POLR3G;RIOK3;IFI35;AKIRIN2;MAVS
prerank,protein targeting to peroxisome (GO:0006625),0.4882842950752013,1.104868079518605,0.3617539585870889,0.9646389426723335,1.0,9/29,17.44%,PXMP2;RAB8B;ABCD2;ZFAND6;ABCD3;ABCD1;PEX14;PEX7;ATAD1
prerank,fatty acid oxidation (GO:0019395),0.45592680628268084,1.1041107522333458,0.34086021505376346,0.9663610286334742,1.0,13/57,14.36%,ACAT1;ECI2;ACADS;ECHS1;DECR1;ABCD2;CROT;ABCD3;ACADL;ABCD1;HSD17B4;ADIPOR1;PPARD
prerank,positive regulation of programmed cell death (GO:0043068),0.43948915456697013,1.1040968963136724,0.23723723723723725,0.9655484087530375,1.0,49/272,12.92%,LRRK2;IGFBP3;UBE2Z;ARHGEF3;FGD3;TFAP4;FGD1;PLEKHG2;PPID;ITGA6;PLEKHG5;SAP18;SMPD1;BCL2L11;ITSN1;OLFM1;MTCH1;NF1;JUN;BCL6;RNPS1;TNFAIP8;ARHGEF12;MAP3K11;APAF1;CTNNBL1;SQSTM1;VAV3;MAP3K20;RBM5;ING3;RRP1B;MAPK8;BNIP3L;DAPK1;FAF1;KALRN;APC;AKAP13;BNIP3;ARHGEF17;ABL1;HMGB1;AIFM1;VAV2;RPS6;ATF6;MLLT11;TP53
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.4416652993368412,1.1038970424242287,0.262,0.96536153788837,1.0,49/234,15.24%,RGCC;TNFRSF11A;DDR2;PRKCZ;CD36;RELA;CX3CL1;SMARCA4;EIF2AK2;ADCY8;FLOT2;RNF31;CLOCK;CAMK1D;AR;ZBTB7A;PRKCB;EP300;SMAD3;ARID5B;BTK;BUD31;ESR1;HDAC5;CRTC1;IKBKB;RPS6KA5;IL1RAP;IL18;IRAK2;TAB3;LRP8;MAVS;PPARG;MTDH;EPHA5;TRIM5;TRAF2;HIPK2;LRP6;PPARGC1B;PRKD2;LGALS9;RELN;RAB7B;PTEN;TLR4;TRIM26;NPM1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5608000809668994,1.1036351925733539,0.3648255813953488,0.9654965107230432,1.0,5/14,12.16%,SAP18;RNPS1;SFSWAP;U2AF2;SRSF9
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.44722023380723763,1.1034107193808564,0.3228180862250263,0.96539629245855,1.0,24/80,16.64%,TAPT1;ACTR3;FAM98A;NDEL1;BBS4;NRP1;FNBP1L;EPS8L1;CCP110;TWF2;APC;EPS8;ARHGAP35;CDC42;ARPC2;WASF2;DOCK11;P2RY12;WASL;GPM6A;AUTS2;PIK3R1;PLEKHM1;CYFIP1
prerank,axonal transport of mitochondrion (GO:0019896),-0.4675596524428932,-1.1028773302355352,0.35082872928176795,0.9682966030143033,1.0,5/11,14.75%,OPA1;TRAK2;TRAK1;ACTR10;NEFL
prerank,endodermal cell differentiation (GO:0035987),0.49635535722238006,1.102853633641917,0.3389423076923077,0.9664864473856444,1.0,5/31,7.49%,CTR9;ITGA4;ITGB5;COL11A1;SETD2
prerank,negative regulation of cellular component movement (GO:0051271),-0.43453194210582224,-1.1027807449222147,0.2918287937743191,0.9644055580409734,1.0,9/15,42.82%,CD9;TGFBR3;ACTN1;FRMD5;WAS;CRK;PIN1;CCDC125;SP100
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.38166293227152115,-1.1024479433886398,0.2901960784313726,0.9614226752944367,1.0,8/20,14.79%,ATP1B3;ATP1B1;ATP1A1;ATP1A2;KCNJ2;ATP1A3;ATP6AP1;KCNMA1
prerank,negative regulation of mRNA processing (GO:0050686),0.5493473394012635,1.1020076255312647,0.3629943502824859,0.9685741355366076,1.0,5/15,12.16%,SAP18;RNPS1;SFSWAP;U2AF2;SRSF9
prerank,regulation of cilium assembly (GO:1902017),0.45471199801243384,1.10185833149053,0.34371643394199786,0.9682462649764574,1.0,22/62,15.00%,TAPT1;BBS4;TBC1D15;EVI5;IFT20;TBC1D17;TBC1D14;CCP110;TBC1D10B;ARHGAP35;ATG3;CDKL5;TBC1D5;TBC1D10A;TBC1D13;CYLD;RABGAP1;ODF2L;TBC1D24;TBC1D22A;TBC1D8;TBC1D1
prerank,atrioventricular valve development (GO:0003171),0.552276365091299,1.1014739047664959,0.38060781476121563,0.9686935471063777,1.0,4/14,11.20%,TGFB2;BMPR1A;ACVR1;TGFBR2
prerank,regulation of ATP biosynthetic process (GO:2001169),0.5401317359581258,1.101375038526708,0.36488340192043894,0.9681879919237251,1.0,4/16,11.73%,AK4;PID1;ENO1;TMSB4X
prerank,long-chain fatty acid transport (GO:0015909),0.4913965048135682,1.1011770744667124,0.34378769601930037,0.9680868186136228,1.0,8/30,14.13%,CD36;ABCD2;SLC25A20;PPARG;ABCD3;SLC27A1;ABCD1;ACACA
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.38560447699566264,-1.1010526374614016,0.30833333333333335,0.9620822324421238,1.0,10/19,32.42%,PRDX1;ACOX1;CYBA;CAT;SOD1;NOX1;PRDX2;PRDX3;PARK7;GPX1
prerank,glycogen catabolic process (GO:0005980),-0.43695404582519565,-1.100945209721652,0.3538961038961039,0.9583418447723662,1.0,8/15,25.30%,PHKA2;PHKB;PYGB;PGM2L1;PHKG2;PYGL;GAA;PGM2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.35034048225632375,-1.1009110789017373,0.24550898203592814,0.9543999244080565,1.0,6/30,2.93%,SMURF2;XIAP;TGFB1;SMAD7;SMAD2;LATS1
prerank,regulation of protein targeting to membrane (GO:0090313),0.4944230483358245,1.1005703689853004,0.3558504221954162,0.9694633174296831,1.0,3/28,3.91%,MIEF2;ITGB1BP1;GDI1
prerank,positive regulation of axonogenesis (GO:0050772),0.4705794487269584,1.1005419391686517,0.3583617747440273,0.9687069323058909,1.0,12/43,16.16%,CHODL;PLXNA1;ZFYVE27;MAPT;TWF2;DBNL;CDKL5;RUFY3;PLXNC1;MAP6;MACF1;GOLGA4
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.4199840831948519,-1.1003657311414012,0.3488372093023256,0.9522690937628451,1.0,7/15,42.52%,SMO;VEGFA;PAX8;PAX2;SOX8;AGT;SOX9
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.4372656709343949,1.1001150318534152,0.14,0.9694249324350184,1.0,144/834,15.59%,POU2F3;FHL5;ISL1;BMP5;GLIS1;RGCC;BRCA1;IER2;RORA;MED10;SIRT7;PELP1;KDM1B;RPRD1B;RELA;CX3CL1;IRF1;DVL1;SMARCA4;SP1;BRD8;ACTR3;PID1;FGF1;CASZ1;ITGA6;SS18L1;ITGB1BP1;CLOCK;ZEB2;RUNX1;SLC9A1;TGFB2;MAX;HCFC1;BMPR1A;EAPP;NFATC1;JUN;AR;PRDM10;ELK3;WBP2;IRF3;CDK7;PAXBP1;EP300;SMAD3;PDGFB;TEAD1;LRP5;PRKDC;SQSTM1;DPF2;ESR1;MRTFB;HDAC5;NR3C1;ACVR1;JUND;MAML3;PRDM4;CRTC1;MAML2;BCLAF3;MEF2A;IKBKB;MLIP;RRP1B;PHF10;TFCP2;AKIRIN2;TLR3;NCOA1;SETD3;AGO2;PRPF6;RPS6KA5;CDK9;NCK1;IL18;DAB2;NCOA3;PCGF5;MAVS;AHI1;PPARG;SSBP3;MICAL2;GLYR1;SETX;TAL1;CDC5L;HIVEP1;HOXC4;TCF12;CHD8;NR5A1;KAT2B;NR2C2;SOX11;ZBTB38;ECD;MAP2K5;ABL1;HMGB1;TCF7L2;ATF6;HIPK2;TP53;ATRX;NR1D2;LRP6;RXRA;EPC1;CDK8;FUBP3;PPARGC1B;WWOX;RREB1;PRKD2;PKD2;CREB1;RFX3;RBPJ;TET2;PPARD;TBL1XR1;NCOA2;WASL;LDB2;LDB1;TLR4;ARNT;SMAD4;ZBTB18;NPM1;PHIP;SMARCA2;AKAP8L;CRLF3;THAP3;AUTS2;HDAC2
prerank,respiratory chain complex IV assembly (GO:0008535),0.5111764527087705,1.0993671573166721,0.36569148936170215,0.971284105604581,1.0,2/21,2.48%,COA3;COX17
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.3898096342565778,-1.0990892501769103,0.30980392156862746,0.9527748812990104,1.0,9/19,28.16%,PRKCE;RAB11FIP2;ITGB2;IRAK1;LY96;NMI;ITGAM;TIRAP;TICAM2
prerank,myeloid leukocyte differentiation (GO:0002573),0.4566124672036483,1.0988145780985,0.3258785942492013,0.9723593233765002,1.0,14/65,13.99%,TNFRSF11A;RUNX1;EP300;FARP2;CDK2;SNX10;THOC5;PPARG;MT1G;CDC42;TGFBR2;MAPK14;RXRA;LGALS9
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.4365049287487882,-1.0987319524274695,0.34838709677419355,0.9499237464733694,1.0,3/13,10.47%,ENPP1;TPST1;BPNT2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.33998836060958293,-1.0986525458797327,0.29775280898876405,0.9462168735522222,1.0,10/29,8.39%,ACSL4;PPT1;HACD2;HSD17B12;ELOVL6;ELOVL7;ACLY;ACSL3;ACSL1;ELOVL5
prerank,response to light stimulus (GO:0009416),0.45772684046824363,1.0986116178697654,0.34725274725274724,0.9722213866104512,1.0,7/55,7.85%,PCLAF;CLOCK;FECH;UBE2A;USP1;MAPK8;ERCC4
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5554558890875259,1.0984777125038792,0.3719247467438495,0.9718396656022429,1.0,2/12,8.68%,NUPR1;IL18
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.4821744803804916,-1.0983553675322422,0.37606837606837606,0.9431845108218427,1.0,4/10,13.79%,PARP14;PTPN2;NF2;PPP2R1A
prerank,negative regulation of cell population proliferation (GO:0008285),0.43945233874770456,1.0979836669046565,0.231,0.9727175657283912,1.0,55/351,15.37%,BMP5;ANG;ALDH1A2;WDR6;RGCC;ROR2;IGFBP3;CGRRF1;IRF1;EIF2AK2;SMAD6;GLMN;IFI35;NUPR1;TFAP4;ITGB1BP1;TGFB2;NF1;RERG;AR;UTP20;NELL1;PTPRJ;ABI1;RBM5;CDK6;IL1A;STK11;DUSP10;SLURP1;PPARG;APC;CTBP1;LYN;HGS;FKTN;PRKRA;KAT2B;SOX11;RAF1;DNAJA3;BRD7;SH2B3;TP53;PTPRU;MCC;NDRG4;PKD2;PPP2R5C;AIF1;PTEN;TSC1;CTCF;NPM1;SMARCA2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.43720216265445805,1.09787387198121,0.2903225806451613,0.9722627310155414,1.0,47/173,15.84%,LMAN1;USE1;COG1;ERGIC1;GOSR2;TMED4;VAMP7;PEF1;CTSC;COPB2;GAS6;AREG;COG3;CAPZB;TMED9;DYNLL2;TRAPPC3;KDELR2;DCTN1;DCTN2;DCTN4;SPTBN1;STX17;RAB2A;PROC;BCAP29;CTSZ;TFG;SEC24B;MIA3;SEC24D;TMED2;TRAPPC8;TGFA;NRBP1;TMED5;NAPA;SAR1B;TRAPPC6B;TRIP11;PROS1;ATL2;DYNC1I2;DYNC1LI2;PGAP1;CAPZA1;VTI1A
prerank,regulation of actomyosin structure organization (GO:0110020),0.5589897406290844,1.0975553719112894,0.37037037037037035,0.9725388444515278,1.0,8/13,18.14%,ALMS1;SLC9A1;AKAP13;CDC42;ROCK2;TSC1;ACTG1;ROCK1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.5481356733879494,1.0973616846611778,0.3678977272727273,0.9724013591569436,1.0,5/15,16.49%,FGF1;THBS1;TMSB4X;PRKD2;LGMN
prerank,negative regulation of cellular process (GO:0048523),0.43661308988667913,1.09731602240055,0.181,0.9717113821890501,1.0,93/521,15.41%,BMP5;ALDH1A2;WDR6;RGCC;ROR2;WFS1;PLXNA1;SIRT7;IGFBP3;BLM;CGRRF1;IRF1;SMARCA4;EIF2AK2;SMAD6;HOPX;GLMN;IFI35;NUPR1;TFAP4;TMEM109;ADAM15;ITGB1BP1;IMPACT;HPGD;TGFB2;MALSU1;VAMP3;RAD18;EPHB2;RERG;AR;UTP20;BCL6;EI24;SMAD3;DCBLD2;PTPRJ;ABI1;RBM5;CDK6;IL1A;CBLL1;PDE3B;STK11;VPS13C;SYT11;BNIP3L;SNX3;LPXN;SLURP1;ALOX5;NCK1;VPS35;ADNP2;APC;CTBP1;LYN;ENO1;HGS;FKTN;BNIP3;PRKRA;MIA3;KAT2B;SOX11;VPS4B;RAF1;DNAJA3;ADAM10;BRD7;SH2B3;TP53;BCL2;ACVR1B;RBBP7;PLXNC1;RTN4;ADAM22;PTPRU;HTRA2;PKD2;PPP2R5C;PTEN;TSC1;ANP32B;CTCF;ARHGDIB;BECN1;SMAD4;NPM1;SMARCA2;CRLF3
prerank,protein methylation (GO:0006479),0.47134409328080296,1.0969652564229,0.36662883087400683,0.9721271172884177,1.0,8/40,9.48%,EHMT1;FAM98A;ETF1;EHMT2;RAB6A;SETD3;EZH2;SNRPD3
prerank,DNA packaging (GO:0006323),0.5356157633749856,1.096879623674558,0.3565459610027855,0.9715828510779104,1.0,4/16,12.92%,BANF1;NOC2L;AIFM1;TP53
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.4917983222220462,1.0968756991590638,0.3773809523809524,0.9707404884307795,1.0,4/31,6.70%,TIMM17A;TOMM40;DNAJC15;TIMM23
prerank,response to glucose (GO:0009749),0.4645450940378296,1.096816362779707,0.3469387755102041,0.9700850056903878,1.0,10/46,12.47%,ADCY8;GAS6;THBS1;PRKACA;IRS2;VAMP2;IGF1R;GCK;ERN1;TCF7L2
prerank,negative regulation of type I interferon production (GO:0032480),-0.3136105260316262,-1.096635686968508,0.265625,0.9448801337167165,1.0,15/40,14.23%,PCBP2;TAX1BP1;NPLOC4;REL;NLRC5;OTUD5;PTPRS;IKBKE;UFD1;RELB;IFIH1;NLRC3;PYCARD;SIRPA;LILRB1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.4722518343643616,1.0964710321867104,0.3468013468013468,0.9704602452220952,1.0,14/46,15.70%,DMAP1;BAG3;GAS6;FLNA;YWHAE;SMAD3;NEDD4;MAVS;IPO5;TCF7L2;UBR5;TP53;ANP32B;PIK3R1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4406517189603674,1.0964439075117078,0.34123711340206186,0.9697145256301987,1.0,5/101,2.34%,FGF18;RGCC;LRRK2;TPD52L1;FGF1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.45198088626745536,1.0964352184136643,0.3297529538131042,0.9688938201113617,1.0,14/67,13.72%,CD36;CX3CL1;RSU1;FLNA;NRP1;PDGFB;DOCK1;CDK6;CCL25;LIMS1;CDC42;ABL1;FN1;RREB1
prerank,organonitrogen compound catabolic process (GO:1901565),0.45778505316881235,1.0962857292438044,0.3509719222462203,0.9685911227956582,1.0,12/57,12.65%,PLA2G7;USE1;UCHL3;PLA2G6;CLPX;PLA2G4A;LNPEP;PDXDC1;NPL;MTOR;SGPL1;ERAP1
prerank,glycerolipid metabolic process (GO:0046486),-0.47298178345514097,-1.096110606231937,0.39039039039039036,0.9426450714343613,1.0,6/11,25.37%,PIP5K1A;PLA2G15;DGKA;DGKG;GAL3ST1;DGKQ
prerank,cellular response to nutrient levels (GO:0031669),0.4474811138884971,1.0959069746338694,0.3490364025695932,0.9691213695199822,1.0,11/62,11.59%,WDR45;RIPOR1;LRRK2;WRN;WDR45B;EHMT2;USP33;FNIP1;VPS41;FADS1;MTOR
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.4533157044849399,1.0958180977180956,0.3617021276595745,0.9685763917168689,1.0,9/57,14.62%,ADCY8;ADCY3;ADCY5;FLNA;ADCY9;MTNR1A;GRM7;GNAI3;P2RY12
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.470809994662754,1.0957661363124336,0.3531390134529148,0.967924138441596,1.0,14/40,15.62%,LDLRAP1;ARRB2;DAB2;AHI1;CD63;ANXA2;DGKD;CBL;TBC1D5;INSR;BICD1;WASL;HIP1;HNRNPK
prerank,positive regulation of stem cell differentiation (GO:2000738),0.536325872789746,1.0954899783167822,0.3603238866396761,0.968021036141362,1.0,2/16,12.64%,TGFB2;SOX6
prerank,regulation of astrocyte differentiation (GO:0048710),-0.4590805352735956,-1.0950975999628205,0.3510971786833856,0.9422037773216814,1.0,3/12,15.56%,SERPINE2;EPHA4;NOTCH1
prerank,negative regulation of biosynthetic process (GO:0009890),0.5358538015532137,1.0949298575854431,0.3746594005449591,0.9690606649721376,1.0,5/16,17.04%,ABCB7;ABCD2;ABCD1;COA8;ASXL3
prerank,pentose-phosphate shunt (GO:0006098),0.5554228500300424,1.0949219882998118,0.397196261682243,0.9682428715690727,1.0,5/11,13.26%,RPIA;RBKS;TKT;TALDO1;RPE
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.45367178346947534,1.0946665014471697,0.339323467230444,0.9682839744067109,1.0,11/69,8.19%,WFS1;MAN1B1;FBXO17;TMEM67;DNAJC18;UBXN4;USP19;UBQLN1;UBE2J2;RHBDD2;ECPAS
prerank,negative regulation of protein modification process (GO:0031400),0.4510700346575805,1.0943037834106302,0.3447204968944099,0.9686999325296382,1.0,12/79,7.60%,CRTAP;LRRK2;IGFBP3;CDK5RAP3;PID1;IMPACT;TARDBP;NIBAN1;EPHB2;PRKDC;PPP1R8;MAPT
prerank,cellular response to purine-containing compound (GO:0071415),-0.4828682527912598,-1.09397892357266,0.37158469945355194,0.9420470479074625,1.0,1/10,0.51%,RYR2
prerank,organic anion transport (GO:0015711),0.45144723035587536,1.093635635194769,0.3708820403825717,0.9702354079305726,1.0,5/76,5.87%,SLC4A3;SLC25A24;SLCO4C1;SLCO1B1;ABCC5
prerank,histone H4 acetylation (GO:0043967),0.4610652352750108,1.0934554028152197,0.37037037037037035,0.9700399699525512,1.0,14/47,16.62%,DMAP1;BRD8;HCFC1;EP300;BRCA2;ING3;PHF20;MORF4L2;JADE3;EPC1;EP400;MSL2;TRRAP;KANSL1
prerank,cartilage development (GO:0051216),0.4662892379458705,1.0934471285908232,0.36212624584717606,0.9692168864467403,1.0,11/49,16.27%,WNT2B;RUNX1;SNX19;ATP7A;ITGB8;CD44;CREB3L2;SOX6;TRIP11;NFIB;MEF2C
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.48042292001401077,1.093201897852987,0.36938031591737547,0.9692551895622068,1.0,8/33,16.20%,DUSP3;RELA;PTPRJ;EZR;PRNP;PRKD2;DGKZ;CD81
prerank,regulation of protein localization to membrane (GO:1905475),0.4899215137495153,1.0931009691327018,0.38313253012048193,0.968743673698551,1.0,10/28,15.78%,LDLRAP1;VPS4A;AR;STX7;SPTBN1;CDK5;GPC3;FYN;GPC6;STX8
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.5421295849130153,1.0930671848849676,0.39136690647482014,0.9680275096977498,1.0,4/13,18.89%,B3GALNT1;B3GNT2;B3GALT1;B3GALT5
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.45811678959575497,1.092991727426483,0.36444444444444446,0.9674736861501629,1.0,13/47,16.10%,MID1;EIF2AK2;TGFB2;IGBP1;MAPK1;PHLPP1;TAOK1;IGF1R;MAP2K2;LGALS9;MAP4K4;ARL6IP5;MAP2K1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.48504331551671137,1.0927045665575141,0.35851318944844124,0.9675964989557326,1.0,3/31,6.69%,PLK1;FBXW7;DCUN1D4
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5407693848082241,1.092682145652722,0.36585365853658536,0.9668328190023869,1.0,6/15,14.94%,BAG3;GAS6;YWHAE;TCF7L2;TP53;ANP32B
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.564870919679874,1.0926143998130577,0.3753581661891118,0.9662487980174538,1.0,3/13,11.73%,PID1;ENO1;TMSB4X
prerank,glycerophospholipid catabolic process (GO:0046475),0.4929552779361642,1.092352183849408,0.3929008567931457,0.9662770832646504,1.0,6/27,12.07%,PLA2G7;PLA2G6;PLA2G4A;ABHD16A;PNPLA6;GPCPD1
prerank,macromolecule catabolic process (GO:0009057),0.5006363042070534,1.0921199382594007,0.3838509316770186,0.9662638966200335,1.0,9/26,12.70%,USE1;UCHL3;PIK3R4;CLPX;NEDD4;KIF16B;MTOR;UVRAG;SH3GLB1
prerank,fibrinolysis (GO:0042730),-0.4409153516274115,-1.092062363877681,0.36577181208053694,0.9444620346821588,1.0,4/13,39.76%,PLAU;PLAUR;SERPINE1;PLAT
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5001662909900397,1.091844856119164,0.3702770780856423,0.9663925064764342,1.0,8/24,18.14%,SGPP1;RUNX1;NCOA3;ZFP36L1;ROCK2;PRKCH;MED1;ROCK1
prerank,erythrocyte differentiation (GO:0030218),0.47054559794041184,1.09179557299332,0.36126840317100795,0.9657105769477387,1.0,11/44,12.99%,CDK5RAP3;UBA5;IKZF1;KMT2E;HSPA9;ACIN1;LYN;TAL1;HIPK2;SH2B3;FLVCR1
prerank,cellular response to ionizing radiation (GO:0071479),0.463448530282542,1.0915417691002856,0.3585972850678733,0.9657682372156932,1.0,10/47,14.72%,BLM;GRB2;TMEM109;CLOCK;WRN;MAP3K20;TANK;MAPK14;TP53;SPIDR
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.42001642383547305,-1.0914352825803506,0.3411371237458194,0.942766608598675,1.0,8/15,18.40%,TJP1;SMAD1;PKM;ITGA5;FGF2;PDPK1;BMPER;JAK1
prerank,endothelial cell migration (GO:0043542),0.474636273908244,1.0910870885321207,0.36964078794901506,0.9664766267029036,1.0,7/37,11.90%,PLEKHG5;NRP1;GIPC1;LPXN;PTP4A3;PXN;ABL1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.5174804224714368,1.090851214197462,0.3743455497382199,0.9656381270347771,1.0,4/20,6.05%,ALDH6A1;ACAT1;ECHS1;MCCC2
prerank,branched-chain amino acid metabolic process (GO:0009081),0.5174804224714368,1.090851214197462,0.3743455497382199,0.9656381270347771,1.0,4/20,6.05%,ALDH6A1;ACAT1;ECHS1;MCCC2
prerank,mRNA methylation (GO:0080009),0.5306693019909211,1.0907696536639615,0.3709449929478138,0.9651253423698306,1.0,5/15,12.81%,METTL8;METTL3;CBLL1;ZC3H13;WTAP
prerank,"transcription, DNA-templated (GO:0006351)",0.4360144187448788,1.090690526706713,0.3002008032128514,0.9645740479948298,1.0,42/207,13.72%,POLR2D;EAF1;PMF1;POLR1C;POLR3G;GTF3A;CTR9;POLR3H;TFB2M;POLR2A;RNPS1;MLLT1;CDK7;ARRB2;MNAT1;MEF2A;CDK9;UBTF;TAF4;CRCP;SETX;GTF2E1;GTF2E2;DEAF1;POLR3A;RNGTT;NELFA;ELOC;GTF2B;GTF2F2;GMEB2;BRF1;TP53;MAF;CTDP1;KLF13;EPC1;FUBP3;NFX1;GTF2H1;DDX5;RREB1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.43552776392498616,1.090424138051607,0.199,0.9646096467921883,1.0,95/509,15.24%,FGF22;FGF18;ROR2;UNC5CL;NRG2;CDK5RAP3;RELA;CX3CL1;IRAK4;EIF2AK2;TMED4;FGF1;IFI35;NUPR1;GRB2;RNF31;ITGB1BP1;PLEKHG5;DDX60;TLR7;TGFB2;BCL2L11;GAS6;SASH1;PELI1;AREG;IRS1;THBS1;FLNA;PRKCB;EP300;PDGFB;KITLG;TRAF7;PUM2;MIOS;PTPRJ;ESR1;AXL;BIRC3;IRS2;HSP90AA1;GOLPH3;IKBKB;NEDD4;TLR3;IL18;LIMS1;TAB3;FNIP1;PUM1;MAVS;MTDH;PTP4A3;LYN;CANT1;F3;ACTN4;TFG;WLS;TRIM5;AKAP13;TRAF2;RIT2;IGF1R;SOX11;CBL;TRIM44;FRS2;PPM1A;HMGB1;SLC38A9;TCF7L2;TGFA;TP53;TGFBR1;BCL2;RTN4;NDFIP1;S100B;FN1;INSR;FYN;PRKD2;LGALS9;RELN;ROCK2;SCHIP1;LARS1;P2RY12;TLR4;PIK3AP1;VAV1;BECN1;HIP1
prerank,cellular response to oxygen levels (GO:0071453),-0.476176391997053,-1.090402929272683,0.3490304709141274,0.942398577347753,1.0,9/10,39.64%,ATP6V1A;CPEB4;ATP6AP1;ATP6V1G1;NDUFS2;TMEM199;PICK1;ATP6V0D1;CCDC115
prerank,regulation of phosphatase activity (GO:0010921),0.5004577613573873,1.0902596592432778,0.3793548387096774,0.964344596491112,1.0,2/24,1.21%,URI1;CDK5RAP3
prerank,protein localization to cell periphery (GO:1990778),0.43478749886463747,1.0901866232795925,0.3340080971659919,0.9637779218746279,1.0,31/133,14.30%,PDZD11;FLOT2;ZFYVE27;EHD4;ITGB1BP1;RAB8B;EHD1;GAS6;RAB40C;RAB12;RAP1A;FLNA;RABEP1;MYO5A;EZR;PPIL2;IKBKB;DLG1;SLMAP;SPTBN1;EFR3B;RAMP1;TMED2;PACS2;EPB41L3;RAB3C;LRP6;LIN7A;PACS1;KCNIP3;ROCK2
prerank,gene silencing by miRNA (GO:0035195),0.4851332298805847,1.090118529384237,0.3686046511627907,0.9631677272707889,1.0,8/32,11.02%,EIF6;PUM2;TNRC6B;AGO2;PUM1;ZC3H7A;ADAR;PRKRA
prerank,motile cilium assembly (GO:0044458),-0.45731671576085475,-1.0898620175655864,0.36024844720496896,0.9402828786529094,1.0,8/12,51.05%,SPATA6;BBOF1;E2F4;BBS5;CCDC39;DNAAF3;CCDC40;RSPH9
prerank,cytokine-mediated signaling pathway (GO:0019221),0.4331435066678908,1.0898053240253498,0.211,0.9634275254480431,1.0,90/532,13.98%,CXCL12;RORA;MID1;TNFRSF11A;S1PR1;IFITM3;CD36;RELA;CX3CL1;IRAK4;IRF1;SMARCA4;MTAP;CTR9;RAPGEF1;CFL1;IFI35;NUMBL;IL16;GRB2;TCP1;TNFRSF25;BCL2L11;MSN;PELI1;PSMD9;IRS1;IRF3;BCL6;LIFR;PSMB8;PDGFB;IL10RB;PRKACA;RPLP0;SQSTM1;PTPRJ;BIRC3;IL1A;IRS2;HSP90AA1;PSMC5;HNRNPA2B1;IKBKB;CCL25;PYDC1;HSPA9;RAP1B;PAK2;STX3;RPS6KA5;IL1RAP;CAMK2D;F13A1;ALOX5;IL18;LIMS1;IRAK2;TAB3;LRP8;CD44;SOCS5;F3;ANXA2;ACTN4;ADAR;TRIM5;CDC42;TRAF2;IFNAR2;ARF1;FBXW11;TALDO1;CBL;TMSB4X;COMMD7;IL17RA;PITPNA;PSMD12;SLC27A1;SH2B3;TP53;PSMA2;BCL2;SYK;CAMK2G;FN1;ADIPOR1;FYN;MAP3K8
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5043674057087406,1.0896468079180812,0.35103626943005184,0.9631443578275108,1.0,4/21,13.94%,DVL1;APC;LRP6;CSNK1A1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5850864174468293,1.0893035362829033,0.3956043956043956,0.9635151037449186,1.0,3/10,12.92%,TFAP4;HIPK2;TP53
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.43332448842862453,1.0892188201868827,0.2802802802802803,0.9629845814158837,1.0,38/259,7.63%,VCL;S1PR1;FGD6;CLUAP1;BBIP1;CCDC57;CEP89;MINK1;ACTR3;FGD3;ARL6;EHD4;FGD1;TMEM67;RAB8B;EHD1;BBS4;IQCB1;DZIP1;CEP250;RAP1A;FLNA;NRP1;TTC39C;FNBP1L;EXOC5;PCNT;DYNLL2;SDCBP;IFT52;IFT20;PARVB;ABLIM3;EZR;GOLPH3;CCDC66;SNX10;RAP1B
prerank,positive regulation of defense response (GO:0031349),0.4488998465558804,1.0890908894492999,0.3645833333333333,0.9626199956551152,1.0,17/89,15.45%,PLA2G7;POLR3G;RIOK3;CX3CL1;IFI35;IL16;TLR7;FEM1A;AKIRIN2;TLR3;IL18;NFKBIZ;IL17RA;SLC15A4;OPTN;TLR4;CD47
prerank,negative regulation of angiogenesis (GO:0016525),0.4420717841879822,1.0890829598408236,0.35051546391752575,0.9618316440612,1.0,10/84,10.93%,THBS2;RGCC;TGFB2;THBS1;PDE3B;MECP2;ALOX5;PPARG;HGS;SEMA6A
prerank,positive regulation of bone mineralization (GO:0030501),0.48177964493182635,1.088779782392331,0.3748517200474496,0.9619967363439356,1.0,5/35,8.47%,WNT4;BMPR1A;NELL1;ACVR1;ALOX5
prerank,cholesterol efflux (GO:0033344),0.515325600138986,1.0886407972877905,0.3784860557768924,0.961672037375144,1.0,5/20,14.68%,SOAT1;ABCA7;ABCG1;ABCA1;ABCA5
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5248347170577375,1.0883311864633034,0.4042838018741633,0.9619460579161998,1.0,2/18,1.74%,DUSP3;TNFAIP8L2
prerank,regulation of cellular catabolic process (GO:0031329),0.45557070213373785,1.0874700722142012,0.3578485181119649,0.9640766068422345,1.0,15/62,14.93%,TYSND1;LRRK2;NUPR1;PIP4K2A;EP300;KEAP1;USP33;MAPT;DAPK1;PIP4K2B;ABL1;DCAF12;ABCD1;TPCN2;SCARB2
prerank,mesonephros development (GO:0001823),0.5645880005007783,1.0873495478968582,0.4107946026986507,0.9636559111838844,1.0,1/11,2.34%,FGF1
prerank,DNA recombination (GO:0006310),0.4748548937069302,1.0873107242425548,0.3678696158323632,0.9629820689251029,1.0,7/37,14.60%,BLM;RAD50;WRN;MRE11;RAD51B;HMGB1;RECQL5
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.5144396529061703,1.0872818219333988,0.37037037037037035,0.9622714046723441,1.0,4/18,11.91%,SIRT7;FLNA;UBTF;HEATR1
prerank,positive regulation of inflammatory response (GO:0050729),0.44890257033019115,1.0872538512714733,0.3666323377960865,0.9615421137446785,1.0,12/86,11.87%,PLA2G7;CX3CL1;IFI35;NUPR1;IL16;VAMP7;TLR7;FEM1A;TLR3;IL18;NFKBIZ;IL17RA
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.43138531608019925,1.0868983551073297,0.167,0.9619302687947541,1.0,143/807,14.53%,ISL1;GLIS1;PLK1;WNT4;BRCA1;MDFI;WFS1;DNAJB1;URI1;SIRT7;EHMT1;HSBP1;PARP9;KDM1B;THAP7;DMAP1;RELA;IRF1;SMARCA4;CD38;CTR9;SUV39H1;ILF3;VPS72;ZFP90;TFAP4;SOX13;PPID;RLIM;ZBTB5;IMPACT;TGIF1;CLOCK;ZEB2;RUNX1;SAP18;MAX;GAS6;HCFC1;IGBP1;ZNF318;JUN;AR;TLE2;ATXN1;ZBTB7A;ELK3;FLNA;BCL6;HDAC9;TRPS1;N4BP2L2;EP300;SMAD3;RBM15;SPEN;ARID5B;PDGFB;CIPC;RBAK;DPF2;ESR1;HDAC5;SDCBP;NR3C1;SCMH1;EHMT2;IKZF1;EZR;TLE1;NCOA5;MEF2A;MLIP;DLG1;PHF10;MECP2;CUX1;SET;RPS6KA5;EZH2;DAB2;LIMS1;NACC1;NCOR1;FNIP1;PHF6;ORC2;PPARG;MTDH;NR6A1;SIN3B;CTBP1;HMBOX1;ENO1;CDK5;DEAF1;HIVEP1;LOXL3;UBE2I;NOC2L;ZNF568;FOXN3;BCL7A;CHD8;FBXW11;PHC3;PSPC1;NR2C2;SOX11;ZBTB38;BCL11A;ZMYND11;MAP2K5;COMMD7;PRDM1;PPM1A;NCOR2;DNMT3A;YEATS2;HMGB1;ZFP69;DNAJA3;TCF7L2;MIER3;BRD7;TP53;NR1D2;MYT1L;LCOR;RXRA;EPC1;NFX1;WWOX;DDX5;KCNIP3;RREB1;CREB1;RFX3;RBPJ;PPARD;ZMYM5;TBL1XR1;UBE2D3
prerank,regulation of amyloid-beta formation (GO:1902003),0.47453104302883187,1.086804267068137,0.3674911660777385,0.9614314009683567,1.0,13/34,18.14%,RELA;SP1;RTN3;ABCA7;ABCG1;PRNP;SORL1;RTN4;ROCK2;GGA3;BIN1;GSAP;ROCK1
prerank,cellular response to hormone stimulus (GO:0032870),0.45036899263410246,1.086760315670219,0.3453389830508475,0.9607605475735107,1.0,12/69,12.05%,URI1;PELP1;BRD8;KLF9;AR;WBP2;NR3C1;NCOA1;NCOA3;GCK;RAMP1;ZFP36L1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5639789484387436,1.0866452192803011,0.3943452380952381,0.9603769045015567,1.0,2/11,5.29%,TPK1;NT5C3A
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4388649903231583,1.086564173791592,0.3445807770961145,0.959825663171669,1.0,23/112,13.43%,WNT4;PRKCZ;SMAD6;ZFYVE9;HPGD;TGFB2;BMPR1A;JUN;SMAD3;ARRB2;NR3C1;ACVR1;ITGB5;LPXN;LIMS1;FURIN;PXN;TGFBR2;CBL;ZFP36L1;SOX6;TGFBR1;WWOX
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5145736516380695,1.086394656206597,0.3864864864864865,0.9595901095155058,1.0,4/20,8.44%,YWHAE;NEDD4;CAMK2D;HECW1
prerank,translational termination (GO:0006415),0.4393449336882978,1.0863139704882527,0.3553038105046344,0.9590687322558243,1.0,10/95,7.30%,MRPS22;MRPS31;MRPS30;MRPL37;MRPS21;ETF1;MRPL48;MRPS35;MRPS28;MRPL1
prerank,membrane raft organization (GO:0031579),0.536708358379548,1.0862906827034462,0.38524590163934425,0.9583470163489783,1.0,4/15,10.14%,FLOT2;RFTN1;ABCA7;ANXA2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5119447882028593,1.0861406886471794,0.3673202614379085,0.9580448523591752,1.0,6/21,11.40%,NDST3;UGDH;GLCE;EXTL3;HS6ST2;HS3ST4
prerank,positive regulation of chromosome organization (GO:2001252),0.5395492476408135,1.0858680539652719,0.3940677966101695,0.9581714445133376,1.0,5/15,15.25%,RAD50;MRE11;NBN;ATRX;PPP1R10
prerank,regulation of telomerase activity (GO:0051972),0.45808222956185063,1.0858362194753006,0.3859060402684564,0.9574864522340346,1.0,12/45,14.13%,SMG6;TCP1;MAPK1;HSP90AA1;ERCC4;PKIB;NEK7;HMBOX1;PARP4;TP53;TERF1;NVL
prerank,protein export from nucleus (GO:0006611),-0.34493123969607303,-1.085693426338699,0.31746031746031744,0.9504297851519858,1.0,11/27,13.66%,SMURF1;TPR;XPO6;TGFB1;XPO4;NUP214;PKD1;CHP1;CALR;XPO5;RANBP3
prerank,response to ATP (GO:0033198),-0.38987655715162334,-1.0852913175437147,0.336,0.9479881217836483,1.0,7/18,32.60%,P2RX7;TAF1;SSH1;P2RX4;DGKQ;HSP90B1;TRPC3
prerank,protein localization to lysosome (GO:0061462),0.48755993819967963,1.0852584056712493,0.38282208588957056,0.9586458686688515,1.0,13/28,17.02%,VPS4A;AP3M1;NEDD4;LMBRD1;HGS;SORL1;MFSD1;RTN4;RAB7A;SCARB2;GGA3;CD81;GCC2
prerank,phosphate ion transport (GO:0006817),0.5366650948668766,1.0851718093768006,0.39783491204330174,0.9581244802256116,1.0,5/16,14.89%,SLC37A2;XPR1;SLC37A3;SLC20A2;SLC25A3
prerank,cardiac muscle contraction (GO:0060048),-0.3321014224868861,-1.0847756866869247,0.3522012578616352,0.9459956106539692,1.0,5/34,7.09%,RYR2;ATP1B1;GRK2;ATP1A2;PIK3CA
prerank,chromatin remodeling (GO:0006338),0.44005734005193164,1.0847695479740653,0.3485005170630817,0.9587736745547305,1.0,28/100,16.68%,SRCAP;ACTR5;SMARCA4;HCFC1;ZBTB7A;KDM5A;ESR1;HDAC5;NUDT5;KDM5B;GATAD1;TADA2A;BAZ2B;KDM4B;CHD8;KAT2B;KDM4C;ATRX;NPM1;SMARCA2;HDAC2;HNRNPC;BAZ1B;ARID1B;PAK1;RB1;SMARCC2;ZBTB1
prerank,cellular response to lipid (GO:0071396),0.4326421260618459,1.0846421849944325,0.32261306532663314,0.9584386166504728,1.0,25/191,10.09%,RORA;URI1;INSIG1;RELA;CTR9;ADCY8;ADCY3;PID1;CHMP5;ADAM15;MSN;AR;ADCY5;IRS1;ESR1;AXL;NR3C1;IL1A;MAPK8;TWF2;NCOA3;ADNP2;LYN;SETX;PLAA
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4317079700005377,1.0842768933075724,0.31626506024096385,0.9588593792525871,1.0,22/151,13.99%,ROR2;TNFRSF11A;PRKCZ;C5AR1;CD36;FBXW7;CX3CL1;BRAF;GAS6;RAP1A;NRP1;PDGFB;PRKCA;ARRB2;CCL25;ABCA7;CD44;NOTCH2;HMGB1;NDRG4;PRKD2;LGALS9
prerank,homotypic cell-cell adhesion (GO:0034109),0.4746002583420911,1.0841978718718175,0.366325369738339,0.9583149036641369,1.0,5/39,7.73%,VCL;CLIC1;METAP1;FLNA;FERMT3
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5054414532830446,1.0841950306021035,0.3689839572192513,0.9575310360248935,1.0,2/20,5.17%,RGCC;PDGFB
prerank,protein import (GO:0017038),0.43875581049897033,1.0838071618871512,0.3543388429752066,0.9580431313970504,1.0,18/84,13.36%,PXMP2;KPNB1;EIF4ENIF1;RAB8B;HIKESHI;HEATR3;RANBP6;IPO7;ABCD2;IPO9;HSP90AA1;PTTG1IP;CSE1L;IPO5;ABCD3;IPO11;ABCD1;SYK
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.4256450964423864,-1.0836248709855152,0.3447098976109215,0.9458034204863753,1.0,5/15,17.67%,VCP;HNRNPA1;ATF3;HSF1;ZC3H12A
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.29495453884849065,-1.0832557028333112,0.29,0.9433764812721355,1.0,31/55,27.93%,PSMD14;PSMA3;PSMB2;USP47;PSMB7;AVEN;PSMC6;PSMD4;PINX1;RBX1;PSMD7;PSMA1;PSMA5;PSMC1;PSMD13;PSMC2;PSMA6;SKP1;PSMA4;PSMD3;PSMF1;FHL1;PSMD2;PSMD5;PSMD1;PSMC3;PSMD8;PSMB3;PSME1;PSMB9;CUL1
prerank,myelination (GO:0042552),0.46156110645599063,1.083235143790176,0.3737259343148358,0.9591943884869367,1.0,11/46,14.99%,DEGS1;ACSBG1;NF1;ACER3;SBF2;ABCD2;B4GALT5;EPB41L3;ABCD1;PLP1;BCAS1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.48283747609973093,1.0830597221430334,0.3801955990220049,0.9590224246694894,1.0,12/30,16.88%,SMARCA4;AR;ZBTB7A;EP300;DAB2;NCOR1;NCOR2;KDM4C;DDX5;NCOA2;PKN1;KLK2
prerank,regulation of B cell activation (GO:0050864),-0.35280074102457826,-1.0828361002294926,0.33157894736842103,0.9410406215773769,1.0,6/25,16.38%,LAPTM5;SAMSN1;FCGR2B;TNIP2;CD22;TNFAIP3
prerank,microvillus organization (GO:0032528),0.5480158795790174,1.0828212656024458,0.39732142857142855,0.9590394691215518,1.0,4/13,7.63%,MINK1;RAP1A;EZR;RAP1B
prerank,positive regulation of intracellular protein transport (GO:0090316),0.43709806360950004,1.0826513792047996,0.34046890927624873,0.958811263568462,1.0,43/144,16.98%,MIEF2;RIPOR1;DMAP1;FBXW7;BAG3;RNF31;ITGB1BP1;GAS6;FLNA;YWHAE;SMAD3;PCNT;KIF20B;TMEM30A;UBE2J2;ABLIM3;MAPK8;MAVS;IPO5;VAMP2;NMT1;HPS4;PRNP;SORL1;TCF7L2;RUFY3;VPS11;SH3GLB1;UBR5;TP53;BCL2;FYN;HTRA2;SAR1B;UBE2D3;ANP32B;PIK3R1;CD81;CEP290;YWHAB;TFDP2;SAE1;MFF
prerank,regulation of chromosome segregation (GO:0051983),0.5201988425970722,1.0824758356701893,0.38670284938941657,0.9586003333856332,1.0,4/16,9.28%,RAD18;PUM2;SMC5;PUM1
prerank,regulation of DNA recombination (GO:0000018),0.48929571709886677,1.0824267104133434,0.3737864077669903,0.9579668103071899,1.0,6/32,14.72%,BLM;RAD50;MRE11;SETD2;PPP4C;SPIDR
prerank,synapse assembly (GO:0007416),0.4526346312576473,1.0822657514372662,0.3917634635691658,0.9577063159451776,1.0,7/67,11.34%,SDK2;PCDHB16;DVL1;FARP1;CDK5;GABRG2;DBNL
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.33281913221968734,-1.0818613162899386,0.3668639053254438,0.9403073767091918,1.0,9/30,10.61%,PTPRC;SAMSN1;PARP14;PTPN2;NF2;SEMA4D;PTPN6;SH3BP5;SRCIN1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.4481071602603274,-1.081763647499949,0.3827893175074184,0.9369306421361365,1.0,10/12,51.10%,UPP2;TK2;UCKL1;DCK;UMPS;UCK2;DHODH;UCK1;TK1;CAD
prerank,negative regulation of protein kinase activity (GO:0006469),0.4384545208078929,1.0817238577382307,0.3573667711598746,0.9587239387146852,1.0,20/88,13.57%,CDK5RAP3;DUSP3;DVL1;ITGB1BP1;NF1;LRP5;PYDC1;PAK2;DUSP10;PTPN1;PTPRT;DTNBP1;GNAQ;ADAR;MVP;ABL1;SORL1;LRP6;PTPRO;SPRED1
prerank,regulation of interferon-beta production (GO:0032648),0.46195050011974187,1.0816067113039254,0.3690078037904125,0.9583167230912755,1.0,13/46,14.85%,POLR3G;RIOK3;IRF1;TLR7;IRF3;HSP90AA1;TLR3;MAVS;RNF216;POLR3A;TRIM56;RNF135;TLR4
prerank,histone modification (GO:0016570),0.4331071096820312,1.0815414631156302,0.372829417773238,0.9577705037491433,1.0,19/109,9.60%,SIRT7;EHMT1;EYA2;BRD8;PADI2;HDAC9;EP300;ATXN7;CDK2;HDAC11;UBE2A;HDAC5;EHMT2;RPS6KA5;PARP2;PHF20;EZH2;MORF4L2;SIN3B
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.4952039430000928,1.0814274581927834,0.39324487334137515,0.9573613802770953,1.0,5/23,11.44%,TSG101;SOCS4;SOCS5;MVP;CBL
prerank,protein K48-linked deubiquitination (GO:0071108),0.4940154793498329,1.081368944538908,0.38491547464239273,0.9567597229762993,1.0,9/23,15.42%,USP34;USP33;USP20;USP5;MINDY2;USP37;ATXN3;OTUD7A;VCPIP1
prerank,histone H3-K4 trimethylation (GO:0080182),0.5578570180518452,1.0807875613789102,0.39692307692307693,0.9580106362896238,1.0,2/11,3.61%,CTR9;SETD1A
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.517131268451837,1.0806121498566021,0.3924581005586592,0.9577650214381067,1.0,4/19,7.16%,NPHP4;RUNX1;PRKACA;IKBKB
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.45136118643178225,1.080421898394131,0.3616557734204793,0.957579304860312,1.0,13/63,13.43%,RELA;ITGA6;AR;THBS1;ACVR1;PAK2;BIRC6;TRAF2;ZMYND11;TCF7L2;CYLD;TGFBR1;WWOX
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4320149448719341,1.079991671212304,0.35110663983903423,0.9583207562307591,1.0,23/149,10.87%,TNFRSF11A;PRKCZ;CD36;RELA;CX3CL1;EIF2AK2;FLOT2;RNF31;CLOCK;AR;ZBTB7A;PRKCB;EP300;BTK;IKBKB;RPS6KA5;IL1RAP;IL18;IRAK2;TAB3;MTDH;TRIM5;TRAF2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.46793134724818186,1.0798986219204982,0.37528604118993136,0.9578613239975146,1.0,5/40,8.47%,WNT4;BMPR1A;NELL1;ACVR1;ALOX5
prerank,autophagy of nucleus (GO:0044804),0.5318064130943725,1.0798505419117512,0.3931034482758621,0.9572337909442369,1.0,6/16,15.14%,WDR45;WDR45B;ULK2;ATG3;RB1CC1;ATG7
prerank,cellular component assembly (GO:0022607),0.43090982177798265,1.0797284582750977,0.2995991983967936,0.9568795662345382,1.0,62/253,17.39%,RSPH4A;DVL1;TFAP4;ZFYVE27;PPID;LLGL1;GAS6;NAPG;WASF1;VAMP3;FLNA;STX7;QSOX1;TEAD1;PLS3;WIPF1;ST13;PARVB;EZR;MNAT1;RANBP9;RTN3;REPS2;SPTBN1;IL1RAP;LPXN;TUBGCP2;YTHDF1;ADD1;LIMS1;APC;MYO9A;VAMP2;EPS8;CD2AP;CFAP74;CDC42;NOC2L;TRAF2;LAMC1;TP53;FBLIM1;LIN7A;RTN4;LIMA1;MDN1;AIF1;WASL;PEX14;VCPIP1;CAPZA1;ACTG1;CEP290;DNM1L;YTHDF3;CYFIP1;ARL6IP1;MYO1B;TAPBP;SNX9;NCKAP1L;GSN
prerank,amyloid-beta metabolic process (GO:0050435),0.5297892638878156,1.0796788072672299,0.3867924528301887,0.9562580333460926,1.0,2/16,8.50%,MGAT3;ABCA7
prerank,pulmonary valve development (GO:0003177),0.5286400179096261,1.0796425665072877,0.3944954128440367,0.9555983238973691,1.0,4/18,11.19%,SMAD6;TGFB2;NFATC1;NOTCH2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.4695346415439631,-1.079259399620576,0.36826347305389223,0.9413653256198287,1.0,1/11,0.10%,PLCG2
prerank,snRNA 3'-end processing (GO:0034472),0.5177273940943362,1.0788759107986914,0.3984272608125819,0.9573742352111145,1.0,4/19,6.57%,INTS12;INTS2;EXOSC5;EXOSC7
prerank,pore complex assembly (GO:0046931),0.5173970422289221,1.0786054344001201,0.391820580474934,0.9575122248820033,1.0,7/19,13.32%,PDZD11;NUP205;AHCTF1;GSDMD;NUP98;ADAM10;RTN4
prerank,cellular biogenic amine catabolic process (GO:0042402),0.5801154346964325,1.0785049178050397,0.41798107255520506,0.9571201201539767,1.0,3/10,15.17%,ALDH7A1;SMOX;SLC44A1
prerank,nucleic acid-templated transcription (GO:0097659),0.4688788804840368,1.078445263920704,0.3847900113507378,0.9565433084737882,1.0,7/42,13.32%,POLR2D;POLR2A;RNPS1;MEF2A;POLR3A;EPC1;FUBP3
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5350893887538398,1.0780294872399994,0.3976945244956772,0.9571325812308689,1.0,5/14,10.69%,MSN;CAMSAP3;EZR;MYO9A;CDC42
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.4386813977040143,1.0778877715901511,0.3723849372384937,0.9568189112603508,1.0,16/88,12.87%,CDK5RAP3;EIF4A3;CNOT10;EIF2AK2;ILF3;EIF4ENIF1;SYNCRIP;MALSU1;NELL1;DAPK1;FXR2;CNOT9;CDK5;LSM14A;DNAJC1;SAMD4A
prerank,oligosaccharide metabolic process (GO:0009311),0.45548745576424143,1.0778134080281716,0.3842696629213483,0.9562893502300545,1.0,4/46,4.71%,MAN1B1;ST8SIA5;ST8SIA4;MPDU1
prerank,Golgi to plasma membrane transport (GO:0006893),0.4537281068160918,1.077758330105519,0.37970353477765106,0.9557059706547305,1.0,18/47,17.66%,SYS1;LLGL1;RABEP1;KIF13A;EXOC5;CCDC93;GOLPH3;SPTBN1;VAMP2;EXOC6B;EXOC4;GGA1;OPTN;MACF1;GGA3;GOLGA4;GCC2;ARL3
prerank,sodium ion transport (GO:0006814),-0.26631042723945086,-1.0777049085028916,0.24489795918367346,0.9427366252801207,1.0,11/85,8.86%,SLC24A3;ANO6;ATP1B3;SGK1;SCN2A;ATP1B1;SCN3A;SCN8A;ATP1A2;NALCN;SLC38A7
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.5417485608545277,1.0775673364224414,0.3686440677966102,0.9555655689702085,1.0,4/13,11.45%,GAS6;AXL;MAVS;TRIM44
prerank,nuclear body organization (GO:0030575),0.5652456165044525,1.0774322839863875,0.40762463343108507,0.9552475669248135,1.0,5/12,16.05%,HABP4;AFF2;SRPK2;HIPK2;SERBP1
prerank,positive regulation of tissue remodeling (GO:0034105),0.5802034015721123,1.0770907359136197,0.405446293494705,0.9556061045445055,1.0,3/10,18.14%,IL18;ROCK2;ROCK1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.5107069741556532,1.0770007644243471,0.3915343915343915,0.9551374682532996,1.0,5/18,9.40%,LRRK2;RAB3GAP1;RAP1A;RAP1B;DTNBP1
prerank,mRNA metabolic process (GO:0016071),0.4357047966031759,1.075893337819896,0.37175493250259606,0.9580211510785809,1.0,27/90,16.08%,CNOT10;ZC3H12D;CSTF3;PRPF3;GEMIN2;PRKACA;U2AF1;METTL3;RNASE4;HNRNPA2B1;SRSF5;PRMT9;SNRPD3;SCAF11;U2AF2;CPSF3;SF3B2;SRSF9;ERN1;SRSF11;TP53;DDX5;PCBP3;SF3B4;ALKBH5;AKAP8L;DHX15
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.48577919871396025,1.0757728624388876,0.3879849812265332,0.957623047960292,1.0,5/26,9.73%,CCDC57;DUSP3;PRKCA;PKN2;TAL1
prerank,negative regulation of response to wounding (GO:1903035),-0.383142276118142,-1.075587288045307,0.34285714285714286,0.9457489167452074,1.0,6/19,17.09%,RTN4RL1;CASK;PTPRS;FGF2;EPHA4;CERS2
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.5481170497730609,1.0755693679642808,0.3929098966026588,0.9575386197819088,1.0,5/13,13.60%,DYRK2;IRS1;IRS2;GCK;INSR
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.44078844808934753,1.075483280291962,0.386892177589852,0.9570608826031773,1.0,24/67,15.00%,TBC1D15;CAPZB;EVI5;IFT20;TBC1D17;TBC1D14;TWF2;FXR2;TBC1D10B;CDC42;ATG3;GAP43;CDKL5;TBC1D5;PLD1;TBC1D10A;TBC1D13;CYLD;RABGAP1;PPP1R16B;TBC1D24;TBC1D22A;TBC1D8;TBC1D1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.504262153530588,1.075076792973749,0.39436619718309857,0.9576736531650539,1.0,3/22,5.80%,MINK1;SASH1;RELL1
prerank,negative regulation of ion transport (GO:0043271),-0.3627307604055601,-1.0746561599703648,0.3284313725490196,0.945029241142611,1.0,8/24,17.98%,PTK2B;CD33;PXK;GPM6B;SNCA;INPP5K;LILRB1;WNK2
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.44880420661519005,1.0744259520340755,0.36627282491944146,0.9574672097860261,1.0,16/61,14.11%,LMAN1;GOSR2;PEF1;CTSC;AREG;TRAPPC3;TRAPPC9;CTSZ;TFG;SEC24B;SEC24D;TMED2;TGFA;NAPA;SAR1B;TRAPPC6B
prerank,vesicle coating (GO:0006901),0.44880420661519005,1.0744259520340755,0.36627282491944146,0.9574672097860261,1.0,16/61,14.11%,LMAN1;GOSR2;PEF1;CTSC;AREG;TRAPPC3;TRAPPC9;CTSZ;TFG;SEC24B;SEC24D;TMED2;TGFA;NAPA;SAR1B;TRAPPC6B
prerank,COPII vesicle coating (GO:0048208),0.44880420661519005,1.0744259520340755,0.36627282491944146,0.9574672097860261,1.0,16/61,14.11%,LMAN1;GOSR2;PEF1;CTSC;AREG;TRAPPC3;TRAPPC9;CTSZ;TFG;SEC24B;SEC24D;TMED2;TGFA;NAPA;SAR1B;TRAPPC6B
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.4891839666509342,1.0744142952366025,0.39039408866995073,0.956738947421247,1.0,5/27,9.16%,DLG1;GPD1L;SLMAP;CAMK2D;PTPN3
prerank,mitochondrial translational elongation (GO:0070125),0.4369326516871819,1.0740800279300198,0.38662486938349006,0.9570546264632079,1.0,9/88,7.30%,MRPS22;MRPS31;MRPS30;MRPL37;MRPS21;MRPL48;MRPS35;MRPS28;MRPL1
prerank,cellular protein catabolic process (GO:0044257),0.44332155607593476,1.0740554338212844,0.38453159041394336,0.9563794266540387,1.0,17/59,16.49%,ADAMTS12;CTSC;RAB12;AP2A1;CLPX;BNIP3L;CHEK2;CTSZ;CAPN2;MYLIP;BNIP3;HTRA2;RSPRY1;RAB7A;CLTC;UBE2G1;LGMN
prerank,MAPK cascade (GO:0000165),0.4283410326509309,1.0740452405832905,0.3183183183183183,0.9556570557804799,1.0,52/295,14.38%,FGF22;FGF18;FNTB;NRG2;LRRK2;NRAS;MINK1;FGF1;GRB2;BRAF;NF1;PSMD9;AREG;IRS1;YWHAE;PSMB8;PDGFB;KITLG;MAPK1;MAP3K20;IRS2;PSMC5;MEF2A;IKBKB;DLG1;MAPK8;RANBP9;ARTN;SPTBN1;IL18;KRAS;PTPN3;SETX;TAOK1;RIT2;FBXW11;FRS2;RAF1;ZFP36L1;PSMD12;TGFA;MAPKAPK2;PSMA2;MAP2K2;SPRED1;CAMKK2;FYN;MAP3K8;LGALS9;SHOC2;CALM1;RASAL2
prerank,regulation of microtubule nucleation (GO:0010968),0.5650927848035802,1.0739823590365194,0.40381558028616854,0.9550911049880174,1.0,4/10,16.23%,DCTN1;MECP2;EML2;PAK1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.5394557250715238,1.0739465640862724,0.4126760563380282,0.9544288922514511,1.0,2/14,5.58%,THBS1;CMKLR1
prerank,membrane repolarization during action potential (GO:0086011),-0.440822286262336,-1.0736750351493025,0.39158576051779936,0.944773839272044,1.0,4/13,8.31%,ATP1B1;ATP1A1;KCNJ2;KCND3
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.4253509466592554,1.0736032695535376,0.324,0.9547883970646096,1.0,38/306,8.22%,POLR2D;BRCA1;RPL18;PCLAF;BLM;RFC2;POLE2;RPS6KB2;RPS23;RNASEH2A;RAD50;MRPL37;RPL41;RPL31;RPS17;RPL4;POLR2A;MRPS21;ORC4;RNPS1;POLA1;WRN;CDK2;RPLP0;HARS1;RPS15A;RPL38;DHPS;POLA2;POLD3;GOLPH3;MEF2A;RBBP8;MRE11;PABPC4;AGO2;NBN;SET
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.4766502202276274,1.0735778619020457,0.3740831295843521,0.9541087327678888,1.0,5/28,6.95%,CDK5RAP3;FBXW7;NUPR1;CTSC;PSMC5
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.43807626635649716,1.0726834570661319,0.37747653806047965,0.9561874848640046,1.0,33/88,17.72%,SYS1;AP1M1;VAMP7;LLGL1;RABEP1;MYO5A;EXOC5;CCDC93;SCAMP1;AP2A1;VPS13A;VPS13C;PUM1;DTNBP1;KIF16B;VAMP2;HGS;ARF1;EXOC6B;EXOC4;SORL1;NAPA;EPS15;CLINT1;CLTC;SH3GL2;FTH1;RP2;MYO1B;SCAMP2;ARL3;AP1B1;FTL
prerank,protein autoprocessing (GO:0016540),-0.395775303280207,-1.072563643796026,0.3920863309352518,0.9446983061744406,1.0,7/17,28.21%,AFG3L2;CTSL;CASP4;OMA1;CASP1;SPRTN;MYRF
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5421414391483252,1.0724537077997103,0.4099099099099099,0.9561654400947588,1.0,4/12,18.89%,B3GALNT1;B3GNT2;B3GALT1;B3GALT5
prerank,blood vessel morphogenesis (GO:0048514),0.44826922689000137,1.0723109640747062,0.3801742919389978,0.9558685428928096,1.0,10/54,14.21%,GLMN;NF1;NRP1;LRP5;ITGB8;TGFBR2;TGFBR1;AGGF1;SYK;RBPJ
prerank,negative regulation of receptor internalization (GO:0002091),0.5466099456813317,1.0722456375822815,0.40294117647058825,0.9553006997494904,1.0,4/12,15.06%,RIN3;SDCBP;ATXN2;ANKRD13A
prerank,peptide metabolic process (GO:0006518),0.43948920057864777,1.0721904796767494,0.3721174004192872,0.9547329473936988,1.0,9/75,12.65%,MGAT3;NLN;CPD;CPE;SPPL3;LNPEP;FURIN;PARL;ERAP1
prerank,positive regulation of histone methylation (GO:0031062),0.4914506656646988,1.0721719991373424,0.38596491228070173,0.9540411507693282,1.0,2/24,2.15%,BRCA1;CTR9
prerank,negative regulation of lymphocyte activation (GO:0051250),0.5045829973699711,1.0714705479395648,0.3892529488859764,0.9554923081668529,1.0,5/21,12.53%,DUSP3;TNFAIP8L2;LST1;SOX11;BANK1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.42534939400870475,1.0713252179420354,0.17,0.9551841611700632,1.0,198/1082,16.13%,POU2F3;FHL5;ISL1;BMP5;GLIS1;WNT4;RGCC;BRCA1;IER2;RORA;ANKRD49;MED10;SIRT7;BLM;PARP9;PELP1;KDM1B;RPRD1B;RELA;CX3CL1;IRF1;DVL1;SMARCA4;CD38;SP1;BRD8;ILF3;ACTR3;PID1;FGF1;ZFP90;CASZ1;TFAP4;ITGA6;SS18L1;SNX5;ITGB1BP1;PCBD2;CLOCK;ZEB2;RUNX1;SLC9A1;MAX;HCFC1;ZNF318;BMPR1A;PSMD9;NFATC1;JUN;AR;PRDM10;KDM5A;ASF1A;ELK3;WBP2;IRF3;PADI2;CDK7;PAXBP1;EP300;SMAD3;PDGFB;TEAD1;LRP5;PRKDC;SQSTM1;DPF2;ESR1;MRTFB;HDAC5;NR3C1;ACVR1;JUND;KDM3A;BRCA2;MAML3;PRDM4;PSMC5;CRTC1;MAML2;BCLAF3;KMT2E;MEF2A;IKBKB;MLIP;RRP1B;THOC5;PHF10;SEC14L2;TFCP2;AKIRIN2;TLR3;NCOA1;SETD3;AGO2;PRPF6;RPS6KA5;CDK9;NCK1;IL18;UBTF;DAB2;NCOA3;CHEK2;PCGF5;ZXDC;MAVS;AHI1;PPARG;SSBP3;GLYR1;SETX;TAL1;CDC5L;DEAF1;HIVEP1;HOXC4;TCF12;NAA16;CHD8;FBXW11;NR5A1;KAT2B;ZNF711;CREB3L2;NR2C2;SOX11;TRIM44;ZBTB38;ECD;MTOR;MAP2K5;PPM1A;ABL1;HEATR1;HMGB1;TP53INP2;TCF7L2;ATF6;BRD7;MLLT11;HIPK2;TP53;ATRX;TGFBR1;RNF20;NR1D2;LRP6;MAP2K2;NAA15;RXRA;EPC1;CDK8;FUBP3;PPARGC1B;WWOX;TRIM56;GTF2H1;CAMKK2;RREB1;PRKD2;PKD2;CREB1;RFX3;EDRF1;RBPJ;TET2;PPARD;HIVEP3;TBL1XR1;NCOA2;WASL;LDB2;LDB1;TLR4;CTCF;ARNT;NPAS3;SMAD4;ZBTB18;NPM1;PHIP;SMARCA2;AKAP8L;CRLF3;THAP3;AUTS2;HDAC2;PIK3R1;FOXK1;NFIB;KMT2C;RGMB;ARID1B;LMO2;MAP2K1;UBP1;MRTFA
prerank,multivesicular body assembly (GO:0036258),0.48297681710506174,1.0713007869009588,0.3872491145218418,0.9545090303238694,1.0,9/30,14.18%,TSG101;VPS4A;CHMP5;HGS;VPS37C;VPS37A;VPS4B;PDCD6IP;IST1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.49139069767295357,1.0709028895374357,0.40660736975857686,0.955074811845988,1.0,6/26,14.85%,CD36;SMAD3;HSP90AA1;INSR;PKD2;TLR4
prerank,miRNA mediated inhibition of translation (GO:0035278),0.5643438265210435,1.0706542643451882,0.4199395770392749,0.9543650353029679,1.0,2/11,8.04%,EIF6;AGO2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.5643438265210435,1.0706542643451882,0.4199395770392749,0.9543650353029679,1.0,2/11,8.04%,EIF6;AGO2
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.42580868250664194,-1.0706344229141942,0.3931297709923664,0.9472889377908223,1.0,6/16,12.44%,POGZ;NIPBL;SMC1A;NAA50;RAD21;PDS5B
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.42842555292432816,1.0705587749163603,0.366869918699187,0.9539420020891072,1.0,19/142,14.78%,C5AR1;CD36;TRPC5;ADCY8;ADCY5;YWHAE;SMAD3;PRKACA;CMKLR1;ESR1;SPPL3;TRPM4;NPTN;CACNA1A;ABL1;HMGB1;CYSLTR1;FZD9;CACNA1C
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.5406155207291403,1.0705184139213269,0.4161931818181818,0.953327757256549,1.0,5/12,11.85%,SMARCA4;ZBTB7A;DAB2;NCOR1;NCOR2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5671255641088193,1.06967278114065,0.40458015267175573,0.9552705869471552,1.0,3/11,12.92%,TFAP4;HIPK2;TP53
prerank,microvillus assembly (GO:0030033),0.5390950288472358,1.0695994736537735,0.4237037037037037,0.9547375627119811,1.0,4/14,7.63%,MINK1;RAP1A;EZR;RAP1B
prerank,negative regulation of synaptic transmission (GO:0050805),0.49928355600589513,1.069171562358448,0.40617283950617283,0.9553965631838577,1.0,4/23,14.70%,LRRK2;SYT11;ARF1;PTEN
prerank,regulation of cellular protein localization (GO:1903827),0.45486522508488275,1.0687132444413083,0.4,0.9560802443933575,1.0,13/45,15.42%,DVL1;NDEL1;MAP1A;HSP90AA1;CCDC66;SUMO3;SETD2;MAPT;PTPN1;GPC3;SPIDR;GPC6;VCPIP1
prerank,regulation of cell killing (GO:0031341),0.5233039991797753,1.0687050825139988,0.4053295932678822,0.9553486851520295,1.0,3/16,7.75%,TGFB2;CFH;MAPK8
prerank,mitochondrial translational termination (GO:0070126),0.4353136948778,1.0686121663638317,0.3872651356993737,0.9548894918678865,1.0,9/88,7.30%,MRPS22;MRPS31;MRPS30;MRPL37;MRPS21;MRPL48;MRPS35;MRPS28;MRPL1
prerank,positive regulation of actin nucleation (GO:0051127),0.5521872501510525,1.0681238161446673,0.4140625,0.9557122737474462,1.0,6/11,19.04%,WASF1;WASF2;CYFIP1;GSN;NCKAP1;BRK1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.5084134387861777,1.0677186819464208,0.39225806451612905,0.9562605703442576,1.0,5/20,11.42%,KPNB1;LDLRAP1;TTC39B;SEC14L2;ACADL
prerank,triglyceride homeostasis (GO:0070328),0.4915011723989506,1.067530387942003,0.41383812010443866,0.9561235548630925,1.0,2/26,8.68%,RORA;IL18
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.5465819741592076,1.0673652958303181,0.4257575757575758,0.9559171624483068,1.0,2/12,2.99%,BRD8;KLF9
prerank,regulation of fibroblast proliferation (GO:0048145),0.4530558263907386,1.067234646016743,0.3923337091319053,0.9555872051433805,1.0,6/45,6.36%,DDR2;GAS6;NF1;S100A6;PDGFB;CDK6
prerank,regulation of translation (GO:0006417),0.42400690181573986,1.0672087585770265,0.3609706774519717,0.954941497710332,1.0,32/173,11.59%,EIF6;EIF4A3;CNOT10;EIF2AK2;EIF3C;ILF3;EIF4ENIF1;EIF3E;IMPACT;SYNCRIP;METAP1;CSDE1;MALSU1;EIF4B;NIBAN1;THBS1;MTG2;PYM1;RBM3;PRKDC;ETF1;METTL3;NSUN3;LARP4B;YTHDF1;DAPK1;FXR2;CNOT9;EIF1;ATXN2;LSM14A;MTOR
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.3789339349416297,-1.0671950970495077,0.3534136546184739,0.9548212498252279,1.0,13/18,45.38%,GSK3B;MPV17L;SLC35F6;BAX;BID;GSK3A;ACAA2;HIP1R;SLC25A5;CHCHD10;BAK1;MUL1;TMEM14A
prerank,regulation of intracellular transport (GO:0032386),0.466898438633584,1.0666212162616855,0.39504716981132076,0.9560883715938077,1.0,5/38,8.42%,GAS1;LRRK2;NDEL1;REEP5;PTPN1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.5025114339948099,1.0662270546941781,0.4038709677419355,0.9565779881220675,1.0,9/21,16.41%,VCL;DUSP3;SLC9A1;CAMSAP3;ROCK2;LDB1;CLASP1;MACF1;ACTG1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.3625976568982926,-1.0660308284312174,0.3480392156862745,0.9550225266995285,1.0,12/23,25.86%,DYNC1I1;KIF5C;CCDC186;MYO10;KIF1A;CCDC88B;CCDC88A;KIF1C;HOOK1;KIF5A;TUBA1B;CCDC88C
prerank,positive regulation of cilium assembly (GO:0045724),0.5085278931896267,1.0659399337672097,0.3983849259757739,0.9567696408256282,1.0,4/18,10.44%,TAPT1;BBS4;CCP110;ARHGAP35
prerank,monocarboxylic acid transport (GO:0015718),0.44411172947417926,1.06587805144246,0.3991031390134529,0.956215787336324,1.0,10/51,15.52%,CD36;SLCO1B1;NCOA1;STARD5;SLC27A1;RXRA;SLCO2B1;NCOA2;SLC16A6;ABCG2
prerank,dendrite morphogenesis (GO:0048813),0.46828934296741787,1.0653752223465929,0.40714285714285714,0.9570510168600891,1.0,13/35,16.94%,DVL1;MINK1;EPHB2;FARP1;MEF2A;CDC42;SDC2;MAP6;PTEN;WASL;BTBD3;DOCK10;CTNNA2
prerank,actin nucleation (GO:0045010),0.4953566862622176,1.065205123988534,0.41919191919191917,0.956858701302992,1.0,6/21,14.28%,ACTR3;IQGAP2;ARPC1A;ARPC4;ARPC2;ARPC3
prerank,nucleotide metabolic process (GO:0009117),0.48082920627357273,1.065138373823548,0.4015151515151515,0.9563243396008267,1.0,4/23,6.40%,AK4;REXO2;NMNAT3;NUDT5
prerank,negative regulation of growth (GO:0045926),0.4273807449624478,1.0647594891318866,0.37067209775967414,0.9568051406886885,1.0,30/121,15.95%,CGRRF1;SMARCA4;ADAM15;TGFB2;RERG;BCL6;EI24;SMAD3;DCBLD2;PTPRJ;STK11;ENO1;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;NOTCH2;TP53;ACVR1B;RBBP7;RTN4;SMAD4;SMARCA2;CRLF3;PPP1R9B;ST7L
prerank,ERBB signaling pathway (GO:0038127),0.44348935432043474,1.0642944977999216,0.3819148936170213,0.9575365987297504,1.0,18/64,15.97%,NRG2;GRB2;BRAF;AREG;PRKCA;MAPK1;HSP90AA1;REPS2;RPS6KA5;KIF16B;DGKD;MVP;CBL;TGFA;PIK3C2A;PTPN18;PIK3R1;IQGAP1
prerank,diol metabolic process (GO:0034311),0.5143308672375205,1.0641394992847513,0.4103896103896104,0.9572937860767905,1.0,5/19,14.29%,SGPP1;SGPP2;HSP90AA1;PTS;CALM1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5048612315366418,1.064113336657228,0.3891102257636122,0.9566356330729776,1.0,7/18,16.10%,ESR1;NCOR1;NCOR2;TP53;MAP2K2;DDX5;MAP2K1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.439716543343028,-1.0641015073078501,0.37898089171974525,0.9575451278069848,1.0,4/12,10.04%,MTPN;PLEKHH2;PIK3CA;CFL2
prerank,cellular response to hypoxia (GO:0071456),0.42117713007138985,1.0631477172048647,0.3866396761133603,0.958939275510689,1.0,23/126,13.05%,RGCC;RORA;AK4;SUV39H1;PSMD9;UBQLN1;PSMB8;EP300;EGLN3;EGLN2;PSMC5;HP1BP3;BNIP3L;EGLN1;ELOC;BNIP3;MTOR;ZFP36L1;PSMD12;HIPK2;TP53;PSMA2;FMN2
prerank,regulation of phosphorylation (GO:0042325),0.430690705762953,1.0630018810248678,0.3941236068895643,0.9586587820597885,1.0,17/120,9.65%,ANG;EIF6;GLMN;PGAM1;ITGA6;AR;ZBTB7A;THBS1;NRP1;NUP205;EP300;SDCBP;IKBKB;NUP98;NUP54;FNIP1;LYN
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.3569753931517904,-1.0620238009746108,0.33490566037735847,0.9605862881129997,1.0,5/23,2.93%,SMURF2;TGFB1;SMAD7;SMAD2;LATS1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.43848447872015217,1.0619181227311776,0.3840425531914894,0.9614636893165035,1.0,13/72,13.65%,POLR2D;RFC2;POLR2A;CDK7;EP300;COPS7B;POLD3;MNAT1;ERCC4;COPS4;CUL4A;UVSSA;GTF2H1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4631583491758355,1.0618536506951082,0.40888382687927105,0.9609409134252026,1.0,4/40,9.87%,ANG;C5AR1;ESR1;GNAQ
prerank,neuron projection morphogenesis (GO:0048812),0.42648940682310593,1.0614715185027255,0.39209726443769,0.9614569849555753,1.0,33/137,16.94%,ISL1;LRRK2;DVL1;MINK1;IMPACT;LLGL1;MAP1A;EPHB2;S100A6;NYAP1;ATP7A;KIF20B;FARP1;MEF2A;SLC9A6;DTNBP1;CDK5;TAOK1;CDC42;SDC2;DBNL;EPB41L3;S100B;MAP6;PTEN;WASL;BTBD3;GPM6A;MAP4K4;IQGAP1;PAK1;DOCK10;CTNNA2
prerank,negative regulation of protein localization to membrane (GO:1905476),0.48720435661258066,1.061462670329297,0.4081381011097411,0.9607616223584191,1.0,5/24,8.83%,PID1;ITGB1BP1;GDI1;PPFIA1;DAB2
prerank,double-strand break repair via homologous recombination (GO:0000724),0.42892777012385414,1.0613657900357372,0.38516992790937177,0.9603075402363346,1.0,18/95,14.72%,BRCA1;BLM;RAD50;WRN;SEM1;BRCA2;RBBP8;MRE11;ERCC4;SMC5;NBN;EXD2;RFWD3;RAD51B;REV3L;RNF138;RECQL5;SPIDR
prerank,negative regulation of JNK cascade (GO:0046329),0.46913470447695604,1.0609334770094914,0.4105642256902761,0.960958264276596,1.0,7/31,12.73%,DUSP3;DUSP10;NCOR1;FKTN;ZMYND11;AIDA;CYLD
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5294876160227792,1.0608481282862219,0.4166666666666667,0.9605055162560536,1.0,8/15,16.79%,ZFYVE27;REEP2;RTN3;RAB18;RTN4;LNPK;ATL2;ARL6IP1
prerank,long-term synaptic potentiation (GO:0060291),0.5017420613470946,1.0605777626824247,0.4044943820224719,0.9606608498639992,1.0,5/21,14.33%,PRKCZ;RGS14;NPTN;VAMP2;GRIN2A
prerank,regulation of interleukin-1 beta production (GO:0032651),0.4405063234974836,1.0604443892011035,0.4053475935828877,0.9603527082547082,1.0,5/66,7.51%,ISL1;CD36;CX3CL1;GSDMD;PYDC1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.4762714532764643,1.0604118478714366,0.3935018050541516,0.9597116090133195,1.0,3/30,7.63%,GJC1;CACNA1D;GPD1L
prerank,apical junction assembly (GO:0043297),0.44787367875011336,1.0601077403802373,0.40458015267175573,0.9599753781823089,1.0,8/53,13.31%,VCL;CTNNA1;DLG1;PKN2;PAK2;APC;WDR1;PDCD6IP
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.4117246203386765,-1.059633304066697,0.3956043956043956,0.9647779677291934,1.0,7/16,23.00%,RIF1;SHLD1;SHLD2;KLHL15;CGAS;UBQLN4;HELB
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.2901455385102149,-1.059417216108063,0.31496062992125984,0.9619389548927184,1.0,11/44,21.16%,PRKCE;HCK;PTK2B;NCK2;VASP;BAIAP2;PYCARD;PFN1;WHAMM;TENM1;CDC42EP3
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.4964042329510806,1.059162605830676,0.4110824742268041,0.9622151100371437,1.0,2/23,5.62%,PLK1;MAPK1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.5502502871937993,1.059159907858685,0.43567251461988304,0.9614832596302485,1.0,2/11,4.55%,BMPR1A;THBS1
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4222583738677122,-1.0587904600211608,0.4064516129032258,0.9604750695231625,1.0,7/14,51.81%,DAGLA;ALDH9A1;SLC5A7;CHAT;NOS1;MOXD1;ACHE
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.5431654888276791,1.0583417196643512,0.4236006051437216,0.9634165007363347,1.0,4/12,11.85%,ESR1;LIN28B;NCOR1;NCOR2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.46045545778462793,1.0580129975928152,0.4190260475651189,0.9637594714682615,1.0,9/37,16.27%,LDLRAP1;BMPR1A;JUN;TPM1;PDGFB;PPARG;ERN1;PTEN;MEF2C
prerank,response to muscle stretch (GO:0035994),-0.4104481204246011,-1.0579638736689827,0.375,0.9595548826589396,1.0,3/15,7.09%,RYR2;PTK2;PIK3CA
prerank,negative regulation of phosphatase activity (GO:0010923),0.4773725908290691,1.0576890092679698,0.40229885057471265,0.96404803260059,1.0,5/25,14.98%,URI1;TGFB2;BOD1L1;TIPRL;GPATCH2
prerank,positive regulation of defense response to virus by host (GO:0002230),0.4903348263478411,1.057661918892672,0.4300254452926209,0.9634044172920019,1.0,5/24,11.45%,PARP9;HSP90AA1;ZDHHC1;MAVS;TRIM44
prerank,positive regulation of cell migration (GO:0030335),0.4224702119630678,1.0575573722935352,0.34434434434434436,0.963003507830342,1.0,41/253,13.72%,CXCL12;ROR2;SYNE2;RIPOR1;DDR2;FGF1;ITGA6;TGFB2;MAPRE1;EPHB2;ELP3;THBS1;NRP1;PDGFB;PRKCA;DOCK1;SEMA6D;KIF20B;SDCBP;ACVR1;CBLL1;FERMT3;AGO2;DAB2;APC;PLAA;F3;ACTN4;SEMA3D;SEMA6A;MIA3;IGF1R;MTOR;RUFY3;ADAM10;TGFBR1;ACVR1B;RTN4;FN1;INSR;RREB1
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5597105316614613,1.0574785633925856,0.4294573643410853,0.9625206192746816,1.0,2/10,7.40%,ATP7A;ASRGL1
prerank,regulation of heart contraction (GO:0008016),0.4263851693777464,1.0574237020763286,0.4192546583850932,0.9619613890231308,1.0,4/90,5.27%,ACE2;TGFB2;TPM1;PRKACA
prerank,regulation of apoptotic process (GO:0042981),0.42074450311198874,1.0568154101805802,0.268,0.9631581125888947,1.0,138/676,15.76%,PLK1;WFS1;GAS1;IGFBP3;UBE2Z;STEAP3;RELA;ARHGEF3;CX3CL1;CD38;WDR73;SMAD6;CFL1;BAG3;DDX42;NUPR1;FGD3;TFAP4;HS1BP3;FGD1;PLEKHG2;PPID;ITGA6;TNFRSF25;PLEKHG5;BRAF;SAP18;SMPD1;BCL2L11;GAS6;ITSN1;OLFM1;TARDBP;MTCH1;NAA35;NF1;JUN;ZBTB7A;THBS1;FLNA;IRF3;BCL6;RNPS1;TNFAIP8;ARHGEF12;MAP3K11;WRN;APAF1;CTNNBL1;PRKDC;SQSTM1;VAV3;MAP3K20;AXL;RBM5;EGLN3;BIRC3;EGLN2;HSP90AA1;GOLPH3;API5;IKBKB;ING3;MRE11;RRP1B;HSPA9;MAPK8;PAK2;BNIP3L;BFAR;ANKRD13C;BABAM2;DAB2;BIRC6;ZFAND6;GRK5;PHLPP1;DAPK1;AREL1;FAF1;LRP8;AHI1;KALRN;FBXO11;MTDH;PROC;APC;CD44;SETX;TMBIM4;CDK5;ACTN4;RNF157;AKAP13;NAA16;BNIP3;TRAF2;NOTCH2;IGF1R;CBL;RNF144B;ARHGEF17;ABL1;HMGB1;RAF1;AIFM1;VAV2;DNAJA3;RPS6;ATF6;ADAM10;MLLT11;TP53;BCL2;FMN2;NAA15;RTN4;HTRA2;ANXA5;NDRG1;ANP32A;FZD9;SPTLC1;DNAJC3;ANP32B;VAV1;ATG7;NPM1;HIP1;PHIP;RHBDD1;HDAC2;HNRNPK;STK3;PIK3R1;GRID2;MAP4K4;RPS6KA2
prerank,negative regulation of cell projection organization (GO:0031345),-0.29113649751390686,-1.0566790427491548,0.27358490566037735,0.9601536206584046,1.0,13/48,15.32%,RTN4RL1;CBFA2T2;GAK;GRIN2B;PRAG1;ITM2C;PTPRS;LPAR1;EPHA4;SEMA3A;SPOCK1;DCC;DPYSL3
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4913339610752797,1.0557712209552061,0.4083769633507853,0.9657725081153934,1.0,5/22,11.35%,DUSP3;PTPRJ;EZR;LPXN;PRNP
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5202968880549877,1.0552964882928395,0.422554347826087,0.9665473784864398,1.0,5/14,14.48%,ECI2;CROT;ABCD1;HSD17B4;ACOX3
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5423361391619367,1.0551770215179084,0.4267241379310345,0.9662149901660606,1.0,5/12,14.70%,EPHB2;HSP90AA1;B4GALT5;ARHGAP35;PTEN
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.4311852113898948,1.055133301777817,0.40670859538784065,0.9656318096586689,1.0,14/78,9.89%,PID1;LDLRAP1;VPS4A;EPHB2;AR;STX7;SQSTM1;ZDHHC5;PPFIA1;DLG1;STX3;SPTBN1;DAB2;CDK5
prerank,regulation of chemotaxis (GO:0050920),0.4757845472869771,1.0551115530960393,0.4262899262899263,0.9649665870225058,1.0,9/30,14.65%,DUSP3;THBS1;PDGFB;ZSWIM6;STX3;YTHDF1;CYRIB;P2RY12;AIF1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5156933829110036,1.0550881236718483,0.4065934065934066,0.964304696359052,1.0,3/15,9.98%,ZC3H12D;POP1;ZC3H12B
prerank,regulation of cell growth (GO:0001558),0.4192620754798252,1.0546314746125156,0.3787575150300601,0.9650320867307501,1.0,30/204,13.32%,SGK3;SGK2;URI1;CGRRF1;SMARCA4;ADAM15;DDX49;TGFB2;RERG;BCL6;EI24;SMAD3;DCBLD2;PTPRJ;SDCBP;EGLN2;STK11;NRG3;CAMK2D;ADNP2;ENO1;CDC42;MTOR;ADAM10;TP53;TGFBR1;BCL2;ACVR1B;RBBP7;RTN4
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.32442404055178226,-1.0545368758754337,0.3902439024390244,0.963436451524974,1.0,8/32,17.48%,P2RX7;AKAP6;TRPC1;CAPN3;SNCA;PDPK1;PLCG1;P2RX4
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.4748786916550685,1.0545223872152736,0.4157303370786517,0.9646835453592811,1.0,4/25,7.55%,DNAJB1;DNAJC18;ST13;HSPA9
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4686810595507144,1.0544999047517378,0.4317073170731707,0.9640233708181069,1.0,6/30,7.46%,UBXN1;MAP1A;STYX;SDCBP;GIPC1;UCHL5
prerank,intracellular protein transmembrane transport (GO:0065002),0.45613803386718077,1.054473721664721,0.4180790960451977,0.9633757756289634,1.0,7/42,12.19%,TIMM17A;TOMM40;DNAJC15;SEC61G;TIMM23;SEC61A1;AIFM1
prerank,extracellular matrix organization (GO:0030198),0.42003136025136784,1.0544350350555851,0.36236236236236236,0.9627746776070548,1.0,34/276,12.97%,SCUBE1;COL14A1;ADAMTS12;CRTAP;DDR1;DDR2;ADAMTS2;ADAM15;ITGA6;TGFB2;GAS6;NF1;ADAM12;THBS1;ADAMTSL3;ATP7A;PDGFB;QSOX1;FLRT2;ITGA4;ITGB5;COL11A1;ITGB8;ADAMTS10;CD44;BGN;LOXL3;FURIN;CAPN2;PXDN;LAMC1;P4HA1;ADAM10;TGFBR1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5150808975493587,1.0544035311444668,0.4383561643835616,0.9621475045291843,1.0,4/17,14.21%,BMPR1A;ACVR1;NOTCH2;RBPJ
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.4318364641664011,-1.054344067434397,0.3888888888888889,0.9605707459183781,1.0,6/13,22.16%,RENBP;NAGK;GFPT1;AMDHD2;GNPDA1;UAP1L1
prerank,regulation of microtubule depolymerization (GO:0031114),0.47953319497541097,1.0541246622036857,0.42604298356510745,0.9622692810224959,1.0,6/25,10.28%,MAP1A;STMN2;ATXN7;CAMSAP3;APC;TAOK1
prerank,bicarbonate transport (GO:0015701),0.47781072826624577,1.0538350432469323,0.43679599499374216,0.9624555340760779,1.0,1/25,0.61%,SLC4A3
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.42815752522681993,-1.0537535671656522,0.4065573770491803,0.9590354174236094,1.0,2/13,3.71%,GLUD1;GLUL
prerank,urogenital system development (GO:0001655),0.5485349164515082,1.053680949984013,0.4161849710982659,0.9622269167666395,1.0,1/11,4.17%,EPHB2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.43543953402806235,1.053632594868212,0.40043057050592035,0.9616520028051379,1.0,19/59,16.83%,LRRK2;DYRK2;PRKCA;PRKDC;MAPK1;ACVR1;CDC42BPB;MAPK8;CAMK2D;CDK5;TGFBR2;HIPK2;TGFBR1;ACVR1B;PRKD2;ROCK2;MAP2K1;TBK1;HIPK1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.30157073870465656,-1.0535529910226864,0.36585365853658536,0.9561401905336614,1.0,7/41,8.21%,ATP1B3;ATP1B1;ATP1A1;ATP1A2;KCNJ2;SLC12A9;ATP1A3
prerank,negative regulation of protein phosphorylation (GO:0001933),0.42640210623733105,1.0534526495594385,0.37701612903225806,0.9614757912322007,1.0,27/150,11.35%,LRRK2;IGFBP3;CDK5RAP3;PRKCZ;DVL1;SMAD6;PMEPA1;PID1;CNKSR3;ITGB1BP1;IMPACT;TARDBP;NIBAN1;NF1;EPHB2;PRKDC;SPRED2;PYDC1;GPD1L;LDLRAD4;PAK2;NCK1;DTNBP1;LYN;GNAQ;MVP;PRNP
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.25979584582840975,-1.0533992552640097,0.32608695652173914,0.9530810847957873,1.0,18/76,16.42%,BCAS3;PRKCE;HCK;P2RX7;PTK2B;FES;HCLS1;NTRK3;CFL2;NCK2;VASP;BAIAP2;PYCARD;PFN1;SORBS3;LIMK1;DYNC1H1;PFDN2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.3318069263111387,-1.0528619676244724,0.3841059602649007,0.9479787129883687,1.0,18/32,24.24%,TPR;NUP153;NUP214;SSB;XPOT;NUP155;NUP188;NUP88;NUP35;NUP133;SEH1L;RAE1;NUP50;NUP210;NUP107;NUP42;RANBP2;POM121
prerank,tRNA export from nucleus (GO:0006409),-0.3318069263111387,-1.0528619676244724,0.3841059602649007,0.9479787129883687,1.0,18/32,24.24%,TPR;NUP153;NUP214;SSB;XPOT;NUP155;NUP188;NUP88;NUP35;NUP133;SEH1L;RAE1;NUP50;NUP210;NUP107;NUP42;RANBP2;POM121
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5162831566941775,1.0528371927450249,0.4299191374663073,0.9625860901702611,1.0,4/15,17.31%,AK4;ENTPD1;CMPK1;AK8
prerank,rRNA catabolic process (GO:0016075),0.5107650149822565,1.0526577825959083,0.43283582089552236,0.9624293806249378,1.0,3/16,7.14%,EXOSC5;EXOSC7;XRN1
prerank,cellular response to estradiol stimulus (GO:0071392),0.512748748405211,1.0521433174994428,0.42456608811748997,0.9633985983426684,1.0,3/18,13.20%,ESR1;NCOA3;LCOR
prerank,hexose transmembrane transport (GO:0008645),0.48209822185204965,1.051998963657088,0.4217948717948718,0.9631220617515519,1.0,1/21,1.39%,SLC2A3
prerank,response to X-ray (GO:0010165),0.5278773813218505,1.0519878966499752,0.4209770114942529,0.9624327583152081,1.0,2/14,3.86%,BLM;XRCC4
prerank,neuron projection organization (GO:0106027),0.5102539208999194,1.0514413031937926,0.40807799442896936,0.9633829764120282,1.0,7/15,13.60%,MAP1A;ABCD2;DCTN1;ARF1;PRNP;ABCD1;INSR
prerank,receptor internalization (GO:0031623),0.4483133603049701,1.0514190368236516,0.41435185185185186,0.9627403492859536,1.0,11/44,14.68%,CD36;LDLRAP1;GRB2;ARRB2;NEDD4;LMBRD1;SNX1;RAMP1;SYK;CALCRL;CLTC
prerank,positive regulation of multicellular organismal process (GO:0051240),0.4209500553721465,1.0513760998364177,0.3633633633633634,0.9621689187273924,1.0,53/308,13.72%,RGCC;EHMT1;CD36;EIF2AK2;TAPT1;CFL1;GLMN;ALMS1;VAMP7;TGFB2;GAS6;OLFM1;BMPR1A;SMAD3;PDGFB;CMKLR1;DECR1;SDCBP;ACVR1;IL1A;KDM3A;KMT5B;AGO2;ABCA7;EZH2;TRPM4;IL18;DAB2;NCOA3;KMT5C;APC;B4GALT5;ENO1;CNOT3;TGFBR2;IGF1R;NR2C2;ACADL;SOX11;MTOR;SCAMP5;SORL1;SOX6;SLC27A1;TRPV2;ABCA1;TGFBR1;ACVR1B;RTN4;PPARGC1B;SYK;ADIPOR1;RREB1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.4768161145794431,1.051258495418279,0.41818181818181815,0.9618165209366647,1.0,4/27,8.39%,SELENON;YWHAE;PRKACA;CAMK2D
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.46873923215488655,-1.0512579703676508,0.41839762611275966,0.9494177733438045,1.0,5/10,14.63%,DIP2A;FLCN;PRKAA1;SIRT1;PRKAA2
prerank,negative regulation of cholesterol transport (GO:0032375),-0.4576667543283597,-1.0512003811244,0.41228070175438597,0.9462439841379094,1.0,3/10,34.41%,SREBF2;ABCA2;APOC1
prerank,regulation of intracellular protein transport (GO:0033157),0.4683520727847242,1.050968722035647,0.42485207100591715,0.9619448950930031,1.0,7/32,9.85%,RIPOR1;SIRT7;NDEL1;PCNT;KIF20B;PTPN1;VAMP2
prerank,regulation of Golgi organization (GO:1903358),0.5105962724499958,1.0508071845750488,0.4279778393351801,0.9616884057782904,1.0,6/17,13.15%,AKAP9;MYO5A;MAPK1;CAMSAP3;ARMH3;MAP2K2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5401306909022442,1.0507808621889916,0.43768545994065283,0.9610494356613546,1.0,1/11,1.16%,BLM
prerank,mitochondrial protein processing (GO:0034982),-0.4494571101718295,-1.050515908227906,0.42038216560509556,0.9450730720232926,1.0,8/11,35.24%,YME1L1;IMMP1L;AFG3L2;OMA1;SPG7;STOML2;ATP23;PMPCA
prerank,negative regulation of cell migration (GO:0030336),0.4188306651187116,1.050448090630485,0.4183467741935484,0.9613849753573361,1.0,30/137,15.64%,VCL;IGFBP3;DUSP3;CX3CL1;SCAI;ADAM15;ITGB1BP1;ZMYND8;NF1;BMPR1A;TPM1;PTPRJ;LDLRAD4;DUSP10;SLURP1;PTPRT;PTPN23;MIA3;RNF20;PTPRU;MCC;ADIPOR1;NDRG4;PTEN;TMEFF2;ARHGDIB;DAG1;CLASP1;EVL;STK24
prerank,regulation of mitochondrial fusion (GO:0010635),0.5537985287133966,1.0503200723368293,0.446875,0.9610800734497493,1.0,4/11,12.38%,ADCK1;PID1;BNIP3;ZDHHC6
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.5162517242975557,1.0502660975228633,0.4295676429567643,0.9605265215901707,1.0,6/15,14.28%,ACTR3;IQGAP2;ARPC1A;ARPC4;ARPC2;ARPC3
prerank,entry into host (GO:0044409),0.5259901001383663,1.0502490712678652,0.40915593705293274,0.9598599576705433,1.0,3/13,11.44%,GRB2;CBLL1;CBL
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4759269679410284,1.0501425583098625,0.4224464060529634,0.9594908919531671,1.0,6/25,10.18%,BCAS2;PRPF3;GEMIN2;PRPF6;SCAF11;DDX23
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.33910071018281485,-1.049961234428219,0.3314917127071823,0.9435131770789328,1.0,8/29,13.92%,HNRNPU;PABPC1;SLC11A1;PAIP1;YBX1;FMR1;TENT5A;LARP1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.4899061280439543,1.0499493708662107,0.4425587467362924,0.9593489473996981,1.0,8/21,17.30%,YWHAE;PPP1R8;BOD1L1;PPP1R16B;TIPRL;ENSA;YWHAB;MFHAS1
prerank,phosphorylation (GO:0016310),0.4189169811383329,1.0499302473630145,0.334,0.9586900392213519,1.0,80/384,14.01%,SGK3;SGK2;PLK1;RSKR;LRRK2;IGFBP3;PRKCZ;MINK1;EIF2AK2;ILF3;GMFB;LIPE;DYRK2;NEK3;BRAF;TGFB2;GAS6;BMPR1A;EPHB2;PIK3R4;MAP3K11;CDK7;PRKCB;PDGFB;PRKCA;PRKACA;CDK2;BTK;PRKDC;MAPK1;MAP3K20;CDK6;ACVR1;STK11;IKBKB;PI4KA;CDC42BPB;MAPK8;DGKI;PKN2;PAK2;RPS6KA5;CDK9;CAMK2D;MAP3K9;MAST2;PPP4R1;BIRC6;GRK5;DAPK1;CHEK2;BRD2;NEK7;CTBP1;LYN;CDK5;DGKD;TAOK1;TGFBR2;BMP2K;GK;MTOR;ABL1;ERN1;CDKL5;ADAM10;SRPK2;HIPK2;MAPKAPK2;TGFBR1;NRBP1;ACVR1B;CDK8;SYK;INSR;CAMKK2;FYN;PRKD2;CSNK1A1;CREB1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.4283136382185016,1.0498952266251713,0.42872340425531913,0.958091125792161,1.0,24/67,15.70%,VEGFC;NRP1;DOCK1;VAV3;ABI1;AXL;HSP90AA1;PAK2;NCK1;CDC42;PXN;CYFIP2;VAV2;MAPK14;NCF4;MAPKAPK2;WASF2;FYN;ELMO1;NRP2;PRKD2;ROCK2;VAV1;PIK3R1
prerank,ureteric bud morphogenesis (GO:0060675),-0.39230426081980285,-1.0498811589651806,0.3854166666666667,0.9404387617728489,1.0,3/16,10.71%,SALL1;NPNT;FGF2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.4419828229556502,1.0498413292626352,0.41104972375690607,0.9575505617121247,1.0,8/53,7.46%,FBXW7;GLMN;NUPR1;DESI1;USP19;PRKACA;PSMC5;UCHL5
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.34201140584487116,-1.0497907486411524,0.32673267326732675,0.9374083708262178,1.0,15/26,24.14%,UBE2N;IRAK1;UBC;IFIH1;TAB1;TIFA;TRAF6;RPS27A;TNFAIP3;IKBKG;TAB2;NOD1;CASP8;UBB;AAMP
prerank,regulation of cytoplasmic transport (GO:1903649),0.5445776922856993,1.0495759705910925,0.4485294117647059,0.9576673522212467,1.0,5/11,16.10%,LRRK2;MAPK1;MAP2K2;DNAJC13;MAP2K1
prerank,sphingosine metabolic process (GO:0006670),0.5084889355579919,1.049566292976116,0.4355495251017639,0.9569867208602337,1.0,5/17,14.77%,SGPP1;SGPP2;ACER3;ASAH1;SPTLC1
prerank,nervous system development (GO:0007399),0.4190152889422715,1.0494196342390856,0.352,0.9567431457371877,1.0,73/429,14.82%,SDK2;PCDH1;ALDH1A2;PCDHB16;ZIC4;BTD;ST8SIA4;DVL1;GBA2;TRPC5;GMFB;NUMBL;TMEM223;VXN;ZEB2;SMPD1;NF1;MBNL1;EPHB2;ELP3;ATXN1;NELL1;APAF1;EP300;MSI1;TEAD1;CRIM1;NAV1;DPF2;AXL;FARP1;DCTN1;SERPINI1;APBA1;RAPGEF5;ARTN;NDUFV2;CHD7;MTR;ITM2B;AHI1;KALRN;GLRB;APC;RBFOX3;CDK5;TRIM3;FKTN;MYLIP;SEMA6A;SDHA;GDA;NOTCH2;NR2C2;DBNL;CHST8;FEZ1;PTS;SOX6;TGFBR1;MYT1L;ACVR1B;S100B;FN1;ADAM22;ATXN3;PKD2;RELN;FZD9;PTEN;LDB2;LDB1;BTBD3
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.3347229675581056,-1.049177739639968,0.35858585858585856,0.9360865855341846,1.0,14/25,33.55%,ITGA5;ITGB2;JAM3;ITGAX;JUP;ITGB3;CD200R1;ITGAV;CD200;PARVA;CXADR;ITGB1;NINJ1;PKP2
prerank,positive regulation of B cell proliferation (GO:0030890),0.4664062932443039,1.0484871001087221,0.41829268292682925,0.9589771026408211,1.0,8/29,17.29%,CD38;EPHB2;VAV3;IRS2;BCL2;CD81;MEF2C;NCKAP1L
prerank,protein N-linked glycosylation (GO:0006487),0.4395744812129976,1.0484042735885162,0.4253490870032223,0.9585282744846692,1.0,10/66,13.51%,MGAT3;LMAN1;ALG3;UGGT2;MPDU1;STT3A;B4GALT1;ST6GAL1;MGAT4B;UGGT1
prerank,regulation of chromatin binding (GO:0035561),0.5591496399829298,1.0480549486261304,0.4488817891373802,0.9588862982071031,1.0,2/10,9.74%,PARP9;HMBOX1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.49695099382025637,1.0480019722074325,0.4481865284974093,0.9583374043171019,1.0,3/18,9.65%,CAMK1D;MTUS1;LYN
prerank,extracellular matrix assembly (GO:0085029),0.48052365788511553,1.0479349568452416,0.4316185696361355,0.9578306582891412,1.0,4/23,11.03%,GAS6;ATP7A;QSOX1;PXDN
prerank,regulation of myoblast fusion (GO:1901739),0.5549533028431292,1.0476835027167142,0.43525741029641185,0.9579352895671569,1.0,3/11,16.32%,EHD1;MAPK14;CFLAR
prerank,regulation of protein metabolic process (GO:0051246),0.44073213690513174,1.0473700736941989,0.4047890535917902,0.9582409099649892,1.0,11/44,14.30%,WFS1;MAPK8;ABCA7;VPS35;CHEK2;FAF1;HGS;FURIN;MAP2K5;PARL;ROCK2
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3622870951403661,-1.0472347782898306,0.40865384615384615,0.938977847834097,1.0,7/23,15.19%,APP;P2RX7;PFKFB4;PRKAA1;IGF1;PRKAA2;PRXL2C
prerank,stem cell development (GO:0048864),0.51084411876632,1.0471550149939983,0.4431977559607293,0.9582190893992736,1.0,3/16,11.42%,TAPT1;PEF1;SOX11
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.2778121108654539,-1.0470456302878102,0.34444444444444444,0.9363998464000809,1.0,30/61,27.11%,PSMD14;PANK2;PSMA3;AZIN1;PSMB2;PSMB7;PSMC6;PSMD4;PSMD7;SIRT1;PSMA1;PSMA5;PSMC1;PSMD13;PSMC2;PSMA6;OAZ2;PSMA4;PSMD3;PSMF1;PSMD2;PSMD5;OAZ1;PSMD1;PSMC3;PRKAG2;PSMD8;PSMB3;PSME1;PSMB9
prerank,protein insertion into ER membrane (GO:0045048),0.45496053302320516,1.0469598543026806,0.42290249433106575,0.9581051207375675,1.0,7/37,12.11%,TRAM1L1;EMC9;SEC61G;UBE2J2;VAMP2;PRNP;CAMLG
prerank,chemical synaptic transmission (GO:0007268),0.4148405515980775,1.0466302370278477,0.399,0.9583485360843186,1.0,50/284,16.82%,STXBP2;CAMKK1;PCDHB16;PDZD11;DVL1;MINK1;GAD2;PRKAR2A;AKAP9;PRKACA;MAPK1;SDCBP;CEL;GIPC1;DLG1;PDE7B;APBA1;SYN3;GRIA4;GLRB;VAMP2;CDK5;CACNA1A;RIT2;GABRG2;GRM7;EXOC4;GLRA3;SLC12A6;AMPH;LRP6;LIN7A;NAPA;TBC1D24;SPG11;CAMKK2;ATXN3;CALM1;GRIN2A;PLP1;PTEN;GRID2;RPS6KA2;KIF1B;UNC13C;KCND2;ERC2;PRKAR1A;KCNA1;PRKACB
prerank,positive regulation of cell cycle process (GO:0090068),0.42801645171344715,1.0465688868846295,0.42176165803108806,0.9578290426811646,1.0,17/91,15.29%,RGCC;SVIL;USP19;PDGFB;LRP5;MAP3K20;KIF20B;IL1A;GIPC1;WIZ;PKN2;CDC42;TGFA;ATRX;INSR;PKP4;PHIP
prerank,positive regulation of DNA recombination (GO:0045911),-0.34282413078733653,-1.0462577217586981,0.35294117647058826,0.9356202774828445,1.0,14/27,26.78%,ACTR2;MMS19;RIF1;ERCC6;SHLD1;SHLD2;PARP1;WDR48;PAXIP1;HMCES;WAS;TFRC;ZCWPW1;PRDM9
prerank,organelle assembly (GO:0070925),0.4174410444455987,1.04606393297877,0.354,0.9586922182773052,1.0,94/384,16.60%,WDR45;TSG101;CLUAP1;BBIP1;CCDC57;CEP89;RPS23;ACTR3;ATXN2L;EIF4ENIF1;ARL6;VPS4A;EHD4;CHMP5;TMEM67;RAB8B;EHD1;BBS4;CSDE1;CCDC61;MAPRE1;IQCB1;DZIP1;TMOD1;CEP250;UBQLN1;FLNA;STX7;TMOD3;TTC39C;WDR45B;FARP2;FNBP1L;AMBRA1;EXOC5;PCNT;DYNLL2;TUBGCP6;IFT52;IFT20;ABLIM3;CCDC66;SNX10;MAPT;TUBGCP2;YTHDF1;NCOR1;CDS1;AHI1;NEK7;PRRC2C;PTPN23;HGS;VPS37C;HPS4;ATXN2;POC1B;VPS37A;ULK2;DBNL;EXOC4;ATG3;KIF3A;LSM14A;VPS4B;PACS2;STARD9;OCRL;PTPDC1;RB1CC1;TP53INP2;EIF2S1;PDCD6IP;RPGR;ARMC9;BICD1;RFX3;IST1;RAB7A;G3BP1;ABLIM1;ATG7;BECN1;NPM1;SCLT1;NEK6;PDE6D;GOLGA8B;CEP83;PATL1;CEP290;RP2;YTHDF3;CENPC
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5414106943156879,1.0459608674411986,0.453416149068323,0.9583181978562614,1.0,4/11,16.52%,PRKCA;LYN;SYK;RDX
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5141250751011875,1.0457118217151693,0.43673469387755104,0.958391993159957,1.0,4/16,8.39%,SLC9A1;PRKCA;MEF2A;CAMK2D
prerank,protein deacetylation (GO:0006476),0.4475329303182023,1.045694303371794,0.42954545454545456,0.9577493793003998,1.0,12/41,16.96%,SIRT7;FLNA;HDAC9;HDAC11;HDAC5;MORF4L2;SIN3B;MIER3;TBL1XR1;HDAC2;RCOR1;TBL1X
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.5283370883732084,1.0456679970746101,0.4554744525547445,0.9571285804363713,1.0,2/13,4.71%,ALG3;MPDU1
prerank,central nervous system myelination (GO:0022010),0.5431301470249241,1.0452526212173003,0.4666666666666667,0.9577410143965782,1.0,4/11,14.70%,TENM4;B4GALT5;PLP1;PTEN
prerank,regulation of macrophage chemotaxis (GO:0010758),0.4862088209361899,1.0451506341444425,0.45046235138705415,0.9573526709750189,1.0,4/21,5.62%,THBS1;MTUS1;CMKLR1;MAPK1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5194036543836682,1.0448827815761894,0.4257142857142857,0.957478234935068,1.0,3/15,9.84%,UST;DSE;BGN
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4173698756509855,1.0448052571061632,0.4194560669456067,0.9570155614065444,1.0,17/85,13.94%,PLK1;LRRK2;FBXW7;DVL1;NUPR1;PSMC5;TMEM259;KEAP1;SUMO2;DAB2;RCHY1;USP5;SOCS5;RNF144B;HECTD1;ATXN3;CSNK1A1
prerank,histone H3-K9 demethylation (GO:0033169),0.5476259629276475,1.0446523082372923,0.44314868804664725,0.9567927718655406,1.0,4/11,11.95%,KDM3A;JMJD1C;KDM4B;KDM4C
prerank,sphingoid metabolic process (GO:0046519),0.5400575348790926,1.0446371335147338,0.42528735632183906,0.9561441964218509,1.0,2/12,5.74%,SGPP1;SGPP2
prerank,secondary alcohol biosynthetic process (GO:1902653),0.46663625707565604,1.0445568423601619,0.4381752701080432,0.9556864669466365,1.0,3/30,4.43%,INSIG1;INSIG2;GGPS1
prerank,telomere maintenance via telomerase (GO:0007004),0.46594392900897474,1.044487038600141,0.4251207729468599,0.9552190239742328,1.0,5/28,7.41%,RAD50;TERF2;CDK2;HSP90AA1;MRE11
prerank,catecholamine biosynthetic process (GO:0042423),0.5474789774102822,1.0443667077854704,0.4302848575712144,0.9549033691843128,1.0,1/11,3.69%,TGFB2
prerank,positive regulation of chemokine production (GO:0032722),0.448475016299573,1.044306038314142,0.43222222222222223,0.9544053425408203,1.0,11/44,14.85%,EIF2AK2;TLR7;TLR3;IL18;MAVS;IL17RA;HMGB1;SYK;LGALS9;AIF1;TLR4
prerank,dendritic cell differentiation (GO:0097028),0.4905631779888185,1.0439310415006628,0.4318471337579618,0.9548466703943985,1.0,5/22,13.99%,GAS6;AXL;LYN;TGFBR2;LGALS9
prerank,positive regulation of interleukin-6 production (GO:0032755),0.43289599203050433,1.0438485253246,0.4057203389830508,0.9543745358794832,1.0,13/68,14.85%,ISL1;IL16;TLR7;IL1A;TLR3;MAVS;IL17RA;HMGB1;SYK;LGALS9;RAB7B;AIF1;TLR4
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.44005430681207164,1.0438433871794888,0.4293537787513691,0.9530071908921077,1.0,8/51,7.70%,BANF1;KPNB1;VPS4A;PPP2R2A;NUP205;AHCTF1;NUP98;LEMD2
prerank,mitotic nuclear membrane organization (GO:0101024),0.44005430681207164,1.0438433871794888,0.4293537787513691,0.9530071908921077,1.0,8/51,7.70%,BANF1;KPNB1;VPS4A;PPP2R2A;NUP205;AHCTF1;NUP98;LEMD2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5538356155257785,1.043523464271268,0.4467408585055644,0.9532985355674265,1.0,4/10,12.92%,ESR1;PSMC5;HMGB1;TP53
prerank,negative regulation of cell differentiation (GO:0045596),0.4177025743230144,1.0435067151489783,0.41783567134268534,0.9526615826664475,1.0,24/181,14.94%,BMP5;RORA;ADAMTS12;SMAD6;CTR9;HOPX;IQCB1;SMAD3;CRIM1;LRP5;SPRED2;CDK6;LDLRAD4;TRPM4;PPARG;ABCG1;USF3;ABCA1;TGFBR1;SPRED1;ADIPOR1;ABCA5;PTEN;ANP32B
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.41842531396657245,1.0431529675472289,0.43548387096774194,0.9530772188279825,1.0,24/151,15.17%,LCAT;DEGS1;MGST3;SGPP1;HACD1;CERS6;SGPP2;ACER3;NFS1;CHKB;GOLPH3;PLA2G4A;SLC25A2;B4GALT5;CERS4;FURIN;SGPL1;SLC27A1;CERS5;CHKA;PRKD2;HACD4;SPTLC1;SLC44A1
prerank,mitotic chromosome condensation (GO:0007076),0.4807268436862417,1.0424787138142635,0.4302030456852792,0.9545004848656832,1.0,3/26,8.22%,PLK1;NCAPD3;SET
prerank,response to ionizing radiation (GO:0010212),0.4265144255991501,1.0416983482714832,0.4362272240085745,0.9562570455981427,1.0,12/70,12.92%,BRCA1;BLM;GRB2;CLOCK;SMPD1;XRCC4;STK11;BABAM2;RFWD3;TANK;MAPK14;TP53
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.4149812887189873,1.041424076738649,0.358,0.9563759831074294,1.0,108/476,17.62%,WNT4;BRCA1;RORA;ANKRD49;BLM;PARP9;RELA;IRF1;SMARCA4;CD38;SP1;ILF3;ZFP90;CASZ1;TFAP4;SS18L1;SNX5;PCBD2;CLOCK;RUNX1;HCFC1;ZNF318;PSMD9;NFATC1;JUN;AR;KDM5A;WBP2;EP300;SMAD3;PDGFB;TEAD1;LRP5;ESR1;ACVR1;KDM3A;BRCA2;PSMC5;KMT2E;IKBKB;SEC14L2;NCOA1;SETD3;CHEK2;ZXDC;PPARG;TAL1;DEAF1;NAA16;CHD8;FBXW11;ZNF711;CREB3L2;SOX11;TRIM44;PPM1A;TP53INP2;BRD7;MLLT11;HIPK2;TP53;TGFBR1;RNF20;NR1D2;LRP6;MAP2K2;NAA15;RXRA;EPC1;FUBP3;TRIM56;GTF2H1;CAMKK2;RREB1;CREB1;RFX3;EDRF1;PPARD;HIVEP3;TBL1XR1;CTCF;NPAS3;SMAD4;NPM1;PHIP;SMARCA2;CRLF3;HDAC2;FOXK1;NFIB;RGMB;ARID1B;MAP2K1;MEF2C;CEP290;SMARCC2;HNRNPD;RORB;TBL1X;NFYA;FOXO3;MAP3K2;MDFIC;MED1;USP21;USP16;CTNNB1;TFEB
prerank,chromosome organization (GO:0051276),0.4214149045388102,1.0408322932519323,0.4395833333333333,0.9574574774868683,1.0,18/99,12.47%,CETN2;EHMT1;SMARCA4;SUV39H1;ZBTB7A;PADI2;COPS7B;HMGN3;HDAC11;HDAC5;MTHFR;GATAD1;EZH2;COPS4;RFWD3;CUL4A;ABL1;TCF7L2
prerank,regulation of fibrinolysis (GO:0051917),0.5253076534331054,1.040766534639645,0.43515850144092216,0.9569721827898534,1.0,1/13,4.55%,THBS1
prerank,membrane lipid metabolic process (GO:0006643),-0.3531268471827669,-1.0407378221198327,0.38392857142857145,0.9495838045709699,1.0,9/22,23.37%,CERK;TEX2;AGK;AGMO;ST3GAL6;ST6GALNAC4;ARV1;GAL3ST1;B4GALT4
prerank,intracellular protein transport (GO:0006886),0.4151672701993984,1.0407253557757299,0.397,0.9564025229976958,1.0,75/304,15.30%,STXBP2;LMAN1;ARL5A;TMED4;BAG3;ARL4A;KPNB1;EIF4ENIF1;ARL6;ARF3;DESI1;COPB2;EHD1;NAPG;HIKESHI;TBC1D15;STX7;KIF13A;HEATR3;SIL1;EVI5;TMED9;RANBP6;IPO7;AP2A1;IPO9;TBC1D17;CAMSAP3;RAB5B;PTTG1IP;GIPC1;VPS45;RAB6A;STX3;CSE1L;TBC1D14;VPS35;STX16;ARL4C;STX17;TBC1D10B;IPO5;WLS;HPS4;ARF1;SNX1;TMED2;TBC1D4;RAB18;TBC1D12;IPO11;SORL1;SNX8;TBC1D5;TBC1D10A;VIPAS39;SRPRA;TBC1D13;ERP29;RABGAP1;TMED5;NAPA;RPGR;SYK;SAR1B;UNC93B1;TBC1D22A;GGA1;TBC1D8;RAB7A;CLTC;TBC1D1;NPM1;PPP1R10;SNX13
prerank,regulation of cellular response to stress (GO:0080135),0.4139783757990599,1.0403642730631601,0.42972699696663297,0.9568383024706761,1.0,20/115,8.68%,DNAJB1;HSBP1;ADCY8;BAG3;NUPR1;HIKESHI;USP19;HSPH1;YWHAE;NUP205;EP300;MAPK1;SLC38A2;CHORDC1;HSP90AA1;MAPT;NUP98;CAMK2D;ALOX5;NUP54
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.48267561870944736,1.0403191367354425,0.4238993710691824,0.9562878613805454,1.0,3/25,6.07%,LRRK2;RAB3GAP1;ARRB2
prerank,regulation of muscle cell differentiation (GO:0051147),0.46001509846880406,1.0402266873399184,0.4304556354916067,0.9558947961182447,1.0,11/31,17.61%,HDAC9;CTNNA1;MEF2A;CDK9;CDC42;ABL1;MAPK14;MEF2C;CTNNA2;CAMK1;CTNNB1
prerank,inner mitochondrial membrane organization (GO:0007007),0.44544715047358574,1.0401875552619473,0.45067264573991034,0.95533119459647,1.0,12/47,15.74%,ATP5F1A;MTX1;ATP5MC3;LETM1;HSPA9;ATP5MC2;MICOS10;DNAJC11;APOOL;CHCHD6;TIMM9;ATP5F1B
prerank,B cell homeostasis (GO:0001782),0.5530011355661513,1.0398034746958071,0.4613003095975232,0.9558212937252311,1.0,6/10,17.29%,LYN;CAMLG;DOCK11;MEF2C;DOCK10;NCKAP1L
prerank,regulation of type I interferon production (GO:0032479),0.42704846773297156,1.0394600326020698,0.4342379958246347,0.9561756150269759,1.0,15/84,10.15%,POLR1C;POLR3G;RELA;IRF1;POLR3H;IRF3;POLA1;ILRUN;EP300;PRKDC;MRE11;CRCP;MAVS;RNF216;POLR3A
prerank,regulation of RNA splicing (GO:0043484),0.42681307897943216,1.0393400922472324,0.43125,0.955847960020515,1.0,28/69,18.61%,HABP4;POLR2A;MBNL1;SLC38A2;PTBP3;RRP1B;SNRNP70;MBNL2;SETX;FUS;U2AF2;AFF2;SF1;QKI;ERN1;SRPK2;HNRNPH3;CLK1;HNRNPH1;HNRNPK;PIK3R1;HNRNPL;SRSF3;SON;TMBIM6;KHDRBS1;CELF1;KHDRBS3
prerank,cochlea morphogenesis (GO:0090103),-0.4482329865141986,-1.0392410889223456,0.4331395348837209,0.950925260296838,1.0,5/10,44.39%,TIFAB;HPN;PAX2;SOX9;MYO3B
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.469727542937773,1.0391980491727897,0.4331742243436754,0.9555776429191333,1.0,8/29,15.08%,RAPGEF1;GRB2;IRS2;LYN;NOTCH2;SHOC2;RELN;VAV1
prerank,N-terminal protein amino acid modification (GO:0031365),0.4998909641269835,1.039197495228943,0.4452054794520548,0.9548967897327266,1.0,4/14,13.16%,METAP1;NAA35;NAA16;NAA15
prerank,response to thyroid hormone (GO:0097066),0.5246464447803617,1.0390110907981027,0.45845697329376855,0.9547826138304781,1.0,2/13,2.99%,BRD8;KLF9
prerank,pigment granule transport (GO:0051904),0.5075349665857796,1.0389316705888116,0.4328947368421053,0.9536619581447723,1.0,3/18,5.36%,ARL6;BBS4;MYO5A
prerank,melanosome transport (GO:0032402),0.5075349665857796,1.0389316705888116,0.4328947368421053,0.9536619581447723,1.0,3/18,5.36%,ARL6;BBS4;MYO5A
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.4713107818909214,1.0388467914031627,0.4197689345314506,0.9532597524272058,1.0,9/24,17.61%,CTNNA1;MEF2A;CDC42;ABL1;MAPK14;MEF2C;CTNNA2;CAMK1;CTNNB1
prerank,protein tetramerization (GO:0051262),0.4294249781742576,1.0387677954292243,0.4256900212314225,0.9528225446543189,1.0,13/67,16.25%,ALDH1A2;FARSA;SSBP1;ALDOA;HPRT1;ACOT13;TRPM4;MCOLN1;PKD2;ACACA;HCN1;GLS;OSBPL2
prerank,neuron projection extension (GO:1990138),0.45939205964299296,1.0385014082924886,0.44260355029585796,0.9529387735328471,1.0,13/32,17.61%,IMPACT;NRP1;HSP90AA1;SLC9A6;CDK5;ULK2;SPG11;NRP2;AUTS2;IQGAP1;SH3GL2;CYFIP1;CTNNB1
prerank,cellular lipid catabolic process (GO:0044242),-0.3352376305304595,-1.0382330781536289,0.3879781420765027,0.9507832076797537,1.0,6/27,8.76%,ENPP2;SIRT2;LPIN2;ACOX1;PLA2G15;LPIN1
prerank,positive regulation of transport (GO:0051050),0.42014583708889214,1.0379517490999042,0.43626943005181346,0.953847949056827,1.0,9/85,10.14%,SGK2;CAMK1D;SMPD1;GAS6;CBLL1;ABCA7;DAB2;PLAA;ANXA2
prerank,regulation of acrosome reaction (GO:0060046),-0.4577296611711929,-1.0378013808064779,0.4481792717086835,0.9489014389897434,1.0,1/10,12.14%,GLRA1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3265862098234794,-1.0376083267148546,0.4,0.9462614647736619,1.0,14/30,20.99%,BMPR2;DACH1;TENT4B;HNRNPU;NIBAN2;EXOSC10;DCP2;HNRNPA1;PINX1;STN1;GNL3L;NAT10;TEN1;SRC
prerank,tryptophan catabolic process (GO:0006569),-0.4405094931293527,-1.0373585867045676,0.39755351681957185,0.9438562738347035,1.0,6/11,50.09%,KYNU;KYAT1;HAAO;KMO;IL4I1;AFMID
prerank,Rho protein signal transduction (GO:0007266),0.43889991615587753,1.0372819529254909,0.43061674008810574,0.9552390436295924,1.0,11/53,14.97%,RIPOR1;ARHGEF3;CFL1;PLEKHG5;EPS8L1;ARHGAP1;EPS8;CDC42;MYO9B;ROCK2;ARHGDIB
prerank,negative regulation of hippo signaling (GO:0035331),-0.43250082712474136,-1.0367483951528338,0.40307692307692305,0.942504865834292,1.0,9/12,31.80%,LIMD1;MARK3;DLG5;CIT;MAP2K3;SHANK2;WWC1;WTIP;WWC2
prerank,cellular response to oxidative stress (GO:0034599),0.41718520269757453,1.0366229705118328,0.43089430894308944,0.9564906183237123,1.0,26/118,15.27%,MGAT3;PYCR2;SLC25A24;LRRK2;VKORC1L1;JUN;TPM1;MAPK1;KEAP1;MAPT;MAPK8;DAPK1;ADNP2;SETX;PXN;ABL1;TXNRD2;NCF4;TP53;EIF2S1;CAMKK2;HTRA2;PKD2;AIF1;ARNT;MSRA
prerank,positive regulation of interleukin-8 production (GO:0032757),0.4402839813398961,1.0365433730688787,0.44568868980963045,0.9560794372996323,1.0,10/49,14.85%,RELA;TLR7;TLR3;MAVS;F3;HMGB1;SYK;PRKD2;LGALS9;TLR4
prerank,proteasome assembly (GO:0043248),0.5420497897700047,1.036502548058388,0.4497816593886463,0.955530039043614,1.0,2/11,5.30%,PSMD9;POMP
prerank,multivesicular body organization (GO:0036257),0.4644103357999844,1.0364355599267414,0.4369846878680801,0.9550514908070281,1.0,9/31,14.18%,TSG101;VPS4A;CHMP5;HGS;VPS37C;VPS37A;VPS4B;PDCD6IP;IST1
prerank,protein localization to membrane (GO:0072657),0.41161685956474764,1.035896011860594,0.4291457286432161,0.9559971877536554,1.0,40/187,13.72%,PDZD11;ARL5A;DVL1;FLOT2;ZFYVE27;EHD4;ITGB1BP1;RAB8B;EHD1;BRAF;GAS6;RAB40C;RAB12;RFTN1;CPE;RAP1A;FLNA;RABEP1;MYO5A;TM9SF1;ITGA4;EZR;PPIL2;IKBKB;DLG1;SLMAP;SPTBN1;NUP54;HGS;EFR3B;RAMP1;TMED2;PACS2;EPB41L3;SH3GLB1;RAB3C;LRP6;LIN7A;PACS1;KCNIP3
prerank,neutrophil mediated immunity (GO:0002446),0.41071776977170127,1.0357611559767432,0.399,0.955721693602444,1.0,74/432,12.95%,STXBP2;TUBB4B;VCL;DEGS1;PDXK;SLC2A3;SLCO4C1;NRAS;C5AR1;CD36;IRAK4;AP1M1;RHOF;KPNB1;PDAP1;VAMP7;UNC13D;PGAM1;CTSC;ACTR1B;COMMD3;ERP44;RAP1A;PADI2;IQGAP2;HMOX2;ALDOA;ENPP4;APAF1;HVCN1;QSOX1;MAPK1;GDI2;STOM;PTPRJ;SCAMP1;SDCBP;TMEM30A;PLEKHO2;OSTF1;HSP90AA1;RAB5B;KMT2E;LAIR1;GSDMD;RAP1B;RAB6A;ARSB;ALOX5;DOK3;ADGRE5;CD44;ATP8B4;B4GALT1;VAMP2;CD63;CANT1;ANXA2;CTSZ;MVP;ASAH1;DIAPH1;DBNL;RAB18;HMGB1;RNASE3;YPEL5;PLD1;PSMD12;MAPK14;ADAM10;FUCA1;NHLRC3;PSMA2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.4871326617038468,1.035732725458581,0.4601889338731444,0.9551330089870992,1.0,6/19,15.74%,NRP1;PTPRJ;LIMS1;ABL1;TSC1;MAP4K4
prerank,brain morphogenesis (GO:0048854),0.5243310795454406,1.0354827728520923,0.45790251107828656,0.955191320818699,1.0,4/12,16.94%,BBS4;FBXW11;PTEN;CTNNA2
prerank,cellular response to virus (GO:0098586),0.4697714329336969,1.0352746734689882,0.43665436654366546,0.9551905222761097,1.0,7/30,13.99%,RIOK3;IRF3;HSP90AA1;RRP1B;ARF1;MAPK14;LGALS9
prerank,smooth muscle cell differentiation (GO:0051145),0.5447043582025451,1.0349465078744138,0.45588235294117646,0.9555141512562642,1.0,3/12,16.27%,MRTFB;MRTFA;MEF2C
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.4881977280578115,1.0345673069133192,0.47035040431266845,0.9559825309813774,1.0,3/19,7.65%,POLD3;HPRT1;DGUOK
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.48709365990706716,1.0340189441496466,0.44049247606019154,0.9569178894977378,1.0,7/19,15.60%,SS18L1;CUX1;LRP8;DBNL;CDKL5;RELN;CAPRIN1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5223892821858913,1.0337797409873712,0.4605263157894737,0.9569826382876497,1.0,4/13,9.84%,KPNB1;KPNA6;NUP54;IPO5
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.43485883982740003,-1.0336844140866468,0.42424242424242425,0.9487485830756703,1.0,4/11,8.31%,ATP1B1;ATP1A1;KCNJ2;KCND3
prerank,error-prone translesion synthesis (GO:0042276),0.4887097567102526,1.0335350637940766,0.4701195219123506,0.957025058959257,1.0,2/21,1.62%,RFC2;POLE2
prerank,regulation of interleukin-6 production (GO:0032675),0.42178605305238714,1.033428130065762,0.42505133470225875,0.9567025561852376,1.0,18/96,15.45%,ISL1;CX3CL1;IL16;TLR7;GAS6;IL1A;SYT11;TLR3;MAVS;IL17RA;HMGB1;MAPKAPK2;SYK;LGALS9;RAB7B;AIF1;TLR4;CD47
prerank,regulation of intracellular signal transduction (GO:1902531),0.4116115151060286,1.033300495739887,0.395,0.9564091586206336,1.0,93/420,15.08%,BRCA1;LRRK2;BLM;BOP1;EHMT1;RFC2;RELA;ARHGEF3;MINK1;RAD50;FGF1;RHOF;FGD3;FGD1;PLEKHG2;DYRK2;PRKAR2A;PLEKHG5;ITSN1;ANKRD54;PIP4K2A;ARHGEF12;WRN;EP300;CDK2;TAGAP;SQSTM1;CMKLR1;MAPK1;VAV3;FAM13B;BIRC3;EHMT2;STK11;FBXO9;RNF34;EZR;RBBP8;ARHGAP22;MRE11;DLG1;MAP2K6;MAPT;PAK2;MAPKAP1;NBN;PHF20;ARHGAP1;TAF4;ZFAND6;PHLPP1;CHEK2;PIP4K2B;KALRN;LYN;TMBIM4;MYO9A;CDK5;TAOK1;ARHGAP35;AKAP13;CDC42;NOC2L;TRAF2;RIT2;ARHGAP39;ARHGEF17;MTOR;TMSB4X;PRDM1;OCRL;VAV2;MAPK14;BRD7;CYLD;ARHGAP15;ARHGAP32;MYO9B;HIPK2;TP53;RBBP7;ARHGAP45;PPP1R16B;SPRED1;PRKD2;PEX5L;SLC15A4;PPP2R5C;OPTN;PTEN;ARHGAP31;ARHGDIB;VAV1
prerank,lipid modification (GO:0030258),0.4524259720162328,1.033191001953213,0.44314185228604924,0.9560488851561662,1.0,6/37,10.16%,PLA2G7;SGPP1;SGPP2;DGKI;ALOX5;DGKD
prerank,regulation of JNK cascade (GO:0046328),0.4138393016410916,1.0327124870670754,0.4387755102040816,0.9567678173758661,1.0,19/101,12.87%,UNC5CL;DUSP3;MINK1;TPD52L1;SH3RF3;MAP3K11;SDCBP;DUSP10;NCOR1;PHLPP1;TAOK1;FKTN;TRAF2;IGF1R;ZMYND11;HMGB1;AIDA;CYLD;HIPK2
prerank,negative regulation of autophagy (GO:0010507),0.43434239769093336,1.0326062784493455,0.44191096634093374,0.9564178046155631,1.0,13/54,15.89%,WDR6;LRRK2;NUPR1;QSOX1;TBC1D14;SNRNP70;TAB3;MTOR;LZTS1;BCL2;TSC1;ATG7;FOXK1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.41349469304148645,1.032592532237877,0.45257731958762887,0.9557932687282598,1.0,19/100,12.89%,PLK1;LRRK2;DVL1;GLMN;UBXN1;DESI1;MAP1A;SDCBP;KEAP1;GIPC1;SUMO2;UCHL5;DAB2;RCHY1;USP5;SOCS5;RNF144B;CAMLG;HECTD1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.42829568303803617,1.0325697529755768,0.43057050592034446,0.9551867373731869,1.0,12/54,14.91%,KCNJ6;CACNA1D;FLNA;YWHAE;NEDD4;DLG1;CD63;KCNIP3;GNG2;GNB1;KCNMB2;KCNMB3
prerank,organic acid transport (GO:0015849),0.41682630096748174,1.032280212552663,0.4494264859228363,0.9553706994024782,1.0,16/94,15.52%,SFXN5;SLCO1B1;SLC7A2;SLC38A2;SLC7A11;SLC7A7;NCOA1;SLC7A8;STARD5;SLC25A32;SLC27A1;RXRA;SLCO2B1;PPARD;NCOA2;ABCG2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.41026017387461355,1.0318276615142037,0.399,0.9560633604114581,1.0,99/497,15.71%,WNT4;BRCA1;EHMT1;EIF4A3;CNOT10;THAP7;DMAP1;RELA;IRF1;SMARCA4;CD38;EIF2AK1;EIF2AK2;SUV39H1;ILF3;TFAP4;EIF4ENIF1;SOX13;RLIM;SYNCRIP;CLOCK;SAP18;GAS6;MALSU1;ZNF318;JUN;TLE2;ATXN1;ZBTB7A;ELK3;BCL6;HDAC9;RBM15;SPEN;ARID5B;PDGFB;CIPC;RBAK;DPF2;HDAC5;NR3C1;SCMH1;IKZF1;TLE1;PDS5A;PHF10;MECP2;SET;RPS6KA5;EZH2;LIMS1;NACC1;NCOR1;DAPK1;FXR2;CNOT9;PPARG;CTBP1;HMBOX1;ENO1;CDK5;DEAF1;LOXL3;UBE2I;ZNF568;FOXN3;BCL7A;CHD8;FBXW11;PHC3;PSPC1;ZBTB38;ZMYND11;LSM14A;COMMD7;NCOR2;YEATS2;TCF7L2;BRD7;SAMD4A;TP53;NR1D2;EPC1;TERF1;RFX3;RBPJ;PPARD;EIF4E2;LDB1;TSC1;CTCF;SMAD4;ZBTB18;PEX14;SMARCA2;PBXIP1;HDAC2;CAPRIN1;CIC
prerank,positive regulation of protein depolymerization (GO:1901881),0.5405009045646061,1.0317732189025361,0.45537065052950076,0.9555683201420277,1.0,2/11,12.08%,STMN2;WDR1
prerank,negative regulation of transport (GO:0051051),-0.2745936604882128,-1.0315419658841827,0.4444444444444444,0.9523095647807784,1.0,16/51,19.56%,PRKN;PXK;MTMR2;SNX12;FCGR2B;PIP4P2;SNCA;SIRPA;EPHA3;PRKD1;RACK1;LILRB1;LRSAM1;TLR2;CTTNBP2NL;BST2
prerank,cellular response to cytokine stimulus (GO:0071345),0.4119153144166478,1.0308865279450488,0.403,0.9574941907034109,1.0,66/416,15.08%,CXCL12;BRCA1;RORA;ADAMTS12;S1PR1;CD36;RELA;CX3CL1;IRAK4;IRF1;RAPGEF1;PID1;LDLRAP1;NUMBL;DOCK8;IL16;GRB2;SYNCRIP;BCL2L11;GAS6;BCL6;LIFR;SMAD3;IL10RB;PRKACA;PTPRJ;AXL;IL1A;HSP90AA1;IKBKB;CCL25;MAPK8;STX3;CDK9;IL1RAP;F13A1;ALOX5;PTPRT;IL18;IRAK2;ZFAND6;DAPK1;LRP8;PTPN23;SOCS5;F3;MT1X;ASAH1;TANK;IFNAR2;LRCH1;CBL;ZFP36L1;SH2B3;TP53;BCL2;SYK;FN1;FYN;HTRA2;LGALS9;AIF1;PTPN9;TLR4;PTPN18;VAV1
prerank,COPII-coated vesicle budding (GO:0090114),0.42753458160073415,1.030727053163218,0.44278074866310163,0.957340283809461,1.0,17/68,14.11%,LMAN1;GOSR2;PEF1;CTSC;AREG;TRAPPC3;TRAPPC9;CTSZ;TFG;SEC24B;MIA3;SEC24D;TMED2;TGFA;NAPA;SAR1B;TRAPPC6B
prerank,"wound healing, spreading of cells (GO:0044319)",0.4746331170317248,1.0305133826440083,0.4327784891165173,0.9572669159231552,1.0,6/24,16.13%,DDR1;FLNA;CD44;ARHGAP35;TMEFF2;MRTFA
prerank,acute inflammatory response (GO:0002526),-0.3407583990840231,-1.0302637525428449,0.39565217391304347,0.9531138500111589,1.0,4/23,22.09%,ANO6;IL22;CEBPB;CTNNBIP1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.44217960258519845,1.0302035364855173,0.4445701357466063,0.9575573465286287,1.0,7/41,12.98%,DEGS1;GPX4;PLA2G4A;ALOX5;FADS1;ABCD1;HSD17B4
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5367650295575643,1.030172113161483,0.43778110944527737,0.9569877439270731,1.0,3/11,6.42%,NUPR1;PELI1;BIRC3
prerank,histone H3 acetylation (GO:0043966),-0.29431668064649563,-1.0301229329150978,0.38524590163934425,0.95031764383445,1.0,23/40,29.91%,KAT6A;MBIP;JADE2;ING4;KAT14;MEAF6;KAT6B;BRPF1;BRD1;BRPF3;WDR5;JADE1;TADA1;DR1;ING5;TAF12;TAF5L;SGF29;TADA3;TAF6L;NAA60;KAT2A;PER1
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.40664239075841285,-1.0300895894957072,0.43973941368078173,0.9472393939060155,1.0,9/14,59.35%,ADAM8;IL6ST;PARK7;TNF;OSM;IL1B;PTGER3;OSMR;IL6
prerank,UV protection (GO:0009650),-0.4495684107714549,-1.0299782188610427,0.4438202247191011,0.9444387858908788,1.0,3/10,10.75%,ERCC5;XPA;CAT
prerank,L-glutamate transmembrane transport (GO:0015813),-0.4563525426095627,-1.0297357327156715,0.44574780058651026,0.9420789813498958,1.0,2/10,3.26%,SLC1A2;SLC25A13
prerank,insulin receptor signaling pathway (GO:0008286),-0.27162032599722313,-1.0294832860154322,0.30434782608695654,0.9396715625772883,1.0,23/69,16.46%,ATP6V0A1;GAB1;ATP6V1A;PTPN2;AP3S1;APPL1;SORBS1;GSK3B;GRB14;IDE;ATP6V1D;PIK3CA;GRB10;ATP6V0C;SLC39A14;ATP6AP1;BAIAP2;ATP6V0B;AKT1;RHOQ;ATP6V1C1;SHC1;ATP6V1G1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.49021323020122326,1.029389670743899,0.46194225721784776,0.958608720708359,1.0,3/18,9.65%,C5AR1;CMKLR1;LYN
prerank,zinc ion homeostasis (GO:0055069),0.4585617172253492,1.0288054492456,0.4441717791411043,0.9596291649840789,1.0,9/28,12.50%,MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;SLC39A10
prerank,innate immune response (GO:0045087),0.41117256945497316,1.0287649150397271,0.4383149448345035,0.959075603247724,1.0,38/217,14.06%,ANG;RNASE6;SERINC5;IFITM3;RELA;IRAK4;TTC4;ADAM15;CYBC1;ANKHD1;SMPD1;AKAP1;BTK;YES1;IKBKB;SETD2;PYDC1;TLR3;ZDHHC1;SERINC3;MAVS;PPARG;LYN;POLR3A;ADAR;COLEC12;TRIM5;HMGB1;RNASE3;CYLD;SRPK2;SYK;S100B;COLEC11;TRIM56;FYN;TRIM59;RNF135
prerank,rRNA methylation (GO:0031167),0.4710227668624576,1.0286859182338843,0.44778067885117495,0.9586658011718123,1.0,3/22,6.76%,EMG1;TFB2M;NSUN3
prerank,phosphate ion transmembrane transport (GO:0035435),0.536702430128778,1.0285935943521074,0.4650817236255572,0.9582841550180983,1.0,5/12,14.89%,SLC37A2;XPR1;SLC37A3;SLC20A2;SLC25A3
prerank,regulation of lymphocyte activation (GO:0051249),-0.43063590643473865,-1.0285493751942494,0.4086687306501548,0.9393596910993728,1.0,1/12,0.43%,PAG1
prerank,cholesterol biosynthetic process (GO:0006695),0.4562060823601075,1.0281909901137691,0.4551971326164875,0.9587937355213271,1.0,3/31,4.43%,INSIG1;INSIG2;GGPS1
prerank,regulation of innate immune response (GO:0045088),0.42589142659173895,1.0281750729480366,0.4626218851570964,0.9581737606075468,1.0,13/57,14.14%,PARP9;POLR3G;RIOK3;IRF1;IFI35;BIRC3;AKIRIN2;PTPN1;LRP8;IFNAR2;ERAP1;RNF135;SLC15A4
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.40873923993145556,1.027884726171807,0.342,0.9583932832302287,1.0,288/1668,15.71%,POU2F3;FHL5;ISL1;BMP5;GLIS1;PLK1;RGCC;BRCA1;MDFI;SRCAP;IER2;RORA;WFS1;DNAJB1;MED10;ZIC4;URI1;SIRT7;SP8;HSBP1;PARP9;PELP1;KDM1B;RPRD1B;THAP7;ZBTB8A;DMAP1;RELA;CX3CL1;IRF1;DVL1;SMARCA4;SP1;BRD8;SMAD6;CTR9;SUV39H1;HOPX;PSIP1;ACTR3;VPS72;PID1;FGF1;ZFP90;CASZ1;TFAP4;POU5F2;SOX13;PPID;KLF9;ITGA6;SS18L1;ITGB1BP1;ZBTB5;IMPACT;TGIF1;CLOCK;ZEB2;BBX;RUNX1;SAP18;SLC9A1;MAX;HCFC1;IGBP1;BMPR1A;NFATC1;JUN;AR;ELP3;ATXN1;ZBTB7A;ZNF569;PRDM10;ELK3;WBP2;IRF3;BCL6;HDAC9;CDK7;TRPS1;N4BP2L2;PRKCB;PAXBP1;TARBP1;EP300;SMAD3;SPEN;ARID5B;TEAD1;RBAK;BUD31;LRP5;PRKDC;SQSTM1;LIN9;TNRC6B;ZNF467;DPF2;ESR1;MRTFB;HDAC5;SDCBP;NR3C1;ACVR1;EHMT2;IKZF1;JUND;RPRD1A;KDM3A;MAML3;PRDM4;MAMLD1;PSMC5;CRTC1;MAML2;EZR;NCOA5;BCLAF3;MNAT1;MEF2A;IKBKB;RBBP8;MLIP;RRP1B;DLG1;PHF10;WIZ;MECP2;TFCP2;AKIRIN2;CUX1;DRGX;TLR3;NCOA1;SETD3;AGO2;KDM5B;PRPF6;RPS6KA5;CDK9;CAMK2D;PHF20;EZH2;NCK1;TADA2A;IL18;DAB2;JMJD1C;NACC1;MAFG;NCOR1;NCOA3;FNIP1;PCGF5;ZXDC;PHF6;BAZ2B;BRD2;MAVS;AHI1;SSU72;ORC2;PPARG;MTDH;SSBP3;NR6A1;SIN3B;CTBP1;GLYR1;SETX;TAL1;HMBOX1;ENO1;FUS;CDC5L;DEAF1;HBP1;HIVEP1;HOXC4;ZBTB46;ELOC;TCF12;UBE2I;NOC2L;ZNF568;ARID4B;SP140;CHD8;ZSCAN29;EPC2;NR5A1;KAT2B;CREB3L2;NR2C2;SOX11;ZBTB38;BCL11A;ECD;MAP2K5;TSHZ2;ZNF182;PRDM1;PPM1A;NCOR2;HIVEP2;DNMT3A;GMEB2;ABL1;KDM4C;RPAP2;YEATS2;HMGB1;ZFP69;BACH2;DNAJA3;TCF7L2;MIER3;MAPK14;ZBTB34;ATF6;SOX6;TGFA;BRD7;BRD3;HIPK2;TP53;ATRX;MAF;CTDP1;NR1D2;KLF13;MYT1L;LRP6;LCOR;RXRA;EPC1;CDK8;MED27;FUBP3;PPARGC1B;NFX1;WWOX;SP4;GTF2H1;DDX5;KCNIP3;RREB1;CARF;PRKD2;PKD2;CREB1;RFX3;RBPJ;PHF20L1;TET2;PPARD;ZMYM5;DACH2;HIVEP3;TBL1XR1;UBE2D3;MED15;NCOA2;PTEN;WASL;LDB2;LDB1;TLR4;CTCF;ARNT;NPAS3;SMAD4;ZBTB18;NPM1;PHIP;PIAS1;SMARCA2;AKAP8L;CRLF3;THAP3;ZFHX4;AUTS2;HDAC2;HNRNPK;BAZ1B;PIK3R1;CIC
prerank,inorganic ion transmembrane transport (GO:0098660),0.5283193188270198,1.0278142947850573,0.45413533834586467,0.9579437465350876,1.0,2/12,13.91%,TRPM4;PKD2
prerank,anterior/posterior axis specification (GO:0009948),0.5079253609575477,1.027763812718434,0.44950213371266,0.9574285648221109,1.0,2/15,11.94%,WLS;TASOR
prerank,phosphate-containing compound metabolic process (GO:0006796),0.41233813940438147,1.0277614451820194,0.42497482376636453,0.95677038265791,1.0,30/198,11.98%,LCAT;INPP1;LRRK2;DUSP3;EPHB2;PIP4K2A;ALDOA;INPP4A;INPP5A;NUDT5;GPX4;PI4KA;PAK2;PLA2G4A;DUSP16;DUSP10;PIP4K2B;CDK5;PLAA;TAOK1;MINPP1;PLD4;IPMK;GK;GCK;MTOR;PLCB4;PFKP;PPM1A;OCRL
prerank,negative regulation of RNA splicing (GO:0033119),0.4850453170114846,1.0276280244415472,0.4367509986684421,0.9564883292647983,1.0,6/19,12.16%,SAP18;RNPS1;PTBP3;SFSWAP;U2AF2;SRSF9
prerank,positive regulation of protein transport (GO:0051222),0.4247696893169943,1.0275940513051365,0.455026455026455,0.9559294871178728,1.0,14/67,12.93%,ANG;RIPOR1;PPID;TGFB2;PCNT;KIF20B;IL1A;EZR;GOLPH3;ABCG1;VAMP2;CD2AP;RUFY3;FRMD4A
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5432659099740506,1.0271758423724544,0.45671641791044776,0.9564681119939054,1.0,4/11,14.16%,RFTN1;TLR3;COLEC12;UNC93B1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.46792980693286257,1.0269477958171012,0.4508816120906801,0.9564629419106907,1.0,2/24,3.16%,MIEF2;ITGB1BP1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.414198316165523,1.0267037860436328,0.43887775551102204,0.9565132404946557,1.0,34/199,15.32%,BMP5;RGCC;SMAD6;CHSY1;GAS6;HDAC9;SPRED2;NRDC;ALDH1A1;BRCA2;STK11;ACOT13;MAP2K6;ABHD6;SYT11;LDLRAD4;RPS6KA5;LNPEP;DUSP10;NPTN;PROC;PTPN23;PAEP;USF3;PTPRO;SPRED1;MCC;ADIPOR1;RBPJ;ROCK2;PTEN;TLR4;ARHGDIB;EVL
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.49280905667524655,1.0265181225072515,0.4587765957446808,0.956441398043209,1.0,5/19,8.90%,NDST3;UGDH;GLCE;EXTL3;HS6ST2
prerank,O-glycan processing (GO:0016266),0.43327576562005793,1.0264085818254733,0.4557235421166307,0.9561018411199039,1.0,7/54,11.61%,GALNT1;GALNT12;GALNT3;C1GALT1;B4GALT5;ST6GAL1;B3GNT2
prerank,fatty acid catabolic process (GO:0009062),0.42311271424916935,1.0262399966203113,0.45464247598719315,0.9559329959106243,1.0,15/67,14.36%,AIG1;ACAT1;ECI2;ACADS;ECHS1;DECR1;ABCD2;CEL;CROT;ABCD3;ACADL;PCCA;ABCD1;HSD17B4;PPARD
prerank,histone H2A monoubiquitination (GO:0035518),-0.380677128349064,-1.0261947073068693,0.4186046511627907,0.9434885107432682,1.0,8/17,22.29%,BCOR;PCGF3;DDB1;RNF168;DDB2;CUL4B;SKP1;PCGF6
prerank,positive regulation of cytokine production (GO:0001819),0.41103777396832086,1.026142876263615,0.431,0.9555438442473864,1.0,48/292,14.95%,ISL1;RGCC;BRCA1;RORA;POLR1C;PRKCZ;POLR3G;RELA;IRF1;EIF2AK2;GLMN;POLR3H;IL16;TLR7;RUNX1;RFTN1;IRF3;EP300;PRKDC;IL1A;MRE11;TLR3;LACC1;SPTBN1;IL18;CRCP;MAVS;SLAMF6;F3;POLR3A;TRAF2;CYRIB;PAEP;SCAMP5;IL17RA;HMGB1;SORL1;MAPK14;SYK;PRKD2;LGALS9;ROCK2;RAB7B;HAVCR2;AIF1;G3BP1;TLR4;ARNT
prerank,glucose transmembrane transport (GO:1904659),0.4898127196802072,1.0260420542991007,0.45026881720430106,0.9551839109416703,1.0,1/18,1.39%,SLC2A3
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.45593832260600464,1.0260203723887318,0.43863912515188336,0.9545909502738087,1.0,9/30,14.53%,FBXW7;RNF31;UBE2J2;ABLIM3;HPS4;VPS11;SH3GLB1;HTRA2;UBE2D3
prerank,fatty acid transport (GO:0015908),0.4953522106719691,1.0260197844250012,0.47796143250688705,0.9539394126547115,1.0,4/17,14.36%,CD36;PPARG;SLC27A1;PPARD
prerank,neuron differentiation (GO:0030182),0.41048216179772934,1.025859429013257,0.4663991975927783,0.9537335230313523,1.0,19/165,14.80%,WNT4;IER2;WNT2B;TDP2;UGDH;VXN;RUNX1;TGFB2;TENM4;ADNP2;CDK5;EPHA5;SOX11;TGFBR1;MYT1L;LRP6;MYEF2;FZD3;LDB1
prerank,cellular response to misfolded protein (GO:0071218),0.4849769044840864,1.0258444174894201,0.4555112881806109,0.9531190453554971,1.0,7/20,13.77%,DNAJC18;UGGT2;POMT2;DERL1;UBE2W;UGGT1;ATXN3
prerank,cardiac cell development (GO:0055006),-0.43347195450980114,-1.0257971309648413,0.4349112426035503,0.9416061585597241,1.0,4/11,32.20%,NOTCH1;VEGFA;JAG1;CXADR
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.4081226418475922,1.0257743778661708,0.424,0.9526734445188226,1.0,82/417,15.71%,WNT4;BRCA1;EHMT1;THAP7;DMAP1;RELA;IRF1;SMARCA4;CD38;SUV39H1;ILF3;TFAP4;SOX13;RLIM;CLOCK;SAP18;GAS6;ZNF318;JUN;TLE2;ATXN1;ZBTB7A;ELK3;BCL6;HDAC9;RBM15;SPEN;ARID5B;PDGFB;CIPC;RBAK;DPF2;HDAC5;NR3C1;SCMH1;IKZF1;TLE1;PHF10;MECP2;SET;RPS6KA5;EZH2;LIMS1;NACC1;NCOR1;PPARG;CTBP1;HMBOX1;ENO1;CDK5;DEAF1;LOXL3;UBE2I;ZNF568;FOXN3;BCL7A;CHD8;FBXW11;PHC3;PSPC1;ZBTB38;ZMYND11;COMMD7;NCOR2;YEATS2;TCF7L2;BRD7;TP53;NR1D2;EPC1;RFX3;RBPJ;PPARD;LDB1;CTCF;SMAD4;ZBTB18;PEX14;SMARCA2;PBXIP1;HDAC2;CIC
prerank,negative regulation of viral life cycle (GO:1903901),0.5087409433120945,1.0255881747829332,0.4755927475592748,0.9525879887021939,1.0,5/15,17.39%,IFITM3;SNX3;TRIM5;TRIM26;GSN
prerank,synaptic vesicle membrane organization (GO:0048499),-0.3834173844707286,-1.0252362678168585,0.4291497975708502,0.9401989725989762,1.0,5/17,7.43%,SYNGR1;SNAP25;AP3D1;STX2;STX4
prerank,negative regulation of cellular metabolic process (GO:0031324),0.4457115179482422,1.0251667841536614,0.4576470588235294,0.9531780626887612,1.0,7/37,15.06%,BRCA1;RIN3;SDCBP;NCOR1;ATXN2;OPTN;ANKRD13A
prerank,cellular component maintenance (GO:0043954),0.5209566014294523,1.0251594314481984,0.4363103953147877,0.9525475461886858,1.0,6/12,17.88%,IGF1R;PRNP;INSR;FYN;LNPK;TREM2
prerank,external encapsulating structure organization (GO:0045229),0.4083938511127201,1.025142324963528,0.4574574574574575,0.9519359673319058,1.0,23/205,11.50%,COL14A1;ADAMTS12;DDR1;DDR2;ADAMTS2;ADAM15;ITGA6;NF1;ADAM12;THBS1;ADAMTSL3;ATP7A;PDGFB;ITGA4;ITGB5;COL11A1;ITGB8;ADAMTS10;CD44;BGN;FURIN;PXDN;LAMC1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.4868473684196357,1.024986106978377,0.4774193548387097,0.9516879486172272,1.0,5/19,9.31%,TLR7;IRF3;SETD2;TLR3;MAVS
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5571975133046249,1.0249197746224281,0.4697885196374622,0.9512055568858359,1.0,4/10,17.88%,CD36;MIA3;TLR4;TREM2
prerank,negative regulation of programmed cell death (GO:0043069),0.40891470459433377,1.0248697858617137,0.428,0.9507071660848899,1.0,59/355,13.16%,PLK1;WFS1;UBE2Z;RELA;CX3CL1;CD38;WDR73;SMAD6;CFL1;BAG3;NUPR1;BRAF;GAS6;NAA35;THBS1;FLNA;TNFAIP8;PRKDC;SQSTM1;AXL;GPX4;BIRC3;PSMC5;GOLPH3;API5;IKBKB;MRE11;HSPA9;MAPK8;PAK2;BNIP3L;BFAR;BABAM2;DAB2;BIRC6;ZFAND6;GRK5;TM7SF3;AREL1;AHI1;MTDH;PROC;CD44;SETX;TMBIM4;RNF157;NAA16;BNIP3;NOTCH2;IGF1R;CBL;RNF144B;DCPS;RAF1;ADAM10;TP53;BCL2;FMN2;NAA15
prerank,regulation of neuron apoptotic process (GO:0043523),0.41986543249041935,1.0243244789812025,0.46059365404298874,0.951671972007243,1.0,12/96,13.03%,ISL1;WFS1;NUPR1;TGFB2;NF1;EGLN3;EGLN2;SET;CDK5;PRNP;SRPK2;BCL2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.42550563747501957,1.0238136448923165,0.45260915867944623,0.9525100366193686,1.0,14/75,14.82%,ISL1;DVL1;MINK1;LLGL1;MAP1A;S100A6;FARP1;MEF2A;CDK5;SDC2;S100B;MAP6;UNK;BTBD3
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.5210318349260594,1.0237157283450578,0.45245398773006135,0.9521288119643049,1.0,4/12,14.68%,PPARG;ABCG1;ABCA1;ABCA5
prerank,positive regulation of receptor internalization (GO:0002092),0.4734038896266486,1.0235317400001622,0.45652173913043476,0.9519605652573699,1.0,5/22,13.60%,ARRB2;AHI1;CD63;TBC1D5;INSR
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.4240265087772372,1.0232230582375312,0.44680851063829785,0.9521992001568458,1.0,15/73,13.25%,POLR1C;KDM1B;GLMN;PPHLN1;WBP2;EP300;POLR1A;HDAC5;MECP2;EZH2;KAT2B;DNMT3A;TASOR;RBBP7;EPC1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.5522674319524488,1.0229571713631243,0.5007751937984496,0.952315874994519,1.0,2/10,5.11%,DCLRE1A;TERF2
prerank,negative regulation of response to stimulus (GO:0048585),0.42622896447443037,1.022941091162085,0.4510226049515608,0.9517189476545859,1.0,12/60,12.90%,WFS1;IGFBP3;TERF2;CDK6;ACVR1;VPS13C;PTPN1;ALOX5;LYN;SOCS5;MAP2K5;SH2B3
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4487476927781876,1.0227540969119853,0.45907473309608543,0.9515997456378705,1.0,9/34,14.87%,DUSP3;PTPRJ;DUSP16;DUSP10;PTPN1;PTPRT;PTPRO;PTPN9;PTPN18
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.4408004274283552,1.0226002447144014,0.45039908779931587,0.951368280207913,1.0,7/42,8.31%,NARS2;TARS1;FARSA;WARS2;HARS1;TARS2;AARS1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.44805940879953193,1.0224052048805337,0.45,0.9512467186562261,1.0,11/33,16.88%,UBA5;RUNX1;AR;EP300;ESR1;GPAM;KDM4C;DDX5;NCOA2;PKN1;KLK2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.474372559920643,1.0222850271923796,0.4722921914357683,0.9509455468533698,1.0,5/23,15.92%,RAET1E;ARRB2;SLAMF6;LGALS9;LAMP1
prerank,positive regulation of organelle organization (GO:0010638),0.45492082864236416,1.0222234849601135,0.4657210401891253,0.9504905959496818,1.0,8/32,14.20%,LMAN1;RAB3GAP1;TMED9;ANXA2;UVRAG;FYCO1;HTRA2;LNPK
prerank,integrated stress response signaling (GO:0140467),0.5013010351773883,1.022081829176629,0.45609065155807366,0.950248807237973,1.0,2/14,3.20%,EIF2AK1;IMPACT
prerank,cell cycle checkpoint signaling (GO:0000075),0.5226339733037823,1.021767148245655,0.4706744868035191,0.9505125825414005,1.0,1/12,0.85%,ZWINT
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5417643810913868,1.0217662074354972,0.4617737003058104,0.9498747414981001,1.0,1/10,1.07%,LRRK2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.41303205926838593,1.0215746652569733,0.4589473684210526,0.9497883111367972,1.0,16/76,15.31%,PLK1;LRRK2;CDK5RAP3;FBXW7;DVL1;KEAP1;SUMO2;DAB2;RCHY1;USP5;SOCS5;RNF144B;HECTD1;CSNK1A1;PTEN;PIAS1
prerank,ceramide biosynthetic process (GO:0046513),0.4477153502248666,1.021573861799462,0.4513172966781214,0.9491518132456066,1.0,8/40,14.77%,DEGS1;ST8SIA4;SMPD1;CERS6;CERS4;ASAH1;CERS5;SPTLC1
prerank,positive regulation of heart rate (GO:0010460),-0.3786445714814536,-1.0213697176794663,0.44140625,0.9488166166272812,1.0,2/17,0.51%,PDE4D;RYR2
prerank,polarized epithelial cell differentiation (GO:0030859),0.5144511705949011,1.0213580912439044,0.4604519774011299,0.9491503072366135,1.0,5/13,10.69%,MSN;CAMSAP3;EZR;MYO9A;CDC42
prerank,epidermal cell differentiation (GO:0009913),-0.29482729871638835,-1.0208617606399732,0.40869565217391307,0.9472036012323872,1.0,7/41,17.01%,PIP5K1A;ADAM9;UGCG;HDAC1;BCR;TXNIP;ST14
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4418272142449169,1.0207349356502329,0.47038327526132406,0.9502737280615526,1.0,7/40,12.68%,SLC38A2;ABCC5;SLC7A11;SLC7A7;SLC7A8;SLC38A9;SLC27A1
prerank,neutrophil degranulation (GO:0043312),0.4047508635690962,1.0206754846603643,0.439,0.9498196129482738,1.0,72/425,12.95%,STXBP2;TUBB4B;VCL;DEGS1;PDXK;SLC2A3;SLCO4C1;NRAS;C5AR1;CD36;AP1M1;RHOF;KPNB1;PDAP1;VAMP7;UNC13D;PGAM1;CTSC;ACTR1B;COMMD3;ERP44;RAP1A;PADI2;IQGAP2;HMOX2;ALDOA;ENPP4;APAF1;HVCN1;QSOX1;MAPK1;GDI2;STOM;PTPRJ;SCAMP1;SDCBP;TMEM30A;PLEKHO2;OSTF1;HSP90AA1;RAB5B;LAIR1;GSDMD;RAP1B;RAB6A;ARSB;ALOX5;DOK3;ADGRE5;CD44;ATP8B4;B4GALT1;VAMP2;CD63;CANT1;ANXA2;CTSZ;MVP;ASAH1;DIAPH1;DBNL;RAB18;HMGB1;RNASE3;YPEL5;PLD1;PSMD12;MAPK14;ADAM10;FUCA1;NHLRC3;PSMA2
prerank,positive regulation of histone modification (GO:0031058),0.45312918667885443,1.0205694361758568,0.46117084826762245,0.9494899421147385,1.0,7/33,12.73%,BRCA1;RPS6KA5;CDK9;TADA2A;CTBP1;GLYR1;BRD7
prerank,phospholipid translocation (GO:0045332),-0.3276130137716594,-1.020496919932696,0.41578947368421054,0.9452130164547259,1.0,10/28,15.69%,ATP8A2;ANO6;P2RX7;ATP9B;ATP11A;ATP9A;ATP10A;ABCB4;ATP8B1;ATP8A1
prerank,regulation of protein kinase activity (GO:0045859),0.41391047679021525,1.0203006264722838,0.46502057613168724,0.9496297435619692,1.0,19/106,14.25%,CAMKK1;DDR2;C5AR1;DVL1;ITGB1BP1;GAS6;NF1;ANKRD54;RAP1A;PYDC1;PAK2;DTNBP1;GNAQ;UVRAG;LRP6;SPRED1;MMD;CAMKK2;RELN
prerank,reticulophagy (GO:0061709),0.5254791167166322,1.020283786603082,0.46130952380952384,0.9490471508367948,1.0,4/12,12.19%,UBA5;UFC1;ULK2;RB1CC1
prerank,histone H3 deacetylation (GO:0070932),0.4981863831865678,1.0202598533424756,0.46494992846924177,0.9484865039193319,1.0,2/15,4.82%,SIRT7;HDAC9
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.4201143731336067,-1.0201299734257887,0.4308176100628931,0.9432849939884337,1.0,4/12,27.73%,SLC11A1;PRKCQ;CARD9;CCR2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.4636418390672956,1.019830387698649,0.45545796737766625,0.9490593043977242,1.0,9/26,18.73%,IFI35;TLR3;WDFY1;HMGB1;RTN4;SLC15A4;MFHAS1;DDX3X;PJA2
prerank,cellular response to alkaloid (GO:0071312),0.48397838620252437,1.019499724914766,0.45454545454545453,0.9493572191732484,1.0,1/17,1.16%,BLM
prerank,negative regulation of immune effector process (GO:0002698),-0.40964822904457276,-1.018804528863334,0.44200626959247646,0.9444442394698989,1.0,4/13,14.23%,GRN;APPL1;RPS19;LILRB1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.44122066382973174,1.0187680150985392,0.45240893066980026,0.9508036409489132,1.0,5/36,12.01%,RGCC;THBS1;MECP2;PPARG;HMGB1
prerank,morphogenesis of an epithelium (GO:0002009),0.47003089904766365,1.018714199186636,0.4621212121212121,0.9503080115496965,1.0,5/25,16.41%,VCL;AHI1;LRP6;DAG1;ACTG1
prerank,cortical cytoskeleton organization (GO:0030865),0.43659496354693983,1.0184248881025955,0.46514285714285714,0.9504459354785112,1.0,6/41,7.48%,LLGL2;RHOF;LLGL1;EZR;IKBKB;DLG1
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.41449827332007344,-1.0182174273044442,0.4413793103448276,0.9430665474542411,1.0,2/13,15.56%,TGFB1;NOTCH1
prerank,neutrophil activation involved in immune response (GO:0002283),0.40343702141392124,1.0175888906197272,0.455,0.9521444523509179,1.0,74/428,13.41%,STXBP2;TUBB4B;VCL;DEGS1;PDXK;SLC2A3;SLCO4C1;NRAS;C5AR1;CD36;AP1M1;RHOF;KPNB1;PDAP1;VAMP7;UNC13D;PGAM1;CTSC;ACTR1B;COMMD3;ERP44;RAP1A;PADI2;IQGAP2;HMOX2;ALDOA;ENPP4;APAF1;HVCN1;QSOX1;MAPK1;GDI2;STOM;PTPRJ;SCAMP1;SDCBP;TMEM30A;PLEKHO2;OSTF1;HSP90AA1;RAB5B;LAIR1;GSDMD;RAP1B;RAB6A;ARSB;ALOX5;DOK3;ADGRE5;CD44;ATP8B4;B4GALT1;VAMP2;CD63;CANT1;ANXA2;CTSZ;MVP;ASAH1;DIAPH1;DBNL;RAB18;HMGB1;RNASE3;YPEL5;PLD1;PSMD12;MAPK14;ADAM10;FUCA1;NHLRC3;PSMA2;SYK;ARHGAP45
prerank,endoplasmic reticulum organization (GO:0007029),0.4180628209264622,1.0171134499118586,0.4574468085106383,0.9528552535743938,1.0,19/72,16.43%,TRAM1L1;LMAN1;LRRK2;SEC61G;REEP2;UBE2J2;RTN3;REEP5;VAMP2;SEC61A1;MIA3;PRNP;RAB18;RTN4;LNPK;ATL2;VCPIP1;VAPB;DNM1L
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4524637849620896,1.0170691614045133,0.4666666666666667,0.9523568615439693,1.0,8/31,15.60%,LRRK2;CFL1;LRP8;CDK5;DBNL;RELN;PTEN;CAPRIN1
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.44894321560725947,-1.0169759647745298,0.45714285714285713,0.94394347051619,1.0,4/10,15.08%,GFPT1;HK3;HK1;PFKL
prerank,positive regulation of JNK cascade (GO:0046330),0.41527682083438844,1.016444991938439,0.4492600422832981,0.9534772034401516,1.0,10/70,12.87%,UNC5CL;MINK1;TPD52L1;SH3RF3;MAP3K11;SDCBP;TAOK1;TRAF2;HMGB1;HIPK2
prerank,mitochondrial translation (GO:0032543),0.4108386395369883,1.0162813794708552,0.4696813977389517,0.9533134477268842,1.0,11/104,7.30%,MRPS22;MRPS31;MRPS30;MRPL37;NOA1;MRPS21;HARS1;MRPL48;MRPS35;MRPS28;MRPL1
prerank,negative regulation of receptor binding (GO:1900121),0.5453138168283788,1.0160594796775482,0.46781789638932497,0.9533464773014376,1.0,1/10,3.00%,ADAM15
prerank,translesion synthesis (GO:0019985),0.4328824338281689,1.0159982960701686,0.4574095682613769,0.9528836274452968,1.0,5/42,8.93%,PCLAF;RFC2;POLE2;POLD3;RCHY1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5216183292835437,1.01561796748078,0.4745762711864407,0.9533142514034224,1.0,4/11,12.97%,TGFB2;ACVR1;TGFBR2;TGFBR1
prerank,positive regulation of secretion (GO:0051047),-0.4442067737695454,-1.0154986693222163,0.45592705167173253,0.9453846571893597,1.0,3/11,33.57%,ACSL3;XBP1;GPLD1
prerank,extracellular structure organization (GO:0043062),0.404746904722723,1.0154511677737377,0.47047047047047047,0.9531848610899815,1.0,23/204,11.50%,COL14A1;ADAMTS12;DDR1;DDR2;ADAMTS2;ADAM15;ITGA6;NF1;ADAM12;THBS1;ADAMTSL3;ATP7A;PDGFB;ITGA4;ITGB5;COL11A1;ITGB8;ADAMTS10;CD44;BGN;FURIN;PXDN;LAMC1
prerank,response to lipid (GO:0033993),0.4131977181001208,1.0154447968391225,0.48201438848920863,0.9525675511299876,1.0,17/105,14.85%,OVCA2;TNFRSF11A;CD36;SMAD6;PELI1;LIAS;ESR1;PPARG;ABCG1;SRR;VPS4B;PAQR8;MAPKAPK2;RXRA;LGALS9;PPARD;TLR4
prerank,regulation of fatty acid oxidation (GO:0046320),0.5084137230428011,1.0154039360036928,0.4816326530612245,0.952048341105842,1.0,3/16,12.94%,TYSND1;ACADL;ABCD1
prerank,positive regulation of nervous system development (GO:0051962),0.4323807914279124,1.0154011437541426,0.4590347923681257,0.951427197263025,1.0,8/42,11.42%,NUMBL;EPHB2;SPEN;CLSTN3;RGS14;IL1RAP;CLSTN1;SOX11
prerank,phospholipid homeostasis (GO:0055091),0.5346841433858407,1.015182227349616,0.4632352941176471,0.9514059956923544,1.0,2/11,12.85%,ABCG1;ABCA1
prerank,macrophage differentiation (GO:0030225),-0.40017778096341344,-1.0151677653819262,0.42244224422442245,0.9434144204397776,1.0,5/13,21.17%,CSF1R;CSF1;PARP1;SIRT1;CASP8
prerank,nucleus organization (GO:0006997),0.4347994548125379,1.0149106005601842,0.46993318485523383,0.9515547309193977,1.0,11/47,13.31%,WDR73;VPS4A;CHMP5;NUP205;ATXN7;CTDNEP1;NUP98;LEMD2;NUP54;VPS4B;PDCD6IP
prerank,negative regulation of viral process (GO:0048525),0.4192202947809466,1.0143662778455693,0.46923076923076923,0.952505761622503,1.0,4/57,2.23%,BANF1;IFITM3;EIF2AK2;ILF3
prerank,amino acid import (GO:0043090),-0.3503830767604399,-1.0143068883250497,0.37662337662337664,0.9431064026955928,1.0,9/21,28.09%,SLC36A1;SLC7A1;SLC1A1;SFXN1;SLC6A1;SLC25A38;SLC16A2;SFXN2;SLC22A4
prerank,axonogenesis (GO:0007409),0.40862895439173275,1.0139601078127443,0.463,0.953009105859601,1.0,45/237,15.70%,CXCL12;ISL1;GRB2;LLGL1;MAP1A;EPHB2;NRP1;S100A6;PRKCA;SEMA6D;MAPK1;IRS2;HSP90AA1;EZR;USP33;RANBP9;ARTN;SPTBN1;RPS6KA5;NPTN;SLC9A6;B4GALT5;CDK5;EPHA5;ARHGAP35;SEMA3D;SEMA6A;PALLD;NOTCH2;ULK2;FRS2;FEZ1;DOK6;S100B;PTPRO;SPG11;FYN;NRP2;RELN;PTEN;DAG1;EVL;AUTS2;SH3KBP1;PIK3R1
prerank,negative regulation of proteolysis (GO:0045861),0.45254609359778664,1.0135143481313227,0.4491017964071856,0.953623489791891,1.0,6/34,11.66%,GAS1;LRRK2;PTPN3;CDK5;PRNP;DNAJC1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5246402153287366,1.01342797728536,0.4707646176911544,0.951982330233443,1.0,3/11,11.12%,ACAT1;PANK1;SLC25A16
prerank,coenzyme A biosynthetic process (GO:0015937),0.5246402153287366,1.01342797728536,0.4707646176911544,0.951982330233443,1.0,3/11,11.12%,ACAT1;PANK1;SLC25A16
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5246402153287366,1.01342797728536,0.4707646176911544,0.951982330233443,1.0,3/11,11.12%,ACAT1;PANK1;SLC25A16
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.48532429562920854,1.0133983052705795,0.4712950600801068,0.9514360436288756,1.0,2/18,4.54%,PSMD9;IRS1
prerank,receptor metabolic process (GO:0043112),0.42477322536356876,1.0127901403081943,0.4895259095920617,0.9524813739919826,1.0,17/53,16.49%,CD36;LDLRAP1;GRB2;PIK3R4;ARRB2;NEDD4;KIF16B;SNX1;RAMP1;UVRAG;SH3GLB1;SYK;CALCRL;CLTC;BECN1;CD81;LGMN
prerank,response to cytokine (GO:0034097),0.4078041196134987,1.0121883729381185,0.4818913480885312,0.9534958411096089,1.0,27/141,14.87%,ALDH1A2;TNFRSF11A;IFITM3;RELA;EIF2AK2;PID1;LDLRAP1;SMPD1;IGBP1;LIFR;SMAD3;PRKCA;SETD2;MAPK8;CDK9;IRAK2;PTPN23;ADAR;YTHDC2;IFNAR2;ADAM10;MAPKAPK2;BCL2;TRIM56;LGALS9;PTPN9;PTPN18
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.4496806698577548,1.0121425075530441,0.4657039711191336,0.9529891560840437,1.0,5/29,7.41%,RAD50;TERF2;CDK2;HSP90AA1;MRE11
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.4389694417560324,1.0120515388401747,0.45127610208816704,0.9526250439237259,1.0,7/40,13.03%,LRRK2;PID1;NDUFS1;MAPT;ABL1;ABCD1;BCL2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.4461458641357068,1.0118086027946822,0.49243306169965073,0.9526326718875311,1.0,5/35,13.77%,PCDHB16;CDH11;PCDHGB4;CDH20;CDH18
prerank,zinc ion transmembrane transport (GO:0071577),0.46648599400082696,1.0118050652810497,0.4714828897338403,0.9520232597901677,1.0,2/22,3.50%,SLC30A6;SLC39A11
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.4350090952754798,-1.0115974968030377,0.48036253776435045,0.9482013195916148,1.0,7/11,32.15%,AHCYL1;ZC3H3;NCBP1;CDC73;NCBP2;PAF1;LEO1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.40684914284971796,1.0114599078114077,0.47213779128672745,0.9523733220401807,1.0,34/140,15.08%,CGNL1;ARHGEF3;RHOF;FGD3;FGD1;PLEKHG2;PLEKHG5;ITSN1;ARHGEF12;TAGAP;SQSTM1;VAV3;FAM13B;ARHGAP22;ARHGAP1;KALRN;MYO9A;ARHGAP35;CD2AP;AKAP13;CDC42;CYRIB;ARHGAP39;ARHGEF17;OCRL;VAV2;ARHGAP15;ARHGAP32;MYO9B;ARHGAP45;RELN;ARHGAP31;ARHGDIB;VAV1
prerank,eye photoreceptor cell development (GO:0042462),0.4946062202271893,1.0107235465890627,0.4574175824175824,0.9537250409676598,1.0,4/15,16.89%,BBS4;RPGRIP1L;CEP290;RORB
prerank,establishment of melanosome localization (GO:0032401),0.4883051871761802,1.0106881877120588,0.47619047619047616,0.9531948385275751,1.0,3/19,5.36%,ARL6;BBS4;MYO5A
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.3342945728834462,-1.0102148282817454,0.40865384615384615,0.9493741127592373,1.0,4/23,6.97%,CACNA2D1;PTK2B;NOS1AP;ATP1A2
prerank,muscle filament sliding (GO:0030049),0.4438747655351103,1.0092469993348998,0.4716106604866744,0.9559685414476418,1.0,2/38,4.91%,TMOD1;TPM1
prerank,actin-myosin filament sliding (GO:0033275),0.4438747655351103,1.0092469993348998,0.4716106604866744,0.9559685414476418,1.0,2/38,4.91%,TMOD1;TPM1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.4013451221170805,1.0092058402563842,0.49295774647887325,0.9554652148911917,1.0,26/175,12.95%,BRCA1;ADAMTS12;TNFRSF11A;RELA;CX3CL1;PID1;TNFRSF25;PSMD9;PSMB8;BIRC3;PSMC5;IKBKB;CCL25;PYDC1;LIMS1;ZFAND6;ACTN4;ASAH1;TANK;TRAF2;TMSB4X;COMMD7;ZFP36L1;PSMD12;TP53;PSMA2
prerank,negative regulation of T cell activation (GO:0050868),0.4418967947363003,1.0087537128217128,0.4711425206124853,0.9561051327769312,1.0,3/35,2.33%,DUSP3;TNFAIP8L2;GLMN
prerank,keratan sulfate catabolic process (GO:0042340),-0.43050572244270335,-1.0086405635556974,0.4649859943977591,0.9512571440564976,1.0,2/11,10.06%,HEXA;GALNS
prerank,cardiac muscle cell action potential (GO:0086001),0.4517652710152091,1.0084517542992062,0.4767580452920143,0.9563232577746564,1.0,3/30,4.70%,SLC4A3;CACNA1D;YWHAE
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4620509037641054,1.0084208641565375,0.48473748473748474,0.9557681802050395,1.0,5/27,9.05%,CD36;IRAK4;BTK;IRAK2;TAB3
prerank,carnitine metabolic process (GO:0009437),0.5052261311829842,1.0084111371718434,0.46567164179104475,0.9551633484164953,1.0,3/12,11.42%,CPT1C;CROT;ACADL
prerank,mitochondrion organization (GO:0007005),0.40666700529540895,1.008149319931652,0.46733668341708545,0.9552635167908726,1.0,21/165,8.06%,MIEF2;LRRK2;TIMM17A;TOMM40;NUBPL;MTX1;ADCK1;PID1;NDUFS1;TFB2M;SLIRP;SSBP1;HCFC1;WASF1;ATP7A;PYROXD2;TIMM23;POLG2;MEF2A;VPS13C;BNIP3L
prerank,cytosolic transport (GO:0016482),0.40627349734812357,1.0078239530466517,0.47918781725888326,0.9555486146127982,1.0,36/108,17.05%,SYS1;GOSR2;SNX5;VAMP3;EEA1;AKTIP;EVI5;AP2A1;VPS13A;TBC1D17;DCTN1;VPS13C;RAB6A;VPS35;STX16;KIF16B;TBC1D10B;PTPN23;HEATR5A;SNX1;ANKFY1;TBC1D5;TBC1D10A;EPS15;GGA1;RAB7A;CLTC;BECN1;STX8;VTI1A;LAMP1;VPS53;TBC1D23;HOOK2;GCC2;MYO1D
prerank,lipid homeostasis (GO:0055088),0.4209904822087888,1.0077823128777341,0.4816810344827586,0.9550365782107425,1.0,11/57,14.48%,FBXW7;ADCK1;TLCD3A;IRS2;PPARG;ABCG1;THADA;ABCA1;ABCD1;NR1D2;ACOX3
prerank,potassium ion transport (GO:0006813),0.40530725324325517,1.0076425745334445,0.47874493927125505,0.9547954796220499,1.0,21/120,17.25%,HCN3;TMEM175;KCNJ6;SLC9A9;SLC9A1;KCNH8;KCNH7;KCNK2;SLC9A7;SLC9A6;KCNK13;KCNK10;PKD2;KCNMB2;KCNMB3;KCNQ5;HCN1;KCND2;KCNA1;KCNA5;KCNB2
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.4542223755257559,1.0074451986785242,0.4801920768307323,0.9541064840381654,1.0,4/29,9.42%,ACAT1;ACOT9;ACOT13;CROT
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.4542223755257559,1.0074451986785242,0.4801920768307323,0.9541064840381654,1.0,4/29,9.42%,ACAT1;ACOT9;ACOT13;CROT
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.508200594003895,1.0074293586129137,0.5042735042735043,0.9535345586859143,1.0,3/13,5.53%,ADCY8;EPHB2;SQSTM1
prerank,heart looping (GO:0001947),0.43618945045858004,1.007414068879375,0.4748283752860412,0.9529646946543998,1.0,7/39,16.27%,BBS4;AHI1;MICAL2;TGFBR2;NDRG4;PKD2;MEF2C
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4266291873706438,1.0072533670264663,0.4737991266375546,0.9527937249350846,1.0,17/52,16.92%,FBXW7;RNF31;YWHAE;UBE2J2;ABLIM3;MAPK8;NMT1;HPS4;VPS11;SH3GLB1;TP53;BCL2;HTRA2;UBE2D3;YWHAB;TFDP2;SAE1
prerank,positive regulation of sodium ion transport (GO:0010765),0.5142378864894024,1.007196610245499,0.49189985272459497,0.952340552626944,1.0,2/12,7.63%,CNKSR3;GPD1L
prerank,histone H2A ubiquitination (GO:0033522),-0.38233095995419963,-1.0070876139904092,0.44086021505376344,0.9528559778497536,1.0,8/17,17.31%,BCOR;DDB1;RNF168;UBR2;DDB2;CUL4B;DTX3L;SKP1
prerank,negative regulation of locomotion (GO:0040013),0.5146177648800618,1.0069821692734684,0.478134110787172,0.9523502342400867,1.0,1/12,1.73%,DUSP3
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.41392341096488455,1.0063382465788406,0.49201277955271566,0.9535415199475977,1.0,17/70,16.07%,EIF2AK2;SETD1A;RUNX1;PSMD9;PSMB8;N4BP2L2;PRKDC;METTL3;PSMC5;TAL1;TCF12;ABL1;PSMD12;PSMA2;LDB1;PSMB1;LMO2
prerank,alanine transport (GO:0032328),-0.4376145273765998,-1.006040606913576,0.47802197802197804,0.9531432171645545,1.0,2/10,11.72%,SLC36A1;SLC36A4
prerank,nuclear membrane reassembly (GO:0031468),0.4214298496946234,1.006027904981564,0.47243243243243244,0.9537894835103802,1.0,8/54,7.70%,BANF1;KPNB1;VPS4A;PPP2R2A;NUP205;AHCTF1;NUP98;LEMD2
prerank,protein localization to microtubule organizing center (GO:1905508),0.4960257182233398,1.0058255445469038,0.4866385372714487,0.953712651076662,1.0,6/15,17.19%,BBS4;SNX10;DCTN2;C2CD3;CEP83;PIBF1
prerank,mRNA stabilization (GO:0048255),0.4323866915338175,1.0055493079914493,0.47344632768361583,0.9538720474884027,1.0,7/40,12.92%,ELAVL4;EIF4ENIF1;SYNCRIP;TARDBP;FUS;MAPK14;MAPKAPK2
prerank,sphingolipid biosynthetic process (GO:0030148),0.41569637156186734,1.0054788370067689,0.4684873949579832,0.9534468811068713,1.0,20/71,17.64%,DEGS1;ST8SIA5;SGPP1;HACD1;SMPD1;CERS6;SGPP2;ACER3;CERS4;ASAH1;SGPL1;CERS5;PRKD2;HACD4;SPTLC1;VAPB;LARGE1;ST3GAL5;SGMS1;PLPP1
prerank,osteoclast differentiation (GO:0030316),0.47110007327283643,1.0054302827037371,0.48538754764930114,0.9529664252775722,1.0,5/22,12.55%,TNFRSF11A;FARP2;SNX10;ANXA2;MAPK14
prerank,regulation of membrane repolarization (GO:0060306),0.5026568348694905,1.0052147333928196,0.48326055312954874,0.9529303643079688,1.0,2/13,4.70%,AKAP9;YWHAE
prerank,cellular response to organic substance (GO:0071310),0.4065716444979836,1.004973782407865,0.4760935910478128,0.9529737321545195,1.0,25/116,14.87%,URI1;LRRK2;PID1;LDLRAP1;BMPR1A;SMAD3;PDGFB;ACVR1;MAPK8;NCOA1;CDK9;TWF2;IL18;NCOA3;PTPN23;TGFBR2;RAMP1;MAP2K5;DCPS;TGFBR1;ACVR1B;HTRA2;NCOA2;PTPN9;PTPN18
prerank,positive regulation of protein polymerization (GO:0032273),-0.2625079975061131,-1.0048021816441832,0.3924050632911392,0.9537954182023456,1.0,14/65,12.98%,NAV3;PRKCE;HCK;PTK2B;RAC1;SLAIN2;TOGARAM1;FES;DRG1;NCK2;VASP;BAIAP2;PYCARD;PFN1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.5108221358372916,1.004775271689235,0.48265895953757226,0.9529285339300924,1.0,1/13,1.07%,LRRK2
prerank,negative regulation of autophagosome assembly (GO:1902902),0.5193131526373194,1.0047713099227458,0.4890190336749634,0.9523290842998517,1.0,5/13,15.54%,LRRK2;NUPR1;FEZ1;TMEM39A;MTM1
prerank,mRNA catabolic process (GO:0006402),0.4243929167198787,1.004762636770234,0.479498861047836,0.95173760590718,1.0,8/44,13.71%,CNOT10;ZC3H12D;TUT4;METTL3;XRN1;XRN2;ERN1;DDX5
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4039772520481312,1.004556477964222,0.4812182741116751,0.9517220788206819,1.0,22/128,13.71%,BMP5;PRKCZ;SMAD6;ZFYVE9;HPGD;TGFB2;BMPR1A;JUN;SMAD3;ARRB2;ACVR1;ITGB5;SLC33A1;LPXN;HIVEP1;FURIN;PXN;TGFBR2;CBL;TGFBR1;ACVR1B;DDX5
prerank,negative regulation of lymphocyte migration (GO:2000402),0.5324053622323954,1.004295505208716,0.48738170347003157,0.9518354004811972,1.0,5/10,17.54%,PADI2;MIA3;LRCH1;WASL;APOD
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5304549137225442,1.0041893727487134,0.5054602184087363,0.951521165090749,1.0,1/10,1.82%,CX3CL1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.4447124188007212,1.0039869518959237,0.47863247863247865,0.9514790283644942,1.0,7/30,14.15%,ACSBG1;HACD1;ABCD2;TECR;ABCD3;ABCD1;HACD4
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.33492026661408225,-1.00392546760399,0.4302788844621514,0.9533777224494442,1.0,4/22,4.37%,RYR2;CALM2;ATP1B1;AKAP6
prerank,cellular transition metal ion homeostasis (GO:0046916),0.40870054412711354,1.0037858297011684,0.4916317991631799,0.9514402089873365,1.0,23/91,15.52%,CP;HMOX2;ATP7A;ABCB7;GLRX3;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;ARF1;PRNP;SLC31A1;SLC39A10;FLVCR1;SLC22A17;NDFIP1;ATP6V0A2;SMAD4;ABCG2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.3388139178150792,-1.003734986202795,0.4725274725274725,0.9509831558758622,1.0,17/27,33.89%,PPP1CC;USP2;PML;FBXL12;MTA1;PER3;BHLHE40;RBM4;CRY2;CRY1;ID2;PER1;FBXL6;PPP1CA;RBM4B;SIK1;PER2
prerank,peptidyl-lysine acetylation (GO:0018394),0.5251298224187876,1.0033404513089308,0.4858490566037736,0.952047851893401,1.0,3/10,11.99%,EP300;KAT2B;ESCO1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.41972992312655266,1.003231744355266,0.48877005347593583,0.9517544909337351,1.0,13/61,15.74%,ARHGEF3;RAPGEF1;GRB2;GPR65;IRS2;LYN;AKAP13;NOTCH2;SHOC2;LPAR6;VAV1;AUTS2;MAP4K4
prerank,regulation of immunoglobulin production (GO:0002637),-0.3356603343233019,-1.0032099817173155,0.41232227488151657,0.9497352731047951,1.0,5/23,7.43%,CD86;PTPRC;GPI;FCGR2B;STX4
prerank,positive regulation of chemotaxis (GO:0050921),0.4255793081760883,1.0027532889851813,0.48180815876515987,0.9524276063787611,1.0,10/43,16.49%,THBS1;NRP1;PDGFB;STX3;F3;TMSB4X;PRKD2;P2RY12;AIF1;LGMN
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.41307316504559366,1.0027373414997824,0.5063559322033898,0.9518668015091537,1.0,32/84,18.61%,SAP18;MBNL1;ZBTB7A;RNPS1;RBM3;RBM15;RBM5;NUP98;SFSWAP;TRA2A;FXR2;MBNL2;RBFOX3;U2AF2;SF1;RBM7;QKI;SRSF9;SRPK2;WTAP;DDX5;SF3B4;HNRNPK;HNRNPL;NSRP1;CELF2;SRSF3;SON;KHDRBS1;NCL;CELF1;KHDRBS3
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.28359591673922246,-1.0024667317703597,0.44642857142857145,0.9489547939970824,1.0,27/50,27.11%,PSMD14;PSMA3;AZIN1;PSMB2;PSMB7;PSMC6;PSMD4;PSMD7;PSMA1;PSMA5;PSMC1;PSMD13;PSMC2;PSMA6;OAZ2;PSMA4;PSMD3;PSMF1;PSMD2;PSMD5;OAZ1;PSMD1;PSMC3;PSMD8;PSMB3;PSME1;PSMB9
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4697330980509886,1.0023842345981253,0.49483204134366926,0.9522208340888288,1.0,5/21,14.30%,SGPP1;RUNX1;MAFG;ZFP36L1;ROCK2
prerank,tRNA modification (GO:0006400),0.4149044022366457,1.002034168578241,0.46030042918454933,0.952586769896259,1.0,6/62,8.31%,WDR6;NSUN6;TRMO;TARBP1;OSGEP;AARS1
prerank,cilium organization (GO:0044782),0.40027211137318486,1.0013275994247353,0.503006012024048,0.9539444750003873,1.0,38/209,14.18%,CLUAP1;BBIP1;CCDC57;CEP89;ACTR3;ARL6;EHD4;TMEM67;RAB8B;EHD1;BBS4;IQCB1;DZIP1;CEP250;FLNA;TTC39C;FNBP1L;EXOC5;PCNT;DYNLL2;IFT52;IFT20;ABLIM3;CCDC66;SNX10;CCP110;ODF2;AHI1;PTPN23;POC1B;EXOC4;KIF3A;OCRL;PTPDC1;RPGR;ARMC9;PKD2;RFX3
prerank,regulation of embryonic development (GO:0045995),0.4403507506245263,1.00113431593365,0.4848837209302326,0.9538809079993328,1.0,8/34,15.10%,EHMT1;CFL1;B4GALT5;NR2C2;INSR;TRIP12;DAG1;CLASP1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.4056633116493463,1.0011024721863155,0.48767967145790553,0.9533689849057245,1.0,21/118,12.56%,VASH2;LRRK2;CFL1;PID1;INF2;NF1;BCL6;CAPZB;NEDD4;MAPT;PAK2;EGLN1;HECW1;ADGRB3;CDK5;ARHGAP35;SDC2;CYRIB;LZTS1;ZMYM6;RUFY3
prerank,inflammatory response (GO:0006954),0.3988051195665625,1.0010583503256725,0.4824120603015075,0.9528804113304533,1.0,20/195,10.27%,SCUBE1;C5AR1;RELA;CX3CL1;ADCY8;THBS1;HDAC9;SIGLEC1;LIAS;IL10RB;CMKLR1;HDAC5;IL1A;IKBKB;CCL25;IL18;ADGRE5;CD44;PARP4;LOXL3
prerank,B cell receptor signaling pathway (GO:0050853),0.4460593807779757,1.000952651889472,0.4859154929577465,0.9525765307824717,1.0,10/32,17.29%,CD38;RFTN1;PRKCB;BTK;VAV3;BCL2;SYK;SH2B2;MEF2C;NCKAP1L
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.48083310681270536,1.0008980448218494,0.47413793103448276,0.9521208182753964,1.0,5/17,14.21%,EP300;MAML3;MAML2;KAT2B;RBPJ
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.42302841145474424,1.0008814199831406,0.4884233737596472,0.9515601697138022,1.0,15/52,16.27%,SAP18;MBNL1;ZBTB7A;RNPS1;RBM15;RBM5;FXR2;MBNL2;RBFOX3;RBM7;WTAP;DDX5;HNRNPL;NSRP1;CELF2
prerank,generation of neurons (GO:0048699),0.39848874898984427,1.0006048164461205,0.511,0.951675608422299,1.0,30/190,16.27%,WNT4;IER2;WNT2B;CX3CL1;VXN;RUNX1;TGFB2;ELP3;NRP1;NAV1;CDK6;MAPT;ARTN;TUBGCP2;ADNP2;CEP85L;CDK5;SOX11;EML1;CDKL5;MYT1L;MYEF2;RELN;FZD3;TAFA1;LDB1;GPM6A;AUTS2;MAP2K1;MEF2C
prerank,protein complex oligomerization (GO:0051259),0.4099184751932709,1.0003490739784382,0.4896049896049896,0.9517760314246647,1.0,16/85,14.06%,BLM;ADCY8;MICU1;EHD4;EHD1;UGDH;SLC9A1;LETM1;G3BP2;GSDMD;FUS;GLRA3;TMEM120B;PDCD6IP;PKD2;RNF135
prerank,positive regulation of developmental growth (GO:0048639),0.42690462591812817,1.0000619824814776,0.49719416386083054,0.9519157391608636,1.0,12/49,16.16%,CPNE5;ZFYVE27;MAPT;TWF2;PLAA;RNF157;DBNL;CDKL5;RUFY3;INSR;MACF1;GOLGA4
prerank,carbohydrate derivative catabolic process (GO:1901136),0.4758149655186664,1.000016189925085,0.4993270524899058,0.9514438054388717,1.0,3/18,12.72%,FBXO17;BPGM;FUCA1
prerank,protein destabilization (GO:0031648),0.4385543520149612,0.9999643028525514,0.4853801169590643,0.9509982791019227,1.0,5/32,11.74%,PLK1;EP300;FBXW11;PRNP;DERL1
prerank,insulin secretion (GO:0030073),-0.3473047163862918,-0.9997175507690114,0.4691358024691358,0.9541465558457157,1.0,5/19,12.26%,RIMS2;RAB11FIP2;RAB11FIP5;RAB11B;SELENOT
prerank,inner ear morphogenesis (GO:0042472),0.4665764512297039,0.9995567707988705,0.4842370744010088,0.9514780602334335,1.0,3/22,8.95%,EPHB2;TTC39C;CHD7
prerank,response to peptide hormone (GO:0043434),0.4255425787203957,0.9994653055122561,0.48755656108597284,0.9511245883632403,1.0,9/43,16.72%,EIF6;IRS1;ZFP36L1;SLC27A1;CREB1;ROCK2;TSC1;STAT2;STAT6
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.38126872487061597,-0.9988619792850869,0.4819672131147541,0.9535568610584443,1.0,6/16,25.24%,PIK3CG;ARHGAP24;GABARAP;SH3BP1;STMN3;CADM4
prerank,cellular response to catecholamine stimulus (GO:0071870),0.4574321706498135,0.9987696478734006,0.5082802547770701,0.9524300109157605,1.0,7/23,14.41%,LRRK2;SLC9A1;PRKACA;MAPK1;ABL1;GNG2;GNB1
prerank,negative regulation of innate immune response (GO:0045824),-0.30069865083364666,-0.9987416057020283,0.46296296296296297,0.9510267195717134,1.0,11/34,20.88%,GRN;PTPN2;NLRC5;CNOT7;NLRC3;RPS19;TNFAIP3;IRAK3;SUSD4;NMI;USP18
prerank,regulation of secretion by cell (GO:1903530),0.41950249528810085,0.9975617068015589,0.48698481561822127,0.955098974018776,1.0,11/54,13.05%,LLGL2;RAB8B;LLGL1;RAB12;VAMP3;LGI3;VAMP2;STXBP5;DNAJC1;STXBP5L;RAB3C
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.39527352325540743,0.9975227050864441,0.4979919678714859,0.9546113809476825,1.0,32/186,13.94%,MDFI;UBAC2;BICC1;NPHP4;DVL1;IGFBP2;SOX13;RBMS3;PSMD9;NFATC1;TLE2;PSMB8;STK11;PSMC5;TMEM170B;TLE1;HECW1;DAB2;NXN;APC;CHD8;HMGXB4;TCF7L2;PSMD12;CYLD;PSMA2;LRP6;WWOX;PTPRU;PTPRO;MCC;CSNK1A1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.49476390661054015,0.9974178327967989,0.4801178203240059,0.9542831835050678,1.0,3/14,5.62%,THBS1;CMKLR1;MAPK1
prerank,coenzyme A metabolic process (GO:0015936),0.5000237825531149,0.9974120803225269,0.5013966480446927,0.953699708776449,1.0,4/14,11.12%,ACAT1;PANK1;CROT;SLC25A16
prerank,water transport (GO:0006833),-0.40747914848057915,-0.9972352261720657,0.45565749235474007,0.9524542020626585,1.0,1/12,9.55%,AQP4
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.4226190864575883,0.9971684003818141,0.4910112359550562,0.9537423083164791,1.0,6/48,6.09%,POLR1C;ASF1A;WBP2;PADI2;EP300;POLR1A
prerank,microtubule depolymerization (GO:0007019),0.4827444821042149,0.997150184839389,0.5123287671232877,0.9532016123172248,1.0,2/17,5.98%,STMN2;NCKAP5L
prerank,negative regulation of gene expression (GO:0010629),0.39593884673541657,0.9969399800432927,0.5245245245245245,0.9531476456835308,1.0,54/302,13.37%,WNT4;RGCC;PARP9;EIF4A3;CNOT10;FBXW7;ZC3H12D;EIF2AK2;ILF3;FLOT2;EIF4ENIF1;PPHLN1;SYNCRIP;RUNX1;TGFB2;MALSU1;OLFM1;TARDBP;BMPR1A;RBMS3;HDAC9;TERF2;PDGFB;TNRC6B;ESR1;METTL3;PTBP3;MAPT;SYT11;MECP2;AGO2;RPS6KA5;EZH2;ITGB8;NPTN;NCOR1;DAPK1;FXR2;CNOT9;NOTCH2;KAT2B;SOX11;LSM14A;NCOR2;DNMT3A;TASOR;ERN1;ERP29;ADAM10;SAMD4A;MAP2K2;RBBP7;EPC1;NDFIP1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.42431947465222875,0.9968666580353834,0.4664351851851852,0.9527656441927864,1.0,7/39,9.16%,NEDD4;GPD1L;NETO1;SLMAP;CAMK2D;HECW1;PTPN3
prerank,monocarboxylic acid metabolic process (GO:0032787),0.39796193424102677,0.9968625714826436,0.5045778229908443,0.952177905314706,1.0,11/117,9.43%,ALDH1A2;PDZD11;BTD;CPT1C;CD36;GBA2;MCCC2;CKB;GPAM;CROT;PPARG
prerank,protein autoubiquitination (GO:0051865),0.4119058677557324,0.9965285039928309,0.5032608695652174,0.952425492019406,1.0,13/61,14.53%,BRCA1;SH3RF3;RAD18;UBE2A;RNF115;BFAR;RNF146;RNF11;RNF157;TRAF2;UBE3A;NFX1;UBE2D3
prerank,cellular response to hexose stimulus (GO:0071331),0.4572561959014486,0.9964186492107691,0.5101265822784811,0.9521495582511151,1.0,5/23,12.18%,ADCY8;GAS6;PRKACA;IGF1R;ERN1
prerank,positive regulation of cell division (GO:0051781),0.43042221955024695,0.9960079624776317,0.48088064889918886,0.9526940907110983,1.0,7/38,10.69%,SVIL;FGF1;KIF20B;GIPC1;PKN2;TAL1;CDC42
prerank,negative regulation of interferon-gamma production (GO:0032689),0.4611930469800263,0.9959152338036759,0.48936170212765956,0.9523544519466528,1.0,7/23,14.85%,GAS6;AXL;PRNP;HMGB1;LGALS9;HAVCR2;TLR4
prerank,positive regulation of lyase activity (GO:0051349),0.5046693991385431,0.9958245525878491,0.4992636229749632,0.952016514575134,1.0,2/14,4.01%,CACNA1D;NF1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.43815585798999684,0.9957936859942519,0.5012106537530266,0.9515041809304452,1.0,9/29,18.00%,SMARCA4;TLE2;EP300;TLE1;TCF7L2;TRRAP;TLE4;CTNNB1;BCL9
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.4025244130435466,0.9957185933024404,0.5103950103950103,0.951102158438395,1.0,13/87,12.65%,COA3;NUBPL;TMEM126A;FOXRED1;COX17;NDUFS1;NDUFA9;UQCC1;NDUFV2;NDUFAF7;IMMP2L;AIFM1;NDUFA10
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.4821914606711193,0.9954050248204773,0.4886211512717537,0.9513531584265668,1.0,2/17,8.02%,CRLS1;PLA2G4A
prerank,response to ketone (GO:1901654),0.45085675531942937,0.9943270212556736,0.47215189873417723,0.9536448861106199,1.0,3/24,4.55%,TGFB2;WBP2;THBS1
prerank,cellular response to gamma radiation (GO:0071480),0.4794012473604786,0.9941971386045306,0.5258855585831063,0.9534160276028734,1.0,3/17,5.83%,TMEM109;WRN;MAP3K20
prerank,cellular protein modification process (GO:0006464),0.39458807505305027,0.994097326984079,0.539,0.9530850521269603,1.0,175/982,14.01%,SGK3;SGK2;PLK1;WDR45;WFS1;CP;FNTB;KLHL42;RSKR;SIRT7;FBXO17;LRRK2;IGFBP3;UST;PRKCZ;VWA1;ALG3;PARP9;UCHL3;ST8SIA5;FBXW7;FBXO30;ST8SIA4;MINK1;EIF2AK2;ILF3;GMFB;SEPHS1;LIPE;GGCX;DYRK2;KLHL11;NEK3;METAP1;BRAF;DAPP1;TGFB2;GAS6;FEM1C;FEM1A;FBXO21;BMPR1A;PSMD9;CPE;SCG3;THBS1;PPP2R2A;PIK3R4;PSMB8;MAP3K11;CDK7;PRKCB;WDR45B;PDGFB;COPS7B;COG3;QSOX1;PRKCA;PRKACA;CDK2;BTK;YES1;PARP8;PRKDC;MAPK1;MAP3K20;PTPRJ;ASB8;EGLN3;CDK6;ACVR1;UBXN7;CTDNEP1;STK11;FBXO9;CEL;PSMC5;KEAP1;IKBKB;CDC42BPB;MAPK8;SETD3;PKN2;PAK2;DUSP16;RPS6KA5;PARP2;CDK9;DUSP10;SSH2;CAMK2D;PTPN1;F13A1;MAP3K9;ABCA7;PTPRT;MAST2;STT3A;PPP4R1;TNKS2;BIRC6;GRK5;DAPK1;CHEK2;COPS4;PTPN3;RAB2A;BRD2;ASB13;FBXO11;NEK7;PROC;CTBP1;LYN;B4GALT5;DCAF17;GAN;CDK5;PARP4;SOCS5;TAOK1;ELOC;UBE2I;SDC2;ASB2;FBXW11;MIA3;B3GALNT1;TGFBR2;ATG3;BMP2K;MAN2A2;LAMC1;MTOR;B3GNT2;PPM1A;CUL4A;ABL1;ERN1;KLHL5;CDKL5;PIGU;ZDHHC6;PRKCSH;PSMD12;UBE2F;ADAM10;SRPK2;HIPK2;MAPKAPK2;PSMA2;TGFBR1;NRBP1;CTDP1;ACVR1B;RBBP7;DUSP12;CDK8;SYK;GPC3;FN1;NUS1;ASB7;PTPRU;PTPRO;INSR;CAMKK2;B3GALNT2;PPP2R3A;FYN;PRKD2;FBXL7;SPARCL1;CSNK1A1;CREB1
prerank,positive regulation of blood coagulation (GO:0030194),0.480747786437896,0.9936323130193678,0.48456375838926175,0.9536768041016549,1.0,3/17,10.13%,THBS1;ENPP4;F3
prerank,positive regulation of mitochondrial translation (GO:0070131),0.48752687940170897,0.9935871636515398,0.5,0.9532037830070932,1.0,1/14,1.42%,COA3
prerank,neuron projection regeneration (GO:0031102),0.5205358211604239,0.9935795402693426,0.4727838258164852,0.9526367570531289,1.0,3/10,11.57%,NREP;MTR;GAP43
prerank,keratan sulfate biosynthetic process (GO:0018146),0.44097576684614925,0.9933768348073012,0.4878345498783455,0.9525621395613108,1.0,4/26,11.61%,B4GALT3;B4GALT5;B4GALT1;B3GNT2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.44999145347156333,0.9928734742565036,0.5126964933494559,0.953296679158996,1.0,4/29,11.10%,RAET1E;STX7;SLAMF6;CYRIB
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.40267643261832214,-0.9926675440530904,0.48986486486486486,0.96313129693206,1.0,8/13,38.84%,UPP2;NT5M;TDG;SMUG1;NEIL2;NT5C;OGG1;NEIL1
prerank,negative regulation of hydrolase activity (GO:0051346),0.4213677675390392,0.9922881464303727,0.504424778761062,0.9542527254864076,1.0,8/49,11.72%,URI1;LRRK2;TERF2;ARFGEF1;RRP1B;EGLN1;LRCH1;TMED2
prerank,myeloid cell development (GO:0061515),-0.36155264495880757,-0.9920278530777522,0.49586776859504134,0.9621112777186345,1.0,2/18,0.16%,APP;FOXP1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.4664031375026953,0.9919413227905174,0.5006289308176101,0.9545426456833375,1.0,5/22,16.68%,STX7;TRAF2;CYRIB;FBXO38;ZBTB1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.44956027418031513,0.9918208186305105,0.4888888888888889,0.9542727367288235,1.0,3/24,6.74%,RFC2;POLD3;POLB
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5278139306959257,0.9916955089388431,0.5096153846153846,0.9540094869530581,1.0,4/10,16.10%,MAPK1;LYN;MAP2K2;MAP2K1
prerank,cellular component disassembly (GO:0022411),0.4215343566624683,0.9912086740381846,0.4994475138121547,0.954732640889926,1.0,7/53,12.66%,SCUBE1;ADAM15;CD44;FURIN;CAPN2;LAMC1;ADAM10
prerank,protein modification by small protein conjugation (GO:0032446),0.39575653974668,0.9910179118762936,0.522,0.9546425209245986,1.0,91/361,17.03%,TRIM55;PLK1;BRCA1;UBE2Z;CDK5RAP3;UCHL3;RNF182;FBXW7;EIPR1;UBA5;CTR9;RLIM;RAD18;NUP205;UBE2V2;CDC23;UFC1;PRKDC;TRAF7;ARRB2;UBE2A;UBE2J2;CBLL1;DCUN1D4;FBXO9;KEAP1;RNF34;SUMO3;SUMO2;NEDD4;NUP98;HECW1;TRPM4;NUP54;BIRC6;RCHY1;AREL1;CDC16;RNF38;TRPC4AP;USP5;FBXO11;UBE2Q2;GAN;RFWD3;ELOC;TRIM5;UBE2I;RNF157;MYLIP;ASB2;FBXW11;ATG3;CBL;TRIM44;BCL11A;DERL1;CUL4A;UBE2W;UBE2F;MIB1;VPS11;RNF138;RNF20;ANAPC16;NFX1;UVSSA;UBE2H;FBXL7;RNF135;UBA6;UBE2D3;DTX3;MSL2;ATG7;PEX14;TRIM26;PIAS1;VCPIP1;ZNRF3;UBE2G1;UBA2;UBE2E3;UBR3;NUP160;CNOT4;NSMCE2;HACE1;SAE1;NUP93;DCUN1D2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.4765065120377558,0.9909697724701592,0.4840499306518724,0.9541806649426449,1.0,5/17,18.26%,TGFB2;SYK;P2RY12;NCKAP1L;PIEZO1
prerank,digestive tract morphogenesis (GO:0048546),-0.3939252222851884,-0.9908135155438867,0.4659498207885305,0.9630918128839377,1.0,2/14,3.58%,FGFR2;NIPBL
prerank,myeloid cell differentiation (GO:0030099),0.4252972145709261,0.9907911784940172,0.5118110236220472,0.9540354754066598,1.0,11/47,14.26%,UBA5;RUNX1;IKZF1;KMT2E;HSPA9;ACIN1;LYN;TAL1;HIPK2;FLVCR1;TET2
prerank,regulation of gene silencing by RNA (GO:0060966),0.419929929005906,0.99063312462253,0.5016648168701443,0.9532957055729768,1.0,8/50,9.28%,POLR2D;POLR2A;NUP205;PUM2;NUP98;AGO2;NUP54;PUM1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.419929929005906,0.99063312462253,0.5016648168701443,0.9532957055729768,1.0,8/50,9.28%,POLR2D;POLR2A;NUP205;PUM2;NUP98;AGO2;NUP54;PUM1
prerank,mitochondrion disassembly (GO:0061726),0.43823600405264007,0.9905522830472225,0.5171192443919717,0.952895646396875,1.0,10/34,15.16%,WDR45;WDR45B;SQSTM1;AMBRA1;BNIP3;ULK2;ATG3;RB1CC1;ATG7;BECN1
prerank,chromatin organization (GO:0006325),0.3956111811273852,0.9903177400590274,0.5056065239551478,0.9529146145633688,1.0,32/132,16.82%,EHMT1;SMARCA4;SUV39H1;HCFC1;ZBTB7A;KDM5A;PADI2;HMGN3;ESR1;HDAC11;HDAC5;NUDT5;SETD2;HP1BP3;KDM5B;GATAD1;EZH2;TADA2A;BAZ2B;KDM4B;KAT2B;KDM4C;ATRX;NPM1;SMARCA2;HDAC2;BAZ1B;PAK1;RB1;SMARCC2;ZBTB1;SETD5
prerank,leukocyte tethering or rolling (GO:0050901),0.47729750730041015,0.9902159264377393,0.497289972899729,0.9526033409723264,1.0,2/17,7.03%,ITGA4;GOLPH3
prerank,long-term memory (GO:0007616),-0.35891962268799416,-0.990202889004176,0.45564516129032256,0.9619664510141416,1.0,3/19,3.51%,CPEB3;SGK1;EIF2AK4
prerank,regulation of myelination (GO:0031641),-0.3303369722405367,-0.9900666664608949,0.4798206278026906,0.959478099992611,1.0,13/25,35.04%,SIRT2;PTPRZ1;EIF2AK3;RNF10;JAM2;ITGAX;TPPP;ZPR1;MYRF;DICER1;CST7;TNFRSF21;NSUN5
prerank,cellular response to unfolded protein (GO:0034620),0.44913295064900866,0.9900252168274344,0.4847715736040609,0.9525162322136416,1.0,9/26,17.68%,BAG3;HSPA9;PTPN1;TM7SF3;ERN1;OPTN;RHBDD1;HSPA5;TMBIM6
prerank,negative regulation of macroautophagy (GO:0016242),0.45410739153525387,0.9897654995870274,0.5139056831922612,0.952607643308201,1.0,9/26,15.54%,LRRK2;NUPR1;QSOX1;MTOR;FEZ1;LZTS1;TMEM39A;TSC1;MTM1
prerank,neuropeptide signaling pathway (GO:0007218),0.41087429138511633,0.989660013929772,0.504885993485342,0.952300271481088,1.0,7/58,13.83%,CPE;GPR149;SORCS3;GLRB;SORL1;GLRA3;CYSLTR1
prerank,I-kappaB phosphorylation (GO:0007252),0.5249880232479776,0.9894345409292579,0.5036927621861153,0.952325821520956,1.0,3/10,14.85%,TLR7;TLR3;TLR4
prerank,ERBB2 signaling pathway (GO:0038128),0.44402715063341214,0.9892617343439328,0.4911242603550296,0.9522171500300995,1.0,4/31,6.93%,NRG2;GRB2;PRKCA;HSP90AA1
prerank,carbohydrate homeostasis (GO:0033500),0.41319865849833987,0.9890331296675979,0.5042918454935622,0.9522076260755266,1.0,13/67,13.69%,WFS1;ADCY8;IRS1;STK11;ALOX5;PPARG;IGF1R;GCK;RPS6;TCF7L2;CYB5R4;INSR;ADIPOR1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.49263080841649587,0.9884037036141416,0.5049928673323824,0.953278460439882,1.0,3/13,9.77%,NFU1;GLRX3;YAE1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.2784971063696769,-0.9883851367746088,0.4074074074074074,0.9616691994462954,1.0,9/57,6.81%,JAK2;PARP14;PTPN2;ERBB4;NF2;GHR;CSF1R;CNOT7;HCLS1
prerank,sterol biosynthetic process (GO:0016126),0.4344977962967088,0.9880731689423768,0.49940968122786306,0.9535599691791601,1.0,3/33,4.43%,INSIG1;INSIG2;GGPS1
prerank,myoblast differentiation (GO:0045445),0.4936386060452603,0.9879857558398153,0.5028901734104047,0.9532156122757908,1.0,5/14,16.57%,MBNL1;PLEKHM3;TCF7L2;DDX5;RB1
prerank,organelle organization (GO:0006996),0.39343842608346685,0.9879823274539095,0.545,0.9526428763348683,1.0,92/388,15.81%,MIEF2;LMAN1;LRRK2;COG1;FGD6;MTX1;ADCK1;WDR73;TMED4;CFL1;FGD3;VPS4A;FGD1;CHMP5;PPID;RAB3GAP1;TFB2M;SSBP1;HCFC1;SIPA1L3;HPS3;STX7;TPM1;ATP7A;ATXN7;COG3;PRPF40A;FNBP1L;CAPZB;TMED9;RAB30;PYROXD2;PACSIN2;ABCD2;ARFGEF1;POLG2;GOLPH3;LYSMD3;CDC42BPB;VPS13C;RANBP9;REEP5;MAST2;YTHDF1;STX17;PI4K2A;ODF2;RAB2A;MICAL2;ATP8B4;MAST3;SEC61A1;CDC42;ABCD3;SEMA6A;DIAPH1;PALLD;MIA3;MCOLN1;KIF3A;VPS4B;TMED2;TRAPPC8;RAB18;DNAJA3;ZMYM6;VPS11;ABCD1;TMED5;MAST4;VPS13D;PDCD6IP;PKD2;CSNK1A1;SAR1B;LNPK;EPS15;TRIP11;OPTN;RAB7A;WASL;NIPSNAP2;CLASP1;PEX14;ATL2;PHIP;MICAL3;PITPNB;SH3KBP1;ATP5F1B;GOLGA5;GOLGA8B
prerank,regulation of cell aging (GO:0090342),-0.42269679193229465,-0.9879814551754943,0.4940119760479042,0.9599998770809756,1.0,6/11,31.13%,PNPT1;RSL1D1;ING2;NEK4;VASH1;LMNA
prerank,RNA transport (GO:0050658),0.40956437952232216,0.9878880874595732,0.5069967707212056,0.9522988768205354,1.0,16/71,12.67%,EIF4A3;DHX38;SARNP;RFTN1;SIDT1;RNPS1;U2AF1;HNRNPA2B1;THOC5;SRSF5;U2AF2;ATXN2;TGFBR2;ZFP36L1;SRSF9;SRSF11
prerank,regulation of cellular component movement (GO:0051270),0.42584443075895617,0.9878407649255895,0.5005549389567148,0.9518291743309467,1.0,15/49,16.23%,NRG2;IGBP1;CDK6;ZSWIM6;PKN2;YTHDF1;LYN;ACTN4;DIAPH1;ABL1;RAF1;TGFBR1;ROCK2;INPP5F;PKN1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.473086604843063,0.9876938672810525,0.50199203187251,0.951659562056338,1.0,6/18,17.12%,MIEF2;VPS35;BNIP3;DNM1L;MFF;RALBP1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4640627993747795,0.9872522795276034,0.495225102319236,0.9521979558894238,1.0,5/19,12.92%,TMEM109;DYRK2;EP300;HIPK2;TP53
prerank,negative regulation of B cell activation (GO:0050869),-0.35060488153331204,-0.9871177312882369,0.46382978723404256,0.959743657610351,1.0,4/21,7.11%,LAPTM5;SAMSN1;FCGR2B;TYROBP
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.40317796937822936,-0.9870362060212043,0.48773006134969327,0.9571301899874441,1.0,3/12,7.56%,FOXP1;MBP;LPL
prerank,protein ubiquitination (GO:0016567),0.39159268298948746,0.9861777031661711,0.554,0.9543617023720724,1.0,103/471,15.66%,TRIM55;PLK1;BRCA1;KLHL42;FBXO17;UBE2Z;UCHL3;RNF182;FBXW7;FBXO30;EIPR1;CTR9;RNF31;RLIM;SH3RF3;SASH1;FBXO21;RAD18;PELI1;PSMD9;PSMB8;UBE2V2;CDC23;AKTIP;PRKDC;TRAF7;RC3H2;ARRB2;NHLRC1;UBE2A;RNF166;UBE2J2;CBLL1;FBXO9;PSMC5;RNF115;KEAP1;RNF34;PPIL2;NEDD4;UNKL;TPP2;BFAR;LNPEP;HECW1;HERC6;RNF146;TNKS2;BIRC6;RCHY1;AREL1;CDC16;RNF38;TRPC4AP;USP5;FBXO11;UBE2Q2;GAN;RNF11;RFWD3;TRIM3;ELOC;TRIM5;RNF157;MYLIP;ASB2;TRAF2;FBXW11;ATG3;CBL;TRIM44;RNF144B;DERL1;CUL4A;UBE3A;UBE2W;UBE3C;PSMD12;MIB1;VPS11;UBR5;RNF138;NHLRC3;PSMA2;RNF20;BCL2;ANAPC16;NFX1;UVSSA;UBE2H;FBXL7;RNF135;UBA6;UBE2D3;DTX3;MSL2;TRIP12;PEX14;TRIM26;VCPIP1;FBXW4;PSMB1;ZNRF3
prerank,dendritic cell migration (GO:0036336),0.46903282613446995,0.9858335109272138,0.5014005602240896,0.9546530115528845,1.0,4/16,12.01%,ALOX5;TRPM4;EPS8;HMGB1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.4404390545565698,0.9854548569191622,0.49939975990396157,0.9550541431339165,1.0,7/33,14.62%,ITGB1BP1;TGFB2;PDE3B;FERMT3;LYN;SYK;P2RY12
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.3721943755150054,-0.9854101015530499,0.4727272727272727,0.9591876076435347,1.0,4/17,3.46%,CALM2;EIF4G1;SMAD7;SIRT2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5177799628206357,0.9853509290922444,0.5129032258064516,0.9547711066746041,1.0,3/10,8.44%,NEDD4;CAMK2D;HECW1
prerank,defense response to bacterium (GO:0042742),0.401841742545707,0.9851925067642671,0.5258264462809917,0.954627678615875,1.0,12/105,14.85%,ANG;RNASE6;PLA2G6;GSDMD;TLR3;LYZL4;MAVS;COLEC12;RNASE3;SYK;OPTN;TLR4
prerank,protein mono-ADP-ribosylation (GO:0140289),0.5098977764135524,0.985029711811832,0.5068285280728376,0.9544651636430533,1.0,3/11,10.02%,PARP9;PARP8;PARP4
prerank,regulation of mitotic cell cycle (GO:0007346),0.3929702872139651,0.9847332823962573,0.5291750503018109,0.9546387844252971,1.0,29/171,13.61%,PLK1;GAS1;CDK5RAP3;CCDC57;DUSP3;TFAP4;PSMD9;PSMB8;ANAPC10;SMAD3;CDC23;PRKCA;KIF20B;SDCBP;PSMC5;BUB3;PKN2;CDK9;CDC16;PTPN3;NEK7;TAL1;HECA;PSMD12;CYLD;PSMA2;RNF20;ANAPC16;TTC28
prerank,phospholipid dephosphorylation (GO:0046839),0.43251612836624864,0.9842438078535072,0.5089887640449439,0.9553247937768049,1.0,4/37,5.74%,MTMR11;SGPP1;MTMR1;SGPP2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.4052019458392937,0.9841372401727753,0.5276595744680851,0.9550269471427686,1.0,17/73,16.07%,EIF2AK2;SETD1A;RUNX1;PSMD9;PSMB8;KITLG;PRKDC;METTL3;PSMC5;TAL1;TCF12;ABL1;PSMD12;PSMA2;LDB1;PSMB1;LMO2
prerank,primary miRNA processing (GO:0031053),0.5172665382504004,0.9841198053344083,0.5173501577287066,0.9544914482464224,1.0,3/10,7.13%,SMAD3;METTL3;HNRNPA2B1
prerank,intracellular lipid transport (GO:0032365),0.46175403376225943,0.984018414362868,0.4973753280839895,0.9541851764487377,1.0,6/21,14.13%,SGPP1;ABCD2;SLC25A20;ABCD3;ABCD1;ACACA
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.4139339962271506,0.9839212032415587,0.5084554678692221,0.9538699897479869,1.0,11/48,13.72%,SS18L1;FLNA;NRP1;DOCK1;PRKDC;CUX1;LIMS1;CDC42;ABL1;CDKL5;RREB1
prerank,regulation of metal ion transport (GO:0010959),0.48488119214717,0.9838521659237187,0.4943977591036415,0.9534599048852427,1.0,5/16,13.39%,IL16;DLG1;EPB41;BCL2;CAMK2G
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.49314074819805476,0.9837607919747857,0.48776978417266187,0.9531282256474518,1.0,3/13,10.70%,UBAC2;ERLEC1;EDEM2
prerank,protein localization to plasma membrane (GO:0072659),0.39036420153152906,0.9837596256794702,0.5233265720081136,0.9525553282656094,1.0,28/129,14.30%,FLOT2;ZFYVE27;EHD4;ITGB1BP1;RAB8B;EHD1;GAS6;RAB40C;RAB12;RAP1A;FLNA;MYO5A;EZR;PPIL2;IKBKB;DLG1;SLMAP;SPTBN1;EFR3B;RAMP1;TMED2;PACS2;EPB41L3;RAB3C;LRP6;PACS1;KCNIP3;ROCK2
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.4897167997579933,0.9830614764672645,0.5021520803443329,0.9538025112008771,1.0,5/14,17.17%,PRKAR2A;PKIB;PKIA;PRKAR1A;RAPGEF2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.4419562928336959,0.9826715765795772,0.5142503097893433,0.954262483999984,1.0,6/27,14.68%,CD36;IL18;PPARG;ABCG1;ABCA1;ABCA5
prerank,regulation of vacuole organization (GO:0044088),0.46542698980279745,0.9824185544553161,0.5012987012987012,0.9543228102750004,1.0,7/20,15.54%,IFT20;TBC1D14;ENO1;ANXA2;TBC1D12;SCARB2;MTM1
prerank,regulation of endocytosis (GO:0030100),0.40586132921087975,0.9819584171803543,0.4968085106382979,0.9549403443164777,1.0,13/61,13.37%,SMPD1;STON2;PACSIN2;CBLL1;RAB5B;SYT11;PTPN1;ABCA7;DAB2;RIT2;SCAMP5;ABL1;GPC3
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.37973058893612927,-0.9819546132126454,0.48771929824561405,0.9665519088353691,1.0,8/15,12.96%,CPEB3;CNOT1;TENT4B;TNRC6C;PABPC1;CNOT7;TNRC6A;TENT4A
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.4436647646172563,0.9818597933298989,0.5091575091575091,0.9545978828564977,1.0,6/29,11.97%,LSM7;EXOSC5;DCP1B;EXOSC7;DCP1A;DCPS
prerank,autophagy of peroxisome (GO:0030242),0.5067898241226813,0.9817883249913876,0.5087209302325582,0.9542195069081987,1.0,4/12,12.19%,PIK3R4;SQSTM1;TRAPPC8;RB1CC1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.29018158394695476,-0.9817398982683435,0.49514563106796117,0.9643745364326068,1.0,9/42,10.79%,ACTR2;MMS19;RIF1;ERCC6;SHLD1;SHLD2;KLHL15;PARP1;WDR48
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.43467188878700624,0.9814872876641624,0.5186074429771909,0.9544489340601164,1.0,10/33,17.53%,ANKRD54;PRKDC;TAL1;MAPK14;ACVR1B;RAB7B;ARNT;FOXO3;NCKAP1L;MED1
prerank,mRNA export from nucleus (GO:0006406),0.39484639016145595,0.9811509039738697,0.5231719876416066,0.9547223632513109,1.0,17/102,12.67%,POLR2D;EIF4A3;SMG6;DHX38;SARNP;RNPS1;NUP205;U2AF1;HNRNPA2B1;THOC5;NUP98;SRSF5;NUP54;U2AF2;CPSF3;SRSF9;SRSF11
prerank,cellular response to interleukin-2 (GO:0071352),-0.40709971986014537,-0.9810288159609966,0.4896142433234421,0.9608183489551205,1.0,5/11,24.55%,PTK2B;SHC1;JAK1;STAT5B;STAT5A
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.40709971986014537,-0.9810288159609966,0.4896142433234421,0.9608183489551205,1.0,5/11,24.55%,PTK2B;SHC1;JAK1;STAT5B;STAT5A
prerank,extracellular matrix disassembly (GO:0022617),0.41667520210462156,0.9810080447533693,0.5077433628318584,0.9545209873860677,1.0,7/53,12.66%,SCUBE1;ADAM15;CD44;FURIN;CAPN2;LAMC1;ADAM10
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3906276241864432,0.9808384469795483,0.5731462925851704,0.9543775919513509,1.0,51/291,14.85%,HCN3;RORA;INSIG1;RELA;CTR9;RAPGEF1;PID1;CHMP5;IMPACT;JUN;AKAP9;IRS1;RAP1A;TPM1;PDGFB;CDK2;MAPK1;ESR1;AXL;IL1A;EZR;MAPT;RAP1B;MAPK8;TWF2;NCOA3;DAPK1;MTR;ADNP2;LYN;SETX;IPO5;PLAA;CAPN2;PXN;MTOR;HMGB1;ZFP36L1;SLC38A9;MAPK14;LCOR;CAMKK2;HTRA2;PKD2;CREB1;GNG2;ROCK2;GNB1;LARS1;P2RY12;TLR4
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.44232008255810057,0.9807634043505892,0.5024330900243309,0.954002326938976,1.0,10/27,16.10%,EIF4ENIF1;PUM2;TNRC6B;AGO2;PUM1;TP53;MAP2K2;DDX5;EIF4E2;MAP2K1
prerank,glycosphingolipid metabolic process (GO:0006687),0.4177246689127204,0.9796816301686232,0.5113122171945701,0.9562219993109893,1.0,7/42,11.14%,ST8SIA5;GBA2;SMPD3;SMPD1;GALC;ASAH1;B3GALNT1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.48797139076906026,0.9795395686973565,0.5226628895184136,0.9560036522733713,1.0,2/15,4.23%,SMPD3;PLA2G6
prerank,cell cycle G1/S phase transition (GO:0044843),0.40467290701141057,0.9795343781567345,0.5147679324894515,0.9554485476633144,1.0,17/61,18.00%,MAX;MAP3K11;CDK7;CDK2;CDK6;ACVR1;USP29;MNAT1;CUL4A;ACVR1B;USP37;CRLF3;RB1;EIF4E;RPS6KB1;PPP6C;KHDRBS1
prerank,cellular response to UV (GO:0034644),0.4013165944718031,0.9790978706888672,0.5180467091295117,0.9559860096977109,1.0,12/76,12.93%,ACTR5;PPID;IMPACT;SMPD1;EP300;METTL3;STK11;NEDD4;ERCC4;NOC2L;TP53;EIF2S1
prerank,phagosome-lysosome fusion (GO:0090385),-0.4326203883106598,-0.9788592188877393,0.5095890410958904,0.9644238253612764,1.0,4/10,16.55%,ARL8B;CLN3;RAB39A;RAB20
prerank,negative regulation of gluconeogenesis (GO:0045721),0.512593314410466,0.9781715681300169,0.523168908819133,0.9577811582882302,1.0,2/11,11.56%,EP300;GCK
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.44711100969883466,0.978046005233718,0.5094102885821832,0.9575330408323361,1.0,6/25,14.78%,AKAP9;DLG1;CAMK2D;TRPM4;CALM1;CACNA1C
prerank,regulation of sensory perception of pain (GO:0051930),-0.41207276797681003,-0.9779141581975022,0.5056818181818182,0.9643341313558818,1.0,8/11,53.11%,MGLL;ZFHX2;ATPSCKMT;CCL3;TMEM100;F2R;ACP3;CCN3
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.4612016451420861,0.9778344190054072,0.5172413793103449,0.9575003965290471,1.0,6/18,15.70%,BCL2L11;TMEM259;NCK1;ERN1;ATXN3;PIK3R1
prerank,autophagosome maturation (GO:0097352),0.4298114543931804,0.9773686295791233,0.5011709601873536,0.9580884965288694,1.0,10/32,15.96%,TSG101;VPS16;VAMP7;UBQLN1;STX17;UVRAG;VIPAS39;CALM1;SNX14;EPG5
prerank,regulation of macrophage differentiation (GO:0045649),-0.3822245192833642,-0.9772691607928814,0.48322147651006714,0.9635718794197757,1.0,4/15,7.26%,C1QC;PTPN2;CSF1;RIPK1
prerank,sensory organ development (GO:0007423),0.4128111151797005,0.9770534182457062,0.5279299014238773,0.9583260396215787,1.0,13/51,18.35%,TGFB2;SIPA1L3;CHD7;AHI1;SMCHD1;RAB18;ATF6;HIPK2;SMG9;HIPK1;PBX3;MEIS1;MEIS2
prerank,regulation of axon extension (GO:0030516),0.41834806429378857,0.976091363618909,0.4941860465116279,0.9601797199408069,1.0,12/37,16.16%,ZFYVE27;OLFM1;MAPT;TWF2;DIP2B;DBNL;ABL1;CDKL5;RUFY3;RTN4;MACF1;GOLGA4
prerank,amide biosynthetic process (GO:0043604),0.41998286581586497,0.975272956230983,0.5206243032329989,0.9616689442281813,1.0,9/47,14.77%,DEGS1;SMPD1;CERS6;SLC25A2;CERS4;FURIN;ASAH1;CERS5;SPTLC1
prerank,regulation of axon guidance (GO:1902667),0.5165989374482807,0.9751129909028784,0.5087719298245614,0.9615266624646148,1.0,3/10,8.77%,NRP1;ZSWIM6;YTHDF1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.49517957856418227,0.9750485017664922,0.5240793201133145,0.9611116696128236,1.0,5/14,16.20%,IL18;TGFBR2;SYK;LGALS9;CD81
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.4557984988695128,0.9748881119132158,0.5152998776009792,0.9609181461413312,1.0,7/23,15.88%,MTMR11;MTMR1;OCRL;PTEN;SYNJ2;MTM1;INPP5F
prerank,regulation of defense response to virus by host (GO:0050691),0.43837471668975586,0.9748672026408166,0.5265700483091788,0.9604060603378638,1.0,6/30,11.45%,PARP9;HSP90AA1;ZDHHC1;MAVS;RNF216;TRIM44
prerank,sensory perception of light stimulus (GO:0050953),0.39736908049945224,0.9745556890215546,0.522466039707419,0.9606187373818794,1.0,14/87,16.46%,WFS1;ATXN7;CRYBG3;COL11A1;MYO9A;DHRS3;PITPNA;EML2;ATF6;RPGR;ABLIM1;SLC4A10;DRAM2;RP2
prerank,T cell proliferation (GO:0042098),0.48740390846210435,0.974200251098482,0.5057471264367817,0.9609229179702337,1.0,2/13,4.01%,DOCK8;MSN
prerank,synaptic vesicle localization (GO:0097479),-0.40466888987423333,-0.9738402077923,0.4983164983164983,0.9706222911181747,1.0,9/13,31.59%,DNM2;KIF5C;RAB27A;SYNDIG1;KIF5A;SYNJ1;TMEM230;TOR1A;SNAPIN
prerank,nuclear migration (GO:0007097),0.4914946207812206,0.9736601817557821,0.5022156573116692,0.9617386892543098,1.0,3/13,11.05%,SYNE2;DCTN1;FBXW11
prerank,negative regulation of apoptotic process (GO:0043066),0.3885083548362531,0.9734763168630199,0.587,0.961636408762176,1.0,64/444,13.16%,ISL1;PLK1;WFS1;UBE2Z;RELA;CX3CL1;CD38;WDR73;SMAD6;CFL1;BAG3;NUPR1;BRAF;GAS6;IGBP1;NAA35;THBS1;FLNA;TNFAIP8;YWHAE;PRKCA;PRKDC;SQSTM1;MAPK1;AXL;BIRC3;GOLPH3;TLE1;API5;IKBKB;MRE11;HSPA9;MAPK8;PAK2;BNIP3L;SET;BFAR;BABAM2;DAB2;BIRC6;ZFAND6;GRK5;FNIP1;AREL1;AHI1;MTDH;PROC;CD44;SETX;TMBIM4;RNF157;NAA16;BNIP3;NOTCH2;IGF1R;CBL;RNF144B;MAP2K5;RAF1;ADAM10;TP53;BCL2;FMN2;NAA15
prerank,regulation of exit from mitosis (GO:0007096),0.4190619314287383,0.973376598066831,0.5232558139534884,0.961341358274502,1.0,5/38,9.14%,RGCC;ANAPC10;CDC23;BUB3;CDC16
prerank,positive regulation of phospholipid transport (GO:2001140),0.4950711516088281,0.9731466563695026,0.5085803432137286,0.9613146058912748,1.0,2/10,8.50%,TMEM30A;ABCA7
prerank,neutral amino acid transport (GO:0015804),0.43489906603100276,0.9729702701799046,0.5258620689655172,0.9611782250533242,1.0,3/28,8.66%,LLGL2;SLC38A2;SLC7A8
prerank,negative regulation of stress fiber assembly (GO:0051497),0.44727025488239047,0.9729061548473619,0.5335018963337548,0.9607737701674071,1.0,7/24,15.70%,CGNL1;PPFIA1;PAK2;WASF2;TMEFF2;CLASP1;PIK3R1
prerank,nucleotide catabolic process (GO:0009166),-0.36710442032969987,-0.97290591216414,0.4641509433962264,0.9704766437698155,1.0,9/16,36.86%,VCP;XDH;DERA;NUDT3;PNP;GPX1;SAMHD1;ITPA;NT5C
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.4195880281686123,0.9728603173417162,0.522543352601156,0.9603377220967698,1.0,7/40,12.96%,BLM;WRN;BOD1L1;CDK9;EXD2;RFWD3;ATRX
prerank,triglyceride metabolic process (GO:0006641),0.4090922489571052,0.9728240491135085,0.5300794551645857,0.9598683226133629,1.0,3/48,11.55%,MOGAT3;GPAM;GK
prerank,brain development (GO:0007420),0.3866676944863739,0.9719545107672346,0.5688259109311741,0.9614593536419445,1.0,37/136,18.35%,CDK5RAP3;UTP3;NNAT;RAB3GAP1;BBS4;SETD1A;NF1;ATXN1;UFC1;PITPNM1;TUBGCP2;AFF2;CHD8;FBXW11;TGFBR2;UGP2;EML1;RAB18;UBE3A;SOX6;NDRG4;RELN;GRIN2A;PTEN;SMG9;SYNJ2;CIC;NFIB;TBC1D23;CTNNA2;RAPGEF2;PBX3;APOD;MEIS1;CDK5RAP2;PROX1;MEIS2
prerank,dendritic spine organization (GO:0097061),0.4420996248987363,0.9714352185864443,0.5202453987730061,0.9621883129474896,1.0,12/26,17.88%,EPHB2;CDC42;ARF1;IGF1R;PRNP;INSR;FYN;PTEN;WASL;LGMN;DOCK10;TREM2
prerank,polyol metabolic process (GO:0019751),0.41674815569516793,0.9707147323852435,0.5280898876404494,0.9634724265602297,1.0,11/46,14.70%,INPP1;INPP4A;INPP5A;MINPP1;PLD4;IPMK;PLCB4;OCRL;CALM1;ITPK1;PTEN
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4540367947724917,0.9705150267018104,0.5222513089005235,0.9634095474004616,1.0,3/18,9.50%,RELA;SP1;ABCG1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.4646694751579552,0.9704441858462377,0.5243243243243243,0.9630181095446334,1.0,2/18,4.96%,BRAF;PRKCB
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.4630966860008457,0.9701539405720253,0.5253077975376197,0.9631598677275947,1.0,4/18,9.28%,DDX60;PUM2;BIRC3;PUM1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.4476974093023114,0.9700936168819513,0.5301837270341208,0.9627473564251944,1.0,3/22,8.61%,BTK;LACC1;TRPM4
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4022291719950552,0.9699658314850016,0.5455497382198953,0.9625285508875616,1.0,16/72,14.97%,ARHGEF3;SCAI;NRP1;GPR65;EPS8L1;EPS8;ARHGAP35;AKAP13;RIT2;ABL1;RAF1;MYO9B;ABCA1;HEG1;LPAR6;ARHGDIB
prerank,regulation of calcium ion transport (GO:0051924),0.40665071289097415,0.9695471712959173,0.5436681222707423,0.963006026182451,1.0,9/54,14.08%,WFS1;IL16;HOMER2;CACNA1D;EPB41;BCL2;CAMK2G;PKD2;CD84
prerank,vesicle transport along actin filament (GO:0030050),0.45869972428359024,0.9693774254053239,0.5529715762273901,0.9628787116565997,1.0,8/19,17.05%,MYO5A;FNBP1L;MYO1G;ACTN4;MYO1E;WASL;MYO1B;MYO1D
prerank,regulation of cell development (GO:0060284),0.41822924919803645,0.9691978937097814,0.5219399538106235,0.9627503451765703,1.0,3/36,4.82%,CX3CL1;CLOCK;HDAC9
prerank,positive regulation of glucose import (GO:0046326),-0.335247179282698,-0.9690940361643484,0.5,0.978729345742599,1.0,9/21,15.31%,APPL1;SORBS1;OSBPL8;IGF1;PRKCI;AKT1;ARPP19;RHOQ;CREBL2
prerank,ribosomal large subunit assembly (GO:0000027),0.4426722331307534,0.9688508405340754,0.52,0.9630172683277008,1.0,3/24,5.60%,BOP1;RPLP0;TRAF7
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.504669257164667,0.9688373297801082,0.5355029585798816,0.9624814613421077,1.0,4/12,12.92%,CDK2;PRKDC;RFWD3;TP53
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.40774418705572196,0.9686129918139297,0.5247747747747747,0.9624729163474397,1.0,4/50,7.11%,BLM;CDK5RAP3;CDK7;MNAT1
prerank,negative regulation of cell motility (GO:2000146),0.3909674968983749,0.9685248975868872,0.5538461538461539,0.9621364781305829,1.0,13/108,8.51%,VCL;DUSP3;CX3CL1;SCAI;ADAM15;ZMYND8;NF1;TPM1;PTPRJ;LDLRAD4;DUSP10;SLURP1;PTPRT
prerank,negative chemotaxis (GO:0050919),-0.29881927543632575,-0.9680975589107428,0.5031446540880503,0.9788852174794259,1.0,14/33,26.18%,RHOA;SLIT2;SEMA4D;EPHA7;PDGFA;SEMA3A;SEMA3E;SEMA4C;SEMA3C;SLIT1;SLIT3;ITGB3;ITGAV;SEMA4G
prerank,macrophage chemotaxis (GO:0048246),-0.42169809443510364,-0.9678927387515818,0.5072046109510087,0.976762914543103,1.0,6/10,49.23%,CKLF;EDNRB;CCL3;CXCL17;CCL2;CCL5
prerank,nuclear pore complex assembly (GO:0051292),0.516284412768839,0.9676940393179839,0.5184049079754601,0.9636558655666833,1.0,4/10,13.32%,NUP205;AHCTF1;NUP98;RTN4
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.5016851426743003,0.9675501483426638,0.5392749244712991,0.9634155278745073,1.0,4/11,13.51%,UGGT2;POMT2;DERL1;UGGT1
prerank,negative regulation of viral transcription (GO:0032897),0.48069522530335507,0.9674073334918012,0.5072046109510087,0.9632185568589136,1.0,1/13,1.47%,IFITM3
prerank,protein modification by small protein removal (GO:0070646),0.38548889960341376,0.9673849500360271,0.585,0.9627060441790307,1.0,61/252,15.89%,BRCA1;ACTR5;KDM1B;USP11;UCHL3;USP32;USP24;DESI1;DESI2;HCFC1;USP19;PSMD9;AR;USP34;PSMB8;EP300;SMAD3;ATXN7;COPS7B;ESR1;ARRB2;USP29;BIRC3;POLB;PSMC5;KEAP1;USP33;USP1;UCHL5;USP48;SNX3;BABAM2;CCP110;COPS4;USP20;USP5;USP46;APC;HGS;TRAF2;KAT2B;USP3;PSMD12;CYLD;TP53;PSMA2;TGFBR1;USP37;ATXN3;USP45;OTULINL;PTEN;RAD23B;NFRKB;OTUD7A;BECN1;SMAD4;VCPIP1;PSMB1;TRRAP;FOXK1
prerank,cellular response to reactive oxygen species (GO:0034614),0.39979475466006725,0.9672893387438244,0.5332606324972737,0.9623836033442371,1.0,12/59,13.91%,RELA;IMPACT;JUN;TPM1;MAPK1;MAPT;MAPK8;SETX;PXN;ABL1;CAMKK2;PKD2
prerank,regulation of AMPA receptor activity (GO:2000311),0.44706828034627705,0.9671949484399482,0.5424354243542435,0.9620525793211482,1.0,2/25,3.10%,MINK1;CACNG7
prerank,lymphocyte chemotaxis (GO:0048247),0.43032304585787823,0.9670781476702662,0.5350467289719626,0.9617894038008312,1.0,3/34,7.28%,CX3CL1;GAS6;CCL25
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.39947454788335646,0.9666868281681417,0.5346638655462185,0.962191210841133,1.0,12/69,14.85%,ISL1;EPHB2;THBS1;PTPRJ;IL1A;TLR3;MAVS;HMGB1;SYK;LGALS9;HAVCR2;TLR4
prerank,prostaglandin metabolic process (GO:0006693),0.4411021907854351,0.966363925041525,0.5409035409035409,0.9624524163784182,1.0,4/26,11.28%,HPGD;PLA2G4A;PLAA;PTGR2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.4485217298445489,0.9663223694412669,0.5038265306122449,0.9619856498675424,1.0,5/24,14.29%,SELENON;PRKACA;CAMK2D;PKD2;CALM1
prerank,establishment of protein localization to organelle (GO:0072594),0.4012271998532335,0.9660460241719449,0.5377258235919234,0.9621662629541039,1.0,11/72,9.84%,NEURL1B;KPNB1;EIF4ENIF1;HIKESHI;HEATR3;RANBP6;IPO7;IPO9;PTTG1IP;CSE1L;IPO5
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.388706187121412,0.9659003283859864,0.5699899295065458,0.9619591477033829,1.0,38/172,15.88%,LCAT;PTDSS2;ARF3;MTMR1;PIP4K2A;PIK3R4;FAR1;CRLS1;INPP4A;HDHD5;CHKB;PITPNM1;PI4KA;GPD1L;GPAM;PLA2G4A;PI4K2A;CDS1;PIP4K2B;LCLAT1;DGKD;FIG4;AGPAT4;ARF1;OCRL;PLD1;SLC27A1;AGPAT5;PIK3C2A;CHKA;ETNK1;PTEN;SLC44A1;SYNJ2;MTM1;PIK3R1;DGKZ;INPP5F
prerank,inositol phosphate metabolic process (GO:0043647),0.41488190970208694,0.9657419162163122,0.5415730337078651,0.961797487533821,1.0,11/46,14.70%,INPP1;INPP4A;INPP5A;MINPP1;PLD4;IPMK;PLCB4;OCRL;CALM1;ITPK1;PTEN
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.49975057074024226,0.9654881374077998,0.5393419170243204,0.961862547687404,1.0,1/11,3.69%,TGFB2
prerank,ephrin receptor signaling pathway (GO:0048013),0.39795237320631893,0.9651484697300453,0.5358649789029536,0.9621206558003855,1.0,22/82,14.75%,ACTR3;ITSN1;EPHB2;YES1;VAV3;SDCBP;AP2A1;ARPC1A;ARPC4;KALRN;LYN;ANKS1A;EPHA5;CDC42;SDC2;ARPC2;VAV2;ANKS1B;FYN;ARPC3;ROCK2;WASL
prerank,cell proliferation in forebrain (GO:0021846),-0.41666494250211195,-0.9649804604224935,0.5137362637362637,0.9823045555124398,1.0,4/10,8.56%,PCM1;CEP120;DOCK7;AKNA
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.3959694551237322,-0.9649095012922788,0.5109034267912772,0.979742967519852,1.0,6/13,15.56%,ZFPM2;ERBB4;FGFR2;FGF2;TGFBR3;NOTCH1
prerank,lipid transport (GO:0006869),0.38634432006761743,0.9644870523994777,0.5677352637021716,0.9632128668025582,1.0,23/97,16.25%,CD36;OSBP;SLCO1B1;ABCD2;PITPNM1;PRELID2;NCOA1;ABCA7;STARD5;ABCG1;ABCD3;PITPNA;SLC27A1;ABCA1;ABCD1;RXRA;CHKA;SLCO2B1;PPARD;NCOA2;ABCA5;PITPNB;OSBPL2
prerank,regulation of protein import into nucleus (GO:0042306),0.4277150579494202,0.9642518511533323,0.5405092592592593,0.9632811458807836,1.0,7/36,12.71%,DMAP1;BAG3;FLNA;SMAD3;MAVS;IPO5;UBR5
prerank,regulation of hemopoiesis (GO:1903706),0.4947500465231326,0.964171408464546,0.5139751552795031,0.962912756792457,1.0,2/10,4.96%,RUNX1;PRKCB
prerank,RNA stabilization (GO:0043489),-0.29882123810189765,-0.9634602381646902,0.5276073619631901,0.9809542048178401,1.0,10/33,13.92%,TENT2;HNRNPU;PABPC1;SLC11A1;PAIP1;YBX1;ZCCHC17;NSUN2;TENT5A;LARP1
prerank,protein deubiquitination (GO:0016579),0.38343156271610407,0.9629511375817383,0.6056056056056056,0.9653418480002964,1.0,59/242,15.89%,BRCA1;ACTR5;KDM1B;USP11;UCHL3;USP32;USP24;DESI2;HCFC1;USP19;PSMD9;AR;USP34;PSMB8;EP300;SMAD3;ATXN7;ESR1;ARRB2;USP29;BIRC3;POLB;PSMC5;KEAP1;USP33;USP1;UCHL5;USP48;SNX3;BABAM2;CCP110;USP20;USP5;USP46;APC;HGS;TRAF2;KAT2B;MINDY2;USP3;PSMD12;CYLD;TP53;PSMA2;TGFBR1;USP37;ATXN3;USP45;OTULINL;PTEN;RAD23B;NFRKB;OTUD7A;BECN1;SMAD4;VCPIP1;PSMB1;TRRAP;FOXK1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.4020231868135634,0.962947689913731,0.5501618122977346,0.9647919774880042,1.0,13/55,16.43%,TPD52L1;NUPR1;BCL2L11;TRAF7;PAK2;TRAF2;CYLD;TP53;TGFBR1;BCL2;WWOX;BECN1;DNM1L
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.48434096988542297,0.9629409941247461,0.5536723163841808,0.964249258264043,1.0,3/15,11.90%,DDR1;IGF1R;ABL1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.3117321459005582,-0.9627318536470061,0.5052083333333334,0.9803383028267905,1.0,9/26,14.73%,PTPN12;PDE8A;EEF1A1;GAREM1;INPP5K;DUSP22;SYAP1;PDPK1;PLCG1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.43888547656728216,0.9626364349744359,0.536019536019536,0.9644504896560234,1.0,8/26,16.52%,CX3CL1;ALMS1;SLC9A1;CDC42;ROCK2;TSC1;ACTG1;RDX
prerank,Golgi ribbon formation (GO:0090161),0.47358097276397193,0.9624316427281716,0.5064377682403434,0.9643989286136392,1.0,7/13,17.02%,GOLPH3;STX16;TMED5;TRIP11;OPTN;VTI1A;GCC2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.484840296086776,0.9620469613772307,0.541029207232267,0.9647547169894336,1.0,3/15,12.68%,FBXW7;CTDNEP1;SLC27A1
prerank,purine-containing compound catabolic process (GO:0072523),-0.386491940012454,-0.9617594844973872,0.5166666666666667,0.9804361675802614,1.0,2/13,3.58%,DPYD;XDH
prerank,ion homeostasis (GO:0050801),0.43182625951208464,0.9616059686650581,0.5280487804878049,0.9652447938873777,1.0,2/30,8.39%,SLC4A3;CAMK2D
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3914548991516371,0.9610448290726897,0.5427974947807933,0.9661015630714926,1.0,17/77,16.57%,URI1;RELA;CX3CL1;ITGA6;AR;THBS1;ACVR1;BIRC6;NOC2L;ZMYND11;TCF7L2;TGFBR1;BCL2;FZD9;PHIP;CFLAR;RB1
prerank,connective tissue development (GO:0061448),0.4214875371527027,0.9609447494537664,0.5071942446043165,0.9658013223228281,1.0,8/35,14.32%,ATP7A;ARID5B;LRP5;ITGB8;CD44;CREB3L2;SOX6;TRIP11
prerank,regulation of glycogen metabolic process (GO:0070873),-0.3982398819804921,-0.9606458046841909,0.542319749216301,0.9808864003647194,1.0,8/12,52.67%,INPP5K;AKT1;PPP1R3B;PPP1R3F;KHK;PPP1R3D;PPP1R3C;PPP1R3E
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.4771375294065249,0.9606168042517997,0.538881309686221,0.9660274999899543,1.0,3/16,12.05%,ZC3H12D;TARDBP;ZFP36L1
prerank,dopamine metabolic process (GO:0042417),0.45989231295298605,0.9606116135460082,0.5330634278002699,0.9654818577577265,1.0,2/18,5.05%,TGFB2;ATP7A
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.4883985487448259,0.960467675187891,0.5383502170767004,0.9652838166784955,1.0,3/13,10.01%,NEDD4;PTPN1;HGS
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4033608941090889,0.9602179866219506,0.5562770562770563,0.9653138488732956,1.0,13/57,17.12%,MIEF2;ADCK1;BCL2L11;VPS35;BNIP3;ZDHHC6;MLLT11;TP53;CAMKK2;HTRA2;DNM1L;MFF;RALBP1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.50050931873737,0.9597435858439621,0.5443037974683544,0.9658792973760724,1.0,1/10,1.43%,EMC9
prerank,integrin-mediated signaling pathway (GO:0007229),0.3944513523465887,0.9597004112554863,0.5488322717622081,0.9654243834450775,1.0,14/73,13.49%,ADAM15;ITGB1BP1;ITGBL1;NRP1;DOCK1;ITGB5;FERMT3;ITGB8;DAB2;CDC42;ABL1;ADAM10;SYK;FN1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3845207015826504,0.9588801387833621,0.5715725806451613,0.96690009990684,1.0,23/136,15.59%,MDFI;WFS1;CDK5RAP3;NUPR1;GAS6;FLNA;CMKLR1;ESR1;ARRB2;KEAP1;PYDC1;EGLN1;IRAK2;PRNP;MAP2K5;TMSB4X;COMMD7;TCF7L2;CYLD;PKD2;HAVCR2;PEX14;HDAC2
prerank,retrograde axonal transport (GO:0008090),-0.36067329507811463,-0.958701990445458,0.5055350553505535,0.9837318482840578,1.0,7/16,16.42%,DLG2;TMEM108;KIF1A;ACTR10;KIF1C;NEFL;DYNC1H1
prerank,phosphatidic acid metabolic process (GO:0046473),0.4072149575625676,0.9586645107753828,0.5369127516778524,0.9668692195537056,1.0,10/48,13.00%,PLA2G6;GPD1L;GPAM;PLA2G4A;LCLAT1;DGKD;AGPAT4;PLD1;SLC27A1;AGPAT5
prerank,regulation of cellular respiration (GO:0043457),0.46082852246350037,0.9586173929687004,0.5187667560321716,0.9664250880250099,1.0,2/17,5.19%,NOA1;IL10RB
prerank,regulation of osteoblast proliferation (GO:0033688),0.4623354767483099,0.9585479008949411,0.5393103448275862,0.9660454189322398,1.0,2/17,4.64%,EIF2AK2;NELL1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.354669369664412,-0.9585340660577973,0.49480968858131485,0.9814890393205267,1.0,7/16,57.67%,CLDN14;CLDN11;CLDN12;CLDN10;CLDN18;CLDN1;CLDN5
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.42031300557124945,0.9584372167898548,0.5365566037735849,0.9657564884026373,1.0,5/33,7.41%,RAD50;TERF2;CDK2;HSP90AA1;MRE11
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.2937512497236956,-0.958421765247239,0.50625,0.979132689913821,1.0,7/33,9.18%,PLCG2;APPL2;TAF1;APPL1;PKD1;PTPN6;STXBP4
prerank,protein localization to mitochondrion (GO:0070585),0.5018546390072381,0.9581067421081185,0.5466472303206997,0.9660287339993769,1.0,1/11,1.07%,LRRK2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.4723374294763921,0.957820988855808,0.5296610169491526,0.9661630258967013,1.0,1/16,0.58%,RORA
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.446006126057422,0.9576443985876001,0.5337748344370861,0.966057161020186,1.0,5/21,10.28%,STMN2;ATXN7;CAMSAP3;APC;TAOK1
prerank,secretion (GO:0046903),0.48204603551061664,0.95726616166702,0.5374823196605375,0.9663814200147025,1.0,1/14,3.48%,TPD52
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3860662674835542,0.9571736071056092,0.5637513171759747,0.9660527796034487,1.0,13/78,13.94%,PLK1;LRRK2;DVL1;UBQLN1;KEAP1;SUMO2;DAB2;RCHY1;USP5;SOCS5;RNF144B;HECTD1;CSNK1A1
prerank,receptor catabolic process (GO:0032801),0.44246259623200274,0.9568977314345088,0.532319391634981,0.9661774005497291,1.0,11/24,16.49%,PIK3R4;AP2A1;NEDD4;KIF16B;MYLIP;UVRAG;SH3GLB1;CLTC;BECN1;ZNRF3;LGMN
prerank,iron ion transport (GO:0006826),0.4058107484042515,0.9568922798840809,0.534698521046644,0.965641920498947,1.0,11/47,14.68%,CP;STEAP3;ABCB7;ATP6V0E1;ARHGAP1;ATP6V1E1;MCOLN1;ATP6V0D2;ATP6V1H;ATP6V0A2;CLTC
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.4263161441007838,0.9567428360086877,0.5324189526184538,0.9654420964146102,1.0,7/27,15.69%,BRD8;EP300;PHF20;MORF4L2;KAT2B;PHF20L1;TRRAP
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.48684869799167757,0.956322461590636,0.5368271954674221,0.9659005385204414,1.0,4/12,15.05%,PPHLN1;APOBEC1;TASOR;RESF1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.317416819511131,-0.9559721701812859,0.5046296296296297,0.9834159033077912,1.0,9/24,13.56%,B2M;FCER1G;IDE;CALR;BCAP31;MFSD6;SEC23A;CANX;SEC24C
prerank,stabilization of membrane potential (GO:0030322),0.46121596389392944,0.955925120742472,0.5405046480743692,0.9662966556859931,1.0,3/16,12.84%,KCNK2;KCNK13;KCNK10
prerank,positive regulation of B cell activation (GO:0050871),0.40269877042369584,0.9557111254386561,0.5484581497797357,0.966231986804692,1.0,13/50,17.29%,CD38;EPHB2;BTK;VAV3;IRS2;KMT5B;KMT5C;BCL2;SYK;SH3KBP1;CD81;MEF2C;NCKAP1L
prerank,sarcomere organization (GO:0045214),0.43430570942745417,0.9555109948245913,0.556930693069307,0.9661743800925393,1.0,2/27,12.08%,TPM1;WDR1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.45391970205567034,0.9552749085052922,0.5278137128072445,0.9662198596428064,1.0,4/18,13.51%,MAN1B1;UGGT2;EDEM2;UGGT1
prerank,nuclear pore organization (GO:0006999),0.48013563366058853,0.9550972196708524,0.5235378031383737,0.9661058999748567,1.0,5/14,13.32%,NUP205;AHCTF1;NUP98;NUP54;RTN4
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.3958548600876821,0.9550686497130358,0.5625,0.965630454883153,1.0,18/70,16.57%,ATRNL1;SIPA1L3;VAMP3;NRP1;METTL3;ITGA4;PARVB;FERMT3;LPXN;PXN;LAMC1;FN1;RELN;UNK;TMEFF2;PIK3R1;MEF2C;RB1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3976726402216677,0.954617814293172,0.5720524017467249,0.966160757025995,1.0,10/63,12.92%,RGCC;CNOT10;EP300;CDK2;PRKDC;CHEK2;CNOT9;RFWD3;CNOT3;TP53
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.4586536994906933,0.9541569209667462,0.551948051948052,0.966702070486207,1.0,3/20,8.04%,EIF6;TNRC6B;AGO2
prerank,miRNA metabolic process (GO:0010586),0.4422721718332497,0.9538612217221065,0.5516778523489932,0.9667987751718178,1.0,4/20,11.02%,TUT4;AGO2;LIN28B;PRKRA
prerank,regulation of small molecule metabolic process (GO:0062012),0.42927868453499535,0.9536063532871334,0.5387409200968523,0.9668918897024978,1.0,6/28,15.89%,RORA;TTC39B;ACADL;NCOR2;ADIPOR1;FOXK1
prerank,response to laminar fluid shear stress (GO:0034616),0.49878147511046733,0.9535875984129637,0.5491679273827534,0.9663895208923132,1.0,3/10,12.85%,SMAD6;MAP2K5;ABCA1
prerank,fluid transport (GO:0042044),-0.40514800786749194,-0.9535567577587792,0.5214521452145214,0.9876005224385628,1.0,1/12,9.55%,AQP4
prerank,negative regulation of translational initiation (GO:0045947),0.4785705356731894,0.9534511824606106,0.5484330484330484,0.9661461327088707,1.0,3/13,8.04%,EIF2AK1;EIF3E;AGO2
prerank,positive regulation of myoblast differentiation (GO:0045663),0.4648468112904166,0.9533947878848592,0.521505376344086,0.9657333536140429,1.0,1/16,1.08%,IGFBP3
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.3245173853648098,-0.953115845420277,0.5180722891566265,0.9861608053059383,1.0,8/20,14.80%,TGFB1;MBTPS2;ADAM9;HM13;NCSTN;MBTPS1;TRAF6;PSEN2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.504707216883884,0.9530143582182093,0.5475460122699386,0.9660884511046226,1.0,3/10,17.53%,NCOA3;PRKCH;MED1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3850807425303117,0.9529636450388899,0.5737704918032787,0.9656663391417232,1.0,20/104,15.19%,DAND5;SMAD6;PMEPA1;BMPR1A;ZBTB7A;SMAD3;CRIM1;SPRED2;ACVR1;LEMD2;LDLRAD4;PPARG;TGFBR2;PPM1A;SORL1;HIPK2;TGFBR1;SPRED1;UBE2D3;SMAD4
prerank,ruffle organization (GO:0031529),-0.3706110910029671,-0.952676546727114,0.49609375,0.9847638011376983,1.0,5/16,10.08%,RAC1;PLEKHA1;PIP5K1A;CSF1R;INPP5K
prerank,negative regulation of cell aging (GO:0090344),-0.35661435887096754,-0.9525338669814982,0.519434628975265,0.9824628571464932,1.0,5/16,14.16%,AKT3;MAP3K3;YBX1;RBL1;SIRT1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3960071077499837,0.9521273687521671,0.5572519083969466,0.9666342402894444,1.0,7/56,9.78%,NUBPL;TMEM126A;FOXRED1;NDUFS1;NDUFA9;NDUFV2;NDUFAF7
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3960071077499837,0.9521273687521671,0.5572519083969466,0.9666342402894444,1.0,7/56,9.78%,NUBPL;TMEM126A;FOXRED1;NDUFS1;NDUFA9;NDUFV2;NDUFAF7
prerank,regulation of interleukin-8 production (GO:0032677),0.39029512695733715,0.9520686093770104,0.5711252653927813,0.9662327457329315,1.0,13/69,14.85%,RELA;TLR7;TLR3;MAVS;MAPKBP1;F3;MAP2K5;TMSB4X;HMGB1;SYK;PRKD2;LGALS9;TLR4
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.28624991028683233,-0.952064200952099,0.5362318840579711,0.981160233606306,1.0,6/35,5.41%,SGIP1;B2M;RAC1;PPT1;SMAP1;RAB21
prerank,negative regulation of protein metabolic process (GO:0051248),0.4042436703377239,0.9520603187378035,0.5623608017817372,0.9657053188813663,1.0,8/48,14.08%,PFDN1;EIF2AK1;FLOT2;FLNA;SNX3;PRNP;FMN2;CD84
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.2679081670583261,-0.9520514880054636,0.5148514851485149,0.9785430335794346,1.0,14/47,18.45%,APP;EIF4G1;TGFB1;MTPN;CSF1;EIF2A;SSH1;WDR91;PUM3;AKT1;TCOF1;PCIF1;NFKBIA;GEMIN5
prerank,mitochondrion localization (GO:0051646),0.4636456407646752,0.9519917108239777,0.5570839064649243,0.9653301805280763,1.0,2/19,7.15%,LRRK2;MEF2A
prerank,carboxylic acid metabolic process (GO:0019752),0.4197484613523843,0.9518736430539185,0.5522565320665083,0.9650517333136458,1.0,4/33,10.61%,SLC2A3;LIAS;PLA2G4A;ST6GAL1
prerank,regulation of muscle contraction (GO:0006937),0.43187857661618323,0.9517393432325446,0.5225885225885226,0.9648312130321682,1.0,6/26,17.25%,TPM1;PPP1R12B;ENO1;KCNA1;CHRM2;KCNB2
prerank,actin filament organization (GO:0007015),0.38010976042669237,0.9516284867751418,0.5887096774193549,0.9645487545760859,1.0,33/151,17.39%,CGNL1;SVIL;RHOF;NEBL;TMOD1;FLNA;TMOD3;ALDOA;TPM1;PLS3;MYO5A;ABI1;DLG1;ARPC4;MYO1G;SHROOM3;EPS8;CD2AP;CDC42;RUFY3;PPP1R9A;ERMN;MYO1E;ELMO1;AIF1;WASL;HIP1;EVL;PPP1R9B;ARHGAP17;MYO1B;MYO1D;GSN
prerank,response to interferon-beta (GO:0035456),0.44799948303889003,0.9512532447835154,0.5544303797468354,0.9648864054796104,1.0,2/22,1.88%,IFITM3;IRF1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.4726383269504597,0.9512347537090488,0.541907514450867,0.9643804986705017,1.0,3/14,8.42%,BCL2L11;BFAR;PTPN1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.4079715744314889,0.9511565335095941,0.5545454545454546,0.9640182942993684,1.0,8/43,16.27%,BBS4;ACVR1;AHI1;MICAL2;TGFBR2;NDRG4;PKD2;MEF2C
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3811193934566364,0.9510264451027821,0.601010101010101,0.9637782930953098,1.0,16/140,14.78%,C5AR1;CD36;ADCY8;ADCY5;GPR65;CMKLR1;ESR1;SPPL3;TRPM4;NPTN;CACNA1A;ABL1;HMGB1;CYSLTR1;LPAR6;CACNA1C
prerank,positive regulation of macroautophagy (GO:0016239),0.4081039986410746,0.9510056714651898,0.5497206703910614,0.9632991264538224,1.0,14/48,14.77%,BAG3;RAB3GAP1;PIP4K2A;EPM2A;BNIP3L;PIP4K2B;BNIP3;UVRAG;GNAI3;FYCO1;SH3GLB1;VPS13D;OPTN;SPTLC1
prerank,acute-phase response (GO:0006953),-0.3902322850866114,-0.9508302783872458,0.5432098765432098,0.9794506507111529,1.0,3/12,33.99%,IL22;CEBPB;PLSCR1
prerank,microtubule anchoring (GO:0034453),0.4906715863965614,0.9507350056554942,0.5321888412017167,0.9634023949630792,1.0,7/12,18.03%,CAMSAP3;BICD1;DAG1;CLASP1;PEX14;GCC2;CLASP2
prerank,granulocyte differentiation (GO:0030851),0.4577458802084715,0.9506464572517058,0.5344129554655871,0.9630817010981669,1.0,4/18,13.22%,EP300;CDK2;TAL1;RXRA
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.40691687223329986,0.9505892779490113,0.5456570155902004,0.9626816897711512,1.0,12/46,15.70%,ATRNL1;VAMP3;NRP1;ITGA4;PARVB;FERMT3;LPXN;PXN;LAMC1;FN1;TMEFF2;PIK3R1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4418125633118874,0.9502940827924969,0.5612903225806452,0.9628762214592594,1.0,7/24,16.32%,PRKCB;NEDD4;PTPN1;HGS;PRKD2;ARNT;EPN2
prerank,axon guidance (GO:0007411),0.38263486678477626,0.9502580772433841,0.6036036036036037,0.9624303950989248,1.0,36/201,15.94%,CXCL12;PLXNA1;GRB2;EPHB2;NRP1;PRKCA;SEMA6D;MAPK1;IRS2;EZR;USP33;RANBP9;ARTN;SPTBN1;RPS6KA5;NPTN;EPHA5;ARHGAP35;SEMA3D;SEMA6A;PALLD;NOTCH2;GAP43;FRS2;FEZ1;DOK6;PLXNC1;PTPRO;FYN;NRP2;RELN;DAG1;EVL;SH3KBP1;PIK3R1;NFIB
prerank,iron ion transmembrane transport (GO:0034755),0.5025251453207036,0.9501941094096616,0.5386949924127465,0.9620302764267138,1.0,2/10,5.93%,ABCC5;ABCB7
prerank,regulation of interferon-alpha production (GO:0032647),0.443303389967447,0.9497367730827889,0.5562659846547314,0.9625588560180847,1.0,8/23,16.40%,TLR7;IRF3;SETD2;TLR3;MAVS;HAVCR2;TLR4;TBK1
prerank,mitochondrial transport (GO:0006839),0.4041065588807945,0.9495860500859664,0.5631174533479693,0.9623563203623696,1.0,9/53,13.03%,SLC25A24;TIMM17A;TOMM40;TIMM23;HSP90AA1;BNIP3;SLC25A16;FLVCR1;BCL2
prerank,neural tube closure (GO:0001843),0.4132330539681148,0.9493495933867118,0.5235294117647059,0.9623631052505471,1.0,6/34,13.13%,DVL1;BBS4;TGFB2;MTHFR;DEAF1;LRP6
prerank,regulation of glycolytic process (GO:0006110),0.39285947965152607,0.9492029098435214,0.576307363927428,0.9621614764129737,1.0,9/68,8.99%,EIF6;NUPR1;PGAM1;ZBTB7A;NUP205;EP300;NUP98;NUP54;NCOR1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.41362452407670236,-0.9491562688178625,0.5300859598853869,0.9814049979596976,1.0,3/10,18.81%,JAK2;IL33;TLR2
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4439182467012518,0.9490779993137953,0.5453296703296703,0.9619047191545677,1.0,6/20,15.19%,RELA;EP300;CARF;RBPJ;CHD6;SMAD4
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.44359804116821805,0.9487959378442005,0.5514993481095176,0.9614895377109766,1.0,4/21,13.03%,EYA2;IL1A;MAP2K5;BCL2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.44359804116821805,0.9487959378442005,0.5514993481095176,0.9614895377109766,1.0,4/21,13.03%,EYA2;IL1A;MAP2K5;BCL2
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.3941619585687382,-0.9486621735672562,0.5031645569620253,0.9801951434506184,1.0,12/12,60.62%,MCM3;CDC7;MCM6;MCMDC2;MCM4;GINS4;GINS2;MUS81;MCM2;MCM7;CDC45;MCM5
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3958136106320203,0.9486156144897503,0.5595628415300546,0.9613948104574553,1.0,8/59,14.67%,ALDH1A2;OSBP;ALOX5;SRR;ABCD3;HSD17B4;ACACA;OSBPL1A
prerank,positive regulation of metabolic process (GO:0009893),0.3831708572727954,0.9483313065915439,0.5816326530612245,0.9615586893167817,1.0,18/103,14.13%,EHMT1;CD36;ALMS1;CAMK1D;CMKLR1;DECR1;KDM3A;IL18;APC;CNOT3;IGF1R;ACADL;TRPV2;PPARGC1B;SYK;INSR;ADIPOR1;ACACA
prerank,cytoskeleton organization (GO:0007010),0.3856814636120151,0.948210155812574,0.5946775844421699,0.9612904635963674,1.0,22/114,13.14%,FGD6;CFL1;RHOF;FGD3;FGD1;SIPA1L3;TPM1;PRPF40A;CAPZB;PACSIN2;CDC42BPB;RANBP9;MAST2;MICAL2;MAST3;LRCH3;SEMA6A;DIAPH1;PALLD;EPB41L3;ZMYM6;MAST4
prerank,chloride transport (GO:0006821),-0.24120440187445863,-0.9479188784463123,0.5555555555555556,0.9798006873294273,1.0,28/74,33.84%,GABRB1;ANO6;GABRA2;ANO3;GABRA3;SLC12A9;PACC1;ANO10;TTYH3;CLCN4;GLRA1;CLCN6;CLCN3;SLC1A1;SLC12A2;GABRA5;SLC6A1;GLRA2;GABRA4;GABRB3;GABRG1;TTYH1;ANO5;GABRA1;SLC12A7;SLC4A8;SLC12A5;LRRC8A
prerank,cardiac muscle cell contraction (GO:0086003),-0.33629701693413583,-0.9478947579554527,0.5045871559633027,0.9772390703912042,1.0,5/19,7.09%,FGF12;CACNA2D1;ATP1A1;KCNJ2;PIK3CA
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3774042030863222,0.9478457062752791,0.657,0.961646455670703,1.0,73/336,15.69%,BRCA1;PCLAF;SIRT7;BLM;RFC2;POLE2;RAD50;SUV39H1;GRB2;DYRK2;BCL2L11;RAD18;ASF1A;IRF3;BCL6;POLA1;WRN;AKTIP;PRKDC;VAV3;UBE2A;METTL3;POLB;STK11;MNAT1;PDS5A;RBBP8;BOD1L1;MRE11;MAP2K6;SLF1;ERCC4;SMC5;KMT5B;NBN;PARP2;BABAM2;CHEK2;KMT5C;APC;LYN;SETX;RFWD3;PARP4;TAOK1;CBX1;TANK;RNF169;RAD51B;ZBTB38;CUL4A;ABL1;UVRAG;USP3;MAPK14;UBR5;MAPKAPK2;TP53;BCL2;FMN2;CHCHD6;GTF2H1;HTRA2;USP45;UBA6;MTREX;RECQL5;SPIDR;TRIP12;NPM1;VCPIP1;BAZ1B;TRRAP
prerank,regulation of neuron differentiation (GO:0045664),0.38617580706715177,0.9478336419270217,0.5776850886339937,0.9611380321294934,1.0,6/76,6.92%,LRRK2;CDK5RAP3;CASZ1;IMPACT;NREP;BEND6
prerank,covalent chromatin modification (GO:0016569),0.4729349689446442,0.9474989629251085,0.5533428165007113,0.9614153127564972,1.0,2/14,8.24%,SIRT7;PARP2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.5030247476770828,0.9471713135843027,0.547945205479452,0.961611657256106,1.0,4/10,17.29%,TGFBR2;LGALS9;CD81;NCKAP1L
prerank,negative regulation of anoikis (GO:2000811),-0.37223665447552234,-0.9469707733641088,0.5414012738853503,0.9773918018125535,1.0,4/14,7.54%,PTK2;MCL1;PIK3CA;ITGA5
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.4264220687015681,0.9468918030821897,0.5625,0.9617470625469736,1.0,5/30,13.51%,LMAN1;UGGT2;STT3A;ST6GAL1;UGGT1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.4255053216457349,0.9467566914553298,0.5462287104622872,0.9615079843889918,1.0,3/27,7.80%,CX3CL1;GAS6;SYT11
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4253076697819481,0.9465857892536282,0.5522012578616352,0.9613581680633624,1.0,4/26,6.12%,HOMER2;DYRK2;SLC9A1;SPPL3
prerank,regulation of protein polymerization (GO:0032271),0.41556551662927116,0.9463503243686961,0.5605700712589073,0.961366016653455,1.0,7/35,11.90%,GBA2;PLEKHG2;CAMSAP3;HSP90AA1;MAPT;DBNL;ABL1
prerank,cellular response to insulin stimulus (GO:0032869),0.37962311367998175,0.9462589449949269,0.604887983706721,0.9610511064985092,1.0,32/124,15.70%,INSIG1;GRB2;RAB8B;INSIG2;RAB12;IRS1;HDAC9;MYO5A;PRKDC;HDAC5;PDE3B;IRS2;ATP6V0E1;ATP6V1E1;PPARG;APC;VAMP2;IGF1R;KAT2B;GCK;TBC1D4;ZFP36L1;SLC27A1;ATP6V0D2;PIK3C2A;ATP6V1H;INSR;ATP6V0A2;SH2B2;PHIP;ZNF106;PIK3R1
prerank,peptide biosynthetic process (GO:0043043),0.37687196002353424,0.9461900031095763,0.6220871327254306,0.9606822174875642,1.0,17/153,8.04%,GGTA1;RPL18;RPS6KB2;RPS23;MRPL37;RPL41;RPL31;RPS17;RPL4;MRPS21;RPLP0;HARS1;RPS15A;RPL38;DHPS;PABPC4;AGO2
prerank,mRNA splice site selection (GO:0006376),0.41910826205817164,0.9460545983175966,0.559322033898305,0.9604738021013715,1.0,7/30,12.16%,PSIP1;LUC7L;SRSF5;SFSWAP;SETX;SF1;SRSF9
prerank,camera-type eye development (GO:0043010),0.4295886964455077,0.946028376106539,0.5669586983729662,0.960002193141248,1.0,2/25,4.01%,RAB3GAP1;NF1
prerank,negative regulation of cell development (GO:0010721),-0.3071940405240985,-0.9459835774926212,0.5104166666666666,0.9775800896710305,1.0,7/25,15.56%,PCM1;B2M;APPL2;GSK3B;IGF1;LILRB1;NOTCH1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.37890778233027306,0.9458445733177243,0.6182364729458918,0.9598780007863106,1.0,36/208,14.38%,RORA;UNC5CL;RIOK3;RELA;CX3CL1;IRAK4;TMED4;RNF31;PLEKHG5;PELI1;FLNA;PRKCB;SQSTM1;ESR1;BIRC3;TLE1;IKBKB;ZFAND6;TAB3;MAVS;MTDH;MAPKBP1;CANT1;TFG;WLS;TRIM5;AKAP13;TANK;TRAF2;ZMYND11;PPM1A;NDFIP1;S100B;TRIM59;LGALS9;OPTN
prerank,peptide catabolic process (GO:0043171),-0.31271016832639953,-0.9452766588643153,0.5265306122448979,0.9769718488739069,1.0,5/23,9.74%,CPQ;IDE;TRHDE;TPP1;LTA4H
prerank,lung epithelium development (GO:0060428),-0.42138006809232714,-0.9451644668637555,0.5584795321637427,0.9746979548477871,1.0,2/10,14.25%,PKD1;ERRFI1
prerank,peripheral nervous system development (GO:0007422),0.4504146946369174,0.9448129574028501,0.5568039950062422,0.9618036728476749,1.0,3/23,8.15%,NF1;SERPINI1;ARTN
prerank,protein insertion into membrane (GO:0051205),0.42251451720464006,0.9447146901387095,0.5576251455180442,0.9614985944131527,1.0,5/32,11.35%,TRAM1L1;SEC61G;UBE2J2;VAMP2;PRNP
prerank,establishment of protein localization to membrane (GO:0090150),0.3924771838353563,0.9446956797319717,0.5769644779332616,0.961006027734423,1.0,12/66,12.38%,ZDHHC24;ARL6;RAB3GAP1;BRAF;RFTN1;SDCBP;NACA;ZDHHC1;VPS37C;VPS37A;ATG3;ZDHHC6
prerank,negative regulation of cytokine production (GO:0001818),0.3780428960949978,0.9444667223544009,0.6114457831325302,0.9610145954076258,1.0,31/163,14.85%,RGCC;CX3CL1;HOMER2;GAS6;THBS1;IRF3;HDAC9;ILRUN;CMKLR1;AXL;ABCD2;EZR;SYT11;RPS6KA5;NPTN;MAVS;CUEDC2;RNF216;MAPKBP1;PRNP;MAP2K5;TMSB4X;HMGB1;CYLD;ABCD1;FN1;LGALS9;RNF135;CD84;HAVCR2;TLR4
prerank,pyroptosis (GO:0070269),-0.3626399786434972,-0.9438879064750348,0.545774647887324,0.9758467514585182,1.0,9/15,35.32%,DHX9;AIM2;CASP4;CASP8;CASP1;GSDME;APIP;NLRC4;ZBP1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.44907703909217467,0.9437875412093523,0.5518169582772544,0.9620880123390283,1.0,2/18,6.62%,POLA1;POLD3
prerank,actin filament network formation (GO:0051639),-0.4054495273836495,-0.943632765992475,0.5833333333333334,0.9739835805859567,1.0,5/11,14.96%,COBL;FHOD3;FHOD1;PLS1;ACTN1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5058803254835244,0.943258325907213,0.5741324921135647,0.9627598769170215,1.0,2/10,4.96%,PID1;PRKCB
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4281844363217511,0.9432199344953388,0.5447852760736196,0.9623200409340871,1.0,4/24,7.73%,MSN;ITGA4;EZR;FERMT3
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.33320213591386727,-0.9432161598615879,0.5298804780876494,0.9725752089628164,1.0,11/19,20.99%,TENT4B;HNRNPU;EXOSC10;DCP2;HNRNPA1;PINX1;STN1;GNL3L;NAT10;TEN1;SRC
prerank,plasma membrane invagination (GO:0099024),0.4232502958193386,0.9430571697580595,0.5744157441574416,0.9621686824662253,1.0,9/29,17.40%,CD36;VAMP7;DOCK1;CDC42;ELMO1;AIF1;SNX9;GSN;FCGR1A
prerank,regulation of cell cycle phase transition (GO:1901987),0.38169647187132344,0.9428941047832109,0.5920915712799167,0.9620152418930402,1.0,14/91,13.15%,PLK1;FBXW7;TFAP4;PSMD9;PSMB8;ANAPC10;CDC23;PSMC5;BUB3;CDC16;PSMD12;TP53;PSMA2;ANAPC16
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.38331226454399636,0.9427237610513785,0.5734989648033126,0.9618614082536117,1.0,16/87,11.44%,PRKCZ;SMAD6;ZFYVE9;HPGD;TGFB2;BMPR1A;JUN;SMAD3;ARRB2;ACVR1;ITGB5;LPXN;FURIN;PXN;TGFBR2;CBL
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.38951916666224645,-0.9425019653472071,0.5292207792207793,0.9719879762197234,1.0,6/12,7.77%,GRN;PPT1;VPS33A;CLN3;ATP6AP2;TMEM165
prerank,signal transduction in response to DNA damage (GO:0042770),0.39507997918302246,0.9423913467274285,0.5714285714285714,0.9621008349611616,1.0,12/49,14.07%,GRB2;CLOCK;MAP3K20;NBN;CHEK2;CDC5L;ABL1;MAPK14;TP53;ATRX;TIPRL;NDRG1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.3933865152550523,0.9420648121370973,0.5946524064171123,0.9623433660643417,1.0,10/63,13.03%,WDR6;CDK5RAP3;NUPR1;NELL1;TBC1D14;TAB3;PTPN3;MTOR;SORL1;BCL2
prerank,hyaluronan metabolic process (GO:0030212),0.43085590465957313,0.9420201076103322,0.5676359039190898,0.9619096955571712,1.0,4/23,9.66%,SLC9A1;CEMIP2;ABCC5;CD44
prerank,negative regulation of viral release from host cell (GO:1902187),-0.38959302624418657,-0.9420146476084463,0.5612903225806452,0.9707230504983848,1.0,6/13,18.40%,CHMP3;TRIM8;TRIM35;PML;TRIM11;MID2
prerank,'de novo' posttranslational protein folding (GO:0051084),0.41857874780963655,0.9419194873943868,0.5413625304136253,0.9616144171097964,1.0,4/30,7.55%,DNAJB1;DNAJC18;ST13;HSPA9
prerank,macroautophagy (GO:0016236),0.3834580989499268,0.9418517719832166,0.601010101010101,0.9612527837327649,1.0,26/118,12.45%,TSG101;VPS16;TOMM40;VAMP7;VPS4A;UBQLN1;PIP4K2A;PIK3R4;EI24;ILRUN;SQSTM1;AMBRA1;DYNLL2;STX17;PIP4K2B;VPS41;HGS;PLAA;VPS37C;VPS37A;ATG3;VPS4B;UVRAG;RB1CC1;TBC1D5;VIPAS39
prerank,protein glycosylation (GO:0006486),0.37918778359089195,0.9412514355383572,0.6134969325153374,0.9621067892092238,1.0,24/125,17.11%,MGAT3;ALG3;ST8SIA5;ST8SIA4;EOGT;GALNT1;POMT2;COG3;STT3A;B4GALT5;B4GALT1;FKTN;B3GALNT1;B3GNT2;MGAT4B;NUS1;B3GALNT2;TET2;MGAT4A;TET3;LARGE1;ST3GAL5;B3GALT1;ST3GAL2
prerank,mitochondrial fusion (GO:0008053),0.44812256675112244,0.9411992822085755,0.5521796565389696,0.9617072218899574,1.0,1/18,0.55%,MIEF2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.42541065711697834,0.9410348814692313,0.5639751552795031,0.9615967457713217,1.0,3/23,12.41%,SLC9A1;SLC9A7;SLC12A6
prerank,negative regulation of GTPase activity (GO:0034260),0.4326560905602266,0.9403040039637696,0.5497448979591837,0.9627029920433329,1.0,5/22,11.72%,LRRK2;ARFGEF1;RRP1B;LRCH1;TMED2
prerank,regulation of histone modification (GO:0031056),0.4744640006180615,0.9402470066381496,0.5714285714285714,0.9622992839661386,1.0,3/13,8.29%,PARG;MTHFR;CDK9
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.483322653569017,0.9402394361145016,0.5486322188449848,0.9617932554460755,1.0,4/11,16.32%,THBS1;ALOX5;SEMA6A;EPN2
prerank,regulation of aerobic respiration (GO:1903715),0.4660230196290823,0.9402098275982226,0.5698005698005698,0.9613335509994283,1.0,2/15,5.05%,AK4;ATP7A
prerank,tryptophan metabolic process (GO:0006568),0.48612820116316213,0.940208894868404,0.5602409638554217,0.9608096347788683,1.0,1/11,5.05%,ATP7A
prerank,erythrocyte development (GO:0048821),0.4985210546839791,0.940136747934563,0.5707692307692308,0.9604552354427301,1.0,4/10,17.53%,ZBTB7A;SH2B3;NCKAP1L;MED1
prerank,sulfur compound transport (GO:0072348),0.4233427418591665,0.9399044014451038,0.5648484848484848,0.9604918689369928,1.0,5/27,15.52%,SLC35F3;SLC26A11;SLC25A26;SLC27A1;ABCG2
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3867433907388525,0.9396123446839896,0.593167701863354,0.9606175770361222,1.0,24/91,16.10%,GAS1;LRRK2;RAB8B;RAB12;NRP1;STON2;LGI3;MAPK1;PACSIN2;RAB5B;PTPN1;VAMP2;STXBP5;RIT2;ABL1;STXBP5L;PLD1;RAB3C;MAP2K2;SYK;HIP1;DNAJC13;INPP5F;MAP2K1
prerank,transport across blood-brain barrier (GO:0150104),0.3786937192298883,0.9395216106236912,0.5909090909090909,0.96029614818457,1.0,12/83,15.52%,SLC4A3;SLC2A3;CD36;SLC7A2;SLC38A2;ABCC5;SLC7A8;SLC27A1;INSR;SLCO2B1;SLC44A1;ABCG2
prerank,establishment of skin barrier (GO:0061436),-0.3608774122004309,-0.9392993155782493,0.4847457627118644,0.9732825714881391,1.0,9/15,56.34%,UGCG;STMN1;MET;HRNR;FA2H;LSR;ALOXE3;SFN;CLDN1
prerank,regulation of water loss via skin (GO:0033561),-0.3608774122004309,-0.9392993155782493,0.4847457627118644,0.9732825714881391,1.0,9/15,56.34%,UGCG;STMN1;MET;HRNR;FA2H;LSR;ALOXE3;SFN;CLDN1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.37421183205166564,0.9392431613772408,0.6348088531187123,0.9604234950262293,1.0,27/161,13.94%,UBAC2;BICC1;NPHP4;DVL1;IGFBP2;SOX13;RBMS3;PSMD9;TLE2;PSMB8;STK11;PSMC5;TMEM170B;TLE1;HECW1;DAB2;APC;CHD8;TCF7L2;PSMD12;CYLD;PSMA2;LRP6;PTPRU;PTPRO;MCC;CSNK1A1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.4576587446828241,0.9391739228416136,0.5680555555555555,0.9600630417727986,1.0,2/17,4.71%,ALG3;MPDU1
prerank,protein localization to cell surface (GO:0034394),0.4314458214453333,0.9390983070578125,0.5597014925373134,0.9597329914506313,1.0,7/26,17.61%,VCL;FLNA;PIGU;PTPRU;GGA1;GGA3;CTNNB1
prerank,phagosome acidification (GO:0090383),-0.3052152627987179,-0.9390672828656703,0.5357142857142857,0.9714171239995308,1.0,9/26,16.55%,ATP6V0A1;ATP6V1A;ATP6V1D;ATP6V0C;RAB39A;ATP6V0B;ATP6V1C1;ATP6V1G1;RAB20
prerank,autophagy of mitochondrion (GO:0000422),0.409180880040114,0.9388970408488722,0.5715935334872979,0.9596793595419474,1.0,10/38,15.16%,WDR45;WDR45B;SQSTM1;AMBRA1;BNIP3;ULK2;ATG3;RB1CC1;ATG7;BECN1
prerank,nitric oxide metabolic process (GO:0046209),-0.37834576678579857,-0.9388518149986484,0.5476923076923077,0.9695400908181218,1.0,3/14,22.61%,CYB5B;AKT1;GCH1
prerank,striated muscle contraction (GO:0006941),-0.25941079682749996,-0.9387289981948962,0.6019417475728155,0.9674024978144101,1.0,6/53,8.49%,RYR2;ATP1B1;GRK2;ATP1A2;PIK3CA;DTNA
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.4512345169136548,0.938386239469034,0.5650406504065041,0.9603113958948767,1.0,2/18,7.03%,ITGA4;GOLPH3
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.31239349212394746,-0.938363562113314,0.5562130177514792,0.965779747428249,1.0,6/25,5.73%,LYST;CHMP4B;CHMP4A;VCP;CHMP3;DENND10
prerank,regulation of ion transmembrane transport (GO:0034765),0.41077313326021836,0.9383588432044067,0.5556844547563805,0.9598591270470904,1.0,4/33,7.47%,KCNJ6;AKAP9;YWHAE;NEDD4
prerank,protein import into nucleus (GO:0006606),0.3887854049098978,0.9379533749587986,0.5853920515574651,0.9602774335076388,1.0,12/66,9.84%,KPNB1;EIF4ENIF1;HIKESHI;HEATR3;RANBP6;IPO7;IPO9;PTTG1IP;KPNA6;CSE1L;NUP54;IPO5
prerank,regulation of filopodium assembly (GO:0051489),0.40056792101528427,0.9378753950020985,0.5494252873563218,0.9599437283049836,1.0,11/38,15.70%,NRP1;FNBP1L;CAPZB;FXR2;CDC42;GAP43;PPP1R16B;DOCK11;WASL;GPM6A;PIK3R1
prerank,regulation of chromatin organization (GO:1902275),0.46261391234759663,0.9375821497823034,0.5490196078431373,0.960103396569738,1.0,3/14,8.29%,PARG;SETD1A;CDK9
prerank,chondroitin sulfate metabolic process (GO:0030204),0.4135527152608475,0.9375222594930666,0.572992700729927,0.9597164438420843,1.0,5/30,9.84%,CHSY1;UGDH;DSE;ARSB;BGN
prerank,B cell activation (GO:0042113),0.3880510918228051,0.9370234866614285,0.6035940803382663,0.9602982647683537,1.0,9/68,6.60%,TPD52;EPHB2;ZBTB7A;HDAC9;PRKCB;BTK;PTPRJ;HDAC5;ITGA4
prerank,diterpenoid metabolic process (GO:0016101),0.38617894956181714,0.9367986097089371,0.5700431034482759,0.9602600443908591,1.0,7/55,15.11%,AKR1B1;ALDH1A1;LRP8;DHRS3;SDC2;GPC3;GPC6
prerank,cellular response to chemical stress (GO:0062197),0.3814571903514964,0.9365953418938009,0.6145940390544707,0.9602251818565554,1.0,17/96,15.27%,MGAT3;PYCR2;SLC25A24;LRRK2;VKORC1L1;KEAP1;ADNP2;SETX;ABL1;TXNRD2;NCF4;EIF2S1;HTRA2;PKD2;AIF1;ATG7;MSRA
prerank,regulation of cell-substrate adhesion (GO:0010810),0.40142181100542695,0.93655420175435,0.5653669724770642,0.9597986716970495,1.0,9/42,14.87%,CX3CL1;MINK1;RSU1;NF1;PDGFB;LIMS1;PTPRO;ATXN3;TSC1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.47577242447852225,0.9365323845330324,0.5626780626780626,0.9593312114575687,1.0,2/12,6.83%,PRPSAP1;HPRT1
prerank,histone mRNA catabolic process (GO:0071044),-0.3618274851599135,-0.9359332589178767,0.5273972602739726,0.9698808194514572,1.0,8/15,17.61%,TENT2;TENT4B;SSB;MTPAP;EXOSC10;DCP2;ERI1;UPF1
prerank,regulation of histone methylation (GO:0031060),0.4697838162194159,0.935517936702525,0.554093567251462,0.9610617256470186,1.0,2/13,6.57%,CTR9;MTHFR
prerank,nucleotide biosynthetic process (GO:0009165),0.44360910154508787,0.9353921382883945,0.5773333333333334,0.9608080906723278,1.0,3/18,6.83%,PRPSAP1;NMNAT3;HPRT1
prerank,post-translational protein modification (GO:0043687),0.37051708856551946,0.9353733506138071,0.7004008016032064,0.9603375349705058,1.0,53/332,13.92%,WFS1;CP;KLHL42;FBXO17;IGFBP3;VWA1;UCHL3;FBXW7;FBXO30;KLHL11;GAS6;FEM1C;FEM1A;FBXO21;PSMD9;SCG3;PSMB8;COPS7B;QSOX1;ASB8;UBXN7;FBXO9;PSMC5;KEAP1;STT3A;COPS4;RAB2A;ASB13;FBXO11;PROC;DCAF17;GAN;SOCS5;ELOC;SDC2;ASB2;FBXW11;MIA3;LAMC1;CUL4A;ESCO1;KLHL5;PRKCSH;PSMD12;UBE2F;ADAM10;PSMA2;RBBP7;GPC3;FN1;ASB7;FBXL7;SPARCL1
prerank,digestive tract development (GO:0048565),-0.28330938395218813,-0.9353383925839628,0.5329341317365269,0.9689128947092043,1.0,14/32,32.84%,SALL1;FGFR2;NIPBL;PKD1;COBL;SMO;MEGF8;CLMP;BBS7;RARB;GLI3;EDNRB;KIT;PKDCC
prerank,toll-like receptor signaling pathway (GO:0002224),0.3792752211163102,0.9346756111724644,0.5995850622406639,0.9614101684417705,1.0,20/84,14.86%,CD36;IRAK4;TLR7;RFTN1;PIK3R4;BTK;BIRC3;IKBKB;TLR3;IRAK2;TAB3;COLEC12;CNPY3;HMGB1;MAPKAPK2;LGALS9;UNC93B1;UBE2D3;TLR4;PIK3AP1
prerank,engulfment of apoptotic cell (GO:0043652),-0.3626851617259066,-0.9345773228702735,0.5228070175438596,0.9684848160839025,1.0,4/15,7.99%,XKR6;RAC1;RHOBTB1;MEGF10
prerank,response to organonitrogen compound (GO:0010243),-0.27876422828609604,-0.9344779377509114,0.5476190476190477,0.9663051132946503,1.0,9/38,12.83%,PRKN;VCP;IRF5;HLCS;RNF185;KYNU;CCDC47;GLRA1;DNAJB12
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.40998290827311556,0.9343703230033471,0.5667789001122334,0.9615928790838374,1.0,9/39,13.10%,SOCS4;SOCS7;PIP4K2A;PI4KA;PI4K2A;PIP4K2B;SOCS5;EFR3B;PIK3C2A
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.2852938915642843,-0.9342269110202001,0.559748427672956,0.96454601869104,1.0,12/33,17.57%,PRKN;OPA1;BCL2L1;HUWE1;FLCN;IGF1;MPV17L;GHITM;AKT1;SLC35F6;HGF;OMA1
prerank,cellular response to interferon-gamma (GO:0071346),0.3833451141335774,0.9341854342403728,0.6182572614107884,0.9614776459174872,1.0,16/88,15.45%,MID1;CX3CL1;IRF1;SYNCRIP;IRF3;CCL25;CAMK2D;DAPK1;CD44;TRIM5;CAMK2G;LGALS9;AIF1;TLR4;TRIM26;CD47
prerank,positive regulation of T cell cytokine production (GO:0002726),0.4486800271555207,0.9336811646883191,0.5701298701298702,0.9621117289612382,1.0,3/20,10.87%,PRKCZ;IL18;TRAF2
prerank,negative regulation of ossification (GO:0030279),0.43719453736884295,0.9336456726681794,0.5661103979460848,0.9616774730725068,1.0,5/23,16.27%,SMAD6;CHSY1;TRPM4;RBPJ;MEF2C
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4586547070200282,0.9334725328489021,0.5598349381017882,0.961544797134262,1.0,4/17,9.50%,FGF1;KPNB1;SEC14L2;ABCG1
prerank,ncRNA 3'-end processing (GO:0043628),0.47320205190474585,0.93305757415481,0.5728155339805825,0.9619751737864818,1.0,3/14,5.83%,INTS12;INTS2;PTCD1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.37059368516310076,0.9329971414809358,0.851,0.9615905421047309,1.0,233/1646,13.72%,POU2F3;ISL1;GLIS1;WNT4;BRCA1;SRCAP;ACTR5;RORA;ANKRD49;ZNHIT3;ZIC4;URI1;SP8;BLM;EHMT1;PARP9;ELAVL2;THAP7;POLR3G;ZBTB8A;DMAP1;RELA;IRF1;DVL1;SMARCA4;CD38;SP1;SMAD6;CTR9;SUV39H1;HOPX;ILF3;PSIP1;ZFP90;CASZ1;TFAP4;POU5F2;SOX13;KLF9;RLIM;SS18L1;SNX5;ZBTB5;TGIF1;PCBD2;CLOCK;ZEB2;BBX;RUNX1;SAP18;MAX;GAS6;HCFC1;ZNF318;POLR2A;PSMD9;NFATC1;JUN;MYCBP;AR;TLE2;ELP3;ATXN1;ZBTB7A;ZNF569;KDM5A;ELK3;WBP2;IRF3;BCL6;HDAC9;TRPS1;POLA1;PRKCB;TARBP1;EP300;SMAD3;RBM15;SPEN;ARID5B;PDGFB;TEAD1;CIPC;RBAK;LRP5;LIN9;ZNF467;DPF2;ESR1;SPTY2D1;HDAC5;NR3C1;ACVR1;SCMH1;IKZF1;JUND;KDM3A;BRCA2;MAMLD1;PSMC5;TLE1;KMT2E;MNAT1;MEF2A;IKBKB;RBBP8;RGS14;HP1BP3;PHF10;WIZ;MECP2;SEC14L2;TFCP2;CUX1;DRGX;NCOA1;ZBTB11;SETD3;KDM5B;SET;RPS6KA5;CAMK2D;PHF20;EZH2;TADA2A;JMJD1C;LIMS1;CHD7;NACC1;MAFG;NCOR1;CHEK2;PCGF5;ZXDC;PHF6;BAZ2B;BRD2;PPARG;MTDH;NR6A1;PTP4A3;ASCC2;CTBP1;TAL1;HMBOX1;ENO1;FUS;CDK5;CDC5L;FADS1;DEAF1;HBP1;HIVEP1;LOXL3;HOXC4;ZBTB46;ELOC;TCF12;UBE2I;NAA16;TULP3;ZNF568;FOXN3;ARID4B;SP140;BCL7A;CHD8;FBXW11;PHC3;ZSCAN29;EPC2;NR5A1;ZNF711;PSPC1;CREB3L2;NR2C2;SOX11;TRIM44;ZBTB38;BCL11A;ZMYND11;TSHZ2;ZNF182;COMMD7;PRDM1;PPM1A;NCOR2;HIVEP2;GMEB2;ABL1;KDM4C;YEATS2;HMGB1;GPBP1;ZFP69;BACH2;TP53INP2;TCF7L2;MAPK14;ZBTB34;ATF6;SOX6;TGFA;BRD7;MLLT11;BRD3;HIPK2;TP53;ATRX;MAF;TGFBR1;RNF20;NR1D2;KLF13;MYT1L;LRP6;MAP2K2;NAA15;ACVR1B;LCOR;RXRA;EPC1;MED27;FUBP3;PPARGC1B;NFX1;SP4;INSR;TRIM56;GTF2H1;CAMKK2;DDX5;RREB1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.4171883110889911,0.9329669342119151,0.5824175824175825,0.961131715248381,1.0,6/31,11.97%,LSM7;EXOSC5;DCP1B;EXOSC7;DCP1A;DCPS
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.41999355956187795,0.9327878133838046,0.5633971291866029,0.9610237421480123,1.0,5/31,12.97%,EIF4A3;HOXC4;TGFBR2;SOX11;TGFBR1
prerank,lipid biosynthetic process (GO:0008610),-0.2304283129606094,-0.9327636104434691,0.6666666666666666,0.9659717831080527,1.0,26/77,25.95%,PAM;PIP5K1A;LPCAT1;ACLY;AGPAT3;LPL;ACSL1;PRKAA1;PDSS1;ACSS2;GNPAT;PRKAA2;ACSL5;MBOAT1;HMGCR;LIPH;PCYT2;GPAT4;FDFT1;ACSL6;PRLR;SCP2;SREBF1;XBP1;NDUFAB1;CLN8
prerank,protein dephosphorylation (GO:0006470),0.3734641910019406,0.9326412738121181,0.6313131313131313,0.9608440966472243,1.0,32/135,15.88%,EYA2;RPRD1B;DUSP3;DAPP1;PPP2R2A;PTPRJ;RPRD1A;CTDNEP1;STK11;DUSP16;DUSP10;SSH2;PTPN1;PTPRT;NCK1;PPP4R1;PTPN3;SSU72;FBXW11;PPM1A;RPAP2;CTDP1;DUSP12;PTPRU;PTPRO;PPP2R3A;PPP2R5C;PTEN;PTPN9;PTPN18;MTM1;PPP2R2D
prerank,adherens junction organization (GO:0034332),0.3948097526500093,0.9325184115623218,0.5686059275521405,0.9606191840247812,1.0,7/48,13.77%,ANG;VCL;CTNNA1;PAK2;CDH11;CDH20;CDH18
prerank,neuron projection fasciculation (GO:0106030),0.4872183412296925,0.9320163836343989,0.557632398753894,0.9612139920689837,1.0,3/10,13.32%,EPHB2;ARHGAP35;RTN4
prerank,positive regulation of telomere capping (GO:1904355),0.4476517309093627,0.9319916040647511,0.5702917771883289,0.9607555014382169,1.0,4/17,9.59%,MAPK1;PKIB;TNKS2;NEK7
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.37151657526693266,0.9316815197562656,0.694,0.9608804208429454,1.0,82/341,15.66%,PLK1;KLHL42;TSG101;FBXW7;UBXN1;VPS4A;RLIM;CLOCK;FEM1C;FEM1A;FBXO21;PELI1;PSMD9;GID4;UBQLN1;GID8;PSMB8;ANAPC10;CDC23;SQSTM1;RC3H2;ARRB2;NHLRC1;UBE2A;RNF166;PSMC5;RNF115;KEAP1;RNF34;BUB3;USP33;NEDD4;BFAR;HECW1;RNF146;BIRC6;RCHY1;AREL1;FAF1;CDC16;TRPC4AP;RNF216;FBXO11;PTPN23;RNF11;PLAA;TRIM3;ELOC;VPS37C;UBE2I;MYLIP;ASB2;FBXW11;VPS37A;RNF150;CBL;RNF144B;VPS4B;CUL4A;UBE2W;UBE3C;PSMD12;MIB1;NHLRC3;PSMA2;RNF20;APPBP2;ANAPC16;NDFIP1;ATXN3;UBE2H;FBXL7;PPP2R5C;UBA6;TBL1XR1;UBE2D3;RAD23B;OTUD7A;TRIP12;FBXW4;PSMB1;ZNRF3
prerank,carboxylic acid transport (GO:0046942),0.3873245172448035,0.931467687195024,0.584070796460177,0.9608505369158975,1.0,7/55,15.51%,SLC66A1;LLGL2;SLC38A2;SLC7A8;SLC15A4;SLC16A6;SLC38A6
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.4233353868113347,0.9313916267616621,0.5741687979539642,0.9604978549684582,1.0,8/24,16.64%,ACTR3;TWF2;CDC42;ARPC2;WASF2;AUTS2;PIK3R1;CYFIP1
prerank,epithelial structure maintenance (GO:0010669),-0.3953844895278025,-0.9312930580917049,0.55,0.9674916663515375,1.0,4/11,42.18%,STRAP;CXADR;NOD2;RBP4
prerank,regulation of protein sumoylation (GO:0033233),-0.3367552472149966,-0.9311868268276535,0.5318352059925093,0.9653156967710933,1.0,10/17,37.39%,ZMIZ1;CAPN3;GNL3;GNL3L;PIAS4;HDAC4;PARK7;EGR1;PIAS3;RWDD3
prerank,plasma membrane organization (GO:0007009),0.38574370786063017,0.9310726054245068,0.5863539445628998,0.9606631122037325,1.0,9/61,8.50%,DEGS1;SMPD1;MYOF;FNBP1L;PACSIN2;ABCD2;SYT11;SPTBN1;ABCA7
prerank,necroptotic process (GO:0070266),0.45756174146548306,0.9306677901839688,0.5667574931880109,0.9610360893537252,1.0,6/16,16.43%,TLR3;IPMK;CYLD;ITPK1;TLR4;DNM1L
prerank,glycolytic process (GO:0006096),0.41570096367324305,0.9306263083407837,0.5772058823529411,0.960600977190432,1.0,5/28,11.56%,PGAM4;PGAM1;ALDOA;ENO1;GCK
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.3992003878354079,-0.9303842113003521,0.5965417867435159,0.9650634246320298,1.0,4/11,16.64%,PDK1;PDCD10;STK25;GSKIP
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3855575483303451,0.9303319391350326,0.6120959332638165,0.9607631894567562,1.0,13/79,12.87%,ADAMTS12;DAND5;SMAD6;BMPR1A;THBS1;CRIM1;NEDD4;LEMD2;PTPN1;PPARG;HGS;SORL1;HIPK2
prerank,peptidyl-asparagine modification (GO:0018196),0.41726427968463503,0.9302455286514549,0.5873388042203986,0.9604229351062834,1.0,5/31,13.51%,LMAN1;UGGT2;STT3A;ST6GAL1;UGGT1
prerank,negative regulation of immune response (GO:0050777),0.37473061028391064,0.9302384351743856,0.6525252525252525,0.9599267729829496,1.0,22/154,14.63%,RXFP1;ADCY8;ADCY3;PRKAR2A;ADCY5;ILRUN;PRKACA;YES1;ADCY9;LYN;MAPKBP1;FURIN;RAMP1;MAPK14;SYK;FYN;CYSLTR1;CALCRL;CREB1;GNG2;GNB1;HAVCR2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3749704819922146,0.930168077335917,0.6128016789087093,0.9595508649625347,1.0,14/86,12.95%,DNAJB1;BAG3;IMPACT;PSMD9;PSMB8;EP300;EGLN3;EGLN2;PSMC5;EGLN1;ELOC;PSMD12;TP53;PSMA2
prerank,regulation of double-strand break repair (GO:2000779),0.4071260773762635,0.9300892460793502,0.6,0.9592205023568849,1.0,9/39,15.07%,SIRT7;SETD2;SLF1;RNF169;UBR5;PPP4C;FMN2;SPIDR;TRIP12
prerank,dendrite self-avoidance (GO:0070593),-0.3394312806889886,-0.9294460890816139,0.5375494071146245,0.9651734501641771,1.0,5/16,17.91%,CNTN6;DSCAML1;CNTN2;EMB;BSG
prerank,aerobic respiration (GO:0009060),0.4387155458140528,0.9293451267103828,0.5801324503311258,0.9603186001375555,1.0,2/20,2.65%,UQCRH;UQCRC1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.4271518536854663,0.9288337580948539,0.5906210392902408,0.9609096819832715,1.0,5/26,13.81%,EYA2;IL1A;MAP2K5;BCL2;HTRA2
prerank,regulation of dendrite morphogenesis (GO:0048814),0.4082143128042399,0.9287250520170324,0.5587878787878788,0.9606334288026577,1.0,8/32,12.22%,SS18L1;NEDD4;CUX1;HECW1;ADGRB3;SDC2;LZTS1;CDKL5
prerank,vasculature development (GO:0001944),0.45058243282862276,0.9287191233361046,0.5727513227513228,0.9601349373222594,1.0,2/16,6.79%,FBXW7;STK11
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3735655151725183,0.928344762882502,0.6103626943005181,0.9604745527318207,1.0,13/95,11.61%,UST;B4GALT3;CHSY1;UGDH;DSE;ABCC5;GLCE;HS6ST2;B4GALT5;B4GALT1;BGN;SDC2;B3GNT2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.37761302694155074,-0.9282984806667258,0.5662251655629139,0.965793499455818,1.0,3/13,7.85%,PTPRC;JAK2;DOT1L
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.41693595148385915,0.9281330204634903,0.5806451612903226,0.9604434956095953,1.0,5/29,11.91%,UTP3;UTP20;RRP36;UTP6;HEATR1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.46354831850761957,0.9279332004379549,0.568081991215227,0.9603685777937415,1.0,1/13,0.96%,D2HGDH
prerank,endoderm formation (GO:0001706),0.4164021104460135,0.9278908586539588,0.5820543093270366,0.9599476509333236,1.0,4/35,7.49%,ITGA4;ITGB5;COL11A1;SETD2
prerank,positive regulation of rRNA processing (GO:2000234),0.47984226803193014,0.927690548441752,0.588597842835131,0.9598746992579249,1.0,1/10,1.00%,SIRT7
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3697514632885302,0.9276728909098756,0.706,0.9594149842699318,1.0,60/314,14.70%,PLK1;WFS1;KLHL42;MAN1B1;FBXO17;FBXW7;UBXN1;TMEM67;DNAJC18;CLOCK;UBXN4;FEM1C;FEM1A;USP19;PELI1;PSMD9;GID4;UBQLN1;GID8;PSMB8;ANAPC10;CDC23;CDK2;ARRB2;NHLRC1;UBE2A;UBE2J2;RHBDD2;FBXO9;PSMC5;RNF34;BUB3;NEDD4;ECPAS;BFAR;HECW1;AREL1;FAF1;CDC16;RNF216;AMN1;PLAA;TRIM3;FBXW11;DERL1;CUL4A;UBE2W;FBXO38;PSMD12;DCAF12;NHLRC3;PSMA2;APPBP2;ANAPC16;ATXN3;FBXL7;PPP2R5C;TBL1XR1;UBE2D3;RAD23B
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.4868027029475644,0.9275935642842732,0.5578778135048231,0.9590768838712533,1.0,3/10,8.44%,NEDD4;CAMK2D;HECW1
prerank,negative regulation of bone mineralization (GO:0030502),-0.38287358935793786,-0.9275779360547811,0.542319749216301,0.965289543835157,1.0,3/13,8.94%,PTK2B;BCOR;ENPP1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.37117444699111346,0.9274805626127169,0.6523046092184369,0.9588126442552548,1.0,38/182,16.57%,WNT4;PARP9;FBXW7;FLOT2;RUNX1;TGFB2;RIN3;OLFM1;TARDBP;BMPR1A;RBMS3;TERF2;PDGFB;TNRC6B;ESR1;SDCBP;MAPT;MECP2;AGO2;ITGB8;APOBEC1;ATXN2;NOTCH2;SOX11;ERP29;ADAM10;MAP2K2;NDFIP1;LGALS9;ROCK2;OPTN;HAVCR2;ANKRD13A;SH3GL2;MAP2K1;MEF2C;LGMN;RB1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3852427909751334,0.9272947155940778,0.602357984994641,0.9587463890604094,1.0,10/64,12.98%,AIG1;ACSBG1;HPGD;GPX4;PLA2G4A;ALOX5;FADS1;ACADL;ABCD1;HSD17B4
prerank,axon extension (GO:0048675),0.43175096373956895,0.9272761069066785,0.576874205844981,0.9582752849372697,1.0,9/23,16.64%,NRP1;HSP90AA1;SLC9A6;CDK5;ULK2;SPG11;NRP2;AUTS2;CYFIP1
prerank,negative regulation of cellular senescence (GO:2000773),-0.37382300750663555,-0.926724699388886,0.5442622950819672,0.9651736542868515,1.0,5/13,14.16%,AKT3;MAP3K3;YBX1;RBL1;SIRT1
prerank,regulation of viral entry into host cell (GO:0046596),0.4126703025516679,0.9266747025625509,0.555952380952381,0.959094338678467,1.0,7/30,17.39%,IFITM3;SNX3;TRIM5;LGALS9;TRIM26;TRIM25;GSN
prerank,regulation of cartilage development (GO:0061035),0.4468225386647278,0.9266498334696175,0.5699346405228758,0.9586456605095425,1.0,4/18,15.86%,TAPT1;TRPS1;SOX6;MBOAT2
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.3282774238402808,-0.9266256150626552,0.574468085106383,0.9630515756504152,1.0,3/20,1.86%,PRKCE;HCK;TGFB1
prerank,regulation of acute inflammatory response (GO:0002673),-0.3386711881436825,-0.9266134816271303,0.5675675675675675,0.9606962388210559,1.0,12/18,66.14%,NLRP3;ADAM8;IL6ST;PTGES;OSM;OSMR;IL6;PLA2G2D;GSTP1;KLKB1;F12;DNASE1
prerank,cellular protein-containing complex assembly (GO:0034622),0.36958912473255223,0.9266016862883489,0.6629778672032193,0.958247586343254,1.0,32/159,15.24%,VAMP1;SPAG1;TBCA;HOPX;ARL6;TCP1;EIF4B;VAMP3;NUP205;SMAD3;AHCTF1;POMP;RPL38;GPX4;HSP90AA1;MAPT;NUP98;NCK1;VAMP2;DNAI4;IMMP2L;TRAF2;GTF2B;PXN;UVRAG;AIFM1;PIK3C2A;RTN4;EPS15;CLTC;SMAD4;HIP1
prerank,establishment of vesicle localization (GO:0051650),-0.3467233439144462,-0.9265623610768577,0.5431034482758621,0.9584875808887852,1.0,13/18,32.51%,DNM2;RAB11A;KIF5C;CCDC186;RAB27A;LIMK2;IKBKG;KIF5A;SYNJ1;TMEM230;TOR1A;SNAPIN;TESK1
prerank,global genome nucleotide-excision repair (GO:0070911),0.4192702362568818,0.9265349724305795,0.5567901234567901,0.9578795634982026,1.0,6/26,14.70%,CETN2;ERCC4;CUL4A;GTF2H1;USP45;RAD23B
prerank,histone deacetylation (GO:0016575),0.39256406551889594,0.9265340575794053,0.5894854586129754,0.9573767729546125,1.0,11/43,16.96%,SIRT7;HDAC9;HDAC11;HDAC5;MORF4L2;SIN3B;MIER3;TBL1XR1;HDAC2;RCOR1;TBL1X
prerank,regulation of T cell mediated immunity (GO:0002709),0.4891096800095259,0.9264230844298373,0.602803738317757,0.9571037791322416,1.0,3/10,16.68%,TRPM4;HMGB1;ZBTB1
prerank,melanosome localization (GO:0032400),0.4402422381169375,0.926293324968879,0.5698254364089775,0.9569026137666274,1.0,3/21,5.36%,ARL6;BBS4;MYO5A
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.37802223736765134,0.9261354025972727,0.6162790697674418,0.9567527339328779,1.0,12/72,14.07%,RGCC;CNOT10;TFAP4;EP300;NBN;CHEK2;CNOT9;CNOT3;HIPK2;TP53;ATRX;NDRG1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.40839000029454314,0.9258458422122838,0.5807600950118765,0.9568888744918757,1.0,6/33,11.07%,CSTF3;CSTF2;SSU72;SNRPD3;SETX;CPSF3
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.4154199788121564,0.9256997078051779,0.5761421319796954,0.9567144550274225,1.0,5/26,7.60%,STMN2;MAPRE1;AKAP9;DCTN1;MAPT
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.458814893699929,0.9255856326028,0.5561797752808989,0.9564564825671327,1.0,2/14,4.64%,VEGFC;NRP1
prerank,endomembrane system organization (GO:0010256),0.3681840662592839,0.9255291258324887,0.6549648946840522,0.9560839723817639,1.0,46/178,16.97%,LMAN1;LRRK2;COG1;TMED4;VPS4A;MYOF;COG3;AKTIP;SQSTM1;TMED9;RAB30;ARFGEF1;CTDNEP1;GOLPH3;LYSMD3;SNX10;LEMD2;SPTBN1;REEP5;STX17;PI4K2A;RAB2A;ATP8B4;SEC61A1;CDC42;MIA3;TMED2;TRAPPC8;VPS11;TMED5;CSNK1A1;WASHC5;LNPK;TRIP11;OPTN;CLASP1;ATL2;DNAJC13;GOLGA5;GOLGA8B;OSBPL2;VAPB;DNM1L;HACE1;HOOK2;NUP93
prerank,response to retinoic acid (GO:0032526),0.3853099875796843,0.92521228431834,0.6023965141612201,0.9562872040937461,1.0,8/59,14.01%,OVCA2;TWF2;ADNP2;LYN;SETX;RXRA;HTRA2;CREB1
prerank,response to metal ion (GO:0010038),0.37650190072091405,0.9251155070765694,0.6072961373390557,0.9559869877311253,1.0,12/67,14.29%,D2HGDH;PEF1;THBS1;HVCN1;IL1A;NEDD4;MAPT;MT1A;MT1X;BCL2;NDRG1;CALM1
prerank,transition metal ion homeostasis (GO:0055076),0.4155510085972728,0.9249117962950199,0.5665024630541872,0.9559324117706938,1.0,3/28,5.93%,CP;HMOX2;ABCB7
prerank,ceramide metabolic process (GO:0006672),0.39001976229631363,0.9245993278203533,0.6023965141612201,0.9561182717043806,1.0,12/49,17.64%,DEGS1;SMPD1;CERS6;ACER3;CERS4;ASAH1;SGPL1;CERS5;SPTLC1;NSMAF;SGMS1;PLPP1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4610292031534698,0.92453435659583,0.5739644970414202,0.9557378179239263,1.0,3/13,10.86%,BCL2L11;BNIP3L;BNIP3
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.49257162750591704,0.9242987298974569,0.5909090909090909,0.9557519130480705,1.0,4/11,13.69%,PTPRT;HGS;SH2B3;ADIPOR1
prerank,synaptic vesicle exocytosis (GO:0016079),-0.276520255409424,-0.924295267731556,0.576,0.9621848424966456,1.0,15/40,24.90%,RIMS2;SYT1;SNAP25;STX2;PIP5K1C;STX4;SNCA;RIMS1;UNC13B;SYT2;SNAP29;SNPH;SYT10;CPLX1;SYT7
prerank,cellular response to starvation (GO:0009267),0.3668344205174061,0.9242349138147464,0.6663306451612904,0.9553907574944143,1.0,26/147,13.11%,WDR45;RIPOR1;LRRK2;EIF2AK2;IMPACT;PIK3R4;WRN;WDR45B;MAPK1;MIOS;EHMT2;USP33;ATP6V0E1;MAPK8;FNIP1;ATP6V1E1;VPS41;FADS1;XPR1;MTOR;SLC38A9;SH3GLB1;TP53;EIF2S1;ATP6V0D2;ATP6V1H
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.43126954193496525,0.9239714134261856,0.5625823451910409,0.9554520329119446,1.0,4/22,13.71%,CDK5RAP3;SPRED2;SPRED1;DDX5
prerank,cotranslational protein targeting to membrane (GO:0006613),0.3730128154216837,0.9239627479874031,0.6276150627615062,0.9549712695101056,1.0,11/91,5.94%,RPL18;RPS23;RPL41;RPL31;RPS17;SSR2;RPL4;SIL1;RPLP0;RPS15A;RPL38
prerank,protein polyubiquitination (GO:0000209),0.36606025470483666,0.9237171612098927,0.704,0.9549798651235762,1.0,61/297,14.06%,BRCA1;KLHL42;FBXO17;FBXW7;FBXO30;RNF31;RLIM;SASH1;FBXO21;PELI1;PSMD9;PSMB8;ANAPC10;UBE2V2;CDC23;AKTIP;RC3H2;NHLRC1;UBE2A;RNF166;UBE2J2;FBXO9;PSMC5;RNF115;RNF34;PPIL2;NEDD4;UNKL;TPP2;BFAR;LNPEP;HECW1;HERC6;RNF146;TNKS2;AREL1;CDC16;RNF216;FBXO11;UBE2Q2;TRIM3;TRIM5;MYLIP;TRAF2;FBXW11;RNF144B;UBE3A;UBE2W;FBXO38;UBE3C;PSMD12;UBR5;NHLRC3;HECTD1;PSMA2;RNF20;BCL2;TRIM56;UBE2H;FBXL7;RNF135
prerank,tyrosine metabolic process (GO:0006570),-0.3965595339966374,-0.9236657892556027,0.5993690851735016,0.9614843203881519,1.0,4/11,44.13%,GSTZ1;THAP4;FAH;IL4I1
prerank,neuron development (GO:0048666),0.3726912024186682,0.923568136706831,0.6686868686868687,0.9548028259109318,1.0,34/141,17.66%,GBA2;ZFYVE27;TDP2;EHD1;UGDH;STMN2;RUNX1;TGFB2;ATP7A;BICDL1;NEDD4;MAPT;TENM4;STX3;DTNBP1;LYN;B4GALT5;CDK5;EPHA5;HMGB1;PPP1R9A;MYT1L;TBC1D24;UNK;PLP1;GPM6A;PPP1R9B;SH3GL2;MEF2C;RB1;TBC1D23;RAPGEF2;PBX3;ARL3
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.38801176213602706,0.9233374228323175,0.5922222222222222,0.9547864433930114,1.0,10/50,12.02%,GAS6;IGBP1;THBS1;YWHAE;RNF34;PAK2;FNIP1;CD44;MAP2K5;RAF1
prerank,ceramide transport (GO:0035627),-0.3843419829096981,-0.9232865714902061,0.5692771084337349,0.9600855098389657,1.0,7/12,20.02%,CERT1;PLEKHA8;PLEKHA3;ABCB4;GLTP;PLTP;ABCA2
prerank,glycogen metabolic process (GO:0005977),-0.2957912046917766,-0.9231587830167546,0.5845410628019324,0.9580804632597831,1.0,13/27,25.88%,PHKA2;GSK3B;PHKB;PYGB;PGM2L1;PGM1;GYG1;PHKG2;GYS1;PYGL;GAA;PGM2;PRKAG2
prerank,actin filament polymerization (GO:0030041),0.416749688289445,0.9226508101236158,0.5842558425584256,0.9557665095417365,1.0,8/29,17.39%,ANG;WASF1;DIAPH1;WASHC5;AIF1;WASL;PREX1;GSN
prerank,regulation of primary metabolic process (GO:0080090),0.371366259032899,0.9224687416948534,0.6361788617886179,0.9556362035532799,1.0,27/126,14.57%,SP1;BBS4;PSMD9;GGPS1;PSMB8;TGS1;IRS2;PSMC5;GPAM;NCOA1;CHD9;ABCA7;NCOR1;PPARG;SIN3B;NCOR2;ZFP69;PSMD12;PSMA2;NR1D2;RXRA;ADIPOR1;ACACA;ROCK2;PPARD;TBL1XR1;NCOA2
prerank,monocyte differentiation (GO:0030224),0.4906400024546229,0.9224649978232978,0.6029173419773096,0.9551472660239705,1.0,3/10,10.58%,THOC5;PPARG;MT1G
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.4619130044615593,0.922436699215886,0.5746478873239437,0.9547136357131433,1.0,3/15,12.97%,EIF4A3;TGFBR2;TGFBR1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.4263858400426557,0.9220768013949537,0.5916030534351145,0.9549664035048174,1.0,3/24,7.60%,STMN2;NCKAP5L;MAPT
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.4410989351171179,0.9220438505752934,0.573997233748271,0.9545354443830896,1.0,4/17,17.12%,HDAC9;FURIN;PCSK6;PCSK5
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.4667735296193445,0.9219029360754681,0.5933147632311978,0.9543386564377047,1.0,4/13,15.19%,CPE;TGFBR2;RBPJ;SMAD4
prerank,neutrophil migration (GO:1990266),0.3838799548700726,0.9216709492697145,0.6050054406964092,0.9543655872001122,1.0,4/58,7.28%,CX3CL1;IRAK4;TGFB2;CCL25
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4015676377363112,0.9216587426843205,0.5960648148148148,0.953897936612257,1.0,3/37,5.92%,PLK1;MAPK1;SPRED2
prerank,organelle fusion (GO:0048284),0.42824765053266034,0.9216165700827211,0.5851197982345523,0.953495475703304,1.0,7/22,18.19%,MIEF2;EEA1;VPS11;MIGA1;MFF;CHCHD3;MFN1
prerank,outer dynein arm assembly (GO:0036158),-0.3674590878887056,-0.9214749372316372,0.568561872909699,0.9599502825186198,1.0,8/14,50.23%,LRRC49;DNAL1;DNAAF5;ODAD1;DNAH8;DNAH5;ODAD2;ODAD4
prerank,Golgi organization (GO:0007030),0.3694424122223981,0.9211170636035686,0.641912512716175,0.9540746215482581,1.0,29/112,15.84%,LMAN1;LRRK2;COG1;GOSR2;TMED4;COG3;TMED9;RAB30;ARFGEF1;GOLPH3;LYSMD3;STX16;STX17;PI4K2A;RAB2A;ATP8B4;CDC42;TMED2;TRAPPC8;TMED5;CSNK1A1;TRIP11;OPTN;CLASP1;ATL2;VCPIP1;GOLGA5;GOLGA8B;VTI1A
prerank,autophagosome assembly (GO:0000045),0.3917725707074195,0.9206614391537588,0.610678531701891,0.9545578006424115,1.0,14/52,15.16%,WDR45;UBQLN1;WDR45B;AMBRA1;STX17;ULK2;ATG3;TRAPPC8;PACS2;RB1CC1;TP53INP2;RAB7A;ATG7;BECN1
prerank,regulation of transport (GO:0051049),0.3999392434943168,0.9205330675921292,0.5923344947735192,0.9543589655189696,1.0,6/36,9.89%,LRRK2;NRP1;EPB41;REEP5;VAMP2;CDK5
prerank,regulation of MAPK cascade (GO:0043408),0.3698791589652035,0.9201181553521545,0.6773547094188377,0.9547584024536709,1.0,31/157,16.23%,ROR2;DUSP3;CX3CL1;MINK1;NF1;STYX;PDGFB;TRAF7;MAPK1;PTPRJ;PAK2;ABCA7;PHLPP1;LYN;TAOK1;TRIM5;RIT2;IGF1R;HMGB1;MAP2K2;SYK;FN1;SPRED1;INSR;ROCK2;DAG1;STK3;MAP4K4;IQGAP1;MAP2K1;PAK1
prerank,regulation of myoblast differentiation (GO:0045661),0.4147180610308247,0.9196398162027236,0.5952380952380952,0.9552346579074646,1.0,4/32,12.55%,IGFBP3;FLOT2;ZFP36L1;MAPK14
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.3071004356407475,-0.9196025712398266,0.5615763546798029,0.9623212766220183,1.0,12/23,27.69%,BTRC;VCP;MOSMO;SUFU;ENPP1;PTCH1;RACK1;MEGF8;IFT122;HHIP;KCTD21;GLI3
prerank,regulation of microglial cell activation (GO:1903978),0.4453712231920003,0.918576375190988,0.5605858854860186,0.9570015400941978,1.0,2/15,7.80%,CX3CL1;SYT11
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.37988520819091226,0.9184117687058836,0.5943293347873501,0.9568657935097391,1.0,8/56,14.30%,PLK1;VPS4A;BBS4;SPTBN1;APC;PDCD6IP;IST1;ROCK2
prerank,nitric oxide biosynthetic process (GO:0006809),-0.3783599597583247,-0.9182883247439028,0.577259475218659,0.9635144779710524,1.0,3/13,22.61%,CYB5B;AKT1;GCH1
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.3932174078203389,0.9180877081313261,0.5983701979045402,0.9570264891651179,1.0,7/39,11.49%,ITGB1BP1;TGFB2;EP300;MAML3;MAML2;KAT2B;BMP2K
prerank,organophosphate biosynthetic process (GO:0090407),0.39573514851174146,0.9179982117947846,0.5806818181818182,0.9567066348637278,1.0,9/37,13.00%,TPK1;NFS1;GPAM;FADS1;TKT;AGPAT4;IPMK;GK;AGPAT5
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.4074801564284579,0.9179512105088389,0.5710754017305315,0.956303746764529,1.0,11/30,17.02%,SYS1;KIF13A;GOLPH3;SPTBN1;VAMP2;GGA1;OPTN;MACF1;GGA3;GOLGA4;GCC2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3724289757539764,0.917695817716379,0.6221532091097308,0.9563584864926026,1.0,9/85,12.48%,WFS1;HOMER2;CACNA1D;ALDH7A1;COL11A1;PIEZO2;GRM7;WDR1;EML2
prerank,regulation of integrin activation (GO:0033623),0.459611783178767,0.9173158972456537,0.5636363636363636,0.9567078058739612,1.0,3/15,13.07%,FARP2;RAP1B;FBLIM1
prerank,interstrand cross-link repair (GO:0036297),-0.2444481494011034,-0.9172582985061152,0.6486486486486487,0.9638210156072426,1.0,19/53,24.45%,VCP;ATR;ERCC6L2;FANCC;MCM9;FANCL;NUCKS1;XPA;WDR48;UBC;FANCE;RPA1;RNF168;RPS27A;FANCM;FAN1;UBB;DCLRE1C;RNF8
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.47943688887618635,0.9168874020783504,0.5675675675675675,0.9571184011726702,1.0,3/10,13.52%,ACADS;ACADL;ETFA
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.45153853209546757,0.9167774254087869,0.5972222222222222,0.956873038593071,1.0,2/15,8.68%,CD36;IL18
prerank,positive regulation of isotype switching (GO:0045830),-0.3579781536514476,-0.9164811630962432,0.5588235294117647,0.9634058754135041,1.0,7/15,22.93%,TGFB1;RIF1;SHLD1;SHLD2;PAXIP1;HMCES;TFRC
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.37486070527211685,0.9164268818769593,0.628099173553719,0.9571531388424103,1.0,15/90,13.69%,EHMT1;CD36;ALMS1;CMKLR1;DECR1;KDM3A;IL18;APC;CNOT3;IGF1R;ACADL;TRPV2;PPARGC1B;SYK;ADIPOR1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.3985193456833523,-0.916210746480565,0.5714285714285714,0.9618370281933657,1.0,6/11,26.95%,TYROBP;STX4;ITGB2;CAMK4;ITGAM;STAP1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.42550549699695844,0.9160473744097056,0.5832258064516129,0.9574534642961793,1.0,5/20,11.02%,PUM2;AGO2;PUM1;ZC3H7A;PRKRA
prerank,intestinal absorption (GO:0050892),0.46235332653802613,0.9158962218374906,0.5956834532374101,0.9572671888443388,1.0,1/13,1.63%,CD36
prerank,protein O-linked glycosylation (GO:0006493),0.37213349505477045,0.9158507194185507,0.651186790505676,0.95685568681245,1.0,14/96,14.26%,POGLUT3;EOGT;GALNT1;POMT2;GALNT12;GALNT3;C1GALT1;B4GALT5;GALNTL6;ST6GAL1;FKTN;B3GNT2;B3GALNT2;TET2
prerank,positive regulation of phospholipase activity (GO:0010518),-0.3179726642561803,-0.9157334097915596,0.5991379310344828,0.9605935287213294,1.0,7/22,15.23%,FGFR2;FLT1;NTRK3;FGF2;PDPK1;PLCG1;ABL2
prerank,negative regulation of macrophage activation (GO:0043031),-0.34605153096619146,-0.9153766918080072,0.5595238095238095,0.959163554591535,1.0,4/16,4.56%,LRFN5;PTPRC;GRN;FCGR2B
prerank,cytoplasmic microtubule organization (GO:0031122),0.38440120504469094,0.9152940288939202,0.614207650273224,0.9575196518808747,1.0,9/54,8.66%,WDR73;KPNB1;TUBGCP6;CAMSAP3;EZR;DCTN1;DLG1;MAPT;TUBGCP2
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.4192831125554248,0.9152052101740544,0.5950617283950618,0.9572260229580646,1.0,5/23,14.70%,CETN2;COPS7B;COPS4;CUL4A;RAD23B
prerank,protein targeting to lysosome (GO:0006622),0.4276916901684064,0.9149677930879376,0.5963777490297542,0.9572322655361749,1.0,9/20,17.02%,VPS4A;AP3M1;NEDD4;HGS;SORL1;RAB7A;SCARB2;GGA3;GCC2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.36461062481358997,0.91493696822419,0.729,0.9568064196334974,1.0,55/327,14.18%,ACTR5;RORA;ZNHIT3;ELAVL2;THAP7;RELA;DVL1;SP1;CTR9;CASZ1;SOX13;CLOCK;HCFC1;POLR2A;MYCBP;ATXN1;EP300;RBAK;ESR1;SPTY2D1;NR3C1;BRCA2;HP1BP3;ZBTB11;RPS6KA5;EZH2;JMJD1C;CHD7;CHEK2;PTP4A3;ASCC2;FUS;FADS1;ACTN4;TULP3;FOXN3;PSPC1;NR2C2;SOX11;ZBTB38;ABL1;GPBP1;SOX6;TP53;ATRX;TGFBR1;RNF20;NR1D2;ACVR1B;PPARGC1B;NFX1;INSR;RREB1;NSD2;RFX3
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.34250015469529993,-0.9144138015529988,0.570281124497992,0.9593263001820341,1.0,2/18,0.30%,AKT3;MAP3K3
prerank,regulation of lipase activity (GO:0060191),-0.3728566971020027,-0.914066504686913,0.5925925925925926,0.9579757919761219,1.0,4/13,15.17%,RHOA;LPL;SNCA;LMF1
prerank,glycoprotein biosynthetic process (GO:0009101),0.3715276264483718,0.913865678953946,0.6037735849056604,0.9585345474802052,1.0,13/79,13.74%,ALG3;ST8SIA5;ST8SIA4;ATP7A;COG3;GOLPH3;B4GALT5;CANT1;B3GALNT1;B3GNT2;CHST8;NUS1;B3GALNT2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.34543755581067465,-0.9135457195180854,0.5617977528089888,0.9570116348680952,1.0,3/17,1.88%,PRKN;DYRK1A;RFFL
prerank,regulation of T cell activation (GO:0050863),0.38492094782734027,0.9135128843156688,0.5944700460829493,0.9587774060501659,1.0,5/42,11.90%,DUSP3;TNFAIP8L2;METTL3;CYRIB;ABL1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.3538137440778834,-0.9134263331996723,0.6117216117216118,0.9550968788709813,1.0,1/15,0.56%,SAT1
prerank,regulation of macrophage activation (GO:0043030),-0.28677571776287547,-0.913384339589568,0.6493506493506493,0.9529707750782256,1.0,8/30,19.83%,LRFN5;FCGR2B;GPR137B;TNIP2;IL33;HSPD1;ZC3H12A;CD74
prerank,positive regulation of synaptic transmission (GO:0050806),0.3760923977043903,0.9132369136604345,0.6065057712486883,0.9588498569934464,1.0,11/72,10.25%,PRKCZ;ADCY8;CACNG7;EPHB2;CLSTN3;SQSTM1;RGS14;NPTN;DTNBP1;VAMP2;CLSTN1
prerank,chondrocyte differentiation (GO:0002062),0.40605214287225205,0.912859296231145,0.6066350710900474,0.9591268427977446,1.0,7/32,16.27%,WNT2B;RUNX1;SNX19;CREB3L2;SOX6;NFIB;MEF2C
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3767238357190248,0.9128113420925292,0.6223849372384938,0.9587277915221419,1.0,12/73,14.85%,ISL1;EPHB2;THBS1;PTPRJ;IL1A;TLR3;MAVS;HMGB1;SYK;LGALS9;HAVCR2;TLR4
prerank,neuronal action potential (GO:0019228),-0.31598038156803515,-0.912804511223789,0.5546218487394958,0.9523054848690204,1.0,3/22,6.37%,SCN2A;SCN3A;SCN8A
prerank,renal filtration (GO:0097205),-0.4036167255666323,-0.912709589661774,0.625,0.9502905817928081,1.0,5/10,23.57%,SULF2;XPNPEP3;CD34;TBC1D8B;SULF1
prerank,regulation of response to biotic stimulus (GO:0002831),0.41470814994233646,0.9126394281205448,0.6117216117216118,0.9585879155347421,1.0,8/28,14.06%,CD36;CX3CL1;IRF1;BIRC3;LRP8;TRIM5;ERAP1;RNF135
prerank,icosanoid metabolic process (GO:0006690),0.3910556276659538,0.9123293052726422,0.5954545454545455,0.9587820562458872,1.0,9/40,17.95%,HPGD;GPX4;PLA2G4A;ALOX5;FADS1;MAPKAPK2;PON3;ABCC1;PTGS1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.4639794426036869,0.9120545566243469,0.5896296296296296,0.9588856532166248,1.0,5/13,18.86%,CYFIP2;TBC1D10A;GRIN2A;LGMN;ASPH
prerank,regulation of neuroinflammatory response (GO:0150077),0.4362988444066007,0.9119978720661615,0.5866141732283464,0.9585152047004816,1.0,2/19,8.68%,NUPR1;IL18
prerank,snRNA metabolic process (GO:0016073),0.4451390807942379,0.91177636393644,0.5766129032258065,0.958485278642568,1.0,6/17,16.04%,INTS12;INTS2;INTS4;RBM7;MTREX;INTS9
prerank,regulation of B cell proliferation (GO:0030888),0.38884042995821083,0.9114397485850193,0.588774341351661,0.9586874181711091,1.0,11/44,18.02%,CD38;EPHB2;VAV3;IRS2;LYN;BCL2;CD81;MEF2C;ATM;NCKAP1L;RC3H1
prerank,regulation of axonogenesis (GO:0050770),0.38552980212873944,0.911380789741773,0.6176142697881828,0.9583259763844689,1.0,10/51,14.70%,CHODL;PLXNA1;GDI1;PAK2;ARHGAP35;RUFY3;PLXNC1;RTN4;MAP6;PTEN
prerank,regulation of centrosome duplication (GO:0010824),0.4119975995481792,0.9109882267390682,0.6063960639606396,0.9586425879426544,1.0,7/29,16.45%,ALMS1;CHMP5;TMEM67;VPS4B;PDCD6IP;NPM1;CEP295
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.41421364678634975,0.9109212082525078,0.5806845965770171,0.9582810168176986,1.0,7/26,16.80%,CD36;ABCB7;ABCD2;ALOX5;ABCD1;TLR4;COA8
prerank,translational elongation (GO:0006414),0.367452047212475,0.9103535507409488,0.6447638603696099,0.9589527376756893,1.0,9/101,7.30%,MRPS22;MRPS31;MRPS30;MRPL37;MRPS21;MRPL48;MRPS35;MRPS28;MRPL1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4075140008261333,0.910248781803454,0.6041412911084044,0.9586621103750633,1.0,6/28,12.73%,RELA;MAP2K6;LACC1;IRAK2;TAB3;CYLD
prerank,positive regulation of protein kinase activity (GO:0045860),0.36311124216537644,0.9099242647697939,0.6838383838383838,0.9588349517735094,1.0,38/148,18.70%,CAMKK1;DDR2;MINK1;TGFB2;GAS6;RAP1A;PDGFB;STK11;HSP90AA1;PAK2;PTPN1;EZH2;LRP8;TAOK1;TGFBR2;PRNP;SLC27A1;MAP2K2;MMD;INSR;RELN;CALM1;STK3;MAP4K4;IQGAP1;MAP2K1;PAK1;SNX9;RAPGEF2;FCGR1A;CAMK1;LCP2;DDX3X;STK4;ALS2;CAB39;TNIK;AXIN1
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.3212951080655916,-0.9094036808526464,0.5823293172690763,0.9564533515493168,1.0,5/19,16.62%,DLST;ASPA;GOT1;GOT2;DLD
prerank,neuron projection development (GO:0031175),0.3620900823635926,0.909227133717368,0.6814516129032258,0.9598363322678155,1.0,39/168,17.29%,VASH2;LRRK2;MINK1;ZFYVE27;EHD1;STMN2;EPHB2;NYAP1;ATP7A;KIF20B;BICDL1;NEDD4;MAPT;STX3;SLC9A6;DTNBP1;LYN;CDK5;TAOK1;CDC42;GRM7;DBNL;HMGB1;EPB41L3;PPP1R9A;TBC1D24;PLP1;PTEN;WASL;GPM6A;MAP4K4;PPP1R9B;SH3GL2;PAK1;RB1;DOCK10;TBC1D23;RAPGEF2;NCKAP1L
prerank,membrane depolarization during action potential (GO:0086010),-0.30509474895070454,-0.9087290272366849,0.5561224489795918,0.9559622454622744,1.0,5/26,7.06%,SCN2A;SCN3A;SCN8A;ATP1A2;KCNJ2
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.42725088798947747,0.908697151140681,0.6036745406824147,0.9604897979444296,1.0,5/21,12.87%,CNOT10;TUT4;CNOT9;CNOT3;SAMD4A
prerank,regulation of gene silencing by miRNA (GO:0060964),0.38000851541536607,0.9086052343528078,0.6334056399132321,0.9602062469176915,1.0,9/62,9.43%,POLR2D;POLR2A;NUP205;PUM2;NUP98;AGO2;NUP54;PUM1;PPARG
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.259093445127718,-0.9083995384921821,0.6276595744680851,0.9545615538388473,1.0,27/53,27.11%,PSMD14;PSMA3;AZIN1;PSMB2;PSMB7;PSMC6;PSMD4;PSMD7;PSMA1;PSMA5;PSMC1;PSMD13;PSMC2;PSMA6;OAZ2;PSMA4;PSMD3;PSMF1;PSMD2;PSMD5;OAZ1;PSMD1;PSMC3;PSMD8;PSMB3;PSME1;PSMB9
prerank,cellular copper ion homeostasis (GO:0006878),0.45663345422942947,0.9082801186006195,0.5994358251057827,0.9603909224386808,1.0,4/14,11.64%,ATP7A;ARF1;PRNP;SLC31A1
prerank,ventricular septum development (GO:0003281),0.3986330282853833,0.9078098319183309,0.6065192083818394,0.9608538533067705,1.0,8/37,12.97%,DAND5;TGFB2;BMPR1A;ACVR1;TGFBR2;SOX11;HECTD1;TGFBR1
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.3948833524673028,-0.9077892780870582,0.604221635883905,0.9538662203118555,1.0,6/10,20.05%,RENBP;NAGK;AMDHD2;ST3GAL1;GNPDA1;GNE
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.47395139403889286,0.9075043606739392,0.5878693623639192,0.9605195916974979,1.0,2/10,10.69%,APC;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),0.47395139403889286,0.9075043606739392,0.5878693623639192,0.9605195916974979,1.0,2/10,10.69%,APC;CDC42
prerank,negative regulation of neuron death (GO:1901215),0.37381586825663715,0.9075003768122774,0.6659793814432989,0.9600384546674162,1.0,12/93,14.50%,ISL1;WFS1;LRRK2;INPP5A;SET;VPS35;CDK5;TRAF2;SORL1;BCL2;HTRA2;FZD9
prerank,nucleotide-sugar metabolic process (GO:0009225),0.46400732587271465,0.9071044378221231,0.6078431372549019,0.9603531485572204,1.0,4/12,17.18%,PARG;UGP2;SLC35A3;GMDS
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.4081284355684813,-0.9068561716994671,0.5950413223140496,0.9538968312008871,1.0,6/10,29.90%,GABRA2;GABRA3;GABRA5;GABRA4;GABRG1;GABRA1
prerank,determination of left/right symmetry (GO:0007368),0.3957838410231095,0.9066005096501673,0.5974025974025974,0.960872853290708,1.0,2/36,2.69%,DAND5;ARL6
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.42972176269104645,0.9061738378023698,0.6086956521739131,0.9612658983833828,1.0,5/20,14.80%,CTR9;CDK6;HSPA9;ZFP36L1;LDB1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.40410314213380694,0.9060339311843822,0.5946601941747572,0.9610767646243392,1.0,6/28,14.25%,ADCY8;EPHB2;SQSTM1;YTHDF1;ABL1;RELN
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.42746671807898545,0.9054997362836864,0.6073369565217391,0.9616738108934341,1.0,2/19,7.51%,CX3CL1;PYDC1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3770079119613798,0.9053116034576177,0.6275565123789021,0.9615569241964337,1.0,11/65,13.57%,DAND5;SMAD6;PMEPA1;ZBTB7A;SMAD3;SPRED2;LDLRAD4;TGFBR2;PPM1A;TGFBR1;SPRED1
prerank,lipid catabolic process (GO:0016042),0.43276752620781817,0.9052607565747147,0.6131191432396251,0.9611889138466112,1.0,3/18,11.42%,LIPE;CEL;ACADL
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.47821705621386595,0.9051485529731488,0.6270676691729323,0.9609341993938381,1.0,4/11,17.17%,LYN;LGALS9;MEF2C;RAPGEF2
prerank,long-chain fatty acid import into cell (GO:0044539),0.4859280041951446,0.9051093093615458,0.6117274167987322,0.9605328597591631,1.0,2/10,12.68%,CD36;SLC27A1
prerank,programmed necrotic cell death (GO:0097300),0.4345678815884905,0.9049414320830006,0.6067114093959731,0.9603817562990203,1.0,6/18,16.43%,TLR3;IPMK;CYLD;ITPK1;TLR4;DNM1L
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.3440499512933446,-0.9047449866652613,0.5853658536585366,0.9569874509798788,1.0,6/17,11.76%,BCAS3;HCK;FES;HCLS1;NTRK3;BAIAP2
prerank,lymphocyte proliferation (GO:0046651),-0.3051036513440475,-0.9045074280482401,0.6130434782608696,0.9553476937911957,1.0,3/22,3.34%,ELF4;PTPRC;PIK3CG
prerank,inositol phosphate-mediated signaling (GO:0048016),0.43325136511747075,0.9044192064636297,0.6119791666666666,0.9609624164486488,1.0,2/19,6.20%,NFATC1;INPP5A
prerank,defense response to Gram-negative bacterium (GO:0050829),0.39117373295621954,0.9044068800814198,0.6082004555808656,0.9605045488607278,1.0,7/42,17.88%,RNASE6;GSDMD;RNASE3;OPTN;TLR4;DROSHA;TREM2
prerank,modification-dependent protein catabolic process (GO:0019941),0.36407685483373153,0.9043491727594812,0.7049345417925479,0.9601536103662645,1.0,51/193,16.71%,PLK1;RLIM;FEM1C;FEM1A;FBXO21;PSMD9;UBQLN1;ANAPC10;CDC23;SQSTM1;RC3H2;UBE2A;RNF166;KEAP1;RNF34;BUB3;USP33;NEDD4;BFAR;RNF146;BIRC6;RCHY1;AREL1;CDC16;TRPC4AP;FBXO11;RNF11;ELOC;UBE2I;MYLIP;ASB2;RNF150;CBL;RNF144B;UBE3C;MIB1;RNF20;ANAPC16;NDFIP1;ATXN3;UBE2H;FBXL7;UBA6;TRIP12;FBXW4;ZNRF3;UBE2G1;TRIM25;UBR3;CNOT4;HACE1
prerank,positive regulation of GTPase activity (GO:0043547),0.3611547765806343,0.904345621316417,0.7008032128514057,0.9596781038354584,1.0,45/188,17.17%,CX3CL1;RAPGEF1;DOCK8;ITGA6;NDEL1;RAB3GAP1;RSU1;SIPA1L3;NF1;TBC1D15;RAP1A;GPR65;EVI5;TBC1D17;CCL25;ARHGAP22;TBC1D14;EZH2;LIMS1;TBC1D10B;RAP1GDS1;SIPA1L2;TBC1D4;TBC1D12;CDKL5;TBC1D5;TBC1D10A;TBC1D13;RABGAP1;ARHGAP45;DOCK9;DOCK11;TBC1D22A;TBC1D8;LARS1;PKP4;TSC1;TBC1D1;SNX13;MAP4K4;DOCK10;TBCK;SNX9;RALBP1;RAPGEF2
prerank,negative regulation of TOR signaling (GO:0032007),-0.2689740400159928,-0.9043018286319883,0.6346153846153846,0.9536416293397362,1.0,14/36,22.94%,UBR1;SESN1;FLCN;SESN3;PRKAA1;DEPTOR;TMEM127;UBR2;SIRT1;PRKAA2;CASTOR2;RNF152;MINAR1;SZT2
prerank,negative regulation of protein catabolic process (GO:0042177),0.39049495409854784,0.9042289891256073,0.6282782212086659,0.9594491958028551,1.0,6/40,9.16%,CDK5RAP3;FLNA;NELL1;SNX3;SNRNP70;PTPN3
prerank,eye development (GO:0001654),0.37950134352817855,0.9040570139508117,0.6407447973713034,0.9592888217409918,1.0,13/54,18.35%,RAB3GAP1;TGFB2;SIPA1L3;RAB18;ATF6;HIPK2;CACNA1C;SMG9;CEP290;HIPK1;PBX3;MEIS1;MEIS2
prerank,neurogenesis (GO:0022008),0.3881706179146134,0.9039792981724255,0.6197021764032073,0.9589776973919405,1.0,5/43,7.60%,VXN;TGFB2;CDK6;METTL3;MAPT
prerank,positive regulation of hydrolase activity (GO:0051345),0.3625377277386887,0.9038745154699578,0.6690283400809717,0.9586945900845036,1.0,28/137,17.17%,CX3CL1;RAPGEF1;DOCK8;ITGA6;NDEL1;RAB3GAP1;RSU1;NF1;RAP1A;WRN;EVI5;CCL25;MAPK8;EZH2;LIMS1;RAP1GDS1;CDKL5;DOCK9;DOCK11;CALM1;LARS1;PKP4;SNX13;MAP4K4;DOCK10;SNX9;RALBP1;RAPGEF2
prerank,regulation of chromosome organization (GO:0033044),0.4183032585807682,0.9031231597202551,0.6052631578947368,0.9597337369196514,1.0,3/22,7.60%,SMG6;TERF2;MAPT
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.3942622377411021,0.9029321649957137,0.6078886310904872,0.9596560595577489,1.0,9/37,15.10%,STMN2;MAPRE1;CAMSAP3;MAPT;TAOK1;CYLD;BICD1;MAP6;CLASP1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.37328683414595976,0.9025484436771434,0.6382513661202186,0.959935515511728,1.0,12/56,14.85%,CD36;IRAK4;TLR7;TLR3;LACC1;IRAK2;TAB3;CNPY3;HMGB1;MAPKAPK2;UNC93B1;TLR4
prerank,regulation of dendrite extension (GO:1903859),0.43870644048643875,0.9024754296976101,0.6072423398328691,0.9596043660523489,1.0,3/18,10.66%,CPNE5;PLAA;RNF157
prerank,positive regulation of T cell differentiation (GO:0045582),0.39940298214269027,0.9023241399445383,0.6025943396226415,0.959404047540387,1.0,3/36,8.29%,SART1;BCL6;DUSP10
prerank,positive regulation of protein binding (GO:0032092),0.3739230708779864,0.9020965364354953,0.6214750542299349,0.9593742608282012,1.0,12/56,14.13%,LRRK2;NMD3;AKTIP;SPPL3;USP33;EPB41;ADD1;DERL1;ABL1;TCF7L2;HIPK2;NVL
prerank,positive regulation of cytokinesis (GO:0032467),0.3965814988603207,0.9019071115078175,0.6033057851239669,0.9593020702624301,1.0,5/32,10.69%,SVIL;KIF20B;GIPC1;PKN2;CDC42
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.38767586442065916,0.9018105830700764,0.6384872080088988,0.9590092028241642,1.0,12/45,15.97%,GRB2;BRAF;AREG;REPS2;RPS6KA5;KIF16B;DGKD;CBL;TGFA;PIK3C2A;PIK3R1;IQGAP1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3785656106379098,0.9016473908469381,0.6291891891891892,0.9588535059806499,1.0,8/49,13.03%,URI1;NUPR1;BCL2L11;UBQLN1;NOC2L;CYLD;TP53;BCL2
prerank,positive regulation of chromatin organization (GO:1905269),0.46239176422095485,0.9014221808953179,0.5982008995502249,0.9588271168406133,1.0,4/12,13.42%,TERF2;TAL1;ATRX;TERF1
prerank,membrane lipid biosynthetic process (GO:0046467),0.37784989986302975,0.9011817352741519,0.6321467098166127,0.9588425927233493,1.0,16/58,17.64%,DEGS1;SGPP1;HACD1;CERS6;SGPP2;ACER3;CERS4;SGPL1;CERS5;PRKD2;HACD4;SPTLC1;VAPB;ST3GAL2;SGMS1;PLPP1
prerank,positive regulation of cell death (GO:0010942),0.3768333005791241,0.9011130314144089,0.6392199349945829,0.9584959724446226,1.0,9/59,13.79%,LRRK2;CD36;MAPT;FAF1;APC;BNIP3;PRNP;EIF2S1;FYN
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3673196187386882,0.9008779263588791,0.6502100840336135,0.9585085398139697,1.0,12/84,13.15%,PLK1;PSMD9;PSMB8;ANAPC10;CDC23;CDK2;PSMC5;BUB3;CDC16;PSMD12;PSMA2;ANAPC16
prerank,regulation of macrophage cytokine production (GO:0010935),-0.3695819600965,-0.9008101067608004,0.5973154362416108,0.9602432816861386,1.0,7/13,19.83%,PLCG2;LAPTM5;TGFB1;SIRT1;LILRB1;IRAK3;CD74
prerank,positive regulation of telomerase activity (GO:0051973),0.3981562765612457,0.9006452123409855,0.6424314660309892,0.9584625062725491,1.0,6/33,9.74%,TCP1;MAPK1;HSP90AA1;PKIB;NEK7;HMBOX1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.36449833107174373,0.9005813687126615,0.6767983789260384,0.9581109925321776,1.0,18/112,15.45%,ISL1;CX3CL1;GAS6;EPHB2;THBS1;ILRUN;PTPRJ;IL1A;SYT11;TLR3;MAVS;HMGB1;MAPKAPK2;SYK;LGALS9;HAVCR2;TLR4;CD47
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3830509333860512,0.9005140233015123,0.623608017817372,0.9577684813390351,1.0,5/48,11.00%,SELENON;CX3CL1;PRKACA;CAMK2D;DIAPH1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3609378938662563,0.9001971368300585,0.6836215666327569,0.9579380664869349,1.0,39/132,18.25%,LRRK2;MSN;IRS1;NRDC;ABCD2;IRS2;STK11;HSP90AA1;EZR;PTTG1IP;PTPN1;LIN28B;VPS35;DAPK1;FAF1;MTDH;TPCN1;FURIN;TRIM5;BNIP3;HMGB1;ATF6;VPS11;SH3GLB1;ABCD1;PIK3C2A;INSR;OPTN;ARNT;RDX;PFKFB3;SNX9;FOXO3;VGLL4;TFEB;PSEN1;RC3H1;ROCK1;ZBTB20
prerank,negative regulation of cell growth (GO:0030308),0.3613982130597188,0.9001604462207926,0.6792260692464358,0.957532934575469,1.0,23/121,15.95%,CGRRF1;SMARCA4;ADAM15;TGFB2;RERG;BCL6;EI24;SMAD3;DCBLD2;PTPRJ;STK11;DIP2B;ENO1;ULK2;TP53;ACVR1B;RBBP7;RTN4;SMAD4;SMARCA2;CRLF3;PPP1R9B;ST7L
prerank,regulation of osteoclast differentiation (GO:0045670),-0.2672857464187707,-0.8996354940205151,0.6073619631901841,0.960880831915568,1.0,9/33,24.68%,MAFB;GPR137B;CSF1;TRAF6;CAMK4;LILRB3;CEBPB;FBN1;TCTA
prerank,regulation of lymphocyte proliferation (GO:0050670),0.43009016669883904,0.8994483285904936,0.597684515195369,0.9584916978066986,1.0,2/16,11.42%,LST1;SOX11
prerank,negative regulation of establishment of protein localization (GO:1904950),0.48685395303535134,0.8994402792935633,0.6151515151515151,0.9580282799385705,1.0,4/10,13.42%,MAPT;SNX3;NDFIP1;TERF1
prerank,protein localization to cell-cell junction (GO:0150105),0.44185856365387544,0.8994022047476455,0.6028776978417266,0.957614568813336,1.0,2/15,8.02%,CGNL1;PAK2
prerank,positive regulation of dendrite extension (GO:1903861),0.43871312845523247,0.8992341676871557,0.6216968011126565,0.9574854348094877,1.0,3/17,10.66%,CPNE5;PLAA;RNF157
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.4326772404541548,0.8991850960271225,0.5935828877005348,0.9571114574910087,1.0,3/17,17.17%,ADCY9;AKAP13;RAPGEF2
prerank,glucan biosynthetic process (GO:0009250),0.45994763891154633,0.8991256279302625,0.620845921450151,0.9562810129699792,1.0,3/12,11.70%,NHLRC1;GBE1;UGP2
prerank,glycogen biosynthetic process (GO:0005978),0.45994763891154633,0.8991256279302625,0.620845921450151,0.9562810129699792,1.0,3/12,11.70%,NHLRC1;GBE1;UGP2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.43436134667610177,0.8982772894393675,0.6168741355463347,0.9575039597451093,1.0,4/19,11.59%,POLR3G;AR;CHD8;MTOR
prerank,regulation of neuron projection development (GO:0010975),0.3601428758811634,0.8974516342429981,0.7039274924471299,0.9586725453561502,1.0,32/163,14.93%,ROR2;LRRK2;CX3CL1;RAPGEF1;CFL1;ITGA6;NDEL1;CAMK1D;STMN2;RAP1A;EP300;SERPINI1;PAK2;SNX3;ARSB;TWF2;NPTN;LYN;SETX;CDK5;ARHGAP35;MYLIP;RIT2;CDKL5;RUFY3;CAMK2G;PTPRO;NDRG4;RELN;PTEN;PTPN9;SCARB2
prerank,RNA interference (GO:0016246),-0.3382540567749466,-0.8973119718505622,0.603112840466926,0.9644147330494302,1.0,6/17,16.96%,DHX9;AGO4;AGO3;AGO1;TSNAX;TSN
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.39730266780684964,0.8972021506296912,0.6211936662606578,0.9586996039133528,1.0,7/32,13.71%,TMEM109;DYRK2;EP300;STK11;HIPK2;TP53;DDX5
prerank,regulation of establishment of cell polarity (GO:2000114),0.4348098757915037,0.8971657213133809,0.603085553997195,0.9583079318295452,1.0,8/16,18.14%,KIF20B;ARFGEF1;RAP1B;CYRIB;RUFY3;ROCK2;GSN;ROCK1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.42307398782097194,0.8971138565079348,0.6062176165803109,0.957924734240245,1.0,3/22,9.94%,RFTN1;IL18;SLAMF6
prerank,mRNA modification (GO:0016556),0.41412461761777464,0.8970745905106081,0.6,0.957538379413625,1.0,5/22,12.81%,METTL8;METTL3;CBLL1;ZC3H13;WTAP
prerank,aortic valve morphogenesis (GO:0003180),0.40328658181530286,0.8966870449536105,0.6091015169194866,0.9578401226816561,1.0,2/30,4.22%,SMAD6;NFATC1
prerank,mitotic cytokinesis (GO:0000281),0.38008682294476814,0.8965512724911706,0.6209223847019123,0.9576151848660358,1.0,4/47,9.63%,PLK1;BBS4;SPTBN1;APC
prerank,purine-containing compound salvage (GO:0043101),0.45619319612521003,0.8963671818609231,0.5970149253731343,0.9575221260633633,1.0,2/12,7.65%,HPRT1;DGUOK
prerank,regulation of autophagy (GO:0010506),0.3569017456959749,0.8962962150835521,0.7417417417417418,0.957198243126118,1.0,45/216,14.45%,WDR6;LRRK2;FBXW7;NUPR1;SNX5;UBQLN1;PIP4K2A;EP300;PRKACA;STK11;KEAP1;USP33;NEDD4;ATP6V0E1;MAPT;MAPK8;TBC1D14;VPS35;DAPK1;TAB3;ATP6V1E1;PIP4K2B;MTDH;CDK5;TPCN1;TRIM5;BNIP3;EXOC4;MTOR;ABL1;HMGB1;ERN1;RB1CC1;SLC38A9;ATF6;DCAF12;SH3GLB1;ATP6V0D2;BCL2;PIK3C2A;ATP6V1H;HTRA2;ATP6V0A2;OPTN;TPCN2
prerank,positive regulation of dephosphorylation (GO:0035306),-0.2859312228150913,-0.8960917973736396,0.6153846153846154,0.965228061050065,1.0,11/27,20.99%,CALM2;TGFB1;CAMTA1;CNEP1R1;PPIA;SYMPK;PPP1R7;NSMF;MTMR9;PTBP1;SRC
prerank,"phototransduction, visible light (GO:0007603)",0.4517511521698728,0.8957342521566021,0.6378066378066378,0.9578548326916205,1.0,2/14,14.41%,GNAQ;GNB1
prerank,positive regulation of cell development (GO:0010720),0.3967249460168578,0.8952088739919695,0.6182472989195679,0.9584140669859653,1.0,5/31,14.18%,NUMBL;SPEN;RGS14;SOX11;RFX3
prerank,synaptonemal complex organization (GO:0070193),-0.349372643483111,-0.8949755912385658,0.6039215686274509,0.9636289297280329,1.0,10/15,57.87%,RAD21;BAG6;SYCP2;SYCE2;STAG3;P3H4;TRIP13;TEX11;REC8;HORMAD1
prerank,synaptonemal complex assembly (GO:0007130),-0.349372643483111,-0.8949755912385658,0.6039215686274509,0.9636289297280329,1.0,10/15,57.87%,RAD21;BAG6;SYCP2;SYCE2;STAG3;P3H4;TRIP13;TEX11;REC8;HORMAD1
prerank,regulation of defense response to virus (GO:0050688),-0.35647469681860455,-0.8947290692724384,0.5888501742160279,0.9620059693455708,1.0,6/14,16.38%,PCBP2;DHX9;ELMOD2;TRAF3;ZMPSTE24;TNFAIP3
prerank,manganese ion transport (GO:0006828),-0.34910435883062735,-0.8946015160239411,0.6197718631178707,0.9601333671031143,1.0,7/14,16.97%,SLC11A1;TRPC1;TMEM165;SLC39A14;SLC11A2;ATP2C1;TRPC4
prerank,protein stabilization (GO:0050821),0.35828430758000435,0.8945995157457016,0.7168674698795181,0.9591207607928969,1.0,35/168,15.92%,WFS1;CRTAP;FBXW7;DVL1;BAG3;FLOT2;TCP1;HCFC1;NAPG;USP19;FLNA;CDK7;EP300;COG3;HSP90AA1;USP33;WIZ;CHEK2;GNAQ;NAA16;HPS4;PRKRA;TRIM44;CAMLG;MFSD1;CCT3;NAA15;RTN4;CREB1;PTEN;TSC1;HIP1;STK3;PIK3R1;LAMP1
prerank,midbody abscission (GO:0061952),0.43563461238652235,0.8943441887334451,0.6013986013986014,0.9591549997806852,1.0,4/17,13.31%,VPS4A;CHMP5;VPS4B;PDCD6IP
prerank,gene expression (GO:0010467),0.35480414727167153,0.8942701873846843,0.798,0.9588331219853783,1.0,57/348,13.76%,POLR2D;ELAVL4;RPL18;EIF4A3;RPS6KB2;RPS23;MRPL37;RPL41;RPL31;SMG6;RPS17;SYNCRIP;DHX38;RPL4;SARNP;POLR2A;ATXN1;MRPS21;RNPS1;NUP205;RBM3;RPLP0;HARS1;U2AF1;RPS15A;RPL38;RBM5;DHPS;GOLPH3;HNRNPA2B1;MEF2A;THOC5;NUP98;PABPC4;SRSF5;AGO2;NUP54;SETX;APOBEC1;POLR3A;RNGTT;U2AF2;ADAR;XRN2;CPSF3;RBM6;SRSF9;RPL21;RPS6;SORL1;SRSF11;DHX8;HNRNPH3;EPC1;FUBP3;HNRNPH1;BICD1
prerank,vesicle transport along microtubule (GO:0047496),0.41431453432631804,0.8941641324244228,0.6041939711664482,0.9585678628023797,1.0,6/23,12.55%,NDEL1;KIF13A;BICDL1;FBXW11;KIF3A;FYCO1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.27023882046447323,-0.8940372955130711,0.6275862068965518,0.9591480996893452,1.0,6/35,7.19%,PDE4D;RIMS2;CAP1;AKAP6;KSR1;ADCY2
prerank,negative regulation of platelet activation (GO:0010544),-0.3456014371464823,-0.8939103802882327,0.5927272727272728,0.9572821498402005,1.0,4/16,11.08%,PRKG1;SERPINE2;CD9;PDGFA
prerank,positive regulation of type 2 immune response (GO:0002830),0.4507327837978393,0.8933629667650141,0.6136363636363636,0.9596861022823169,1.0,2/14,8.68%,PRKCZ;IL18
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.392054913907126,0.8930416589852439,0.6156501726121979,0.9598601098977021,1.0,7/35,13.83%,FLNA;NRP1;FARP2;SEMA6D;SEMA3D;SEMA6A;NRP2
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3868892269261576,0.8925453208973554,0.6386946386946387,0.9603687495497482,1.0,5/36,7.46%,UBXN1;MAP1A;SDCBP;GIPC1;UCHL5
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3857624139126744,0.89236497857524,0.6363636363636364,0.9602472471937419,1.0,4/46,6.70%,TIMM17A;TOMM40;DNAJC15;TIMM23
prerank,protein targeting to mitochondrion (GO:0006626),0.3813477761805526,0.8922057219342129,0.6502793296089385,0.9601108203101966,1.0,7/52,12.19%,TIMM17A;TOMM40;DNAJC15;TIMM23;HSP90AA1;IMMP2L;AIFM1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4011054823352658,0.8921259729320398,0.6421686746987951,0.959797598517475,1.0,6/29,14.70%,CETN2;CDK7;MNAT1;CUL4A;GTF2H1;RAD23B
prerank,negative regulation of chemotaxis (GO:0050922),0.40251598380227016,0.8920920890667473,0.6143552311435523,0.959400020212286,1.0,5/31,10.93%,DUSP3;THBS1;SEMA6D;SEMA3D;SEMA6A
prerank,adipose tissue development (GO:0060612),0.4626912454846071,0.8917591466315896,0.6246006389776357,0.9596147155892834,1.0,2/11,5.48%,ARID5B;LRP5
prerank,regulation of postsynapse organization (GO:0099175),0.3964020777535602,0.8915335215338877,0.6150061500615006,0.9595789615888991,1.0,6/28,12.22%,LRRK2;CFL1;ARHGAP22;VPS35;CDK5;CDKL5
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.35411871432121406,0.8911371958672003,0.798,0.9598343781535462,1.0,63/366,14.87%,ACTR5;RORA;ZNHIT3;ELAVL2;THAP7;RELA;DVL1;SP1;CTR9;CASZ1;SOX13;CLOCK;METAP1;HCFC1;POLR2A;MYCBP;ATXN1;RBM3;EP300;RBAK;ESR1;SPTY2D1;NR3C1;EHMT2;BRCA2;HP1BP3;ZBTB11;RPS6KA5;EZH2;JMJD1C;CHD7;CHEK2;PTP4A3;ASCC2;FUS;FADS1;TULP3;ATXN2;FOXN3;PSPC1;NR2C2;SOX11;ZBTB38;ABL1;ESCO1;GPBP1;SOX6;TP53;ATRX;TGFBR1;RNF20;NR1D2;ACVR1B;PPARGC1B;NFX1;INSR;USP37;RREB1;NSD2;RFX3;NCOA2;LDB1;TSC1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2723217423886635,-0.89093224899697,0.65,0.9624485297427897,1.0,11/31,18.47%,PSMD14;ZRANB1;OTUD4;OTUD5;BRCC3;ABRAXAS2;USP50;USP13;USP8;TNFAIP3;STAMBP
prerank,mismatch repair (GO:0006298),0.4044386083484766,0.8909287295027242,0.6333333333333333,0.9597890518621556,1.0,5/27,12.66%,RNASEH2A;POLD3;SETD2;ABL1;MLH3
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.35739320280564024,-0.8908489872109091,0.6372881355932203,0.9604767431271135,1.0,4/13,25.91%,JAK2;IL33;TLR2;SELENOS
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.41071367599264574,0.88989835588733,0.6173333333333333,0.9613059678927675,1.0,3/22,11.72%,FLOT2;CD44;MAP2K5
prerank,second-messenger-mediated signaling (GO:0019932),0.36349367806341776,0.8896452442922294,0.6694386694386695,0.9613353906844896,1.0,13/82,15.82%,LRRK2;CD36;BTK;INPP5A;TRPM4;RCAN2;DGKD;RCAN3;PPP1R9A;CAMKK2;TPCN2;P2RY12;PPP1R9B
prerank,regulation of rRNA processing (GO:2000232),0.4257063871909688,0.8892080881018584,0.6191135734072022,0.9617132646527206,1.0,3/16,11.91%,SIRT7;KAT2B;HEATR1
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3193602617096714,-0.8888579685297704,0.6153846153846154,0.963169951737169,1.0,14/20,33.20%,HNRNPU;MORC3;PML;SUN1;SUN2;SKP1;SYNE1;RANGAP1;TOPORS;TAF8;BCL3;ARL2BP;PARK7;ARL2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3709786155993604,0.8884898402401259,0.6395604395604395,0.9626087428715389,1.0,7/54,12.92%,RGCC;CNOT10;EP300;CHEK2;CNOT9;CNOT3;TP53
prerank,regulation of proteolysis (GO:0030162),0.37908526183839425,0.8884307652472002,0.6380846325167038,0.9622444577540804,1.0,9/48,15.59%,PLK1;CDK5;FBXW11;CYFIP2;DNAJC1;PARL;TBC1D10A;IST1;HDAC2
prerank,mitochondrial transcription (GO:0006390),0.47048663042520494,0.8881669131774393,0.6302652106084243,0.9622688783685349,1.0,1/10,3.24%,TFB2M
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.45318391141259357,0.8880874487083841,0.6417033773861968,0.9619584304810632,1.0,4/13,17.17%,SPRED2;SPRED1;DDX5;ATM
prerank,regulation of macroautophagy (GO:0016241),0.35954114692994327,0.8879249993450401,0.6894790602655771,0.9618116417281696,1.0,24/105,13.11%,LRRK2;SNX5;UBQLN1;QSOX1;PRKACA;EPM2A;NEDD4;ATP6V0E1;MAPK8;BNIP3L;VPS35;ATP6V1E1;CDK5;BNIP3;EXOC4;MTOR;LZTS1;ERN1;RB1CC1;SLC38A9;GNAI3;SH3GLB1;ATP6V0D2;ATP6V1H
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.35884953487055515,0.8878492239184378,0.6782077393075356,0.9614897721635868,1.0,21/124,14.68%,WNT4;ROR2;DVL1;PSMD9;NFATC1;PSMB8;TNRC6B;ARRB2;AP2A1;PSMC5;AGO2;CDC42;TCF7L2;PSMD12;PSMA2;GNG2;CALM1;GNB1;FZD9;FZD3;CLTC
prerank,artery development (GO:0060840),0.4112158732815735,0.8876975804462088,0.6085858585858586,0.9613224574786865,1.0,5/23,13.91%,NF1;NRP1;HECTD1;TGFBR1;PKD2
prerank,regulation of protein localization to centrosome (GO:1904779),0.4712506855312269,0.8876081404671413,0.6024653312788906,0.9610225238309433,1.0,3/10,13.76%,CEP250;APC;BICD1
prerank,retinal metabolic process (GO:0042574),-0.36422907926933323,-0.8875676833179441,0.6207951070336392,0.9641805261870404,1.0,4/12,35.27%,BCO2;RDH10;RDH11;RDH13
prerank,vasculogenesis (GO:0001570),0.3924864007372112,0.8875478057866999,0.6163742690058479,0.9606721811118838,1.0,5/32,13.57%,GLMN;ITGB8;TGFBR2;AGGF1;SPRED1
prerank,mitochondrial gene expression (GO:0140053),0.37975425267549734,0.8875416983822623,0.6539792387543253,0.9602193360781386,1.0,5/42,7.17%,NOA1;TFB2M;MRPS21;HARS1;MRPS28
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.41983738866400583,0.8872431479711134,0.6381578947368421,0.9603131749650197,1.0,4/22,8.15%,RAD50;PDGFB;MRE11;NBN
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.3139178773430168,-0.8871952560562616,0.5692307692307692,0.9628607449192192,1.0,11/19,60.37%,RIC3;CHRFAM7A;CHRNA7;SLC5A7;CHRNA4;ACHE;CHRNB2;COLQ;RAPSN;CHRNA5;NQO1
prerank,positive regulation of neuron differentiation (GO:0045666),-0.2606219041998147,-0.8867650533585083,0.6690647482014388,0.9617300527390918,1.0,4/40,1.49%,RHOA;ARHGEF2;BRINP1;NRCAM
prerank,regulation of receptor binding (GO:1900120),0.47517195915676175,0.8864841669759604,0.6259904912836767,0.9613246623766983,1.0,1/10,3.00%,ADAM15
prerank,establishment of endothelial barrier (GO:0061028),0.3936202706007468,0.8864247091823387,0.6203143893591294,0.9609753496274821,1.0,5/29,7.63%,RAPGEF1;MSN;RAP1A;EZR;RAP1B
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.40073909301323696,0.8863577176702195,0.6131840796019901,0.9606576153184829,1.0,4/27,5.54%,IRS1;PIK3R4;PDGFB;AMBRA1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3053514053245535,-0.8863160380527133,0.6172248803827751,0.9607242235077282,1.0,9/23,18.40%,JAK2;PARP14;PTPN2;IFNGR1;NLRC5;SUMO1;CDC37;IRGM;JAK1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4516642839615776,0.8853932511157728,0.6215429403202329,0.9620362055572711,1.0,2/13,11.20%,NRP1;TGFBR2
prerank,regulation of microtubule polymerization (GO:0031113),0.3759815634561041,0.8848797561251452,0.6283084004602992,0.9625222682774188,1.0,12/40,16.23%,GBA2;STMN2;MAPRE1;AKAP9;CAMSAP3;DCTN1;MAPT;ABL1;EML2;CLASP1;CLIP1;PAK1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.39017169684938524,0.8846949720777489,0.6460280373831776,0.9624146810379722,1.0,8/35,13.07%,TCP1;MAPK1;HNRNPA2B1;PKIB;TNKS2;NEK7;HMBOX1;CCT3
prerank,protein localization to cell junction (GO:1902414),0.40724733714392153,0.8845015173839582,0.6243523316062176,0.9623111572573894,1.0,4/22,13.87%,CGNL1;PAK2;KIF3A;HEG1
prerank,eye morphogenesis (GO:0048592),-0.3168550338454108,-0.8843224879761661,0.6567796610169492,0.9633728386914804,1.0,12/19,34.37%,AGTPBP1;NIPBL;FBN2;SHROOM2;IFT122;TENM3;STAT3;FBN1;VEGFA;COL5A2;RARG;EFEMP1
prerank,histone mRNA metabolic process (GO:0008334),-0.28434232172850543,-0.8842970288208948,0.6229508196721312,0.9613102362677903,1.0,15/27,25.34%,TENT2;TENT4B;SSB;MTPAP;EXOSC10;DCP2;ERI1;CPSF2;SNRPB;UPF1;NCBP1;SLBP;TUT1;LSM1;NCBP2
prerank,response to hexose (GO:0009746),0.40229313079319784,0.8839033663446902,0.6288265306122449,0.9630095797033537,1.0,4/25,12.47%,THBS1;IRS2;VAMP2;TCF7L2
prerank,regulation of stem cell differentiation (GO:2000736),0.3617739250727476,0.8837073782089652,0.6778947368421052,0.9629365223480697,1.0,18/89,16.33%,EIF2AK2;SETD1A;RUNX1;BMPR1A;PSMD9;PSMB8;PRKDC;METTL3;PSMC5;TAL1;TCF12;ABL1;PSMD12;PSMA2;LDB1;PSMB1;LMO2;OCIAD1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3583905289836433,0.8835869986919446,0.6891891891891891,0.9626930426612221,1.0,18/94,13.81%,BRCA1;BCL2L11;APAF1;PRKDC;STK11;CHEK2;BNIP3;TRAF2;CUL4A;ABL1;ERN1;AIFM1;MLLT11;HIPK2;TP53;BCL2;DDX5;HTRA2
prerank,response to UV-A (GO:0070141),0.4481205297965313,0.8833132918505514,0.6362339514978602,0.9627659224176195,1.0,1/14,2.94%,PPID
prerank,positive regulation of growth (GO:0045927),0.36862871766065264,0.8831627611663313,0.6612729234088457,0.9626037281604123,1.0,11/64,13.60%,WFS1;DDX49;TGFB2;RFTN1;SDCBP;ADNP2;CDC42;ADAM10;TGFBR1;BCL2;INSR
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.24036883145152613,-0.8825938780918221,0.6696428571428571,0.9633506440430568,1.0,11/47,29.57%,TIMP2;SERPINE2;SERPINA2;AKT1;SPOCK1;SPOCK2;TIMP3;RECK;GAPDH;SERPINB8;SERPINE1
prerank,B cell differentiation (GO:0030183),0.38109607409008517,0.8824564954390093,0.6465997770345596,0.9634690877871442,1.0,7/46,9.08%,TPD52;ZBTB7A;HDAC9;PTPRJ;HDAC5;ITGA4;FNIP1
prerank,cardiac muscle cell differentiation (GO:0055007),0.4180236107540151,0.8823623357327299,0.6277561608300908,0.9631656473725895,1.0,3/21,16.27%,ACVR1;AKAP13;MEF2C
prerank,negative regulation of cell adhesion (GO:0007162),0.36141927429677584,0.8822576782023288,0.6875,0.9629083479375169,1.0,13/72,13.55%,PLXNA1;CX3CL1;ITGB1BP1;EPHB2;CBLL1;PDE3B;LPXN;SEMA6A;MIA3;ADAM10;PLXNC1;ADAM22;PTPRO
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.4082822579579088,0.8818079798862796,0.6223337515683814,0.9632903965112202,1.0,5/22,14.79%,MAN1B1;UGGT2;EDEM2;UGGT1;MAN1A2
prerank,microtubule-based transport (GO:0099111),-0.3712179015834678,-0.8815652436900381,0.6006493506493507,0.9636647600935029,1.0,1/12,0.91%,DYNC1I1
prerank,vitamin transport (GO:0051180),0.3952717068653736,0.8815622406678559,0.628158844765343,0.9632913627714517,1.0,4/29,15.52%,SLC35F3;SLC25A32;SLC27A1;ABCG2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.46203509342892823,0.8813439645364401,0.6480891719745223,0.9632465463034044,1.0,3/10,17.29%,RUNX1;HMGB1;NCKAP1L
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4494880330896032,0.8807483461475741,0.6290322580645161,0.9639531184861088,1.0,3/13,12.01%,SP1;ITGA4;HMGB1
prerank,cellular response to interleukin-1 (GO:0071347),0.3520502428618712,0.8804770771426441,0.7181818181818181,0.9640191741209096,1.0,20/143,12.95%,ADAMTS12;RELA;CX3CL1;IRAK4;PELI1;PSMD9;PSMB8;SQSTM1;IL1A;PSMC5;IKBKB;CCL25;RPS6KA5;IL1RAP;IRAK2;TAB3;TANK;FBXW11;PSMD12;PSMA2
prerank,zymogen activation (GO:0031638),0.3760250800881956,0.880383232581489,0.6459770114942529,0.9637307465977408,1.0,9/39,18.86%,CD5L;FURIN;CYFIP2;TBC1D10A;GRIN2A;LGMN;KLK2;CTSH;ASPH
prerank,regulation of sodium ion transport (GO:0002028),0.38650299694834855,0.8799632064240063,0.6483644859813084,0.9640626553098657,1.0,6/34,10.04%,CNKSR3;NEDD4;DLG1;GPD1L;SLMAP;NKAIN1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.35591322029180467,0.8798894346950797,0.6913319238900634,0.9637268480957795,1.0,14/80,13.81%,UACA;DELE1;GAS6;IGBP1;THBS1;YWHAE;DAPK1;FNIP1;CD44;MAP2K5;HMGB1;RAF1;SYK;HTRA2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.42266128653710755,0.8798775386701466,0.6291834002677377,0.9632873017140393,1.0,4/18,12.01%,SP1;ITGA4;PPARG;HMGB1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3766473620846376,0.8796097199725944,0.627039627039627,0.9633402717090803,1.0,5/39,9.16%,CACNA1D;YWHAE;NEDD4;GPD1L;PTPN3
prerank,negative regulation of peptidase activity (GO:0010466),-0.23991725146238868,-0.8794887594067634,0.6868686868686869,0.9665327224941823,1.0,4/47,3.59%,CST3;TIMP2;SERPINE2;SERPINA2
prerank,negative regulation of protein depolymerization (GO:1901880),0.402126090864265,0.8791808021903156,0.6341463414634146,0.9637016441035069,1.0,7/24,15.10%,STMN2;ATXN7;CAMSAP3;APC;TAOK1;LIMA1;CLASP1
prerank,lymphocyte differentiation (GO:0030098),0.36798848807032525,0.8791513265358197,0.6854410201912858,0.963293622100119,1.0,9/68,8.95%,TPD52;ZBTB7A;HDAC9;PTPRJ;AXL;HDAC5;IKZF1;ITGA4;CHD7
prerank,bone development (GO:0060348),0.3793939610886845,0.879141345025956,0.6693181818181818,0.962852187257017,1.0,6/39,13.13%,SBDS;PLS3;LRP5;AKAP13;TP53;LRP6
prerank,mitotic DNA replication (GO:1902969),0.46803550880700157,0.8786820670424484,0.6285714285714286,0.9632715460181397,1.0,1/10,4.91%,POLA1
prerank,retina homeostasis (GO:0001895),0.409447843233715,0.878582697163707,0.631979695431472,0.9629842310969039,1.0,3/23,10.98%,BBS4;CCDC66;POC1B
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.3079457829112278,-0.878223113521586,0.6271186440677966,0.9673917027964282,1.0,4/19,8.56%,MCU;RAC1;RIPOR2;MOSPD2
prerank,glucose catabolic process to pyruvate (GO:0061718),0.4004364674190563,0.8780944046099303,0.6213093709884467,0.963016759514348,1.0,7/24,16.85%,PGAM1;ALDOA;ENO1;GCK;PFKP;FOXK1;HK2
prerank,canonical glycolysis (GO:0061621),0.4004364674190563,0.8780944046099303,0.6213093709884467,0.963016759514348,1.0,7/24,16.85%,PGAM1;ALDOA;ENO1;GCK;PFKP;FOXK1;HK2
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.4523878926968449,0.8780735368912277,0.6292466765140325,0.9625955742331134,1.0,1/12,1.99%,PFDN1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.25746906436443484,-0.8780522311789506,0.6846153846153846,0.9657448801521409,1.0,13/40,21.53%,PRKN;OPA1;BCL2L1;IGF1;GHITM;PYCARD;AKT1;HGF;PLAUR;FAM162A;BMF;BAX;BID
prerank,inorganic anion transport (GO:0015698),-0.23985949141967705,-0.8780193196521265,0.6582278481012658,0.9637220806037029,1.0,9/53,12.68%,ANO6;SLC11A1;ENPP1;PACC1;ANO10;TTYH3;CLCN4;GLRA1;CLCN6
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3518625394574318,0.8773958003413106,0.7459839357429718,0.9633789703329304,1.0,25/158,13.99%,UNC5CL;RELA;CX3CL1;IRAK4;TMED4;RNF31;PLEKHG5;PELI1;FLNA;PRKCB;BIRC3;IKBKB;TAB3;MAVS;MTDH;CANT1;TFG;WLS;TRIM5;AKAP13;TRAF2;PPM1A;NDFIP1;S100B;LGALS9
prerank,P-body assembly (GO:0033962),0.45036508200617326,0.8773361554653573,0.6352765321375187,0.9630195374811612,1.0,5/12,18.02%,EIF4ENIF1;ATXN2;LSM14A;PATL1;RC3H1
prerank,autophagosome organization (GO:1905037),0.37372208278688007,0.8772744123243942,0.6714922048997772,0.9626858263664706,1.0,12/50,15.16%,WDR45;UBQLN1;WDR45B;AMBRA1;ULK2;ATG3;PACS2;RB1CC1;TP53INP2;RAB7A;ATG7;BECN1
prerank,protein catabolic process (GO:0030163),0.3663555753460338,0.8770010357225533,0.6663090128755365,0.9627163407544757,1.0,7/59,9.06%,FBXO17;USE1;UCHL3;RAB12;HSP90AA1;CLPX;CHEK2
prerank,cellular response to osmotic stress (GO:0071470),-0.3036098762408988,-0.876989658744357,0.6157024793388429,0.9638388076204154,1.0,3/21,7.55%,ARHGEF2;SCN2A;CAPN3
prerank,negative regulation of potassium ion transport (GO:0043267),-0.3568163809330236,-0.8769403596851422,0.6163934426229508,0.9618508033923349,1.0,1/13,2.26%,PTK2B
prerank,anterograde trans-synaptic signaling (GO:0098916),0.34776668720775056,0.8769347562160571,0.7615230460921844,0.9623699283406816,1.0,32/224,14.58%,CAMKK1;PCDHB16;MINK1;GAD2;PRKAR2A;AKAP9;PRKACA;MAPK1;SDCBP;CEL;GIPC1;DLG1;PDE7B;APBA1;GRIA4;GLRB;CDK5;CACNA1A;RIT2;GABRG2;GRM7;EXOC4;GLRA3;SLC12A6;AMPH;LRP6;SPG11;CAMKK2;ATXN3;CALM1;GRIN2A;PLP1
prerank,cellular amino acid catabolic process (GO:0009063),0.3560991108933309,0.8766406926461423,0.6898340248962656,0.9624609951336452,1.0,6/87,6.67%,CBS;ALDH6A1;ACAT1;ECHS1;MCCC2;ALDH7A1
prerank,rRNA 3'-end processing (GO:0031125),0.46977315848506845,0.876597286537788,0.6362229102167183,0.9620843467680628,1.0,2/10,6.89%,EXOSC7;ERI3
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.2841343017546651,-0.8764809888095924,0.6284153005464481,0.9607378555416144,1.0,7/29,8.89%,PRKN;TJP1;SLIT2;PLEKHH2;PIK3CA;SSH1;CORO1A
prerank,regulation of T cell proliferation (GO:0042129),-0.2289285671699938,-0.8764523009558819,0.7466666666666667,0.958737471956112,1.0,12/61,20.12%,CD86;PTPRC;NCK2;CCDC88B;CD274;CD46;TNFSF8;LILRB1;SLC7A1;CD80;DLG5;CEBPB
prerank,potassium ion transmembrane transport (GO:0071805),0.35123467185251844,0.8764338501712217,0.7327935222672065,0.9619417601630492,1.0,20/135,17.25%,HCN3;TMEM175;KCNJ6;SLC9A9;SLC9A1;KCNH8;KCNH7;KCNK2;SLC9A7;SLC9A6;KCNK13;SLC12A6;KCNK10;PKD2;KCNQ5;HCN1;KCND2;KCNA1;KCNA5;KCNB2
prerank,mitochondrial membrane organization (GO:0007006),0.39504936211123504,0.8762766978502321,0.6545454545454545,0.9617749769855545,1.0,8/32,13.42%,MTX1;HSPA9;MICOS10;DNAJC11;BNIP3;APOOL;BCL2;CHCHD6
prerank,regulation of cellular biosynthetic process (GO:0031326),0.38891386867712263,0.8762144491562764,0.6378244746600742,0.9614342153841557,1.0,1/28,0.30%,EIF6
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.2671162886970482,-0.8761308879553256,0.7094594594594594,0.957452463071635,1.0,7/35,12.33%,PPP6R3;CALM2;PPP6R2;GSK3B;PPP1R2;PPP6R1;FKBP1A
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.3558111302873186,-0.8760113247305792,0.6366459627329193,0.9556627987560978,1.0,5/12,19.40%,CNOT1;ASXL1;CALR;SNW1;CTBP2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.34959625951133727,0.8758734344349869,0.7855711422845691,0.9616110794548623,1.0,43/248,14.50%,LRRK2;UBAC2;BICC1;NPHP4;DVL1;IGFBP2;SOX13;ZEB2;RBMS3;PSMD9;TLE2;GID8;USP34;PSMB8;LRRK1;STK11;PSMC5;TMEM170B;TLE1;HECW1;TRPM4;CSNK1G1;RNF146;TNKS2;DAB2;APC;GNAQ;WLS;CHD8;PPM1A;TCF7L2;PSMD12;UBR5;CYLD;PSMA2;LRP6;GPC3;PTPRU;PTPRO;MCC;CSNK1A1;TBL1XR1;FZD9
prerank,piRNA metabolic process (GO:0034587),-0.3203542046096841,-0.875629604801622,0.6285714285714286,0.9545294884205758,1.0,12/19,67.97%,TDRKH;TEX15;MYBL1;EXD1;DDX4;PIWIL2;TDRD12;GPAT2;TDRD9;MOV10L1;PIWIL4;PIWIL1
prerank,supramolecular fiber organization (GO:0097435),0.3488344533558931,0.8755593553282441,0.816,0.9617168259411831,1.0,42/333,12.97%,COL14A1;CGNL1;CRTAP;DDR2;CD36;ADAMTS2;WDR73;RHOF;ITGA6;STMN2;TGFB2;NF1;TMOD1;TMOD3;ALDOA;TPM1;ATP7A;MYO5A;NCKAP5L;TUBGCP6;CAMSAP3;DCTN1;COL11A1;DLG1;MAPT;TUBGCP2;MYO1G;ITM2B;SHROOM3;LOXL3;FURIN;CD2AP;CDC42;PXDN;VPS4B;SORL1;P4HA1;RUFY3;ADAM10;PPP1R9A;ERMN;TGFBR1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.4651386733834221,0.8752238041444477,0.6228748068006182,0.961877844288085,1.0,4/10,18.02%,PRNP;LGALS9;PRKAR1A;RC3H1
prerank,nuclear export (GO:0051168),0.35706642347642287,0.8751992684461615,0.6823899371069182,0.9614619448488044,1.0,14/80,12.67%,EIF4A3;PHAX;DESI1;DHX38;SARNP;ATXN1;RNPS1;U2AF1;THOC5;SRSF5;CSE1L;U2AF2;SRSF9;SRSF11
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.42428480489064335,0.8751940845534895,0.6268656716417911,0.9610187806546505,1.0,2/16,11.10%,STX7;CYRIB
prerank,regulation of urine volume (GO:0035809),-0.3931082098920412,-0.8751129528364975,0.6629213483146067,0.953661909298525,1.0,8/10,60.71%,INPP5K;ADCY6;NPR3;HAS2;NPR1;TFAP2B;HYAL2;ADM
prerank,regulation of gluconeogenesis (GO:0006111),0.39597459885865705,0.8747199641271993,0.6342364532019704,0.9614340574025849,1.0,2/27,5.03%,SIRT7;EP300
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.43710819371714643,0.8747005876623484,0.6257309941520468,0.9610184759555336,1.0,1/13,2.02%,DAND5
prerank,tRNA wobble uridine modification (GO:0002098),-0.3410593991560018,-0.8746859953262586,0.6227758007117438,0.9526140681989607,1.0,4/14,8.88%,ELP4;ALKBH8;MTO1;ELP1
prerank,cellular response to glucose starvation (GO:0042149),-0.26103238197944256,-0.8746460264326245,0.7079646017699115,0.950697702614209,1.0,20/41,25.94%,SESN1;CPEB4;EIF2AK3;SESN3;PIK3C3;PRKAA1;HNRNPA1;PRKAG1;MTMR3;PRKAA2;ATG14;NUAK2;SIK2;ZC3H12A;ATF4;NIM1K;SZT2;XBP1;PRKAG2;MYBBP1A
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3775982932767725,0.8746204844986353,0.6462264150943396,0.9607128018345198,1.0,12/36,17.02%,SYS1;KIF13A;GOLPH3;SPTBN1;VAMP2;GGA1;OPTN;RAB7A;MACF1;GGA3;GOLGA4;GCC2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.3744322745860559,-0.8745670731489859,0.6363636363636364,0.9488518727275411,1.0,6/11,13.71%,GIGYF1;GHR;EIF2AK3;GIGYF2;IGF1;AKT1
prerank,fatty acid elongation (GO:0030497),0.44123296015152624,0.874534738686819,0.6293604651162791,0.9604093549541655,1.0,4/13,14.15%,HACD1;TECR;ABCD1;HACD4
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.40816590024397875,0.8744477697986166,0.6516129032258065,0.9601018386963549,1.0,3/21,8.59%,LRRK2;BCL2L11;NCK1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.3814891237538788,-0.8744203134941996,0.6382978723404256,0.9471383591860573,1.0,6/10,19.95%,MTMR2;ABCA3;MTMR3;DNAJC19;MTMR4;MTMR9
prerank,cytoplasmic translation (GO:0002181),0.3535692393883797,0.8743563517519124,0.6920668058455115,0.9598299371944109,1.0,10/91,5.94%,RPL18;RPS23;RPL41;RPL31;RPS17;RPL4;RPLP0;ETF1;RPS15A;RPL38
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3828441541142637,0.8742185069172522,0.6332138590203107,0.959645350752532,1.0,7/34,13.72%,FLNA;NRP1;DOCK1;LIMS1;CDC42;ABL1;RREB1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.4433687988410318,0.8737788870822539,0.6274509803921569,0.959993672620496,1.0,3/11,12.96%,CABIN1;ASF1A;ATRX
prerank,positive regulation of DNA replication (GO:0045740),-0.3392491418265365,-0.8736937737499583,0.6106870229007634,0.9467556013191102,1.0,6/16,22.56%,DHX9;DNA2;STN1;BRPF3;ATAD5;EGFR
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.3870526911366125,0.8734681619383806,0.6420927467300832,0.9601585338037839,1.0,7/34,16.27%,LRRK2;RAB3GAP1;ARRB2;GABRG2;GRIN2A;GRID2;MEF2C
prerank,nuclear envelope organization (GO:0006998),0.4139592595364147,0.87288733571423,0.6526867627785059,0.9607806090055204,1.0,3/20,7.70%,VPS4A;CTDNEP1;LEMD2
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3624643017920032,0.8728460104034063,0.6730564430244942,0.9604086195154818,1.0,13/67,14.25%,DDR1;DDR2;EPHB2;PDGFB;BTK;ABI1;LYN;IGF1R;ABL1;SYK;INSR;FYN;RELN
prerank,amide transport (GO:0042886),-0.27763476038853274,-0.8727622431448362,0.6428571428571429,0.9468585839388813,1.0,7/26,17.07%,CERT1;DISP1;PLEKHA8;PLEKHA3;GLTP;PLTP;TAP2
prerank,mesenchymal to epithelial transition (GO:0060231),-0.3871511545709326,-0.8725553031381411,0.6256830601092896,0.945328269592586,1.0,3/10,30.40%,SALL1;PAX8;PAX2
prerank,centromere complex assembly (GO:0034508),-0.25882056012170584,-0.8723938844562161,0.697841726618705,0.9436810008290527,1.0,8/36,15.52%,SMARCA5;POGZ;RBBP4;HJURP;NASP;CENPV;CENPO;ITGB3BP
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4064404999960535,0.8721249487774541,0.6529032258064517,0.9612862021783675,1.0,2/24,3.19%,PID1;NDUFS1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.4519621015499636,0.8719772275331645,0.6349206349206349,0.9611072384752,1.0,2/12,7.47%,SIRT7;NEDD4
prerank,glucose homeostasis (GO:0042593),0.3592436487920247,0.8718941635515661,0.6951092611862643,0.9608064836471782,1.0,15/83,15.89%,WFS1;ADCY8;IRS1;STK11;ALOX5;PPARG;IGF1R;GCK;RPS6;TCF7L2;CYB5R4;INSR;ADIPOR1;PIK3R1;FOXK1
prerank,membrane assembly (GO:0071709),0.3900075977941352,0.871847637096306,0.6589057043073341,0.9604400021001059,1.0,6/34,10.14%,FLOT2;VPS4A;RFTN1;CEL;SPTBN1;ANXA2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.3832733345210041,-0.8716710301779174,0.6450704225352113,0.9433722448927003,1.0,3/10,6.20%,APP;SYNGR1;RAB5A
prerank,negative regulation of insulin secretion (GO:0046676),0.42324971509104914,0.8714089964714061,0.6407506702412868,0.9607765218872555,1.0,2/17,4.54%,PSMD9;IRS1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.400280463552554,0.8713026236528802,0.6408268733850129,0.9605288178693004,1.0,2/26,7.10%,RGCC;KMT2E
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.39277836885532963,0.8712875599268853,0.6384522370012092,0.9601042850221948,1.0,6/29,13.81%,THBS1;PAK2;TRAF2;CYLD;WWOX;HTRA2
prerank,sphingolipid metabolic process (GO:0006665),0.34927420218644034,0.8711003029930565,0.7134146341463414,0.9599951549851672,1.0,21/108,14.77%,DEGS1;GBA2;SGPP1;SMPD3;HACD1;SMPD1;CERS6;SGPP2;ACER3;TECR;PDXDC1;CERS4;GALC;ASAH1;SERINC1;B3GALNT1;SGPL1;CERS5;PRKD2;HACD4;SPTLC1
prerank,early endosome to late endosome transport (GO:0045022),0.41772127645911317,0.8709139578390007,0.6575520833333334,0.9598707454383095,1.0,8/20,16.86%,EEA1;AKTIP;KIF16B;PTPN23;RAB7A;BECN1;STX8;HOOK2
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.43864739942331193,0.8694294479392118,0.6396148555708391,0.9621771419887969,1.0,2/15,13.36%,HSPH1;SYK
prerank,tetrahydrofolate metabolic process (GO:0046653),0.45676227352280296,0.8693754536516889,0.6565977742448331,0.9618174652818695,1.0,2/10,6.57%,MTHFD2L;MTHFR
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.4474182514231612,0.8692832833203418,0.6226993865030674,0.9615262889909867,1.0,1/11,6.07%,ARRB2
prerank,macrophage activation involved in immune response (GO:0002281),-0.343070360221904,-0.8691438647031047,0.6403785488958991,0.9472450651992025,1.0,3/13,7.11%,PLCG2;GRN;TYROBP
prerank,peptidyl-lysine modification (GO:0018205),0.35431656698168457,0.8689368572080692,0.6937307297019527,0.961727652058745,1.0,17/99,12.45%,SIRT7;NNAT;NUP205;HDAC9;EP300;ATP7A;SUMO3;SUMO2;NUP98;TRPM4;NUP54;LOXL3;UBE2I;KAT2B;BCL11A;ESCO1;VIPAS39
prerank,proteolysis (GO:0006508),0.34684665692102873,0.8686688674534618,0.8026052104208417,0.9617753649336561,1.0,29/252,13.24%,TYSND1;ADAMTS12;VASH2;NLN;CPD;CTSC;DESI1;DESI2;FBXO3;CPE;FOLH1;SPPL3;DPP3;CLPX;LNPEP;LRP8;PROC;F3;CTSZ;FURIN;CAPN2;UBE3A;PARL;XPNPEP1;ERAP1;ADAM10;ATG4C;NAPSA;PCSK6
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3541712652487285,0.8685452450611885,0.7206645898234684,0.9615397425238488,1.0,22/98,17.22%,MIEF2;ITGB1BP1;EPHB2;YWHAE;SQSTM1;ZDHHC5;DLG1;MAPK8;STX3;SPTBN1;NMT1;PRNP;TP53;BCL2;FYN;PTPN9;PIK3R1;CD81;YWHAB;TFDP2;MFF;PRKCH
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.3748154335209801,-0.8684057400563119,0.6412698412698413,0.9469646231728509,1.0,5/11,22.42%,PPIP5K1;IP6K2;FGF2;IPPK;ITPKB
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.39750571337116614,0.8683362789307463,0.6662531017369727,0.9614567000757177,1.0,6/25,14.80%,EAF1;EAPP;NELFA;ZMYND11;RECQL5;LDB1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.41029182028727995,0.868297228761733,0.6431372549019608,0.9610758649768716,1.0,5/20,14.78%,SLC9A1;PRKACA;CAMK2D;CALM1;CACNA1C
prerank,smooth muscle contraction (GO:0006939),0.4289976371460268,0.8680882430431432,0.6505681818181818,0.9610290177633775,1.0,4/14,18.14%,PIK3C2A;ROCK2;TPCN2;ROCK1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.4230803151409523,0.8675447426563238,0.6297814207650273,0.9615716560792732,1.0,3/18,6.09%,ILRUN;CTNNA1;POLR1A
prerank,positive regulation of hormone secretion (GO:0046887),0.41628100224442,0.8672827510205904,0.6635761589403973,0.9615528355335533,1.0,2/17,11.42%,VAMP7;SOX11
prerank,membrane organization (GO:0061024),0.34481686475730905,0.8672571318787959,0.792,0.9611454225671595,1.0,59/227,17.09%,ACTR3;LDLRAP1;VAMP7;VPS4A;GRB2;CHMP5;NAPG;ITSN1;FNBP1;MTCH1;VAMP3;AREG;MYOF;RABEP1;STON2;FNBP1L;ARRB2;PACSIN2;AP2A1;CTDNEP1;ARPC1A;ARPC4;LEMD2;REPS2;SNX3;SPTBN1;DAB2;VAMP2;HGS;REPS1;ARPC2;CBL;VPS4B;OCRL;TGFA;SH3GLB1;AMPH;PIK3C2A;NAPA;PDCD6IP;SAR1B;EPS15;ARPC3;CLTC;WASL;SCARB2;HIP1;SYNJ2;SH3KBP1;SH3GL2;OSBPL2;VAPB;EPN2;ACTG1;DNM1L;HACE1;NUP93;SNX9;CHRM2
prerank,phasic smooth muscle contraction (GO:0014821),-0.38471369950374,-0.867004804368965,0.670926517571885,0.94813668953526,1.0,6/10,51.23%,TIFAB;HTR2B;EDNRB;DRD2;PTGER3;HTR1D
prerank,regulation of lipid storage (GO:0010883),0.40516338706627847,0.8666156040172021,0.6467532467532467,0.9618807424962074,1.0,2/22,5.34%,FBXW7;FTO
prerank,protein polymerization (GO:0051258),0.3636068380987937,0.8664711182818768,0.6821705426356589,0.9617075557811845,1.0,10/55,14.75%,ANG;ARL6;WASF1;GPX4;MAPT;DIAPH1;WASHC5;RNF135;AIF1;WASL
prerank,nucleosome disassembly (GO:0006337),0.43115425429027665,0.8663131126289825,0.6309859154929578,0.9610921050131216,1.0,2/14,8.22%,SMARCA4;SET
prerank,chromatin disassembly (GO:0031498),0.43115425429027665,0.8663131126289825,0.6309859154929578,0.9610921050131216,1.0,2/14,8.22%,SMARCA4;SET
prerank,melanocyte differentiation (GO:0030318),0.4561496783415193,0.8663009243011205,0.6790123456790124,0.9606605835452213,1.0,2/11,11.31%,SLC24A5;LRMDA
prerank,regulation of platelet aggregation (GO:0090330),-0.3302338460651385,-0.8662480690571995,0.651685393258427,0.947920434988867,1.0,4/17,5.58%,F11R;PRKG1;SERPINE2;CD9
prerank,regulation of protein dephosphorylation (GO:0035304),-0.26198663196172167,-0.8660780458949844,0.6902654867256637,0.9463226323394021,1.0,11/37,14.35%,PPP6R3;CALM2;TGFB1;CAMTA1;PPP6R2;PPP1R2;CNEP1R1;PPP6R1;PPIA;ARPP19;SYMPK
prerank,cellular protein metabolic process (GO:0044267),0.343381258009226,0.8657111088820659,0.849,0.9612709599674762,1.0,55/396,13.92%,WFS1;CP;RPL18;D2HGDH;IGFBP3;VWA1;RPS6KB2;ST8SIA4;RPS23;MRPL37;RPL41;RPL31;IGFBP2;SEPHS1;RPS17;GGCX;GAS6;RPL4;RAB12;CPE;SCG3;MRPS21;QSOX1;RPLP0;YES1;PRKDC;HARS1;RPS15A;RPL38;SPPL3;DHPS;PABPC4;AGO2;CHEK2;FBXO11;PROC;PARP4;FURIN;UBE2I;SDC2;MIA3;ATG3;LAMC1;ABL1;RPL21;RPS6;PARL;PRKCSH;ADAM10;DUSP12;NAPSA;GPC3;FN1;HTRA2;SPARCL1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.3968459572639949,0.8656923138405338,0.635,0.9608621500388013,1.0,4/23,8.72%,ACSBG1;HACD1;FAR1;TECR
prerank,organic substance transport (GO:0071702),0.345550987163543,0.8656804600532082,0.7245934959349594,0.9604384824883986,1.0,26/121,17.01%,SLCO1B1;HIKESHI;SLC35F3;SCAMP1;ABCD2;TAP1;ABCA7;ABCG1;VAMP2;ABCD3;MIA3;KIF3A;RAMP1;SCAMP5;ABCA1;ABCD1;FLVCR1;CALCRL;CHKA;SLCO2B1;RAB7A;ABCA5;ABCG2;ARL6IP5;CEP290;SCAMP2
prerank,regulation of stem cell proliferation (GO:0072091),0.4146258466310667,0.8653207890587084,0.6337662337662338,0.9606268575528608,1.0,3/17,12.05%,EIF2AK2;SOX11;ZFP36L1
prerank,TOR signaling (GO:0031929),0.39994083544312764,0.8650455651097213,0.6603295310519645,0.9606547230600031,1.0,6/26,13.93%,RPS6KB2;MAPKAP1;FNIP1;MTOR;RPS6;TIPRL
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.38237688170405065,0.8648319951163599,0.6596244131455399,0.9605812710490317,1.0,5/35,10.44%,SCAI;TGFB2;EPHB2;MAPKAP1;ARHGAP35
prerank,negative regulation of actin filament polymerization (GO:0030837),0.4076974617580422,0.8646974532752313,0.6503225806451612,0.960364338944891,1.0,5/22,11.73%,ARFGEF1;SSH2;TWF2;CYRIB;TMSB4X
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.37062315402310697,-0.8642276684353742,0.64,0.948473048114094,1.0,2/11,3.46%,BCL2L1;SIRT2
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.38086018637358726,0.864078596759308,0.6674727932285369,0.9610265527391653,1.0,6/32,13.10%,ITGB1BP1;THBS1;HDAC9;HDAC5;MAP2K5;PIK3C2A
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.45457695111380025,0.8639614030718544,0.6366279069767442,0.9607806474004004,1.0,2/11,10.11%,RC3H2;SOCS5
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.2933648142376404,-0.8638973970655616,0.6292682926829268,0.9472467145010176,1.0,6/23,10.41%,SLIT2;MCU;RAC1;RIPOR2;MOSPD2;JAM3
prerank,in utero embryonic development (GO:0001701),0.386853692892704,0.8636755298353426,0.6368221941992434,0.9608558430377998,1.0,5/25,12.97%,MBNL1;CHD7;ZNF568;ADAM10;TGFBR1
prerank,bone morphogenesis (GO:0060349),-0.3570805166772805,-0.8630272090003923,0.6597222222222222,0.9471097883858036,1.0,2/14,3.13%,BMPR2;FGFR2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.3280823647526474,-0.8628461538959986,0.6840148698884758,0.9455608579362738,1.0,4/16,3.61%,CDK13;DHX9;RSRC1;CELF4
prerank,actin filament bundle organization (GO:0061572),0.378228246126079,0.8627578860056241,0.6443914081145584,0.9620212386215944,1.0,7/33,16.91%,PLS3;EZR;ADD1;EPS8;LIMA1;AIF1;MYO1B
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.39086570719705305,0.8627507902139283,0.6424314660309892,0.961590267152429,1.0,5/28,16.24%,BAG3;DELE1;BCL2;CASP8AP2;DEDD
prerank,cellular response to amyloid-beta (GO:1904646),0.384251363779524,0.8623484000276097,0.6805225653206651,0.9618901336447675,1.0,14/35,18.37%,CD36;ITGA4;CDK5;CACNA1A;IGF1R;PRNP;FYN;GRIN2A;TLR4;LGMN;ABCC1;TREM2;PSEN1;SNX6
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.3484352128454745,0.8616248164054497,0.6996871741397289,0.962706618931857,1.0,14/80,13.23%,USE1;ERGIC1;ARF3;COPB2;COG3;TMED9;KDELR2;GOLPH3;KIF11;RAB6A;KIF3A;TMED2;UVRAG;NAPA
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3490302014334082,0.8612077407197898,0.7329896907216494,0.9629895886905928,1.0,19/105,13.79%,NRAS;RELA;PSMD9;PSMB8;EP300;PRKACA;PSMC5;IKBKB;PAK2;RPS6KA5;KRAS;TAB3;LYN;FBXW11;RAF1;PSMD12;PSMA2;SYK;FYN
prerank,regulation of protein autophosphorylation (GO:0031952),0.3800441122502719,0.8609332944608429,0.6697892271662763,0.963024264129659,1.0,9/36,15.90%,RAD50;IMPACT;PDGFB;MRE11;NBN;MVP;PPP2R5C;CALM1;PDGFC
prerank,protein maturation (GO:0051604),0.35308629782895606,0.860931429346409,0.7229800629590766,0.962581524928598,1.0,14/95,13.24%,TYSND1;CPD;NNAT;NAA35;CPE;NFU1;GLRX3;F3;FURIN;NAA16;SORL1;ADAM10;NAA15;PCSK6
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.373966618514316,-0.8609291379680797,0.680672268907563,0.9480230240019478,1.0,5/11,21.42%,CORO1C;ENPP2;ARHGEF7;SRC;KANK1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.32273446007333156,-0.8607409903104845,0.6555555555555556,0.9464861114314036,1.0,3/17,5.43%,TGFB1;SERPINE2;PTPRZ1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.35507491947103254,0.8607067459905031,0.7107180020811654,0.9625354903626749,1.0,20/85,16.60%,RAPGEF1;GRB2;TGFB2;EPHB2;SQSTM1;IRS2;EPS8L1;MAPKAP1;LYN;EPS8;AKAP13;NOTCH2;RAF1;MYO9B;SHOC2;ARHGDIB;VAV1;RALGPS1;RDX;ARHGAP17
prerank,response to UV (GO:0009411),0.34546889346386506,0.8607040165326493,0.6983471074380165,0.9620971685872431,1.0,18/95,15.57%,PCLAF;RELA;SMPD1;WRN;EP300;UBE2A;METTL3;USP1;NEDD4;MAPK8;ERCC4;NOC2L;TP53;EIF2S1;UVSSA;NPM1;SDF4;RHBDD1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.4240463865100619,0.8606452843845911,0.6516220028208745,0.9617641401613194,1.0,2/14,7.51%,GAS6;PYDC1
prerank,cellular response to lectin (GO:1990858),0.3490388887165166,0.8605045593576179,0.737874097007224,0.9611089193342746,1.0,19/104,13.79%,NRAS;RELA;PSMD9;PSMB8;EP300;PRKACA;PSMC5;IKBKB;PAK2;RPS6KA5;KRAS;TAB3;LYN;FBXW11;RAF1;PSMD12;PSMA2;SYK;FYN
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3490388887165166,0.8605045593576179,0.737874097007224,0.9611089193342746,1.0,19/104,13.79%,NRAS;RELA;PSMD9;PSMB8;EP300;PRKACA;PSMC5;IKBKB;PAK2;RPS6KA5;KRAS;TAB3;LYN;FBXW11;RAF1;PSMD12;PSMA2;SYK;FYN
prerank,"phagocytosis, engulfment (GO:0006911)",0.37633283072478146,0.8604502342534383,0.6536180308422301,0.9607692598345862,1.0,10/36,17.40%,CD36;VAMP7;THBS1;DOCK1;CDC42;ELMO1;AIF1;XKR4;GSN;FCGR1A
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.274091663571677,-0.8604107592140084,0.6822916666666666,0.9453121082254974,1.0,15/25,32.51%,SLIT2;ABI3;ARHGAP24;LIMK2;CEP97;EVI5L;TBC1D30;CDK10;KANK1;STAP1;RAP1GAP;TCHP;PFN2;PRKCD;TESK1
prerank,vascular transport (GO:0010232),0.3457502728040173,0.8602666400999501,0.7041237113402062,0.9606496774068575,1.0,11/81,15.52%,SLC4A3;SLC2A3;SLC7A2;SLC38A2;ABCC5;SLC7A8;SLC27A1;INSR;SLCO2B1;SLC44A1;ABCG2
prerank,positive regulation of protein metabolic process (GO:0051247),0.34733678758183517,0.8602439763224217,0.7420998980632009,0.9602440790537198,1.0,18/110,15.14%,ISL1;WFS1;EGLN2;NEDD4;MAPK8;RANBP9;HECW1;IL18;AREL1;APC;PAEP;MAP2K5;SORL1;GPC3;ROCK2;RAB7A;LDB1;ATG7
prerank,positive regulation of neuron death (GO:1901216),0.36295903421526293,0.8599766343735445,0.661588683351469,0.9603024766251386,1.0,10/46,14.85%,NUPR1;TGFB2;NF1;MAPT;CDK5;PRNP;SRPK2;EIF2S1;FYN;TLR4
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.23095524236462128,-0.8599718482200881,0.7272727272727273,0.9443414527652195,1.0,19/54,22.65%,HEXA;GUSB;GCNT2;HS6ST1;NDST1;XYLT1;HS3ST5;HPSE;HGSNAT;SDC3;NDST2;NAGLU;IDS;HS3ST1;B3GAT3;SLC35D2;CHST9;IDUA;GPC5
prerank,neural crest cell development (GO:0014032),0.3671303132549646,0.8599552945508709,0.6603351955307263,0.9598856387644231,1.0,6/44,11.42%,TAPT1;PEF1;SEMA6D;SEMA3D;SEMA6A;SOX11
prerank,dicarboxylic acid metabolic process (GO:0043648),0.36185472957172143,0.8596734434995563,0.6736493936052922,0.9599507378580651,1.0,7/52,12.20%,D2HGDH;ALDH1L1;MTHFD2L;MTHFR;SDHA;IDH2;SLC25A32
prerank,axonemal dynein complex assembly (GO:0070286),0.38615330972225825,0.8593454013238897,0.6658385093167701,0.960045889572038,1.0,2/27,10.04%,SPAG1;DNAI4
prerank,histone monoubiquitination (GO:0010390),-0.2913190638568828,-0.8593057602770559,0.6813725490196079,0.9439542047967143,1.0,12/24,27.00%,WAC;BCOR;DDB1;RNF168;DDB2;CUL4B;DTX3L;SKP1;CDC73;ATXN7L3;RNF40;PAF1
prerank,regulation of fat cell differentiation (GO:0045598),0.35151515631105484,0.8591965596276891,0.7014925373134329,0.9598705354111571,1.0,12/74,14.36%,RORA;SMAD3;FTO;LRP5;CMKLR1;ALOX5;TRPM4;CDS1;PPARG;ZFP36L1;CREB1;PPARD
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.3516783109844861,0.8589581319902113,0.6869747899159664,0.9598405961888881,1.0,18/72,16.83%,RNF31;RUNX1;GAS6;LIFR;AXL;BIRC3;IKBKB;PTPN1;IRAK2;TRAF2;IFNAR2;TRIM44;CYLD;SYK;PIAS1;CFLAR;ABCE1;HIPK1
prerank,protein ADP-ribosylation (GO:0006471),0.38120530627969634,0.8588378920461068,0.654320987654321,0.9596015968225048,1.0,5/28,10.02%,PARP9;PARP8;PARP2;TNKS2;PARP4
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.3546494286289825,0.8585997203839738,0.6832971800433839,0.9595624159016123,1.0,10/59,10.87%,RELA;RNF31;TLR7;BIRC3;IKBKB;TLR3;IRAK2;TAB3;TANK;TRAF2
prerank,synaptic vesicle transport (GO:0048489),-0.37399441901493785,-0.8583924952052894,0.6366366366366366,0.9440572561785069,1.0,8/11,31.59%,DNM2;KIF5C;RAB27A;KIF5A;SYNJ1;TMEM230;TOR1A;SNAPIN
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.3979347689571704,0.8577279442095666,0.6654366543665436,0.9606761864415958,1.0,4/24,10.93%,NRP1;SEMA6D;SEMA3D;SEMA6A
prerank,acylglycerol catabolic process (GO:0046464),0.38128224060490623,0.8567446371631358,0.6423267326732673,0.9619503428600337,1.0,3/30,10.19%,LIPE;ABHD6;ABHD16A
prerank,organophosphate catabolic process (GO:0046434),-0.364289004236745,-0.85661049312099,0.6781609195402298,0.9460698274963488,1.0,1/11,2.45%,ENPP2
prerank,negative regulation of RNA metabolic process (GO:0051253),0.40175499329891007,0.856574715236611,0.6554054054054054,0.9618027371868915,1.0,5/18,11.85%,ESR1;PTBP3;NCOR1;KAT2B;NCOR2
prerank,negative regulation of lipid metabolic process (GO:0045833),0.40408092100174553,0.8563707190915996,0.6427640156453716,0.9617166774118351,1.0,5/22,18.29%,PDE3B;NCOR1;ASXL3;APOD;ALK
prerank,embryonic organ morphogenesis (GO:0048562),-0.24864726929505523,-0.8555769676176449,0.7480314960629921,0.9463167804078484,1.0,4/42,3.58%,RYR2;DSCAML1;FGFR2;NIPBL
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.37352650362731643,-0.8554681574312548,0.6428571428571429,0.9446512700798615,1.0,4/10,21.67%,EIF2AK3;HERPUD1;DDIT3;ATF4
prerank,positive regulation of binding (GO:0051099),0.34756633676909016,0.8554594711124448,0.709508881922675,0.9628246047421251,1.0,15/84,14.13%,LRRK2;PARP9;NMD3;AKTIP;SPPL3;USP33;EPB41;ADD1;PPARG;HMBOX1;DERL1;HMGB1;TCF7L2;HIPK2;NVL
prerank,regulation of cilium movement (GO:0003352),-0.3845719307054984,-0.8554387282803185,0.6811989100817438,0.9428111797012861,1.0,10/10,61.57%,CCDC39;CFAP43;DNAH11;CFAP298;ODAD2;CCDC40;CFAP206;DRC1;DNAAF1;CCDC65
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.4390270535896629,0.8553572744715428,0.6591928251121076,0.9625658018399122,1.0,2/12,5.17%,TPM1;PDGFB
prerank,camera-type eye morphogenesis (GO:0048593),0.4516019153663044,0.8551866966429709,0.6650943396226415,0.9624223979284134,1.0,2/10,13.13%,NF1;LRP6
prerank,negative regulation of phagocytosis (GO:0050765),-0.3128356371243485,-0.8550368310432581,0.6728624535315985,0.9417263552843919,1.0,6/17,13.44%,APPL1;FCGR2B;PIP4P2;CD300LF;SIRPA;RACK1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.4447303866464193,0.8549583450917153,0.6610942249240122,0.9623661590490438,1.0,1/10,1.70%,RIOK3
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3056283602407798,-0.8549433298182794,0.6666666666666666,0.938142687434778,1.0,9/21,19.45%,PARP1;DDB1;ERCC5;XPA;RBX1;RPA1;DDB2;CUL4B;CHD1L
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3056283602407798,-0.8549433298182794,0.6666666666666666,0.938142687434778,1.0,9/21,19.45%,PARP1;DDB1;ERCC5;XPA;RBX1;RPA1;DDB2;CUL4B;CHD1L
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3792622555280638,0.8540269622844722,0.6550435865504358,0.9635456577851037,1.0,5/28,7.80%,MAPRE1;AKAP9;DCTN1;MAPT;MECP2
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.4544337518309415,0.8540196934306502,0.656298600311042,0.9631149606706452,1.0,2/10,10.64%,IMPACT;MVP
prerank,embryonic digit morphogenesis (GO:0042733),-0.30587884084646205,-0.854003343575066,0.6470588235294118,0.9383016374224086,1.0,7/18,27.69%,WDPCP;SALL1;HDAC1;CREBBP;ECE1;INTU;GLI3
prerank,muscle tissue morphogenesis (GO:0060415),-0.3198193930617801,-0.8538201382807217,0.6688963210702341,0.936783949097405,1.0,2/16,15.56%,TGFBR3;NOTCH1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.34609364259207054,0.8536546333880906,0.7141350210970464,0.9633234303027279,1.0,9/87,5.94%,RPL18;RPS23;RPL41;RPL31;RPS17;RPL4;RPLP0;RPS15A;RPL38
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3666163754732237,0.8536239125748423,0.6860730593607306,0.9629371329715094,1.0,4/44,7.78%,INSIG1;OSBP;INSIG2;PSAT1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.29144848067140505,-0.8535714144479355,0.6891891891891891,0.9354551347208991,1.0,3/22,5.53%,IL10RA;ERBB4;GHR
prerank,negative regulation of secretion (GO:0051048),0.4569385624839457,0.8535660928200413,0.6511278195488722,0.962607211172237,1.0,1/10,4.13%,VAMP3
prerank,phospholipid biosynthetic process (GO:0008654),0.3739891761356177,0.8535352306829811,0.6882966396292005,0.9622192607738226,1.0,8/36,13.50%,FAR1;CRLS1;HDHD5;GPAM;FADS1;AGPAT4;AGPAT5;NUS1
prerank,regulation of regulated secretory pathway (GO:1903305),0.3773479183861111,0.8533405824046797,0.666270783847981,0.9621329766418537,1.0,5/34,9.40%,LRRK2;UNC13D;SYT12;SYT11;DTNBP1
prerank,embryonic organ development (GO:0048568),0.3557743273084658,0.8533327491553491,0.6967741935483871,0.961708765889604,1.0,12/61,17.49%,TGFB2;BMPR1A;KITLG;TEAD1;TAL1;TGFBR2;SH2B3;NDRG4;RBPJ;TBC1D23;PCSK5;PBX3
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3589405075362288,0.8531425879804305,0.695364238410596,0.9615929692695978,1.0,7/52,8.18%,EPHB2;SQSTM1;ZDHHC5;DLG1;EPB41;STX3;SPTBN1
prerank,positive regulation of endocytosis (GO:0045807),0.37020340471437174,0.8530898682926622,0.6792237442922374,0.9612453152651466,1.0,12/45,15.62%,LDLRAP1;SMPD1;AXL;CBLL1;DAB2;CDC42;CBL;ANKFY1;GPC3;BICD1;HIP1;HNRNPK
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.31983250541379327,-0.8530752654132795,0.6678966789667896,0.934662520499614,1.0,3/18,1.30%,NAV3;PTPRC;LAPTM5
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.3871953242467257,0.8529864403195562,0.6653944020356234,0.9609845754654922,1.0,7/25,16.85%,PGAM1;ALDOA;ENO1;GCK;PFKP;FOXK1;HK2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.3918657569455489,0.8528729590464309,0.676923076923077,0.9607380341837914,1.0,3/21,9.84%,CHSY1;UGDH;BGN
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.3836282187684808,0.8527571646596476,0.6833740831295844,0.960500090189408,1.0,7/27,15.70%,CGNL1;PPFIA1;PAK2;WASF2;TMEFF2;CLASP1;PIK3R1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.4198644944720796,0.8525214039187602,0.6685159500693482,0.9604436898286178,1.0,3/16,15.92%,RAET1E;SLAMF6;LAMP1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.38243949756937445,0.8522863295423022,0.6801909307875895,0.960421266045553,1.0,4/30,14.23%,ARHGEF3;GPR65;AKAP13;LPAR6
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.45126005103987715,0.852034855053155,0.6779661016949152,0.9604179079042443,1.0,2/10,10.96%,RC3H2;NFKBIZ
prerank,response to gamma radiation (GO:0010332),0.39385978595382276,0.8517560636171156,0.6726342710997443,0.9604461256972612,1.0,3/24,5.83%,TMEM109;WRN;MAP3K20
prerank,ganglioside biosynthetic process (GO:0001574),0.4159275897136784,0.8516739224163412,0.6544943820224719,0.9601452736948879,1.0,4/15,17.11%,ST8SIA4;B4GALT5;ST3GAL5;ST3GAL2
prerank,protein K63-linked ubiquitination (GO:0070534),0.3690341842508922,0.8515750824640979,0.6951080773606371,0.9598762391508425,1.0,14/41,17.85%,PELI1;UBE2V2;RNF115;NEDD4;BFAR;TRIM5;TRAF2;HECTD1;TRIM56;RNF135;UBE2G1;UBE2E3;UBE2B;TRAF5
prerank,visual system development (GO:0150063),0.3709682909955038,0.8515727639250258,0.6759259259259259,0.9594456263465737,1.0,10/37,18.35%,TGFB2;SIPA1L3;RAB18;ATF6;HIPK2;SMG9;HIPK1;PBX3;MEIS1;MEIS2
prerank,fatty acid metabolic process (GO:0006631),0.3398206967768517,0.8512449351732381,0.7479591836734694,0.9595989060001118,1.0,16/115,14.36%,CPT1C;CD36;ACSBG1;HPGD;GPX4;ABCD2;CEL;GPAM;ALOX5;CROT;PPARG;ABCD3;SGPL1;ADIPOR1;ACACA;PPARD
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.3119015432433123,-0.8506828206775043,0.6386861313868614,0.9378714288116207,1.0,7/18,20.06%,NXF1;POLDIP3;ENY2;MCM3AP;DDX19B;NUP133;DDX19A
prerank,apoptotic process (GO:0006915),0.33923238425728014,0.8506756113240947,0.7941767068273092,0.9601407169233849,1.0,32/203,13.79%,MRPS30;IRF1;TRPC5;ADAM15;NDUFS1;TNFRSF25;BCL2L11;IRF3;APAF1;EP300;AKAP1;PRUNE2;TRAF7;DPF2;EGLN3;IL1A;STK11;DAPK1;CDK5;BNIP3;SEMA6A;PAEP;NOTCH2;TGFBR2;MTOR;CYFIP2;MAGI3;RAF1;AIFM1;BCL2;RTN4;ELMO1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3837905808686267,0.8504492566949078,0.6740467404674046,0.9600921182787076,1.0,4/29,5.54%,IRS1;PIK3R4;PDGFB;AMBRA1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.4154017737040011,0.8502861090070358,0.663923182441701,0.9599533109615251,1.0,3/17,15.92%,RAET1E;SLAMF6;LAMP1
prerank,regulation of chemokine production (GO:0032642),0.3764309343302614,0.8502194229785329,0.6794871794871795,0.9596263410785864,1.0,7/36,14.85%,EIF2AK2;TLR7;TLR3;IL18;LGALS9;AIF1;TLR4
prerank,proteoglycan biosynthetic process (GO:0030166),0.3795302179918235,0.850182779160498,0.6753864447086801,0.9592557377687368,1.0,6/31,11.86%,NDST3;UGDH;GLCE;EXTL3;CANT1;CHST8
prerank,positive regulation of catalytic activity (GO:0043085),0.3711140385665048,0.8494120380545139,0.6842723004694836,0.960124182310871,1.0,7/37,12.55%,SSBP1;XRCC4;WRN;ATP7A;MAPK8;ABL1;MAPK14
prerank,melanosome organization (GO:0032438),0.38859824535038334,0.8493387442948686,0.6707021791767555,0.9598294565948748,1.0,4/26,10.76%,AP1M1;KIF13A;DTNBP1;HPS4
prerank,mitotic recombination (GO:0006312),0.4214463278243243,0.8493323791500561,0.6555555555555556,0.9594043112871748,1.0,2/15,7.92%,RAD50;SMC5
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.4006508939358119,0.8492120571884217,0.652,0.9591720288833199,1.0,4/17,14.85%,IL18;MYO1G;BACH2;TLR4
prerank,sensory perception of sound (GO:0007605),0.3445397486923397,0.8488414279225196,0.7066115702479339,0.9593238170507579,1.0,8/88,12.48%,WFS1;HOMER2;CACNA1D;ALDH7A1;COL11A1;GRM7;WDR1;EML2
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.3943758241915111,0.8486712330051478,0.6658354114713217,0.9591701783972993,1.0,5/24,13.60%,DYRK2;IRS1;IRS2;GCK;INSR
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.3638981240117328,0.8482305941705232,0.6935300794551645,0.9595011417784511,1.0,6/45,10.54%,MID1;IRF1;IRF3;CAMK2D;CD44;TRIM5
prerank,transferrin transport (GO:0033572),0.3732851665375534,0.8481172543031551,0.6715328467153284,0.9592480404402633,1.0,9/33,14.68%,STEAP3;ATP6V0E1;ARHGAP1;ATP6V1E1;MCOLN1;ATP6V0D2;ATP6V1H;ATP6V0A2;CLTC
prerank,positive regulation of cell growth (GO:0030307),0.3458542552166756,0.8480974404951852,0.739938080495356,0.9588464132189903,1.0,17/96,13.03%,CPNE5;ZFYVE27;DDX49;TGFB2;SDCBP;MAPT;TWF2;ADNP2;PLAA;RNF157;CDC42;DBNL;CDKL5;RUFY3;ADAM10;TGFBR1;BCL2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.340800458105013,0.8480713718544837,0.736896197327852,0.958452973622436,1.0,16/104,14.29%,BLM;CDK5RAP3;TSG101;CDK7;LRP5;MNAT1;EZH2;HGS;CCNI;ABL1;UVRAG;SLC27A1;LRP6;MAP2K2;GTF2H1;CALM1
prerank,protein localization to centrosome (GO:0071539),0.40981337527279493,0.8475160145465839,0.6802168021680217,0.9589787563711025,1.0,6/17,17.19%,BBS4;SNX10;DCTN2;C2CD3;CEP83;PIBF1
prerank,somite development (GO:0061053),0.4404691123463242,0.8474654986261231,0.6788856304985337,0.9586417213474572,1.0,3/11,13.78%,LOXL3;SOX11;PPP2R3A
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.35464579058486495,-0.8473372300058731,0.7035928143712575,0.943213607602788,1.0,9/11,46.98%,TOMM70;AGK;TIMM22;TIMM10B;NDUFA13;TIMM13;TIMM8B;ROMO1;TIMM29
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3603443055282963,0.8472699894089695,0.6919592298980748,0.9585238116364501,1.0,9/47,13.72%,ITGB1BP1;FLNA;NRP1;DOCK1;LIMS1;ACTN4;CDC42;ABL1;RREB1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.3079565095725318,-0.8472696732056008,0.610236220472441,0.9414854204093362,1.0,4/17,8.56%,MCU;RAC1;RIPOR2;MOSPD2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.34068918155513694,0.8470707794364204,0.7489711934156379,0.9584413897521853,1.0,16/96,12.67%,EIF4A3;SMG6;DHX38;SARNP;RNPS1;NUP205;U2AF1;HNRNPA2B1;THOC5;NUP98;SRSF5;NUP54;U2AF2;CPSF3;SRSF9;SRSF11
prerank,cellular response to dsRNA (GO:0071359),0.41759455767457976,0.8469134586346341,0.6585014409221902,0.9582566188526802,1.0,3/15,10.41%,RIOK3;MAVS;COLEC12
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.37597668750425434,0.8464447028255254,0.6574850299401198,0.9585990495280757,1.0,4/31,11.42%,GLMN;LST1;LYN;SOX11
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3759497835259226,0.8463312981860419,0.7021276595744681,0.958379957520642,1.0,7/36,14.75%,NOSTRIN;TERF2;IL1A;HSP90AA1;NUS1;CALM1;WASL
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.36169734281715193,0.8461184719878548,0.6818181818181818,0.9583087565414065,1.0,9/46,13.00%,GPD1L;GPAM;PLA2G4A;LCLAT1;DGKD;AGPAT4;PLD1;SLC27A1;AGPAT5
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.4044837739738172,0.8458166566820449,0.6604774535809018,0.9584141311901286,1.0,4/19,14.48%,SLC35D1;UGDH;UGP2;UAP1
prerank,positive regulation of DNA repair (GO:0045739),0.36253997871773824,0.8457707208264186,0.7034559643255296,0.9580625197915063,1.0,8/46,13.05%,BRCA1;EYA2;FAM168A;SLF1;BABAM2;SMCHD1;HMGB1;FMN2
prerank,small GTPase mediated signal transduction (GO:0007264),0.3434148733887757,0.845509750592759,0.7648261758691206,0.9580827110456709,1.0,27/103,17.17%,NRAS;GRB2;NF1;RERG;RASSF1;JUN;CDK2;G3BP2;RAPGEF5;ARHGAP1;KRAS;RIT2;RAB18;PLD1;MAPK14;ARHGAP32;TP53;RREB1;SHOC2;GNB1;ARHGAP31;G3BP1;RRAS2;RB1;RIN2;RALBP1;RAPGEF2
prerank,positive regulation of integrin activation (GO:0033625),0.4522553977447106,0.845117031841924,0.6901197604790419,0.9582915206571647,1.0,4/11,18.67%,RAP1B;P2RY12;PIEZO1;PLEK
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.4265869974027625,0.8450898237834569,0.6744186046511628,0.9579120624659604,1.0,2/14,7.80%,CX3CL1;SYT11
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.36881205017752106,0.8449555288837266,0.7016317016317016,0.9577204967525607,1.0,8/38,15.45%,CD36;SMAD3;HSP90AA1;INSR;PKD2;ROCK2;TLR4;CD47
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.4052169304373335,0.8448428570616432,0.6680497925311203,0.9574669178130908,1.0,2/17,9.95%,PLA2G4A;LCLAT1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.3973434845627302,0.8445192709957537,0.6569148936170213,0.9575974760738578,1.0,8/20,19.07%,MPDU1;B4GALT1;B3GALT1;ST3GAL2;ST3GAL4;B3GALT5;ST3GAL3;FUT8
prerank,cation transport (GO:0006812),-0.19473934821933347,-0.8444097731521861,1.0,0.9456246393636794,1.0,24/167,14.79%,ANO6;KCNN2;SGK1;SCN2A;KCNAB1;ATP1B1;SLC36A1;CLN3;SCN3A;SCN8A;SLC8B1;ATP1A2;KCNJ2;CHP1;KCND3;SLC38A7;ANO10;SLC7A6;SLC11A2;SLC36A4;KCNK6;SLC3A2;SLC7A1;KCNMA1
prerank,translation (GO:0006412),0.3344132022771184,0.8442255479357451,0.8242971887550201,0.9576484288485276,1.0,23/208,8.31%,RPL18;RPS6KB2;RPS23;MRPL37;RPL41;RPL31;TARS1;NOA1;RPS17;FARSA;RPL4;MRPS21;WARS2;RPLP0;HARS1;ETF1;RPS15A;RPL38;DHPS;MRPS28;PABPC4;AGO2;AARS1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.26496071885498135,-0.8428696580778732,0.7633136094674556,0.947063253222712,1.0,7/32,14.73%,CALM2;AKAP6;TRPC1;CAPN3;SNCA;PDPK1;PLCG1
prerank,smooth muscle tissue development (GO:0048745),0.4535736872272806,0.8426464772758154,0.6869983948635634,0.9598692296501016,1.0,1/10,4.01%,NF1
prerank,stress-activated MAPK cascade (GO:0051403),0.3489402020626732,0.8423814279570025,0.7174151150054765,0.9598912799809285,1.0,13/61,13.99%,MINK1;MAP3K11;MAPK1;MAP3K20;IKBKB;MAPK8;IRAK2;TAB3;FBXW11;ZFP36L1;MAPK14;MAP3K8;LGALS9
prerank,positive regulation of vasculogenesis (GO:2001214),0.44483836718880776,0.8423658924257736,0.6761904761904762,0.9594913075295519,1.0,3/10,17.17%,RAP1A;RIN2;RAPGEF2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.4532333868780581,0.8421022957014067,0.6765163297045101,0.9595025625066341,1.0,1/10,7.73%,FERMT3
prerank,negative regulation of protein ubiquitination (GO:0031397),0.359464199410051,0.842063314832632,0.7097862767154106,0.9591295575902156,1.0,8/50,12.11%,SIRT7;UBXN1;SQSTM1;ARRB2;NXN;U2AF2;ABL1;CAMLG
prerank,transepithelial transport (GO:0070633),-0.33065807456692586,-0.8420422402980494,0.6508474576271186,0.9468844952666531,1.0,5/15,33.57%,SLC1A2;SLC1A1;SLC12A2;CXADR;GPLD1
prerank,histone acetylation (GO:0016573),0.3467017393899686,0.8417019417567283,0.7417640807651434,0.9593282192140941,1.0,14/69,14.24%,DMAP1;BRD8;EP300;BRCA2;ING3;PHF20;TADA2A;MORF4L2;JADE3;KAT2B;YEATS2;EPC1;EP400;PHF20L1
prerank,nucleosome assembly (GO:0006334),0.36506813576215585,0.84109608161153,0.6849148418491484,0.959916075797873,1.0,7/31,15.24%,CABIN1;ASF1A;SPTY2D1;BRD2;ATRX;ANP32B;NPM1
prerank,sprouting angiogenesis (GO:0002040),0.3524563717836115,0.8408982284009857,0.70509977827051,0.9598083134337054,1.0,4/51,4.64%,ITGB1BP1;VEGFC;THBS1;NRP1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3563867752134665,0.8407344732235065,0.7012263099219621,0.959658787048,1.0,10/47,14.36%,SOX13;LRP5;CMKLR1;TRPM4;CDS1;PPARG;ZFP36L1;RREB1;CREB1;PPARD
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.42132024012038316,0.8406371842037669,0.688622754491018,0.9593825052601568,1.0,5/13,16.20%,CD36;PPARG;ABCA1;SYK;CD81
prerank,phosphatidylinositol metabolic process (GO:0046488),0.3439558464961195,0.8404065202920323,0.7551229508196722,0.959346950283079,1.0,24/109,15.88%,MTMR11;ARF3;MTMR1;PIP4K2A;PIK3R4;INPP4A;PITPNM1;PI4KA;PLA2G4A;PI4K2A;CDS1;PIP4K2B;LCLAT1;FIG4;ARF1;OCRL;SLC27A1;PIK3C2A;PTEN;SYNJ2;MTM1;PGAP1;PIK3R1;INPP5F
prerank,negative regulation of kinase activity (GO:0033673),0.34834650989765237,0.8403112282330656,0.7172043010752688,0.9590874111647694,1.0,11/62,13.57%,DVL1;ITGB1BP1;NF1;IRS2;PYDC1;MAPT;PAK2;DTNBP1;GNAQ;LRP6;SPRED1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.3363116007623619,0.8398218785160824,0.7520491803278688,0.9594762334188758,1.0,17/114,12.95%,TNFRSF11A;RELA;TNFRSF25;PSMD9;PSMB8;BIRC3;PSMC5;IKBKB;PYDC1;LIMS1;ACTN4;TRAF2;TMSB4X;COMMD7;PSMD12;TP53;PSMA2
prerank,regulation of lymphocyte migration (GO:2000401),0.4514608416877022,0.8393812484093339,0.6825396825396826,0.9597748202024282,1.0,3/10,14.75%,MSN;MIA3;WASL
prerank,DNA damage checkpoint signaling (GO:0000077),0.37949156074282364,0.8391864332903092,0.7051442910915935,0.9596828844760934,1.0,5/28,9.93%,CLOCK;MAP3K20;NBN;CHEK2;CDC5L
prerank,energy reserve metabolic process (GO:0006112),0.4022939686804778,0.8386593134120813,0.6707317073170732,0.960129436929736,1.0,3/19,11.70%,PID1;GBE1;UGP2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.3572141171037923,0.8386434284575707,0.6910755148741419,0.9597268569444153,1.0,8/44,12.02%,GAS6;IGBP1;THBS1;YWHAE;FNIP1;CD44;MAP2K5;RAF1
prerank,negative regulation of protein polymerization (GO:0032272),0.38010248289396276,0.838539774436646,0.7014925373134329,0.9594687465214039,1.0,7/27,12.48%,STMN2;MAPRE1;ARFGEF1;SSH2;TWF2;CYRIB;EML2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.41903583120035454,0.8381346044636118,0.6876790830945558,0.9597290770211833,1.0,1/14,1.76%,RELA
prerank,protein targeting (GO:0006605),0.33690595626542846,0.8379371114824935,0.7854251012145749,0.9596111039891521,1.0,19/118,12.58%,TIMM17A;ZDHHC24;TOMM40;ARL6;SEC61G;SDCBP;TIMM23;GIPC1;NACA;ZDHHC1;ZFAND6;SEC61A1;VPS37C;HPS4;VPS37A;ATG3;SORL1;ZDHHC6;SRPRA
prerank,response to exogenous dsRNA (GO:0043330),0.40648886724128874,0.8379253200160687,0.6603260869565217,0.9592117300431608,1.0,4/18,10.41%,RFTN1;TLR3;MAVS;COLEC12
prerank,actin filament bundle assembly (GO:0051017),0.36788848514222316,0.8378905760480565,0.6801426872770512,0.9588439241054525,1.0,7/33,16.91%,PLS3;EZR;ADD1;EPS8;LIMA1;AIF1;MYO1B
prerank,positive regulation of double-strand break repair (GO:2000781),0.36247898624035957,0.8377607271905106,0.6917808219178082,0.9586283764261483,1.0,9/39,14.72%,PARP9;PRKDC;SLF1;KMT5B;KMT5C;FUS;SMCHD1;FMN2;SPIDR
prerank,positive regulation of response to stimulus (GO:0048584),0.3642529411131007,0.8377270768911161,0.7183580387685291,0.9582688377673341,1.0,4/40,9.31%,SELENON;TGFB2;FXR2;MAVS
prerank,embryonic limb morphogenesis (GO:0030326),0.37119460439782503,0.8375130773616866,0.7099767981438515,0.9581915281387468,1.0,7/34,15.59%,TGFB2;MBNL1;MAP3K20;LRP6;CACNA1C;FBXW4;HDAC2
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.3887020728414892,0.8374716674512733,0.6936936936936937,0.9574128537047406,1.0,4/22,14.15%,ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC20
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3887020728414892,0.8374716674512733,0.6936936936936937,0.9574128537047406,1.0,4/22,14.15%,ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC20
prerank,chromatin remodeling at centromere (GO:0031055),-0.24892867943765556,-0.837405691602347,0.764367816091954,0.9546932854076877,1.0,7/31,15.52%,SMARCA5;RBBP4;HJURP;NASP;CENPV;CENPO;ITGB3BP
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.44994465249941834,0.8371231251784675,0.6828125,0.9575737974074292,1.0,2/10,11.20%,LRP5;TGFBR2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3833782468072963,0.8366626623392358,0.6793193717277487,0.9579249136514306,1.0,8/22,19.59%,IKBKB;BOD1L1;TIPRL;ROCK2;NCKAP1L;ROCK1;PTPA;MGAT5
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3655911934095494,0.8366153597262861,0.6847058823529412,0.9575833164273362,1.0,4/33,11.90%,RELA;IMPACT;SETX;ABL1
prerank,regulation of cell size (GO:0008361),0.39711783582742766,0.8365797432347397,0.7119496855345911,0.9572176889929604,1.0,9/23,16.52%,MSN;VAV3;EZR;MTOR;VAV2;LARS1;PTEN;VAV1;RDX
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3391285767110162,0.8364011016396261,0.7237394957983193,0.9566683763659656,1.0,24/78,16.87%,AP1M1;ACTR1B;CAPZB;DYNLL2;AP2A1;KIF11;DCTN1;DCTN2;DCTN4;ARF1;SEC24B;SEC24D;KIF3A;SAR1B;RAB7A;OSBPL1A;CLTC;DYNC1I2;DYNC1LI2;CAPZA1;SH3GL2;LGMN;SEC24A;KIF2A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3391285767110162,0.8364011016396261,0.7237394957983193,0.9566683763659656,1.0,24/78,16.87%,AP1M1;ACTR1B;CAPZB;DYNLL2;AP2A1;KIF11;DCTN1;DCTN2;DCTN4;ARF1;SEC24B;SEC24D;KIF3A;SAR1B;RAB7A;OSBPL1A;CLTC;DYNC1I2;DYNC1LI2;CAPZA1;SH3GL2;LGMN;SEC24A;KIF2A
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.3508779953851472,-0.8363294916185069,0.6676923076923077,0.9549707154072987,1.0,4/12,4.93%,CHMP4B;CHMP4A;SEC62;SEC61A2
prerank,regulation of mRNA stability (GO:0043488),0.33300104729491764,0.8361375800687688,0.7870837537840565,0.9566915259226505,1.0,32/145,16.77%,EIF4ENIF1;CARHSP1;PSMD9;PSMB8;EXOSC5;PRKCA;FTO;PUM2;RC3H2;METTL3;EXOSC7;PSMC5;XRN1;SET;YTHDF1;FXR2;PUM1;FUS;DCP1A;ZFP36L1;PSMD12;SAMD4A;MAPKAPK2;PSMA2;ROCK2;ANP32A;NPM1;PSMB1;SERBP1;YWHAB;YTHDF3;HNRNPD
prerank,ventricular septum morphogenesis (GO:0060412),0.38356653784347644,0.8360814647660562,0.6895261845386533,0.9563512238873934,1.0,7/27,15.19%,TGFB2;BMPR1A;ACVR1;TGFBR2;SOX11;TGFBR1;SMAD4
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.29242576674254755,-0.8352866506224681,0.7008928571428571,0.9552165902469275,1.0,7/19,13.62%,PRKN;CSNK2A2;FBXO7;SREBF2;ATP13A2;VDAC1;USP36
prerank,myoblast fusion (GO:0007520),0.4287160041843546,0.8350787992199653,0.6810089020771514,0.9576270591002347,1.0,2/12,8.60%,ADAM12;ADGRB3
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.3221377394478764,-0.8344692473100338,0.696551724137931,0.9552075100605885,1.0,4/16,6.34%,ACSS1;PPT1;DIP2A;ACLY
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.35186316438678805,0.8339463022126438,0.7192008879023307,0.9590186144976715,1.0,13/51,15.61%,SMG6;TCP1;TERF2;MAPK1;XRN1;PKIB;TNKS2;NEK7;HMBOX1;CCT3;TERF1;CTC1;HNRNPC
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3628708522071241,0.8338611747934479,0.7037457434733257,0.9587352353697942,1.0,7/41,14.85%,CX3CL1;GAS6;ILRUN;SYT11;LGALS9;HAVCR2;TLR4
prerank,protein K11-linked ubiquitination (GO:0070979),0.37312488085949747,0.8337957544725858,0.6825980392156863,0.9584184303474044,1.0,10/27,17.58%,ANAPC10;CDC23;UBE2A;CDC16;UBE2W;UBE2H;UBE2D3;UBE2E3;ANAPC1;UBE2B
prerank,ether lipid biosynthetic process (GO:0008611),0.44342350459255964,0.8337352399202286,0.6865671641791045,0.958093376455982,1.0,4/10,17.26%,FAR1;PLA2G4A;PEDS1;PEX7
prerank,positive regulation of interleukin-4 production (GO:0032753),0.41096280376972355,0.833647095645689,0.6606397774687065,0.957808533998083,1.0,4/17,14.63%,PRKCZ;SYK;LGALS9;HAVCR2
prerank,production of siRNA involved in RNA interference (GO:0030422),0.43347974013765656,0.8336272438928536,0.6806853582554517,0.9574127362029711,1.0,3/10,16.48%,AGO2;PRKRA;DROSHA
prerank,defense response to tumor cell (GO:0002357),0.4380699945092412,0.833580707692134,0.6714285714285714,0.9570661408797676,1.0,2/10,9.02%,RBMS3;DAPK1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3655174266665349,0.833534534923359,0.6911942098914354,0.9567189535563414,1.0,6/36,13.03%,CX3CL1;TPD52L1;TRAF7;CYLD;TGFBR1;BCL2
prerank,embryonic axis specification (GO:0000578),0.4174367295328385,0.8333704315347915,0.6615384615384615,0.956555676518405,1.0,2/15,11.94%,SMAD6;TASOR
prerank,regulation of viral release from host cell (GO:1902186),0.3882633577783954,0.8333613445154515,0.6883780332056194,0.9561485880714549,1.0,2/21,2.78%,TSG101;VPS4A
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.44359550008950166,0.8331957772431338,0.6722817764165391,0.9559928627325076,1.0,3/11,14.29%,HSP90AA1;PTS;CALM1
prerank,positive regulation of ATPase activity (GO:0032781),0.35673522734634094,0.8331471180484992,0.7007963594994312,0.9556579341292502,1.0,4/41,5.96%,DNAJB1;SSBP1;TPM1;DYNLL2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.38502850644995024,0.832937885950972,0.6892067620286085,0.9555839202387176,1.0,6/22,17.88%,IFI35;WDFY1;LYN;RAB7B;MFHAS1;TREM2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.3826555153571023,0.8327837134348909,0.6925837320574163,0.9554241778779331,1.0,2/26,1.24%,LRRK2;PRKCZ
prerank,carboxylic acid catabolic process (GO:0046395),-0.3456812003502411,-0.8325673160733631,0.7080745341614907,0.9573264087878246,1.0,4/12,15.67%,RENBP;NAGK;AMDHD2;GNPDA1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.37856269374317353,0.8323033186127137,0.6703431372549019,0.9557527574630793,1.0,4/27,8.61%,AKAP9;DLG1;CAMK2D;TRPM4
prerank,endosome organization (GO:0007032),0.3627633125321999,0.8322587256637729,0.7243367935409458,0.9554082510107887,1.0,10/41,16.86%,EEA1;AKTIP;SQSTM1;SNX10;SNX3;PI4K2A;VPS11;WASHC5;DNAJC13;HOOK2
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.4368535270471171,0.8322338783382994,0.6861538461538461,0.9550207589236964,1.0,3/10,13.22%,PPARG;ACTN4;RXRA
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.27362132657285354,-0.832144732523416,0.7487684729064039,0.9563814182435714,1.0,4/26,5.34%,MAFB;C1QC;PTPN2;GPR137B
prerank,myotube differentiation (GO:0014902),0.4100714507005093,0.8320740211767435,0.6643356643356644,0.9548606493924335,1.0,4/17,16.27%,ADAM12;ADGRB3;MYEF2;MEF2C
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.3530293477658681,0.8316620482198931,0.7210065645514223,0.9551224674538682,1.0,8/53,13.71%,BRCA1;EYA2;SPRED2;BABAM2;FXR2;SMCHD1;SPRED1;DDX5
prerank,positive regulation of protein processing (GO:0010954),-0.2935091855830271,-0.8316282732782603,0.6844106463878327,0.9555325732476445,1.0,2/19,3.23%,PLGRKT;LPCAT3
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.412444277013876,0.8315234191930901,0.6764295676429568,0.9549223429612638,1.0,15/15,58.79%,NCOA3;PRKCH;MED1;CYP27B1;VDR;KDF1;SULT2B1;TRIM16;SFN;SFRP4;BMP4;NME2;FOXC1;ETV4;NUMA1
prerank,positive regulation of cholesterol efflux (GO:0010875),0.38211999285514875,0.8308685978932618,0.7037037037037037,0.9555843883292835,1.0,4/21,13.22%,EEPD1;ABCA7;PPARG;RXRA
prerank,mRNA transport (GO:0051028),0.3343643665153207,0.8305035721233178,0.7701736465781409,0.9557346734300447,1.0,17/101,12.67%,EIF4A3;SMG6;DHX38;SARNP;RNPS1;NUP205;U2AF1;HNRNPA2B1;THOC5;NUP98;SRSF5;NUP54;U2AF2;CPSF3;ZFP36L1;SRSF9;SRSF11
prerank,non-motile cilium assembly (GO:1905515),0.37591183463182054,0.8299891180638402,0.715674362089915,0.956149654564833,1.0,6/30,13.68%,CEP89;BBS4;CEP250;DCTN1;RPGRIP1L;C2CD3
prerank,hippo signaling (GO:0035329),0.37076843625929923,0.8296619769945616,0.6773794808405439,0.9562831014980049,1.0,3/26,5.25%,NPHP4;YWHAE;TEAD1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.35412553872828295,0.8295993910913494,0.7246049661399548,0.9559615042826786,1.0,7/46,8.27%,NRDC;ALDH1A1;STK11;ACOT13;MAP2K6;ABHD6;LNPEP
prerank,sodium ion transmembrane transport (GO:0035725),0.3377933609209169,0.8294228093361063,0.7502601456815817,0.9558242125866273,1.0,6/84,8.80%,HCN3;SLC9A9;SLC9A1;TRPM4;SLC9A7;SLC9A6
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.4014172310745895,0.8288556804373044,0.7049180327868853,0.956303746764529,1.0,2/17,5.17%,NRP1;PDGFB
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.4115090004602822,0.8283801035881204,0.6931982633863966,0.9566447426933911,1.0,2/14,10.26%,SLC9A1;ACTN4
prerank,protein K48-linked ubiquitination (GO:0070936),0.34872170910124667,0.8282982535768557,0.7338444687842278,0.9563444119273404,1.0,16/54,16.71%,PELI1;UBE2A;RNF115;RNF34;BFAR;RNF146;RNF216;UBE2Q2;UBE3A;FBXO38;UBR5;UBE2H;UBE2D3;UBE2G1;UBE2E3;HACE1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.38559580348866,0.8280475832540054,0.6863979848866498,0.9563216758168651,1.0,3/22,6.89%,UTP20;EXOSC7;ERI3
prerank,calcium ion transmembrane transport (GO:0070588),0.3392083662198961,0.828037498062577,0.7669094693028096,0.9559237235249349,1.0,15/86,14.78%,SLC24A5;TRPC5;MICU1;CACNA1D;GAS6;LETM1;TRPM4;TRPC4AP;CACNA1A;MCOLN1;PARL;TRPV2;PKD2;GRIN2A;CACNA1C
prerank,epithelial cell development (GO:0002064),0.39240076400402635,0.8280059999118744,0.6893840104849279,0.9555584811382575,1.0,1/20,3.84%,SIPA1L3
prerank,cGMP metabolic process (GO:0046068),-0.3521141795079703,-0.8277594239284167,0.7016949152542373,0.9616175730599225,1.0,10/12,61.86%,GUCY1B1;GUCY1A1;PDE9A;NPPC;NPR2;PDE2A;NPR1;GUCY2F;GUCY2D;GUCY2C
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.404054257952605,0.827544209490253,0.6896551724137931,0.9558800049786911,1.0,2/16,8.47%,RELA;ALOX5
prerank,regulation of stem cell population maintenance (GO:2000036),-0.3102621992739423,-0.8275217566772254,0.72,0.9601720114267313,1.0,3/18,6.35%,CNOT2;CNOT1;WDR43
prerank,regulation of cholesterol efflux (GO:0010874),0.36181832567935235,0.826981760379602,0.7007299270072993,0.9563328103450036,1.0,6/30,14.68%,EEPD1;TTC39B;ABCA7;PPARG;RXRA;ABCA5
prerank,presynapse assembly (GO:0099054),0.4081714300752669,0.8269591616718939,0.7003994673768309,0.9559563535133062,1.0,2/16,6.94%,DVL1;CEL
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.35568544978082217,0.8266001053987904,0.7375565610859729,0.9561644290365724,1.0,7/52,12.58%,WFS1;GOSR2;DCTN1;EXTL3;ADD1;ERN1;SRPRA
prerank,endochondral bone morphogenesis (GO:0060350),-0.3685618858894547,-0.8265647890544063,0.7084639498432602,0.9602029534981599,1.0,2/11,10.68%,BMPR2;INPPL1
prerank,respiratory system development (GO:0060541),0.36522975972081834,0.8264947666313228,0.7026378896882494,0.955906488997435,1.0,4/32,10.27%,FGF1;CHD7;SMCHD1;LOXL3
prerank,regulation of DNA damage checkpoint (GO:2000001),0.4364788980013722,0.8264519609312166,0.6911076443057722,0.9555532576836026,1.0,2/10,9.90%,THOC5;RFWD3
prerank,cytosolic calcium ion transport (GO:0060401),-0.26622506364836307,-0.8262530912920159,0.783068783068783,0.9590127354546722,1.0,4/28,6.96%,RYR2;CACNA2D1;MCU;AFG3L2
prerank,epithelial tube morphogenesis (GO:0060562),-0.2584917385851707,-0.8261093444309947,0.7875,0.957483687586077,1.0,4/32,5.81%,RYR2;SLIT2;PKD1;CSF1R
prerank,negative regulation of lipid storage (GO:0010888),0.3905594217579947,0.8252470041574731,0.7109589041095891,0.9570735529633666,1.0,5/19,14.36%,TTC39B;PPARG;ABCG1;ABCA1;PPARD
prerank,import into cell (GO:0098657),0.356086452657739,0.8248440444677104,0.7297605473204105,0.9572697399092248,1.0,4/41,12.68%,NEURL1B;SLC7A8;SLC12A6;SLC27A1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.28959094210207653,-0.8246225686715405,0.7324561403508771,0.958516249957528,1.0,2/21,0.26%,MED13;MITF
prerank,endocytic recycling (GO:0032456),0.34913071945159646,0.8241160869122539,0.729608938547486,0.9580208781851101,1.0,8/50,9.83%,EIPR1;EHD4;EHD1;CCDC93;SNX3;VPS35;ARL4C;PTPN23
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3825399277232114,0.8237866887278142,0.7030625832223701,0.9581246681477694,1.0,6/21,13.26%,RPIA;RBKS;TKT;TALDO1;GCK;RPE
prerank,response to muramyl dipeptide (GO:0032495),-0.3481548740208591,-0.823767201983605,0.6891025641025641,0.9584203106680361,1.0,6/12,21.35%,ARHGEF2;IRF5;TRIM41;VIM;NOD1;PTPN22
prerank,cytoplasmic translational initiation (GO:0002183),0.39340055953745057,0.8235358496243715,0.6865671641791045,0.958116292937006,1.0,2/17,3.90%,DENR;EIF4B
prerank,cellular senescence (GO:0090398),-0.2636222600812374,-0.8228178389890368,0.75,0.9584052844311771,1.0,6/27,14.16%,KAT6A;OPA1;SMC6;CALR;PML;SIRT1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.43770397111746984,0.8227755337622675,0.6943164362519201,0.9588616821957818,1.0,2/10,6.71%,IRS1;IRS2
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.33314306873842553,0.8227508587023113,0.7408184679958028,0.9584870812653348,1.0,24/79,16.87%,AP1M1;ACTR1B;CAPZB;DYNLL2;AP2A1;KIF11;DCTN1;DCTN2;DCTN4;ARF1;SEC24B;SEC24D;KIF3A;SAR1B;RAB7A;OSBPL1A;CLTC;DYNC1I2;DYNC1LI2;CAPZA1;SH3GL2;LGMN;SEC24A;KIF2A
prerank,bicellular tight junction assembly (GO:0070830),-0.22825625371283917,-0.8225090918391962,0.7788461538461539,0.9572298823710247,1.0,3/46,2.17%,F11R;STRN;TBCD
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.4008340732616972,0.8220286615312646,0.6869918699186992,0.9592149219310259,1.0,4/15,12.58%,SEC61G;RAB3GAP1;SEC61A1;SRPRA
prerank,positive regulation of reproductive process (GO:2000243),0.3656499861052564,0.8217477049852454,0.7127272727272728,0.9592369247010503,1.0,4/31,13.18%,PGAM4;AGO2;LHFPL2;ACVR1B
prerank,microglial cell activation (GO:0001774),0.38553157837834295,0.8214417436306296,0.7006451612903226,0.959304258496457,1.0,3/21,7.60%,C5AR1;CX3CL1;MAPT
prerank,ncRNA metabolic process (GO:0034660),0.3529115636581715,0.8212665155417866,0.6936619718309859,0.9591633662619221,1.0,6/37,16.48%,TUT4;MAPT;AGO2;PRKRA;DTD1;DROSHA
prerank,cellular glucose homeostasis (GO:0001678),0.35368926503100356,0.8209807203119038,0.7198177676537585,0.9592135171733266,1.0,9/41,16.85%,ADCY8;GAS6;PRKACA;IGF1R;GCK;ERN1;PIK3R1;FOXK1;HK2
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.29522474310832925,-0.8209287801266127,0.7217391304347827,0.9585044826056353,1.0,4/18,12.85%,PLCG2;FCER1G;TYROBP;PYCARD
prerank,protein modification process (GO:0036211),0.3376668566453968,0.8203105954367647,0.7636554621848739,0.9598647256877821,1.0,14/76,15.27%,ST8SIA4;SEPHS1;GGCX;CPE;YES1;PRKDC;FBXO11;PARP4;UBE2I;ATG3;ABL1;DUSP12;UBE2D3;MSRA
prerank,inorganic cation transmembrane transport (GO:0098662),0.3263340563476233,0.820184372234563,0.883,0.9596552069556163,1.0,26/268,13.11%,HCN3;SLC24A5;SLC30A6;TRPC5;TMEM175;SLC9A9;SLC39A11;SLC9A1;CACNA1D;GAS6;KCNH8;KCNH7;HVCN1;ABCB7;KCNK2;ATP6V0E1;TRPM4;SLC9A7;SLC9A6;TRPC4AP;CACNA1A;MCOLN1;KCNK13;TRPV2;KCNK10;ATP6V1H
prerank,vesicle organization (GO:0016050),0.3510575495617288,0.8201832672810003,0.7249154453213078,0.9592450880938985,1.0,11/46,15.39%,AKTIP;FNBP1L;SQSTM1;SNX10;PI4K2A;VPS11;SAR1B;WASHC5;EPS15;WASL;DNAJC13
prerank,negative regulation of cell activation (GO:0050866),0.40413480159416526,0.8199746191745192,0.6923076923076923,0.9591431698414566,1.0,1/14,5.17%,PDGFB
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.371740288210418,0.8196333194640179,0.6925,0.9592533601150904,1.0,5/26,14.29%,UBQLN1;YWHAE;THADA;PKD2;CALM1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3351367863260606,0.8191619241471254,0.7747933884297521,0.9596153143924314,1.0,19/83,18.00%,MAX;CDK7;POLA1;CDK2;CDK6;ACVR1;USP29;MNAT1;CDK5;CUL4A;ACVR1B;USP37;CRLF3;RB1;TFDP2;EIF4E;RPS6KB1;PPP6C;KHDRBS1
prerank,endothelial cell proliferation (GO:0001935),0.4034922104421396,0.8190259761514206,0.6847222222222222,0.9594431940945384,1.0,3/17,12.18%,ITGB1BP1;DLG1;ERN1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.42655672050329463,0.8190086196745909,0.6867283950617284,0.9590546511810125,1.0,5/11,16.79%,RTN4;ATL2;VCPIP1;VAPB;ARL6IP1
prerank,RNA export from nucleus (GO:0006405),0.329264984986188,0.8188579906794723,0.7909371781668383,0.9588811662333979,1.0,16/100,12.67%,EIF4A3;SMG6;DHX38;SARNP;RNPS1;NUP205;U2AF1;HNRNPA2B1;THOC5;NUP98;SRSF5;NUP54;U2AF2;CPSF3;SRSF9;SRSF11
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.4190851828396564,0.8187898170022428,0.6834319526627219,0.9585908772509831,1.0,5/12,18.50%,DLG1;TRPM4;CACNA1C;BIN1;CTNNA3
prerank,regulation of protein modification process (GO:0031399),0.34913301533239965,0.8185244655790959,0.7241758241758242,0.9586064479045245,1.0,14/50,16.44%,PARG;SPRED2;CDK9;FNIP1;LYN;ASPSCR1;FKTN;KAT2B;PPP1R16B;FN1;SPRED1;ATG7;PHIP;STAT2
prerank,negative regulation of DNA metabolic process (GO:0051053),0.3829095452900637,0.8185020434523312,0.7141025641025641,0.9582303082827061,1.0,3/24,7.85%,BLM;TERF2;ERCC4
prerank,protein targeting to ER (GO:0045047),0.32976287679763727,0.818408668732616,0.7767393561786086,0.9579634190668437,1.0,10/99,5.94%,RPL18;RPS23;RPL41;RPL31;SEC61G;RPS17;RPL4;RPLP0;RPS15A;RPL38
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.36214151773553016,0.8181015767429359,0.7289940828402367,0.9580531378876499,1.0,7/32,13.07%,TCP1;MAPK1;PKIB;TNKS2;NEK7;HMBOX1;CCT3
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.3290381082190889,0.8176868898921477,0.766287487073423,0.9582739064454897,1.0,17/94,13.98%,RELA;IRAK4;PELI1;PSMD9;PSMB8;SQSTM1;IL1A;PSMC5;IKBKB;RPS6KA5;IL1RAP;IRAK2;TAB3;FBXW11;PSMD12;PSMA2;MAP3K8
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.3292406132603106,0.8172805308628592,0.7868852459016393,0.9585067193912848,1.0,30/109,17.83%,RELA;GRB2;PSMD9;NFATC1;JUN;PSMB8;BTK;MAPK1;VAV3;PSMC5;IKBKB;MAPK8;PAK2;TAB3;LYN;FBXW11;VAV2;PSMD12;PSMA2;SYK;CALM1;VAV1;PSMB1;PIK3R1;PAK1;MAP2K4;FER;PSME4;LCP2;PPP3CA
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3855971931212347,0.817203786435486,0.7010309278350515,0.9582222631156104,1.0,3/21,9.57%,MICU1;LETM1;RAP1GDS1
prerank,nucleoside catabolic process (GO:0009164),-0.347813004928264,-0.8169479541013523,0.7435158501440923,0.9643512710314905,1.0,4/11,16.33%,DPYD;UPP2;DERA;NT5M
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.28642230136222635,-0.8166378071433972,0.7280334728033473,0.9630930733452178,1.0,4/21,8.76%,LPIN2;ACOX1;PLA2G15;LPIN1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.405167852566714,0.8165594205397844,0.697841726618705,0.9588093599015478,1.0,4/14,12.96%,TERF2;BRCA2;TNKS2;ATRX
prerank,cellular iron ion homeostasis (GO:0006879),0.34289701683731155,0.8164564055249938,0.7373626373626374,0.9585695242072025,1.0,13/55,17.72%,CP;HMOX2;ABCB7;GLRX3;FLVCR1;SLC22A17;NDFIP1;ATP6V0A2;SMAD4;ABCG2;FTH1;FRRS1;FTL
prerank,regulation of cation channel activity (GO:2001257),0.33252343716147026,0.8155654963879709,0.7769784172661871,0.9595171078945334,1.0,11/89,9.85%,SELENON;MINK1;CACNG7;PRKACA;DLG1;NETO1;SLMAP;CAMK2D;DAPK1;GRIA4;VAMP2
prerank,maintenance of protein localization in organelle (GO:0072595),0.3897908602212247,0.8154564180427148,0.7163398692810458,0.9592601720618585,1.0,2/19,3.53%,TAPT1;BBS4
prerank,clathrin coat assembly (GO:0048268),-0.31598864079591915,-0.8153542070586706,0.7132616487455197,0.9637925576026553,1.0,4/15,14.44%,SGIP1;CLTA;FCHO2;NSG2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.33534892197150895,0.8147298219282115,0.75,0.9600118575417949,1.0,11/63,17.29%,CD38;EPHB2;VAV3;IRS2;NCK1;IL18;BCL2;AIF1;CD81;MEF2C;NCKAP1L
prerank,hemopoiesis (GO:0030097),0.332093854548155,0.8147049267477275,0.7777777777777778,0.9596425457701697,1.0,13/87,12.92%,WNT2B;SBDS;RUNX1;TGFB2;PDGFB;KITLG;TAL1;PRRC2C;NOTCH2;TGFBR2;PLD4;SH2B3;TP53
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.3962291139715855,0.8146193740490631,0.6925133689839572,0.959380660092098,1.0,2/18,7.91%,FBXW7;TLR3
prerank,protein deneddylation (GO:0000338),0.43788908110017655,0.8143084229350613,0.7034795763993948,0.9594641318507066,1.0,2/10,9.10%,COPS7B;COPS4
prerank,protein localization to vacuole (GO:0072665),0.40946870021892573,0.8142891783059123,0.6948905109489051,0.9590933500122676,1.0,5/13,16.20%,LMBRD1;MFSD1;SH3GLB1;RTN4;CD81
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.32805274244879307,0.8140303291624922,0.7596656217345873,0.9590933807558848,1.0,11/76,12.73%,CDK5RAP3;CMKLR1;ARRB2;G3BP2;PYDC1;IRAK2;FAF1;MAP2K5;TMSB4X;COMMD7;CYLD
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3819810357765706,0.8137937168543965,0.712484237074401,0.9586294115750381,1.0,8/23,18.07%,YWHAE;MAPK8;NMT1;TP53;BCL2;YWHAB;TFDP2;PPP3CC
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3819810357765706,0.8137937168543965,0.712484237074401,0.9586294115750381,1.0,8/23,18.07%,YWHAE;MAPK8;NMT1;TP53;BCL2;YWHAB;TFDP2;PPP3CC
prerank,transport along microtubule (GO:0010970),0.41601783859302255,0.8136351610678406,0.6964539007092199,0.9584593936026845,1.0,6/13,15.37%,BAG3;CAMSAP3;APBA1;CDC42;SPG11;DYNC1I2
prerank,regulation of neurogenesis (GO:0050767),0.3361375794667828,0.8133621912168149,0.7193932827735645,0.9584614301838468,1.0,6/55,12.31%,CX3CL1;NUMBL;SPEN;RGS14;SOX11;SORL1
prerank,clathrin-dependent endocytosis (GO:0072583),0.36929327524046957,0.813269308415601,0.694647201946472,0.9582005023330621,1.0,5/26,8.57%,ITSN1;SIGLEC1;FNBP1L;AP2A1;LMBRD1
prerank,Fc receptor signaling pathway (GO:0038093),0.32752895217230443,0.8127982913209255,0.7958974358974359,0.958528391558134,1.0,30/110,17.83%,RELA;GRB2;PSMD9;NFATC1;JUN;PSMB8;BTK;MAPK1;VAV3;PSMC5;IKBKB;MAPK8;PAK2;TAB3;LYN;FBXW11;VAV2;PSMD12;PSMA2;SYK;CALM1;VAV1;PSMB1;PIK3R1;PAK1;MAP2K4;FER;PSME4;LCP2;PPP3CA
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.3661151775486807,0.8125247975941293,0.7076167076167076,0.9585412353471592,1.0,6/27,13.98%,MAPK1;MAP3K20;IKBKB;MAPK8;FBXW11;MAP3K8
prerank,maturation of SSU-rRNA (GO:0030490),0.3575073241152666,0.8124347039108175,0.7359154929577465,0.9582788722295443,1.0,5/34,11.91%,UTP3;RIOK3;RRP36;UTP6;HEATR1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.35480103312042816,-0.8124170227408757,0.7155425219941349,0.9677178767591511,1.0,7/10,53.78%,NAF1;DKC1;GAR1;RPUSD4;TSR3;RPUSD1;NOP10
prerank,regulation of Wnt signaling pathway (GO:0030111),0.32811065497959085,0.8119562018323101,0.8032955715756952,0.9586413999127005,1.0,14/108,13.43%,MDFI;LRRK2;SMARCA4;RUNX1;NFATC1;ESR1;TLE1;SNX3;NXN;GNAQ;WLS;HMGXB4;GPC3;WWOX
prerank,negative regulation of secretion by cell (GO:1903531),-0.24560215049106765,-0.8116569487516577,0.7971014492753623,0.967312264826174,1.0,8/38,15.97%,IL1RAPL1;STXBP6;SNCA;RHBDF2;LILRB1;SYT4;NOTCH1;HMGCR
prerank,muscle cell development (GO:0055001),0.36319496646657734,0.8113483239596422,0.7275985663082437,0.9591716289390086,1.0,2/30,4.50%,NEBL;MYOF
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.42768269991060637,0.811286840266951,0.7151607963246555,0.9588526316668085,1.0,2/10,12.94%,ABCD2;ABCD1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.37470249125167004,0.8109900213067153,0.7121212121212122,0.9588769923476271,1.0,3/24,11.18%,GGCX;VKORC1L1;TTLL4
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.41363675931398625,0.8101930424974001,0.6863905325443787,0.9593043283691607,1.0,2/12,10.26%,ITGB1BP1;ACTN4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.41363675931398625,0.8101930424974001,0.6863905325443787,0.9593043283691607,1.0,2/12,10.26%,ITGB1BP1;ACTN4
prerank,bile acid metabolic process (GO:0008206),0.36900079653262896,0.8101435545258706,0.7072570725707257,0.9589650741011756,1.0,2/27,2.58%,GBA2;OSBP
prerank,regulation of interleukin-17 production (GO:0032660),0.3643596455675957,0.8097724061861079,0.6982035928143713,0.9591487221404476,1.0,6/31,17.29%,RFTN1;IL18;SLAMF6;PRNP;TLR4;NCKAP1L
prerank,positive regulation of histone deacetylation (GO:0031065),-0.3322744711844589,-0.8097075091927078,0.7215568862275449,0.969160456833775,1.0,5/12,18.18%,AKAP8;NIPBL;PRKD1;SAP30BP;ING2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.34985835784071717,0.8094544507420733,0.7304550758459744,0.9591841312029751,1.0,4/39,4.55%,CX3CL1;ADAM15;ITGB1BP1;THBS1
prerank,steroid biosynthetic process (GO:0006694),0.33916904083010535,0.8088984177857078,0.7527472527472527,0.959596683838017,1.0,3/56,3.74%,INSIG1;OSBP;INSIG2
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.419757126748445,0.8088700228306361,0.71875,0.9592307030920988,1.0,3/11,13.99%,RUNX1;HMGB1;LGALS9
prerank,regulation of T cell cytokine production (GO:0002724),-0.3213361318484682,-0.8086730455206087,0.7040816326530612,0.9693285736762617,1.0,2/15,1.91%,B2M;SMAD7
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.34242081071610597,0.8085279944340245,0.7597402597402597,0.9593453706172781,1.0,11/56,16.70%,RGCC;CDC23;KMT2E;MECP2;CDC16;RAD51B;VPS4B;AIF1;RDX;RB1;NSMCE2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3292660591500778,0.8084881410293225,0.7794273594909862,0.958997475851684,1.0,4/76,6.00%,C5AR1;GPR65;CMKLR1;ESR1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.26693426607028126,-0.8084122421930555,0.7828282828282829,0.9680064873517059,1.0,10/27,17.59%,RHOA;ETS1;ITGB2;IRAK1;CCDC88B;PYCARD;SIRPA;TRAF6;HSPD1;PRKCQ
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.42038733753854984,0.8082215598789164,0.7142857142857143,0.9585643948025312,1.0,2/12,6.12%,SLC9A1;SPPL3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.42038733753854984,0.8082215598789164,0.7142857142857143,0.9585643948025312,1.0,2/12,6.12%,SLC9A1;SPPL3
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.3555503865023184,0.8075213301158427,0.7298524404086265,0.9591703018015855,1.0,4/40,3.07%,CDK5RAP3;FBXW7;GLMN;DESI1
prerank,cellular response to glucose stimulus (GO:0071333),0.3593217012297614,0.8069305807493101,0.7409638554216867,0.9596844798047194,1.0,5/30,12.18%,ADCY8;GAS6;PRKACA;IGF1R;ERN1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4004726508101967,0.8068447123068339,0.7244623655913979,0.9594124412878029,1.0,2/16,5.34%,SOX13;FTO
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.3056639656536918,-0.8063023546250467,0.7121771217712177,0.9700298931357315,1.0,8/17,17.77%,CPEB3;ZC3H14;CCNT1;CPSF6;ZC3H3;NUDT21;HSF1;NCBP1
prerank,amino acid transport (GO:0006865),0.3406829437712053,0.8062461798597407,0.7536557930258717,0.95986460687385,1.0,6/49,12.24%,SLC7A2;SLC38A2;SLC7A11;SLC7A7;SLC7A8;SLC38A9
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.3569477044734348,-0.8045859484788944,0.7301136363636364,0.9697709505233972,1.0,1/10,1.58%,MBP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.3569477044734348,-0.8045859484788944,0.7301136363636364,0.9697709505233972,1.0,1/10,1.58%,MBP
prerank,epithelial cell morphogenesis (GO:0003382),0.39064058068032936,0.8045842967750249,0.734375,0.9619596913808645,1.0,1/17,3.84%,SIPA1L3
prerank,cellular response to peptide (GO:1901653),0.3385244410740864,0.8040717917252512,0.7494553376906318,0.9623184812920856,1.0,17/56,18.37%,CD36;CHMP5;ITGA4;CDK5;CACNA1A;IGF1R;PRNP;ZFP36L1;TP53;FYN;GRIN2A;TLR4;LGMN;ABCC1;TREM2;PSEN1;SNX6
prerank,protein-DNA complex disassembly (GO:0032986),0.39325096934625864,0.8037145971427216,0.6988950276243094,0.9624390975801627,1.0,2/16,8.22%,SMARCA4;SET
prerank,Notch signaling pathway (GO:0007219),0.3368756188706769,0.8036312674845134,0.7837541163556532,0.9621561725762555,1.0,10/59,14.67%,EP300;TRAF7;MAML3;MAML2;NOTCH2;KAT2B;MIB1;ADAM10;RBPJ;DTX3
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3476617673834133,0.8033327670242316,0.746031746031746,0.9621926695292022,1.0,7/43,14.85%,CX3CL1;GAS6;ILRUN;SYT11;LGALS9;HAVCR2;TLR4
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.2952746842111151,-0.8030829998920055,0.7443946188340808,0.9706969032751911,1.0,11/18,27.41%,EXOSC10;DCP2;CCT4;SHQ1;CCT6A;CCT8;CCT2;CCT7;NAF1;CCT5;DKC1
prerank,positive regulation of vasoconstriction (GO:0045907),0.3986151110265627,0.8028743377140954,0.7138728323699421,0.9624589892845614,1.0,1/13,8.61%,TRPM4
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3322941344689275,0.8027774388578898,0.783068783068783,0.9621888429944768,1.0,9/75,12.80%,KCNJ6;SLC9A9;SLC9A1;TRPM4;SLC9A7;SLC9A6;SLC12A6;SLC39A10;TRPV2
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.38028977271773107,0.802160734457778,0.7203495630461922,0.9626884577903015,1.0,1/22,1.07%,LRRK2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.34041555453372113,0.8020836151495896,0.7421965317919075,0.9623948857842175,1.0,7/45,10.78%,PARP9;METAP1;RBM3;PUM2;PUM1;ZC3H7A;ATXN2
prerank,modulation by symbiont of host process (GO:0044003),-0.3527059837887532,-0.801941750348469,0.7422096317280453,0.9710185738202302,1.0,6/10,22.24%,B2M;UBC;RPS27A;TLR2;PGK1;UBB
prerank,sensory perception of pain (GO:0019233),-0.2722948864096314,-0.8019220666295354,0.7456896551724138,0.9692425881283557,1.0,8/21,27.73%,P2RX7;OPRM1;P2RX4;RETREG1;SCN9A;MME;KCNA2;CCR2
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3752136650013502,0.8015235842855148,0.7439180537772087,0.9628100854562089,1.0,4/22,12.05%,KLF9;AREG;NOTCH2;ZFP36L1
prerank,sensory perception (GO:0007600),0.33975563864433356,0.8013704535579462,0.7564534231200898,0.962634817922512,1.0,3/45,3.99%,C5AR1;BBS4;NIPSNAP1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.3915366839554184,0.8013172970304758,0.7219101123595506,0.9623104111755435,1.0,2/15,11.22%,HOMER2;GRM7
prerank,cellular response to interleukin-15 (GO:0071350),0.40716564012465495,0.8012285699691661,0.7200557103064067,0.9616376231447937,1.0,1/13,2.87%,GRB2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.40716564012465495,0.8012285699691661,0.7200557103064067,0.9616376231447937,1.0,1/13,2.87%,GRB2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.3767248288927743,0.801208884330144,0.711864406779661,0.9612644833355459,1.0,7/21,17.22%,RUNX1;PRKCB;LPXN;LYN;SLC39A10;CD81;PRKCH
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.25447731967040665,-0.8011924066889872,0.7819905213270142,0.9687450142238186,1.0,10/28,24.58%,ITPR1;ERO1A;DNAJC10;CASP4;DDIT3;CEBPB;BAX;ATF4;SELENOK;BAG6
prerank,regulation of complement activation (GO:0030449),0.34420067172579744,0.8011183829163373,0.7268518518518519,0.9609847498621663,1.0,5/40,16.20%,C5AR1;CFH;C1QB;PROS1;CD81
prerank,glycine metabolic process (GO:0006544),-0.33963237150775155,-0.8009060898712618,0.729483282674772,0.9674249761850278,1.0,6/12,46.29%,DLD;RIDA;AMT;GCSH;SHMT2;SHMT1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.37254342096985005,0.8007907267129627,0.7358247422680413,0.9610796062542045,1.0,1/22,0.51%,CETN2
prerank,purine-containing compound biosynthetic process (GO:0072522),0.36439251890244034,0.8006549001699977,0.720098643649815,0.9608727195611557,1.0,3/25,7.65%,PRPSAP1;HPRT1;DGUOK
prerank,nitrogen compound transport (GO:0071705),0.3194519227468593,0.8006411664597447,0.8299595141700404,0.9604941247745244,1.0,27/141,17.27%,SLC7A2;HIKESHI;SLC35F3;SLC38A2;SLC7A11;SCAMP1;TMEM30A;SLC7A7;SLC15A3;SLC7A8;VAMP2;MIA3;KIF3A;RAMP1;SCAMP5;FLVCR1;CALCRL;SLC15A4;RAB7A;SCARB2;SLC44A1;ABCG2;ARL6IP5;CEP290;SCAMP2;RALBP1;ABCC1
prerank,tRNA aminoacylation (GO:0043039),0.3535395845192313,0.800066521126706,0.7384615384615385,0.9609237325788449,1.0,8/37,15.42%,TARS1;FARSA;WARS2;HARS1;AARS1;GATB;LARS1;NARS1
prerank,smoothened signaling pathway (GO:0007224),0.3484366552914056,0.7999781206982045,0.7318235995232419,0.960652821572752,1.0,2/32,3.31%,DYRK2;DISP2
prerank,kinetochore organization (GO:0051383),-0.3276062852005353,-0.7999026460136638,0.744408945686901,0.9675137872259478,1.0,12/13,56.12%,POGZ;MIS12;CENPE;CENPA;CENPF;DLGAP5;CENPT;NDC80;CENPH;CDT1;CENPW;NUF2
prerank,limb development (GO:0060173),0.3619865200302294,0.7998011618572594,0.7285886610373945,0.960532077883216,1.0,7/28,17.12%,MAP3K20;IQCE;CHD7;KAT2B;LNPK;ZNRF3;PCSK5
prerank,snRNA processing (GO:0016180),0.39238635361448604,0.7997761648464541,0.7037533512064343,0.9601674559034669,1.0,3/16,9.20%,INTS12;INTS2;INTS4
prerank,muscle tissue development (GO:0060537),0.405674807652029,0.7991789392370154,0.7083333333333334,0.9606790530826145,1.0,1/13,4.01%,NF1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.3452692764579594,0.7991160187918064,0.7467760844079718,0.9603780638099573,1.0,2/34,5.09%,RORA;SMAD3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.3632692912857085,0.7990237062034203,0.7385204081632653,0.9601147480715706,1.0,6/25,16.98%,BCL2L11;BNIP3;MLLT11;TP53;DNM1L;MFF
prerank,regulation of lamellipodium assembly (GO:0010591),0.35111376860116006,0.7990186627929378,0.7508982035928143,0.9597241264482018,1.0,11/34,18.34%,ACTR3;CAPZB;TWF2;CDC42;ARPC2;WASF2;AUTS2;PIK3R1;CYFIP1;FER;NCKAP1
prerank,mitochondrion transport along microtubule (GO:0047497),-0.3321534388115674,-0.7987522925586565,0.7290322580645161,0.9678569133781084,1.0,4/13,15.24%,OPA1;RHOT1;NEFL;MAP1S
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.3336630522313085,-0.7984062160417421,0.7191358024691358,0.9667073978966968,1.0,3/12,11.23%,PTK2B;FCGR2B;GPR183
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.3827559621210796,0.7982414399714042,0.6957123098201936,0.9604725796124831,1.0,4/15,14.75%,DAB2;DGKD;BMP2K;WASL
prerank,histone H4-K5 acetylation (GO:0043981),0.38714474668837384,0.7982048714788986,0.7056396148555708,0.9597213072225488,1.0,3/15,10.82%,HCFC1;PHF20;JADE3
prerank,histone H4-K8 acetylation (GO:0043982),0.38714474668837384,0.7982048714788986,0.7056396148555708,0.9597213072225488,1.0,3/15,10.82%,HCFC1;PHF20;JADE3
prerank,hyaluronan catabolic process (GO:0030214),0.3813876064271133,0.7979198988443154,0.7266576454668471,0.959752480239683,1.0,3/18,9.66%,SLC9A1;CEMIP2;CD44
prerank,response to interferon-gamma (GO:0034341),0.3327368071229996,0.7976431674240881,0.7931769722814499,0.959765810931125,1.0,9/67,15.45%,IFITM3;CX3CL1;SYNCRIP;CCL25;DAPK1;LGALS9;AIF1;TLR4;CD47
prerank,aorta morphogenesis (GO:0035909),0.3850238791748812,0.797240661321753,0.71334214002642,0.9599411080024001,1.0,4/17,19.14%,BMPR1A;RBPJ;PROX1;LRP1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.3386003717833764,0.7969737690044337,0.7661909989023051,0.9599217130056381,1.0,10/51,15.19%,DAND5;SMAD6;BMPR1A;CRIM1;LEMD2;PPARG;SORL1;HIPK2;UBE2D3;SMAD4
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.38084786885018757,0.7963410261873433,0.7335127860026918,0.9604145547415776,1.0,6/19,17.42%,RUNX1;BMPR1A;TGFBR1;RBPJ;MEF2C;VGLL4
prerank,tube closure (GO:0060606),0.3488194723905466,0.79615246217284,0.7176749703440095,0.960291646188628,1.0,5/31,13.13%,BBS4;TGFB2;MTHFR;DEAF1;LRP6
prerank,central nervous system development (GO:0007417),0.3170396451750848,0.7961367606858978,0.8988988988988988,0.9599165396966957,1.0,43/250,16.09%,ZIC4;BTD;CDK5RAP3;UTP3;GBA2;NNAT;RAB3GAP1;SETD1A;NF1;ELP3;ATXN1;UFC1;PITPNM1;SERPINI1;TUBGCP2;CHD7;AHI1;CDK5;LOXL3;AFF2;CHD8;TGFBR2;SOX11;UGP2;EML1;CHST8;RAB18;UBE3A;PTS;SOX6;S100B;ADAM22;NDRG4;PKD2;RELN;GRIN2A;PTEN;SMG9;SYNJ2;CIC;PDGFC;NFIB;SH3GL2
prerank,positive regulation of immune response (GO:0050778),0.32640692845027725,0.7958469591922267,0.7780126849894292,0.9599297692930236,1.0,5/64,7.87%,POLR3G;RIOK3;IFI35;TGFB2;AKIRIN2
prerank,ribosomal small subunit biogenesis (GO:0042274),0.34445553292397024,0.7957366407080592,0.7578215527230591,0.9596896281523767,1.0,4/39,7.38%,RIOK3;EMG1;RPS17;RRP36
prerank,cellular response to interferon-beta (GO:0035458),0.39966771148512614,0.7956580591065926,0.7260083449235049,0.9594162849056458,1.0,1/14,1.88%,IRF1
prerank,protein monoubiquitination (GO:0006513),-0.24505152791313878,-0.7955225144824257,0.8157894736842105,0.9700229769873645,1.0,18/36,28.17%,WAC;PRKN;HUWE1;FANCL;CUL3;RBX1;UBE2O;KLHL22;DTX3L;OBI1;KLHL12;TOPORS;CDC73;ATXN7L3;RNF40;UBE3D;PAF1;UBE2R2
prerank,positive regulation of protein catabolic process (GO:0045732),0.32649236611542404,0.7950567514036305,0.8045738045738046,0.9599047313470336,1.0,22/84,17.42%,MSN;NRDC;EGLN2;HSP90AA1;EZR;PTTG1IP;NEDD4;HECW1;VPS35;AREL1;FAF1;APC;FURIN;SORL1;VPS11;GPC3;RAB7A;ATG7;RDX;HACE1;SNX9;VGLL4
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.3371754147402555,-0.7947361392603735,0.76,0.9695965327958691,1.0,5/11,21.17%,TGFB1;CSF1;RIPK1;HSF1;CASP8
prerank,axonal fasciculation (GO:0007413),0.40171936006994574,0.79443279608146,0.7181008902077152,0.9604113614246926,1.0,3/12,13.32%,EPHB2;ARHGAP35;RTN4
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.41972131559126297,0.7940808042238592,0.724191063174114,0.9605438620497808,1.0,10/10,58.05%,GNB1;GRK1;RHO;CNGA1;GNAT1;CNGB1;PDE6A;PDE6B;PDE6G;SAG
prerank,positive regulation of potassium ion transport (GO:0043268),0.3446532167667248,0.7939222421444421,0.7375,0.960361368550214,1.0,7/38,14.91%,KCNJ6;FLNA;DLG1;GNG2;GNB1;KCNMB2;KCNMB3
prerank,primary neural tube formation (GO:0014020),0.3508391112578386,0.7936605158165378,0.7342995169082126,0.9603275427045463,1.0,5/30,13.13%,BBS4;TGFB2;MTHFR;DEAF1;LRP6
prerank,positive regulation of filopodium assembly (GO:0051491),0.3607403352237222,0.7933490188482197,0.7395701643489254,0.9603468851389734,1.0,7/24,15.70%,NRP1;FNBP1L;CDC42;DOCK11;WASL;GPM6A;PIK3R1
prerank,positive regulation of neutrophil migration (GO:1902624),-0.2876812956348328,-0.7927957836380408,0.7142857142857143,0.9712273496060158,1.0,4/18,8.56%,MCU;RAC1;RIPOR2;MOSPD2
prerank,lytic vacuole organization (GO:0080171),0.3550632044310084,0.7927854024178503,0.7358943577430972,0.9607245501303754,1.0,7/32,14.45%,LRRK2;AKTIP;ARSB;HPS4;MTOR;ABCA1;TPCN2
prerank,regulation of synapse maturation (GO:0090128),-0.35452969866127293,-0.7925399819136983,0.7472527472527473,0.9699129822564119,1.0,5/10,32.50%,NRXN1;YWHAZ;ADGRL1;CAMK2B;DAB2IP
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.3478492587986562,0.7923155176102165,0.7336561743341404,0.9610041385277849,1.0,4/33,12.05%,RUNX1;PRKCA;ACIN1;ZFP36L1
prerank,negative regulation of cell junction assembly (GO:1901889),0.36682807297922454,0.7920062401964323,0.7478042659974906,0.961057718642288,1.0,8/25,18.14%,ITGB1BP1;THBS1;IKBKB;ROCK2;PTEN;APOD;CLASP2;ROCK1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3256975548394739,0.7918138781747113,0.8301119023397762,0.9609205173896873,1.0,21/100,15.90%,ROR2;TGFB2;PIP4K2A;PDGFB;MAPK1;IRS2;NEDD4;IL18;PIP4K2B;LYN;IGF1R;CBL;PPP1R16B;FN1;INSR;PPP2R5C;PTEN;PIK3AP1;BECN1;PIK3R1;PDGFC
prerank,response to amyloid-beta (GO:1904645),0.34254614801217753,0.7918077468257579,0.7522727272727273,0.9605351100440072,1.0,14/44,18.37%,CD36;ITGA4;CDK5;CACNA1A;IGF1R;PRNP;FYN;GRIN2A;TLR4;LGMN;ABCC1;TREM2;PSEN1;SNX6
prerank,negative regulation of JUN kinase activity (GO:0043508),0.41720773029017677,0.7915765790378545,0.7438271604938271,0.9604832197789066,1.0,2/10,12.26%,DUSP10;AIDA
prerank,positive regulation of interleukin-10 production (GO:0032733),0.35702615982683683,0.7913703045732021,0.7479091995221028,0.9603708154328869,1.0,6/30,17.19%,PRKCZ;HMGB1;SYK;LGALS9;TLR4;PIBF1
prerank,tight junction assembly (GO:0120192),-0.2145043707559668,-0.7912948135369284,0.8613861386138614,0.970493156577417,1.0,3/49,2.17%,F11R;STRN;TBCD
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.32722281670670605,0.7912711102300239,0.7989637305699482,0.9601059128046672,1.0,15/72,15.90%,ROR2;TGFB2;PDGFB;IRS2;NEDD4;IL18;LYN;IGF1R;CBL;FN1;INSR;PIK3AP1;BECN1;PIK3R1;PDGFC
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.3584595602723368,0.7911901641045014,0.7314930991217063,0.9598197985560571,1.0,3/25,11.54%,EAF1;THOC5;ZMYND11
prerank,regulation of cell morphogenesis (GO:0022604),0.35458960248187654,0.7911607313825976,0.7479091995221028,0.9594608370533786,1.0,7/30,15.63%,CFL1;CAPZB;CD44;MYO9A;ZMYM6;PHIP;MACF1
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.32485290568925573,-0.7911293093940414,0.7411003236245954,0.9690184273519097,1.0,3/13,8.09%,TGFB1;TYROBP;ITGB2
prerank,mesoderm development (GO:0007498),0.3814147359126988,0.791002645466559,0.7123834886817576,0.9593024352602016,1.0,2/18,6.56%,BTK;IKZF1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.38085889565597913,0.7904015546066057,0.7367021276595744,0.9598022054096157,1.0,5/18,17.98%,LDLRAP1;ABCG1;ADAM10;ADAM19;PSEN1
prerank,regulation of multicellular organismal development (GO:2000026),0.3597105605225541,0.7900666157338458,0.72375,0.9599009452853953,1.0,1/25,1.20%,EHMT1
prerank,carbohydrate transport (GO:0008643),-0.339449091050898,-0.789840804216123,0.7558823529411764,0.9695333063696403,1.0,7/11,65.98%,SLC2A5;SLC50A1;SLC26A6;AQP11;AQP1;SLC2A2;SLC5A1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.3815439260791298,0.7892229774404066,0.7142857142857143,0.9606826844366769,1.0,1/16,2.34%,FGF1
prerank,negative regulation of leukocyte activation (GO:0002695),0.3940131078992447,0.7887581829791582,0.726123595505618,0.9609478048298358,1.0,1/15,0.91%,MILR1
prerank,positive regulation of signaling (GO:0023056),0.34076588659879425,0.7887178461934279,0.7505800464037123,0.9606076992287688,1.0,7/37,11.42%,VAMP3;CLSTN3;PTPN23;ANXA2;CLSTN1;WLS;SOX11
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3754883979975556,0.7886788669124823,0.7266483516483516,0.9602691289446074,1.0,2/18,7.87%,NF1;TENM4
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.42361519776805473,0.7883099601979475,0.7436305732484076,0.9604034779501841,1.0,3/10,14.95%,PRKCB;PRKD2;ARNT
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.3798587621943723,0.78805531392059,0.7369109947643979,0.9603607057484415,1.0,4/17,16.27%,TPM1;PPARG;PTEN;MEF2C
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.37227361275592125,0.7876429381631277,0.7375328083989501,0.9605400830453765,1.0,2/20,6.93%,HOPX;HSP90AA1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.34661443653601137,0.7875994424698624,0.7532163742690059,0.960210875382761,1.0,5/36,11.45%,PARP9;GAS6;AXL;MAVS;TRIM44
prerank,phospholipid transport (GO:0015914),0.32943566529685003,0.7867614155026259,0.767260579064588,0.9609836595516523,1.0,13/52,17.27%,ATP11C;TMEM30A;PITPNM1;PRELID2;ABCA7;ABCG1;ATP8B4;PITPNA;ABCA1;SCARB2;PITPNB;OSBPL2;ABCC1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.33376611105454723,0.7859215054748986,0.8118918918918919,0.9617228068539105,1.0,4/59,11.07%,SDK2;PTPRT;NPTN;PALLD
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.3428288427841619,0.7858968668745242,0.7861339600470035,0.961358440135986,1.0,12/39,17.68%,NDEL1;MYO5A;FNBP1L;BICDL1;MYO1G;ACTN4;FBXW11;MYO1E;WASL;MYO1B;MYO1D;RAB1A
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.2951718492275454,-0.7858008503358271,0.7665369649805448,0.9747623735211255,1.0,1/17,0.51%,RYR2
prerank,iron ion homeostasis (GO:0055072),0.32752914505476766,0.7857756543080909,0.7727771679473107,0.9611521635290253,1.0,13/58,17.72%,CP;HMOX2;ABCB7;GLRX3;FLVCR1;SLC22A17;NDFIP1;ATP6V0A2;SMAD4;ABCG2;FTH1;FRRS1;FTL
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.3976151291472914,0.7855742410780325,0.7372262773722628,0.9610374374549767,1.0,3/13,14.15%,HACD1;TECR;HACD4
prerank,T cell activation (GO:0042110),-0.20020665381490257,-0.7850735109369691,0.9565217391304348,0.9743675236200331,1.0,17/69,22.78%,PTPRC;PTPN2;PIK3CG;EIF2AK4;KIF13B;NCK2;NLRC3;FKBP1A;HSPD1;GPR89B;GPR89A;NHEJ1;CD74;LMBR1L;CASP8;PTPN22;SCRIB
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.39881131393876024,0.7850021556095282,0.7302052785923754,0.9614350027082701,1.0,5/13,16.20%,TMEM30A;EDEM2;SORL1;SAR1B;CD81
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.3424395718123971,0.7847495305865294,0.7621247113163973,0.9614098945370851,1.0,7/41,16.16%,CX3CL1;DENND6A;CD44;PTPN23;PTPRU;CD47;ADAM19
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.34503010281577573,0.7847153968079519,0.7399756986634265,0.9610693205170959,1.0,3/33,8.54%,RGCC;KMT2E;EZH2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.27472614209997,-0.7844135384459769,0.8304347826086956,0.9737526222885968,1.0,4/21,15.94%,LPCAT3;OSBPL8;PLAAT3;MBOAT1
prerank,protein neddylation (GO:0045116),-0.3171881199365949,-0.7842055380112063,0.7894736842105263,0.9723430640731544,1.0,6/13,18.03%,DCUN1D1;UBA3;NAE1;RBX1;DCUN1D3;NEDD8
prerank,positive regulation of heart contraction (GO:0045823),0.3737117359596718,0.7839223302259704,0.7400530503978779,0.9617775781346511,1.0,2/19,8.61%,TGFB2;TRPM4
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.37070765117460275,0.7838399998776268,0.758485639686684,0.9614916827795723,1.0,3/20,8.83%,PID1;PPFIA1;DAB2
prerank,response to organic cyclic compound (GO:0014070),0.32233669846328367,0.783602160558892,0.7642543859649122,0.9614486937211845,1.0,4/52,8.68%,LRRK2;ESR1;TLR3;IL18
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.2978222663121767,-0.7833841263004857,0.7554744525547445,0.9720057607565791,1.0,3/15,6.70%,PTPN2;NLRC5;CNOT7
prerank,regulation of interleukin-4 production (GO:0032673),0.3683629815330199,0.7831940284172179,0.7069408740359897,0.9616449854916649,1.0,4/21,14.63%,PRKCZ;SYK;LGALS9;HAVCR2
prerank,apoptotic mitochondrial changes (GO:0008637),0.3478805333198752,0.7831109397656302,0.7297619047619047,0.9613703070110603,1.0,9/32,16.98%,NDUFS1;VPS35;BNIP3;ATG3;BCL2;FZD9;DNM1L;HK2;MFF
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.4054003743538091,0.7816385832739329,0.7309941520467836,0.9630007772690035,1.0,1/12,4.27%,AKR1B1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3453654478927486,0.7815516090042349,0.7624242424242424,0.9627399001451119,1.0,7/32,12.48%,STMN2;MAPRE1;ATXN7;CAMSAP3;APC;TAOK1;EML2
prerank,cell projection assembly (GO:0030031),-0.26025919117031726,-0.7812215529778532,0.7853658536585366,0.9738708711063367,1.0,12/22,32.25%,RAC1;PDGFA;PARVG;RHOQ;CAPG;RHOJ;NEFH;RHOH;RHOG;RAC2;PARVA;RHOU
prerank,negative regulation of metabolic process (GO:0009892),0.3288094364834337,0.7810712176851781,0.8021978021978022,0.9630350441990267,1.0,7/54,8.27%,NRDC;ALDH1A1;STK11;ACOT13;MAP2K6;ABHD6;LNPEP
prerank,negative regulation of double-strand break repair (GO:2000780),-0.24860570406643745,-0.7809228747100818,0.861271676300578,0.9726098152244016,1.0,5/30,7.31%,RIF1;ERCC6;SHLD1;SHLD2;KLHL15
prerank,protein alkylation (GO:0008213),0.3652369887505525,0.7803570805062258,0.7404980340760158,0.9636135531029248,1.0,3/22,9.48%,FAM98A;ETF1;SNRPD3
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.32944074236448523,-0.779880281157284,0.7476340694006309,0.9725932615030165,1.0,1/11,14.46%,RTP4
prerank,lipid phosphorylation (GO:0046834),0.41138958464038716,0.7792827896936909,0.7386018237082067,0.9646651813142219,1.0,4/10,17.83%,DGKI;DGKD;DGKZ;DGKH
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.3252396850439686,0.7790758980582699,0.7879746835443038,0.9645691808694864,1.0,7/57,9.10%,MINK1;CACNG7;AKAP9;DLG1;NETO1;DAPK1;GRIA4
prerank,DNA conformation change (GO:0071103),-0.28341068306071304,-0.7790069261146206,0.7617328519855595,0.9722808155021838,1.0,8/17,31.14%,KAT6A;HAT1;TOP3B;TOP3A;TOP1;HHEX;ERCC3;HMGB2
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3471821888043371,0.7789176949809956,0.7590643274853801,0.9643986073013388,1.0,7/33,15.32%,THBS1;DUSP10;PTPN23;MCC;ADIPOR1;PTEN;EVL
prerank,regulation of interleukin-2 production (GO:0032663),0.3368939985302804,0.7788872321691218,0.7808219178082192,0.9640499114316659,1.0,10/43,14.63%,GLMN;HOMER2;RUNX1;IL1A;EZR;SPTBN1;TRAF2;PRNP;PRKD2;HAVCR2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.39014443413198624,0.7788826855392946,0.7286931818181818,0.9636658607920621,1.0,2/13,11.20%,RUNX1;TGFBR2
prerank,keratan sulfate metabolic process (GO:0042339),0.3371139346260502,0.7785211895142036,0.7526377491207503,0.9637468805898601,1.0,4/31,11.61%,B4GALT3;B4GALT5;B4GALT1;B3GNT2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4022191949809703,0.778066123500691,0.7466666666666667,0.9639582622713827,1.0,3/11,15.19%,MLIP;GLRX3;SMAD4
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.3778319057898371,0.7780531523653005,0.7400820793433652,0.96358382113898,1.0,2/16,13.44%,THBS1;PPP1R16B
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.3717482054843214,0.7778068179673014,0.7526737967914439,0.9635174912708651,1.0,3/18,8.72%,ACSBG1;HACD1;TECR
prerank,heterochromatin assembly (GO:0031507),-0.2769075265470372,-0.7773586822660151,0.7869565217391304,0.9732164643185954,1.0,7/20,15.13%,ZNFX1;SIRT2;EZH1;H3-3A;HDAC1;SIRT1;CENPV
prerank,cyclooxygenase pathway (GO:0019371),-0.3397177486799524,-0.7773477449485684,0.744,0.9715044852799949,1.0,6/10,50.90%,PTGES3;PTGES;CBR1;PTGDS;PTGIS;PTGES2
prerank,magnesium ion transport (GO:0015693),0.39198204077383697,0.7768917195630846,0.7299270072992701,0.96433828600693,1.0,2/12,12.14%,NIPAL3;NIPA2
prerank,protein palmitoylation (GO:0018345),0.34713013598491393,0.7767349811931179,0.7684848484848484,0.9641447951484226,1.0,5/30,14.15%,ZDHHC24;ZDHHC5;ZDHHC1;ZDHHC6;ZDHHC20
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.3560525796655088,0.7767289837904677,0.7422552664188352,0.9637626200840269,1.0,7/24,17.58%,PRKAR2A;PDE3B;RNF157;PEX5L;PRKAR1A;RAPGEF2;UBE2B
prerank,regulation of catecholamine secretion (GO:0050433),-0.24272153551391534,-0.7767250196896397,0.8465608465608465,0.9707792955502881,1.0,13/29,31.83%,PRKN;SYT1;GRK2;SNCA;SYT4;SYT2;SYT9;SYT10;SYT7;KCNA2;STX1A;KCNB1;SYT6
prerank,regulation of cation transmembrane transport (GO:1904062),0.3484218167260429,0.7760697916833905,0.7533742331288343,0.9642770751660693,1.0,5/29,13.72%,CACNA1D;DLG1;SLMAP;CD63;KCNIP3
prerank,proteoglycan metabolic process (GO:0006029),0.35608668858083337,0.7760315273498797,0.7601977750309024,0.9639323151671698,1.0,4/26,11.86%,ADAMTS12;CANT1;HS3ST4;CHST8
prerank,regulation of response to interferon-gamma (GO:0060330),0.3917826808998171,0.7759651405412158,0.7690100430416069,0.9636361216985746,1.0,1/14,1.34%,PARP9
prerank,receptor-mediated endocytosis (GO:0006898),0.3113192154909879,0.7758842669510969,0.858728557013118,0.9633645079739125,1.0,28/132,16.20%,CD36;LDLRAP1;GRB2;WASF1;HSPH1;FNBP1L;ARRB2;AP2A1;HSP90AA1;NEDD4;LMBRD1;DAB2;COLEC12;SNX1;RAMP1;SORL1;LRP6;SYK;COLEC11;INSR;CALCRL;EPS15;TPCN2;CLTC;SCARB2;DNAJC13;INPP5F;CD81
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3511960207723009,0.7754361338874092,0.754017305315204,0.9635801392568577,1.0,5/27,13.71%,SPRED2;PTTG1IP;CD44;SPRED1;DDX5
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.34352593727160263,-0.7753631096963315,0.7762039660056658,0.9711849965537448,1.0,4/10,12.33%,SESTD1;ATP1A2;VDAC1;FKBP1A
prerank,cellular response to amino acid starvation (GO:0034198),0.31451591548772984,0.7750986174806125,0.7918454935622318,0.9636476103320968,1.0,14/71,14.53%,EIF2AK2;IMPACT;MAPK1;MIOS;ATP6V0E1;MAPK8;ATP6V1E1;MTOR;SLC38A9;SH3GLB1;EIF2S1;ATP6V0D2;ATP6V1H;LARS1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.312847881863184,0.7750725328524549,0.877139979859013,0.9632951465323553,1.0,13/159,12.29%,SDK2;PCDHB16;MILR1;TGFB2;ACVR1;TENM4;PTPRT;NPTN;CDH11;PALLD;TGFBR2;PCDHGB4;CDH20
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.33160906061460815,0.7748857115217533,0.7649043869516311,0.963160854308345,1.0,8/44,12.05%,EIF4ENIF1;FTO;TNRC6B;METTL3;AGO2;YTHDF1;PUM1;ZFP36L1
prerank,regulation of protein localization (GO:0032880),0.32314828896444914,0.7746263799850783,0.7864077669902912,0.9630946040249423,1.0,7/58,10.54%,FBXW7;DVL1;VPS4A;HSP90AA1;DLG1;MAPK8;TRIM5
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.32593942732193104,-0.7745294822088078,0.7580174927113703,0.9708356818996812,1.0,4/12,14.18%,DHX9;RALB;IFIH1;CGAS
prerank,cellular respiration (GO:0045333),0.3265908012141512,0.7743830975992035,0.7837837837837838,0.9630399306217657,1.0,3/41,3.19%,UQCRH;UQCRC1;NDUFS1
prerank,selective autophagy (GO:0061912),0.3249302499764189,0.7742369924063042,0.789815817984832,0.9628573596923592,1.0,13/56,15.48%,UBA5;UBQLN1;UFC1;SQSTM1;AMBRA1;PCNT;DYNLL2;ULK2;RB1CC1;RAB7A;BECN1;DYNC1I2;DYNC1LI2
prerank,RNA modification (GO:0009451),0.32925575787332856,0.7736477091260808,0.8035126234906695,0.9632510578552174,1.0,6/54,10.36%,NSUN6;RBM15;METTL3;NSUN3;AARS1;ADAR
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.3812255682825915,0.7736425847080187,0.7349397590361446,0.9628724749195384,1.0,2/15,8.52%,COL11A1;PIEZO2
prerank,response to cholesterol (GO:0070723),-0.2850318098338782,-0.7729918709073346,0.7733812949640287,0.97167986884493,1.0,6/17,20.02%,TGFB1;SMAD2;PTCH1;SMO;OSBPL7;ABCA2
prerank,detection of mechanical stimulus (GO:0050982),-0.2785919491195395,-0.7729734878974244,0.7950819672131147,0.9700034916904331,1.0,2/19,4.89%,PTK2;PKD1
prerank,negative regulation of cellular protein localization (GO:1903828),0.3378511719475704,0.7725480165203854,0.7704728950403691,0.963956558413581,1.0,4/34,7.60%,MAP1A;ILRUN;CTNNA1;MAPT
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.34078889999186324,0.7724096819913677,0.7610722610722611,0.9637607693247304,1.0,11/36,17.83%,NFATC1;TNRC6B;AGO2;TCF7L2;GNG2;CALM1;GNB1;FZD3;GNAO1;CTNNB1;PPP3CA
prerank,protein-DNA complex assembly (GO:0065004),0.3095903482409839,0.7723551215398768,0.8469387755102041,0.9634526439296458,1.0,20/116,15.65%,CETN2;PSMD9;ORC4;ASF1A;PSMB8;CDK7;SPTY2D1;PSMC5;MNAT1;BRD2;ORC2;CUL4A;PSMD12;PSMA2;ATRX;GTF2H1;RAD23B;ANP32B;NPM1;PSMB1
prerank,protein acylation (GO:0043543),0.33303457027832667,0.7720870362512467,0.7876712328767124,0.9634185002383077,1.0,8/38,14.15%,CLOCK;EP300;ZDHHC5;ZDHHC1;GTF2B;KAT2B;ZDHHC6;ZDHHC20
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3569183143831288,0.7718425502423812,0.7645569620253164,0.9633519757103441,1.0,4/24,12.68%,CRLS1;GPAM;PLA2G4A;SLC27A1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.3281345362254317,0.771823053911831,0.7610208816705336,0.9629914869352398,1.0,1/39,0.38%,RGCC
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.3707979448738431,0.7715230046191219,0.7441540577716643,0.9630153655731235,1.0,3/17,14.85%,EMC9;CAMLG;EMC2
prerank,response to lipopolysaccharide (GO:0032496),0.3094945885054159,0.77041113107298,0.8675429726996967,0.9641344533806618,1.0,15/138,12.92%,TNFRSF11A;RELA;SMAD6;CTR9;CHMP5;PELI1;LIAS;AXL;IL1A;MAPK8;PLAA;SRR;HMGB1;MAPK14;MAPKAPK2
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3516760551778936,0.770266817924282,0.7673202614379085,0.963932179746441,1.0,4/22,14.78%,CACNA1D;NF1;GNAI3;CACNA1C
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.2386713713556961,-0.769844425294755,0.8273381294964028,0.9734785991032432,1.0,9/34,17.41%,OTUD4;CD300LF;PTPRS;LGR4;GPS2;LY96;TNFAIP3;IRAK3;GRAMD4
prerank,mitotic cytokinetic process (GO:1902410),0.3614149775800544,0.7693610786218364,0.7405913978494624,0.9647646449219426,1.0,4/20,13.31%,VPS4A;CHMP5;VPS4B;PDCD6IP
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.3168848498669429,-0.7690226280761114,0.7941176470588235,0.9731051778160863,1.0,6/13,34.39%,SYT1;SYT4;SYT10;STX1A;KCNB1;CACNA1G
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.3699676380174239,0.768355783321153,0.774496644295302,0.9657372233458914,1.0,3/20,13.90%,THBS1;NPTN;PRKD2
prerank,ketone body metabolic process (GO:1902224),0.39845020761962646,0.7682760219723718,0.7439613526570048,0.9654580526824534,1.0,1/10,3.78%,ACAT1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.39775198744734264,0.7678779121983247,0.7543859649122807,0.9655908853205889,1.0,2/12,9.65%,RUNX1;LYN
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3261784491774416,0.7678704490700663,0.8108407079646017,0.9652130782384744,1.0,7/54,12.11%,SIRT7;UBXN1;SQSTM1;ARRB2;NXN;U2AF2;CAMLG
prerank,regulation of exocytosis (GO:0017157),0.32154652040000303,0.767638074268483,0.7981859410430839,0.9651362958118836,1.0,9/46,13.05%,UNC13D;RAB8B;RAB12;CADPS;LGI3;VAMP2;STXBP5;STXBP5L;RAB3C
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.3918572396213161,0.7675674236971716,0.7654867256637168,0.9648561782103731,1.0,2/13,8.20%,PRPF3;PRPF6
prerank,regulation of peptidase activity (GO:0052547),0.3681419490635146,0.7674907769087836,0.7421052631578947,0.9645775093146713,1.0,3/19,10.43%,PSMB8;NRDC;FURIN
prerank,oligodendrocyte differentiation (GO:0048709),0.3695123118169267,0.7671993043068671,0.7449933244325768,0.9645802443383942,1.0,3/19,12.64%,SOX13;CDK5;SOX6
prerank,regulation of DNA replication (GO:0006275),0.3231867919301493,0.767099183726144,0.8002219755826859,0.9643288320959446,1.0,9/49,15.15%,BLM;EHMT2;PDS5A;FAF1;ZBTB38;ESCO1;TERF1;USP37;CTC1
prerank,positive regulation of ERAD pathway (GO:1904294),0.38048226702956794,0.7670939435788653,0.7690058479532164,0.9639512104305908,1.0,3/13,13.77%,UBQLN1;TMEM259;ATXN3
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3340599077906776,0.7667534641431594,0.7760180995475113,0.9640251165812909,1.0,8/37,14.85%,ABCD2;ALOX5;CUEDC2;PLD4;IL17RA;MAPK14;ABCD1;TLR4
prerank,linoleic acid metabolic process (GO:0043651),0.3694024284867887,0.766635537367689,0.7564276048714479,0.9638011182808291,1.0,3/17,12.94%,ALOX5;FADS1;ABCD1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.36901495743728996,0.766298397497888,0.742296918767507,0.963868508749957,1.0,3/17,11.73%,MAPKBP1;MAP2K5;TMSB4X
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.29381632177758765,-0.7661202783484862,0.7857142857142857,0.9760036077937556,1.0,12/16,35.64%,PIGN;PIGV;PIGB;PIGL;PIGG;PIGX;PIGM;PIGZ;PIGF;PIGA;DPM2;PIGC
prerank,cellular response to light stimulus (GO:0071482),0.31332194230178295,0.7657729162840609,0.8177920685959271,0.9641650566399268,1.0,12/66,16.68%,SMPD1;EP300;METTL3;NEDD4;ERCC4;NOC2L;TP53;EIF2S1;GNB1;NPM1;RHBDD1;ZBTB1
prerank,rRNA modification (GO:0000154),0.3581605404744957,0.7655610478172834,0.7755102040816326,0.9640552197802591,1.0,2/21,6.76%,TFB2M;NSUN3
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.3229617674915052,0.765488376412363,0.7916207276736494,0.9637611898649778,1.0,11/46,18.29%,LRRK2;CACNG7;DGKI;CDK5;GRM7;RELN;DGKZ;MEF2C;ATAD1;TSHZ3;HOMER1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3054774815226786,0.765265211265577,0.8804020100502512,0.9636715265099938,1.0,32/163,16.52%,RELA;CD38;RNF31;RFTN1;PSMD9;PSMB8;PRKCB;BTK;VAV3;PTPRJ;RC3H2;SPPL3;PSMC5;IKBKB;PAK2;NCK1;ICOSLG;NFKBIZ;FBXW11;PSMD12;PSMA2;BCL2;SYK;FYN;PRKD2;SH2B2;THEMIS2;PSMB1;PIK3R1;PAK1;MEF2C;FYB1
prerank,glycerolipid catabolic process (GO:0046503),0.3607018755771572,0.7651410047518724,0.7423638778220452,0.9634445454398073,1.0,4/19,12.07%,ABHD6;PLA2G4A;PNPLA6;GPCPD1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.34505484527090474,0.7651188151238434,0.7407407407407407,0.9630877241856558,1.0,2/25,4.31%,COX17;AKAP9
prerank,ion transport (GO:0006811),0.30793199865937937,0.7649741181954071,0.8598984771573605,0.9628806511043992,1.0,14/111,14.42%,SLC24A5;SLC9A9;SLC9A1;SLC26A11;SLC15A3;PIEZO2;SLC25A26;SLC9A7;SLC9A6;GLRB;MCOLN1;SLC12A6;SLC15A4;SLC20A2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.3088460194039827,-0.7649658347195981,0.7741935483870968,0.9760632289265154,1.0,3/13,5.07%,SYNGR1;SHISA9;CLN3
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.36005052445155256,0.7649618228359927,0.7801778907242694,0.9625105338912757,1.0,5/21,18.31%,CX3CL1;FZD9;FZD3;CTNNB1;PROX1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.36789040952820196,0.7646458584508092,0.7711640211640212,0.9625676445452134,1.0,1/20,4.27%,AKR1B1
prerank,histone H3-K4 methylation (GO:0051568),0.3460016294731355,0.7643639776368133,0.7809762202753442,0.9625650764338127,1.0,2/26,3.61%,CTR9;SETD1A
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.32112997621283423,0.763674800006498,0.8157894736842105,0.9631152182658919,1.0,12/59,14.70%,MED10;RELA;JUN;TNRC6B;MECP2;SETX;TCF7L2;TP53;CDK8;MED27;MED15;PTEN
prerank,DNA integrity checkpoint signaling (GO:0031570),0.3298261149080881,0.7635744186872535,0.7722543352601156,0.9628546339225678,1.0,5/36,9.93%,CLOCK;MAP3K20;NBN;CHEK2;CDC5L
prerank,organelle transport along microtubule (GO:0072384),0.3376019194509715,0.7634728853616446,0.7781774580335732,0.9626051963500745,1.0,9/31,16.28%,NDEL1;BICDL1;MAPT;RAB6A;CDC42;FBXW11;BICD1;PEX14;LRPPRC
prerank,pinocytosis (GO:0006907),0.4053596843902264,0.7633778841366847,0.7642526964560863,0.9623527163789015,1.0,2/10,12.92%,SNX5;MAPKAPK2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.35486217138535814,0.7633618268380112,0.7790697674418605,0.9619923374703098,1.0,3/20,8.83%,PID1;PPFIA1;DAB2
prerank,regulation of B cell differentiation (GO:0045577),0.3691382928866463,0.7632705130903106,0.7777777777777778,0.961723707467507,1.0,4/17,17.29%,BTK;ZFP36L1;SYK;NCKAP1L
prerank,sphingosine biosynthetic process (GO:0046512),0.3986521750163119,0.7628418104220269,0.7430769230769231,0.9615081669346355,1.0,3/11,14.77%,ACER3;ASAH1;SPTLC1
prerank,sphingoid biosynthetic process (GO:0046520),0.3986521750163119,0.7628418104220269,0.7430769230769231,0.9615081669346355,1.0,3/11,14.77%,ACER3;ASAH1;SPTLC1
prerank,CENP-A containing chromatin organization (GO:0061641),-0.23411387017626215,-0.7622740783518068,0.8791208791208791,0.9770111714800443,1.0,6/29,15.52%,SMARCA5;RBBP4;HJURP;NASP;CENPO;ITGB3BP
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.23411387017626215,-0.7622740783518068,0.8791208791208791,0.9770111714800443,1.0,6/29,15.52%,SMARCA5;RBBP4;HJURP;NASP;CENPO;ITGB3BP
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.3930357475576727,0.7622240312721387,0.7474892395982783,0.9619341010894076,1.0,5/13,16.97%,BMPR1A;DAB2;TGFBR1;SMAD4;NUP93
prerank,proteasomal protein catabolic process (GO:0010498),0.3042724491055369,0.7619508739925833,0.9188376753507014,0.9619184596119191,1.0,37/201,14.70%,KLHL42;FBXW7;UBXN1;CLOCK;FEM1C;PELI1;PSMD9;GID4;GID8;PSMB8;ARRB2;NHLRC1;UBE2A;PSMC5;RNF34;NEDD4;ERLEC1;BFAR;HECW1;AREL1;FAF1;RNF216;PLAA;TRIM3;FBXW11;DERL1;CUL4A;UBE2W;PSMD12;NHLRC3;PSMA2;APPBP2;ATXN3;PPP2R5C;TBL1XR1;UBE2D3;RAD23B
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4017231092695519,0.7614729868873941,0.7488789237668162,0.9621350758409194,1.0,2/11,11.20%,LRP5;TGFBR2
prerank,protein deacylation (GO:0035601),0.3489057541152715,0.7614026554728729,0.7609561752988048,0.9618476467131962,1.0,2/23,6.16%,SIRT7;HDAC5
prerank,glycolipid metabolic process (GO:0006664),0.32087419703872794,0.7613769908957486,0.7906976744186046,0.9614978889184745,1.0,7/47,12.72%,GBA2;SMPD3;SMPD1;GALC;ASAH1;B3GALNT1;FUCA1
prerank,embryonic digestive tract development (GO:0048566),-0.28073072029296803,-0.7613245309632276,0.7768924302788844,0.9768358314268029,1.0,3/18,3.58%,SALL1;FGFR2;NIPBL
prerank,tRNA wobble base modification (GO:0002097),-0.29501307360204376,-0.7610177789693258,0.78125,0.9756260668016347,1.0,3/14,7.21%,ELP4;ALKBH8;MTO1
prerank,presynaptic endocytosis (GO:0140238),0.35265553527965104,0.7606936057898953,0.7774936061381074,0.9619847102653942,1.0,6/24,15.36%,STON2;CEL;VAMP2;CDK5;AMPH;SYNJ2
prerank,response to amino acid starvation (GO:1990928),0.30874658560327944,0.7605754621812462,0.8113612004287245,0.9617642199940304,1.0,13/72,13.11%,EIF2AK2;IMPACT;MAPK1;MIOS;ATP6V0E1;MAPK8;ATP6V1E1;MTOR;SLC38A9;SH3GLB1;EIF2S1;ATP6V0D2;ATP6V1H
prerank,membrane fusion (GO:0061025),0.331617890573877,0.7602553925963423,0.7790834312573442,0.961807133247647,1.0,4/33,4.77%,NAPG;VAMP3;MYOF;RABEP1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3162678005873739,-0.7599339578005556,0.7908309455587392,0.973874501415594,1.0,4/11,26.05%,CALM2;FKBP1A;SRI;CALM3
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3162678005873739,-0.7599339578005556,0.7908309455587392,0.973874501415594,1.0,4/11,26.05%,CALM2;FKBP1A;SRI;CALM3
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.3485623495085882,0.7597525150888034,0.7831021437578815,0.9620804994415069,1.0,4/22,11.91%,SMARCA4;UBTF;MTOR;HEATR1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.29165874773278283,-0.7596124339979773,0.7946768060836502,0.9726983361795949,1.0,3/16,3.71%,PARP14;PTPN2;NF2
prerank,skeletal system morphogenesis (GO:0048705),0.32850350294641417,0.7594117390195017,0.8036739380022963,0.9621131843846427,1.0,7/42,13.43%,LRP5;HOXC4;ANKRD11;SOX11;TGFBR1;LRP6;WWOX
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.24540525071943564,-0.7591302567166757,0.8324873096446701,0.9717966502902498,1.0,9/25,25.61%,BMPR2;SMAD2;ACVR2B;UBE2O;NOTCH1;BMPR1B;ENG;SULF1;ZNF423
prerank,respiratory electron transport chain (GO:0022904),-0.3066066273154497,-0.7584226619956648,0.8047945205479452,0.9712059082473579,1.0,10/14,39.26%,SLC25A13;GPD2;SDHB;PPARGC1A;ETFDH;SLC25A12;UQCRFS1;ETFRF1;NDUFA5;SLC25A22
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3781914443077618,0.7580625289299445,0.7703081232492998,0.963427418950006,1.0,1/14,1.07%,LRRK2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.4004292091657543,0.7577114652937247,0.7677224736048266,0.9635001971728421,1.0,3/11,13.42%,TCP1;CCT3;TERF1
prerank,embryonic skeletal system development (GO:0048706),-0.2279899829779196,-0.7576559088505124,0.8591549295774648,0.9706723593824751,1.0,4/35,8.34%,KIAA1217;DSCAML1;XYLT1;SULF2
prerank,cGMP biosynthetic process (GO:0006182),-0.3441336782493658,-0.7575300550855458,0.817910447761194,0.9691873017676457,1.0,8/10,61.86%,GUCY1B1;GUCY1A1;NPPC;NPR2;NPR1;GUCY2F;GUCY2D;GUCY2C
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.39644946372688605,0.7570331127595569,0.7734724292101341,0.9635679656438326,1.0,1/10,4.22%,NFATC1
prerank,calcineurin-mediated signaling (GO:0097720),0.39644946372688605,0.7570331127595569,0.7734724292101341,0.9635679656438326,1.0,1/10,4.22%,NFATC1
prerank,chromatin assembly (GO:0031497),0.3242833540394743,0.7564451590471264,0.7969483568075117,0.9639613966132468,1.0,9/38,15.24%,ASF1A;SPTY2D1;BRD2;NOC2L;TP53;ATRX;ANP32B;CTCF;NPM1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.37509977816960105,0.7562925212834998,0.7602739726027398,0.9633936642617936,1.0,2/16,4.55%,ITGB1BP1;THBS1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.37509977816960105,0.7562925212834998,0.7602739726027398,0.9633936642617936,1.0,2/16,4.55%,ITGB1BP1;THBS1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.3841100769006352,0.7558914632048869,0.7611940298507462,0.963514466916464,1.0,3/12,8.76%,PARP8;PARP2;TNKS2
prerank,neutrophil activation (GO:0042119),0.3820157529360922,0.7558808658985747,0.7592319054652881,0.9631471140085028,1.0,3/12,16.65%,KMT2E;SYK;PREX1
prerank,regulation of monooxygenase activity (GO:0032768),0.35967765963257864,0.7558807463798543,0.7777777777777778,0.9627688158490337,1.0,5/23,14.75%,NOSTRIN;IL1A;HSP90AA1;CALM1;WASL
prerank,regulation of humoral immune response (GO:0002920),0.32115684892216056,0.7552599506149764,0.7772778402699663,0.963148399103465,1.0,5/44,16.20%,C5AR1;CFH;C1QB;PROS1;CD81
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.36550077976230194,0.7547023865147834,0.7736093143596378,0.9634755683109911,1.0,6/18,19.21%,CTR9;CBL;SMAD4;FER;PTPN11;SPI1
prerank,female gamete generation (GO:0007292),-0.2439395206690906,-0.7544548056722857,0.8306010928961749,0.9720088762378011,1.0,3/29,6.79%,USP9X;KMT2D;MCM9
prerank,calcium ion import (GO:0070509),0.34028022646751677,0.7542953180940878,0.7734470158343484,0.9636217489647213,1.0,3/28,9.90%,MICU1;CACNA1D;CACNA1A
prerank,response to molecule of bacterial origin (GO:0002237),0.31045663916724364,0.7542493394026765,0.8276955602536998,0.963303143724104,1.0,9/69,14.85%,TNFRSF11A;SMAD6;PELI1;LIAS;SRR;CYRIB;MAPKAPK2;LGALS9;TLR4
prerank,calcium import into the mitochondrion (GO:0036444),0.3985603407323677,0.7542353345615929,0.7672281776416539,0.962946748217187,1.0,1/10,2.55%,MICU1
prerank,carbohydrate catabolic process (GO:0016052),0.3257206616683202,0.7542092911403366,0.7865429234338747,0.9626090441944214,1.0,5/38,11.56%,PGAM4;PGAM1;ALDOA;ENO1;GCK
prerank,positive regulation of lipid metabolic process (GO:0045834),0.3512492402997407,0.7541017852685603,0.7914507772020726,0.9623740323595714,1.0,4/22,14.36%,PPARG;MTOR;CREB1;PPARD
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.33757593329501356,0.7538519367915615,0.7764423076923077,0.9623183827338638,1.0,7/31,16.57%,CDK6;DLG1;APC;BRD7;PKD2;PTEN;RB1
prerank,dephosphorylation (GO:0016311),0.3027665893366961,0.7538280348575507,0.907258064516129,0.9619713262994065,1.0,26/147,14.87%,DUSP3;SGPP1;DAPP1;PPP2R2A;SGPP2;PTPRJ;CTDNEP1;STK11;DUSP16;DUSP10;SSH2;PTPN1;PTPRT;PPP4R1;PTPN3;FBXW11;PPM1A;CTDP1;DUSP12;PTPRU;PTPRO;PPP2R3A;PPP2R5C;PTEN;PTPN9;PTPN18
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.30649336676912675,0.7536333602185389,0.8645621181262729,0.9618311544448237,1.0,27/119,15.91%,ARF3;SOCS4;SOCS7;MTMR1;PIP4K2A;PIK3R4;PIGP;INPP4A;PITPNM1;PI4KA;PI4K2A;CDS1;PIP4K2B;SOCS5;FIG4;ARF1;EFR3B;OCRL;PIGU;SLC27A1;PIK3C2A;PTEN;SYNJ2;MTM1;PIK3R1;INPP5F;PIGQ
prerank,calcium-mediated signaling (GO:0019722),0.3043090668550851,0.753421732224297,0.8574358974358974,0.9617302414679303,1.0,14/93,14.78%,LRRK2;SLC9A1;PRKACA;BTK;PTPRJ;TRPM4;RCAN2;RCAN3;PRNP;PPP1R9A;CAMKK2;TPCN2;P2RY12;CACNA1C
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3322390671194278,0.7533909725080503,0.7836538461538461,0.9613930064755525,1.0,9/32,18.14%,PGAM1;METAP1;RBM3;ATXN2;TSC1;CYFIP1;EIF4E;FOXO3;ROCK1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.4038224762885307,0.7532925601437156,0.799373040752351,0.961141457393083,1.0,4/10,17.54%,PTPRJ;HGS;NDRG4;APOD
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3036508498957383,0.7531123263076251,0.8580183861082737,0.960983474085291,1.0,22/108,17.43%,UACA;MTCH1;APAF1;SMAD3;EGLN3;MAPT;DAPK1;PPARG;F3;TRAF2;HMGB1;AIFM1;SYK;HTRA2;LGALS9;CASP8AP2;ANP32B;HIP1;ARL6IP5;CFLAR;GSN;SENP1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.265447933680455,-0.7526273612252203,0.8008130081300813,0.9729754936707723,1.0,4/20,7.46%,ACSL4;PPT1;ACLY;ACSL3
prerank,actin crosslink formation (GO:0051764),0.38369562018637793,0.7523375461985558,0.7850877192982456,0.9615910228348241,1.0,3/12,14.65%,FLNA;EPS8;AIF1
prerank,oogenesis (GO:0048477),0.3693755765779296,0.7516618910804733,0.7774524158125915,0.9620828723106487,1.0,2/15,13.05%,METTL3;FMN2
prerank,positive regulation of interleukin-2 production (GO:0032743),0.3516630248178236,0.7511037157120436,0.7911392405063291,0.9623985788179235,1.0,6/25,13.90%,GLMN;RUNX1;IL1A;SPTBN1;TRAF2;PRKD2
prerank,steroid catabolic process (GO:0006706),-0.32478649474542653,-0.7510152362293288,0.7870619946091644,0.9735459617118961,1.0,1/10,5.39%,SPP1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3000845910763166,0.7509784175619634,0.8685015290519877,0.962176609051275,1.0,16/121,12.92%,PARP9;GAS6;NRP1;PDGFB;PTPRJ;ACVR1;PAK2;PTPN1;IL18;LRP8;LYN;CD44;PRNP;ABL1;BANK1;TP53
prerank,positive regulation of monooxygenase activity (GO:0032770),0.3421861141888828,0.7508482669073829,0.7987730061349694,0.961967555915424,1.0,2/26,5.11%,ATP7A;TERF2
prerank,inorganic anion transmembrane transport (GO:0098661),-0.20191512335827497,-0.7504374656213953,0.9324324324324325,0.9727254876355229,1.0,27/63,33.84%,GABRB1;ANO6;GABRA2;ANO3;GABRA3;SLC12A9;GLRA1;CLCN3;SLC20A1;SLC1A1;SLC12A2;GABRA5;SLC6A1;SLC25A30;SLC26A2;GLRA2;GABRA4;GABRB3;GABRG1;SLC25A11;ANO5;SLC25A14;GABRA1;SLC12A7;SLC4A8;SLC12A5;LRRC8A
prerank,positive regulation of glucose metabolic process (GO:0010907),0.381210943889022,0.7504027535676832,0.7763713080168776,0.962162717829024,1.0,2/14,6.71%,IRS1;IRS2
prerank,negative regulation of catabolic process (GO:0009895),0.3195061599833225,0.7501298768968673,0.8042505592841164,0.9621181763452108,1.0,5/47,8.99%,NUPR1;FLNA;PDE3B;SNX3;NCOR1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.33384823293051596,0.7500648434200359,0.7905325443786982,0.961821482823692,1.0,10/32,18.25%,PID1;NUPR1;ENO1;TMSB4X;INSR;ARNT;PFKFB3;TREM2;PSEN1;ZBTB20
prerank,regulation of hippo signaling (GO:0035330),-0.2762296603696813,-0.7498336356285552,0.8208955223880597,0.9720154368535113,1.0,10/17,31.80%,NF2;LIMD1;MARK3;DLG5;CIT;MAP2K3;SHANK2;WWC1;WTIP;WWC2
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3315072108575177,0.7498220062117226,0.7963636363636364,0.9617691565233873,1.0,9/32,16.64%,ACTR3;TWF2;CDC42;ARPC2;WASF2;RREB1;AUTS2;PIK3R1;CYFIP1
prerank,heart process (GO:0003015),-0.30189707104240937,-0.7496692678170426,0.7866242038216561,0.9706102258403608,1.0,2/14,6.06%,SGCZ;SGCD
prerank,positive regulation of viral genome replication (GO:0045070),0.3300265061774006,0.7495641850074961,0.777511961722488,0.961711703946857,1.0,9/29,18.60%,PPID;PKN2;ADAR;SRPK2;TMEM39A;VAPB;TOP2B;DDX3X;STAU1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.3221338941784456,0.7491089123747016,0.7979568671963677,0.9618855285741176,1.0,8/38,15.09%,PTPRJ;ARRB2;PHLPP1;BANK1;SH2B3;PPP2R5C;PTEN;DAG1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3612145952109035,0.7485371699692291,0.7916083916083916,0.9622438938289185,1.0,2/17,11.81%,UNC13D;SCAMP5
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.3750747082355961,0.7484054685537364,0.7796610169491526,0.9620438014888024,1.0,1/14,4.55%,THBS1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3304454028840058,0.7483296114994231,0.7687793427230047,0.9617617179832818,1.0,4/34,5.54%,IRS1;PIK3R4;PDGFB;AMBRA1
prerank,aortic valve development (GO:0003176),0.33262202389668727,0.7476878802658221,0.8248847926267281,0.9622085722649046,1.0,2/34,4.22%,SMAD6;NFATC1
prerank,neuron cell-cell adhesion (GO:0007158),-0.3049402675988542,-0.7473804543403912,0.800711743772242,0.9722005542146718,1.0,8/14,34.25%,ASTN2;NRXN1;NINJ2;NRXN2;CDK5R1;NCAM2;NLGN2;NLGN3
prerank,regulation of trans-synaptic signaling (GO:0099177),0.3298927341481894,0.7471349002649293,0.8004722550177096,0.9625051891720493,1.0,8/33,15.72%,CEL;PSMC5;NRG3;LRP8;CACNA1A;RELN;IQSEC2;GRID2
prerank,positive regulation of wound healing (GO:0090303),0.3223975378853139,0.7470824372032506,0.7755813953488372,0.9621951119128884,1.0,5/36,13.72%,THBS1;ENPP4;ARFGEF1;MTOR;RREB1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.33008555906609083,0.7467630166702545,0.7927823050058207,0.9622034462296858,1.0,8/33,15.70%,NF1;IRS1;NYAP1;IGF1R;ZFP36L1;PIK3C2A;PTEN;PIK3R1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.37689329613212785,0.7458887985284639,0.7578347578347578,0.9628763867308616,1.0,2/15,9.37%,TGFB2;CUEDC2
prerank,arachidonic acid metabolic process (GO:0019369),0.32379712954411183,0.7457295176601716,0.7927823050058207,0.9627039106575245,1.0,3/35,8.47%,GPX4;PLA2G4A;ALOX5
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.3201308813231495,-0.7450114620743339,0.811965811965812,0.973881694700634,1.0,5/11,21.67%,MBTPS2;ATF3;DDIT3;CEBPB;ATF4
prerank,anion transport (GO:0006820),0.33098667760133277,0.7449620316924158,0.8066429418742586,0.9632708616783042,1.0,4/33,15.52%,SLCO1B1;LRRC8B;SLCO2B1;ABCG2
prerank,negative regulation of developmental process (GO:0051093),0.30521909994447466,0.743912228534404,0.8290870488322718,0.9642088551718678,1.0,10/69,15.94%,ADCK1;HOPX;GAS6;CDK6;MAPT;BNIP3;BCL11A;ROCK2;ANP32B;NFIB
prerank,cardiac muscle cell development (GO:0055013),-0.26817913827848255,-0.743505468952375,0.821917808219178,0.974356522199541,1.0,10/20,57.05%,FHOD3;VEGFA;PDGFRA;CXADR;PDGFRB;SLC8A1;MYH11;HEY2;OBSL1;MYL2
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3056099556522315,0.7433018448658409,0.8439490445859873,0.9645877315529031,1.0,15/72,15.19%,PFDN1;STMN2;MAPRE1;ATXN7;ARFGEF1;CAMSAP3;SSH2;TWF2;APC;TAOK1;CYRIB;EML2;LIMA1;CLASP1;SMAD4
prerank,regulation of superoxide anion generation (GO:0032928),-0.29757085311131404,-0.7430339921887703,0.7920792079207921,0.9733837107939695,1.0,3/14,8.09%,TGFB1;TYROBP;ITGB2
prerank,neuromuscular process (GO:0050905),0.3653978141200938,0.7424283500686778,0.7645429362880887,0.9652643768318753,1.0,2/16,7.27%,UBA5;DCTN1
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.3333194923559641,-0.7423805799978923,0.8061797752808989,0.9726905522304808,1.0,5/10,35.37%,UFL1;MLLT3;LMBR1L;BATF;HOXB4
prerank,estrogen metabolic process (GO:0008210),0.3678821455355812,0.7421567970827667,0.7821782178217822,0.9652240826479483,1.0,2/15,12.98%,HSD17B11;HSD17B4
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.32147792192814406,0.7416754607935976,0.8030842230130486,0.9654433360442354,1.0,4/37,6.45%,CLUAP1;DYNLL2;IFT52;IFT20
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.373613486962611,0.74062601318652,0.7862371888726208,0.9663301103890553,1.0,3/13,8.04%,EIF4ENIF1;TNRC6B;AGO2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.32348935557974284,0.7405657953348553,0.8093023255813954,0.9660301352526279,1.0,7/37,12.87%,UBXN1;MAP1A;SDCBP;GIPC1;UCHL5;CAMLG;HIPK2
prerank,regulation of receptor recycling (GO:0001919),0.36089469193414,0.7405192450510211,0.7927807486631016,0.9657221064132872,1.0,5/16,15.88%,VAMP3;KIF16B;ANXA2;OPTN;INPP5F
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.34200585040911186,0.7404015995003477,0.8071065989847716,0.9654789957408577,1.0,3/26,6.71%,BRAF;IRS1;IRS2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.39624702941333534,0.7400869579406276,0.7835365853658537,0.9654923286602353,1.0,3/10,17.29%,PRNP;TLR4;NCKAP1L
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3286039178252065,0.7400561872623549,0.8028846153846154,0.9651616126426805,1.0,4/31,11.81%,RAB3GAP1;SYT12;SYT11;SCAMP5
prerank,regulation of immune effector process (GO:0002697),0.3168113842059286,0.7397021929730239,0.8011494252873563,0.9652049968004337,1.0,5/41,16.20%,C5AR1;CFH;C1QB;PROS1;CD81
prerank,regulation of mRNA catabolic process (GO:0061013),0.2971593456971459,0.7395368015429675,0.8665318503538928,0.9650404295807959,1.0,20/121,12.95%,CARHSP1;PSMD9;PSMB8;EXOSC5;PRKCA;PUM2;RC3H2;EXOSC7;PSMC5;XRN1;SET;YTHDF1;FXR2;PUM1;DCP1A;ZFP36L1;PSMD12;SAMD4A;MAPKAPK2;PSMA2
prerank,T cell homeostasis (GO:0043029),-0.32619211703715345,-0.7394028367354523,0.8222222222222222,0.9752134301375862,1.0,3/10,23.37%,AKT1;PPP2R3C;ZC3H8
prerank,activation of GTPase activity (GO:0090630),0.29942507237715577,0.7390612102548633,0.8593429158110883,0.9652377371934009,1.0,20/89,15.00%,SIPA1L3;TBC1D15;GPR65;EVI5;TBC1D17;ARHGAP22;TBC1D14;TBC1D10B;SIPA1L2;TBC1D4;TBC1D12;TBC1D5;TBC1D10A;TBC1D13;RABGAP1;ARHGAP45;TBC1D22A;TBC1D8;TSC1;TBC1D1
prerank,response to axon injury (GO:0048678),0.3566097992186697,0.738999932208937,0.7932885906040269,0.9649347789841464,1.0,6/18,17.88%,NREP;MTR;GAP43;P2RY12;APOD;TREM2
prerank,carbohydrate biosynthetic process (GO:0016051),0.3432537912876061,0.7381292231731807,0.7710526315789473,0.9655902036866759,1.0,8/21,19.07%,MPDU1;B4GALT1;B3GALT1;ST3GAL2;ST3GAL4;B3GALT5;ST3GAL3;FUT8
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.34771276680427515,0.7381149530267983,0.7971576227390181,0.96523622993659,1.0,2/20,4.25%,MICU1;LETM1
prerank,transcription preinitiation complex assembly (GO:0070897),-0.301685243746251,-0.7380057329638419,0.8189910979228486,0.9755443308969787,1.0,7/12,31.90%,TAF1;GTF2A2;TBP;DR1;TAF12;TAF11;TAF7
prerank,ERK1 and ERK2 cascade (GO:0070371),0.35205228167302144,0.7378164110479869,0.7864583333333334,0.9652346802205404,1.0,6/21,18.23%,MAPK1;ZFP36L1;MAP2K2;LGALS9;MAP2K1;CTSH
prerank,macrophage activation (GO:0042116),0.32493541971775897,0.7377668745613849,0.7917159763313609,0.964916474267721,1.0,4/34,7.60%,C5AR1;CX3CL1;IFI35;MAPT
prerank,organelle disassembly (GO:1903008),0.32711984926898635,0.7377278620730677,0.8215568862275449,0.964588302166076,1.0,5/33,12.19%,DENR;UBA5;UFC1;ULK2;RB1CC1
prerank,determination of bilateral symmetry (GO:0009855),0.336289879715435,0.7374914021424913,0.7934508816120907,0.9645026000010913,1.0,1/24,2.69%,ARL6
prerank,negative regulation of coagulation (GO:0050819),-0.3017659484547538,-0.7373475209958313,0.7835051546391752,0.9748034149558966,1.0,4/14,20.98%,SERPINE2;HS3ST5;CD34;TFPI
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.38094476258558396,0.73727093202454,0.775112443778111,0.9644075455466264,1.0,3/12,15.97%,PTPRO;MYO1E;IQGAP1
prerank,regulation of anoikis (GO:2000209),-0.2629869245172859,-0.7364393453161808,0.8531746031746031,0.9743103587262913,1.0,11/19,32.66%,PTK2;MCL1;PIK3CA;ITGA5;NOTCH1;SRC;TLE5;MYBBP1A;PTRH2;ITGB1;SIK1
prerank,heterochromatin organization (GO:0070828),-0.2886101659728497,-0.7361494181865488,0.8426229508196721,0.9730917221346506,1.0,5/14,17.95%,SETDB1;EZH1;SETD7;SIRT1;SETDB2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3648119723566653,0.736082324747236,0.7939914163090128,0.9654780033994079,1.0,4/15,17.88%,EHD1;MAPK14;CAMK1;TREM2
prerank,genitalia development (GO:0048806),-0.2968266125380373,-0.7351528581434517,0.7951388888888888,0.9728507869642268,1.0,3/12,19.48%,PKD1;DNAJC19;TIFAB
prerank,regulation of macromolecule metabolic process (GO:0060255),0.29445820757151053,0.7350830945415361,0.9065326633165829,0.9663170721715904,1.0,29/170,15.66%,C1D;TARDBP;MTMR1;PRDM10;NELL1;CDK2;CDK6;PRDM4;ADNP2;KIF16B;AFF2;TRIM5;ARF1;NFKBIZ;ZNF711;TRIM44;AFF1;PRDM1;ZFP36L1;FUBP3;COQ7;PCBP3;ROCK2;AIF1;SCARB2;CTCF;TRIM26;HNRNPK;AFF4
prerank,peptidyl-arginine modification (GO:0018195),0.3631958645396974,0.7348123425245748,0.7859195402298851,0.9662410294093899,1.0,1/15,4.60%,PADI2
prerank,regulation of BMP signaling pathway (GO:0030510),0.3050344145252464,0.7346768358967382,0.8631578947368421,0.9660173287235257,1.0,13/73,15.19%,DAND5;SMAD6;BMPR1A;CRIM1;LEMD2;PPARG;SOX11;SORL1;HIPK2;PCSK6;RBPJ;UBE2D3;SMAD4
prerank,Notch signaling involved in heart development (GO:0061314),0.385474919734206,0.7344989387893623,0.7767722473604827,0.9658619501817427,1.0,3/11,18.39%,NOTCH2;RBPJ;GALNT11
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.3404328136039843,0.734436554309442,0.78562421185372,0.965573965483,1.0,1/25,1.82%,CX3CL1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.345193727686803,0.7342063715754686,0.7908847184986595,0.9654685798602203,1.0,8/20,19.38%,RGS14;RNF157;RPGRIP1L;BICD1;YWHAB;GPRASP1;PLEK;GRK3
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.2975204523557361,0.7336836721617653,0.8640167364016736,0.9657400198796705,1.0,14/87,14.70%,RGCC;PSMD9;PSMB8;CDK6;PSMC5;DLG1;APC;ZFP36L1;PSMD12;BRD7;PSMA2;PKD2;FBXL7;PTEN
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.2907098072902863,-0.733539606933713,0.8157894736842105,0.9734071776866354,1.0,6/14,22.93%,RIF1;SHLD1;SHLD2;PAXIP1;HMCES;TFRC
prerank,histone H4-K16 acetylation (GO:0043984),0.3452636470042709,0.7334761055159585,0.7897574123989218,0.9656268299710214,1.0,8/19,18.80%,HCFC1;PHF20;JADE3;MSL2;KANSL1;KANSL3;KAT7;KMT2A
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.3873094666639621,0.7333725754189546,0.7786624203821656,0.9653788590848618,1.0,4/10,17.83%,DGKD;GAP43;PLPP1;DGKH
prerank,modulation by symbiont of entry into host (GO:0052372),-0.27955656211259017,-0.7333369941638177,0.8217821782178217,0.9720544671034075,1.0,5/16,19.89%,HS3ST5;EXOC2;EXOC7;FUCA2;TRIM27
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.2972263729676937,0.7328865158144633,0.8556485355648535,0.9656015662922129,1.0,15/88,15.65%,FBXO17;FBXW7;PSMD9;PSMB8;FBXO9;PSMC5;AMN1;FBXW11;CUL4A;FBXO38;PSMD12;PSMA2;FBXL7;FBXW4;PSMB1
prerank,negative regulation of chemokine production (GO:0032682),0.3629860975245726,0.7325412538251835,0.8005698005698005,0.9656569171089885,1.0,3/14,17.54%,MAP2K5;LGALS9;APOD
prerank,JNK cascade (GO:0007254),0.3155256898655117,0.73228490585266,0.8268551236749117,0.9655927410801277,1.0,5/40,9.05%,MINK1;MAP3K11;MAPK8;IRAK2;TAB3
prerank,polyamine metabolic process (GO:0006595),-0.30321206544909374,-0.7309761116342024,0.82,0.9735851802534774,1.0,5/13,19.03%,SAT1;SMS;AMD1;PAOX;OAZ2
prerank,GPI anchor biosynthetic process (GO:0006506),-0.23074879936152864,-0.7309244137827253,0.9393939393939394,0.9720347342778793,1.0,17/30,35.64%,PIGN;PGAP2;PIGV;PIGB;DPM1;PIGL;PIGG;PIGX;PIGM;PIGT;MPPE1;PIGZ;PIGF;PIGA;PIGS;DPM2;PIGC
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3391005050243221,0.7308657819523728,0.8041504539559015,0.9669084062880365,1.0,2/23,5.65%,LMAN1;TMED9
prerank,lipid translocation (GO:0034204),0.34160193021582536,0.7304656448128705,0.8076416337285902,0.9669983101642012,1.0,5/21,12.85%,ATP11C;TMEM30A;ABCA7;ATP8B4;ABCA1
prerank,dendritic spine morphogenesis (GO:0060997),0.3640919762988815,0.7300205337208074,0.8166666666666667,0.9671727808186966,1.0,5/15,16.64%,EPHB2;CDC42;PTEN;WASL;DOCK10
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.3779459178943082,0.7297862541732806,0.810126582278481,0.9670730353388737,1.0,2/13,11.65%,SOAT1;RAMP1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.35422147873808113,0.7295125112491768,0.7969821673525377,0.9670376709964633,1.0,3/16,8.78%,RBM3;NUP98;TRA2A
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.3798359458146324,0.7293277374245228,0.7791411042944786,0.9668862391509062,1.0,2/10,10.69%,APC;CDC42
prerank,calcium-ion regulated exocytosis (GO:0017156),0.3293104861700833,0.7288174586937178,0.801980198019802,0.967123574171343,1.0,4/27,9.85%,VAMP7;SYT12;SYT11;VAMP2
prerank,protein processing (GO:0016485),0.29537526958813903,0.7284002797801922,0.8607983623336745,0.9672357688220211,1.0,16/102,17.12%,TYSND1;CD5L;CPD;CPE;SPPL3;F3;FURIN;PARL;ADAM10;PCSK6;HTRA2;ADAM19;LGMN;KLK2;FAM111A;PCSK5
prerank,peptidyl-tyrosine modification (GO:0018212),0.3049088795380504,0.7283443112696337,0.8369803063457331,0.966936563825403,1.0,11/56,14.25%,DDR2;EPHB2;PDGFB;BTK;ABI1;LYN;ABL1;SYK;INSR;FYN;RELN
prerank,calcium ion import across plasma membrane (GO:0098703),-0.2902171315428205,-0.7280273504989359,0.8213058419243986,0.9741561051146636,1.0,1/14,1.07%,CACNA2D1
prerank,pteridine-containing compound metabolic process (GO:0042558),0.3733602659852771,0.7277567563915631,0.7876506024096386,0.9672498496772751,1.0,3/13,14.29%,HSP90AA1;PTS;CALM1
prerank,cardiac ventricle development (GO:0003231),0.34702082919238236,0.7272942309334619,0.8002610966057441,0.9674404132686037,1.0,1/20,2.02%,DAND5
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.36124029362178134,0.7263786210444297,0.7929078014184398,0.9681306863214214,1.0,4/14,14.61%,CHKB;SLC27A1;CHKA;ETNK1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.3429075928261509,0.7262269964284404,0.8142857142857143,0.9679415534019308,1.0,6/21,17.22%,RELA;PRKCB;SLC39A10;PRKD2;CD81;PRKCH
prerank,axonal transport (GO:0098930),0.3198664227797836,0.7262212173665132,0.8270858524788391,0.967583613026113,1.0,7/36,11.52%,AP3M1;DCTN1;MAPT;DTNBP1;AP3M2;FBXW11;KIF3A
prerank,L-amino acid transport (GO:0015807),0.32256997057573505,0.7260742309565762,0.7995110024449877,0.9673668780912642,1.0,3/28,8.66%,SLC7A2;SLC38A2;SLC7A8
prerank,T cell differentiation in thymus (GO:0033077),-0.2800451161238093,-0.7252658992933622,0.8475177304964538,0.9759844432343364,1.0,1/14,1.20%,PTPRC
prerank,negative regulation of cation channel activity (GO:2001258),0.3295594823017103,0.7249187254974718,0.8179551122194514,0.9683130513245214,1.0,4/26,14.29%,EPHB2;UBQLN1;PKD2;CALM1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.37587740300667316,0.7243047780570145,0.7915360501567398,0.9686296369175486,1.0,3/11,16.27%,FRS2;SOX6;MEF2C
prerank,positive regulation of autophagy (GO:0010508),0.29474139960890106,0.724194724479439,0.8607329842931937,0.9683805639827092,1.0,16/81,14.38%,LRRK2;EPM2A;STK11;BNIP3L;DAPK1;MTDH;TPCN1;TRIM5;BNIP3;HMGB1;GNAI3;ATF6;SH3GLB1;PIK3C2A;CAMKK2;OPTN
prerank,response to reactive oxygen species (GO:0000302),0.30302151071909267,0.7229138028769012,0.8408839779005525,0.9694718095357012,1.0,14/54,17.54%,JUN;TPM1;MAPK1;MAPT;MAPK8;PXN;TXNRD2;CAMKK2;FYN;PKD2;STK24;COA8;FER;APOD
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3266079297317511,0.7225591678582061,0.833939393939394,0.9695085882507295,1.0,8/29,16.40%,IRF3;BIRC3;IKBKB;TLR3;TANK;UBE2D3;TLR4;TBK1
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.3453808123652726,0.7225215835566455,0.8106355382619974,0.9691816054472902,1.0,5/21,16.97%,BMPR1A;DAB2;TGFBR1;SMAD4;NUP93
prerank,calcium ion import into cytosol (GO:1902656),-0.2837406987034643,-0.7213762327944925,0.8279569892473119,0.979260098201383,1.0,1/15,1.07%,CACNA2D1
prerank,negative regulation of DNA replication (GO:0008156),-0.29296057723644053,-0.7208686737356585,0.8354430379746836,0.9783093076852268,1.0,2/13,3.59%,WAPL;ATR
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3288272641109418,0.7208298472753674,0.8123393316195373,0.9707731381760297,1.0,6/25,17.14%,NDST3;B3GALNT1;B3GNT2;EXT1;B3GALT1;EXT2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.2632329546163678,-0.7205824604692805,0.8366533864541833,0.9770138118817216,1.0,5/18,23.23%,CHRM3;GRK2;OPRM1;CDK5R1;GNA11
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.24101804663769424,-0.7205791771948745,0.8851063829787233,0.9754083845858239,1.0,13/24,32.37%,SUCLA2;ALAS1;CPOX;COX10;ATP5IF1;ABCB10;PGRMC1;SLC25A38;NFE2L1;PPOX;COX15;RSAD1;TSPO
prerank,copper ion homeostasis (GO:0055070),0.35262793385231395,0.7202010074568851,0.8194254445964432,0.9711240692136374,1.0,4/17,11.64%,ATP7A;ARF1;PRNP;SLC31A1
prerank,ear morphogenesis (GO:0042471),0.33803322732199104,0.7198684060069326,0.8032786885245902,0.9711350163805443,1.0,2/20,8.95%,EPHB2;CHD7
prerank,tRNA processing (GO:0008033),0.2992893839711918,0.7197562424094277,0.8571428571428571,0.9708844946400823,1.0,5/61,8.31%,NSUN6;CSTF2;PTCD1;POP1;AARS1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.3517389140779627,0.7195428891405143,0.8098495212038304,0.9707373926659072,1.0,4/16,14.78%,PRKACA;CAMK2D;CALM1;CACNA1C
prerank,adrenergic receptor signaling pathway (GO:0071875),0.3389047273947191,0.7193755195972545,0.8233034571062741,0.9705668265198644,1.0,3/20,10.68%,ADCY9;LMBRD2;AKAP13
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.28942846669603106,-0.719322153005112,0.8398692810457516,0.9753375929781426,1.0,5/13,22.94%,SESN1;SESN3;CASTOR2;RNF152;SZT2
prerank,positive regulation of cartilage development (GO:0061036),0.35057317866816534,0.7186244149891847,0.7924528301886793,0.9710732521828737,1.0,1/17,2.21%,TAPT1
prerank,neutrophil chemotaxis (GO:0030593),0.30229896105775533,0.7186164192362775,0.8520971302428256,0.9707142267518466,1.0,3/53,7.28%,CX3CL1;TGFB2;CCL25
prerank,regulation of establishment of planar polarity (GO:0090175),0.29307374373042844,0.7185103184854972,0.8782791185729276,0.970462021165908,1.0,7/88,6.95%,ROR2;DVL1;PSMD9;PSMB8;ARRB2;AP2A1;PSMC5
prerank,membrane protein proteolysis (GO:0033619),0.3166009718090572,0.7177849128397898,0.8366394399066511,0.9709096416593831,1.0,12/37,18.23%,RELA;SPPL3;PARL;ERAP1;ADAM10;NAPSA;DAG1;RHBDD1;ADAM19;PSEN1;SPPL2A;CTSH
prerank,alcohol catabolic process (GO:0046164),0.38043252126005656,0.7176065665002443,0.8052550231839258,0.9707354749944457,1.0,1/10,6.94%,CEL
prerank,response to interleukin-4 (GO:0070670),-0.3126412252071303,-0.717198272970244,0.8005698005698005,0.9763428752294364,1.0,9/10,68.76%,XBP1;JAK3;SHPK;LEF1;TCF7;GATA3;DCSTAMP;CITED1;RUFY4
prerank,calcium ion transport (GO:0006816),0.28908470541731,0.7171501091747305,0.8977505112474438,0.9708872785808729,1.0,16/113,14.78%,SLC24A5;TRPC5;MICU1;CACNG7;CACNA1D;GAS6;TRPM4;TRPC4AP;CACNA1A;MCOLN1;RAMP1;TRPV2;FYN;CALCRL;PKD2;CACNA1C
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.3565393753885638,0.7161807039566997,0.819327731092437,0.971241789348679,1.0,3/15,10.36%,AP3M1;DTNBP1;AP3M2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.3565393753885638,0.7161807039566997,0.819327731092437,0.971241789348679,1.0,3/15,10.36%,AP3M1;DTNBP1;AP3M2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.2928048843541565,0.7160281292461564,0.857449088960343,0.9710492718885968,1.0,12/70,12.95%,CD36;VAMP3;PSMD9;PSMB8;PSMC5;ITGB5;IKBKB;TAP1;LNPEP;PSMD12;NCF4;PSMA2
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.3757544640258467,0.7151105328933672,0.8206599713055954,0.9717339901613623,1.0,1/12,1.63%,CD36
prerank,regulation of store-operated calcium entry (GO:2001256),0.37388919924752234,0.7148967298666402,0.8028391167192429,0.9716095563528364,1.0,1/10,2.77%,HOMER2
prerank,myelination in peripheral nervous system (GO:0022011),0.3556402555503866,0.7145392937996702,0.8052325581395349,0.9716468056365674,1.0,1/13,4.01%,NF1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.29226639953557887,0.7141658412193465,0.8783068783068783,0.9716740274867258,1.0,7/85,6.95%,ROR2;DVL1;PSMD9;PSMB8;ARRB2;AP2A1;PSMC5
prerank,phosphate ion homeostasis (GO:0055062),0.379743942533634,0.7139000874429865,0.8159879336349924,0.9716124215980891,1.0,1/10,11.18%,XPR1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.3577853865398689,0.7135129612931974,0.8068181818181818,0.9716911324127514,1.0,2/14,10.87%,TLR3;TRAF2
prerank,glutamine family amino acid metabolic process (GO:0009064),0.31709888498440225,0.7134273671323009,0.8388625592417062,0.9714163588526727,1.0,1/33,0.82%,PYCR2
prerank,regulation of gastrulation (GO:0010470),0.3588413175633783,0.7132499531107471,0.8164116828929068,0.9712393312864546,1.0,4/14,18.03%,TENM4;DAG1;CLASP1;CLASP2
prerank,regulation of epithelial cell migration (GO:0010632),0.3023055680495021,0.7132130189701469,0.8604143947655398,0.9709146471843482,1.0,13/51,15.63%,TGFB2;SASH1;DOCK1;DUSP10;ARSB;PTPN23;RTN4;MCC;ADIPOR1;RREB1;CLASP1;EVL;MACF1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.32843815527579406,0.7127728383716948,0.815989847715736,0.9710311068861996,1.0,5/24,12.73%,RNF34;MAP2K6;IRAK2;TAB3;CYLD
prerank,regulation of nuclear division (GO:0051783),-0.25208428244397396,-0.7125322305010118,0.902542372881356,0.9802903618869789,1.0,2/20,5.72%,CDK13;CUL9
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.37441753196770367,0.7124754020639632,0.8208955223880597,0.9709898274286312,1.0,2/12,7.83%,KPNB1;SEC14L2
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3557710234986663,0.7124004304961169,0.8166431593794076,0.9707196672050968,1.0,1/14,3.24%,TFB2M
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.32184525291463867,0.7122839149214752,0.8475609756097561,0.9704807564533001,1.0,8/30,16.40%,IRF3;BIRC3;IKBKB;TLR3;TANK;UBE2D3;TLR4;TBK1
prerank,regulation of protein neddylation (GO:2000434),-0.3269179461997065,-0.7122053996303427,0.8567164179104477,0.9790768876906881,1.0,4/10,13.45%,DCUN1D1;RPL5;DCUN1D3;RPL11
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.32500795065097343,0.711346420183291,0.8190954773869347,0.9711470231712309,1.0,2/23,8.02%,PLA2G6;PLA2G4A
prerank,cardiac conduction system development (GO:0003161),0.3295518744017798,0.7112978342819666,0.8175,0.9708430204124804,1.0,3/24,15.19%,BMPR1A;NOTCH2;SMAD4
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.33695871791897236,0.7110242258907851,0.8189300411522634,0.9707685798261881,1.0,4/18,15.51%,HDAC5;FRS2;SOX6;TMEM119
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.3685357829480478,0.7104799602751051,0.8006042296072508,0.9709869746454974,1.0,4/11,16.10%,TP53;MAP2K2;DDX5;MAP2K1
prerank,negative regulation of complement activation (GO:0045916),-0.3157450354732625,-0.7101447004001037,0.8273972602739726,0.9799384463476435,1.0,6/10,50.61%,CD46;SUSD4;CD55;A2M;SERPING1;VSIG4
prerank,positive regulation of immunoglobulin production (GO:0002639),0.31531705666020915,0.7095894050370741,0.8380952380952381,0.971600023399559,1.0,4/31,9.33%,VAMP3;EPHB2;KMT5B;KMT5C
prerank,polyol biosynthetic process (GO:0046173),-0.26410866425211166,-0.7085752702391716,0.8587786259541985,0.9801183854567741,1.0,5/16,14.90%,CYP27A1;PPIP5K1;IP6K2;FGF2;IPPK
prerank,prostanoid biosynthetic process (GO:0046457),-0.2716333640933679,-0.707884988810281,0.837037037037037,0.9793227890236829,1.0,2/15,6.69%,PNPLA8;PTGES3
prerank,regulation of interleukin-1 production (GO:0032652),0.3415687669631487,0.7073269545068511,0.7890173410404624,0.9737404285117125,1.0,3/15,14.85%,GAS6;HMGB1;TLR4
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.28719244072255856,-0.7070814574855542,0.8204334365325078,0.978590611174815,1.0,2/12,10.19%,WAPL;RAD21
prerank,inner dynein arm assembly (GO:0036159),-0.30937735375345216,-0.7066151492667416,0.8547945205479452,0.9775215689778054,1.0,9/10,69.08%,DNAAF5;CCDC39;CCDC40;DNAI3;DNAAF1;DNAH1;CFAP100;DNAAF4;CFAP73
prerank,cellular response to acid chemical (GO:0071229),-0.2304886839961909,-0.7052341309189863,0.91005291005291,0.9774217670991036,1.0,11/27,24.04%,CPEB3;CPEB4;GLRA1;LAMTOR1;LAMTOR3;RRAGD;RRAGB;RPTOR;NSMF;GLRA2;XBP1
prerank,aggrephagy (GO:0035973),0.3204471770650118,0.7050274874865055,0.8401486988847584,0.9759033157163529,1.0,4/27,5.96%,UBQLN1;SQSTM1;PCNT;DYNLL2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.316886230884727,0.704979870796027,0.8377358490566038,0.9755940123562782,1.0,3/27,9.84%,CHSY1;UGDH;BGN
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.297573719971434,0.7048855452504084,0.8626799557032115,0.9753334546973982,1.0,6/52,8.18%,EPHB2;SQSTM1;ZDHHC5;DLG1;STX3;SPTBN1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.35841752340947614,0.7045456046137469,0.8225352112676056,0.9753373389878929,1.0,2/15,10.43%,NRDC;FURIN
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.2204129967883925,-0.7043144532552539,0.9593023255813954,0.9768660179945166,1.0,7/29,15.31%,SORBS1;CHP1;ELOVL5;CNEP1R1;AKT1;SCARB1;CREBL2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.3450903325912406,0.7042852498397234,0.831081081081081,0.975251135085284,1.0,3/18,11.58%,MECP2;RAD51B;VPS4B
prerank,regulation of macrophage migration (GO:1905521),0.3716226370967265,0.7040392926956545,0.8421875,0.9751665218849962,1.0,3/10,16.20%,MTUS1;P2RY12;CD81
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.37934882904725953,0.7039509063050857,0.8177570093457944,0.9745368868178393,1.0,3/10,14.68%,AP2A1;MYLIP;CLTC
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.37934882904725953,0.7039509063050857,0.8177570093457944,0.9745368868178393,1.0,3/10,14.68%,AP2A1;MYLIP;CLTC
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.35171048776533326,0.7036958486994501,0.8512518409425626,0.9744434873018878,1.0,1/14,4.31%,AKAP9
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.307531912907092,-0.7032121228065815,0.8538011695906432,0.976528771868445,1.0,2/10,5.56%,ADAM9;EPB41L4B
prerank,catecholamine metabolic process (GO:0006584),0.3496686043379749,0.7025528369402304,0.8231098430813124,0.9753270554018886,1.0,1/14,5.05%,ATP7A
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.28956824204717274,0.7025219370333031,0.8701298701298701,0.9749946295785885,1.0,11/67,12.95%,CD36;VAMP3;PSMD9;PSMB8;PSMC5;ITGB5;IKBKB;TAP1;PSMD12;NCF4;PSMA2
prerank,acetyl-CoA metabolic process (GO:0006084),-0.2741085667569264,-0.7024526516899294,0.8475177304964538,0.975789326249348,1.0,3/15,6.34%,ACSS1;DIP2A;ACLY
prerank,ganglioside metabolic process (GO:0001573),0.3232413786670986,0.7019604017607609,0.8242894056847545,0.975252950483398,1.0,1/20,1.79%,ST8SIA4
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.34868600196981936,0.7019566990405476,0.814388489208633,0.9748949205681947,1.0,2/13,9.66%,PTTG1IP;CD44
prerank,modulation of chemical synaptic transmission (GO:0050804),0.2848924925917466,0.7015233522433166,0.9125514403292181,0.9749815087288664,1.0,20/107,16.27%,LRRK2;AKAP9;CLSTN3;CEL;PSMC5;NRG3;SYN3;DGKI;LRP8;USP46;CDK5;CACNA1A;CLSTN1;GRM7;RELN;PTEN;IQSEC2;GRID2;DGKZ;MEF2C
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.31137787813931533,-0.7009824025961123,0.8559322033898306,0.9758634107106107,1.0,2/10,4.56%,PTPRC;FCGR2B
prerank,protein mannosylation (GO:0035268),-0.23652956154679405,-0.7007688224781881,0.9036697247706422,0.9745332231687543,1.0,6/22,17.97%,TMTC2;DPY19L4;TMTC1;TMTC3;RXYLT1;DPM1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.2805458713117342,0.700744962665226,0.9074262461851476,0.9754559345336863,1.0,20/113,14.85%,CD36;BCL2L11;ESR1;HSP90AA1;PSMC5;RAP1B;SLF1;ERCC4;FNIP1;FAF1;TAL1;CUL4A;SH3GLB1;ABCA1;TP53;SYK;TERF1;GTF2H1;SPIDR;TLR4
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3124395909215101,0.7005615487418356,0.846517119244392,0.9752924878434639,1.0,3/32,4.55%,ADAM15;ITGB1BP1;THBS1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.37165843043611635,0.7001161493533729,0.8140243902439024,0.9754221529699156,1.0,1/10,6.68%,PDE3B
prerank,negative regulation of defense response to virus (GO:0050687),0.36181219051377,0.6999238048706744,0.8119402985074626,0.9752580806656325,1.0,1/10,4.92%,ILRUN
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.30486816944510803,0.6995520620083246,0.8380614657210402,0.9752714645840447,1.0,3/34,8.10%,VAMP3;EPHB2;LACC1
prerank,protein lipidation (GO:0006497),0.2922182522491942,0.6992152515792726,0.8766233766233766,0.9752563693363071,1.0,10/59,15.91%,WDR45;WDR45B;PIGP;ZDHHC5;ZDHHC1;PIGU;ZDHHC6;ZDHHC20;ATG7;PIGQ
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.34509657442003155,0.6991060907509273,0.819718309859155,0.9750003354552572,1.0,2/14,13.57%,SPRED2;SPRED1
prerank,regulation of autophagosome maturation (GO:1901096),-0.2889023097621152,-0.6985895743856557,0.8762214983713354,0.9753092428394405,1.0,7/13,27.59%,CLEC16A;CLN3;IRGM;SMCR8;UBQLN4;PHF23;TBC1D25
prerank,aminoglycan catabolic process (GO:0006026),0.31095537851329186,0.6985820857628156,0.8343483556638246,0.9751871437821834,1.0,6/28,16.08%,CTBS;SDC2;FUCA1;GPC3;GPC6;GNS
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.3663761652156067,0.69853613536656,0.8343023255813954,0.9748790006448954,1.0,3/11,15.05%,PPHLN1;TASOR;RESF1
prerank,regulation of oxidoreductase activity (GO:0051341),0.35649972182165235,0.6984054608426467,0.8228228228228228,0.9746605363656553,1.0,2/13,11.90%,ATP7A;ABL1
prerank,cation transmembrane transport (GO:0098655),0.2982338741977415,0.6981791142154585,0.8610478359908884,0.974540365522243,1.0,4/44,8.66%,SLC7A2;SLC25A20;TRPM4;SLC7A8
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.36131988978822277,0.6980658305524827,0.8074179743223966,0.973587711938503,1.0,4/12,16.70%,CDC23;CDC16;RB1;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.36131988978822277,0.6980658305524827,0.8074179743223966,0.973587711938503,1.0,4/12,16.70%,CDC23;CDC16;RB1;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.36131988978822277,0.6980658305524827,0.8074179743223966,0.973587711938503,1.0,4/12,16.70%,CDC23;CDC16;RB1;NSMCE2
prerank,synaptic vesicle recycling (GO:0036465),0.31202198488435445,0.6977737168963859,0.8588661037394452,0.9735479428930688,1.0,7/31,15.36%,STON2;CEL;VAMP2;CDK5;AMPH;TBC1D24;SYNJ2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.35567961736772175,0.6976159510934766,0.8261474269819193,0.9733656278445152,1.0,1/13,2.70%,SOX13
prerank,aerobic electron transport chain (GO:0019646),0.2871232236922814,0.6975864953577741,0.8783638320775027,0.9730371446175058,1.0,8/68,12.65%,UQCRH;UQCRC1;NDUFS1;NDUFA9;NDUFV2;COX7C;SDHA;NDUFA10
prerank,positive regulation of cell communication (GO:0010647),0.31076589871543214,0.6975215374912862,0.8414634146341463,0.9727542529686279,1.0,5/28,11.42%,CLSTN3;PTPN23;CLSTN1;WLS;SOX11
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.3305104931069142,0.6974311143417995,0.8469387755102041,0.9725017917300516,1.0,3/22,10.43%,NRDC;PTPN3;FURIN
prerank,negative regulation of nuclear division (GO:0051784),0.3619431612253894,0.6972590635668863,0.8401826484018264,0.9723246645255944,1.0,1/11,9.33%,TOM1L2
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.34400841856509423,0.6970484056886924,0.8141711229946524,0.9721963638561845,1.0,5/16,17.88%,ABCD2;CUEDC2;ABCD1;APOD;TREM2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.3246447294369637,0.6969108285671161,0.825,0.9719821230943442,1.0,3/19,11.35%,PRKACA;PTPRJ;PRNP
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.30532950536168474,0.6965312717651887,0.8752886836027713,0.9720313307941894,1.0,7/37,16.43%,NUPR1;BCL2L11;NCK1;TP53;BCL2;BECN1;DNM1L
prerank,regulation of cytoskeleton organization (GO:0051493),0.278784777028384,0.6963353487871019,0.9195876288659793,0.9718753775013182,1.0,23/108,16.60%,RHOF;IQGAP2;MAPK1;CAMSAP3;EZR;MAPT;PAK2;TWF2;EPHA5;TAOK1;ARHGAP35;CAPN2;DIAPH1;MTOR;ABL1;CYLD;BICD1;MAP6;ROCK2;CLASP1;IQGAP1;PAK1;ARHGAP17
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3349604776404234,0.6950328191987423,0.8355795148247979,0.9728944246807658,1.0,4/16,13.60%,ETF1;BNIP3;IGF1R;INSR
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.28517259691272223,0.694207640731139,0.8838709677419355,0.9734357049200455,1.0,8/69,12.65%,UQCRH;UQCRC1;NDUFS1;NDUFA9;NDUFV2;COX7C;SDHA;NDUFA10
prerank,actomyosin structure organization (GO:0031032),0.2829367426133839,0.6940709825810145,0.8848996832101372,0.9732183889584003,1.0,9/75,12.11%,TMOD1;TMOD3;TPM1;ITGB5;EPB41;CDC42BPB;FRMD6;WDR1;EPB41L3
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.35520640535034725,0.6932308063129419,0.8328313253012049,0.9737282768194759,1.0,1/12,2.57%,ADSS1
prerank,regulation of leukocyte activation (GO:0002694),-0.2744786709754997,-0.6929460480649624,0.8518518518518519,0.979907022090715,1.0,2/14,5.34%,CD33;GPR137B
prerank,regulation of RNA metabolic process (GO:0051252),0.28827637976903925,0.6926478203554443,0.8792735042735043,0.9739720697899623,1.0,12/59,13.88%,MBNL1;RC3H2;PTBP3;RRP1B;SNRNP70;MBNL2;FUS;AFF2;HNRNPH3;CLK1;HNRNPH1;PCBP3
prerank,negative regulation of blood coagulation (GO:0030195),0.2981292510073855,0.6917710834075231,0.8561484918793504,0.9745557987956734,1.0,3/38,10.13%,PDGFB;PROC;F3
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.28838193679511537,0.6906697942890052,0.8784648187633263,0.9753207521186386,1.0,11/66,16.57%,RGCC;CDK6;KMT2E;DLG1;APC;BRD7;PKD2;AIF1;PTEN;RDX;RB1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3115203898164231,0.6906682785715746,0.8627684964200477,0.9749644140902692,1.0,7/29,17.50%,CTR9;IFNAR2;PKD2;PIAS1;STAT2;STAT6;FER
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.28385239190587547,0.6904615521272144,0.8958990536277602,0.9748135353485367,1.0,13/73,16.32%,MTCH1;APAF1;SMAD3;EGLN3;MAPT;PPARG;F3;TRAF2;AIFM1;CASP8AP2;ANP32B;HIP1;CFLAR
prerank,cellular response to retinoic acid (GO:0071300),0.29710228269690897,0.6904404694706091,0.8818076477404403,0.9744801868116878,1.0,8/42,17.17%,TWF2;ADNP2;LYN;SETX;HTRA2;CREB1;RORB;ATM
prerank,granulocyte chemotaxis (GO:0071621),0.28884455861675085,0.6898692348167311,0.8862144420131292,0.9747036373565061,1.0,3/55,7.28%,CX3CL1;TGFB2;CCL25
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.32988166573778477,0.6896574432152468,0.8322496749024707,0.9745451373085784,1.0,3/18,13.87%,SCAI;ARHGAP35;HEG1
prerank,amino acid transmembrane transport (GO:0003333),0.29490377970623066,0.6893508279746752,0.8870056497175142,0.9744892014901168,1.0,5/45,12.24%,SLC38A2;SLC7A11;SLC7A7;SLC7A8;SLC38A9
prerank,cellular response to lipopolysaccharide (GO:0071222),0.28008041776894665,0.6891352588600275,0.9079627714581179,0.9743680343537137,1.0,12/101,12.55%,RELA;CTR9;CHMP5;AXL;IL1A;MAPK8;IL18;MTDH;LYN;PLAA;HMGB1;MAPK14
prerank,receptor signaling pathway via STAT (GO:0097696),0.31545717979726323,0.6890603048755836,0.8520345252774353,0.9740920848828709,1.0,6/25,16.72%,CTR9;IFNAR2;PKD2;PIAS1;STAT2;STAT6
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.3304669365921995,0.6885966861486034,0.8404669260700389,0.9741983135815212,1.0,3/20,10.93%,SEMA6D;SEMA3D;SEMA6A
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.31095842144154423,0.6885180122610911,0.8523748395378691,0.9739188816689852,1.0,6/26,17.11%,GOLPH3;B4GALT5;TKT;GK;LARGE1;ST3GAL2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.31071485829437,0.6883701949933341,0.8596698113207547,0.9737040821961497,1.0,4/30,12.92%,SBDS;PRRC2C;PLD4;TP53
prerank,ameboidal-type cell migration (GO:0001667),0.2962282365925581,0.6880787241555212,0.8793296089385475,0.9736541943262503,1.0,8/51,13.37%,SEMA6D;ITGA4;PKN2;PDXDC1;SEMA3D;SEMA6A;SGPL1;GPC3
prerank,regulation of cell-cell adhesion (GO:0022407),0.2974647792197735,0.6877698362001241,0.8765571913929785,0.9736062145375619,1.0,3/39,7.73%,MINK1;FLOT2;FERMT3
prerank,regulation of protein kinase C signaling (GO:0090036),0.34520114181005584,0.6877464518087227,0.838150289017341,0.9732735289047371,1.0,2/14,10.16%,GPD1L;DGKD
prerank,amino sugar metabolic process (GO:0006040),-0.31444679552853416,-0.6877129422150736,0.8472622478386167,0.9837396259902955,1.0,4/10,20.05%,GFPT1;CSGALNACT1;ST3GAL1;GNE
prerank,membrane lipid catabolic process (GO:0046466),0.36529552699706375,0.6874684027066859,0.8446909667194928,0.9731868245334762,1.0,3/10,12.72%,PDXDC1;SGPL1;FUCA1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.35507781988090226,0.6873871325362682,0.849772382397572,0.9729147327253809,1.0,2/12,3.87%,STMN2;MAPRE1
prerank,macrophage migration (GO:1905517),-0.2761571329636644,-0.6873181244770756,0.8721311475409836,0.9825569698621401,1.0,8/13,49.23%,CKLF;P2RX4;CCR2;EDNRB;CCL3;CXCL17;CCL2;CCL5
prerank,respiratory tube development (GO:0030323),0.3087331878327365,0.6870994099452673,0.8531553398058253,0.9728450421140487,1.0,3/28,12.45%,FGF1;LOXL3;HECA
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3393793939478332,0.686809107536379,0.8436619718309859,0.9727772705806637,1.0,3/15,13.03%,PTTG1IP;CD44;BCL2
prerank,positive regulation of cholesterol transport (GO:0032376),0.30653242290587474,0.6866160732505954,0.8565989847715736,0.9726191657578604,1.0,5/27,14.68%,EEPD1;ABCA7;PPARG;RXRA;ABCA5
prerank,replicative senescence (GO:0090399),0.3512770388876537,0.686070690161427,0.8452380952380952,0.9728304160356652,1.0,3/12,17.17%,CHEK2;TP53;ATM
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.31424667452048827,0.6854928203887255,0.8462515883100381,0.9730612920734346,1.0,6/24,13.25%,PPHLN1;EZH2;DNMT3A;TASOR;RBBP7;EPC1
prerank,histone H2B ubiquitination (GO:0033523),0.3705682668383795,0.6847128321747774,0.8333333333333334,0.9734651056260456,1.0,1/10,2.15%,CTR9
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.3149916406496915,0.6845125686298652,0.8483290488431876,0.9733181686935509,1.0,4/24,12.10%,CTSC;PRKACA;UCHL5;UBE3A
prerank,plasma membrane tubulation (GO:0097320),0.3466966640700191,0.6842369321480185,0.8378378378378378,0.973249254487133,1.0,2/13,6.28%,FNBP1L;PACSIN2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.3568514217563241,0.6840773261813998,0.8359375,0.9730499577110235,1.0,11/11,64.34%,BIN1;CAB39;CAV3;KCNE5;CASQ2;KCNE3;STK39;KCNH2;NEDD4L;CAV1;ACTN2
prerank,negative regulation of catalytic activity (GO:0043086),0.31637247960220616,0.6838985298830538,0.8505025125628141,0.9728929021215476,1.0,1/24,1.34%,PARP9
prerank,histone deubiquitination (GO:0016578),0.3301000693166365,0.683541493795573,0.841897233201581,0.9729080068775826,1.0,6/18,17.61%,ATXN7;USP3;TRRAP;UIMC1;USP21;USP16
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.2767354018586933,0.6833042146684832,0.9405737704918032,0.9727961606929263,1.0,25/124,17.17%,ZFYVE27;EHD1;STMN2;TPM1;BICDL1;NEDD4;MAPT;STX3;ODF2;DTNBP1;LYN;CDK5;HMGB1;PPP1R9A;TBC1D24;LIMA1;PKD2;PLP1;GPM6A;PPP1R9B;SH3GL2;RB1;CYFIP1;TBC1D23;RAPGEF2
prerank,positive regulation of synapse assembly (GO:0051965),0.3120463486213748,0.6832962475480021,0.8635794743429287,0.9724492147369505,1.0,4/27,10.25%,EPHB2;CLSTN3;IL1RAP;CLSTN1
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.2230561374434614,-0.683216379726327,0.9497206703910615,0.9851447574570955,1.0,17/26,42.28%,PCBP2;SIRT2;NLRC3;TNFAIP3;IRAK3;CARD16;NMI;TRAF3IP1;DHX58;NFKBIL1;PPM1B;TRIB1;CACTIN;TRIM21;C1QBP;LYAR;TYRO3
prerank,regulation of neuron death (GO:1901214),0.2781437393767812,0.6830914731492812,0.894681960375391,0.9723056262306958,1.0,19/82,16.40%,LRRK2;INPP5A;EGLN3;EGLN2;MAPT;VPS35;CDK5;CTSZ;TRAF2;PRNP;SORL1;EIF2S1;FYN;HTRA2;TSC1;GRID2;RRAS2;MEF2C;TBK1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.29254176646557023,0.6829483600060284,0.8765859284890427,0.9721019023525972,1.0,6/38,11.35%,GAS6;PDGFB;PTPN1;LRP8;MVP;PRNP
prerank,lysosome organization (GO:0007040),0.3045139239506333,0.6829194653779259,0.8556085918854416,0.9717819796361311,1.0,7/36,14.45%,LRRK2;AKTIP;ARSB;HPS4;MTOR;ABCA1;TPCN2
prerank,peptide hormone secretion (GO:0030072),0.30935540641500275,0.6828779577597921,0.8663303909205549,0.9714797539722478,1.0,3/26,13.39%,SNX19;CYB5R4;CAMK2G
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.27449573102472197,0.6824353728034893,0.9331306990881459,0.9715495652188624,1.0,20/129,14.50%,LRRK2;ZEB2;PSMD9;GID8;USP34;PSMB8;LRRK1;PSMC5;TRPM4;CSNK1G1;RNF146;TNKS2;WLS;PPM1A;PSMD12;UBR5;PSMA2;GPC3;TBL1XR1;FZD9
prerank,acidic amino acid transport (GO:0015800),-0.2573789800102378,-0.682138565193347,0.8833333333333333,0.9846218937262566,1.0,2/17,3.26%,SLC1A2;SLC25A13
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3072062387192035,0.6817693920563833,0.8608374384236454,0.9718532514167653,1.0,2/27,8.39%,AK4;AK2
prerank,negative regulation of neurogenesis (GO:0050768),0.2965289439196339,0.6815322488733703,0.8445229681978799,0.9717384018778823,1.0,6/34,14.70%,GDI1;NF1;SORL1;RUFY3;RTN4;PTEN
prerank,neuron apoptotic process (GO:0051402),0.32094886643420645,0.6814717005445774,0.8462566844919787,0.9714499886372409,1.0,4/19,13.03%,TRPC5;CDK5;BNIP3;BCL2
prerank,regulation of neuron projection arborization (GO:0150011),0.3405195096218492,0.6811528100468693,0.8395573997233748,0.9714232736929831,1.0,2/15,9.82%,DVL1;MYO9A
prerank,prostaglandin biosynthetic process (GO:0001516),-0.24756610400948076,-0.6808556854051203,0.8938775510204081,0.9842863947134942,1.0,2/18,6.69%,PNPLA8;PTGES3
prerank,regulation of endothelial cell migration (GO:0010594),0.27879609137133854,0.6808475311474924,0.9091858037578288,0.9713661748767027,1.0,7/85,5.26%,FGF1;ITGB1BP1;SASH1;NF1;THBS1;NRP1;PRKCA
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.3497909276382559,0.6807248383272013,0.8455988455988456,0.971138253838598,1.0,2/12,8.14%,SNAP47;STX3
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.3278278032821271,0.6807064809655824,0.8416107382550335,0.9708063869190819,1.0,1/17,4.31%,AKAP9
prerank,positive regulation of neuron migration (GO:2001224),0.3614636305742639,0.6799935434959035,0.8452200303490136,0.9711506826760703,1.0,3/11,10.93%,KIF20B;PLAA;SEMA6A
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.30845162148415484,0.6799826319848734,0.863225806451613,0.970807944802474,1.0,7/24,15.61%,TERF2;XRN1;ERCC4;TNKS2;TERF1;CTC1;HNRNPC
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.3469148264237046,0.6791525774422799,0.8647482014388489,0.9713081726406513,1.0,1/12,3.77%,SOAT1
prerank,action potential (GO:0001508),0.28766004215526225,0.6789185917583521,0.8883774453394706,0.9711883454092554,1.0,6/44,16.61%,SLC4A3;GNAQ;KCNMB2;KCNMB3;KCND2;KCNA1
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.22526513829945802,-0.6784481419918839,0.9389671361502347,0.9851165689855497,1.0,6/22,26.95%,INPP5K;SIRT1;CDKN1B;DYNLL1;PRKRIP1;STAP1
prerank,cellular response to increased oxygen levels (GO:0036295),-0.29410841578663954,-0.6778763032613304,0.8879310344827587,0.984126207766527,1.0,3/11,16.46%,ATP6V1A;ATP6AP1;ATP6V1G1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.3258544552537661,0.6777442559388526,0.8660477453580901,0.9719883767638018,1.0,2/18,11.90%,ATP7A;ABL1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.363199450579302,0.677692632793534,0.8072669826224329,0.9716861289717459,1.0,1/10,4.31%,AKAP9
prerank,regulation of keratinocyte migration (GO:0051547),0.34685796619071946,0.6769233508081052,0.8477951635846372,0.972087011079462,1.0,5/12,18.36%,MTOR;PTEN;MAP4K4;IQSEC1;MAPRE2
prerank,synaptic vesicle endocytosis (GO:0048488),0.3011031263763341,0.6764476940422971,0.8551236749116607,0.9721976002062986,1.0,6/33,12.71%,ITSN1;STON2;CEL;VAMP2;CDK5;AMPH
prerank,protein sumoylation (GO:0016925),0.2885760469515182,0.6764100899222925,0.8781838316722038,0.9718848949768606,1.0,14/49,16.97%,NUP205;SUMO3;SUMO2;NUP98;TRPM4;NUP54;UBE2I;BCL11A;PIAS1;UBA2;NUP160;NSMCE2;SAE1;NUP93
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3172867995398658,0.6761296476399257,0.8525469168900804,0.9718072037978052,1.0,3/21,8.59%,CNKSR3;GPD1L;NCK1
prerank,ribosomal small subunit assembly (GO:0000028),-0.25984358218723475,-0.6753108863317353,0.8892988929889298,0.984896254391447,1.0,10/16,35.94%,XRCC5;RPS14;RPS19;RPS15;RPS28;RPS27;RRP7A;RPS5;ERAL1;MRPS7
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3367730757648611,0.6750986643250053,0.8378378378378378,0.9724502847228572,1.0,1/14,2.57%,ADSS1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.3566147011649678,0.6749320099848893,0.8657187993680885,0.9722566118397372,1.0,1/10,3.35%,TUT4
prerank,cellular response to leucine starvation (GO:1990253),0.35564387918055235,0.6748508366890738,0.8483920367534457,0.9719908010983795,1.0,4/10,16.99%,IMPACT;MTOR;LARS1;GCN1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.28030025429317995,0.6745172698140542,0.900106269925611,0.9719577881594565,1.0,10/70,14.31%,BAG3;DELE1;TGFB2;SMAD3;TLR3;TRAF2;MLLT11;BCL2;ACVR1B;CASP8AP2
prerank,regulation of glucose import (GO:0046324),0.303630639053622,0.6744758704208954,0.861557478368356,0.9716484257772274,1.0,3/30,6.71%,PID1;IRS1;IRS2
prerank,signal peptide processing (GO:0006465),0.35571028445700476,0.6743783970285772,0.8548148148148148,0.971384963754287,1.0,3/11,12.32%,SPPL3;FURIN;PARL
prerank,response to histamine (GO:0034776),0.35108467838580687,0.6739080338990941,0.8551401869158879,0.9714987612536455,1.0,2/10,11.00%,GABRG2;DIAPH1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3054228098894261,0.6738991069514189,0.8590852904820766,0.97115861029124,1.0,6/25,13.77%,UGGT2;POMT2;DERL1;UBE2W;UGGT1;ATXN3
prerank,maintenance of blood-brain barrier (GO:0035633),0.294834804408152,0.6732243102483858,0.8773809523809524,0.9714663257976319,1.0,1/30,0.78%,VCL
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.2789287512145476,0.6727134616972816,0.8920704845814978,0.9716204328248711,1.0,11/57,16.49%,UACA;DAPK1;CYFIP2;HMGB1;TBC1D10A;SYK;FYN;HTRA2;GRIN2A;ARL6IP5;LGMN
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.27342017569950455,0.6725871885160422,0.9160545645330536,0.9713979022693653,1.0,22/86,18.67%,CX3CL1;STMN2;MAPRE1;AKAP9;DCTN1;MAPT;NCK1;WDR1;CLASP1;EVL;CLIP1;PAK1;RB1;SNX9;NCKAP1L;FER;BIN1;PSEN1;CDK5RAP2;PROX1;NCKAP1;PLEK
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.2743525969881905,0.6722325670212698,0.9029126213592233,0.9713846788978837,1.0,13/71,15.57%,ADAMTS12;VPS4A;CTSC;CLPX;CTSZ;CAPN2;VPS4B;UBE2W;PDCD6IP;ATXN3;RSPRY1;OTUD7A;RHBDD1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.29919434677960827,0.6720552990082975,0.8722627737226277,0.9712219180756534,1.0,7/29,16.59%,METTL3;PTPN1;MAVS;IFNAR2;ABCE1;STAT2;YTHDF3
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.27786346394143724,-0.6718600573172606,0.8908554572271387,0.9864438129245054,1.0,7/13,28.35%,HEXA;VCAN;CSPG4;IDS;IDUA;DCN;CSPG5
prerank,proton transmembrane transport (GO:1902600),0.29201195548688363,0.6716261461399926,0.8779342723004695,0.9712745151138136,1.0,3/36,7.56%,SLC9A1;HVCN1;ATP6V0E1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.27216497997095734,-0.6706881709823866,0.8789808917197452,0.9859540711817192,1.0,2/12,13.71%,FUT9;AKT1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.23231696929095547,-0.6705778720540732,0.8947368421052632,0.9844929311177718,1.0,12/22,34.43%,PSMA3;PSMB2;PSMB7;PSMA1;PSMA5;PSMA6;PSMA4;PSMB3;PSMB9;PSMB4;PSMA8;PSMB6
prerank,negative regulation of B cell proliferation (GO:0030889),-0.29185606980757883,-0.6695715906010129,0.8905325443786982,0.9838212557618206,1.0,2/11,7.11%,FCGR2B;TYROBP
prerank,regulation of T cell differentiation (GO:0045580),0.2976150182694523,0.6695254121283561,0.8683574879227053,0.9729580572701616,1.0,4/33,11.90%,RUNX1;METTL3;PRDM1;ABL1
prerank,regulation of adaptive immune response (GO:0002819),0.31908247954427926,0.6694375411155786,0.8776041666666666,0.9726902998128827,1.0,1/18,1.88%,IRF1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.28050455066884317,0.6690561249292286,0.886117136659436,0.9726971828895419,1.0,10/60,14.70%,MED10;RELA;TNRC6B;MECP2;TCF7L2;TP53;CDK8;MED27;MED15;PTEN
prerank,regulation of amyloid fibril formation (GO:1905906),0.3325595418229546,0.6688040870498926,0.8532763532763533,0.9725929274146847,1.0,1/15,1.99%,PFDN1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.29842943947730843,0.6685725499283569,0.8954703832752613,0.9724586818155054,1.0,3/32,9.40%,LRRK2;SYT11;DTNBP1
prerank,regulation of potassium ion transport (GO:0043266),0.29935692478808346,0.6685222679887108,0.8513189448441247,0.9721530038234947,1.0,6/31,17.73%,CACNA1D;DLG1;CD63;KCNIP3;KCNA5;DPP6
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3367320575410796,0.6682643345652385,0.881578947368421,0.9720582152908595,1.0,2/14,8.59%,PPP2R2A;NCK1
prerank,regulation of ion transport (GO:0043269),0.2766039324881972,0.6677234976218526,0.9213011542497377,0.9722352533825241,1.0,8/76,10.04%,KCNJ6;VAMP3;NEDD4;SYT12;SYT11;DTNBP1;VAMP2;NKAIN1
prerank,hexose biosynthetic process (GO:0019319),0.28762888234725814,0.6668813505235583,0.8832951945080092,0.9726918804579227,1.0,4/42,9.86%,PGAM1;AKR1B1;ALDOA;ENO1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.3377739107828266,0.666664637530863,0.8567493112947658,0.972543932315937,1.0,3/15,15.59%,ANKRD11;LRP6;HDAC2
prerank,glycerol metabolic process (GO:0006071),-0.2896089138999547,-0.6658108731769175,0.8774373259052924,0.9856516199494604,1.0,5/10,27.38%,GOT1;COQ2;TPI1;COQ3;GK5
prerank,positive regulation of epithelial cell migration (GO:0010634),0.2718733390754935,0.6649722863329837,0.9202072538860103,0.9738148875348941,1.0,19/92,16.78%,FGF1;ITGB1BP1;TGFB2;SASH1;THBS1;NRP1;PRKCA;DOCK1;MTOR;ABL1;RTN4;RREB1;NRP2;PRKD2;ROCK2;CLASP1;MAP4K4;IQSEC1;RIN2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.286014643668539,0.6638560837296804,0.8794901506373117,0.9745326848477808,1.0,5/37,13.65%,RFC2;POLD3;ERCC4;CUL4A;GTF2H1
prerank,histone lysine methylation (GO:0034968),0.29617413585106006,0.663446953875034,0.87409200968523,0.9745703251484262,1.0,4/33,8.54%,SUV39H1;EHMT2;SETD3;EZH2
prerank,negative regulation of stem cell differentiation (GO:2000737),0.33534784435095566,0.6634247968867409,0.8728323699421965,0.9742421077270171,1.0,1/12,4.94%,N4BP2L2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.34729700203670716,0.6632472847095936,0.8689759036144579,0.9740540482386624,1.0,2/11,13.03%,CD44;BCL2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3117589229544806,0.6630320906557264,0.8682476943346509,0.9739157909660546,1.0,2/20,7.02%,PPID;PPIL2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.35417517268987714,0.6622458224393983,0.8690292758089369,0.9742891004546591,1.0,2/10,13.07%,TCP1;CCT3
prerank,regulation of nervous system development (GO:0051960),0.28339494798155035,0.6619726887874593,0.8954171562867215,0.9742074241669596,1.0,2/37,7.87%,CX3CL1;TENM4
prerank,metal ion transport (GO:0030001),0.27040364411500184,0.6614673203965707,0.9261603375527426,0.9743399512779221,1.0,12/86,14.78%,TRPC5;NIPAL3;CACNG7;CACNA1D;CACNA1A;RAMP1;NIPA2;NDFIP1;FYN;CALCRL;PKD2;CACNA1C
prerank,regulation of synapse organization (GO:0050807),0.29363131776230594,0.6612266233741856,0.8745247148288974,0.97422294095623,1.0,8/26,17.37%,ARHGAP22;NEDD4;ABL1;CDKL5;MEF2C;SETD5;CTNNA2;GRIPAP1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.2920783996456361,-0.6609239480944653,0.8709677419354839,0.9883516508803389,1.0,5/10,33.09%,XDH;CADM4;DCN;DAB2IP;PIK3CB
prerank,sulfate transport (GO:0008272),0.32940548593797986,0.6607357305952527,0.8666666666666667,0.9743360466622709,1.0,1/14,6.52%,SLC26A11
prerank,neural crest cell migration (GO:0001755),0.2910645890220245,0.6598898968732719,0.8676639815880323,0.9747708565149572,1.0,5/36,13.49%,NRP1;SEMA6D;SEMA3D;SEMA6A;FN1
prerank,stem cell differentiation (GO:0048863),0.28544421484717614,0.6590106182706311,0.8904109589041096,0.9752705645518701,1.0,7/39,16.27%,TGFB2;SETD2;PUM1;TP53;LRP6;GPM6A;MEF2C
prerank,regulation of actin filament-based process (GO:0032970),0.26865370122155585,0.658911173305689,0.9176470588235294,0.9750255683123522,1.0,13/70,16.60%,RHOF;IQGAP2;EZR;TWF2;EPHA5;TAOK1;ARHGAP35;MTOR;ABL1;ROCK2;IQGAP1;PAK1;ARHGAP17
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.30562940884747636,0.6586556517343733,0.8802547770700637,0.9749168949018662,1.0,2/21,6.42%,DELE1;BIRC3
prerank,receptor recycling (GO:0001881),-0.2989368634729636,-0.6583826496864661,0.8836565096952909,0.9888567466219992,1.0,2/10,9.13%,RAB11B;LMTK2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.3161132896493931,0.6575162880732279,0.8786666666666667,0.9756128883412158,1.0,2/17,11.42%,N4BP2L2;SOX11
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.2963789039036584,0.6573744227055323,0.8867469879518072,0.9753985889013397,1.0,7/33,16.57%,CDK6;DLG1;APC;BRD7;PKD2;PTEN;RB1
prerank,purine nucleotide catabolic process (GO:0006195),-0.2607899466695841,-0.6569923069356822,0.9018987341772152,0.9884790466309855,1.0,7/13,41.27%,XDH;HINT1;PNP;GPX1;ITPA;NT5C;NT5E
prerank,B cell proliferation (GO:0042100),-0.24835251136318603,-0.6566459738229548,0.9172661870503597,0.9871956258039558,1.0,4/17,28.96%,PTPRC;HSPD1;CD180;CTPS1
prerank,amino acid import across plasma membrane (GO:0089718),0.2969268959233706,0.6566120578896384,0.88,0.9757204530781687,1.0,2/24,8.66%,SLC7A2;SLC7A8
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.3388688854036889,0.6565237521964683,0.8643067846607669,0.9754659177824562,1.0,2/12,9.65%,MAPK1;LYN
prerank,positive regulation of T cell proliferation (GO:0042102),0.2749925782695344,0.6547138270649719,0.903470715835141,0.9767363275566593,1.0,7/55,14.65%,IGFBP2;NCK1;IL18;ICOSLG;HMGB1;SYK;AIF1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.3223878773853647,0.6544546739700874,0.8678474114441417,0.9766359957873774,1.0,2/17,12.31%,PDE3B;SORL1
prerank,regulation of protein localization to cell surface (GO:2000008),0.2879269347677197,0.6543896805108892,0.8950471698113207,0.9763487250708512,1.0,4/33,8.50%,MAP1A;GPD1L;STX3;ABCA7
prerank,positive regulation of protein maturation (GO:1903319),-0.2816033022413136,-0.6543115017074608,0.8914285714285715,0.987582179417847,1.0,4/11,34.28%,ADAM8;CCBE1;SOX4;NLRC4
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3112618818877985,0.654150602843127,0.8767833981841764,0.9762250074996934,1.0,4/21,15.24%,MECP2;RAD51B;VPS4B;NPM1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.28542703545129683,0.6537132085020958,0.877030162412993,0.9762566856592935,1.0,8/38,17.90%,CABIN1;ASF1A;CENPP;ATRX;RBBP7;NPM1;CENPC;UBN1
prerank,photoreceptor cell development (GO:0042461),0.33140654845491635,0.6536907646411602,0.8504273504273504,0.9759281405929543,1.0,4/14,17.66%,AHI1;CEP290;RORB;ARL3
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2659253063782798,0.6535204590080204,0.9345114345114345,0.9757394340737446,1.0,10/95,12.55%,RELA;CTR9;CHMP5;AXL;IL1A;MAPK8;PLAA;CYRIB;HMGB1;MAPK14
prerank,embryonic heart tube development (GO:0035050),0.32528800788227996,0.6531922053659208,0.8662790697674418,0.9756795427578213,1.0,2/14,13.74%,ACVR1;NDRG4
prerank,cellular biogenic amine metabolic process (GO:0006576),0.336881364260616,0.6524554600905316,0.8733431516936672,0.9760219067356413,1.0,1/12,5.05%,ATP7A
prerank,positive regulation of immune effector process (GO:0002699),0.29896189031849285,0.6522834935086861,0.9055900621118013,0.9758239498577131,1.0,2/27,5.98%,DDX60;PTPRJ
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.2661978714778324,0.6520059100300273,0.922037422037422,0.9757231753152626,1.0,14/86,14.25%,PRKCZ;NRP1;PDGFB;PTPRJ;ACVR1;PAK2;LRP8;CD44;PRNP;ABL1;BANK1;TP53;FYN;RELN
prerank,pyruvate metabolic process (GO:0006090),0.2705733647904773,0.651079760894,0.9003285870755751,0.9762063276525881,1.0,6/52,11.56%,PGAM4;PGAM1;ALDOA;ENO1;SRR;GCK
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.24364403313546645,-0.6507624390376735,0.9172932330827067,0.9889780595343401,1.0,3/16,15.97%,IFNGR1;HDAC1;HMGCR
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.33584060312059794,0.6507570303006577,0.881578947368421,0.9761308178857938,1.0,1/12,3.40%,ALDH6A1
prerank,negative regulation of axonogenesis (GO:0050771),0.2937215933582197,0.650665788428439,0.886107634543179,0.9758622072200741,1.0,6/27,14.70%,GDI1;DIP2B;ULK2;RUFY3;RTN4;PTEN
prerank,GPI anchor metabolic process (GO:0006505),-0.21639125451364152,-0.6503439462781788,0.9790575916230366,0.9877593517624564,1.0,15/26,35.64%,PIGN;PGAP2;PIGV;PIGB;DPM1;PIGL;PIGG;PIGM;MPPE1;PIGZ;PIGF;PIGA;DPM2;GPLD1;PIGC
prerank,regulation of microtubule-based movement (GO:0060632),0.3348962992124958,0.649681800803589,0.8780120481927711,0.976401565991618,1.0,1/11,3.82%,IGBP1
prerank,cellular response to drug (GO:0035690),-0.20833333092398515,-0.6494491009370014,0.9567307692307693,0.9868938937763512,1.0,3/25,4.82%,RAP2A;AIM2;PDE4B
prerank,T cell receptor signaling pathway (GO:0050852),0.26020832581138015,0.6494345577300762,0.9491353001017294,0.9762678728288824,1.0,24/138,16.52%,RELA;RNF31;RFTN1;PSMD9;PSMB8;PTPRJ;RC3H2;SPPL3;PSMC5;IKBKB;PAK2;NCK1;ICOSLG;NFKBIZ;FBXW11;PSMD12;PSMA2;FYN;PRKD2;THEMIS2;PSMB1;PIK3R1;PAK1;FYB1
prerank,purine nucleotide metabolic process (GO:0006163),0.30718118119821036,0.6491677112551543,0.9104859335038363,0.9761429461324267,1.0,3/24,11.13%,PRPSAP1;HPRT1;GDA
prerank,myeloid dendritic cell activation (GO:0001773),0.32841337229441475,0.6491254562209536,0.869753979739508,0.9758317282251077,1.0,2/12,12.01%,TGFBR2;HMGB1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.27311276945277796,0.6486784761036282,0.9204419889502763,0.9758655550727607,1.0,5/48,9.43%,GAS6;PADI2;METTL3;PYDC1;PPARG
prerank,glycosaminoglycan catabolic process (GO:0006027),0.2683552010040471,0.6468944616218695,0.9264544456641054,0.9770818152548446,1.0,10/55,16.08%,SLC9A1;CEMIP2;ARSB;CD44;BGN;SDC2;FUCA1;GPC3;GPC6;GNS
prerank,negative regulation of transferase activity (GO:0051348),0.286531222381613,0.6466721440392685,0.8892988929889298,0.9769322419406306,1.0,6/28,13.42%,IRS2;MAPT;ERCC4;ABL1;TP53;TERF1
prerank,regulation of neuron migration (GO:2001222),0.29759089668964556,0.6464048631598793,0.8839506172839506,0.9768419275039767,1.0,4/26,10.93%,CX3CL1;KIF20B;PLAA;SEMA6A
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.29336248080273525,0.6450613960132779,0.8833967046894804,0.977651282037813,1.0,3/25,10.78%,RIN3;SDCBP;ATXN2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.3021622029294737,0.6450593893843366,0.8850129198966409,0.9773095537379383,1.0,1/20,1.88%,PTDSS2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.31569985306683807,0.6450341456923957,0.8781163434903048,0.9769850010319673,1.0,2/15,9.52%,SYN3;USP46
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.2919941280292546,0.6447411820770481,0.8883495145631068,0.9768908333750415,1.0,5/27,14.61%,PLA2G6;CHKB;SLC27A1;CHKA;ETNK1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.28897756786459783,0.6446483245849891,0.9006060606060606,0.97662102534228,1.0,3/29,7.66%,RAB3GAP1;EPHB2;NETO1
prerank,negative regulation of T cell proliferation (GO:0042130),0.29024123547615266,0.6443665137678454,0.8904109589041096,0.976537850137191,1.0,5/28,18.02%,GLMN;PRNP;LGALS9;PRKAR1A;RC3H1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.3211976104585428,0.6437724009771373,0.8888888888888888,0.9767166687927709,1.0,2/16,10.06%,CHMP5;TMEM50B
prerank,retinol metabolic process (GO:0042572),0.3177454034003081,0.642107794783805,0.8794326241134752,0.9777798011125919,1.0,1/14,10.20%,DHRS3
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.2797675074700441,0.641796209626675,0.8845265588914549,0.9777092495860016,1.0,7/39,17.61%,NRP1;LRP5;TGFBR2;LRP6;PKD2;PAK1;CTNNB1
prerank,regulation of biosynthetic process (GO:0009889),0.3326460778399905,0.6417507922918532,0.8950617283950617,0.9773990136446394,1.0,1/11,8.47%,ALOX5
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.28965301095198864,0.6416976125906432,0.9107142857142857,0.9771037270421933,1.0,8/31,18.07%,YWHAE;MAPK8;NMT1;TP53;BCL2;YWHAB;TFDP2;PPP3CC
prerank,positive regulation of mRNA processing (GO:0050685),0.2997536553680146,0.6415505319860411,0.8851612903225806,0.9768758126289515,1.0,3/21,8.78%,RBM3;NUP98;TRA2A
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.3413764910549861,0.6412125003780823,0.8804347826086957,0.976833324305882,1.0,1/10,5.29%,NT5C3A
prerank,regulation of monocyte differentiation (GO:0045655),0.31829389186197726,0.6410086327797125,0.876453488372093,0.9766691932407375,1.0,3/14,12.05%,CDK6;ACIN1;ZFP36L1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.3237195252167058,0.6406542524277885,0.8737446197991392,0.9766185551662679,1.0,3/12,14.60%,EAPP;NELFA;RECQL5
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.3132254263026089,0.6383107502361964,0.8905608755129959,0.9782931273450803,1.0,2/17,8.61%,CACNA1D;TRPM4
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.30839565157656734,0.6379704915585722,0.8652777777777778,0.978248767044569,1.0,1/16,2.57%,ADSS1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3344104005228196,0.6378045824094619,0.8852713178294573,0.9780481700314417,1.0,1/10,3.92%,DSE
prerank,regulation of protein localization to Cajal body (GO:1904869),0.33197950874107596,0.6375754407342598,0.8820058997050148,0.9775546342827623,1.0,2/11,13.07%,TCP1;CCT3
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.33197950874107596,0.6375754407342598,0.8820058997050148,0.9775546342827623,1.0,2/11,13.07%,TCP1;CCT3
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.27193543366540746,0.6369183509861146,0.914187643020595,0.9777494047723315,1.0,5/39,13.65%,RFC2;POLD3;ERCC4;CUL4A;GTF2H1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3085229049818913,0.6363488846726735,0.8919288645690835,0.9778892785189942,1.0,2/15,9.06%,MRE11;CHEK2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.32465816857579927,0.6357597614002571,0.8857142857142857,0.9780312009892886,1.0,4/13,19.14%,SOX11;TMSB4X;PSEN1;SIN3A
prerank,epithelial cell differentiation (GO:0030855),0.2579750282977935,0.6356111511738022,0.93717277486911,0.9778064230704624,1.0,1/88,0.19%,SCUBE1
prerank,ceramide catabolic process (GO:0046514),0.3159939852890664,0.6355385806899474,0.8827785817655571,0.9775285298890773,1.0,2/14,10.83%,ACER3;ASAH1
prerank,regulation of vasculogenesis (GO:2001212),0.3220966245548367,0.635425018283185,0.888243831640058,0.9772822831867461,1.0,1/14,4.54%,RAP1A
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.33369508486976873,0.6351402014165511,0.8768545994065282,0.977183409842622,1.0,2/11,12.68%,CTDNEP1;SLC27A1
prerank,T-helper cell differentiation (GO:0042093),0.3167385464371424,0.634630964388052,0.8805755395683453,0.9772624709684335,1.0,2/14,12.01%,ATP7A;HMGB1
prerank,regulation of cell communication (GO:0010646),0.2828643156244286,0.6343386197985601,0.9131985731272295,0.9771779550454857,1.0,4/35,9.00%,MTCH1;CAMK2D;PTPN1;GRK5
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.2591799936648016,0.6342403491609291,0.9357601713062098,0.9769178986082048,1.0,13/74,15.65%,PSMD9;PSMB8;EP300;EGLN3;EGLN2;PSMC5;EGLN1;ELOC;PSMD12;PSMA2;RBPJ;ARNT;PSMB1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.25972860506840106,0.6334142743551893,0.9356913183279743,0.9772841815877757,1.0,5/65,6.95%,CDK5RAP3;VPS4A;PSMD9;PSMB8;PSMC5
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.307487162286451,0.6332950048297707,0.8894668400520156,0.9770499492174901,1.0,1/18,1.24%,PRKCZ
prerank,androgen metabolic process (GO:0008209),0.3026706701347701,0.632749147173594,0.8825910931174089,0.9771531633953888,1.0,3/18,17.53%,HSD17B11;HSD17B4;MED1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.3265191164151918,0.6316034589598062,0.874439461883408,0.9777545689299658,1.0,1/11,4.60%,PADI2
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.19275441064638874,-0.6313624406647398,0.9935483870967742,0.9986111918677519,1.0,7/32,18.84%,CDK17;NPAT;CDK16;TFDP1;CDK18;HINFP;CDK14
prerank,cell differentiation in hindbrain (GO:0021533),0.3286048147559524,0.6308120689413368,0.8785185185185185,0.9780495041709673,1.0,1/11,5.05%,ATP7A
prerank,organophosphate ester transport (GO:0015748),0.28857660933541,0.6307256292288445,0.9065300896286812,0.9777775783542867,1.0,6/24,16.25%,PITPNM1;PRELID2;PITPNA;PITPNB;EPG5;OSBPL2
prerank,positive regulation of TOR signaling (GO:0032008),0.26985476603636716,0.6306887642574879,0.9183197199533255,0.9774638295099141,1.0,7/40,14.53%,GAS6;MIOS;GOLPH3;GPR137C;FNIP1;SLC38A9;LARS1
prerank,histone H4 deacetylation (GO:0070933),0.33502267591386564,0.6303682320626346,0.8888888888888888,0.9773859149267398,1.0,3/10,16.15%,HDAC9;HDAC2;RCOR1
prerank,negative regulation of ATPase activity (GO:0032780),-0.246807407710767,-0.629337132094227,0.9354838709677419,0.9984707700657279,1.0,4/16,16.31%,PXK;SIRT1;OXA1L;ATP5IF1
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.2273727732033196,-0.6290669588511834,0.9536679536679536,0.9971055207513686,1.0,2/20,4.41%,CHRM3;GRK2
prerank,cilium-dependent cell motility (GO:0060285),0.2943467336683415,0.6289240808041496,0.9045161290322581,0.9782306203366811,1.0,22/22,70.61%,RFX3;TEKT3;TEKT4;TEKT1;TEKT2;TEKT5;DNAH1;CCDC65;DNAH17;DNAAF2;GAS8;DRC1;DNAH3;RSPH9;DNAI3;DNAH2;EFHC1;EFHC2;DNAH8;CFAP44;CCDC39;CFAP54
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.2690384350222303,0.6287717247366617,0.9251396648044693,0.9780141385664943,1.0,7/44,14.91%,KCNJ6;AKAP9;FLNA;GNG2;GNB1;KCNMB2;KCNMB3
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2616080236699335,0.6283147161118204,0.9286498353457738,0.9780345992598644,1.0,8/54,13.36%,RNF31;GAS6;BIRC3;IKBKB;PYDC1;TRAF2;CYLD;SYK
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.31781720647713785,0.6281474548399335,0.9005763688760807,0.9778275772494613,1.0,1/13,4.51%,UTP20
prerank,cellular response to superoxide (GO:0071451),0.3354744066370046,0.6281386145957137,0.8863287250384024,0.9774920821556357,1.0,1/10,5.05%,ATP7A
prerank,peroxisome organization (GO:0007031),0.28432410043825945,0.6261998795139906,0.9160493827160494,0.9787458613043432,1.0,8/25,17.26%,ABCD2;ABCD3;ABCD1;PEX14;DNM1L;TMEM135;MFF;PEX7
prerank,basement membrane organization (GO:0071711),0.3079724904345633,0.624900793719545,0.8998589562764457,0.9794356613695044,1.0,2/14,11.03%,FLRT2;PXDN
prerank,signal transduction by p53 class mediator (GO:0072331),0.27707456679310344,0.6247427476798991,0.9106280193236715,0.9792185023576341,1.0,6/30,14.07%,STK11;NBN;TP53;ATRX;DDX5;NDRG1
prerank,meiosis I (GO:0007127),0.2892356308583458,0.6245752864503226,0.8973042362002568,0.9790156862916137,1.0,1/23,3.73%,BCL2L11
prerank,ethanol metabolic process (GO:0006067),0.3199658838822649,0.6241098425513937,0.8982035928143712,0.979045680507059,1.0,1/12,6.50%,ALDH1A1
prerank,error-free translesion synthesis (GO:0070987),0.28851152412941167,0.6240867756889111,0.9152759948652118,0.9787285436644412,1.0,2/22,8.93%,RFC2;RCHY1
prerank,protein import into peroxisome matrix (GO:0016558),-0.2556011184121427,-0.6230155932988065,0.9353846153846154,0.9995200612741737,1.0,5/12,27.01%,PEX13;PEX1;PEX6;PEX5;PEX2
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.3146269804422651,0.6223828645182566,0.9021897810218978,0.9797021170402178,1.0,5/14,17.68%,SEC24B;MIA3;SEC24D;SEC24A;RAB1A
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.3160587570858881,0.621851025124949,0.9042709867452136,0.979801995317697,1.0,1/13,4.60%,PADI2
prerank,aorta development (GO:0035904),0.3060020090406829,0.621767748299831,0.8790760869565217,0.9795242408900448,1.0,14/14,69.43%,HECTD1;PKD2;LRP1;ROBO2;TBX1;APLNR;TBX2;TFAP2B;PDGFRB;PDE2A;EFEMP2;ROBO1;JAG1;ADAMTS9
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.2930534082999487,0.6216194276112458,0.9190897597977244,0.9793004967904875,1.0,5/20,17.71%,UBQLN1;HSP90AA1;TGFBR1;DCUN1D2;DCUN1D5
prerank,negative regulation of cilium assembly (GO:1902018),-0.2617505244828554,-0.6214916478154483,0.928125,0.9989857653135061,1.0,8/12,32.51%,LIMK2;CEP97;EVI5L;TBC1D30;CDK10;TCHP;MAP4;TESK1
prerank,positive regulation of T cell activation (GO:0050870),0.25793479478029435,0.6210339024181286,0.9556277056277056,0.9794312033287473,1.0,10/62,17.29%,FLOT2;DOCK8;NCK1;CYRIB;LGALS9;AIF1;CD47;CD81;ZBTB1;NCKAP1L
prerank,spermatid development (GO:0007286),0.2733350030839116,0.6210281904758492,0.9130434782608695,0.9790954858200674,1.0,2/32,10.50%,BBS4;YTHDC2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.2930134682117749,0.6208698536010664,0.9007731958762887,0.9788728299956219,1.0,2/21,6.83%,ACAT1;HPRT1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.2658449677140306,0.6204826288080744,0.9424379232505643,0.9788419654741751,1.0,3/49,9.65%,PARP9;IL18;LYN
prerank,tRNA metabolic process (GO:0006399),0.2973336813151586,0.6190088844623366,0.9002695417789758,0.9796519840415313,1.0,3/17,15.00%,POP1;AARS1;DTD1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.2876595863437609,0.6187454593275487,0.9065656565656566,0.9795237057502235,1.0,2/23,6.93%,BCL2L11;HSP90AA1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.24797424392351533,0.6185580140937745,0.973816717019134,0.9793418286583916,1.0,21/152,14.50%,LRRK2;SMARCA4;ZEB2;PSMD9;GID8;USP34;PSMB8;LRRK1;PSMC5;TRPM4;CSNK1G1;RNF146;TNKS2;WLS;PPM1A;PSMD12;UBR5;PSMA2;GPC3;TBL1XR1;FZD9
prerank,regulation of phospholipase C activity (GO:1900274),0.30747597261584,0.6184464249050562,0.8966480446927374,0.9790947565345669,1.0,3/15,13.76%,ESR1;ABL1;BICD1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.27213725568944286,-0.6183370786839357,0.9153005464480874,0.9993713298684727,1.0,5/10,38.21%,FMR1;GNB5;CALM3;CBARP;GPR35
prerank,histone ubiquitination (GO:0016574),0.2948645638915711,0.6169475133976777,0.905440414507772,0.9798979207568779,1.0,2/21,6.14%,CTR9;UBE2A
prerank,diol biosynthetic process (GO:0034312),0.3059479621187715,0.6163682567529509,0.8934659090909091,0.9800167236677546,1.0,3/15,14.77%,ACER3;ASAH1;SPTLC1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.2457556641912109,-0.6163137617505265,0.9276315789473685,0.9991342386463358,1.0,1/14,2.26%,PTK2B
prerank,regulation of actin filament polymerization (GO:0030833),0.2526222943921544,0.615871843469854,0.9420442571127503,0.9800444429098891,1.0,16/69,18.66%,GBA2;PLEKHG2;ARFGEF1;SSH2;NCK1;TWF2;CYRIB;DBNL;WASHC5;EVL;SNX9;NCKAP1L;FER;BIN1;NCKAP1;ARHGAP18
prerank,odontogenesis (GO:0042476),0.2747755640367746,0.6156930713574976,0.9223529411764706,0.9798387233289532,1.0,4/35,15.59%,TGFB2;ANKRD11;LRP6;HDAC2
prerank,steroid hormone biosynthetic process (GO:0120178),0.27468575170811277,0.6154339063874799,0.9245508982035928,0.9796874270323561,1.0,2/29,12.06%,AKR1B1;HSD17B11
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.23831908894643605,-0.6144475541389856,0.9456521739130435,0.9986784527364527,1.0,4/16,16.33%,DPYD;UPP2;DPYSL3;NT5M
prerank,regulation of centrosome cycle (GO:0046605),0.29188618611850764,0.6144469175043832,0.9162303664921466,0.9800933075138806,1.0,4/21,15.24%,CHMP5;VPS4B;PDCD6IP;NPM1
prerank,glial cell development (GO:0021782),0.28073523943334294,0.6143756965550375,0.9069182389937107,0.9798117015776048,1.0,3/25,11.42%,NF1;CDK6;SOX11
prerank,T cell mediated immunity (GO:0002456),-0.24712257648847802,-0.6138339187685348,0.941717791411043,0.9975109865335771,1.0,6/13,36.77%,CADM1;CD46;BTN3A3;GNL1;JAG1;CD55
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.25113847621640595,0.6135931949676368,0.9616977225672878,0.9800436684104041,1.0,10/93,9.66%,CNKSR3;BRAF;GAS6;AKAP9;HSP90AA1;GPD1L;NCK1;FNIP1;CNOT9;CD44
prerank,aminoglycan biosynthetic process (GO:0006023),0.2584783653941645,0.613090339556333,0.9340044742729307,0.9800850486750423,1.0,10/49,17.14%,UGDH;HS6ST2;SDC2;B3GALNT1;B3GNT2;GPC3;GPC6;EXT1;B3GALT1;EXT2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.3202828844996272,0.6119397223550936,0.8995695839311334,0.9805989604379008,1.0,2/11,9.28%,PUM2;PUM1
prerank,regulation of leukocyte migration (GO:0002685),-0.23505596609014412,-0.6117720102022993,0.9473684210526315,0.9971858565348947,1.0,6/16,29.31%,RAC1;RHOH;RHOG;HMOX1;RAC2;VEGFA
prerank,glial cell differentiation (GO:0010001),-0.1912451067867711,-0.6117245169367936,0.9774011299435028,0.9956945025729599,1.0,21/28,47.28%,PTPRZ1;TPPP;GPR157;STAT3;SOX2;CDH2;MYRF;FGF10;EIF2B5;PAX2;SOX4;PICK1;ADGRG6;SOX8;ERBB3;SOX10;SOX9;SLC8A3;EGR2;GPC1;METRN
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.2796458947368869,0.6116277414590617,0.9168765743073047,0.9804857037084468,1.0,1/26,1.07%,LRRK2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.3253394493073477,0.6111300329162221,0.8906009244992296,0.9805409541441646,1.0,2/10,17.61%,LRP6;CTNNB1
prerank,lung development (GO:0030324),0.26769394941731284,0.6108176499855673,0.9337209302325581,0.9804400980220562,1.0,3/33,11.42%,FGF1;LOXL3;SOX11
prerank,anterior/posterior pattern specification (GO:0009952),-0.16604400215441478,-0.6107092700335996,1.0,0.9947035838866354,1.0,4/53,7.04%,BMPR2;SMAD2;ATP6AP2;BHLHE41
prerank,cellular glucan metabolic process (GO:0006073),0.3185460984688543,0.6105678408658098,0.8945736434108527,0.9802767647962479,1.0,2/11,11.70%,GBE1;UGP2
prerank,response to amino acid (GO:0043200),0.2738131760132578,0.6102744310698448,0.9168704156479217,0.9801669360250993,1.0,7/31,14.53%,GLRB;IPO5;CAPN2;MTOR;SLC38A9;GLRA3;LARS1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3034510789668134,0.6102478217761702,0.9152777777777777,0.9798486037011233,1.0,3/13,14.60%,EAPP;NELFA;RECQL5
prerank,positive regulation of leukocyte migration (GO:0002687),-0.19502183483665536,-0.6097612030905684,0.9760765550239234,0.9937337032049554,1.0,4/27,18.19%,CSF1;JAM3;ICAM1;ADAM8
prerank,cell projection organization (GO:0030030),0.26927679525012743,0.609291035582133,0.921968787515006,0.9802156861506464,1.0,9/30,18.67%,PACSIN2;PARVB;CDC42;P2RY12;CYFIP1;NCKAP1L;GSN;NCKAP1;PLEK
prerank,protein heterooligomerization (GO:0051291),0.2970409114427844,0.6085727930153351,0.9171122994652406,0.9804000473824022,1.0,3/17,13.91%,FARSA;TMEM120B;PKD2
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.2603003892907958,-0.6085718861607414,0.9325153374233128,0.9928650875166971,1.0,7/11,42.90%,PRDX1;CAT;PRDX2;PRDX3;GPX1;PRDX5;PRDX4
prerank,substantia nigra development (GO:0021762),0.2656383293465899,0.6080069771112362,0.9279811097992916,0.9804681733331008,1.0,7/37,14.58%,PADI2;YWHAE;CKB;MAPKAP1;CDC42;CALM1;PLP1
prerank,positive regulation of protein acetylation (GO:1901985),0.3144044158427606,0.6079813841156179,0.9050445103857567,0.9801533306665847,1.0,5/12,18.25%,DIP2B;TAOK1;CEP295;CAMK1;DDX3X
prerank,regulation of endopeptidase activity (GO:0052548),0.2501870606150783,0.6075096016250935,0.9525862068965517,0.9801499842243917,1.0,5/59,10.43%,PSMB8;BIRC3;NRDC;SERPINI1;FURIN
prerank,glucose metabolic process (GO:0006006),0.254280209122989,0.6074305446407035,0.948237885462555,0.9798719104547695,1.0,8/58,15.71%,PGAM1;ALDOA;LRP5;IRS2;ENO1;PPARD;MDH1;SLC25A1
prerank,regulation of trophoblast cell migration (GO:1901163),0.3051061879012978,0.6073015911896038,0.923728813559322,0.9796367640404043,1.0,4/14,16.59%,AGO2;ACVR1B;ARHGDIB;YTHDF3
prerank,NIK/NF-kappaB signaling (GO:0038061),0.24944225915823848,0.6070261489856082,0.9443850267379679,0.9794872228141118,1.0,10/72,12.95%,RELA;PSMD9;PSMB8;BIRC3;PSMC5;TLR3;TRAF2;FBXW11;PSMD12;PSMA2
prerank,protein heterotetramerization (GO:0051290),0.31234021742309825,0.6067407860032549,0.909221902017291,0.979351086369991,1.0,1/13,2.89%,FARSA
prerank,aspartate family amino acid metabolic process (GO:0009066),0.286887024357038,0.6058832066583744,0.9175392670157068,0.9796157247831885,1.0,2/18,6.57%,FOLH1;MTHFR
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.31964265007585047,0.6056358543606888,0.9227340267459139,0.9794471042781984,1.0,1/11,4.75%,EXOSC5
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.32040612412630265,0.6052637254783145,0.8942598187311178,0.9793730184006613,1.0,2/10,10.66%,PDE3B;RNF157
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.2748200604033496,-0.6050178864276406,0.9450867052023122,0.9933818775884459,1.0,7/10,41.81%,FGR;LILRB1;BAG6;KIT;BTLA;CD40;CD24
prerank,cell junction maintenance (GO:0034331),0.3036744993003806,0.6048728177346924,0.9217638691322901,0.9793157631184183,1.0,1/14,7.27%,DCTN1
prerank,lysine catabolic process (GO:0006554),0.31011852618422325,0.6047456263190775,0.9028400597907325,0.9787325532746597,1.0,1/12,6.67%,ALDH7A1
prerank,lysine metabolic process (GO:0006553),0.31011852618422325,0.6047456263190775,0.9028400597907325,0.9787325532746597,1.0,1/12,6.67%,ALDH7A1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.30786653136903996,0.6039698634629309,0.9002890173410405,0.9789367940479867,1.0,3/12,12.98%,FADS1;ABCD1;HSD17B4
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.2873786627958809,0.6029275302313994,0.91343669250646,0.9793503570580299,1.0,8/21,18.97%,SPPL3;ERAP1;ADAM10;DAG1;ADAM19;PSEN1;SPPL2A;MYH9
prerank,regulation of histone deacetylation (GO:0031063),0.3037029114880843,0.6026766435380625,0.9050991501416431,0.9791871162487478,1.0,3/13,15.39%,CAMK2D;CTBP1;AKAP8L
prerank,carbohydrate derivative transport (GO:1901264),0.29256137431475204,0.602302886647303,0.9135135135135135,0.9791244599503209,1.0,3/18,14.14%,SLC15A3;ABCG1;SLC15A4
prerank,regulation of myotube differentiation (GO:0010830),0.27899509552591406,0.6022995010853665,0.9302615193026152,0.9787929636528356,1.0,4/24,15.51%,HDAC9;HDAC5;MAPK14;TMEM119
prerank,endothelial tube morphogenesis (GO:0061154),-0.2658832570427709,-0.6010295861579735,0.9245810055865922,0.9939219587590229,1.0,1/10,0.80%,RHOA
prerank,response to hydrogen peroxide (GO:0042542),0.2557943957389443,0.6010271524804145,0.9411764705882353,0.9793716087370813,1.0,6/45,15.64%,RELA;IMPACT;SETX;ABL1;FYN;STK24
prerank,negative regulation of axon extension (GO:0030517),0.271564811288934,0.6003747603548908,0.9296116504854369,0.9794825103757868,1.0,5/30,13.32%,SEMA6D;DIP2B;SEMA3D;SEMA6A;RTN4
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.2957795484830473,0.5991885587297114,0.9127324749642346,0.9799563573582577,1.0,2/15,13.18%,ACVR1;ACVR1B
prerank,C-terminal protein amino acid modification (GO:0018410),-0.25991663093931855,-0.5975356364591309,0.9348534201954397,0.9942853277255401,1.0,2/11,3.44%,AGTPBP1;ATG5
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.21353670678945175,-0.5972309577753818,0.952755905511811,0.9929627293840115,1.0,12/19,41.75%,XDH;MYO1C;ADAMTS3;CADM4;CCBE1;DCN;DAB2IP;PIK3CB;ROBO1;TSPAN12;JCAD;SMOC2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.2975125828596275,0.5970060431756864,0.9104046242774566,0.9811549791301163,1.0,1/14,3.95%,CSTF2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.21750112406567648,-0.5967923056805283,0.9637096774193549,0.9917059594869979,1.0,14/18,58.98%,AQP4;OFD1;SPEF2;NPHP3;CCDC39;NEK10;CCDC40;CABYR;ODAD4;CFAP53;ADCY10;SPAG17;DNAAF2;SPA17
prerank,protein kinase B signaling (GO:0043491),0.2768290212476665,0.5963516542995161,0.9250936329588015,0.9812703818112027,1.0,4/23,14.70%,GAS6;SETX;ZFP36L1;PTEN
prerank,regulation of NMDA receptor activity (GO:2000310),0.2645773195283169,0.5959580297787566,0.9419953596287703,0.9812047289197565,1.0,7/32,16.27%,EPHB2;DLG1;DAPK1;GRIA4;RELN;GRIN2A;MEF2C
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.24854672566107522,-0.595688843379091,0.94375,0.9907892007820429,1.0,5/12,28.91%,RAB10;SCRIB;ZDHHC7;TRAF3IP1;LAMA3
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.24617333771584554,0.5950112742562406,0.9600840336134454,0.9815256532325984,1.0,9/73,13.90%,BRAF;GAS6;AKAP9;HSP90AA1;FNIP1;CNOT9;CD44;RAF1;PRKD2
prerank,regulation of isotype switching (GO:0045191),0.29843182305394617,0.5937994971154226,0.926490984743412,0.9820011280333952,1.0,3/14,14.14%,KMT5B;KMT5C;SLC15A4
prerank,negative regulation of hemostasis (GO:1900047),-0.2515256337174119,-0.5937890673612267,0.9337349397590361,0.9903219214257869,1.0,3/12,20.98%,SERPINE2;CD34;TFPI
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.2906600737177786,0.5935296586968509,0.9096045197740112,0.981857413767957,1.0,2/15,12.18%,CSTF2;ERN1
prerank,response to peptide (GO:1901652),0.2660171190677709,0.5927915574390675,0.9407496977025392,0.9820067894446461,1.0,8/33,18.75%,IRS1;CACNA1A;PRNP;FYN;STAT2;STAT6;ERBIN;KAT7
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.27556305531839664,0.5926164833602572,0.90234375,0.9817926405618597,1.0,3/22,11.84%,DUSP16;DUSP10;PPM1A
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.3055260259873179,0.5924456367108472,0.928462709284627,0.9815661336977727,1.0,1/11,4.64%,NRP1
prerank,striated muscle cell differentiation (GO:0051146),0.2924333910889867,0.5922237943311071,0.9191780821917809,0.9813675571735515,1.0,3/16,16.27%,AKAP13;MYEF2;MEF2C
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.2990677853301783,0.5916861470279788,0.9172510518934082,0.9813714670286776,1.0,1/13,3.95%,CSTF2
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.26182303528969103,0.5913819117254829,0.9395734597156398,0.981227912569972,1.0,5/32,14.29%,SMPD1;SPPL3;MTOR;PPP1R16B;CALM1
prerank,response to estradiol (GO:0032355),0.26518030300588413,0.5904990324052182,0.9375736160188457,0.9814600950072833,1.0,3/31,13.20%,ESR1;NCOA3;LCOR
prerank,glycolipid biosynthetic process (GO:0009247),0.25382415123429236,0.5898854395345426,0.9419795221843004,0.9815145924954158,1.0,7/38,17.11%,ST8SIA5;PIGP;PIGU;PIGQ;LARGE1;ST3GAL5;ST3GAL2
prerank,dendritic cell chemotaxis (GO:0002407),0.28399916430143274,0.5889527741471238,0.9097421203438395,0.981781528237265,1.0,2/14,12.01%,TRPM4;HMGB1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.3015381567042436,0.5885347975236955,0.9181286549707602,0.9817156449745793,1.0,2/12,13.03%,CD44;BCL2
prerank,regulation of interleukin-10 production (GO:0032653),0.2540695674101876,0.5883151992907661,0.9483726150392817,0.9815133325458039,1.0,7/44,17.19%,PRKCZ;HMGB1;SYK;LGALS9;TLR4;CD47;PIBF1
prerank,carnitine shuttle (GO:0006853),0.30272572304237805,0.5869295155959944,0.9240121580547113,0.9820632403129685,1.0,2/11,14.13%,SLC25A20;ACACA
prerank,innate immune response in mucosa (GO:0002227),0.3108790461287363,0.5867902750896459,0.919431279620853,0.9818204481779965,1.0,1/10,12.02%,RNASE3
prerank,secretory granule organization (GO:0033363),0.31064895347529664,0.5863509284010531,0.9171875,0.9817726344759855,1.0,2/10,12.85%,DTNBP1;ABCA1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.2923508668504313,0.5855557807707211,0.9203910614525139,0.9819362048596261,1.0,2/14,12.18%,CSTF2;ERN1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.28025214915601815,0.5853002646328614,0.9392265193370166,0.9817659732552716,1.0,2/17,11.09%,NRP1;MIA3
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.30628808104775496,0.584994622851346,0.9173913043478261,0.9816252394131,1.0,1/12,8.68%,IL18
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.2361665286224937,0.5842002581319455,0.9680082559339526,0.9818021704974894,1.0,16/87,16.60%,RHOF;IQGAP2;EZR;TWF2;EPHA5;EPS8;TAOK1;ARHGAP35;NOTCH2;MTOR;ABL1;ROCK2;ARHGDIB;IQGAP1;PAK1;ARHGAP17
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.26773254899524324,0.5839708409687641,0.9351969504447268,0.9816124666649604,1.0,1/24,3.74%,GAS6
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.3001255492780913,0.5837614042952901,0.9342657342657342,0.9814028621644805,1.0,12/12,70.01%,TLR4;MUC4;MUC13;MUC2;VSIG1;MUC6;INAVA;TLR9;SOX9;RBP4;NOD2;STRAP
prerank,lipid droplet formation (GO:0140042),0.3098213795509528,0.5831978707938469,0.9301242236024845,0.9814257254816071,1.0,2/10,17.24%,CDS1;CDS2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.2574195028914782,-0.5820180989871021,0.9327731092436975,0.9943508651830538,1.0,4/10,32.84%,ZBTB16;BMPR1B;ACVRL1;PKDCC
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.300064609129511,0.5815251135761951,0.9310872894333844,0.9821232303616835,1.0,2/11,13.79%,UBQLN1;FYN
prerank,negative regulation of protein secretion (GO:0050709),0.25389721157482126,0.5809146497054034,0.9430232558139535,0.9821641187077692,1.0,2/38,4.54%,PSMD9;IRS1
prerank,cellular response to fluid shear stress (GO:0071498),0.2966613057198283,0.5796459906008052,0.925531914893617,0.9826188115493527,1.0,4/12,18.62%,MAP2K5;PKD2;MEF2C;NFE2L2
prerank,dicarboxylic acid transport (GO:0006835),-0.1878539328008696,-0.5794946556332371,0.9945054945054945,0.9939097162390297,1.0,2/28,3.26%,SLC1A2;SLC25A13
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.2783121048193056,0.5789108917163374,0.9422336328626444,0.9827443119892803,1.0,1/18,3.10%,CACNG7
prerank,regulation of wound healing (GO:0061041),0.2466099891884525,0.5779661184852828,0.9624309392265193,0.9829758729814431,1.0,3/42,8.47%,EPHB2;ARFGEF1;ALOX5
prerank,chromatin assembly or disassembly (GO:0006333),0.29503803112219107,0.577637637942157,0.9234234234234234,0.9828438185079458,1.0,2/11,12.92%,NOC2L;TP53
prerank,regulation of cholesterol esterification (GO:0010872),0.2988248205232744,0.5772351178077202,0.9151234567901234,0.982745948185179,1.0,1/10,9.50%,ABCG1
prerank,protein oxidation (GO:0018158),0.30146161627187845,0.5755700871523038,0.92,0.9834065903115857,1.0,1/11,10.27%,LOXL3
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.29580762628148743,0.5753641416960185,0.93026706231454,0.9831950225590493,1.0,1/12,4.17%,EPHB2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.2468669271730927,0.574421219215452,0.953970080552359,0.9834188167938369,1.0,4/38,12.65%,NDUFS1;NDUFA9;NDUFV2;NDUFA10
prerank,peptidyl-proline modification (GO:0018208),0.26179385371757274,0.5742705915091963,0.9440914866581956,0.983161988479975,1.0,2/25,7.02%,PPID;PPIL2
prerank,regulation of smooth muscle contraction (GO:0006940),-0.2085888702268101,-0.5742533696911694,0.9737827715355806,0.9946403702879695,1.0,3/20,12.55%,CHRM3;ZDHHC21;PLCE1
prerank,regulation of dopamine secretion (GO:0014059),0.2600179754082604,0.5740869322785072,0.9406565656565656,0.9829318068426713,1.0,3/25,9.40%,SYT12;SYT11;DTNBP1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.2795757271645181,0.5732496729550749,0.9305740987983978,0.9830922229909349,1.0,2/16,12.68%,CTDNEP1;SLC27A1
prerank,mucosal immune response (GO:0002385),0.2813330513461046,0.5729766935329593,0.9405099150141643,0.9829247519771667,1.0,1/15,12.02%,RNASE3
prerank,positive regulation of leukocyte activation (GO:0002696),0.27268545355094115,0.5710207015215344,0.9366754617414248,0.9837493308653151,1.0,1/18,4.55%,THBS1
prerank,metanephros development (GO:0001656),0.25795233720931027,0.5705790452439454,0.945054945054945,0.9836840707947699,1.0,1/26,4.01%,NF1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.29302797312769746,0.5701219480315644,0.9327485380116959,0.9836106168755332,1.0,1/12,3.17%,TCP1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.28163311245980027,0.569483761580653,0.9398907103825137,0.9836586776563582,1.0,1/15,3.17%,TCP1
prerank,regulation of immune response (GO:0050776),0.23056394934634755,0.5680922393497804,0.9919678714859438,0.9840956763763088,1.0,14/135,14.06%,IRF1;RAET1E;TGFB2;BCL6;BIRC3;ITGA4;LAIR1;LRP8;LYN;SLAMF6;COLEC12;ERAP1;SYK;RNF135
prerank,growth hormone receptor signaling pathway (GO:0060396),0.28413029698036535,0.5670259360293416,0.9412587412587412,0.984346534189863,1.0,5/14,16.72%,PTPN1;LYN;PXN;PIK3R1;STAT6
prerank,myelin assembly (GO:0032288),0.296951987683143,0.5666949907429575,0.9410876132930514,0.9842143416896265,1.0,2/10,12.11%,TENM4;EPB41L3
prerank,regulation of spindle organization (GO:0090224),-0.20699077454773793,-0.56561048833553,0.991701244813278,0.9965907128948281,1.0,12/18,42.33%,GNAI1;RNF4;DYNC1H1;RAE1;GPSM2;BORA;SENP6;MAP9;TACC3;PARP3;NUMA1;TPX2
prerank,positive regulation of establishment of protein localization (GO:1904951),0.26855470922333546,0.5652956731603563,0.9474375821287779,0.9846613367472801,1.0,5/18,17.88%,TCP1;PTP4A3;CCT3;CEP295;TREM2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.15208307202522187,-0.5652657572496063,1.0,0.9952396248543163,1.0,7/53,22.27%,CHRM3;CNR2;OPRM1;HTR4;HTR1F;HTR7;HTR2B
prerank,inhibitory synapse assembly (GO:1904862),-0.23736129202801032,-0.5644114522958402,0.961764705882353,0.9940718240127813,1.0,5/11,34.95%,GABRA2;LGI2;GABRB3;GABRA1;FGF13
prerank,regulation of T cell chemotaxis (GO:0010819),0.2887403889220929,0.5634072555447188,0.9200603318250377,0.9853450746316083,1.0,10/11,54.71%,ADAM10;CXCL13;XCL1;WNK1;CXCL10;STK39;OXSR1;CCL5;WNT5A;ADAM17
prerank,negative regulation of biomineral tissue development (GO:0070168),0.26738266657754906,0.5634017829429275,0.9377382465057179,0.9850178363498654,1.0,3/21,14.30%,GAS6;TRPM4;ROCK2
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.2994950879686047,0.5603938024538926,0.9408284023668639,0.9863161411364838,1.0,3/10,19.22%,WDR1;PLEK;SEMA5A
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.2931873842076034,0.5602968991380146,0.9213313161875946,0.9860404694283356,1.0,2/11,17.61%,LRP6;CTNNB1
prerank,ncRNA export from nucleus (GO:0097064),0.24432812201923398,0.5597801826911853,0.9660818713450292,0.9859784454440461,1.0,4/36,8.68%,PHAX;NUP205;NUP98;NUP54
prerank,positive regulation of cell killing (GO:0031343),0.2819900363388922,0.5588067875150282,0.9323529411764706,0.9861360101334693,1.0,2/13,13.36%,MAPK8;SYK
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.24867246781454733,0.5579411387054066,0.9463414634146341,0.9862524462423654,1.0,2/27,8.66%,SLC7A2;SLC7A8
prerank,blood vessel endothelial cell migration (GO:0043534),0.2567682788608464,0.5576993384233013,0.9664516129032258,0.9860472224683104,1.0,2/22,11.09%,NRP1;MIA3
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.29063858136043497,0.5573132943503797,0.9403202328966521,0.9859172947057874,1.0,4/11,19.17%,HTRA2;LGALS9;GSN;CAAP1
prerank,regulation of cell projection organization (GO:0031344),0.2836757986068942,0.5565332095866021,0.9377652050919377,0.9859879239540308,1.0,4/13,17.88%,MYO9A;ERMN;MACF1;TREM2
prerank,nucleoside salvage (GO:0043174),0.2986430471966668,0.5556799298303791,0.945054945054945,0.9861039124914587,1.0,1/10,6.83%,HPRT1
prerank,regulation of TOR signaling (GO:0032006),0.22822167230936463,0.5551841412450749,0.9827586206896551,0.9860310911487877,1.0,9/67,14.87%,GAS6;MIOS;EPM2A;FBXO9;GOLPH3;FNIP1;SLC38A9;LARS1;TSC1
prerank,negative regulation of lyase activity (GO:0051350),-0.2078752306083142,-0.5551236121762272,0.9695945945945946,0.9957729421014332,1.0,6/16,34.06%,GRM3;CCR2;EDNRB;MTRR;PALM;ADGRV1
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.2079204083574175,-0.5546588433413464,0.98,0.9944493818750766,1.0,1/17,1.09%,KLF7
prerank,response to prostaglandin E (GO:0034695),0.2931932620721492,0.5541609824233876,0.9274924471299094,0.9862217049390832,1.0,2/10,14.41%,GNG2;GNB1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.26339178614725617,0.5516841134084101,0.9621109607577808,0.9870909014240625,1.0,4/18,18.82%,CAMK2D;BIN1;CAB39;SLC43A2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.28499681439907437,0.5509133091378567,0.9446935724962631,0.987138859555663,1.0,1/11,10.96%,NFKBIZ
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.29672771925440705,0.5502876707605525,0.9374090247452693,0.9871288441255863,1.0,2/10,13.49%,FURIN;FN1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.2600203554658443,0.5502523082309678,0.948509485094851,0.9868166176194898,1.0,3/18,16.34%,NF1;TP53;FTH1
prerank,regulation of actin nucleation (GO:0051125),0.2864124896003941,0.549858779790739,0.9429429429429429,0.9866854607980815,1.0,3/12,17.39%,ARF1;WASHC5;GSN
prerank,positive regulation of cation channel activity (GO:2001259),0.23805795420306552,0.5489180471002467,0.9754385964912281,0.9868155486703981,1.0,5/40,14.29%,EPHB2;TMSB4X;PKD2;RELN;CALM1
prerank,negative regulation of endocytosis (GO:0045806),0.24992781273266068,0.5486532587561885,0.967459324155194,0.9866116386364346,1.0,3/24,11.81%,SYT11;ABCA7;SCAMP5
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.24025871734361146,0.5485893089067859,0.9515738498789347,0.9863132707775782,1.0,2/29,8.02%,PLA2G6;PLA2G4A
prerank,positive regulation of macrophage activation (GO:0043032),0.26790658291323943,0.5479540002397141,0.9513157894736842,0.9863140949826145,1.0,1/17,4.55%,THBS1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.27780580774262303,0.5473938845435475,0.95,0.9862469109440413,1.0,5/14,17.98%,ABCA7;ABCG1;ADAM10;ADAM19;PSEN1
prerank,glycine transport (GO:0015816),0.2823457220432116,0.5472872032510346,0.9353846153846154,0.9859690179238904,1.0,1/10,8.66%,SLC7A8
prerank,positive regulation of dendritic spine development (GO:0060999),0.25429368542396164,0.5472401737456802,0.956989247311828,0.9856614063193309,1.0,6/20,17.98%,LRP8;DBNL;RELN;CAPRIN1;CAMK1;PSEN1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.2724465263597786,0.5463347165224619,0.9542203147353362,0.9857616383847301,1.0,1/14,5.29%,NT5C3A
prerank,bile acid biosynthetic process (GO:0006699),0.25345971605577455,0.546139663581017,0.9593908629441624,0.9855317259272105,1.0,4/24,16.25%,OSBP;HSD17B4;OSBPL1A;OSBPL2
prerank,negative regulation of neuron projection development (GO:0010977),0.2277319932174171,0.5459068846871762,0.9691969196919692,0.9853135083831279,1.0,10/56,15.59%,STMN2;GDI1;MYLIP;BCL11A;RUFY3;RTN4;PTPRO;PTEN;PTPN9;HDAC2
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.21469997635881877,-0.5434962475619328,0.9817518248175182,0.9964626507926007,1.0,2/15,10.85%,PTPN12;RHBDF2
prerank,anion transmembrane transport (GO:0098656),0.22469463395617065,0.5404561717169359,0.9722222222222222,0.9875015028907942,1.0,9/67,17.27%,SLC7A2;ABCC5;LRRC8B;SLC7A8;SLC27A1;SLC25A1;ARL6IP5;SLC35A3;ABCC1
prerank,negative regulation of developmental growth (GO:0048640),0.23888610927425974,0.540062997897183,0.9657282741738066,0.9873540181694571,1.0,5/30,14.70%,DUSP10;DIP2B;ULK2;RTN4;PTEN
prerank,apoptotic cell clearance (GO:0043277),0.24329499184549577,0.5398572810419711,0.9684466019417476,0.9871194736028887,1.0,2/30,4.55%,GAS6;THBS1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.28158900431599365,0.5395771589244908,0.9214175654853621,0.9869216991828337,1.0,9/10,54.71%,ADAM10;CXCL13;XCL1;WNK1;STK39;OXSR1;CCL5;WNT5A;ADAM17
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.2622885567077715,0.539287186446122,0.9550561797752809,0.9867240559999519,1.0,2/16,13.50%,TERF2;NUS1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.28731930551269436,0.5372052128285234,0.9395770392749244,0.9872939210983935,1.0,2/10,9.65%,PTPN1;LYN
prerank,regulation of neutrophil migration (GO:1902622),0.2852911754101795,0.5371641252992417,0.9470404984423676,0.9869821485372005,1.0,1/10,6.01%,MPP1
prerank,protein localization to condensed chromosome (GO:1903083),0.28013259737450846,0.5368595788818334,0.9627976190476191,0.986787051860528,1.0,1/12,7.07%,BUB3
prerank,oxoacid metabolic process (GO:0043436),0.23831715881279109,0.5362997673592446,0.9628297362110312,0.9867010689443377,1.0,3/27,15.81%,LIAS;MINPP1;TPST2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.25583547522549904,0.5360145664553269,0.9536423841059603,0.9865021344293157,1.0,2/20,10.90%,EP300;GTF2B
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.20209052072897096,-0.5353352921224548,0.9744525547445255,0.9973466910101879,1.0,9/15,43.57%,APPL1;CARD9;STAT3;MYD88;TICAM1;NOD2;GBP5;TNF;TLR6
prerank,photoperiodism (GO:0009648),0.24350596132952043,0.5348965219817218,0.9679012345679012,0.9866720099301614,1.0,3/28,12.92%,CLOCK;CRTC1;TP53
prerank,acylglycerol metabolic process (GO:0006639),0.227989520424545,0.5332224961721777,0.9762470308788599,0.9870148929597737,1.0,7/37,17.83%,ABHD6;DGKI;DGKD;GK;DGKZ;ABHD12;DGKH
prerank,positive regulation of myelination (GO:0031643),-0.23414101715052357,-0.5321294590469243,0.9647058823529412,0.996715548328817,1.0,6/11,32.57%,RNF10;ITGAX;TPPP;MYRF;DICER1;CST7
prerank,neuromuscular synaptic transmission (GO:0007274),0.25509424395893954,0.5309722385672873,0.962707182320442,0.9875904400881517,1.0,3/18,16.38%,TBC1D24;KIF1B;ERC2
prerank,sulfur compound catabolic process (GO:0044273),0.22873482958855862,0.5289711182662314,0.9800235017626322,0.9880730214863459,1.0,3/38,9.84%,ACAT1;ARSB;BGN
prerank,pre-replicative complex assembly (GO:0036388),0.21790581822844035,0.5250144018603264,0.990301724137931,0.9892629528087938,1.0,7/64,12.95%,PSMD9;ORC4;PSMB8;PSMC5;ORC2;PSMD12;PSMA2
prerank,gluconeogenesis (GO:0006094),0.22716483556384337,0.523010508069612,0.9685314685314685,0.9896852309418435,1.0,3/39,9.86%,PGAM1;ALDOA;ENO1
prerank,electron transport chain (GO:0022900),0.2550897047001248,0.5200107044266912,0.9746478873239437,0.9904542481154922,1.0,3/15,13.52%,SDHA;ENOX2;ETFA
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.19313932573267104,-0.5167967500363472,0.98828125,0.9989050414929272,1.0,11/17,45.25%,BCL2L1;SOD2;BAX;BID;FIS1;CLU;BBC3;BAD;GGCT;BAK1;TIMM50
prerank,protein hydroxylation (GO:0018126),0.2526356987096247,0.5144697546401397,0.9654218533886584,0.9920886661137668,1.0,2/15,12.45%,EGLN3;VIPAS39
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.23778560624882064,0.5140215288225348,0.9724770642201835,0.9918922544008624,1.0,3/22,12.92%,ESR1;PSMC5;TP53
prerank,oligodendrocyte development (GO:0014003),-0.19672174023939665,-0.5131675062786494,0.9831649831649831,0.9982008798000512,1.0,9/15,39.84%,EIF2B3;TPPP;MYRF;EIF2B5;EIF2B4;NSUN5;EIF2B2;SOX10;CNTNAP1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.2701094062682851,0.5128313748185571,0.9608763693270735,0.9919859918525717,1.0,2/10,12.90%,MAP2K5;SH2B3
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.26237512441758715,0.5107595070212897,0.9654654654654654,0.9923257655076739,1.0,1/11,8.83%,DAB2
prerank,histone H3-K36 demethylation (GO:0070544),0.2706762144124091,0.5104038717667078,0.9609984399375975,0.9921109344542917,1.0,2/10,11.95%,KDM4B;KDM4C
prerank,xenobiotic transport (GO:0042908),0.24510526174976605,0.5100126963377732,0.9803370786516854,0.9919231969722365,1.0,3/17,17.27%,ABCC5;ABCG2;ABCC1
prerank,thymus development (GO:0048538),0.25532048465063706,0.50851410971191,0.9560761346998536,0.9920525000417434,1.0,13/13,74.49%,TGFBR1;ZBTB1;SIX1;AIRE;TBX1;RIPK3;FADD;SHH;HES1;EPHB3;FGF10;FOXE1;SOD1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.1987034172909819,-0.5059323626274495,0.9822064056939501,0.9981175252853196,1.0,6/15,31.68%,GOT2;GGT5;GGACT;HOGA1;GGT7;CHAC2
prerank,protein O-linked mannosylation (GO:0035269),0.24247604592641903,0.5055068684374706,0.9731903485254692,0.9926564313107824,1.0,2/18,10.73%,POMT2;FKTN
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.24515325854183934,0.504713114337453,0.9755766621438263,0.992569669245096,1.0,4/17,18.62%,UBQLN1;HTRA2;TREM2;NFE2L2
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.24572512055620738,0.49876479487723546,0.9781121751025992,0.9940252713325504,1.0,3/17,16.57%,BUB3;CTCF;RB1
prerank,negative regulation of myotube differentiation (GO:0010832),0.25297187334646265,0.4971889159391864,0.9578947368421052,0.9941530392562581,1.0,1/12,6.16%,HDAC5
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.24481454514361095,0.49150074436175595,0.9705882352941176,0.9954363555743629,1.0,2/15,14.36%,PPARG;PPARD
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.22406097704149752,0.48948838429931735,0.9826302729528535,0.995632480152624,1.0,3/26,14.77%,ACER3;ASAH1;SPTLC1
prerank,steroid metabolic process (GO:0008202),0.2007560529692336,0.48930997528129105,0.9936575052854123,0.9953499950365584,1.0,2/72,6.93%,GBA2;LIPA
prerank,embryonic eye morphogenesis (GO:0048048),-0.20544171422278357,-0.48695333867236296,0.9910714285714286,0.9996922418429145,1.0,5/11,38.75%,FBN2;FBN1;RARG;EFEMP1;KDM2B
prerank,regulation of cholesterol transport (GO:0032374),0.22610385023564514,0.4829603958532168,0.9841688654353562,0.996575556232635,1.0,3/20,14.68%,TTC39B;NUS1;ABCA5
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.23301720151644767,0.4804508048222292,0.9874125874125874,0.9968295405005737,1.0,1/16,7.85%,ERCC4
prerank,positive regulation of phosphatase activity (GO:0010922),-0.1633231519790103,-0.4803102684053819,1.0,0.9991318736759293,1.0,1/21,1.34%,CALM2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.19647403997625068,-0.4797752379785888,0.9968454258675079,0.9977393048763671,1.0,5/13,34.06%,GRM3;CCR2;EDNRB;PALM;ADGRV1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.22059632878542315,0.47879518589317777,0.9827160493827161,0.9968500599329796,1.0,1/27,4.83%,GPR65
prerank,skin development (GO:0043588),0.19758435527461726,0.4785516270983294,0.9989247311827957,0.9965766064204824,1.0,2/65,5.05%,ITGA6;ATP7A
prerank,negative regulation of protein transport (GO:0051224),0.22027911113646903,0.47648767702077244,0.9899497487437185,0.9966907887695348,1.0,3/25,13.37%,SNX3;ERP29;NDFIP1
prerank,acyl-CoA metabolic process (GO:0006637),0.20989990194380195,0.47545950627037925,0.9859649122807017,0.9965919490056291,1.0,4/35,15.79%,ACOT9;ACOT13;ACACA;SUCLG2
prerank,negative regulation of cyclase activity (GO:0031280),-0.18798542526934003,-0.47515024132120487,0.984375,0.9968858682577836,1.0,5/14,34.06%,GRM3;CCR2;EDNRB;PALM;ADGRV1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.2491633042923028,0.4748978003414109,0.9790419161676647,0.9963852269127916,1.0,4/11,18.73%,LYN;MFHAS1;TREM2;PJA2
prerank,positive regulation of lymphocyte activation (GO:0051251),0.21356909525048196,0.469577090984248,0.9889162561576355,0.997176992086346,1.0,5/28,17.29%,PRKDC;CYRIB;CD47;SH3KBP1;NCKAP1L
prerank,lymphocyte mediated immunity (GO:0002449),0.2322520559342014,0.46852851442545873,0.9836552748885586,0.9970452581635136,1.0,1/12,8.96%,MYO1G
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.2352387177124788,0.468500923456039,0.975867269984917,0.996724386459324,1.0,1/12,9.06%,CHEK2
prerank,T cell differentiation (GO:0030217),0.2039961066829625,0.4673377128730119,0.9908151549942594,0.9966427724756723,1.0,3/40,12.05%,SOX13;CHD7;ZFP36L1
prerank,hexose metabolic process (GO:0019318),0.1987512118575799,0.46159635026057183,0.9952662721893492,0.9973845507421186,1.0,4/39,14.36%,ALDOA;IRS2;FUCA1;PPARD
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.21121349262476777,0.4614084088659528,0.9910371318822023,0.9970923225841378,1.0,7/24,18.62%,ATF6;TP53;RBPJ;CHD6;GCN1;HSPA5;NFE2L2
prerank,cellular response to interleukin-4 (GO:0071353),0.24045945267386395,0.4599509663640875,0.9801526717557252,0.9970143474797176,1.0,10/10,75.97%,STAT6;XCL1;RUFY4;DCSTAMP;GATA3;TCF7;LEF1;SHPK;JAK3;XBP1
prerank,protein localization to kinetochore (GO:0034501),0.23133447790692432,0.45828650042686686,0.9929178470254958,0.9969808935543301,1.0,1/14,7.07%,BUB3
prerank,negative regulation of vascular permeability (GO:0043116),0.2370148168664645,0.4580377213062378,0.9785604900459418,0.9966954351534253,1.0,1/12,5.98%,PTPRJ
prerank,negative regulation of wound healing (GO:0061045),0.2039692295250518,0.45504625710532415,0.9975728155339806,0.9968699444694669,1.0,4/28,15.10%,ALOX5;PROC;PTEN;CLASP1
prerank,tRNA 5'-leader removal (GO:0001682),0.22646249232169308,0.4529804005451117,0.9896907216494846,0.9968609550574556,1.0,1/13,7.51%,POP1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.22217040895474854,0.4471217965824222,0.9889042995839112,0.9974226487902159,1.0,2/17,14.18%,AHI1;RFX3
prerank,regulation of protein acetylation (GO:1901983),0.23213706879487853,0.4467502076417931,0.9884057971014493,0.9971420925907639,1.0,4/12,18.25%,TAOK1;CEP295;CAMK1;DDX3X
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.22565444907042417,0.43866909727455644,0.9938650306748467,0.9978781896810316,1.0,1/12,9.66%,CD44
prerank,organic cation transport (GO:0015695),0.2041630802092117,0.4359673983644516,0.9961190168175937,0.9978942361463181,1.0,4/20,18.87%,SLC25A26;SLC44A1;RALBP1;SLC44A2
prerank,modified amino acid transport (GO:0072337),-0.16105159155246201,-0.4295885212526139,1.0,0.9992699500982908,1.0,9/15,51.01%,CTNS;SLC6A8;SLC1A4;MGST1;PDPN;SLC46A1;SLC5A6;SLC19A1;SLC16A12
prerank,heme biosynthetic process (GO:0006783),0.19746077344785096,0.42550071528237887,0.9947712418300654,0.9987139796561862,1.0,3/22,15.52%,FECH;FLVCR1;ABCG2
prerank,vasoconstriction (GO:0042310),0.22277320946582138,0.4242386221148615,0.9910313901345291,0.9985113791287125,1.0,11/11,77.74%,PIK3C2A;EDN1;EDN2;CRP;EDN3;KEL;ACTA2;SLC8A1;EDNRA;EDNRB;HTR2B
prerank,tRNA 5'-end processing (GO:0099116),0.20617937974636769,0.4240887378739176,0.9957203994293866,0.9982012642748751,1.0,1/15,7.51%,POP1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.1692909573220486,-0.40308212959374073,0.9968652037617555,0.9989396350322234,1.0,1/12,4.52%,MAD1L1
prerank,positive regulation of protein sumoylation (GO:0033235),0.2095533537012461,0.39021233117922305,0.9888535031847133,1.0,1.0,3/10,16.92%,PIAS1;UBA2;SAE1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.18163514893097793,0.3726815665442289,0.9986754966887417,1.0,1.0,2/18,13.03%,BNIP3;BCL2
prerank,toxin transport (GO:1901998),0.19763980825544583,0.3704152285067643,0.9954337899543378,1.0,1.0,1/10,12.66%,ADAM10
prerank,vitamin D metabolic process (GO:0042359),0.18318789628978607,0.3612001268510768,0.9970457902511078,1.0,1.0,13/13,81.70%,LGMN;CYP27B1;GC;CYP11A1;CYP24A1;VDR;FGF23;UGT1A4;CUBN;LRP2;CYP1A1;CYP2R1;PIAS4
prerank,negative regulation of reproductive process (GO:2000242),0.1733797671487202,0.347357425124179,1.0,1.0,1.0,2/17,14.97%,PAEP;ARHGDIB
prerank,negative regulation of immune system process (GO:0002683),0.17267420977761588,0.3411506671014935,1.0,1.0,1.0,1/16,9.65%,LYN
prerank,skeletal muscle contraction (GO:0003009),0.16266481318447318,0.3383479005821725,0.9986684420772304,1.0,1.0,18/19,62.44%,RCSD1;TCAP;MYH8;MYH3;JSRP1;CHRNA1;TNNC2;TNNT1;MYH7;TNNI3;TNNC1;CCDC78;TNNT3;TNNI2;STAC3;TNNI1;MYH14;STAC2
prerank,protein polyglutamylation (GO:0018095),0.17528158178863557,0.33740785921854416,0.9954819277108434,0.9998969469512832,1.0,1/11,11.18%,TTLL4
prerank,dopaminergic neuron differentiation (GO:0071542),0.14492889097878014,0.30266996930004364,1.0,0.9999192522559524,1.0,2/19,17.61%,LRP6;CTNNB1
